data_3msp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3msp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.527 0.167 0 CA-C-O 120.683 0.201 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.13 97.02 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.621 2.214 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.56 131.46 26.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -57.74 109.03 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.1 pt -68.72 123.37 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.74 145.37 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.51 136.24 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.241 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' B' ' 22' ' ' PRO . 14.7 mt-30 -140.85 105.57 6.28 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.66 161.48 40.68 Favored 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.506 0.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.3 t -92.36 -26.07 18.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.71 49.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.53 107.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 tt -129.7 120.1 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 46.0 t -109.27 92.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.564 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 20.9 m-85 -52.74 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -67.18 141.41 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.431 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -49.13 169.42 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.821 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.479 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 66.3 Cg_endo -91.1 166.97 28.8 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.371 -1.096 . . . . 0.0 112.974 0.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -108.87 31.1 5.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.755 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.37 3.61 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.399 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -164.31 151.49 11.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.821 0.343 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.65 109.11 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.49 110.46 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.0 m -93.43 110.85 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 19' ' ' PHE . 79.6 m-85 -89.02 121.8 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -77.9 131.43 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.435 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 31' ' ' ILE . 16.0 mt -113.89 151.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -112.93 121.76 45.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 111.482 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.3 mt -125.45 150.19 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.505 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.81 145.37 27.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.42 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.13 106.69 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.279 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.51 20.68 5.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.422 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.12 -170.8 24.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.18 -28.72 8.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.74 178.3 5.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -64.81 170.64 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 12.2 pt -152.98 136.18 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.655 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.84 112.2 4.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.511 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 93' ' ' TRP . 37.6 p-90 -117.17 156.98 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.221 0.534 . . . . 0.0 111.811 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.99 153.35 40.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.286 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 mm -115.46 151.27 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.578 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -147.5 130.51 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.531 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.3 p -120.41 154.7 34.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 p -52.0 -30.27 24.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -139.07 117.8 12.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.69 17.11 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -108.74 -49.58 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -76.3 -50.51 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.52 148.41 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -136.53 107.35 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.89 118.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -142.17 136.46 14.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.93 132.77 28.11 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.575 -1.427 . . . . 0.0 112.05 -0.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.4 -45.57 9.13 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.404 2.069 . . . . 0.0 112.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 p -133.36 148.75 51.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.82 175.29 46.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 t -116.21 108.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mp -80.29 158.83 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.31 170.13 5.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.62 110.57 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.647 2.231 . . . . 0.0 112.259 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.66 37.0 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.29 142.28 31.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.219 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -102.57 143.16 32.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.78 148.5 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.49 143.82 32.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.31 156.34 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.649 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.79 113.95 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.294 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 29' ' ' TYR . 7.3 p -114.16 88.14 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.94 146.48 33.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.6 107.5 9.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.74 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 146.17 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.037 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 p -56.75 164.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -178.65 -173.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -116.15 109.52 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.97 16.94 13.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.457 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.47 -24.94 29.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.9 p -147.01 44.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.35 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.73 134.71 55.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.71 69.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -155.68 28.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -130.35 6.45 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.617 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.87 119.3 34.12 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.45 136.0 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.056 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 89' ' ' ILE . 7.8 mt -98.69 165.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.2 m -137.75 123.07 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.79 112.2 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.54 155.01 35.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.445 ' CH2' ' CG ' ' A' ' 116' ' ' ARG . 11.4 p90 -157.59 147.28 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.452 HG23 ' CE1' ' A' ' 109' ' ' PHE . 0.6 OUTLIER -141.25 134.12 28.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -52.52 125.2 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.7 p -66.6 151.63 96.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.7 165.05 28.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.536 2.158 . . . . 0.0 112.148 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.93 117.44 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.43 51.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.234 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.43 166.08 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 0.0 111.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.09 164.31 25.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.314 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.94 69.42 9.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.63 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.08 122.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.88 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.2 122.28 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -117.23 150.52 38.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.91 -19.02 45.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.41 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.83 -23.66 66.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 0.0 111.234 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.16 -13.95 43.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.452 ' CE1' HG23 ' A' ' 94' ' ' THR . 5.3 m-85 . . . . . 0 C--N 1.333 -0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 111.191 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.823 0.344 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.24 136.15 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.445 ' CG ' ' CH2' ' A' ' 93' ' ' TRP . 12.4 tpt180 -99.4 152.86 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.92 137.71 9.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.07 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -145.21 132.23 20.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -91.56 133.86 35.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.82 117.8 61.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.668 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.37 128.7 19.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.354 2.036 . . . . 0.0 112.359 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.5 mm -92.54 148.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.225 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.21 160.2 40.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.657 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -132.15 110.74 10.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.207 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.43 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 2.8 t30 -99.29 132.24 44.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.633 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.941 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.718 0.216 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.13 97.18 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.54 2.16 . . . . 0.0 112.308 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 131.72 27.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -57.91 108.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.1 pt -68.7 123.46 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 145.19 55.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.657 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.34 136.07 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.234 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -140.66 105.64 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.78 161.57 41.2 Favored 'Cis proline' 0 C--N 1.35 0.658 0 C-N-CA 123.854 -1.311 . . . . 0.0 112.461 0.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.8 t -92.37 -26.06 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.112 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.67 49.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.68 106.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.58 120.12 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 45.9 t -109.27 92.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.573 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.471 ' HA ' ' CE2' ' B' ' 29' ' ' TYR . 21.0 m-85 -52.91 96.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.495 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -67.17 141.35 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.441 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -49.14 169.47 0.16 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.805 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 64.6 Cg_endo -91.13 166.82 28.77 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.948 0.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -108.83 31.23 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.719 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.55 3.71 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.429 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -164.38 151.27 11.37 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.5 109.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.4 110.49 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.9 m -93.45 110.72 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.047 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.471 ' CE2' ' HA ' ' B' ' 19' ' ' PHE . 79.6 m-85 -88.93 121.82 31.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -77.87 131.36 37.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.454 HD11 HG22 ' B' ' 31' ' ' ILE . 16.2 mt -113.77 152.03 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.486 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -113.08 121.53 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.524 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 39.2 mt -125.3 150.24 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.567 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 53.6 m -148.9 145.11 27.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.423 . . . . 0.0 111.437 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -88.89 106.66 18.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.265 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.43 20.34 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.4 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.93 -170.87 24.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.554 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.12 -28.54 9.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.93 178.21 5.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -64.72 170.7 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.438 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 12.1 pt -152.95 136.09 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.623 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.66 112.17 4.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -117.21 157.03 26.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.209 0.528 . . . . 0.0 111.861 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.05 153.48 40.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.257 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 mm -115.49 151.51 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -147.76 130.46 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.516 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 35.4 p -120.42 154.7 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.923 0.392 . . . . 0.0 111.12 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -52.07 -30.11 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -139.18 117.65 12.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.54 17.26 7.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.26 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -108.84 -49.63 3.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -76.25 -50.5 14.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.62 148.32 24.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.999 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -136.49 107.11 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.62 118.66 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.2 136.32 14.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.05 132.75 28.1 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.603 -1.416 . . . . 0.0 112.079 -0.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.54 -45.31 9.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.449 2.1 . . . . 0.0 112.191 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -133.48 148.56 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.766 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.64 175.23 46.33 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.526 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -116.17 108.35 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mp -80.13 158.81 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.21 170.11 6.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.7 110.33 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.637 2.225 . . . . 0.0 112.3 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.89 36.97 9.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.18 142.31 31.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.272 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -102.74 143.03 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.71 148.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.32 143.9 32.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.993 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.29 156.41 31.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.87 113.88 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.237 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.428 ' CG1' ' HB2' ' B' ' 29' ' ' TYR . 7.2 p -114.1 87.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.968 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.78 146.57 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.69 107.62 9.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.708 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.78 146.2 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -56.75 164.32 1.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -178.61 -173.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -116.3 109.31 17.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.93 17.16 12.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.492 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.68 -24.92 28.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.056 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 59.7 p -146.94 44.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.58 22.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.841 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -64.12 134.7 55.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.64 69.74 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -155.64 29.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -130.41 6.34 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.629 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.75 119.24 33.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.826 0.346 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.39 136.09 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.431 HD11 HG22 ' B' ' 89' ' ' ILE . 7.9 mt -98.82 165.53 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 58.7 m -137.81 122.84 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.51 112.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.52 154.81 36.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.833 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.446 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 11.4 p90 -157.42 147.14 20.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.449 HG23 ' CE1' ' B' ' 109' ' ' PHE . 0.6 OUTLIER -141.06 134.11 29.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -52.44 125.37 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 43.8 p -66.86 151.6 96.69 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.63 165.01 28.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.586 2.19 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.91 117.39 1.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.38 47.63 50.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.218 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.52 166.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 111.324 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.21 164.22 25.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.88 69.51 9.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.585 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.99 122.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.12 122.17 6.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -116.98 150.56 38.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -19.01 44.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.332 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.76 -23.73 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.773 0.321 . . . . 0.0 111.242 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.19 -13.85 42.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.449 ' CE1' HG23 ' B' ' 94' ' ' THR . 5.3 m-85 . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.772 0.32 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.16 136.12 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.446 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 12.4 tpt180 -99.38 152.79 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.78 137.8 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.796 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -91.44 133.78 35.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.71 117.72 62.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.656 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.37 128.76 19.94 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.389 2.06 . . . . 0.0 112.294 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 31.9 mm -92.63 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.17 160.2 40.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.726 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -132.1 110.78 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.231 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.426 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 2.9 t30 -99.46 132.19 44.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.623 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.955 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.659 0.191 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.07 124.0 10.91 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.481 2.121 . . . . 0.0 112.266 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 111.09 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -54.07 120.23 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.65 130.67 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.46 151.18 27.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.587 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.09 149.59 46.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 111.303 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -141.28 108.89 6.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.454 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.6 159.72 51.33 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 124.038 -1.234 . . . . 0.0 112.501 0.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.15 -3.57 12.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -120.43 -48.48 2.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -170.38 141.24 1.96 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 tt -109.07 144.83 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.605 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.426 ' CB ' ' HB3' ' A' ' 123' ' ' GLU . 10.2 p -125.11 101.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.774 0.321 . . . . 0.0 111.653 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' CD1' ' A' ' 29' ' ' TYR . 30.8 m-85 -58.11 111.15 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.463 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -72.22 139.77 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -57.55 167.42 1.34 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.844 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -89.99 163.12 34.9 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.734 0.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -101.31 28.83 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.13 5.81 46.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.06 156.12 41.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.778 0.323 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -76.35 108.1 9.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.89 136.34 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.79 106.94 17.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 39.5 m-85 -91.94 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -79.96 154.05 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 32' ' ' LYS . 26.0 mt -130.32 147.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.793 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' N ' HG21 ' A' ' 31' ' ' ILE . 27.2 tttt -100.98 126.98 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.6 mt -124.16 159.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.5 m -156.28 153.7 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.419 ' OD1' ' CD1' ' A' ' 41' ' ' ILE . 13.3 t30 -112.61 76.01 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.752 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.62 -30.98 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.954 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.07 174.43 3.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.354 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.01 35.14 4.84 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.553 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.22 171.54 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -74.61 152.35 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.419 ' CD1' ' OD1' ' A' ' 35' ' ' ASN . 8.7 pt -149.82 142.53 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 111.554 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.94 107.97 3.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.455 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -109.48 157.56 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.171 0.51 . . . . 0.0 111.756 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.13 155.56 41.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.485 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.424 ' CD1' HG21 ' A' ' 91' ' ' ILE . 6.2 mm -121.64 144.93 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.8 135.86 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.917 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 p -118.69 156.73 28.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.006 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.8 p -49.87 -64.27 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 114.17 25.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.99 22.5 5.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -42.89 5.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -95.14 -51.34 4.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.8 mt -76.13 140.18 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.9 125.02 28.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.38 140.72 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -168.02 127.06 1.01 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.71 132.6 24.12 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 123.937 -1.276 . . . . 0.0 111.977 -0.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.96 -44.15 52.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.46 2.106 . . . . 0.0 112.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 104' ' ' PHE . 3.5 m -139.38 141.4 37.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.711 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.38 155.84 26.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.548 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.78 115.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 0.0 111.019 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.42 156.41 19.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -110.97 178.53 0.97 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.805 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.1 Cg_exo -58.21 110.24 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.533 2.155 . . . . 0.0 112.282 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.68 40.65 29.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.67 155.64 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -114.23 143.98 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.874 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 m -133.61 151.55 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.73 141.47 30.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.092 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -125.52 161.27 27.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.565 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.73 132.19 23.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.304 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.11 90.37 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.046 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 148.4 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.98 152.58 42.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -105.84 137.24 44.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.019 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -59.97 145.86 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -165.56 -166.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -114.6 118.52 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.46 19.22 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.07 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -142.66 46.5 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.008 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -143.03 147.74 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.57 150.81 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.433 HD21 ' CD1' ' A' ' 124' ' ' TYR . 49.6 mt -128.29 29.08 5.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.16 32.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.03 -19.09 12.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.389 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.57 117.79 23.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.2 137.77 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.3 mt -108.13 166.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 m -153.1 123.6 7.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.424 HG21 ' CD1' ' A' ' 45' ' ' ILE . 3.6 mp -112.69 122.5 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 135.78 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.747 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -141.1 145.1 35.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 111.026 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 109' ' ' PHE . 5.0 t -131.27 149.67 52.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -51.52 135.91 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.81 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 129.77 65.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.472 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 53.0 Cg_exo -55.03 159.9 8.88 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.411 2.074 . . . . 0.0 112.245 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -51.68 124.95 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.998 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.78 42.52 78.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.53 143.31 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.073 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.33 164.36 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 69.51 9.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.599 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.95 129.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.738 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE2' ' SG ' ' A' ' 59' ' ' CYS . 34.8 t80 -49.04 128.14 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -120.01 150.66 40.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -86.07 -36.6 19.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.74 -19.66 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.283 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.472 ' CD1' ' CD ' ' A' ' 97' ' ' PRO . 18.2 m0 -53.58 -22.28 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 94' ' ' THR . 57.1 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.983 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.855 0.359 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.65 150.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.53 139.89 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -128.44 146.53 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.46 159.61 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -129.06 147.81 50.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.477 . . . . 0.0 111.369 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -138.34 86.73 16.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 147.64 92.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.654 2.236 . . . . 0.0 112.613 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.2 mm -100.67 152.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 18' ' ' VAL . 6.9 tp10 -141.45 154.54 45.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.979 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 2.3 m-85 -113.51 126.86 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.168 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.55 82.05 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.772 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.981 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.707 0.211 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.09 123.85 10.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.514 2.143 . . . . 0.0 112.24 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.69 111.16 0.85 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.614 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -54.01 120.13 5.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.849 0.356 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.53 130.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.49 151.35 27.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.552 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.33 149.48 45.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 111.255 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -141.05 108.94 6.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.576 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.59 159.83 50.96 Favored 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.902 -1.291 . . . . 0.0 112.504 0.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.18 -3.36 12.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.721 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -120.49 -48.66 2.28 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.823 0.345 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -170.3 141.46 2.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.355 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -109.43 144.8 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.568 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.433 ' CB ' ' HB3' ' B' ' 123' ' ' GLU . 10.4 p -125.09 101.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.857 0.361 . . . . 0.0 111.693 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.474 ' CD2' ' CD1' ' B' ' 29' ' ' TYR . 30.6 m-85 -58.21 111.02 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.405 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -72.08 139.69 48.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.269 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -57.4 167.52 1.25 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.868 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 69.7 Cg_endo -89.9 163.17 35.29 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.77 0.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -101.42 28.78 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.028 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.18 5.67 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.421 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.88 156.36 42.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.703 0.287 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -76.5 108.16 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.97 136.6 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.95 106.97 17.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.474 ' CD1' ' CD2' ' B' ' 19' ' ' PHE . 39.7 m-85 -91.97 113.45 25.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.65 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -79.73 154.07 28.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.382 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.426 HG21 ' N ' ' B' ' 32' ' ' LYS . 25.9 mt -130.4 147.03 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.783 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.426 ' N ' HG21 ' B' ' 31' ' ' ILE . 27.4 tttt -100.83 126.94 47.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.226 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 13.8 mt -124.02 159.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -156.45 153.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.071 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.426 ' OD1' ' CD1' ' B' ' 41' ' ' ILE . 13.4 t30 -112.76 75.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.789 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.59 -30.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.998 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.3 174.61 3.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 35.36 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.33 171.72 18.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -74.77 152.45 39.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.426 ' CD1' ' OD1' ' B' ' 35' ' ' ASN . 8.5 pt -149.91 142.52 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.39 . . . . 0.0 111.582 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.92 107.96 3.51 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.408 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.4 ' CZ2' ' HA3' ' B' ' 60' ' ' GLY . 37.6 p-90 -109.35 157.51 18.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.204 0.526 . . . . 0.0 111.729 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.46 41.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.401 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' B' ' 91' ' ' ILE . 6.2 mm -121.65 144.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 111.298 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.74 136.13 20.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 2.7 p -119.04 156.77 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.928 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 4.4 p -49.94 -64.12 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.2 114.19 25.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.94 22.6 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -42.93 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.768 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -95.15 -51.47 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.12 140.17 41.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.82 125.29 29.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.53 140.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.985 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -168.17 126.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.6 132.5 23.64 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.948 -0.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.87 -44.06 53.36 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.39 2.06 . . . . 0.0 112.233 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . 0.446 ' SG ' ' CE2' ' B' ' 104' ' ' PHE . 3.5 m -139.59 141.22 37.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.4 ' HA3' ' CZ2' ' B' ' 43' ' ' TRP . . . -153.27 155.81 26.37 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.626 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.74 115.53 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 111.088 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 156.75 19.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.455 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.2 OUTLIER -111.29 178.61 0.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 32.2 Cg_exo -58.33 110.21 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 0.0 112.282 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.83 40.72 28.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 155.62 18.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.027 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -114.34 143.77 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 m -133.4 151.8 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.02 141.19 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.179 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -125.19 161.27 27.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.704 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.77 132.25 23.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.283 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.15 90.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.13 148.44 48.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.94 152.55 42.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.823 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -105.82 137.32 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -60.02 145.97 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -165.68 -166.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -114.38 118.66 34.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.6 19.0 15.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 -28.29 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -142.46 46.37 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -142.77 147.93 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.64 151.04 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' B' ' 124' ' ' TYR . 49.0 mt -128.53 29.23 5.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.38 32.91 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.01 -18.98 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.66 117.59 23.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.02 137.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 mt -107.98 166.55 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 8.3 m -153.14 123.45 7.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.886 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.422 HG21 ' CD1' ' B' ' 45' ' ' ILE . 3.6 mp -112.58 122.51 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.254 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.13 135.99 51.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.764 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -141.32 145.12 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.989 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.453 HG23 ' CD1' ' B' ' 109' ' ' PHE . 5.0 t -131.22 149.88 52.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -51.59 136.09 27.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.22 129.84 65.13 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . 0.47 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 53.0 Cg_exo -55.1 159.93 9.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.444 2.096 . . . . 0.0 112.235 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.84 124.94 13.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.01 42.34 80.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.54 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.45 143.07 50.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.09 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.22 164.42 7.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.084 0.468 . . . . 0.0 111.266 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.84 69.28 9.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.575 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.7 129.41 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.825 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.446 ' CE2' ' SG ' ' B' ' 59' ' ' CYS . 34.9 t80 -49.02 128.09 15.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.012 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.07 150.52 40.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -85.9 -36.66 19.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.59 -19.68 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.306 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.47 ' CD1' ' CD ' ' B' ' 97' ' ' PRO . 18.2 m0 -53.62 -22.4 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.104 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' B' ' 94' ' ' THR . 57.6 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.76 0.314 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.897 0.38 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 43.6 t -91.68 150.01 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.64 139.72 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.766 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.22 146.54 50.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.41 159.44 43.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -128.9 147.83 50.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.381 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -138.25 86.75 16.67 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.38 147.76 92.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.586 2.191 . . . . 0.0 112.576 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 28.8 mm -100.72 152.2 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.433 ' HB3' ' CB ' ' B' ' 18' ' ' VAL . 7.1 tp10 -141.63 154.52 45.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.896 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 124' ' ' TYR . 2.4 m-85 -113.56 126.96 55.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.67 81.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.913 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo . . . . . 0 N--CA 1.465 -0.193 0 CA-C-O 120.722 0.218 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.95 110.39 3.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.526 2.151 . . . . 0.0 112.261 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.94 132.81 28.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 36.2 m-20 -55.78 140.41 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG23 ' CD1' ' A' ' 41' ' ' ILE . 9.2 pt -102.78 146.34 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.2 142.85 27.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.91 151.54 51.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.024 0.44 . . . . 0.0 111.16 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -135.67 111.5 10.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.528 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.97 165.09 43.11 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.958 -1.268 . . . . 0.0 112.609 0.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.9 t -45.57 -70.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.431 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -154.76 39.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.007 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 137.9 4.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.242 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 12.3 tt -148.2 138.34 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.795 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 123' ' ' GLU . 48.2 t -119.11 116.23 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 111.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.38 95.9 2.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.349 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -70.55 135.8 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.594 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -74.8 172.6 8.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.381 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 92.3 Cg_endo -82.12 163.87 75.32 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 124.275 -1.135 . . . . 0.0 113.065 0.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.06 45.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -124.97 8.11 8.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.464 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.64 8.38 3.07 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HG3' ' CG2' ' A' ' 76' ' ' THR . 15.0 mttt 62.5 137.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -140.17 95.81 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.945 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -76.16 118.21 18.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.416 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 95.7 m-85 -101.79 111.71 24.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -84.2 135.38 34.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 31' ' ' ILE . 42.3 mt -112.92 138.0 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.686 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 125.66 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' CE ' ' A' ' 70' ' ' MET . 14.3 mt -120.63 155.0 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.2 m -150.64 158.32 44.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 111.221 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.29 108.95 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.738 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 8' ' ' ASP . . . -95.37 22.42 6.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.094 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.57 -152.07 10.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.613 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.9 -19.43 4.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.696 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.04 152.73 39.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.318 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 168.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.752 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 9' ' ' ILE . 25.1 pt -155.34 149.05 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.642 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.49 112.62 3.88 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.13 161.52 13.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 0.0 111.85 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 151.28 37.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.115 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 45' ' ' ILE . 18.5 mm -115.1 144.18 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 111.891 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.07 143.98 46.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 76.9 p -138.68 150.63 46.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.069 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.0 78.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -137.51 114.49 10.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.7 mtp -90.46 10.57 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.567 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.12 -35.48 10.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.927 0.394 . . . . 0.0 110.626 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HD3' ' CG ' ' A' ' 77' ' ' PHE . 2.5 ttm180 -94.55 -25.5 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.779 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.17 141.1 50.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.8 p -133.8 110.98 10.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.42 121.79 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.027 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -142.2 131.02 11.97 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.948 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.8 140.81 67.66 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.658 -1.392 . . . . 0.0 112.154 -0.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.25 -39.65 12.7 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 21.9 m -138.19 167.12 22.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.26 -168.73 41.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.731 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.6 138.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.64 0.257 . . . . 0.0 110.832 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.19 151.35 51.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.403 . . . . 0.0 111.146 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 1.1 m-20 -84.11 178.01 2.65 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 27.7 Cg_exo -62.45 127.48 21.0 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.736 2.291 . . . . 0.0 112.422 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER 81.61 -7.98 1.39 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.035 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.34 156.74 25.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.6 149.74 51.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.976 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.62 152.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 mt -104.85 138.49 41.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.408 ' CE ' HD12 ' A' ' 33' ' ' ILE . 43.1 mtm -129.21 154.12 47.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.77 117.61 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.312 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 7.5 p -106.31 86.84 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.9 131.29 42.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.63 97.55 5.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.732 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -51.94 148.92 5.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.17 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.427 ' CG2' ' HG3' ' A' ' 26' ' ' LYS . 3.2 p -64.23 138.37 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.405 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 21.7 p90 -154.21 -173.69 4.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -105.68 109.47 21.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.02 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.414 ' CB ' HD23 ' A' ' 126' ' ' LEU . . . -95.43 18.89 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.81 -24.15 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -139.17 52.13 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -141.6 176.16 9.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.63 112.24 25.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD12 ' CD2' ' A' ' 124' ' ' TYR . 22.9 mt -134.25 60.38 1.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -141.98 17.31 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.352 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.08 10.02 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.77 137.25 39.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -163.4 133.86 4.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 89' ' ' ILE . 56.7 mt -96.74 112.09 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.6 m -93.98 122.49 36.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.49 109.93 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.884 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.04 131.73 55.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.976 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.405 ' CZ2' ' HD3' ' A' ' 116' ' ' ARG . 5.9 p90 -136.5 141.81 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 109' ' ' PHE . 1.3 t -131.85 144.55 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.76 143.05 26.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 144.13 57.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.7 159.17 53.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.562 2.175 . . . . 0.0 112.165 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -51.45 124.06 11.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.05 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.38 35.96 91.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.57 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.15 135.92 56.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.814 0.34 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.09 164.48 0.63 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.146 0.498 . . . . 0.0 111.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.39 70.2 7.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.567 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.38 139.04 0.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -50.49 139.25 16.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.449 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 1.2 mmp_? -129.97 148.57 51.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -32.62 39.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.6 -9.48 58.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.449 ' CD2' ' HB2' ' A' ' 105' ' ' ARG . 17.6 m0 -62.66 -18.49 62.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.57 0.224 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 94' ' ' THR . 10.6 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.745 0.307 . . . . 0.0 110.795 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.411 HG12 ' CD2' ' A' ' 109' ' ' PHE . 11.0 t -106.43 130.25 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.405 ' HD3' ' CZ2' ' A' ' 93' ' ' TRP . 13.6 mtt-85 -94.31 135.11 36.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -123.55 118.68 27.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 162.97 17.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -140.87 143.22 34.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.6 mt -124.6 104.65 30.8 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.678 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.93 138.7 87.17 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.489 2.126 . . . . 0.0 112.453 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 14.1 mm -113.93 104.91 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.958 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 4.2 mt-10 -97.05 117.92 32.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.464 ' CD2' HD12 ' A' ' 84' ' ' LEU . 11.6 m-85 -81.8 99.39 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.8 83.65 1.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.007 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.414 HD23 ' CB ' ' A' ' 79' ' ' ALA . 30.6 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.749 0.229 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.96 110.35 3.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.536 2.157 . . . . 0.0 112.249 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.86 132.86 27.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' B' ' 36' ' ' ALA . 37.2 m-20 -55.77 140.43 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.401 HG23 ' CD1' ' B' ' 41' ' ' ILE . 9.4 pt -102.82 146.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.209 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.26 142.97 26.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.01 151.38 51.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -135.6 111.42 10.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.12 164.96 44.42 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.958 -1.267 . . . . 0.0 112.607 0.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.5 t -45.43 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.476 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -154.75 39.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.044 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.8 137.86 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.262 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 12.4 tt -148.24 138.25 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' B' ' 123' ' ' GLU . 48.0 t -118.99 116.29 50.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.526 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.55 95.98 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -70.51 135.85 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.48 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -74.77 172.52 8.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.48 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -82.23 164.13 74.53 Favored 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.257 -1.143 . . . . 0.0 112.975 0.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.31 45.35 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.403 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 70.7 m-20 -124.95 7.93 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.36 8.29 3.13 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . 0.436 ' HG3' ' CG2' ' B' ' 76' ' ' THR . 15.1 mttt 62.7 138.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.661 0.267 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -140.53 95.76 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -76.05 118.47 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.423 ' HB2' ' CG1' ' B' ' 72' ' ' VAL . 95.9 m-85 -102.04 111.87 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -84.49 135.46 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.225 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.511 HD11 HG22 ' B' ' 31' ' ' ILE . 41.8 mt -112.92 138.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.715 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 125.59 54.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.961 0.41 . . . . 0.0 111.186 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.413 HD12 ' CE ' ' B' ' 70' ' ' MET . 14.1 mt -120.6 155.0 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.872 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.4 m -150.65 158.42 44.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.057 0.456 . . . . 0.0 111.279 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.24 109.13 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.705 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' B' ' 8' ' ' ASP . . . -95.56 22.49 7.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.53 -151.99 9.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.93 -19.52 4.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.61 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.2 152.68 39.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.993 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 168.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.687 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.401 ' CD1' HG23 ' B' ' 9' ' ' ILE . 24.8 pt -155.29 149.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.622 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.65 112.86 3.92 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.31 161.52 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.279 0.561 . . . . 0.0 111.935 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.03 151.45 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.146 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.23 144.1 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 111.876 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.04 143.84 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.34 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 74.7 p -138.58 150.73 46.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.017 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -36.04 78.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -137.56 114.55 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 42.5 mtp -90.53 10.76 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.46 -35.09 10.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 0.0 110.604 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.4 ' HD3' ' CG ' ' B' ' 77' ' ' PHE . 2.5 ttm180 -94.87 -25.5 16.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.23 141.01 50.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 97.7 p -133.81 110.67 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.2 121.71 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -142.1 131.0 12.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.86 140.94 68.56 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.068 -0.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.46 -39.44 12.5 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.109 . . . . 0.0 112.247 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 22.5 m -138.36 167.11 22.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.28 -168.74 41.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.682 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -150.7 138.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.674 0.274 . . . . 0.0 110.769 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.34 151.48 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.211 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.442 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 1.1 m-20 -84.25 177.82 2.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 27.8 Cg_exo -62.26 127.18 20.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.787 2.325 . . . . 0.0 112.435 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER 81.95 -8.26 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.977 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.16 156.84 25.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.55 149.85 51.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.81 152.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 12.6 mt -104.72 138.3 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' MET . . . . . 0.413 ' CE ' HD12 ' B' ' 33' ' ' ILE . 43.1 mtm -128.98 154.16 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.87 117.6 13.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' B' ' 29' ' ' TYR . 7.3 p -106.46 86.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.98 131.2 41.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 p -123.39 97.59 5.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.702 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -52.17 148.92 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.058 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.436 ' CG2' ' HG3' ' B' ' 26' ' ' LYS . 3.2 p -64.3 138.31 58.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.4 ' CG ' ' HD3' ' B' ' 52' ' ' ARG . 21.3 p90 -154.12 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -105.73 109.67 21.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.953 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.76 19.23 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.428 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.35 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.3 p -139.2 52.21 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -141.65 175.92 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.51 111.95 24.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.468 HD12 ' CD2' ' B' ' 124' ' ' TYR . 22.4 mt -134.04 60.54 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -142.03 17.27 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.1 10.09 2.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.89 137.27 39.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -163.45 133.88 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 55.8 mt -96.78 112.03 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 88.5 m -93.87 122.53 36.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.333 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.62 109.83 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.877 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -111.92 131.8 55.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.403 ' CZ2' ' HD3' ' B' ' 116' ' ' ARG . 5.8 p90 -136.62 141.84 43.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.023 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.417 HG21 ' CE1' ' B' ' 109' ' ' PHE . 1.3 t -131.86 144.5 50.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.66 142.96 26.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.12 144.34 58.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.93 159.2 53.98 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.658 2.239 . . . . 0.0 112.215 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -51.46 123.83 10.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.45 35.94 91.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.05 136.04 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.754 0.311 . . . . 0.0 111.077 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.38 164.24 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.218 0.532 . . . . 0.0 111.277 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 70.27 7.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.653 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.33 138.95 0.09 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.39 138.91 16.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.451 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 1.2 mmp_? -129.69 148.48 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -32.51 40.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.73 -9.22 58.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.649 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.451 ' CD2' ' HB2' ' B' ' 105' ' ' ARG . 17.9 m0 -62.86 -18.63 63.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.658 0.266 . . . . 0.0 111.256 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.421 ' CD2' HG12 ' B' ' 115' ' ' VAL . 10.6 m-85 . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.36 . . . . 0.0 110.891 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.421 HG12 ' CD2' ' B' ' 109' ' ' PHE . 11.1 t -106.41 130.36 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.403 ' HD3' ' CZ2' ' B' ' 93' ' ' TRP . 13.8 mtt-85 -94.46 134.86 36.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.076 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -123.43 118.59 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 163.06 17.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.754 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -141.08 143.23 34.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mt -124.51 104.49 31.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.82 138.76 86.98 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.503 2.135 . . . . 0.0 112.429 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 13.8 mm -113.95 104.8 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.946 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.411 ' O ' ' CG1' ' B' ' 18' ' ' VAL . 4.1 mt-10 -96.95 117.77 31.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.981 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.468 ' CD2' HD12 ' B' ' 84' ' ' LEU . 11.1 m-85 -81.76 99.2 8.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.68 83.63 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.054 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.9 mt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.908 179.751 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.683 0.201 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.65 106.29 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.621 2.214 . . . . 0.0 112.24 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.65 129.91 49.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -55.0 128.87 35.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.2 138.69 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.318 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 149.73 39.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.693 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.29 149.87 35.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.962 0.411 . . . . 0.0 111.094 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -144.86 107.17 4.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.662 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.87 154.64 61.49 Favored 'Cis proline' 0 C--N 1.352 0.717 0 C-N-CA 123.748 -1.355 . . . . 0.0 112.457 0.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.2 m -59.45 -53.11 61.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -160.05 39.89 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.47 111.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.085 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.403 ' CG2' HD11 ' A' ' 122' ' ' ILE . 15.9 tt -129.9 134.01 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.941 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 123' ' ' GLU . 6.1 p -130.69 110.63 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -57.34 154.37 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.968 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.14 120.13 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.372 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -50.33 169.01 0.21 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 61.4 Cg_endo -72.7 163.44 88.73 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.443 0.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 24.4 m-85 -111.63 34.92 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.017 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.76 4.5 25.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.72 131.63 20.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.826 0.346 . . . . 0.0 110.74 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -51.77 122.58 8.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -118.39 150.22 39.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.642 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.72 109.83 14.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -98.33 116.59 30.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.406 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -81.4 130.6 35.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.2 mt -110.77 143.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.527 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 131.6 46.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 111.47 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 64.2 mt -125.93 154.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.639 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.421 HG21 ' N ' ' A' ' 35' ' ' ASN . 53.2 m -153.21 156.65 38.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 111.328 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' N ' HG21 ' A' ' 34' ' ' THR . 47.5 t30 -105.66 109.31 21.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.532 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.61 21.64 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.89 -145.47 13.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.545 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.79 -39.39 0.29 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -103.36 159.34 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -52.04 158.68 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.77 117.18 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 111.545 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.0 116.91 4.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.906 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.466 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 26.2 p-90 -113.78 154.9 26.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.597 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.61 156.33 45.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 45' ' ' ILE . 2.3 mp -118.08 147.29 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.434 . . . . 0.0 111.742 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -145.27 131.26 19.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 p -113.19 150.09 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -36.2 47.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.07 115.81 11.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.8 mmm -93.31 21.86 5.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.45 -37.22 7.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -101.99 -27.94 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.013 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.5 150.16 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.61 109.75 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.76 144.47 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -159.27 136.38 6.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.52 144.54 81.34 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.66 -1.392 . . . . 0.0 112.236 0.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 -4.85 15.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.589 2.192 . . . . 0.0 112.96 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -171.87 161.67 5.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 169.96 157.75 12.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.608 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 t -94.14 134.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -108.89 132.87 53.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -88.87 168.37 15.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 25.3 Cg_endo -62.12 113.59 1.95 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.538 2.158 . . . . 0.0 112.359 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.7 30.89 2.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.67 148.37 24.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.792 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' CG ' ' OG1' ' A' ' 34' ' ' THR . 42.0 mttt -115.64 121.87 43.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 14.0 p -112.4 146.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.73 147.12 23.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.253 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.4 ttp -129.47 156.93 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.494 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.42 122.38 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.591 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -111.91 115.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.27 129.26 46.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.6 t -116.18 127.57 54.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.66 147.99 31.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.111 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -62.65 161.02 12.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -176.68 -175.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 111.02 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.43 108.65 20.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.28 18.7 6.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.453 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.48 -38.4 12.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.3 p -131.31 44.31 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.074 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -138.13 177.25 8.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.3 149.66 21.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 47.5 mt -139.46 29.37 2.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.54 26.59 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.53 -12.51 9.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.53 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.77 120.33 24.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.94 134.52 17.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.12 165.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 92.4 m -136.73 118.77 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -116.59 108.88 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.78 156.71 24.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -155.81 141.11 17.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.6 t -138.57 154.65 48.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -68.0 128.81 37.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.9 p -70.38 139.81 87.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.784 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 72.1 Cg_exo -48.25 164.22 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.417 2.078 . . . . 0.0 112.35 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.26 99.73 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.64 45.3 94.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.473 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.17 -85.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.744 0.307 . . . . 0.0 111.102 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.38 1.51 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.126 0.489 . . . . 0.0 111.277 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 70.45 10.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.67 124.26 0.05 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.451 ' HA ' ' CZ3' ' A' ' 108' ' ' TRP . 31.7 t80 -56.46 145.03 28.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -135.31 156.36 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.14 30.32 1.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -116.96 -34.14 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.958 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CD1' ' CD ' ' A' ' 97' ' ' PRO . 24.7 m0 -59.3 -29.71 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.403 ' CD2' HG22 ' A' ' 115' ' ' VAL . 4.6 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.403 HG22 ' CD2' ' A' ' 109' ' ' PHE . 7.4 p -111.54 130.74 64.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -104.04 154.5 19.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.824 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -132.47 141.93 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 163.07 24.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.7 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -141.03 124.24 16.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.033 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.37 117.24 57.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.772 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.89 137.38 32.07 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.33 2.02 . . . . 0.0 112.236 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.403 HD11 ' CG2' ' A' ' 17' ' ' ILE . 8.7 mm -105.68 136.06 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 2.2 mt-10 -124.95 157.94 34.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 88.0 m-85 -120.62 96.68 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.241 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.424 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 66.4 t30 -79.2 81.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.894 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.898 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.526 0.125 0 CA-C-O 120.748 0.228 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.81 106.4 1.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.541 2.161 . . . . 0.0 112.248 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.82 129.76 48.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.443 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -54.78 128.63 33.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.84 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.12 138.89 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.88 149.81 39.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.38 149.92 35.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -144.88 107.34 4.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.648 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' LYS . 26.4 Cg_endo -61.72 154.72 60.44 Favored 'Cis proline' 0 C--N 1.351 0.668 0 C-N-CA 123.802 -1.333 . . . . 0.0 112.391 0.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.9 m -59.58 -53.13 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.9 39.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' B' ' 13' ' ' PRO . 0.3 OUTLIER -163.47 111.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.063 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.02 133.99 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' B' ' 123' ' ' GLU . 6.1 p -130.67 110.76 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.284 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 21.6 m-85 -57.37 154.39 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.92 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.36 119.95 37.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -50.13 169.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.928 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 60.5 Cg_endo -72.55 163.67 87.83 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.598 -1.417 . . . . 0.0 112.385 0.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 24.4 m-85 -111.76 34.7 4.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.6 4.61 26.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.312 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -144.74 131.55 20.16 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.831 0.348 . . . . 0.0 110.85 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -51.64 122.73 8.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.038 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -118.67 150.08 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.552 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.56 109.97 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 111.217 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' B' ' 19' ' ' PHE . 15.0 m-85 -98.5 116.42 30.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -81.25 130.49 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.484 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 12.1 mt -110.81 143.48 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 131.68 46.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 0.0 111.508 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.428 ' HB ' ' CG1' ' B' ' 68' ' ' VAL . 64.4 mt -126.03 154.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.645 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' THR . . . . . 0.422 HG21 ' N ' ' B' ' 35' ' ' ASN . 53.2 m -153.13 156.66 39.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 111.285 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.422 ' N ' HG21 ' B' ' 34' ' ' THR . 47.6 t30 -105.64 109.45 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.479 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.65 21.51 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.231 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.87 -145.5 13.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.67 -39.44 0.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.577 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -103.13 159.36 15.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -52.16 158.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.55 117.19 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.607 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.98 116.89 4.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.876 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.471 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 26.1 p-90 -113.74 154.89 26.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.648 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.58 156.4 45.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.419 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' B' ' 45' ' ' ILE . 2.3 mp -118.06 147.33 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.976 0.417 . . . . 0.0 111.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -145.39 131.14 19.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 68.8 p -113.15 150.14 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.069 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.94 -36.09 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.809 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.18 115.77 11.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 79.2 mmm -93.33 22.09 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.942 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -37.33 7.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 ttp85 -101.9 -27.93 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.42 150.26 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.85 110.02 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.04 144.61 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.37 136.35 6.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.85 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 144.53 81.31 Favored 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.688 -1.38 . . . . 0.0 112.3 -0.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.0 -4.68 15.47 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.947 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -172.01 161.63 5.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 169.91 157.86 12.89 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.656 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.09 134.05 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.794 0.33 . . . . 0.0 110.998 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -108.89 132.53 53.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.019 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.436 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -88.54 168.34 16.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 24.9 Cg_endo -62.05 113.45 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.509 2.139 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.94 30.6 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 148.37 24.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.416 ' CG ' ' OG1' ' B' ' 34' ' ' THR . 42.1 mttt -115.73 121.83 43.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 13.8 p -112.41 146.15 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.85 147.27 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.194 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 13.4 ttp -129.58 156.92 43.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.471 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.32 122.71 16.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.578 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -112.3 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.658 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.62 129.1 46.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 111.297 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.01 127.7 55.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.751 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.81 148.05 31.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -62.84 160.97 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.763 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -176.53 -175.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.37 108.66 20.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.39 18.9 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.456 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.56 -38.54 12.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 111.086 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.0 p -131.2 44.31 2.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -138.06 177.32 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.35 149.62 21.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.4 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 47.6 mt -139.5 29.41 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.37 26.31 1.98 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.972 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.18 -12.62 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.64 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.61 120.22 24.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.946 0.403 . . . . 0.0 111.104 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.78 134.6 17.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.911 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.23 165.56 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.983 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 93.8 m -136.64 118.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.993 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -116.58 108.9 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -114.78 156.56 24.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -155.62 141.05 17.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 13.7 t -138.55 154.61 48.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -67.97 128.91 38.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 21.2 p -70.45 139.8 86.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . 0.481 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 70.9 Cg_exo -48.2 164.08 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.541 2.161 . . . . 0.0 112.303 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.11 99.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.53 45.47 94.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.22 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 70.32 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.75 124.27 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.817 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.452 ' HA ' ' CZ3' ' B' ' 108' ' ' TRP . 30.5 t80 -56.49 145.07 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -135.43 156.38 49.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.19 30.48 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -116.99 -34.2 4.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CD1' ' CD ' ' B' ' 97' ' ' PRO . 25.0 m0 -59.23 -29.84 67.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.406 ' CD2' HG22 ' B' ' 115' ' ' VAL . 4.6 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' B' ' 109' ' ' PHE . 7.4 p -111.65 130.7 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -103.9 154.53 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -132.56 142.05 48.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.91 162.93 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -140.94 124.36 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.36 117.45 57.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.734 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 137.39 31.76 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.365 2.044 . . . . 0.0 112.225 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 8.8 mm -105.66 136.13 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.359 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . 2.2 mt-10 -124.96 158.08 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.445 ' HB3' ' CE2' ' B' ' 23' ' ' TYR . 87.8 m-85 -120.73 96.54 5.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.422 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 66.4 t30 -79.14 81.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 37.1 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.828 -179.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo . . . . . 0 N--CA 1.465 -0.148 0 CA-C-O 120.775 0.24 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.15 146.69 82.41 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.527 2.151 . . . . 0.0 112.223 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.28 113.01 3.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.528 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -48.1 121.56 4.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 0.0 111.067 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 93' ' ' TRP . 5.0 pt -93.21 147.02 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -92.67 145.34 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.57 154.15 51.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.136 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' O ' ' CG2' ' A' ' 31' ' ' ILE . 13.6 mm-40 -139.97 127.93 12.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.389 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.78 163.97 77.55 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.697 0.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.4 -53.21 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.725 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -178.3 50.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.165 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -169.92 107.15 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.174 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -120.95 150.22 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 123' ' ' GLU . 42.4 t -132.99 95.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.0 111.641 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -54.8 97.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.265 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -59.09 151.39 22.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -64.2 169.69 4.42 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.656 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 66.8 Cg_endo -93.11 164.12 23.14 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.502 -1.041 . . . . 0.0 112.789 0.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.01 37.29 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.695 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.64 -5.87 13.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.59 -161.43 1.29 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.838 0.351 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.39 142.39 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -159.56 91.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.466 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.5 m -83.3 143.83 30.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.511 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -121.48 130.3 53.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.176 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.35 133.89 42.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.04 0.448 . . . . 0.0 111.671 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 31' ' ' ILE . 9.4 mm -99.99 149.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.05 126.38 46.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.277 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.5 mt -125.09 153.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.5 m -154.49 155.27 34.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -102.86 81.74 2.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.091 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.75 -23.4 17.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.96 -160.26 7.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.625 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.06 0.94 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.7 139.15 12.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.19 138.59 16.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 pt -137.62 174.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.461 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.94 98.16 0.34 Allowed Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.684 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CZ3' ' CD1' ' A' ' 45' ' ' ILE . 30.1 p-90 -92.43 155.68 17.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.126 0.489 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.3 158.12 43.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.446 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -125.32 149.68 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.001 0.429 . . . . 0.0 111.723 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -159.66 131.31 6.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.484 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -109.79 158.39 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.307 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -29.89 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.45 117.8 23.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.18 18.19 7.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -109.4 -43.74 4.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.6 -58.97 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mt -83.9 140.79 31.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.09 107.46 5.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.011 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.408 HG12 ' CG2' ' A' ' 45' ' ' ILE . 3.2 m -74.42 152.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -168.52 113.27 0.56 Allowed Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.35 141.11 70.79 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.304 0.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.59 -3.87 14.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.544 2.162 . . . . 0.0 112.747 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.2 p -170.42 147.6 3.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.792 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.23 175.32 43.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -106.2 122.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.175 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.16 125.27 38.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.74 161.42 61.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.95 100.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.561 2.174 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt 69.47 45.21 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -107.61 154.13 21.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.957 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -110.77 137.14 48.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.988 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.42 145.56 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.91 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.1 117.14 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.429 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 1.8 tmm? -101.66 147.93 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -113.92 140.91 47.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.439 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.95 84.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.23 129.42 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.05 122.07 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -92.31 138.76 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.844 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.38 162.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -169.21 -161.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.19 119.89 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.6 19.42 20.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.39 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.35 -31.01 12.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.3 p -136.87 44.77 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.07 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -144.31 139.81 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.93 146.59 17.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.975 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 16.2 mt -130.86 32.24 4.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.26 27.89 1.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -127.68 6.19 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.654 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.04 119.99 39.14 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.47 131.23 14.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.291 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.6 mt -84.67 162.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.51 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.2 m -138.66 137.36 36.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 0.0 111.375 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.6 mt -120.53 146.94 24.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.606 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 4.4 mt-10 -149.28 111.59 4.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.192 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.421 ' CE2' HG12 ' A' ' 9' ' ' ILE . 7.8 p90 -123.79 138.53 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.46 130.39 26.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.976 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -54.03 125.03 17.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -67.05 144.68 98.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 163.05 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.433 2.089 . . . . 0.0 112.204 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.46 118.39 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.983 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.37 46.12 52.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.47 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.83 151.13 46.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.12 164.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.284 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 71.13 5.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.6 142.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.763 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.36 134.44 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 155.22 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.986 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -93.4 -6.74 46.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.653 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.81 -17.59 35.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.546 0.213 . . . . 0.0 111.464 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.36 -16.15 32.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.294 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 1.5 m-85 . . . . . 0 C--N 1.332 -0.166 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 t -122.28 117.1 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.34 147.24 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.415 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.436 ' HB3' ' CG ' ' A' ' 92' ' ' GLU . 12.8 ptp180 -143.93 153.84 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.045 0.45 . . . . 0.0 111.507 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -147.73 131.78 17.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.29 134.13 48.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.132 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.79 137.7 19.83 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.5 138.73 17.66 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.542 2.161 . . . . 0.0 112.597 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.409 HG21 HD11 ' A' ' 122' ' ' ILE . 11.5 mm -101.52 146.56 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.029 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . 2.7 mt-10 -132.67 163.72 28.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 71.5 m-85 -126.37 131.5 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.195 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.408 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 4.2 t30 -120.18 115.16 23.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.913 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo . . . . . 0 CA--C 1.528 0.184 0 CA-C-O 120.744 0.227 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 146.76 82.39 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.554 2.169 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.23 113.21 3.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.451 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -48.24 121.72 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.415 HG12 ' CE2' ' B' ' 93' ' ' TRP . 5.1 pt -93.34 146.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -92.83 145.45 24.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.768 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.62 154.24 51.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.098 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.407 ' O ' ' CG2' ' B' ' 31' ' ' ILE . 13.5 mm-40 -139.95 127.94 12.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.9 163.77 78.48 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.047 -1.231 . . . . 0.0 112.695 0.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.23 -53.25 4.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.694 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -178.32 50.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.141 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -170.04 106.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.7 150.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' B' ' 123' ' ' GLU . 42.2 t -133.07 95.35 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.705 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -54.89 96.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.309 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -59.01 151.21 22.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.761 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -63.97 169.72 4.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.602 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 65.5 Cg_endo -93.14 164.07 23.07 Favored 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.476 -1.052 . . . . 0.0 112.834 0.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -102.87 37.23 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.705 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 -5.87 14.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.231 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.58 -161.33 1.27 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.847 0.356 . . . . 0.0 110.957 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.54 142.27 27.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -159.28 91.07 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.42 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 31.1 m -83.38 143.88 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.562 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -121.65 130.12 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.159 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.07 133.78 42.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.949 0.404 . . . . 0.0 111.688 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.43 HD11 HG22 ' B' ' 31' ' ' ILE . 9.6 mm -99.9 149.65 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.89 126.52 46.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.8 mt -125.18 153.83 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.909 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 82.1 m -154.46 155.23 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.075 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -102.9 81.67 2.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.73 -23.26 16.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 -160.43 7.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.29 0.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.511 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.83 138.99 12.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.775 0.321 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.18 138.67 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 pt -137.76 174.1 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.418 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.95 98.35 0.34 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.643 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.459 ' CZ3' ' CD1' ' B' ' 45' ' ' ILE . 29.9 p-90 -92.46 155.82 17.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 111.816 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.47 157.88 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' B' ' 45' ' ' ILE . 1.0 OUTLIER -125.12 149.46 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.7 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -159.41 131.35 6.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 24.1 p -109.9 158.43 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.93 -29.93 22.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.57 117.91 23.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.27 18.25 7.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -109.3 -43.98 4.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.847 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.35 -59.1 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.68 140.7 31.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.22 107.37 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' B' ' 45' ' ' ILE . 3.2 m -74.26 152.16 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.133 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -168.41 113.16 0.57 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.738 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.28 141.09 70.71 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.791 -1.337 . . . . 0.0 112.417 0.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.52 -4.11 14.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.529 2.153 . . . . 0.0 112.723 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.3 p -170.25 147.44 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.04 175.38 43.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.6 t -106.33 122.28 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.143 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.72 125.34 38.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.85 161.47 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.93 100.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.574 2.183 . . . . 0.0 112.382 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt 69.29 45.44 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -107.79 154.23 21.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.886 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -110.89 137.14 48.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.4 145.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.23 117.19 33.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' MET . . . . . 0.43 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 1.8 tmm? -101.68 147.81 26.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.431 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.43 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -113.83 140.98 47.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 111.443 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 43.6 t -124.98 84.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.84 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.15 129.48 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.21 121.86 36.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.01 138.76 31.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.44 162.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -169.18 -161.98 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.08 119.99 37.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.54 19.19 20.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.29 -31.09 12.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 73.6 p -136.8 44.8 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -144.49 139.8 28.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.86 146.68 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 16.1 mt -130.91 32.23 4.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.27 28.27 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -127.95 6.17 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.19 120.36 39.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.748 0.309 . . . . 0.0 110.757 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.79 131.0 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.255 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 37.2 mt -84.5 161.88 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.585 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 73.6 m -138.49 137.5 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 111.301 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -120.59 146.95 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.684 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 4.3 mt-10 -149.34 111.54 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.868 0.366 . . . . 0.0 111.135 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.415 ' CE2' HG12 ' B' ' 9' ' ' ILE . 7.9 p90 -123.74 138.59 54.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.6 130.18 25.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.997 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -53.78 125.03 16.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.9 p -67.09 144.86 98.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.86 163.03 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.536 2.157 . . . . 0.0 112.162 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.49 118.63 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.031 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.1 46.1 50.98 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.442 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.9 151.26 46.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.17 164.32 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.314 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.54 71.27 5.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.35 142.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.09 134.34 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.14 155.36 31.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -93.51 -6.7 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.691 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.87 -17.49 35.44 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.602 0.239 . . . . 0.0 111.518 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.44 -16.07 32.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.323 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 1.5 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 110.972 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 t -122.59 117.13 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.36 147.22 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.511 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . 0.425 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 12.7 ptp180 -143.87 153.86 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 111.469 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -147.72 131.79 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.25 134.27 47.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.159 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.92 137.57 19.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.36 138.42 17.66 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.589 2.193 . . . . 0.0 112.616 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.413 HG21 HD11 ' B' ' 122' ' ' ILE . 11.8 mm -101.19 146.82 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.419 ' HB2' ' CG2' ' B' ' 18' ' ' VAL . 2.7 mt-10 -132.93 163.8 28.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 70.1 m-85 -126.48 131.31 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.404 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 4.2 t30 -119.8 115.17 23.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.879 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.732 0.222 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.09 120.94 9.16 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.75 143.66 35.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.379 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -61.84 114.06 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 3.0 pt -73.31 142.51 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.095 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.77 139.09 31.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.76 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 149.49 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -142.66 105.41 5.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.755 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 155.14 54.13 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 123.844 -1.315 . . . . 0.0 112.348 0.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.9 -44.34 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.931 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.02 44.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.984 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.76 109.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -130.76 142.82 42.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.77 99.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.513 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 19.8 m-85 -52.58 121.65 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.89 131.15 34.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -55.53 168.18 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.803 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 93.2 Cg_endo -83.67 163.89 68.86 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.674 0.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.1 25.46 10.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.847 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.32 7.96 45.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.483 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -140.73 175.44 9.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -103.1 112.6 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.08 147.62 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 128.62 56.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 19' ' ' PHE . 65.6 m-85 -92.23 119.74 32.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.744 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -78.46 132.77 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.1 mt -120.84 148.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.519 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.45 125.52 54.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 111.355 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 mt -122.93 151.42 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.508 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.5 m -147.92 155.66 41.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -98.28 75.65 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.62 -26.27 13.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.49 -148.97 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.33 3.78 4.79 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.108 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -138.0 172.91 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.907 0.354 . . . . 0.0 110.831 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -70.22 155.45 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.673 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.423 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 20.8 pt -149.31 134.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 111.794 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.04 113.17 4.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.487 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -108.58 160.36 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.309 0.576 . . . . 0.0 111.919 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.65 22.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.967 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.7 mm -115.49 139.07 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.724 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.85 129.6 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.673 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.0 p -107.71 148.36 29.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -54.21 -27.71 36.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -125.61 104.37 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.51 24.94 6.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -106.57 -44.67 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.779 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.95 -40.0 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.81 150.23 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.16 177.04 11.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.97 154.44 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -161.85 128.67 2.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.07 133.26 27.0 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 123.892 -1.295 . . . . 0.0 111.945 -0.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.91 -47.7 25.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.381 2.054 . . . . 0.0 112.102 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.0 p -136.27 165.83 24.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.668 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.26 -167.77 37.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.566 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.25 125.35 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.339 . . . . 0.0 111.118 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -103.21 160.25 14.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -110.55 172.32 3.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.424 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 36.6 Cg_exo -60.84 116.23 3.22 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.618 2.212 . . . . 0.0 112.354 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.94 27.57 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.231 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -103.59 148.24 26.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.476 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.78 136.82 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.223 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 62' ' ' LEU . 11.8 p -125.88 155.2 35.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.4 mt -103.63 141.13 36.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.3 mtm -124.2 155.7 38.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.802 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.41 121.68 31.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.168 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.95 100.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -65.87 117.68 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.984 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.5 m -123.03 116.18 23.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.66 151.92 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 p -53.94 167.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -177.59 -164.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -130.88 98.14 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.04 -22.47 61.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.41 -39.0 31.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.9 p -129.82 47.09 2.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -143.24 151.79 40.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.06 147.99 47.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 23.2 mt -125.95 24.09 7.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.27 28.53 1.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.771 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -124.94 7.4 8.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.46 123.88 48.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.23 148.15 35.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.9 mt -118.58 108.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 120.8 33.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.28 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.38 100.21 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.911 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 11.5 mt-10 -97.66 157.8 15.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -163.64 142.36 7.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.039 0.447 . . . . 0.0 111.145 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.5 t -143.06 131.34 22.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -48.05 146.5 2.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.473 HG21 ' CZ3' ' A' ' 108' ' ' TRP . 1.7 p -90.22 140.92 27.32 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.18 160.72 3.04 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.496 2.13 . . . . 0.0 111.91 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.42 117.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.49 48.98 33.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.401 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.49 48.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 111.438 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.7 165.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.129 0.49 . . . . 0.0 111.554 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.12 73.81 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.45 152.35 3.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.881 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -64.25 153.09 39.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.835 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 2.4 mmt180 -142.88 150.25 39.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.032 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 106' ' ' ARG . 8.0 ttp-105 -102.58 25.78 8.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.69 -29.68 7.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.477 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 23.2 m0 -62.56 -27.57 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.419 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.3 mtm . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 114' ' ' MET . 7.5 p 169.98 98.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.93 160.41 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.133 0.492 . . . . 0.0 111.597 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.409 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 4.8 ptp85 -141.41 104.54 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.751 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -92.17 166.45 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -128.55 152.23 48.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.939 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.99 93.13 17.64 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.04 133.1 53.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.622 2.215 . . . . 0.0 112.471 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 12.9 mm -99.08 146.05 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -138.36 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.285 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 13.4 m-85 -119.26 137.51 53.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -121.36 78.93 1.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.983 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.528 0.193 0 CA-C-O 120.75 0.229 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.04 121.03 9.31 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.498 2.132 . . . . 0.0 112.283 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.96 143.74 36.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.337 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -61.94 114.03 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 3.0 pt -73.26 142.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.62 139.1 31.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.92 149.57 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -142.84 105.44 5.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.627 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 154.85 54.33 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.894 -1.294 . . . . 0.0 112.317 0.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.41 -44.5 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.93 44.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.69 109.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.147 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -130.57 142.84 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.81 99.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 111.503 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.439 ' HA ' ' CZ ' ' B' ' 29' ' ' TYR . 19.8 m-85 -52.54 121.59 7.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.442 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -86.7 131.02 34.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 111.325 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -55.33 168.25 0.6 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 94.8 Cg_endo -83.6 163.81 69.3 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.925 -1.281 . . . . 0.0 112.669 0.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.05 25.46 10.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.951 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.3 7.89 45.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.363 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -140.71 175.19 9.81 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -102.74 112.55 25.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.2 147.63 51.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 128.62 56.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.439 ' CZ ' ' HA ' ' B' ' 19' ' ' PHE . 66.9 m-85 -92.14 119.66 32.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.35 132.72 37.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.4 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 11.0 mt -120.78 148.53 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.55 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.39 125.47 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.506 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.1 mt -122.87 151.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.564 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 99.3 m -147.88 155.49 41.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 0.0 111.553 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -98.2 75.83 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.86 -25.92 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.69 -149.05 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.444 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.26 3.68 4.81 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.93 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -137.9 172.77 12.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.94 0.37 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -69.97 155.48 40.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.599 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 20.5 pt -149.36 134.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 0.0 111.781 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.06 113.34 4.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.426 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -108.72 160.24 16.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 0.0 111.866 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 144.9 22.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.033 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 11.9 mm -115.76 139.04 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 111.689 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.76 130.04 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.599 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 71.4 p -108.23 148.09 30.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.061 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -53.82 -27.98 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.963 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -125.37 104.73 8.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.89 25.07 6.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -106.54 -44.92 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.65 -39.97 6.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.88 150.25 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.18 177.05 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.89 154.68 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -162.16 128.64 2.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.09 133.27 27.09 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.888 -1.297 . . . . 0.0 111.96 0.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.0 -47.61 25.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.372 2.048 . . . . 0.0 112.123 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 11.7 p -136.33 165.6 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.05 -167.74 37.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.559 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.28 125.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 111.046 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.401 ' CD1' ' CG1' ' B' ' 68' ' ' VAL . 0.2 OUTLIER -103.13 160.18 14.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.4 OUTLIER -110.58 172.4 3.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.747 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.415 ' CD ' ' HB3' ' B' ' 63' ' ' ASP . 36.4 Cg_exo -60.88 116.35 3.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.622 2.215 . . . . 0.0 112.363 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.81 27.83 4.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -103.86 148.23 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.45 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 136.91 55.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' B' ' 62' ' ' LEU . 12.0 p -125.98 155.29 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.035 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.77 141.28 36.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 4.2 mtm -124.36 155.64 38.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.47 121.77 31.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.201 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.02 100.25 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.015 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.5 m -66.03 117.54 8.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.84 116.13 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.73 151.77 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 7.2 p -53.8 167.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -177.8 -164.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -130.61 98.29 4.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.43 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.34 -39.13 30.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.5 p -129.65 47.02 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -143.17 151.81 41.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -71.02 148.38 47.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 23.4 mt -126.26 24.08 6.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.31 28.45 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.738 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -124.9 7.51 8.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.614 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.48 123.78 48.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.06 148.34 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.67 108.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.926 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.48 120.67 33.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.29 100.13 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . 0.412 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 11.4 mt-10 -97.52 157.85 15.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -163.69 142.19 7.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 111.183 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 1.6 t -142.89 131.48 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.657 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -48.35 146.44 2.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.474 HG21 ' CZ3' ' B' ' 108' ' ' TRP . 1.7 p -90.09 140.86 27.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.85 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.04 160.77 2.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.471 2.114 . . . . 0.0 112.025 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.62 117.61 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.6 48.85 34.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.375 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.36 48.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.83 165.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.176 0.512 . . . . 0.0 111.483 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.13 73.73 1.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.769 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.39 152.26 3.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.06 153.11 38.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.475 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 2.4 mmt180 -142.94 150.08 39.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.94 0.4 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.424 ' HB3' ' NH1' ' B' ' 106' ' ' ARG . 8.1 ttp-105 -102.43 25.66 8.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -29.56 7.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.475 ' CE2' ' HB2' ' B' ' 105' ' ' ARG . 23.4 m0 -62.78 -27.35 69.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' MET . . . . . 0.422 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 4.3 mtm . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' B' ' 114' ' ' MET . 7.4 p 169.88 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.081 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.84 160.55 14.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.158 0.504 . . . . 0.0 111.542 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . 0.412 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 4.6 ptp85 -141.51 104.25 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -92.04 166.47 12.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 111.132 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -128.51 152.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.91 93.17 17.84 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.11 133.23 54.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 12.9 mm -99.19 146.16 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.044 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -138.38 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 13.7 m-85 -119.35 137.12 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.996 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -121.09 79.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.463 -0.272 0 CA-C-O 120.658 0.191 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.62 132.85 26.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.552 2.168 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.05 -142.78 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.565 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -130.8 136.97 49.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 93' ' ' TRP . 23.0 pt -93.93 153.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.42 133.05 49.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.658 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.7 p -126.42 155.16 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -139.97 114.54 7.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.84 161.63 67.5 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.924 -1.282 . . . . 0.0 112.497 0.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -50.13 70.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.177 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -167.76 46.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.084 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -162.9 106.96 1.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.931 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.1 tt -131.19 125.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.129 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.428 HG22 ' CB ' ' A' ' 123' ' ' GLU . 7.5 p -122.04 101.57 10.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.186 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 22.9 m-85 -47.32 162.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.567 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -122.85 119.4 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.969 0.414 . . . . 0.0 111.545 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.66 0.13 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.755 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 77.6 Cg_endo -76.84 164.27 87.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.764 0.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.82 40.92 2.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -108.14 6.8 27.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.4 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.49 -160.99 1.23 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.797 0.332 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.26 112.34 24.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -112.48 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.52 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 113.78 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.429 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 8.7 m-85 -105.51 112.64 25.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.259 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -84.13 145.09 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.638 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.423 HD13 ' CE ' ' A' ' 70' ' ' MET . 3.7 mt -116.12 145.43 21.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.383 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -94.32 129.67 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.962 0.411 . . . . 0.0 111.528 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.6 mt -128.55 151.76 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.705 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.412 HG21 ' N ' ' A' ' 35' ' ' ASN . 54.1 m -152.33 155.83 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.412 ' N ' HG21 ' A' ' 34' ' ' THR . 1.3 m-20 -94.61 100.79 12.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.48 18.03 6.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.512 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.11 -149.83 19.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.07 -26.75 2.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -125.55 162.39 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.855 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -52.06 168.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 93' ' ' TRP . 13.9 pt -154.22 129.97 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.635 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.03 106.43 2.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.517 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.18 156.52 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.158 0.504 . . . . 0.0 111.909 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.64 154.72 40.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.036 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.4 mm -127.73 137.96 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 111.72 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -142.36 129.55 20.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.643 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.9 p -104.25 157.26 17.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.111 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.27 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -143.0 118.33 10.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.17 17.81 6.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.272 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -110.05 -39.22 5.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.365 . . . . 0.0 110.952 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.42 -27.06 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.7 mt -116.62 149.72 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -138.83 144.16 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.25 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.02 120.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.731 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.18 136.49 24.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 132.49 27.26 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.632 -1.404 . . . . 0.0 112.0 0.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.39 -39.38 44.3 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.334 2.023 . . . . 0.0 112.112 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.24 163.58 35.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.87 154.68 10.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.82 122.34 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.757 0.313 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -98.42 149.27 22.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.46 167.99 12.89 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.76 121.44 9.17 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.632 2.222 . . . . 0.0 112.384 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.85 18.43 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 152.76 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -122.3 153.02 39.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.63 152.9 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.84 91.93 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.251 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.423 ' CE ' HD13 ' A' ' 31' ' ' ILE . 35.4 ttp -72.7 158.95 34.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.615 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.417 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -124.41 129.82 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.9 93.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.992 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.96 127.61 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.43 101.73 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.753 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.0 145.24 44.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.129 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.39 162.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CZ ' ' CE2' ' A' ' 124' ' ' TYR . 0.5 OUTLIER -168.55 -163.14 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.88 119.14 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.58 18.36 20.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.506 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.95 -23.07 15.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.19 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.9 p -141.44 49.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.1 147.77 21.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -60.61 139.04 57.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 75.2 mt -116.29 27.08 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -146.63 27.59 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.608 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.72 -29.33 9.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.78 132.93 53.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.903 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -148.5 145.61 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.39 115.62 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.935 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -96.4 124.42 40.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.32 113.26 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -110.85 155.49 22.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.465 ' CD1' HD11 ' A' ' 41' ' ' ILE . 6.6 p90 -154.81 129.16 9.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.782 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 4.4 t -130.37 135.08 47.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.4 138.64 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.0 p -76.92 138.79 65.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.36 165.3 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.478 2.119 . . . . 0.0 112.043 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -50.35 105.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.63 48.67 49.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.36 -79.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.404 ' CB ' ' NH1' ' A' ' 105' ' ' ARG . . . 179.5 164.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 111.298 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -92.43 70.29 5.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.22 142.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.761 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -51.69 138.08 23.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.404 ' NH1' ' CB ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -126.2 149.7 48.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -99.57 25.21 7.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.94 -16.54 10.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.409 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -69.27 -19.23 63.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 111.344 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 3.2 m-85 . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.734 0.302 . . . . 0.0 111.261 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.992 0.425 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.423 ' CB ' ' O ' ' A' ' 114' ' ' MET . 3.8 t 82.84 111.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.238 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.13 151.75 21.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.607 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.99 140.38 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 0.0 111.276 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -126.17 162.12 26.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.546 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -130.88 152.52 50.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.25 95.73 9.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.729 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.61 127.41 20.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.468 2.112 . . . . 0.0 112.213 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 mm -96.16 154.54 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.428 ' CB ' HG22 ' A' ' 18' ' ' VAL . 93.2 mt-10 -145.66 163.18 35.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.467 ' CE2' ' CZ ' ' A' ' 77' ' ' PHE . 33.7 m-85 -125.35 120.9 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.065 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -100.73 88.98 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.947 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.962 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.73 0.221 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.57 132.78 26.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.527 2.151 . . . . 0.0 112.302 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -142.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -130.69 137.16 49.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.452 HG22 ' CD1' ' B' ' 93' ' ' TRP . 22.9 pt -94.15 153.01 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.183 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.35 132.98 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -126.42 155.18 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.142 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -139.89 114.49 7.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.588 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.88 161.46 68.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.607 0.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -50.15 70.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -167.78 46.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -162.87 106.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 tt -131.15 125.42 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.102 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' B' ' 123' ' ' GLU . 7.6 p -122.1 101.64 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.494 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 22.9 m-85 -47.4 162.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.576 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -122.94 119.31 30.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.558 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -49.07 170.54 0.13 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.755 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 72.2 Cg_endo -76.78 164.34 87.63 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.749 0.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.89 40.95 2.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.789 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.34 7.16 27.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.479 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.74 -160.98 1.23 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.833 0.349 . . . . 0.0 110.779 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.4 112.65 25.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . 0.407 ' HB3' ' CZ ' ' B' ' 29' ' ' TYR . 0.3 OUTLIER -112.54 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 113.59 27.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.487 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 8.6 m-85 -105.3 112.65 25.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.259 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -84.08 144.96 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.691 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.429 HD13 ' CE ' ' B' ' 70' ' ' MET . 3.8 mt -116.09 145.36 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.408 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -94.28 129.63 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.977 0.418 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 58.5 mt -128.54 151.65 35.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' THR . . . . . 0.409 HG21 ' N ' ' B' ' 35' ' ' ASN . 54.0 m -152.23 155.73 38.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 111.398 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.409 ' N ' HG21 ' B' ' 34' ' ' THR . 1.3 m-20 -94.64 100.76 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.59 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.36 18.01 6.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.04 -149.73 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.52 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.19 -26.79 2.85 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.49 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -125.63 162.3 25.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -51.85 168.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.47 HD11 ' CD1' ' B' ' 93' ' ' TRP . 14.0 pt -154.13 129.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 111.66 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.01 106.45 2.67 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.511 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.28 156.56 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.54 . . . . 0.0 111.85 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.57 155.04 40.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.963 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 mm -127.92 137.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -142.39 129.48 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.606 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 43.8 p -104.13 157.35 17.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.53 -27.6 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.98 118.18 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.713 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.1 17.8 6.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -110.18 -39.04 5.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.48 -27.11 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.7 mt -116.59 149.86 38.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.797 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -139.01 144.3 38.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.27 120.99 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -135.24 136.5 24.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.11 132.44 27.1 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.046 -0.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.37 -39.59 44.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.401 2.067 . . . . 0.0 112.088 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.1 p -146.06 163.51 35.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.344 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.94 154.56 10.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.835 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.65 122.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 111.001 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -98.58 149.39 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.54 168.06 12.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.94 121.37 9.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 112.356 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.9 18.64 9.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.94 21.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.328 . . . . 0.0 110.767 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -122.43 152.99 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.58 152.92 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.81 92.02 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.232 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' MET . . . . . 0.429 ' CE ' HD13 ' B' ' 31' ' ' ILE . 35.7 ttp -72.78 158.99 34.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.425 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -124.6 129.68 51.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.72 93.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.91 127.49 32.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.28 101.94 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.24 145.11 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.11 162.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.456 ' CZ ' ' CE2' ' B' ' 124' ' ' TYR . 0.5 OUTLIER -168.57 -163.06 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.896 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.95 119.21 38.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.71 18.31 20.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.526 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.22 15.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.7 p -141.3 49.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.22 147.68 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -60.56 139.1 57.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 76.1 mt -116.38 27.23 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.109 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -146.66 27.38 1.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.7 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.63 -29.22 9.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.93 132.88 53.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.945 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -148.45 145.5 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.996 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.32 115.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.013 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 81.7 m -96.23 124.45 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.33 113.23 42.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.812 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -110.71 155.47 22.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.47 ' CD1' HD11 ' B' ' 41' ' ' ILE . 6.8 p90 -154.9 128.79 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.407 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 4.3 t -129.94 135.01 47.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.25 138.69 44.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 68.7 p -77.07 138.79 64.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 165.08 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.525 2.15 . . . . 0.0 112.057 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -50.21 105.41 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.56 48.85 48.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.395 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.65 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 0.0 111.24 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . 0.409 ' CB ' ' NH1' ' B' ' 105' ' ' ARG . . . 179.53 164.76 1.04 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.168 0.509 . . . . 0.0 111.307 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -92.54 70.36 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.699 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.17 141.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.686 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -51.8 137.88 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.409 ' NH1' ' CB ' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -125.96 149.76 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -99.46 25.11 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.188 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -116.9 -16.64 10.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.45 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -69.2 -19.27 63.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.605 0.24 . . . . 0.0 111.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.308 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' MET . . . . . 0.428 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.941 0.4 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.428 ' CB ' ' O ' ' B' ' 114' ' ' MET . 3.9 t 82.82 112.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.248 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.23 151.75 21.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.93 140.13 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 111.315 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -126.1 162.17 25.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -131.0 152.63 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.095 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.29 95.87 9.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.646 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.66 127.49 20.81 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.439 2.093 . . . . 0.0 112.132 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 13.1 mm -96.3 154.52 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.268 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.426 ' CB ' HG22 ' B' ' 18' ' ' VAL . 93.0 mt-10 -145.63 163.31 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.456 ' CE2' ' CZ ' ' B' ' 77' ' ' PHE . 33.8 m-85 -125.27 121.26 33.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -101.1 88.87 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.948 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.908 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.749 0.229 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.63 149.51 55.28 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -165.51 1.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.23 111.88 23.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.88 147.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.58 149.69 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.799 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.36 151.5 45.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.56 107.71 3.81 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.37 157.38 62.06 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.347 0.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.05 -20.15 12.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.277 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -94.71 -45.93 7.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 111.096 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.78 -176.66 0.24 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.4 tt -144.33 156.28 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 123' ' ' GLU . 3.6 p -133.09 92.43 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 19.2 m-30 -50.78 113.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.668 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -79.14 136.21 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -50.89 168.52 0.24 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.684 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 2.0 Cg_endo -82.58 163.76 73.94 Favored 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.255 -1.144 . . . . 0.0 112.364 0.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -106.33 26.61 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -110.68 7.1 22.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.106 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -141.46 134.14 28.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.788 0.328 . . . . 0.0 111.034 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -55.42 107.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -116.66 124.15 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.8 113.21 25.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.985 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 85.5 m-85 -89.73 99.33 12.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.489 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -66.68 153.32 43.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.577 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mt -139.27 148.73 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HB2' ' CG ' ' B' ' 22' ' ' PRO . 25.3 ttmt -104.91 140.48 38.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.41 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.419 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 46.7 mt -131.54 154.03 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.779 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.0 m -145.47 155.59 43.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.029 0.442 . . . . 0.0 111.189 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.42 ' ND2' HG12 ' A' ' 41' ' ' ILE . 36.0 t-20 -104.08 102.27 12.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.42 21.32 6.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.29 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.85 -122.86 4.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.542 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.36 -42.0 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.563 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -113.26 166.6 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.44 156.3 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.42 HG12 ' ND2' ' A' ' 35' ' ' ASN . 21.9 pt -143.82 174.01 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.33 100.03 0.46 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.918 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 -92.12 159.35 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 111.712 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.64 130.73 11.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.514 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 HD11 HG22 ' A' ' 45' ' ' ILE . 5.6 mm -100.31 141.09 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.732 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -142.0 131.99 24.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.575 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.1 p -107.46 156.97 18.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.41 . . . . 0.0 111.399 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -29.16 3.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.38 122.77 13.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.65 -8.62 59.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.417 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.17 -41.19 13.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 110.604 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -84.8 -59.28 2.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.65 134.12 37.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.706 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 m -127.49 109.13 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -68.29 156.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -170.09 113.85 0.48 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.3 149.58 92.19 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.112 -1.203 . . . . 0.0 112.278 0.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.88 -15.31 21.12 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 0.0 112.586 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -179.49 153.26 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.83 167.73 40.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.791 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 t -98.36 120.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' A' ' 35' ' ' ASN . 4.5 tp -96.98 162.93 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -115.17 170.97 4.92 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.19 111.13 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.576 2.184 . . . . 0.0 112.419 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.27 39.79 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -106.74 154.31 21.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.894 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.38 38.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 10.5 p -138.39 143.36 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.937 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.23 151.64 23.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -133.47 161.56 34.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.764 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.98 118.24 7.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.268 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -107.82 86.51 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.992 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.16 145.57 53.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 43.2 t -136.19 102.96 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.18 150.16 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -67.4 112.46 4.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -123.58 178.02 5.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.93 89.97 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.18 -26.57 39.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.87 -49.12 59.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.7 p -125.61 50.63 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.068 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -136.28 162.34 33.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -80.12 130.2 35.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.2 mt -125.9 52.91 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -112.77 -23.66 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -65.46 -91.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.448 ' CB ' ' HB ' ' A' ' 122' ' ' ILE . 2.1 p-10 41.66 84.64 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.573 0.225 . . . . 0.0 111.513 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -167.4 135.17 2.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.607 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.403 HD13 ' CD1' ' A' ' 122' ' ' ILE . 28.1 mt -119.81 163.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.874 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.2 m -149.59 114.63 5.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.963 0.411 . . . . 0.0 111.363 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.37 98.7 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.955 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.89 137.9 40.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -139.08 150.3 45.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.242 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.446 HG23 ' CE1' ' A' ' 109' ' ' PHE . 4.4 t -147.6 132.24 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -53.33 147.79 9.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 p -98.2 142.87 25.27 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.751 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.13 160.62 3.07 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.377 2.051 . . . . 0.0 112.039 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -47.03 116.28 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.175 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.4 50.77 23.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.42 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 62.74 7.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.727 0.299 . . . . 0.0 111.549 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.42 164.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.612 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -104.55 73.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.57 147.83 0.18 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.71 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.41 150.39 48.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.48 146.85 38.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.14 -23.77 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.22 -22.26 64.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.162 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.83 -30.07 71.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 94' ' ' THR . 9.2 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.989 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 t -128.44 128.3 68.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -96.8 152.61 18.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.03 130.08 18.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.042 0.449 . . . . 0.0 111.585 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.74 162.74 16.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.033 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -131.95 149.34 52.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 0.0 111.48 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 mt -143.26 98.47 5.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.656 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.91 151.04 59.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.703 2.269 . . . . 0.0 112.795 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 87' ' ' ASP . 43.9 mm -101.46 158.26 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.018 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -140.08 153.66 46.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.902 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -119.81 113.54 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -102.94 82.63 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.975 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 CA--C 1.528 0.191 0 CA-C-O 120.702 0.209 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.73 149.54 54.75 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.576 2.184 . . . . 0.0 112.335 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.68 -165.53 1.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.17 111.85 23.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.814 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.89 147.54 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.49 149.52 21.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.19 151.55 45.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.6 107.63 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.33 157.6 61.28 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.824 -1.323 . . . . 0.0 112.377 0.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.39 -20.24 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.231 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -94.67 -46.09 7.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.891 0.376 . . . . 0.0 111.068 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.89 -176.46 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 tt -144.69 156.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.244 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' B' ' 123' ' ' GLU . 3.5 p -133.22 92.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.566 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 19.0 m-30 -50.87 112.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.74 136.22 37.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.303 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -50.88 168.62 0.24 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.795 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 1.9 Cg_endo -82.54 163.73 74.1 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 124.276 -1.135 . . . . 0.0 112.476 0.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.35 26.43 9.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -110.43 6.97 22.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.125 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -141.4 134.22 28.82 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 120.787 0.327 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -55.38 107.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -116.67 124.13 48.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.716 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.75 113.23 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.566 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 85.8 m-85 -89.86 99.44 12.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.471 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -66.73 153.43 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.578 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mt -139.43 148.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -105.03 140.54 38.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.443 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.405 ' HB ' ' CG1' ' B' ' 68' ' ' VAL . 46.1 mt -131.45 154.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.828 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.7 m -145.47 155.72 43.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.998 0.428 . . . . 0.0 111.208 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.426 ' ND2' HG12 ' B' ' 41' ' ' ILE . 36.1 t-20 -104.26 102.38 12.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.535 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.44 21.23 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.293 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.89 -122.78 4.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.444 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.33 -42.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -113.2 166.63 11.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.49 156.45 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.426 HG12 ' ND2' ' B' ' 35' ' ' ASN . 21.5 pt -143.92 174.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.35 100.0 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.883 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -92.01 159.4 15.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.234 0.54 . . . . 0.0 111.651 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.73 130.81 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.414 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.43 HD11 HG22 ' B' ' 45' ' ' ILE . 5.6 mm -100.34 141.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 111.717 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -142.08 131.94 24.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.513 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 11.4 p -107.52 156.88 18.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 111.316 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -29.02 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.014 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.57 122.82 12.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.77 -8.59 59.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.455 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.12 -41.23 13.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -84.66 -59.59 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.778 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -94.48 134.1 37.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.756 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -127.46 109.01 11.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.07 156.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.071 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -169.96 113.87 0.48 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.32 149.81 92.62 Favored 'Cis proline' 0 C--N 1.351 0.667 0 C-N-CA 124.014 -1.244 . . . . 0.0 112.249 0.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.92 -15.45 20.95 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 112.546 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p -179.52 153.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.538 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.46 168.17 41.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.696 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 26.3 t -98.7 121.12 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.011 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.412 ' CD2' ' HB2' ' B' ' 35' ' ' ASN . 4.6 tp -96.98 163.13 13.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.427 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.4 OUTLIER -115.36 171.08 4.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.29 111.32 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.571 2.181 . . . . 0.0 112.349 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.04 39.87 9.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.427 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.6 OUTLIER -106.87 154.38 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.799 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.6 38.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 10.5 p -138.63 143.36 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.28 151.62 23.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -133.39 161.6 34.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.728 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.96 118.29 7.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.309 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 t -108.03 86.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.35 145.44 53.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.033 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.7 t -136.07 103.19 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.26 150.32 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -67.64 112.47 4.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -123.47 178.17 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.97 89.91 3.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.1 -26.74 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.028 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.18 57.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 61.3 p -125.65 50.56 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.066 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.12 162.46 32.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -80.15 130.22 35.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 12.6 mt -125.82 52.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -112.51 -23.43 10.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -65.64 -91.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.779 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' B' ' 122' ' ' ILE . 2.1 p-10 41.51 84.59 0.02 OUTLIER 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.76 0.314 . . . . 0.0 111.564 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -167.25 135.17 2.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.643 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' B' ' 122' ' ' ILE . 29.0 mt -119.8 163.69 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.795 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 21.8 m -149.5 114.79 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.939 0.4 . . . . 0.0 111.247 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.47 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.861 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 137.79 40.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.832 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -138.97 150.29 45.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.434 HG23 ' CE1' ' B' ' 109' ' ' PHE . 4.6 t -147.7 132.07 17.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -53.19 147.62 9.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -98.08 142.83 25.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.18 160.62 3.14 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.428 2.085 . . . . 0.0 112.022 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -46.98 116.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.58 50.78 24.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.364 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.04 62.81 7.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.726 0.298 . . . . 0.0 111.562 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.36 164.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.24 0.543 . . . . 0.0 111.663 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -104.48 73.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.49 147.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.3 150.44 48.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 146.84 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.677 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.1 -23.68 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.162 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.33 -22.17 64.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.149 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -62.98 -30.08 71.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.062 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' B' ' 94' ' ' THR . 9.2 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.983 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 t -128.5 128.32 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -96.82 152.56 18.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.604 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.06 130.06 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.449 . . . . 0.0 111.546 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.78 162.73 16.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.966 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -131.96 149.19 52.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 0.0 111.498 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 mt -143.25 98.46 5.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.665 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.77 151.03 58.68 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.789 2.326 . . . . 0.0 112.642 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.44 ' HB ' ' CB ' ' B' ' 87' ' ' ASP . 43.7 mm -101.47 158.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.968 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . 0.8 OUTLIER -140.0 153.67 46.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.891 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -119.84 113.51 20.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -102.96 82.86 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.684 0.202 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.52 109.75 2.7 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.607 2.204 . . . . 0.0 112.226 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.45 135.75 47.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.505 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.25 152.49 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.0 147.16 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.63 140.9 31.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.578 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.79 139.12 47.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.188 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -137.25 110.07 9.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.54 167.52 32.84 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.672 0.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -43.08 -68.41 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.429 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.11 43.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.69 123.54 3.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.037 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.55 151.89 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.61 100.15 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.39 113.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -81.21 132.87 35.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.11 0.14 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.857 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 72.1 Cg_endo -76.72 167.74 79.16 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.733 0.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.4 m-85 -115.85 31.54 6.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.013 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.6 6.59 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.271 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -149.76 -178.57 6.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.14 107.95 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -111.16 132.98 53.87 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.4 m -107.15 135.78 48.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -116.88 121.81 42.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.02 150.88 45.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.435 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 31' ' ' ILE . 15.0 mt -133.43 153.96 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.702 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.24 135.25 53.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.409 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 69.4 mt -145.46 121.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.669 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -118.19 153.46 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 111.108 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -94.54 81.68 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.95 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.43 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.92 -154.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.629 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.72 -19.33 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.743 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -132.61 167.16 20.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.009 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -49.78 164.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.811 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 pt -156.74 132.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.798 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.13 109.48 3.83 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -99.51 159.3 15.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.988 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.77 155.05 44.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.408 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.1 mm -117.24 132.37 67.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 111.586 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 150.8 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.737 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 p -143.27 153.71 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -41.97 95.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.62 114.87 15.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.68 20.6 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -97.14 -31.69 12.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -113.37 -19.25 11.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.3 mt -108.11 132.45 53.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.05 107.74 5.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.73 127.12 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.032 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.22 130.96 22.8 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.1 142.86 76.05 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.875 -1.302 . . . . 0.0 112.022 0.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.22 -31.7 43.93 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.434 2.089 . . . . 0.0 112.036 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -145.91 -177.93 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.495 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.27 -171.0 39.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.596 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.31 129.47 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.4 153.55 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.141 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -90.05 168.1 15.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.79 133.69 46.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.497 2.131 . . . . 0.0 112.231 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 tttm 77.7 12.07 1.99 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.841 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -108.51 142.98 38.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.187 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.27 161.21 13.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.193 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.62 141.93 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.063 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.03 118.95 33.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.946 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.8 mtm -112.46 158.21 20.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.71 102.23 6.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.22 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.05 109.43 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.809 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.2 m -91.24 129.88 37.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.302 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 41.0 t -114.99 150.82 35.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.9 154.58 21.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.119 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.9 p -58.59 161.03 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.418 ' CZ ' ' HB1' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -173.53 -165.63 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.94 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 92.4 m-20 -121.92 82.86 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB1' ' CZ ' ' A' ' 77' ' ' PHE . . . -57.24 -22.11 38.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.216 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.296 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.4 p -141.56 43.13 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.168 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 19.6 mm-40 -122.52 6.5 9.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.26 140.01 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.23 24.46 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -142.26 28.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.767 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.21 9.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.02 126.91 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.84 139.63 26.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.5 mt -107.35 122.36 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.615 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.0 m -110.56 118.66 36.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.487 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.15 154.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -149.71 101.72 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -122.14 137.9 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.997 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 115' ' ' VAL . 0.8 OUTLIER -134.37 148.97 50.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.029 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -60.22 144.16 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -85.77 150.89 54.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.418 ' HG2' ' CB ' ' A' ' 100' ' ' ALA . 39.3 Cg_endo -67.04 163.63 33.22 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.5 2.133 . . . . 0.0 112.059 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -47.18 116.45 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.21 46.64 56.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.688 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.418 ' CB ' ' HG2' ' A' ' 97' ' ' PRO . . . -65.13 150.65 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.113 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.41 165.03 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.142 0.496 . . . . 0.0 111.282 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.9 71.33 7.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.621 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.02 140.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.05 120.21 9.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.16 156.16 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.024 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.77 -27.16 16.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -18.22 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.339 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.85 -16.25 57.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.428 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 2.5 m-85 . . . . . 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.403 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 2.9 mtt . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 121.03 0.443 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' A' ' 94' ' ' THR . 3.3 t 81.76 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.118 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.28 26.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.773 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.76 139.39 46.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.004 0.43 . . . . 0.0 111.174 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -125.37 166.77 15.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.489 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -121.69 152.05 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -141.31 88.56 9.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 141.8 47.29 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.566 2.177 . . . . 0.0 112.633 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.37 138.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.817 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.62 159.18 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.264 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.478 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 97.7 m-85 -122.8 113.07 18.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 60.4 t30 -95.15 90.57 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.917 -179.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.465 -0.15 0 CA-C-O 120.729 0.22 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.45 109.75 2.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.508 2.139 . . . . 0.0 112.33 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.38 135.8 47.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -49.31 152.45 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 111.017 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 11.2 pt -117.99 147.2 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.66 140.82 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.63 139.53 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -137.62 109.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.561 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.46 167.29 33.23 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.996 -1.252 . . . . 0.0 112.636 0.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.3 m -43.01 -68.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.469 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.24 43.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.63 123.19 3.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.402 ' CG2' HD11 ' B' ' 122' ' ' ILE . 13.0 tt -131.19 151.68 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.36 100.13 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.602 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.38 113.19 1.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -81.06 132.73 35.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -49.15 170.12 0.14 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 72.6 Cg_endo -76.71 167.84 78.86 Favored 'Cis proline' 0 C--N 1.35 0.628 0 C-N-CA 123.898 -1.293 . . . . 0.0 112.699 0.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.5 m-85 -115.87 31.49 6.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.031 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.63 6.65 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.3 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -149.78 -178.69 6.6 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.75 0.31 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.07 108.08 20.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.942 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -111.43 132.78 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 94.9 m -106.89 135.96 47.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -116.91 122.09 43.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.29 150.85 44.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.443 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.456 HD11 HG22 ' B' ' 31' ' ' ILE . 15.0 mt -133.48 153.8 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.662 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.09 135.32 53.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.439 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 68.5 mt -145.48 121.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.73 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.6 m -118.32 153.47 33.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -94.52 81.63 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.74 -15.91 59.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.473 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.04 -154.19 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.84 -19.43 5.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.639 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mtp85 -132.72 167.29 20.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -49.86 164.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 31.3 pt -156.6 132.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.746 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.01 109.22 3.78 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.475 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.46 159.22 15.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.241 0.543 . . . . 0.0 111.899 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.7 155.08 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 25.4 mm -117.24 132.4 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.928 0.394 . . . . 0.0 111.576 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.07 150.65 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.809 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 31.5 p -143.16 153.75 43.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.008 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.6 -42.01 95.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.61 114.85 15.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.64 20.68 7.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -97.21 -31.58 12.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -113.38 -19.34 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -108.06 132.51 53.48 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.09 107.57 5.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.56 127.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -131.32 130.96 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.16 142.76 75.74 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.001 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.11 -31.87 44.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.491 2.127 . . . . 0.0 111.97 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 p -145.75 -177.98 5.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.424 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.26 -170.89 39.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.37 129.47 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.45 153.57 43.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.193 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.407 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.2 p30 -90.2 168.0 15.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.836 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 30.9 Cg_exo -61.71 133.71 46.66 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.455 2.103 . . . . 0.0 112.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.8 tttm 77.53 12.42 2.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.882 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -108.73 142.96 38.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.12 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.19 161.24 13.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.183 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.61 141.65 41.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.097 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 mt -117.78 118.99 33.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.016 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 9.7 mtm -112.53 158.07 20.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.63 102.12 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.284 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.88 109.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 43.0 m -91.32 130.06 37.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.1 t -115.09 150.9 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.681 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.98 154.66 21.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.7 p -58.67 160.87 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.413 ' CZ ' ' HB1' ' B' ' 79' ' ' ALA . 0.7 OUTLIER -173.38 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 92.4 m-20 -121.91 82.77 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' B' ' 77' ' ' PHE . . . -57.26 -22.12 39.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.232 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.335 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -141.72 43.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' B' ' 78' ' ' ASN . 19.8 mm-40 -122.58 6.29 9.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.627 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.41 140.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.52 24.31 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -142.01 28.33 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.12 9.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.06 126.86 35.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.82 139.79 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 78.2 mt -107.65 122.16 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.631 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 64.0 m -110.17 118.77 37.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.369 . . . . 0.0 111.512 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.38 154.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.7 101.7 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -122.17 137.77 54.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.034 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' B' ' 115' ' ' VAL . 0.8 OUTLIER -134.26 149.2 50.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.004 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.46 143.99 52.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 70.7 p -85.59 150.89 54.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . 0.411 ' HG2' ' CB ' ' B' ' 100' ' ' ALA . 39.8 Cg_endo -67.03 163.54 33.54 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.63 2.22 . . . . 0.0 111.996 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -47.1 116.53 1.4 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.12 46.56 56.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.78 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.411 ' CB ' ' HG2' ' B' ' 97' ' ' PRO . . . -65.01 150.69 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.48 164.96 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.462 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -89.78 71.24 7.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.99 140.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.84 120.22 9.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.22 156.2 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.94 -26.86 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.996 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -18.39 65.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.303 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.6 -16.39 56.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.405 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 2.4 m-85 . . . . . 0 C--N 1.332 -0.165 0 CA-C-O 120.673 0.273 . . . . 0.0 111.05 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' MET . . . . . 0.411 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 2.9 mtt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' B' ' 94' ' ' THR . 3.3 t 81.72 117.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.53 148.08 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.45 139.55 46.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.994 0.426 . . . . 0.0 111.199 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -125.43 166.72 16.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.595 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -121.77 151.78 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.076 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -140.99 88.56 10.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.17 141.49 48.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.632 2.222 . . . . 0.0 112.607 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.402 HD11 ' CG2' ' B' ' 17' ' ' ILE . 7.4 mm -107.09 138.36 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.752 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.68 159.06 39.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 111.256 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.478 ' HB3' ' CE2' ' B' ' 23' ' ' TYR . 97.5 m-85 -122.78 113.04 18.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 60.4 t30 -95.03 90.58 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.4 ' CD2' ' CE2' ' B' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.674 0.197 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.9 123.18 8.74 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.557 2.171 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.69 138.32 46.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -59.03 130.65 48.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.27 120.34 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.225 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 146.75 24.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.631 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.78 153.44 49.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.888 0.375 . . . . 0.0 111.218 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -144.85 108.94 4.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.657 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.0 165.18 37.32 Favored 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.842 -1.316 . . . . 0.0 112.664 0.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -45.13 -59.61 2.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.418 ' HA ' ' CD2' ' A' ' 120' ' ' LEU . 22.9 pt20 -170.9 45.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.15 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -178.52 132.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.7 tt -132.28 153.85 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.1 t -120.78 92.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.674 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.14 95.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.283 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.81 139.39 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.579 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -76.56 175.23 4.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.586 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 40.6 Cg_endo -66.7 165.58 64.44 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.683 0.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CE2' HD22 ' A' ' 126' ' ' LEU . 23.1 m-85 -108.63 43.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -123.06 7.21 9.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.323 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.17 142.14 48.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.3 115.63 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.05 103.3 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -84.76 102.47 13.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -89.48 117.91 28.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.659 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.39 135.43 33.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mt -119.98 133.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -97.93 139.18 34.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 111.342 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -133.02 146.22 32.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.652 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.41 HG21 ' N ' ' A' ' 35' ' ' ASN . 55.4 m -150.09 156.53 41.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 0.0 111.212 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.41 ' N ' HG21 ' A' ' 34' ' ' THR . 18.4 t30 -97.89 111.07 23.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.727 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.51 19.45 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.396 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.21 -140.49 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.566 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.44 53.19 0.47 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -175.97 177.12 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.432 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 25.5 ttm-85 -77.61 151.15 34.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 pt -146.58 167.47 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 111.38 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.64 106.14 0.63 Allowed Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.585 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -104.42 160.41 14.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.259 0.552 . . . . 0.0 111.75 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.65 143.11 17.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 mm -99.4 154.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.008 0.432 . . . . 0.0 111.634 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.53 132.08 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.4 149.7 42.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.77 -32.14 69.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.96 109.21 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.732 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.69 24.88 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.013 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.54 -55.38 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.23 -28.23 27.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.46 156.69 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.982 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.44 141.33 28.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 56' ' ' ASP . 2.2 p -139.21 161.07 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.966 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -176.49 131.06 0.37 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.813 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.17 148.71 92.58 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.186 0.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.6 -12.8 24.76 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.599 2.2 . . . . 0.0 112.847 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.54 172.75 0.72 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.45 174.48 38.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.449 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.432 ' CG1' ' HG2' ' A' ' 40' ' ' ARG . 21.7 t -107.12 114.42 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -87.53 169.54 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.072 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.412 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -129.89 176.3 2.94 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.792 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.6 Cg_exo -61.24 114.45 2.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.633 2.222 . . . . 0.0 112.291 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.69 32.28 13.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.411 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -97.9 148.0 23.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -113.53 156.2 24.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.84 144.76 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.04 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.51 137.07 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.0 158.76 34.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.03 35.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.187 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.03 91.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.895 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -82.77 151.67 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.48 116.61 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.11 142.78 58.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 p -56.55 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -133.43 -168.89 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -121.31 119.8 33.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.46 18.92 15.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.47 -24.44 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.229 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.3 p -143.1 41.63 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.036 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -138.33 159.59 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -89.2 134.19 34.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.62 56.09 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.48 25.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -134.02 6.58 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.637 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.57 108.21 19.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.812 0.339 . . . . 0.0 110.824 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.08 136.1 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.101 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.8 mt -94.87 163.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 m -144.87 123.96 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.51 98.1 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.85 136.93 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.675 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' A' ' 116' ' ' ARG . 6.6 p90 -145.52 143.69 30.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.161 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -141.46 143.48 33.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.78 122.48 14.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.0 p -52.93 145.05 24.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.79 160.53 43.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.534 2.156 . . . . 0.0 112.292 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.4 119.16 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.7 41.5 97.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.763 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.33 139.57 49.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.8 164.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 0.0 111.403 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 70.32 7.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.45 131.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -51.25 152.01 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.33 152.09 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -91.77 -23.71 19.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.069 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -18.91 65.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.39 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -60.18 -16.14 30.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.276 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.819 0.342 . . . . 0.0 110.89 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.2 mmt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p 176.84 115.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.431 ' HD3' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -102.23 154.14 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -139.73 96.82 3.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.029 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.34 162.42 18.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -140.56 126.52 19.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.067 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 15' ' ' GLN . 1.4 mt -110.85 100.52 46.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.42 144.13 74.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.604 2.203 . . . . 0.0 112.529 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 122' ' ' ILE . 8.2 mm -110.53 93.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.68 140.81 32.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -103.7 104.43 14.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.66 82.45 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.407 HD22 ' CE2' ' A' ' 23' ' ' TYR . 34.7 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.711 0.213 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.02 123.27 8.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.186 . . . . 0.0 112.286 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.7 138.33 46.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.567 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -58.95 130.75 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.839 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.37 120.51 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.85 146.89 24.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.537 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.93 153.3 49.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.204 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -144.72 108.99 4.77 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.07 165.17 37.76 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.611 0.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -45.02 -59.55 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 0.409 ' HA ' ' CD2' ' B' ' 120' ' ' LEU . 22.9 pt20 -170.95 44.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.148 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -178.49 132.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.41 . . . . 0.0 111.254 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 18.5 tt -132.25 154.0 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.721 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.98 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.812 0.339 . . . . 0.0 111.579 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -57.21 95.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.277 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.581 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -76.49 175.28 4.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 40.2 Cg_endo -66.51 165.73 62.55 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.951 -1.271 . . . . 0.0 112.786 -0.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . 0.41 ' CE2' HD22 ' B' ' 126' ' ' LEU . 23.1 m-85 -108.9 43.69 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.959 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.89 6.98 9.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.361 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.0 142.06 48.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.849 0.357 . . . . 0.0 110.972 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -65.16 115.44 5.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -115.91 103.16 10.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.749 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -84.53 102.37 12.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.083 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -89.51 117.87 28.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.725 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.26 135.36 33.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.332 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 22.6 mt -119.93 133.12 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.681 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -97.99 138.96 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.38 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -132.9 146.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' THR . . . . . 0.42 HG21 ' N ' ' B' ' 35' ' ' ASN . 55.1 m -150.13 156.41 41.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.276 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.42 ' N ' HG21 ' B' ' 34' ' ' THR . 18.4 t30 -97.71 111.08 23.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.51 19.34 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.2 -140.26 9.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.6 53.16 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -175.92 177.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.432 ' HG2' ' CG1' ' B' ' 61' ' ' VAL . 25.9 ttm-85 -77.66 151.17 34.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 pt -146.66 167.37 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 111.428 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.56 106.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.568 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 34.0 p-90 -104.53 160.57 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 111.703 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.87 142.92 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.461 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 14.2 mm -99.11 154.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.694 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.75 131.94 15.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.25 149.57 42.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.066 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.6 -32.33 68.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.75 109.18 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.66 24.71 5.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -55.3 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.36 -28.24 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.33 156.64 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.5 141.36 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' B' ' 56' ' ' ASP . 2.2 p -139.29 160.96 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.197 0.522 . . . . 0.0 111.004 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . 0.464 ' N ' ' CG2' ' B' ' 55' ' ' VAL . 0.5 OUTLIER -176.43 131.08 0.38 Allowed Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.826 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.17 148.6 92.31 Favored 'Cis proline' 0 C--N 1.352 0.731 0 C-N-CA 123.691 -1.379 . . . . 0.0 112.314 -0.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.49 -12.63 24.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.617 2.211 . . . . 0.0 112.916 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.37 172.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.33 174.4 38.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.556 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.432 ' CG1' ' HG2' ' B' ' 40' ' ' ARG . 21.7 t -106.99 114.64 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.066 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -87.78 169.35 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.411 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.3 OUTLIER -129.76 176.26 2.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 34.2 Cg_exo -61.17 114.4 2.18 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.665 2.244 . . . . 0.0 112.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.72 32.27 13.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.411 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -97.79 148.2 23.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -113.69 156.27 24.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.93 144.72 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.52 137.1 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.08 158.83 34.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.829 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.43 146.76 35.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.78 90.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -82.76 151.47 26.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.32 116.48 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.07 142.76 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -56.58 128.07 34.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.39 -168.8 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.02 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -121.45 119.71 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.35 18.93 15.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.53 -24.47 20.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.8 p -143.14 41.8 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -138.54 159.47 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -89.1 134.06 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.0 mt -123.45 55.98 1.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.44 25.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -133.76 6.33 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.687 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.54 108.05 19.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.797 0.332 . . . . 0.0 110.864 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.0 136.27 26.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.03 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.93 163.92 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -144.95 123.89 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.51 98.05 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.007 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.77 136.94 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' B' ' 116' ' ' ARG . 6.7 p90 -145.53 143.7 30.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 2.5 t -141.49 143.51 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.82 122.38 14.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 12.0 p -52.76 144.94 23.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.81 160.67 42.72 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.617 2.211 . . . . 0.0 112.22 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.43 119.1 3.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.085 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.66 41.92 97.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.587 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.63 139.7 49.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 111.048 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.09 164.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.342 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 70.46 7.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.651 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.51 131.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -51.21 151.98 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.21 152.26 50.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -92.21 -23.49 19.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.056 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -19.0 65.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.348 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -60.09 -16.36 31.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.213 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 5.1 mmt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.816 0.341 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p 176.72 115.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.431 ' HB3' ' CZ3' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -102.33 154.21 19.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -139.71 96.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.032 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 162.52 18.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -140.59 126.63 19.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.409 ' CD2' ' HA ' ' B' ' 15' ' ' GLN . 1.4 mt -110.98 100.53 46.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.4 144.15 73.94 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.425 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.48 HD11 HG22 ' B' ' 122' ' ' ILE . 8.3 mm -110.49 93.71 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.195 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.78 141.06 32.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.0 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -103.9 104.43 14.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.137 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.8 82.38 5.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' B' ' 23' ' ' TYR . 34.2 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.896 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.661 0.192 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.97 119.2 5.9 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.594 2.196 . . . . 0.0 112.284 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.64 131.6 40.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.5 113.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.2 pt -85.12 124.64 40.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.072 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -67.7 138.09 56.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.831 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.52 153.37 51.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.48 102.49 4.66 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.853 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.18 157.51 46.39 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.311 -0.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.59 -10.82 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.763 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.05 -61.5 1.67 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.909 0.385 . . . . 0.0 111.069 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -143.86 175.19 10.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.236 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 ' CG2' HD11 ' A' ' 122' ' ' ILE . 19.5 tt -148.11 123.16 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.729 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -113.41 118.01 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.457 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 29' ' ' TYR . 48.4 m-85 -77.12 96.03 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.48 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -70.36 131.95 44.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.535 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -58.39 169.19 1.04 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.736 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 67.8 Cg_endo -89.1 160.27 38.72 Favored 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.296 -1.127 . . . . 0.0 112.803 0.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -97.88 46.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.924 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.7 9.0 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.43 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.34 -5.87 7.7 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.59 134.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -153.32 101.27 2.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.2 m -75.12 102.71 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 36.9 m-85 -74.09 116.06 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.21 121.09 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -104.47 126.79 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.006 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.38 124.69 36.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 mt -119.29 158.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.3 m -162.0 153.07 17.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -95.87 108.79 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.628 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.34 22.11 5.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.87 -147.29 20.54 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.569 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.71 -25.38 2.86 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.686 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.85 167.45 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 110.99 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.43 162.34 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.553 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 8.3 pt -150.24 137.86 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.828 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.47 111.21 4.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.599 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.439 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 27.5 p-90 -105.22 157.86 16.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.116 0.484 . . . . 0.0 111.772 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.65 148.89 33.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 mm -121.67 150.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -151.75 135.93 16.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.681 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.36 154.53 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -62.42 -32.67 73.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.014 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.15 108.23 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.962 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.09 25.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.765 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.07 -38.11 6.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.775 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.29 -32.01 7.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.82 118.33 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.673 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.6 m -122.15 106.8 11.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.91 154.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.21 129.88 0.55 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.171 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.56 131.67 22.12 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.942 -1.274 . . . . 0.0 111.88 -0.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.23 -48.43 15.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.407 2.071 . . . . 0.0 112.051 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.3 p -135.96 -178.84 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.53 -168.22 33.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.64 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -144.75 142.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -134.04 136.91 44.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.033 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -64.77 -179.66 0.32 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.968 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 29.6 Cg_exo -61.52 116.18 3.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.585 2.19 . . . . 0.0 112.435 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.52 29.8 2.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -90.53 153.26 20.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.636 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -115.29 142.57 46.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.264 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.3 129.82 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.775 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.74 141.19 30.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 36.4 ttp -127.58 158.04 38.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.601 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.88 151.05 45.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.391 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.7 84.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.015 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.67 133.74 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 87.86 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.807 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.28 152.67 2.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -66.87 117.64 9.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -137.9 -163.99 1.54 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.62 139.04 43.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.712 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.56 18.64 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.509 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.33 15.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.02 47.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -138.29 165.82 25.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.15 127.0 18.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.5 84.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.997 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.53 25.16 7.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.178 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 73.27 93.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -70.37 147.61 49.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -142.35 137.37 30.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.418 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 78.8 mt -110.32 94.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.2 140.24 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 89' ' ' ILE . 3.9 mp -132.96 111.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.006 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.91 124.43 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.027 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.469 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 11.7 p90 -133.5 142.08 48.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -141.3 144.99 34.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -60.74 131.36 50.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 p -73.61 142.45 80.8 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.01 162.74 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.475 2.116 . . . . 0.0 112.16 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.44 118.31 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.95 45.65 70.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.265 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.75 167.71 7.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.211 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.11 163.67 27.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.34 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.44 69.83 8.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.13 146.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -69.8 116.72 10.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.99 155.14 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -84.01 -26.04 29.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -22.66 66.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -59.35 -17.7 31.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 2.7 m-85 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.422 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 120.959 0.409 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.427 ' CG2' ' HB ' ' A' ' 94' ' ' THR . 5.1 t 82.55 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.252 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.469 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 5.7 tpt180 -106.83 144.27 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -134.04 103.5 5.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 131.49 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.544 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.17 143.36 30.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.9 94.98 42.96 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.506 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.13 139.2 62.8 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.632 2.221 . . . . 0.0 112.58 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 17' ' ' ILE . 7.6 mm -114.51 111.9 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.96 127.91 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -89.39 107.4 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.27 76.89 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.946 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo . . . . . 0 C--O 1.231 0.137 0 CA-C-O 120.731 0.221 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.1 119.33 6.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.566 2.177 . . . . 0.0 112.256 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.67 131.4 40.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.293 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.13 113.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 111.019 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.469 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.2 pt -85.13 124.54 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -67.65 138.1 56.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.43 153.34 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.4 102.4 4.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.12 157.71 45.69 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.777 -1.343 . . . . 0.0 112.222 0.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.73 -10.78 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.729 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.06 -61.58 1.66 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.886 0.374 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -143.8 174.96 10.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.232 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.402 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 19.5 tt -147.94 123.23 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 44.4 t -113.49 117.96 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.53 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.461 ' CE2' ' CD1' ' B' ' 29' ' ' TYR . 48.3 m-85 -77.08 95.98 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.531 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -70.28 131.84 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.629 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -58.39 169.24 1.03 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.68 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 67.7 Cg_endo -89.12 160.23 38.62 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.712 0.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -97.92 46.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.882 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.87 8.98 4.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.345 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -5.97 7.74 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.68 134.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.768 0.318 . . . . 0.0 110.596 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.39 101.35 2.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -75.24 102.75 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CD1' ' CE2' ' B' ' 19' ' ' PHE . 36.9 m-85 -74.17 116.0 14.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -94.18 121.02 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.37 126.85 59.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.45 124.8 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.35 158.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.953 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.9 m -162.0 153.17 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -95.99 108.91 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.44 22.03 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.147 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.78 -147.46 20.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.573 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.59 -25.36 2.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.685 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 167.46 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.937 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.55 162.32 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.538 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 8.2 pt -150.22 137.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.401 . . . . 0.0 111.878 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.46 111.15 4.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.568 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.441 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 27.6 p-90 -105.09 157.85 16.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 111.763 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.68 148.97 33.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -121.71 150.67 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 111.679 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -151.8 136.1 16.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.51 154.42 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.387 . . . . 0.0 111.15 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 68.6 p -62.35 -32.76 73.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.03 108.13 13.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.006 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 30.7 mmm -102.92 25.13 9.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.13 -38.17 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.773 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.23 -32.0 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.79 118.63 36.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.667 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m -122.4 106.71 11.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.192 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.85 154.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.27 129.87 0.54 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.61 131.66 22.15 Favored 'Cis proline' 0 C--N 1.35 0.636 0 C-N-CA 123.932 -1.278 . . . . 0.0 111.887 -0.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.23 -48.5 15.61 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.327 2.018 . . . . 0.0 112.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p -135.8 -178.69 5.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.48 -168.32 33.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.651 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.76 142.86 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' B' ' 62' ' ' LEU . 0.4 OUTLIER -134.28 136.76 43.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.966 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -64.57 -179.73 0.32 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 29.6 Cg_exo -61.62 116.35 3.37 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.547 2.165 . . . . 0.0 112.377 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.44 29.75 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.407 ' CB ' ' HB2' ' B' ' 62' ' ' LEU . 0.5 OUTLIER -90.43 153.36 20.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.637 179.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -115.38 142.71 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.264 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.34 129.71 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.815 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.7 141.36 30.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.236 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 36.5 ttp -127.79 158.08 38.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.04 151.01 45.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.354 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.6 84.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.77 133.59 55.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.3 t -141.49 87.83 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.15 152.67 2.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -66.84 117.97 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -138.2 -164.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.57 139.14 43.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.69 18.64 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.508 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.83 -26.28 15.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 111.033 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -150.02 48.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.49 165.79 25.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.14 126.96 17.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 88.0 mt -151.47 84.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.44 25.11 7.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.216 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 73.49 93.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.894 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.42 147.63 49.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -142.39 137.3 30.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' B' ' 91' ' ' ILE . 77.9 mt -110.23 94.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.19 140.22 38.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.417 ' CD1' ' O ' ' B' ' 89' ' ' ILE . 3.9 mp -133.02 111.24 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.937 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.93 124.29 50.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.021 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 11.8 p90 -133.44 142.05 48.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.423 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 0.7 OUTLIER -141.26 145.07 35.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -60.74 131.35 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 3.9 p -73.6 142.36 80.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.05 162.49 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.512 2.141 . . . . 0.0 112.101 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.17 118.23 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.98 45.71 70.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.239 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.76 167.87 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 163.76 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.268 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 69.86 8.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.617 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.3 147.2 0.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.801 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.32 116.7 10.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.892 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.94 154.99 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -83.71 -26.43 29.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -22.68 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -59.45 -17.56 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.249 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 2.7 m-85 . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.891 0.377 . . . . 0.0 110.814 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' MET . . . . . 0.417 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.96 0.409 . . . . 0.0 110.897 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' B' ' 94' ' ' THR . 5.1 t 82.57 129.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.23 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.474 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 5.7 tpt180 -106.84 144.29 33.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.42 55.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.08 143.4 30.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.228 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.07 95.11 43.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.383 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 139.21 64.26 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.638 2.225 . . . . 0.0 112.548 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 7.6 mm -114.41 111.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.6 128.05 56.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.098 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -89.63 107.4 19.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.2 76.86 9.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.832 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 CA--C 1.528 0.204 0 CA-C-O 120.602 0.168 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.06 138.72 28.63 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.422 2.081 . . . . 0.0 112.342 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 111.84 2.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.541 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 8.3 p-10 -46.95 140.38 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.678 0.275 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.477 HG12 ' CE2' ' A' ' 93' ' ' TRP . 1.3 pt -116.71 147.12 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.39 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.2 145.03 25.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.17 144.0 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.297 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -133.05 111.46 13.14 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.59 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.84 161.81 60.19 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.928 -1.28 . . . . 0.0 112.446 0.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -20.48 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.385 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.56 -49.35 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.901 0.381 . . . . 0.0 111.205 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 152.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.429 ' CG2' HD11 ' A' ' 122' ' ' ILE . 12.3 tt -105.95 153.21 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 123' ' ' GLU . 8.0 p -136.19 100.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.418 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.12 114.26 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.542 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.92 142.1 38.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.287 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -66.39 170.6 5.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.732 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 6.9 Cg_exo -73.96 167.04 80.69 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.514 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -110.99 32.84 4.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -117.41 7.22 12.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.25 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.76 149.82 48.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.926 0.393 . . . . 0.0 110.961 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -67.5 107.95 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -108.01 138.09 44.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.846 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.16 112.86 24.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.094 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -105.03 108.5 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -79.76 151.08 30.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.407 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.422 HG21 ' N ' ' A' ' 32' ' ' LYS . 29.1 mm -126.06 150.06 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.713 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.422 ' N ' HG21 ' A' ' 31' ' ' ILE . 12.2 ttmm -104.85 120.57 41.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.93 0.395 . . . . 0.0 111.298 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.5 mt -121.9 130.06 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.717 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.425 HG21 ' N ' ' A' ' 35' ' ' ASN . 53.5 m -139.76 155.02 47.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.148 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.425 ' N ' HG21 ' A' ' 34' ' ' THR . 11.4 t-20 -92.46 114.24 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.763 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 8' ' ' ASP . . . -91.35 18.53 7.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.387 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.09 -141.43 6.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.52 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.43 52.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -174.59 164.78 3.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.776 0.322 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.18 137.09 46.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.733 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.431 ' CD1' HG23 ' A' ' 9' ' ' ILE . 2.5 pt -139.11 114.86 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.33 122.67 9.78 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.919 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -114.63 157.9 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 111.458 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.73 135.96 14.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.693 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 mm -93.06 141.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.472 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.26 133.03 15.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.58 160.37 32.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 111.139 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.73 -47.83 41.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -114.29 112.56 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 23.48 6.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.988 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -45.78 3.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -81.99 -50.82 8.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -76.21 154.08 35.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -143.84 110.9 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.774 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.04 146.71 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -164.26 123.75 1.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 135.42 38.59 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.774 -1.344 . . . . 0.0 112.08 0.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.48 -10.64 23.98 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 0.0 112.74 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 p -162.53 165.47 26.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.33 -154.78 25.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.542 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 t -135.02 149.26 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.79 123.41 47.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -77.02 168.27 29.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.73 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 36.3 Cg_endo -65.25 116.46 3.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.573 2.182 . . . . 0.0 112.454 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt 62.09 28.61 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -101.34 150.06 23.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.127 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 30.0 mttt -111.19 154.84 23.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.94 142.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.003 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.67 136.06 36.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 159.09 25.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.69 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.78 124.75 34.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.37 93.86 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.6 p -86.33 154.15 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.0 p -133.14 108.54 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.24 145.49 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 p -61.05 142.0 56.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.821 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.06 -169.92 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -116.44 111.77 20.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.41 20.37 11.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.35 -28.84 14.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.202 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.7 p -142.16 46.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -147.16 144.43 28.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.79 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -71.95 150.78 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.425 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 54.8 mt -132.95 66.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -157.48 31.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.025 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -132.72 6.35 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.649 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.91 117.19 33.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -149.02 134.19 18.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 62.2 mt -86.96 161.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.05 110.89 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.105 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.05 111.95 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' CG ' ' CB ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -113.72 131.61 56.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.969 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.477 ' CE2' HG12 ' A' ' 9' ' ' ILE . 17.8 p90 -141.67 150.48 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.6 t -154.34 154.61 33.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.49 153.51 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.408 HG23 ' CZ2' ' A' ' 108' ' ' TRP . 0.6 OUTLIER -101.41 133.06 21.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.786 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.03 158.2 11.91 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.461 2.108 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -52.73 124.21 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.85 32.19 70.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.386 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 96' ' ' THR . . . -62.03 -18.28 60.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.581 0.229 . . . . 0.0 111.452 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 73.01 166.06 0.3 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.359 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -87.22 71.29 10.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.22 129.42 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.46 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 77.5 t80 -56.94 150.32 16.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.4 155.24 45.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -93.05 22.33 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.35 -6.3 17.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.6 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.46 ' CH2' ' HA ' ' A' ' 104' ' ' PHE . 8.8 m0 -91.14 19.65 5.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.626 0.25 . . . . 0.0 111.057 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 C--N 1.333 -0.132 0 CA-C-O 120.758 0.313 . . . . 0.0 111.151 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.9 ptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.73 0.3 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.6 t -82.64 143.14 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.36 125.36 50.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.438 ' CB ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -135.5 153.72 51.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.31 135.5 48.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -96.18 129.48 43.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.261 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.9 mt -111.43 98.7 41.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.652 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.92 150.14 10.22 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.66 2.24 . . . . 0.0 112.596 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.429 HD11 ' CG2' ' A' ' 17' ' ' ILE . 37.5 mm -100.87 149.84 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.962 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 29.3 mt-10 -133.22 156.93 46.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.009 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 84' ' ' LEU . 54.6 m-85 -123.81 105.23 9.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.974 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -87.49 81.38 7.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.759 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.903 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 CA--C 1.527 0.128 0 CA-C-O 120.663 0.193 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 138.94 29.14 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.5 2.133 . . . . 0.0 112.289 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.28 112.05 2.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 36' ' ' ALA . 8.2 p-10 -47.0 140.34 4.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 111.089 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.477 HG12 ' CE2' ' B' ' 93' ' ' TRP . 1.3 pt -116.42 147.25 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.53 144.92 25.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.0 144.16 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.1 111.52 13.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.86 162.01 59.65 Favored 'Cis proline' 0 C--N 1.351 0.669 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.42 0.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -20.38 11.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.57 -49.47 4.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.07 152.26 1.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.425 ' CG2' HD11 ' B' ' 122' ' ' ILE . 12.4 tt -105.88 153.19 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' B' ' 123' ' ' GLU . 7.9 p -136.23 100.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.99 114.21 3.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.75 142.37 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -66.53 170.34 5.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.663 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 6.7 Cg_exo -74.21 167.09 80.78 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.559 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -111.04 32.99 4.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -117.54 7.19 12.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.211 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.67 150.14 48.32 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -67.84 107.88 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.87 138.17 44.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 112.88 24.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.14 108.51 20.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -79.51 150.99 31.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.435 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.421 HG21 ' N ' ' B' ' 32' ' ' LYS . 29.0 mm -126.1 150.15 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.689 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.437 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 12.0 ttmm -104.89 120.51 41.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.318 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -121.85 130.13 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.739 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' THR . . . . . 0.426 HG21 ' N ' ' B' ' 35' ' ' ASN . 52.9 m -139.8 155.12 47.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.426 ' N ' HG21 ' B' ' 34' ' ' THR . 11.4 t-20 -92.53 114.32 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.692 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' B' ' 8' ' ' ASP . . . -91.41 18.71 6.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.356 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.18 -141.46 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.564 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.25 51.85 0.55 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -174.32 164.84 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.15 137.12 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.434 ' CD1' HG23 ' B' ' 9' ' ' ILE . 2.5 pt -139.05 115.14 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.317 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.58 122.56 9.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.922 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -114.56 157.98 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.91 136.0 14.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.657 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 41.7 mm -93.13 141.92 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.5 133.1 15.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.754 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.73 160.45 32.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.06 0.457 . . . . 0.0 111.084 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -47.7 43.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -114.33 112.63 23.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 23.38 6.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -45.82 3.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.87 -50.97 8.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.13 154.26 35.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.143 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 9.7 m -144.03 110.81 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.07 146.53 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.213 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -164.19 123.74 1.31 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.26 135.33 38.02 Favored 'Cis proline' 0 C--N 1.352 0.748 0 C-N-CA 123.756 -1.352 . . . . 0.0 112.137 0.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.4 -10.45 23.96 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.507 2.138 . . . . 0.0 112.744 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 24.3 p -162.75 165.44 25.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.31 -154.93 26.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 t -134.88 149.28 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.789 0.328 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.88 123.28 46.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.99 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.43 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 0.6 OUTLIER -76.84 168.26 29.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.703 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 36.5 Cg_endo -65.25 116.56 3.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.587 2.191 . . . . 0.0 112.381 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt 62.04 28.55 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' B' ' 67' ' ' LYS . 0.2 OUTLIER -101.24 150.3 23.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . 0.411 ' N ' ' HG3' ' B' ' 66' ' ' GLU . 30.1 mttt -111.44 154.84 24.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.99 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 p -149.94 142.88 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.968 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.66 135.95 36.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.28 159.18 25.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.92 124.59 33.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.317 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 31.0 t -126.27 93.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -86.44 154.26 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 p -133.25 108.42 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -53.23 145.41 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.969 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.5 p -61.04 141.88 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.97 -169.8 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -116.54 111.55 20.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.29 20.54 11.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.41 -29.15 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 60.0 p -141.96 46.74 1.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -147.19 144.41 28.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -71.87 150.97 43.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' B' ' 124' ' ' TYR . 55.6 mt -133.16 67.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.784 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -157.51 32.08 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -132.8 6.31 3.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.615 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.81 117.27 33.96 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.878 0.37 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -149.11 134.08 18.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.77 161.09 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.99 111.01 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.12 111.92 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . 0.43 ' CG ' ' CB ' ' B' ' 117' ' ' ARG . 0.4 OUTLIER -113.68 131.63 56.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.477 ' CE2' HG12 ' B' ' 9' ' ' ILE . 18.0 p90 -141.59 150.74 42.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 11.5 t -154.55 154.68 33.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.56 153.49 4.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.966 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.4 HG23 ' CZ2' ' B' ' 108' ' ' TRP . 0.6 OUTLIER -101.37 132.99 21.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.0 158.17 11.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.5 2.133 . . . . 0.0 112.316 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -52.67 124.29 13.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.57 32.41 71.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.427 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.06 -18.35 60.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.611 0.243 . . . . 0.0 111.511 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 73.29 166.2 0.3 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.215 0.531 . . . . 0.0 111.231 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -87.49 71.45 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.78 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.35 129.36 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.461 ' HA ' ' CH2' ' B' ' 108' ' ' TRP . 77.3 t80 -56.83 150.29 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.45 155.13 45.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.973 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -92.93 22.32 5.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.159 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.33 -6.44 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.636 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.461 ' CH2' ' HA ' ' B' ' 104' ' ' PHE . 9.0 m0 -91.1 19.61 5.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.66 0.266 . . . . 0.0 111.069 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.746 0.307 . . . . 0.0 111.203 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.893 0.377 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 19.3 t -82.57 143.26 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.59 125.27 50.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . 0.43 ' CB ' ' CG ' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -135.4 153.63 51.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.181 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.24 135.6 48.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.623 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -96.23 129.36 43.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.293 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 79.1 mt -111.3 98.75 41.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.681 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.94 150.17 10.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.638 2.225 . . . . 0.0 112.518 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.425 HD11 ' CG2' ' B' ' 17' ' ' ILE . 36.9 mm -100.92 149.9 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.006 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.412 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . 30.4 mt-10 -133.23 156.87 46.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' B' ' 84' ' ' LEU . 55.5 m-85 -123.82 105.09 9.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 81.42 7.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.789 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.95 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 N--CA 1.465 -0.166 0 CA-C-O 120.697 0.207 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.67 157.87 51.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.296 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.09 129.6 9.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -50.77 129.99 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.411 HG12 ' CZ2' ' A' ' 93' ' ' TRP . 1.1 pt -99.16 120.22 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.426 ' ND2' ' HB ' ' A' ' 34' ' ' THR . 1.1 p30 -81.8 142.52 32.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.826 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -136.95 155.72 49.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.45 106.58 4.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.02 154.47 48.54 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.508 0.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -50.36 11.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.199 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -159.49 41.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.117 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -153.53 92.9 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.33 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 10.4 tt -123.28 130.78 74.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.599 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.43 HG22 ' CB ' ' A' ' 123' ' ' GLU . 7.4 p -138.97 113.98 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.516 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -71.84 104.6 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.376 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 153.52 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.595 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -77.11 170.35 16.77 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.655 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 96.1 Cg_endo -79.07 166.77 78.23 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.786 0.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' CD2' ' A' ' 126' ' ' LEU . 22.3 m-85 -106.84 50.03 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.871 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.53 -3.33 10.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.309 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -137.5 150.31 47.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.844 0.354 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.82 110.72 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.25 83.49 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 114.94 10.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.81 132.92 42.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.15 138.89 38.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.96 145.18 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.442 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.86 138.85 39.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 mt -121.04 157.92 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.64 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.426 ' HB ' ' ND2' ' A' ' 10' ' ' ASN . 88.8 m -162.12 148.53 13.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -121.03 84.63 2.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 110.495 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.42 -27.32 0.68 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.56 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.65 154.08 1.4 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.685 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.71 54.83 0.93 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.435 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 154.89 4.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -65.79 148.37 51.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.5 pt -145.47 165.55 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.07 106.51 0.91 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 62.5 p-90 -104.29 157.58 17.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.227 0.537 . . . . 0.0 112.183 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 153.44 40.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.357 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 91' ' ' ILE . 11.9 mm -119.92 145.36 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.979 0.419 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.69 134.83 20.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.683 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.1 p -112.36 153.74 26.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.071 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -26.17 18.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.721 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.68 114.16 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.3 19.84 5.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.285 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -96.33 -44.27 7.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.87 -50.7 4.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.96 153.76 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.27 151.25 28.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.017 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.8 150.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.786 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.15 115.71 0.62 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.51 139.56 61.34 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.219 -0.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 -32.94 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.655 2.237 . . . . 0.0 112.185 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 m -139.68 155.59 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 179.28 159.29 23.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.419 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 10.6 p -96.1 114.6 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.217 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.91 166.07 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 3.9 m-20 -119.18 166.21 15.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.781 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.01 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.752 2.301 . . . . 0.0 112.518 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 70.18 38.92 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 155.56 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.996 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.11 136.48 50.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG22 ' CZ2' ' A' ' 43' ' ' TRP . 5.9 m -122.33 129.16 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.039 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 127.04 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.793 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.47 159.03 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.0 155.33 26.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.48 82.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.792 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -53.24 136.32 36.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.196 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 51.2 m -152.62 82.11 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.04 150.16 45.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.85 162.16 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -167.56 -169.51 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -102.33 114.53 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.98 22.19 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.407 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.84 -32.16 12.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.0 p -142.91 56.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.61 179.84 4.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.68 82.42 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.002 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 8.3 mt -117.11 67.76 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.417 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -85.94 -27.97 24.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 85' ' ' ASN . 3.0 m-80 178.54 -49.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.324 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.09 147.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -155.45 132.74 10.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.161 0.505 . . . . 0.0 111.938 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.5 mt -101.15 102.18 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.71 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -83.75 138.12 33.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.091 0.472 . . . . 0.0 111.675 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 45' ' ' ILE . 12.9 mt -122.4 123.6 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.09 112.43 19.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.485 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 10.6 p90 -126.87 128.74 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.437 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 1.4 t -127.87 148.99 50.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.393 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -52.03 147.55 7.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.8 p -84.64 134.69 41.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.6 161.44 2.96 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.31 2.006 . . . . 0.0 111.94 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -50.81 125.39 13.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.76 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.21 48.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.241 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.62 143.32 57.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 111.241 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.14 164.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.267 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -88.4 69.82 9.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.61 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 179.16 137.69 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.802 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -54.97 145.75 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.435 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 5.2 mmt180 -131.74 150.71 52.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.09 -25.46 23.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.936 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.86 -14.97 59.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.502 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.435 ' CD2' ' HB2' ' A' ' 105' ' ' ARG . 19.0 m0 -55.45 -20.43 12.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.281 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.739 0.304 . . . . 0.0 111.07 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.86 0.362 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.437 ' CG2' ' HB ' ' A' ' 94' ' ' THR . 25.5 t -122.6 130.22 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.485 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 10.5 mtt180 -103.09 137.38 41.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.17 102.42 6.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.22 170.84 8.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.583 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.8 122.86 13.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.98 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 106.26 38.33 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.663 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.2 138.63 82.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.514 2.143 . . . . 0.0 112.79 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 5.0 mm -110.97 150.81 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.591 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' CB ' HG22 ' A' ' 18' ' ' VAL . 67.6 mt-10 -141.53 140.87 33.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 0.0 111.423 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CE1' ' HB3' ' A' ' 84' ' ' LEU . 38.4 m-85 -101.66 96.82 7.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.11 94.79 3.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.429 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 42.0 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 CA--C 1.527 0.144 0 CA-C-O 120.74 0.225 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.68 157.88 51.5 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.596 2.197 . . . . 0.0 112.24 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.18 129.7 9.22 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -50.88 129.99 24.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.412 HG12 ' CZ2' ' B' ' 93' ' ' TRP . 1.1 pt -99.11 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.007 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . 0.434 ' ND2' ' HB ' ' B' ' 34' ' ' THR . 1.1 p30 -81.85 142.66 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.843 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 16.0 p -137.02 155.83 49.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.27 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.6 106.55 4.34 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.649 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.02 154.4 48.53 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.613 0.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -50.27 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.185 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -159.67 41.89 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -153.51 92.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.301 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.465 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 10.5 tt -123.19 130.89 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.434 HG22 ' CB ' ' B' ' 123' ' ' GLU . 7.6 p -138.97 113.84 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.568 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -71.76 104.69 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.3 153.32 42.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.439 . . . . 0.0 111.525 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -76.9 170.32 16.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.672 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 97.1 Cg_endo -78.97 166.97 77.93 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.027 -1.239 . . . . 0.0 112.759 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' B' ' 126' ' ' LEU . 22.2 m-85 -106.98 49.89 0.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.872 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.48 -3.16 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.304 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -137.57 150.36 47.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.82 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 110.75 3.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.19 83.84 1.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 85.6 m -72.27 114.77 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.62 133.0 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.29 138.93 38.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.406 ' N ' HD11 ' B' ' 31' ' ' ILE . 5.3 mp -131.92 145.31 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.549 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.07 138.5 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.941 0.4 . . . . 0.0 111.481 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.79 157.67 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.659 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' THR . . . . . 0.434 ' HB ' ' ND2' ' B' ' 10' ' ' ASN . 87.7 m -161.93 148.5 13.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -120.95 84.6 2.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.513 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.47 -27.34 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.77 153.8 1.54 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.657 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.44 55.0 0.95 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 154.97 4.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.8 0.333 . . . . 0.0 110.827 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -65.9 148.23 52.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.737 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 pt -145.16 165.57 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 111.586 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -125.15 106.21 0.89 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 62.7 p-90 -104.27 157.37 17.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.217 0.532 . . . . 0.0 112.207 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.88 153.38 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.422 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.423 ' CD1' HG12 ' B' ' 91' ' ' ILE . 12.3 mm -119.88 145.51 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.81 134.74 20.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 36.7 p -112.27 153.52 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.22 -26.21 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.739 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.65 114.15 7.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.23 19.85 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -96.32 -44.38 7.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.741 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.83 -50.79 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.88 154.01 30.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.5 151.11 28.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.7 150.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.09 115.86 0.62 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.47 139.6 61.5 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.098 -0.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.41 -32.84 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.547 2.165 . . . . 0.0 112.102 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.64 155.58 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.479 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 179.4 159.5 23.55 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.411 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 p -96.29 114.79 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.211 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.08 166.19 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.43 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 3.8 m-20 -119.29 166.2 15.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.685 2.257 . . . . 0.0 112.483 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? 69.81 39.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.67 155.47 24.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.02 136.39 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.99 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.445 HG22 ' CZ2' ' B' ' 43' ' ' TRP . 6.0 m -122.27 128.76 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.16 126.84 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.28 158.97 37.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.83 155.36 25.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.52 82.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.759 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 15.1 m -52.94 136.29 34.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.158 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 50.9 m -152.65 82.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.66 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.13 150.07 46.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.84 162.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -167.56 -169.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -102.46 114.63 28.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.1 22.22 5.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.344 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.03 -31.95 12.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.223 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.4 p -143.16 56.18 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -123.74 179.93 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.73 82.46 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.453 ' HB3' ' CE1' ' B' ' 124' ' ' TYR . 8.1 mt -117.08 67.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.73 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 0.7 OUTLIER -85.97 -28.05 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 85' ' ' ASN . 2.9 m-80 178.61 -49.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.01 147.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 -155.5 132.67 10.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 111.869 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 56.8 mt -101.11 102.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.744 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 20.3 m -83.73 137.89 33.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.187 0.518 . . . . 0.0 111.654 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.423 HG12 ' CD1' ' B' ' 45' ' ' ILE . 13.0 mt -122.32 123.47 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.269 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -119.99 112.48 19.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 10.5 p90 -126.84 128.79 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.573 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 1.4 t -128.02 148.91 50.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.391 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -51.91 147.73 6.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -84.75 134.71 41.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.63 161.57 2.91 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.384 2.056 . . . . 0.0 111.867 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -50.87 125.37 13.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.09 48.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.203 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.51 143.11 57.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 0.0 111.34 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.65 164.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.288 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -88.61 69.82 8.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.53 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? 179.2 137.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.812 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -55.34 145.95 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.991 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 5.0 mmt180 -131.93 150.71 52.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.22 -25.25 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.007 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.93 -15.14 59.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.454 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.441 ' CD2' ' HB2' ' B' ' 105' ' ' ARG . 19.0 m0 -55.27 -20.45 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.613 0.245 . . . . 0.0 111.25 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 111.104 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.789 0.328 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' B' ' 94' ' ' THR . 25.5 t -122.5 130.45 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.479 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 10.5 mtt180 -103.18 137.51 41.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.734 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.31 102.3 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.411 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.11 170.91 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.578 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -142.78 123.02 13.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.53 106.2 38.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.677 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.14 138.81 83.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.62 2.213 . . . . 0.0 112.77 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.465 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 5.0 mm -111.21 150.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.513 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.434 ' CB ' HG22 ' B' ' 18' ' ' VAL . 67.6 mt-10 -141.79 140.59 33.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 111.442 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' B' ' 84' ' ' LEU . 37.5 m-85 -101.44 96.68 7.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.94 94.88 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' B' ' 23' ' ' TYR . 41.3 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 CA--C 1.527 0.147 0 CA-C-O 120.666 0.194 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.29 135.51 46.96 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.568 2.178 . . . . 0.0 112.173 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.3 122.91 16.17 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.273 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.7 108.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.36 145.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.317 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.5 146.7 23.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.576 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.07 155.9 49.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.24 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -153.96 106.23 2.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.645 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.73 161.97 45.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.474 0.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.3 -10.96 11.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.616 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.28 -56.35 2.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.879 0.371 . . . . 0.0 111.18 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.89 -175.43 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tt -150.26 136.34 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 123' ' ' GLU . 7.3 p -126.19 107.94 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.711 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -65.13 119.99 11.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -84.37 134.95 34.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 111.654 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -51.74 170.5 0.21 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.683 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 89.1 Cg_endo -80.13 164.11 81.07 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 124.065 -1.223 . . . . 0.0 112.721 0.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 20.2 m-85 -109.62 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.81 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.22 5.65 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.155 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.67 129.09 25.93 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 0.0 110.773 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.79 106.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -105.61 150.3 25.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.44 97.97 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -87.23 125.52 34.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.4 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -94.97 130.68 41.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.6 mt -97.84 150.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.663 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -104.6 134.27 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.361 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.8 mt -136.87 154.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.1 m -153.83 158.35 40.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.061 0.458 . . . . 0.0 111.238 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 20.4 t-20 -107.85 114.04 27.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.544 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.02 19.91 6.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.424 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.3 -177.26 19.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.632 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.45 19.63 26.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.71 161.94 37.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -65.67 164.11 15.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 pt -149.19 142.0 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.403 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.42 100.98 2.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.731 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -105.71 149.76 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.047 0.451 . . . . 0.0 111.528 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.57 132.23 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.597 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 9.2 mm -92.75 151.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.268 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -138.63 138.2 37.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -124.25 148.97 46.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -55.7 -40.08 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -127.52 118.17 23.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.73 16.72 7.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.408 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -110.88 -31.63 7.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -23.11 14.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 mt -126.85 138.75 53.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.988 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 m -149.5 116.7 6.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.43 153.48 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -145.65 123.3 6.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.0 144.93 77.32 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.498 0.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.21 -13.63 40.26 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.584 2.19 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.61 130.75 0.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 110.586 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.21 -178.82 25.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.668 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 10.5 p -114.34 111.52 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.56 145.48 31.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 2.8 m-20 -101.81 171.88 4.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' O ' ' CD ' ' A' ' 65' ' ' LYS . 42.3 Cg_exo -57.06 127.87 27.54 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.527 2.151 . . . . 0.0 112.505 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CD ' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 46.89 34.86 2.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.4 136.64 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.67 113.82 27.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.057 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.87 155.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.87 119.3 26.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.83 164.66 13.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.46 155.46 30.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.399 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.5 t -129.68 104.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.798 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 125.69 32.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 p -129.6 98.19 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.712 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.84 153.9 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -64.62 151.16 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.481 ' CZ ' ' CD2' ' A' ' 124' ' ' TYR . 3.5 p90 -148.58 -161.44 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.089 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.09 93.47 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.23 -19.02 64.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.58 -28.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.788 0.328 . . . . 0.0 111.462 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 71.7 p -143.56 59.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 81' ' ' THR . 47.1 mt-10 -159.24 160.31 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -82.76 153.16 25.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.414 HD21 ' CD1' ' A' ' 124' ' ' TYR . 12.5 mt -128.43 38.36 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.67 30.04 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.16 -45.37 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.39 138.47 54.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 132.3 3.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.82 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 78.4 mt -107.73 121.93 61.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 118' ' ' LYS . 4.0 m -103.79 138.76 39.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 91' ' ' ILE . 4.0 mp -118.16 124.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 122.01 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.407 ' CZ2' ' HB2' ' A' ' 116' ' ' ARG . 6.2 p90 -130.94 143.66 50.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.429 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 1.3 t -145.18 120.57 10.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -43.22 142.83 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.595 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 p -82.01 146.06 54.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.953 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.69 165.92 14.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.547 2.164 . . . . 0.0 112.158 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -45.16 114.38 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.498 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.73 49.67 16.16 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.902 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.6 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 172.68 163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.074 0.464 . . . . 0.0 111.243 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.49 69.51 9.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.518 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.21 128.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.735 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -48.97 131.28 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.994 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -121.47 150.33 41.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 27.16 7.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.27 -1.09 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.787 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -92.47 19.87 6.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.588 0.232 . . . . 0.0 111.193 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.28 . . . . 0.0 111.306 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.444 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 1.4 mpt? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.976 0.417 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 114' ' ' MET . 4.5 t 87.07 106.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.39 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.407 ' HB2' ' CZ2' ' A' ' 93' ' ' TRP . 48.0 mtt-85 -98.87 146.14 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.67 156.78 17.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.385 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -145.18 161.74 38.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.524 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.93 148.97 34.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.33 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.6 mt -151.17 86.36 4.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.569 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.1 158.77 3.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.697 2.265 . . . . 0.0 112.66 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.1 mm -114.53 145.72 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.048 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -139.06 165.12 27.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 111.037 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 90.1 m-85 -132.59 108.2 8.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.993 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.18 83.18 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.6 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.831 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.684 0.202 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.27 135.47 46.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.206 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.35 122.98 16.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.306 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -50.67 108.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.25 145.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.67 146.64 24.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.559 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.88 156.09 48.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.232 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -154.18 106.32 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.661 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.76 162.06 45.87 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.872 -1.304 . . . . 0.0 112.381 0.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -11.02 11.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.23 -56.31 2.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 111.204 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -154.9 -175.3 5.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tt -150.44 136.36 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.638 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' B' ' 123' ' ' GLU . 7.3 p -126.25 107.86 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.702 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -65.19 119.96 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.3 134.99 34.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -51.72 170.52 0.21 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.637 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -80.19 164.12 80.87 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.704 0.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 20.2 m-85 -109.58 47.42 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.29 5.62 5.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.66 128.97 25.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.768 0.318 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.7 106.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.65 150.33 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.676 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.49 97.87 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.091 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.04 125.52 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.546 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -94.95 130.64 41.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.89 150.54 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -104.6 134.48 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 23.8 mt -137.01 154.92 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.818 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -153.93 158.2 40.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.145 0.497 . . . . 0.0 111.251 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -107.75 114.05 27.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.493 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.19 20.09 6.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.365 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.61 -177.58 18.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.32 19.92 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.613 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.89 162.07 37.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.734 0.302 . . . . 0.0 110.788 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -65.86 164.09 15.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.664 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 pt -149.18 141.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.429 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.26 101.12 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.696 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -105.85 149.71 26.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 111.516 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.46 132.38 19.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.673 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 9.1 mm -92.77 151.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.323 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -138.7 138.29 37.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 30.6 p -124.29 149.19 46.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.2 p -55.95 -40.14 72.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -127.4 117.97 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.853 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.51 16.62 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.383 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -110.77 -31.7 7.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -23.19 14.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 mt -126.75 138.75 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.963 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 36.7 m -149.39 116.73 6.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.52 153.47 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -145.64 123.41 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.98 145.03 77.62 Favored 'Cis proline' 0 C--N 1.351 0.67 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.481 -0.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.2 -13.63 40.29 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.15 . . . . 0.0 112.524 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.6 130.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.613 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.12 -178.79 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.606 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' B' ' 61' ' ' VAL . 10.3 p -114.41 111.37 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.38 145.56 31.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.021 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.8 171.79 5.01 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.417 ' O ' ' CD ' ' B' ' 65' ' ' LYS . 41.5 Cg_exo -56.91 127.94 27.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.546 2.164 . . . . 0.0 112.558 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.417 ' CD ' ' O ' ' B' ' 64' ' ' PRO . 0.0 OUTLIER 46.72 34.8 2.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.623 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.32 136.77 40.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 113.9 27.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.014 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.92 155.22 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.96 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.95 119.21 26.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.022 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.75 164.7 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.722 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.55 155.29 31.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.54 104.72 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.776 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.34 125.19 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.977 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 1.7 p -129.11 98.1 4.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 153.89 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -64.73 151.11 45.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.76 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.483 ' CZ ' ' CD2' ' B' ' 124' ' ' TYR . 3.5 p90 -148.52 -161.55 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.999 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.05 93.41 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.17 64.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.45 -29.23 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.751 0.31 . . . . 0.0 111.404 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -143.28 59.33 1.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -159.22 160.34 35.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -82.82 153.36 25.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' B' ' 124' ' ' TYR . 12.4 mt -128.53 38.24 4.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.52 30.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.41 -45.19 3.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.48 138.53 54.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 132.26 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 77.6 mt -107.73 121.81 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' B' ' 118' ' ' LYS . 4.0 m -103.77 138.84 39.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.416 HD11 ' N ' ' B' ' 91' ' ' ILE . 4.0 mp -118.26 124.33 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.31 121.95 37.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.409 ' CZ2' ' HB2' ' B' ' 116' ' ' ARG . 6.2 p90 -130.91 143.7 50.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.091 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.438 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 1.3 t -145.18 120.5 10.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -43.24 142.87 0.94 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.513 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 6.9 p -81.99 146.03 54.59 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 165.76 15.12 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.597 2.198 . . . . 0.0 112.168 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -44.9 114.5 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.537 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.55 49.63 15.5 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.905 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.35 -76.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.035 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 172.38 163.57 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 111.161 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.55 69.41 9.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.4 128.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -48.98 131.24 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.065 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -121.41 150.28 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 26.93 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -113.08 -1.01 14.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.789 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -92.67 20.15 6.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.703 0.287 . . . . 0.0 111.185 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.179 -179.811 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' MET . . . . . 0.437 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 1.4 mpt? . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.041 0.448 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.438 ' CG2' ' HB ' ' B' ' 94' ' ' THR . 4.5 t 87.06 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.318 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.409 ' HB2' ' CZ2' ' B' ' 93' ' ' TRP . 48.2 mtt-85 -99.05 146.23 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.78 156.73 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' B' ' 90' ' ' THR . 0.0 OUTLIER -145.11 161.73 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.481 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -144.96 148.95 34.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 35.1 mt -151.11 86.44 4.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.582 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.09 158.94 2.94 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.691 2.261 . . . . 0.0 112.683 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 25.3 mm -114.74 145.73 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.002 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . 0.3 OUTLIER -139.08 165.0 28.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.056 0.455 . . . . 0.0 111.093 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' B' ' 77' ' ' PHE . 90.0 m-85 -132.51 108.09 8.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.976 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.05 83.23 3.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.906 179.897 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 CA--C 1.527 0.14 0 CA-C-O 120.752 0.23 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.27 138.83 62.94 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.532 2.155 . . . . 0.0 112.303 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.15 -152.92 0.41 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -112.06 151.84 28.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.765 0.316 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.433 HG22 ' CD1' ' A' ' 93' ' ' TRP . 1.1 pp -110.75 127.55 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.157 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.19 152.48 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.0 143.03 30.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.95 111.08 24.59 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.51 168.53 24.73 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.09 -1.213 . . . . 0.0 112.828 0.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -38.9 -48.76 1.61 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.99 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 177.22 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.033 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.57 112.19 16.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.1 tt -113.22 130.06 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 38.8 t -105.37 87.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.879 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -51.81 101.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.356 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -72.13 137.82 47.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.539 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -70.2 169.34 13.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 72.6 Cg_endo -76.11 166.23 83.41 Favored 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.641 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 17.2 m-85 -108.14 30.41 6.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.14 7.38 36.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.353 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -135.18 154.64 51.55 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.859 0.361 . . . . 0.0 111.101 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -71.34 131.98 44.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -140.24 93.15 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.78 111.4 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -98.09 106.42 18.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -79.37 121.29 24.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -109.81 125.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.21 155.42 16.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -133.89 154.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.404 HG21 ' N ' ' A' ' 35' ' ' ASN . 53.9 m -144.84 151.69 39.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.404 ' N ' HG21 ' A' ' 34' ' ' THR . 14.0 t-20 -98.51 105.48 17.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.673 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.88 20.93 6.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.28 20.26 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.469 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.81 40.34 2.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 175.87 161.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -55.15 169.85 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.706 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 pt -158.92 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.82 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.16 107.08 2.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.444 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 51.3 p-90 -103.76 159.37 15.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 112.033 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.73 145.06 30.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.449 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 13.1 mm -123.9 151.11 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.033 0.444 . . . . 0.0 111.553 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.38 163.41 39.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.1 p -139.37 149.82 44.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.984 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.42 -31.06 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.967 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -136.1 117.74 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.03 16.56 8.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.327 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -54.84 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.93 -40.14 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 122.4 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.638 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.12 107.84 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.207 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.53 129.12 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -140.28 140.92 24.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.06 153.37 97.47 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.917 -1.285 . . . . 0.0 112.265 0.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.55 -11.68 26.45 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.589 2.193 . . . . 0.0 112.662 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.4 p -172.68 158.77 4.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.903 0.382 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 175.86 148.04 6.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.69 128.02 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 165.32 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -117.41 169.59 7.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.32 112.96 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.584 2.189 . . . . 0.0 112.515 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 62.56 34.86 14.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.282 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -102.19 154.61 18.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.43 160.28 16.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.436 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.01 151.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.698 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.2 125.13 53.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 ttm -121.61 158.54 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.75 38.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.507 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.6 t -114.05 91.73 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.749 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.38 129.41 39.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.247 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 10.7 t -130.56 140.16 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.1 151.97 26.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 p -55.6 111.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.918 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 23' ' ' TYR . 27.2 p90 -118.82 -172.43 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.98 126.93 52.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.17 19.01 21.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.329 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.28 -25.19 21.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -135.64 29.23 3.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.53 129.2 20.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.69 146.94 29.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.1 mt -117.31 41.44 2.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.847 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.35 25.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -118.26 -15.1 9.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.468 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.98 114.52 13.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.841 0.353 . . . . 0.0 111.013 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.19 135.52 21.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.436 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 15.6 mt -98.46 107.63 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -71.03 121.12 17.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.06 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 45' ' ' ILE . 14.2 mm -109.86 149.76 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.816 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -148.23 159.92 43.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.488 ' CZ2' ' HB3' ' A' ' 116' ' ' ARG . 10.0 p90 -177.91 123.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 134.75 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -56.34 112.78 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.441 HG23 ' CH2' ' A' ' 108' ' ' TRP . 8.1 p -58.72 148.22 68.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.22 164.68 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.628 2.219 . . . . 0.0 112.316 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.48 115.54 1.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.292 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.04 47.81 32.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.732 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.09 166.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 110.955 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.49 16.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.097 0.475 . . . . 0.0 111.404 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 70.96 8.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.643 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 132.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.838 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -53.25 152.45 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 13.3 mmm180 -136.91 145.25 44.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.35 -27.71 19.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.55 -18.76 65.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.441 ' CH2' HG23 ' A' ' 96' ' ' THR . 26.5 m0 -56.58 -20.35 20.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.307 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 111.049 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.62 127.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.488 ' HB3' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -119.07 157.87 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.94 124.61 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.35 131.76 40.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.762 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.1 122.65 39.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.075 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 mt -81.72 133.42 52.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.547 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.35 134.94 11.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.611 2.207 . . . . 0.0 112.697 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.426 ' O ' ' CE1' ' A' ' 124' ' ' TYR . 7.5 mm -108.06 82.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.016 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 162.06 26.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' A' ' 122' ' ' ILE . 57.5 m-85 -131.08 100.75 5.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.901 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.426 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 28.6 t30 -80.07 81.5 6.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.919 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 CA-C-O 120.731 0.221 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.33 139.07 63.75 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.317 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.41 -152.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.21 151.76 29.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.436 HG22 ' CD1' ' B' ' 93' ' ' TRP . 1.1 pp -110.62 127.28 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.0 152.5 41.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.09 142.95 30.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 0.0 111.488 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.89 111.0 24.77 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.38 168.48 24.26 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.9 0.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.7 t -38.85 -48.76 1.59 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.98 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 177.21 -50.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -79.58 112.14 16.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 7.7 tt -113.33 130.18 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 39.2 t -105.3 87.31 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.934 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -51.37 100.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.423 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -71.97 137.73 47.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.48 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -70.15 169.27 13.93 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.697 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 72.1 Cg_endo -76.16 166.27 83.27 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.736 0.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' B' ' 77' ' ' PHE . 17.1 m-85 -108.22 30.38 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.09 7.46 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -135.27 154.63 51.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.341 . . . . 0.0 111.12 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -71.37 132.12 44.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -140.31 93.24 2.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.85 111.48 11.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.984 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -98.06 106.5 18.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -79.45 121.51 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.12 125.32 67.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 155.43 16.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.268 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.99 153.83 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.617 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' THR . . . . . 0.427 HG21 ' N ' ' B' ' 35' ' ' ASN . 54.1 m -144.75 151.74 39.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 111.474 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.427 ' N ' HG21 ' B' ' 34' ' ' THR . 14.2 t-20 -98.63 105.54 17.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.616 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.83 20.85 6.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.308 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.54 -161.12 20.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.89 40.28 2.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.531 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 175.89 161.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -55.21 169.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.607 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 pt -158.92 115.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 0.0 111.864 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.06 107.18 2.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.478 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 51.2 p-90 -103.87 159.22 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.51 145.11 30.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.353 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.43 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 13.0 mm -123.89 150.94 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 111.627 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.23 163.51 38.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.552 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 24.3 p -139.5 149.69 44.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.27 -31.24 13.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.008 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -135.89 117.74 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.0 16.48 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.78 -55.03 2.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 110.506 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.82 -40.3 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.88 122.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.711 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.06 108.2 13.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.83 129.09 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.027 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -140.21 140.92 24.68 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.0 153.46 97.64 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.199 0.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.72 -11.52 26.03 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.52 2.146 . . . . 0.0 112.582 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 20.1 p -172.74 158.67 4.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 175.98 147.99 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.51 128.1 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.91 165.37 11.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.807 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.437 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.9 OUTLIER -117.54 169.63 7.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.451 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.43 112.66 1.19 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.645 2.23 . . . . 0.0 112.534 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp 62.8 34.99 14.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.197 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.437 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -102.19 154.64 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.51 160.38 16.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.344 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.15 151.88 15.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.629 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.2 125.12 53.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.311 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 2.1 ttm -121.7 158.62 28.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.523 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.8 38.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.489 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.17 91.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.651 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.29 129.36 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 10.8 t -130.67 140.0 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -110.04 152.24 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.038 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.3 p -55.8 112.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' B' ' 23' ' ' TYR . 27.5 p90 -119.02 -172.39 2.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.005 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.0 127.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.71 21.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.13 -25.13 22.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 111.121 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.8 p -135.69 29.23 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.037 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.42 129.35 20.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.87 146.94 30.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 29.1 mt -117.32 41.57 2.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.42 24.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -118.0 -15.28 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.561 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.94 114.6 13.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.888 0.375 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.2 135.53 21.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.43 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 15.7 mt -98.52 107.65 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -70.97 121.1 17.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.128 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' B' ' 45' ' ' ILE . 14.4 mm -109.89 149.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.907 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -148.12 159.98 43.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.016 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' B' ' 116' ' ' ARG . 10.1 p90 -177.94 123.57 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.908 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.79 134.66 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -56.56 112.57 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.438 HG23 ' CH2' ' B' ' 108' ' ' TRP . 8.0 p -58.4 147.94 66.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.01 164.68 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.602 2.201 . . . . 0.0 112.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.51 115.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.208 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.98 47.77 31.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.825 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 166.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.019 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.75 164.63 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.179 0.514 . . . . 0.0 111.342 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 71.03 7.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.608 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.91 132.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.07 152.27 4.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 13.3 mmm180 -136.77 145.28 44.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -27.89 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.49 -18.5 65.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.279 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.438 ' CH2' HG23 ' B' ' 96' ' ' THR . 26.1 m0 -56.86 -20.22 21.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.981 -179.904 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.866 0.365 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.59 127.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.475 ' HB3' ' CZ2' ' B' ' 93' ' ' TRP . 0.1 OUTLIER -119.09 157.94 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.04 124.86 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.057 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.56 131.75 40.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.401 ' N ' ' ND2' ' B' ' 119' ' ' ASN . 0.7 OUTLIER -96.08 122.55 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 mt -81.66 133.31 52.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.665 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.16 134.95 11.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.622 2.215 . . . . 0.0 112.661 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.428 ' O ' ' CE1' ' B' ' 124' ' ' TYR . 7.6 mm -108.23 82.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.44 161.89 26.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.154 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' B' ' 122' ' ' ILE . 58.6 m-85 -130.89 101.0 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.433 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 28.9 t30 -80.58 81.55 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.908 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.527 0.166 0 CA-C-O 120.677 0.199 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.25 116.13 4.56 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.572 2.181 . . . . 0.0 112.266 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.38 114.07 3.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.546 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.75 146.33 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pt -110.8 146.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -96.01 141.18 29.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.47 145.36 50.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.157 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.4 118.13 12.59 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.33 157.27 72.63 Favored 'Cis proline' 0 C--N 1.352 0.74 0 C-N-CA 124.22 -1.158 . . . . 0.0 112.644 0.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.11 -33.11 75.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -179.47 51.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.743 0.306 . . . . 0.0 111.32 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -174.21 108.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.313 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 tt -131.08 155.25 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 73.8 t -135.5 96.14 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.678 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE2' ' CG2' ' A' ' 122' ' ' ILE . 18.8 m-85 -63.28 100.12 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -69.67 151.4 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.493 . . . . 0.0 111.89 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -48.64 170.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 80.1 Cg_endo -87.62 169.02 39.76 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.241 -1.149 . . . . 0.0 112.961 0.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' A' ' 125' ' ' ASN . 21.7 m-30 -110.42 18.97 19.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.185 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -104.1 3.21 32.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.983 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.64 -171.49 3.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.697 0.284 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -99.13 105.56 17.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.35 121.46 38.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -106.55 107.51 18.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.49 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -97.2 126.19 42.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.155 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -86.89 141.1 29.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.814 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.424 HG21 ' N ' ' A' ' 32' ' ' LYS . 17.1 mt -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.575 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 31' ' ' ILE . 8.4 mttm -102.89 119.38 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -117.34 145.85 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.2 m -147.61 158.42 44.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 111.323 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -111.26 113.56 26.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.457 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.32 23.18 6.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.72 -158.66 23.63 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.531 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.61 18.7 5.4 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.617 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.87 159.74 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -57.3 151.64 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.666 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt -150.36 121.34 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.861 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 168.5 54.31 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -166.03 155.21 11.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.523 0.662 . . . . 0.0 112.109 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.78 156.78 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.061 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.7 mm -121.51 136.19 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.948 0.404 . . . . 0.0 111.796 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 126.18 17.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.519 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.0 p -112.25 162.08 15.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.195 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.49 -28.2 1.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.282 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.42 120.5 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.7 11.34 27.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.486 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.62 -54.12 2.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 110.679 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.96 -28.19 60.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mt -115.22 122.08 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.46 157.84 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.94 155.04 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.875 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.87 109.17 0.65 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.1 140.79 67.96 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.83 -1.321 . . . . 0.0 112.32 0.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.41 -24.89 30.77 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.406 2.071 . . . . 0.0 112.209 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.9 p -151.91 172.85 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.78 -163.33 35.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.648 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 t -137.88 152.57 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 111.2 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.432 ' CD1' HG23 ' A' ' 68' ' ' VAL . 5.7 mp -124.52 161.45 26.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.409 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.6 p30 -115.03 170.53 5.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.744 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 49.4 Cg_exo -56.7 114.0 1.72 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.485 2.124 . . . . 0.0 112.562 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.02 39.24 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.546 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.35 139.31 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.52 112.3 21.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -101.75 149.12 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.29 127.18 43.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.765 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.43 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 54.0 ttp -113.7 161.38 17.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.082 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.43 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -129.48 141.4 51.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.094 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.07 101.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.8 145.98 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 142.63 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.691 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.9 143.07 26.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.005 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -57.07 161.47 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.145 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -172.27 -160.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -127.29 94.4 3.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.21 -22.18 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.33 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.78 -43.95 94.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -131.27 60.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -158.28 162.14 37.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -70.43 152.24 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.4 mt -138.26 23.26 2.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.061 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -145.54 27.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.971 0.415 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.38 -28.46 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.101 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.53 124.63 24.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.81 132.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.6 mt -94.47 127.88 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.8 m -112.58 104.58 12.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.43 148.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 4.9 mt-10 -144.77 154.27 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.294 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -162.42 149.46 13.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.0 141.84 25.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.779 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.02 139.5 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 p -92.6 146.65 32.73 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.2 163.4 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.518 2.145 . . . . 0.0 112.107 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.16 112.32 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.979 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.56 47.1 58.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.72 155.46 19.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 111.21 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.68 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.29 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -88.42 69.76 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.618 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -173.01 124.69 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -52.31 125.76 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.22 149.77 27.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -21.89 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -73.77 -9.74 58.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.633 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -69.31 -29.59 67.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 179.773 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.926 0.393 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 115' ' ' VAL . 7.4 p 175.36 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.664 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -107.26 155.84 19.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.991 0.424 . . . . 0.0 111.157 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.409 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -145.71 132.64 20.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.952 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 152.22 33.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -102.86 156.37 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.809 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.51 129.33 19.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.56 128.07 6.75 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.645 2.23 . . . . 0.0 112.2 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 122' ' ' ILE . 11.6 mm -100.0 138.86 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.513 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.51 160.08 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.284 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -123.11 117.74 26.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.42 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 38.2 t30 -114.8 141.48 47.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.49 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.6 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.856 -179.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 CA--C 1.527 0.151 0 CA-C-O 120.699 0.208 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.26 116.0 4.51 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.519 2.146 . . . . 0.0 112.349 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.99 114.28 3.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.09 146.21 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 pt -110.57 146.11 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.21 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.87 141.16 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.664 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.46 145.5 50.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.401 ' HG2' ' HB3' ' A' ' 22' ' ' PRO . 32.8 mt-30 -135.62 117.97 12.31 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.534 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 157.18 72.3 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 124.217 -1.159 . . . . 0.0 112.729 0.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.01 -33.1 75.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.444 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -179.6 51.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 0.0 111.301 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -174.54 108.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.388 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 tt -131.02 155.55 42.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 74.2 t -135.82 96.19 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.737 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' B' ' 122' ' ' ILE . 18.8 m-85 -63.36 100.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.086 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -69.64 151.21 46.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.151 0.501 . . . . 0.0 111.869 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.481 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -48.35 170.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.481 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 73.9 Cg_endo -87.73 168.76 39.75 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 124.312 -1.12 . . . . 0.0 112.94 0.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' B' ' 125' ' ' ASN . 21.9 m-30 -110.15 18.85 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -103.99 3.22 33.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.927 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.55 -171.38 3.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.771 0.32 . . . . 0.0 110.555 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -99.29 105.52 17.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.34 121.65 38.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.373 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.4 m -106.63 107.8 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.413 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.46 126.43 42.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.094 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -87.05 141.21 28.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.743 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.427 HG21 ' N ' ' B' ' 32' ' ' LYS . 18.0 mt -113.68 154.63 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.478 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.427 ' N ' HG21 ' B' ' 31' ' ' ILE . 8.4 mttm -102.81 119.58 39.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 111.479 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 75.2 mt -117.48 145.88 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.585 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 53.5 m -147.69 158.41 44.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.365 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -111.17 113.77 26.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 23.01 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.67 -158.36 23.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.577 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.57 18.38 5.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.658 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.65 159.84 42.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.779 0.323 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -57.29 151.87 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.644 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 pt -150.61 121.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.322 . . . . 0.0 111.804 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.25 168.66 54.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.451 -0.88 . . . . 0.0 110.906 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -166.05 155.31 11.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.536 0.668 . . . . 0.0 112.075 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.9 156.91 43.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.057 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 mm -121.63 136.22 59.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.905 0.383 . . . . 0.0 111.848 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.33 126.09 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.505 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 34.8 p -112.23 162.25 15.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.249 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -28.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.41 120.55 23.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.73 11.46 26.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.467 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -54.23 2.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.355 . . . . 0.0 110.704 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -74.71 -28.32 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.804 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 mt -115.06 122.08 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.829 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.36 157.88 26.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.254 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 155.06 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.98 109.11 0.64 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.02 140.73 67.73 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.404 0.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.35 -24.81 31.16 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.458 2.105 . . . . 0.0 112.242 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.0 p -152.01 172.74 15.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.647 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.03 -163.64 35.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.597 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.64 152.74 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 111.115 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.43 ' CD1' HG23 ' B' ' 68' ' ' VAL . 5.5 mp -124.82 161.43 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' B' ' 64' ' ' PRO . 1.6 p30 -114.98 170.55 5.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' B' ' 63' ' ' ASP . 51.7 Cg_exo -56.82 113.97 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.562 2.175 . . . . 0.0 112.568 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.1 39.25 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.486 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.42 139.33 46.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.262 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.63 112.22 20.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.786 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . 0.43 HG23 ' CD1' ' B' ' 62' ' ' LEU . 27.4 m -101.77 149.3 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.359 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.37 127.24 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' MET . . . . . 0.429 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 53.8 ttp -113.63 161.35 17.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -129.46 141.54 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.25 101.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.9 145.99 32.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.06 142.68 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.669 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.94 143.11 26.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 4.2 p -57.08 161.71 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -172.33 -160.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.76 94.69 4.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.35 -22.47 66.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.99 93.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.301 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 80.6 p -131.26 60.37 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -158.5 161.96 37.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -70.25 151.88 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 12.2 mt -137.97 23.34 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -145.45 27.55 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.58 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.26 -28.48 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -70.44 124.48 24.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 132.67 21.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.061 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 66.6 mt -94.41 127.96 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 87.3 m -112.63 104.7 12.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.46 148.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.627 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . 0.411 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 4.9 mt-10 -144.84 154.36 42.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -162.53 149.52 13.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.028 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.407 HG23 ' CZ ' ' B' ' 109' ' ' PHE . 0.0 OUTLIER -148.05 141.83 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.08 139.38 28.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.7 p -92.53 146.61 32.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.27 163.03 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.607 2.205 . . . . 0.0 112.175 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.71 112.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.34 47.59 55.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 155.55 20.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.95 163.97 2.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.373 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -88.0 69.68 9.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.62 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -172.98 124.68 0.43 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -52.39 125.65 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 149.85 27.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -21.74 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -73.9 -9.62 58.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.69 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -69.34 -29.62 67.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.687 0.279 . . . . 0.0 111.021 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.407 ' CZ ' HG23 ' B' ' 94' ' ' THR . 15.0 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.811 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.229 0.019 0 CA-C-O 120.883 0.373 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' B' ' 115' ' ' VAL . 7.4 p 175.41 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 32.4 mtt180 -107.12 155.79 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.168 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . 0.411 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -145.82 132.47 19.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.976 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 152.24 33.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -102.73 156.53 17.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.797 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.67 129.2 19.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.102 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.37 128.09 6.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.458 2.105 . . . . 0.0 112.167 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.421 HD11 HG22 ' B' ' 122' ' ' ILE . 11.6 mm -99.94 138.73 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.38 160.14 22.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -123.14 117.82 26.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 111.569 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.418 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 38.1 t30 -114.82 141.72 47.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.522 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.836 -179.987 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo . . . . . 0 C--O 1.232 0.204 0 CA-C-O 120.707 0.211 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.07 159.85 51.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.648 2.232 . . . . 0.0 112.262 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.37 -146.56 5.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.604 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.3 137.72 54.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.418 HG22 ' NE1' ' A' ' 93' ' ' TRP . 1.1 pt -113.19 149.79 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.236 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 153.45 20.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.603 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -144.98 152.48 40.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.273 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -137.71 116.47 9.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.488 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.02 154.25 76.81 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.963 -1.265 . . . . 0.0 112.484 0.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.9 9.1 38.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.688 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.17 -59.57 1.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -169.37 173.38 6.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -121.51 155.23 25.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.018 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 44.7 t -118.15 85.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.634 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 29' ' ' TYR . 5.2 m-30 -49.7 102.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -73.3 135.6 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -54.15 170.33 0.32 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.695 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 98.4 Cg_endo -78.6 168.47 75.08 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.837 0.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.2 m-85 -112.98 29.93 7.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.01 6.44 12.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.05 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -140.82 157.83 44.83 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.39 114.05 14.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -115.67 149.82 37.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.5 m -114.98 126.92 55.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.471 ' CZ ' ' CG ' ' A' ' 19' ' ' PHE . 42.9 m-85 -107.18 128.68 54.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.506 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -90.98 115.17 27.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.455 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.05 143.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.565 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.72 140.95 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 111.626 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.5 mt -134.49 152.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.481 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 35' ' ' ASN . 49.5 m -152.59 158.78 42.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.24 0.543 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.419 ' N ' HG21 ' A' ' 34' ' ' THR . 52.4 t30 -112.76 107.37 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.29 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.97 -4.29 49.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.661 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 -173.15 49.54 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.34 22.46 10.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -145.16 -179.65 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.94 155.81 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.9 pt -148.86 170.88 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.985 0.422 . . . . 0.0 111.304 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.56 108.17 0.98 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 92' ' ' GLU . 30.6 p-90 -104.8 157.83 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 112.023 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.33 157.65 41.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.431 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 2.7 mp -121.86 142.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.908 0.385 . . . . 0.0 111.939 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.31 125.87 14.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.6 p -102.03 158.34 16.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.226 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.24 -33.83 3.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.051 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -137.86 123.87 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.36 8.3 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.474 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.65 -47.54 5.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.752 0.31 . . . . 0.0 110.864 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -82.14 -53.61 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.739 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 mt -91.07 155.36 18.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.6 152.38 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 153.6 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.83 110.28 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.31 140.72 60.82 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.722 -1.366 . . . . 0.0 112.344 0.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.23 -6.11 16.9 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.556 2.171 . . . . 0.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 p -174.76 171.4 3.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.726 0.298 . . . . 0.0 110.683 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.03 171.75 38.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.634 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.09 120.51 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 0.0 111.116 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -94.37 159.42 15.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -115.44 167.25 10.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 9.9 Cg_endo -53.28 109.47 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.68 2.253 . . . . 0.0 112.411 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? 62.47 46.85 5.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.42 153.74 25.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -121.12 142.6 49.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.4 m -143.45 149.67 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.009 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.8 tp -96.67 153.51 17.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.988 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.8 ttm -134.16 148.28 50.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.0 129.8 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 97.78 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.68 125.42 29.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.73 147.8 31.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -101.1 142.17 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -55.74 148.91 15.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CD2' ' N ' ' A' ' 78' ' ' ASN . 35.3 p90 -161.79 -164.67 1.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.421 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 3.6 m-80 -125.9 113.15 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 77' ' ' PHE . . . -97.38 21.5 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.278 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.01 -23.52 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.2 p -138.51 40.4 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -151.51 145.15 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -61.36 147.14 45.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HB3' ' CD2' ' A' ' 124' ' ' TYR . 11.0 mt -130.51 63.85 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -160.06 27.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -129.05 4.91 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.685 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.91 111.58 23.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -146.13 132.73 19.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.279 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.431 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 63.0 mt -94.18 130.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -106.3 126.19 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.18 116.76 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.9 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -118.31 159.55 23.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.006 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.418 ' NE1' HG22 ' A' ' 9' ' ' ILE . 9.4 p90 -155.96 130.59 9.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.426 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -128.06 140.82 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -53.77 137.09 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.0 p -80.47 149.92 69.4 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.18 163.99 2.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 112.08 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -50.67 108.24 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.937 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.96 47.74 59.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.435 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.69 173.1 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.368 . . . . 0.0 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.5 164.66 26.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.1 70.08 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 178.8 136.81 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -53.97 149.09 9.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -138.73 148.16 43.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -18.95 62.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.34 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.13 -6.79 45.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.831 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 48.7 m0 -87.55 13.25 10.56 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.494 0.187 . . . . 0.0 111.448 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 108' ' ' TRP . 49.3 m-85 . . . . . 0 C--N 1.333 -0.131 0 CA-C-O 120.872 0.367 . . . . 0.0 110.613 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.422 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 12.5 mmt . . . . . 0 CA--C 1.521 -0.169 0 CA-C-O 121.073 0.463 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.426 ' CG2' ' HB ' ' A' ' 94' ' ' THR . 3.4 t 82.92 116.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.139 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -92.23 146.32 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.5 134.03 54.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.53 161.18 29.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.624 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -131.08 154.32 48.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 95.1 5.48 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.756 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -52.13 150.99 17.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.692 2.262 . . . . 0.0 112.678 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.0 mm -108.63 149.51 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -131.45 164.43 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.43 . . . . 0.0 110.983 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.467 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -130.28 114.35 15.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.242 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.432 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 25.4 t30 -103.16 80.72 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.815 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo . . . . . 0 CA--C 1.528 0.197 0 CA-C-O 120.698 0.208 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.01 159.54 52.13 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.11 -146.83 5.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.614 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.1 137.56 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.826 0.346 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.428 HG22 ' NE1' ' B' ' 93' ' ' TRP . 1.1 pt -113.18 149.73 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.22 153.34 20.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.712 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -144.82 152.32 40.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -137.51 116.43 10.04 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.467 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.05 154.22 76.95 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.016 -1.244 . . . . 0.0 112.58 0.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.89 9.15 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.737 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.36 -59.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.802 0.334 . . . . 0.0 111.168 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -169.55 173.4 6.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.011 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -121.66 155.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 45.1 t -118.23 84.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.476 ' CG ' ' CZ ' ' B' ' 29' ' ' TYR . 5.2 m-30 -49.51 102.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.602 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -73.37 135.5 44.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.446 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -53.91 170.44 0.3 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.787 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.455 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 97.0 Cg_endo -78.45 168.61 74.95 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.723 0.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.2 m-85 -113.11 29.85 7.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.956 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.91 6.72 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.132 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.09 157.82 44.77 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.25 114.02 14.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.092 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -115.86 149.63 38.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -114.87 126.76 55.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 111.246 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.476 ' CZ ' ' CG ' ' B' ' 19' ' ' PHE . 43.4 m-85 -106.92 128.68 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.476 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -91.07 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -103.84 142.91 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.545 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.58 140.91 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 61.6 mt -134.5 152.96 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' THR . . . . . 0.419 HG21 ' N ' ' B' ' 35' ' ' ASN . 49.5 m -152.61 158.96 43.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.413 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . 0.419 ' N ' HG21 ' B' ' 34' ' ' THR . 52.3 t30 -112.94 107.39 15.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.313 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.0 -4.1 48.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.82 -173.1 49.54 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.453 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.4 22.43 10.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -145.03 -179.53 6.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.366 . . . . 0.0 110.829 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.04 155.9 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 pt -148.88 170.82 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.385 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.41 107.88 0.96 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 30.8 p-90 -104.7 157.67 17.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 112.093 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.5 41.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.231 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.44 ' CD1' ' N ' ' B' ' 45' ' ' ILE . 2.7 mp -121.67 142.81 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.012 0.434 . . . . 0.0 111.924 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.51 125.86 14.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 56.2 p -101.97 158.6 16.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.23 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.46 -33.79 4.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.067 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -137.81 123.78 20.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.24 8.33 16.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.487 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -47.39 5.07 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.752 0.311 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 mtt-85 -82.18 -53.69 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 mt -91.05 155.59 18.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.778 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.7 152.26 29.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.027 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 153.58 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.02 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.75 110.35 0.35 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.38 140.69 60.86 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.29 0.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.18 -6.16 16.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.595 2.197 . . . . 0.0 112.846 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 3.8 p -174.75 171.42 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.716 0.293 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.01 171.83 38.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.556 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.18 120.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -94.2 159.43 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.442 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -115.48 167.31 10.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 9.8 Cg_endo -53.36 109.46 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.643 2.228 . . . . 0.0 112.434 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? 62.62 46.74 5.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.35 153.62 25.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -121.01 142.47 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.42 149.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.65 153.41 17.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 3.8 ttm -134.03 148.38 51.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.08 129.8 55.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.038 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 97.94 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.2 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.35 29.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.826 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 38.6 t -108.56 147.66 31.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.977 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -101.09 142.23 32.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -55.85 148.75 16.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.039 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' B' ' 78' ' ' ASN . 35.2 p90 -161.53 -164.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . 0.427 ' N ' ' CD2' ' B' ' 77' ' ' PHE . 3.6 m-80 -125.96 113.05 16.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . 0.41 ' HB1' ' CE2' ' B' ' 77' ' ' PHE . . . -97.28 21.56 9.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.399 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.85 -23.57 12.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.29 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 58.3 p -138.58 40.54 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.311 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -151.74 145.13 24.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -61.35 147.28 45.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' B' ' 124' ' ' TYR . 11.4 mt -130.5 63.58 1.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -159.93 27.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -129.33 4.92 5.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.765 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.93 111.57 23.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.645 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -146.04 132.73 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.27 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.437 HG23 HD11 ' B' ' 89' ' ' ILE . 62.5 mt -94.23 130.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -106.31 125.86 51.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.86 116.92 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.54 159.5 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.428 ' NE1' HG22 ' B' ' 9' ' ' ILE . 9.2 p90 -155.96 130.68 9.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.435 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 0.7 OUTLIER -128.15 140.85 51.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -53.83 137.37 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 59.1 p -80.69 149.92 68.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.14 164.24 1.87 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.539 2.159 . . . . 0.0 112.074 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.01 108.31 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.98 47.62 59.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.462 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.51 172.98 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.53 164.69 26.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.275 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.11 69.76 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.17 137.12 0.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.835 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -54.12 148.97 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -138.61 148.15 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.301 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.2 -6.54 43.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.798 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.473 ' O ' ' CD1' ' B' ' 109' ' ' PHE . 48.8 m0 -87.75 13.38 10.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.527 0.203 . . . . 0.0 111.467 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' B' ' 108' ' ' TRP . 49.3 m-85 . . . . . 0 C--N 1.333 -0.139 0 CA-C-O 120.853 0.359 . . . . 0.0 110.589 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' MET . . . . . 0.421 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 12.5 mmt . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.435 ' CG2' ' HB ' ' B' ' 94' ' ' THR . 3.4 t 83.06 116.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -91.94 146.26 23.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.764 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.57 134.13 54.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.56 161.01 29.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -130.84 154.32 48.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.48 95.11 5.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.72 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.17 151.11 17.66 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.681 2.254 . . . . 0.0 112.639 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 19.9 mm -108.68 149.34 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.993 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -131.31 164.41 25.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.022 0.439 . . . . 0.0 111.02 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' B' ' 84' ' ' LEU . 89.4 m-85 -130.23 114.28 15.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.249 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.422 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 24.6 t30 -103.34 80.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 43.4 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.856 -179.911 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 CA--C 1.529 0.27 0 CA-C-O 120.56 0.15 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.05 140.6 80.2 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.367 2.045 . . . . 0.0 112.229 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.8 132.36 46.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.537 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -51.22 128.76 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 pp -102.35 142.84 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.22 150.02 35.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -142.2 150.05 40.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.994 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -146.13 104.51 4.12 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.758 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.409 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 31.6 Cg_endo -63.7 159.94 64.69 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.465 0.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.37 -18.24 12.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.81 -46.78 4.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' PRO . 31.5 pttt -172.73 -179.13 2.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.2 tt -135.93 138.72 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.031 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -121.94 91.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -59.96 102.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.554 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.88 138.43 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.462 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -60.22 167.71 2.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.716 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 7.7 Cg_endo -88.05 164.8 43.31 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 124.415 -1.077 . . . . 0.0 112.484 0.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 38.6 m-85 -101.19 47.52 0.91 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.964 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.71 1.78 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.485 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -139.35 152.09 46.88 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.839 0.352 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -63.01 121.19 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.781 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -112.86 99.98 8.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.067 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.4 m -99.76 109.59 22.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.437 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 60.4 m-85 -92.09 163.85 13.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.1 0.476 . . . . 0.0 111.222 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -118.09 109.19 16.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.738 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.411 ' CG1' ' HE1' ' A' ' 70' ' ' MET . 8.9 mm -91.1 141.9 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.94 128.63 56.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mt -128.9 153.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.6 m -148.82 157.71 43.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 111.275 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -104.4 73.84 1.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.982 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.71 -26.09 61.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.09 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.15 -62.49 5.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.57 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.5 21.67 4.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.682 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -149.7 159.3 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.44 149.03 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 pt -154.37 167.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.63 100.14 0.48 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.87 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -95.57 157.04 16.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.11 128.94 10.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.686 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.01 142.67 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 111.469 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -145.23 132.84 20.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.572 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.71 155.14 29.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.042 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -65.45 -35.21 80.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.76 112.76 17.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.2 21.63 9.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -46.3 6.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -106.11 -33.07 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 mt -95.96 131.92 41.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.43 167.18 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 56' ' ' ASP . 2.5 p -151.99 160.53 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.315 0.578 . . . . 0.0 111.004 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.457 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 23.1 t70 -165.42 125.98 1.31 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.65 143.54 77.4 Favored 'Cis proline' 0 C--N 1.352 0.75 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.303 -0.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.03 4.89 6.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 113.035 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.7 p -179.71 158.28 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.09 164.7 30.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.627 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.08 117.51 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 111.127 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.49 160.8 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.966 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.452 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -109.99 178.62 0.97 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 22.5 Cg_exo -65.35 105.72 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.737 2.291 . . . . 0.0 112.649 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 72.08 22.65 3.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.256 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.2 150.08 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -116.63 132.29 56.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.82 143.46 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.905 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.1 126.04 54.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.411 ' HE1' ' CG1' ' A' ' 31' ' ' ILE . 25.9 ptt? -122.68 168.13 12.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.56 137.43 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.747 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 29' ' ' TYR . 8.8 p -115.41 96.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 144.19 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 t -138.76 81.93 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -51.88 153.48 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -65.65 122.53 17.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 8.8 p90 -130.91 179.32 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.84 127.28 56.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.8 18.35 6.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.513 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.93 -29.36 13.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.9 p -136.15 42.72 2.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -143.16 133.37 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -52.55 134.24 35.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.433 HD23 ' CG ' ' A' ' 124' ' ' TYR . 16.8 mt -121.88 21.38 10.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -144.07 21.78 1.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -132.32 4.03 3.99 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.694 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -96.75 118.86 34.13 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 110.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.7 133.11 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.7 mt -85.3 164.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.593 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 121.39 12.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 111.405 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.03 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.793 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -99.63 122.47 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.444 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 5.6 p90 -133.59 143.7 48.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.3 136.75 33.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -50.1 144.66 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.29 139.42 41.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.71 160.82 47.04 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -48.73 129.33 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.169 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.94 38.06 94.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.647 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 134.09 45.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.63 163.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.144 0.497 . . . . 0.0 111.289 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.29 6.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.54 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.01 145.55 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.812 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.43 115.77 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 0.5 OUTLIER -106.06 153.75 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.827 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -87.19 -27.42 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.68 -33.2 72.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.48 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 54.0 m0 -53.54 -31.85 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.74 125.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.25 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.444 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -97.05 108.05 20.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -103.26 115.89 31.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.03 157.69 16.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.433 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.31 126.01 17.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.394 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.6 114.46 47.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.15 145.56 79.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.1 mm -95.03 151.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.852 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.6 156.68 48.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.433 ' CG ' HD23 ' A' ' 84' ' ' LEU . 6.5 m-85 -127.69 104.93 8.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.98 78.46 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.664 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.922 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 CA--C 1.529 0.236 0 CA-C-O 120.513 0.131 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.93 140.39 79.19 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.462 2.108 . . . . 0.0 112.272 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.75 132.36 46.76 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.414 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -51.07 128.96 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 pp -102.46 142.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.31 150.1 35.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -142.26 149.98 40.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -146.07 104.48 4.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.66 160.24 63.66 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.399 0.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -18.45 12.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.69 -46.55 4.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.77 0.319 . . . . 0.0 111.274 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -172.87 -179.29 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.1 tt -135.72 138.82 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.059 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 62.5 t -122.09 91.47 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.23 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -59.91 102.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.562 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.85 138.58 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.468 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -60.4 167.73 2.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.717 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 7.8 Cg_endo -88.16 164.51 42.98 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.385 -1.09 . . . . 0.0 112.544 0.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . 0.403 ' CD1' ' CE1' ' B' ' 77' ' ' PHE . 39.4 m-85 -100.9 47.64 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.061 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.68 1.67 11.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.44 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -139.21 152.11 47.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -63.01 121.16 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.724 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -112.86 100.16 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.996 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -99.9 109.85 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.627 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.436 ' HB2' ' CG1' ' B' ' 72' ' ' VAL . 59.9 m-85 -92.29 163.85 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 111.133 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -118.12 109.04 15.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.704 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.415 ' CG1' ' HE1' ' B' ' 70' ' ' MET . 9.0 mm -91.05 141.95 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.02 128.53 56.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 36.0 mt -128.86 153.34 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 59.5 m -148.77 157.53 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -104.3 73.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.926 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.79 -25.93 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.112 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.4 -62.32 5.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.572 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.58 21.53 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.651 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 mtm-85 -149.63 159.32 44.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.4 148.87 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.725 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.22 167.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.992 0.425 . . . . 0.0 111.522 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.54 100.11 0.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.839 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -95.56 157.07 16.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 111.589 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.23 129.04 10.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.713 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 25.6 mm -93.05 142.6 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 111.472 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -145.23 132.77 20.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.651 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.58 155.18 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 3.0 p -65.5 -35.27 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.7 112.76 17.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.29 21.77 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.97 -46.29 6.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -106.17 -33.27 7.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -95.71 131.83 41.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.796 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.47 167.05 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' B' ' 56' ' ' ASP . 2.5 p -151.79 160.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . 0.463 ' N ' ' CG2' ' B' ' 55' ' ' VAL . 22.9 t70 -165.46 126.03 1.31 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.54 143.6 77.73 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.831 -1.32 . . . . 0.0 112.252 -0.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.88 4.72 6.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.618 2.212 . . . . 0.0 113.095 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 9.6 p -179.7 158.23 0.79 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.14 164.74 30.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.603 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.2 t -100.19 117.65 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 111.087 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.53 160.97 15.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -110.14 178.39 1.02 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.804 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 22.3 Cg_exo -65.11 106.03 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 71.81 22.5 3.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.363 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.1 150.2 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -116.69 132.19 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.68 143.64 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.922 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.3 125.88 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' MET . . . . . 0.415 ' HE1' ' CG1' ' B' ' 31' ' ' ILE . 25.9 ptt? -122.45 168.32 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.77 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.65 137.48 53.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.721 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' B' ' 29' ' ' TYR . 8.9 p -115.51 96.23 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.722 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 144.14 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 t -138.76 81.88 1.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.732 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.7 153.4 2.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -65.7 122.62 17.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CE1' ' CD1' ' B' ' 23' ' ' TYR . 9.2 p90 -130.97 179.22 6.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.93 127.32 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.69 18.07 6.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.599 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.76 -29.3 13.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.6 p -136.14 42.67 2.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -143.14 133.41 24.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -52.6 134.32 35.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.007 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.442 HD23 ' CG ' ' B' ' 124' ' ' TYR . 16.9 mt -121.95 21.29 10.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -143.95 21.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.897 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -132.28 4.1 4.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.733 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.74 118.99 34.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.731 0.3 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.72 133.3 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 18.2 mt -85.43 164.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.524 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 121.59 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.09 92.04 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.811 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -99.77 122.56 42.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.458 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 5.6 p90 -133.76 143.8 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.856 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 137.18 33.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.785 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -50.29 144.96 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.54 139.5 41.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.68 161.01 46.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.535 2.157 . . . . 0.0 112.32 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -48.9 129.27 17.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.89 38.16 94.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.65 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 134.16 45.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.09 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.57 163.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.127 0.489 . . . . 0.0 111.331 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.43 6.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.634 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.81 145.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.44 115.73 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.481 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 0.5 OUTLIER -105.95 153.56 21.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.04 -27.43 23.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.69 -33.07 72.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CE2' ' HB2' ' B' ' 105' ' ' ARG . 54.0 m0 -53.69 -31.79 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.937 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.836 0.35 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.88 125.29 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.458 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -97.33 107.88 20.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -102.99 115.91 31.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.26 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 157.59 16.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.444 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -141.34 125.9 17.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.53 114.55 47.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.3 145.52 78.1 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.406 2.07 . . . . 0.0 112.645 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 40.7 mm -94.97 151.51 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.887 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.7 156.59 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.442 ' CG ' HD23 ' B' ' 84' ' ' LEU . 6.4 m-85 -127.47 105.05 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.038 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.2 78.57 9.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.834 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo . . . . . 0 CA--C 1.527 0.156 0 CA-C-O 120.776 0.24 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.15 142.98 47.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.562 2.175 . . . . 0.0 112.295 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.13 126.13 13.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.444 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -52.73 121.9 8.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.442 HG12 ' CE2' ' A' ' 93' ' ' TRP . 1.1 pt -94.49 128.98 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.02 146.62 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.741 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.21 138.69 35.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.065 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -136.11 112.1 10.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.723 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.09 154.55 70.02 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.401 0.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.45 -38.94 88.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.116 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.04 49.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -169.16 118.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.26 147.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.43 99.72 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 111.603 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 19.2 m-30 -51.51 108.18 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.74 137.15 40.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -59.85 167.09 2.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 83.3 Cg_endo -86.68 161.61 52.65 Favored 'Cis proline' 0 C--N 1.348 0.548 0 C-N-CA 124.013 -1.244 . . . . 0.0 112.583 0.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.97 29.51 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -107.07 7.06 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.533 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -148.68 147.83 29.35 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -56.98 117.99 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 112.16 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.9 m -102.7 114.2 28.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.001 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.567 ' CE1' ' CD1' ' A' ' 19' ' ' PHE . 4.9 m-85 -96.01 122.08 38.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -81.1 132.51 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.41 HG21 ' N ' ' A' ' 32' ' ' LYS . 32.2 mm -114.65 152.49 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.924 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' N ' HG21 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -113.27 127.73 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.238 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -131.54 130.3 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.79 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.9 m -142.15 156.61 45.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.215 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -100.08 113.75 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.23 20.23 6.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.344 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.65 -140.39 9.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.583 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.31 29.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -155.89 148.39 23.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.434 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 5.7 ttp180 -54.67 159.24 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.1 pt -154.2 166.45 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.041 0.448 . . . . 0.0 111.577 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.19 109.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.597 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -104.21 161.67 13.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.226 0.536 . . . . 0.0 111.79 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.36 151.29 26.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.28 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.438 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 20.0 mm -122.14 140.4 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' CG ' ' HB ' ' A' ' 90' ' ' THR . 21.5 ptmt -142.14 131.28 23.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.1 p -114.03 154.81 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.068 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.06 -37.09 73.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -124.89 112.16 16.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.2 -37.53 9.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.759 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -32.38 7.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.81 141.87 29.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.72 132.48 27.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.09 128.0 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -145.71 129.52 8.55 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.52 133.35 28.03 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.153 -0.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.33 -46.81 29.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.388 2.059 . . . . 0.0 112.232 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.83 150.3 36.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.728 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.74 -172.03 27.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.598 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' HG2' ' A' ' 40' ' ' ARG . 6.0 t -123.16 114.49 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.842 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.86 161.44 17.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.028 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -121.23 178.39 1.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.675 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 33.5 Cg_exo -61.55 108.89 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.623 2.215 . . . . 0.0 112.323 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.72 34.45 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.06 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 151.23 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.798 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -106.44 156.81 18.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.4 t -148.74 147.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mt -112.55 135.63 53.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.686 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 157.74 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.3 123.03 26.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.97 85.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.192 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.73 131.62 49.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.939 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.5 t -123.53 87.59 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.91 149.42 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.001 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 p -63.93 135.88 56.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' A' ' 83' ' ' ASP . 26.4 p90 -145.35 -164.5 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -127.15 131.48 50.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.61 19.97 13.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.376 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.68 -37.48 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.287 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 77.6 p -138.65 25.03 2.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 81' ' ' THR . 28.4 mt-10 -161.13 161.87 31.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER 59.63 166.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.957 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.469 HD21 ' CE1' ' A' ' 124' ' ' TYR . 6.2 mt 84.18 54.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ASN . 1.1 p30 -125.4 27.36 6.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.964 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 85' ' ' ASN . 10.7 m-20 82.37 97.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.753 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.7 139.2 53.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.92 132.89 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.438 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 8.4 mt -83.67 166.03 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.744 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.408 ' HB ' ' CG ' ' A' ' 46' ' ' LYS . 2.5 m -140.63 117.56 11.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 111.057 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.408 HG13 ' CD1' ' A' ' 45' ' ' ILE . 3.3 mp -108.34 103.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.79 140.45 48.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.48 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 9.4 p90 -149.94 141.47 23.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.009 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.427 HG23 ' CD1' ' A' ' 109' ' ' PHE . 4.0 t -132.43 147.43 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.992 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.4 137.86 28.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.446 ' CG2' ' CH2' ' A' ' 108' ' ' TRP . 3.0 p -82.38 143.36 48.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -55.87 160.73 9.42 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.495 2.13 . . . . 0.0 112.071 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.8 121.38 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.41 42.56 65.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.09 160.64 17.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.401 . . . . 0.0 111.149 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.85 164.37 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.218 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -88.12 70.17 9.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.583 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.23 134.98 0.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.829 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.12 145.04 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 3.0 mmt180 -124.8 152.31 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -80.7 -44.55 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.046 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.51 -14.07 62.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.526 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 105' ' ' ARG . 5.0 m0 -51.49 -24.57 5.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.333 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.427 ' CD1' HG23 ' A' ' 94' ' ' THR . 19.9 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 8.1 mtt . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.891 0.377 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.06 124.31 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.48 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -87.65 141.25 28.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.168 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.41 129.2 39.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.766 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -126.22 162.83 24.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -143.7 142.82 31.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -128.56 95.75 31.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.67 135.61 70.47 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 17.4 mm -97.24 144.76 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -132.39 163.67 28.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.685 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.469 ' CE1' HD21 ' A' ' 84' ' ' LEU . 1.8 m-85 -126.08 125.7 43.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.319 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -114.76 80.93 1.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.841 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.924 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.752 0.23 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 142.87 47.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 112.35 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.99 125.86 12.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.524 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -52.71 121.73 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.438 HG12 ' CE2' ' B' ' 93' ' ' TRP . 1.1 pt -94.28 129.13 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.2 146.84 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.684 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.4 138.91 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.038 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -136.22 112.13 10.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.08 154.59 69.98 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 123.99 -1.254 . . . . 0.0 112.43 0.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.29 -39.25 89.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.949 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.85 49.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -169.29 118.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.04 148.18 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.62 99.72 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 19.5 m-30 -51.6 108.1 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.465 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.83 137.16 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.367 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -59.69 167.08 2.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.859 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 81.9 Cg_endo -86.7 161.64 52.5 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.976 -1.26 . . . . 0.0 112.613 0.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.0 29.62 3.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -107.09 6.99 29.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.474 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -148.75 147.83 29.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.01 117.76 4.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.97 112.2 22.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -102.75 114.33 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' B' ' 19' ' ' PHE . 5.1 m-85 -96.1 121.9 38.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.814 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -80.95 132.44 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.061 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.414 HG21 ' N ' ' B' ' 32' ' ' LYS . 32.2 mm -114.6 152.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.414 ' N ' HG21 ' B' ' 31' ' ' ILE . 0.8 OUTLIER -113.34 127.87 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.62 130.37 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.794 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 51.1 m -142.13 156.69 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.19 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -100.22 113.71 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.892 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.18 20.19 6.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.43 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.61 -140.33 9.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.535 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.27 29.45 0.97 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -155.91 148.31 23.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.768 0.318 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . 0.437 ' HG2' ' CG1' ' B' ' 61' ' ' VAL . 5.6 ttp180 -54.52 159.12 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 12.3 pt -154.19 166.4 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.592 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.14 109.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.566 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -104.26 161.66 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.299 0.571 . . . . 0.0 111.789 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.23 151.43 26.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.352 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.438 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 20.5 mm -122.32 140.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 0.0 111.637 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.409 ' CG ' ' HB ' ' B' ' 90' ' ' THR . 21.5 ptmt -142.23 131.07 22.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.641 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 67.8 p -113.92 154.84 26.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.144 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.05 -37.21 73.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -124.85 112.13 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.26 -37.15 9.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.767 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -32.22 7.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.9 141.58 29.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 132.46 27.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.022 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.08 127.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.047 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.47 129.54 8.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.68 133.46 28.72 Favored 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.731 -1.362 . . . . 0.0 112.092 0.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.35 -46.78 29.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.355 2.037 . . . . 0.0 112.286 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.3 p -144.84 150.18 36.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.732 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.64 -172.1 27.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.586 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' B' ' 40' ' ' ARG . 5.9 t -123.02 114.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.78 161.24 17.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.071 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.446 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -121.01 178.32 1.21 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.797 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 30.7 Cg_exo -61.5 108.98 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.653 2.235 . . . . 0.0 112.355 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.53 34.75 9.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.9 151.04 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -106.49 156.71 18.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 59.1 t -148.71 147.31 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.234 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mt -112.43 135.69 52.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.63 157.73 34.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 111.126 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.25 123.08 26.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.01 85.49 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.261 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 131.83 50.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 t -123.75 87.58 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.89 149.54 2.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 p -63.93 135.99 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' B' ' 83' ' ' ASP . 26.5 p90 -145.57 -164.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -127.11 131.31 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.95 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.384 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.63 -37.62 5.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 111.265 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 77.9 p -138.54 25.1 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' B' ' 81' ' ' THR . 28.5 mt-10 -161.03 161.83 31.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . 0.482 ' HB2' ' CD2' ' B' ' 77' ' ' PHE . 0.6 OUTLIER 59.56 166.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 110.95 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.479 HD21 ' CE1' ' B' ' 124' ' ' TYR . 6.2 mt 84.3 54.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.492 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' B' ' 86' ' ' ASN . 1.2 p30 -125.65 27.48 6.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.946 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' B' ' 85' ' ' ASN . 10.9 m-20 82.31 97.15 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.76 139.29 53.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.88 132.93 4.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.438 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 8.8 mt -83.73 166.23 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' THR . . . . . 0.409 ' HB ' ' CG ' ' B' ' 46' ' ' LYS . 2.5 m -140.79 117.38 10.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.962 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . 0.411 HG13 ' CD1' ' B' ' 45' ' ' ILE . 3.4 mp -108.22 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.73 140.56 48.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . 0.468 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 9.5 p90 -149.91 141.6 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' THR . . . . . 0.436 HG23 ' CD1' ' B' ' 109' ' ' PHE . 4.0 t -132.63 147.24 52.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.32 138.03 27.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.446 ' CG2' ' CH2' ' B' ' 108' ' ' TRP . 3.1 p -82.5 143.37 47.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.8 160.72 9.28 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 121.48 5.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.21 42.67 63.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.46 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.12 160.55 18.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 111.134 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.79 164.22 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.27 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -87.94 70.15 9.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.634 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.27 134.91 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.836 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -58.89 144.96 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . 0.481 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 3.0 mmt180 -124.81 152.15 44.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -80.57 -44.54 18.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.613 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CG ' ' HB2' ' B' ' 105' ' ' ARG . 4.9 m0 -51.63 -24.44 5.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.78 0.324 . . . . 0.0 110.96 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . 0.436 ' CD1' HG23 ' B' ' 94' ' ' THR . 19.8 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 8.4 mtt . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.93 0.395 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.1 124.34 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . 0.468 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -87.75 141.21 28.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.47 129.08 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -125.97 162.82 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -143.77 142.79 31.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.7 mp -128.55 95.81 31.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.61 135.57 70.34 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.629 2.219 . . . . 0.0 112.146 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 17.5 mm -97.27 144.5 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.277 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -132.3 163.62 28.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . 0.479 ' CE1' HD21 ' B' ' 84' ' ' LEU . 1.8 m-85 -125.93 125.92 43.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.286 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -114.93 81.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.986 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 CA--C 1.528 0.19 0 CA-C-O 120.623 0.176 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.83 156.41 9.34 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.489 2.126 . . . . 0.0 112.331 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.52 122.86 23.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.43 115.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.38 138.09 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.85 146.43 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -135.65 149.67 49.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 111.153 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -135.4 116.37 11.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.483 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.51 163.81 63.74 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.514 0.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 t -44.6 -62.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.383 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.16 48.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.949 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 104.89 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 8.2 tt -131.93 145.31 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.478 ' CG1' ' CG1' ' B' ' 18' ' ' VAL . 6.6 p -150.6 121.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -72.65 113.9 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -81.89 134.61 35.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -65.68 170.72 4.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.805 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 62.5 Cg_endo -73.19 164.99 85.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.766 -1.348 . . . . 0.0 112.675 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -107.27 46.65 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -115.11 -4.77 12.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.406 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -123.08 144.47 49.28 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.94 126.78 31.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.85 155.43 41.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.52 116.06 16.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -102.42 116.12 31.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -92.49 131.7 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.433 ' HB ' ' CG ' ' A' ' 70' ' ' MET . 5.3 mm -107.55 143.25 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.525 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -104.65 119.91 40.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.397 . . . . 0.0 111.242 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -112.88 153.79 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.748 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.69 155.86 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.143 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -102.48 109.9 21.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.582 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.15 19.19 6.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.493 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.63 -143.53 12.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.457 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.54 20.73 2.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 159.86 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -55.85 152.36 10.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.728 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.69 116.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.38 115.47 5.11 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.841 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 67.4 p-90 -118.06 158.86 24.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.122 0.487 . . . . 0.0 111.566 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.6 152.99 31.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.566 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 mm -104.02 154.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.424 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -155.65 132.64 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.678 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.27 160.16 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.161 0.505 . . . . 0.0 111.272 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.13 -55.16 36.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.44 113.16 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.59 22.05 5.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -113.23 -58.57 2.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.915 0.388 . . . . 0.0 110.788 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -33.2 63.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.779 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -98.02 145.88 26.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.689 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.92 147.11 36.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.03 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 56' ' ' ASP . 2.3 p -139.98 160.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.26 0.552 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.46 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 9.8 t70 -172.92 129.04 0.55 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.06 146.71 86.74 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.217 -0.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.95 -0.42 10.65 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.66 2.24 . . . . 0.0 113.151 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.55 177.1 0.36 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.822 0.344 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 154.71 167.37 16.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.64 128.93 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 111.115 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.86 123.06 46.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -79.72 171.54 12.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 114.54 2.31 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.618 2.212 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.49 28.49 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.293 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -96.75 148.27 23.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.768 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 128.38 52.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.117 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.38 138.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.033 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.58 123.54 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.433 ' CG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.24 163.06 17.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 154.58 51.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -134.37 89.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.702 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 p -74.0 139.44 44.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m -131.05 149.38 52.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.659 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.76 148.73 24.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 111.196 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -71.49 127.65 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.756 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.69 -173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.006 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -129.59 121.46 27.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.99 -21.01 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.39 65.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.38 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.9 p -141.15 67.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.304 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -150.19 171.92 16.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.65 136.53 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.0 mt -152.78 86.51 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.46 22.43 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.265 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER 73.83 93.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.174 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.1 152.54 43.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.354 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -157.8 131.02 7.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.706 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mm -85.1 163.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.317 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.2 m -144.2 118.92 9.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.88 0.371 . . . . 0.0 111.493 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.13 97.16 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.76 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.38 133.95 48.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.101 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -138.66 154.89 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.31 151.41 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -55.71 150.88 11.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.43 HG23 ' CZ2' ' A' ' 108' ' ' TRP . 0.6 OUTLIER -96.07 142.17 24.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.0 156.59 61.73 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.609 2.206 . . . . 0.0 112.279 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -50.16 128.24 18.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.993 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.83 34.46 87.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.39 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.35 127.04 29.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.153 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.88 166.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.249 0.547 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -85.89 70.85 10.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.0 128.77 0.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -52.11 151.31 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.22 155.77 49.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.039 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.46 -34.44 16.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.99 -24.98 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.43 ' CZ2' HG23 ' A' ' 96' ' ' THR . 21.9 m0 -50.05 -34.7 22.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.985 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.999 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.758 0.313 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 t -109.06 125.23 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.234 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.1 142.45 27.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.93 97.77 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.04 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -87.27 159.34 18.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.76 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.6 120.25 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.885 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 mt -94.73 135.18 24.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.76 130.42 5.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.664 2.243 . . . . 0.0 112.627 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 3.4 mm -114.04 119.54 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.419 ' CB ' HG22 ' A' ' 18' ' ' VAL . 45.7 mt-10 -117.82 157.53 26.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.533 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.37 109.06 18.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.959 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -83.13 81.56 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.869 -179.907 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.602 0.168 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.83 156.51 9.19 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.532 2.155 . . . . 0.0 112.281 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.63 122.88 23.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.536 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.44 115.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.84 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.32 137.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.78 146.47 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 149.55 49.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -135.4 116.45 11.99 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 163.65 63.67 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.533 0.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.5 t -44.48 -62.42 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.462 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.26 48.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.996 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.05 104.82 2.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.479 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 8.3 tt -131.96 145.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.478 ' CG1' ' CG1' ' A' ' 18' ' ' VAL . 6.8 p -150.88 121.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -72.49 113.62 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.704 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -81.58 134.41 35.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -65.59 170.85 4.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 64.8 Cg_endo -73.12 164.92 85.66 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.866 -1.306 . . . . 0.0 112.723 0.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -107.24 46.67 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -115.15 -4.6 12.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.395 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.27 144.44 49.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.913 0.387 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.9 126.68 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.992 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.84 155.37 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.44 115.96 16.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -102.36 116.23 32.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.659 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -92.74 131.5 37.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.254 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.435 ' HB ' ' CG ' ' B' ' 70' ' ' MET . 5.2 mm -107.31 143.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.616 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -104.59 120.09 40.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.267 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 mt -113.09 153.73 14.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.78 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.72 155.98 34.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 111.17 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -102.64 109.89 21.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.24 19.37 5.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.48 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.74 -143.64 12.84 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.432 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.44 20.81 2.23 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.52 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.74 160.08 37.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.855 0.359 . . . . 0.0 110.808 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -56.04 152.65 10.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.61 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.93 116.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.445 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.67 115.5 5.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.878 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 67.5 p-90 -118.18 158.75 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.101 0.477 . . . . 0.0 111.495 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.43 153.2 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.527 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 mm -104.2 154.26 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.431 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -155.61 132.73 10.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.677 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.3 160.35 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.0 111.251 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.39 -54.88 40.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.7 113.23 26.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.771 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.56 21.97 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -113.2 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -33.16 63.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.16 145.74 26.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.77 146.96 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' B' ' 56' ' ' ASP . 2.3 p -139.74 160.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.295 0.569 . . . . 0.0 110.922 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . 0.457 ' N ' ' CG2' ' B' ' 55' ' ' VAL . 9.8 t70 -172.69 128.98 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.793 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.07 146.72 86.8 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.293 -0.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.03 -0.46 10.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.678 2.252 . . . . 0.0 113.084 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.64 177.07 0.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 154.8 167.21 16.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.65 129.02 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.99 123.19 46.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.951 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.404 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.2 OUTLIER -79.74 171.47 12.34 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.81 114.45 2.29 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.591 2.194 . . . . 0.0 112.346 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.61 28.31 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.228 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.404 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.2 OUTLIER -96.54 148.37 22.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.766 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 128.45 52.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.08 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.48 138.49 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.51 123.51 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.01 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' MET . . . . . 0.435 ' CG ' ' HB ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -119.22 163.08 17.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.962 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.72 51.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.435 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -134.58 89.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.589 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 20.5 p -74.06 139.38 44.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.99 149.35 52.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.588 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.59 148.86 24.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.252 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -71.52 127.72 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.78 -173.85 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.957 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.52 121.54 27.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.21 -20.8 66.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.306 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.9 -43.45 66.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -140.97 67.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.274 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -150.28 171.82 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.059 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.56 136.35 45.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 55.7 mt -152.59 86.48 1.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.5 22.43 12.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.238 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' B' ' 86' ' ' ASN . 0.3 OUTLIER 73.74 93.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.16 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.37 152.27 43.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.349 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -157.44 131.01 7.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mm -85.1 163.36 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 81.9 m -144.08 118.88 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.389 . . . . 0.0 111.492 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.06 97.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.718 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -104.5 133.91 48.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.02 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -138.68 154.91 48.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.12 151.32 36.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -55.63 150.85 11.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.009 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' THR . . . . . 0.424 HG23 ' CZ2' ' B' ' 108' ' ' TRP . 0.6 OUTLIER -96.04 142.19 24.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 156.48 62.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.206 . . . . 0.0 112.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -50.09 128.25 18.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.74 34.54 87.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.371 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.42 126.99 29.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.66 166.72 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.381 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -86.0 70.88 10.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.02 128.81 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -52.11 151.25 3.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.15 155.7 49.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.39 -34.35 16.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.02 -25.04 68.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' TRP . . . . . 0.424 ' CZ2' HG23 ' B' ' 96' ' ' THR . 22.3 m0 -49.93 -34.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.043 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.985 -179.923 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 12.4 t -108.78 125.32 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.254 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.24 142.51 27.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.99 97.61 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.074 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -87.08 159.26 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.48 120.29 11.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.77 135.21 23.99 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.81 130.45 5.04 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.665 2.243 . . . . 0.0 112.814 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 3.4 mm -114.08 119.39 61.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.623 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.422 ' CB ' HG22 ' B' ' 18' ' ' VAL . 45.1 mt-10 -117.72 157.49 26.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 111.48 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.36 109.13 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -83.28 81.62 8.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.847 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.796 0.332 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -108.09 -179.14 3.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.3 p -53.2 151.04 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.63 107.58 5.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.137 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.98 166.21 21.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.387 2.058 . . . . 0.0 112.28 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.13 97.02 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.621 2.214 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.56 131.46 26.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -57.74 109.03 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.1 pt -68.72 123.37 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.74 145.37 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.51 136.24 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.241 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.407 ' NE2' ' HG3' ' B' ' 22' ' ' PRO . 14.7 mt-30 -140.85 105.57 6.28 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.66 161.48 40.68 Favored 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.506 0.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.3 t -92.36 -26.07 18.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.71 49.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.53 107.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 tt -129.7 120.1 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.43 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 46.0 t -109.27 92.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.564 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.478 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 20.9 m-85 -52.74 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -67.18 141.41 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.431 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -49.13 169.42 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.821 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.479 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 66.3 Cg_endo -91.1 166.97 28.8 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.371 -1.096 . . . . 0.0 112.974 0.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -108.87 31.1 5.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.755 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.37 3.61 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.399 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -164.31 151.49 11.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.821 0.343 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.65 109.11 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.49 110.46 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 83.0 m -93.43 110.85 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 19' ' ' PHE . 79.6 m-85 -89.02 121.8 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -77.9 131.43 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.435 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 31' ' ' ILE . 16.0 mt -113.89 151.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -112.93 121.76 45.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 111.482 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.3 mt -125.45 150.19 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.505 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.81 145.37 27.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.42 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.13 106.69 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.279 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.51 20.68 5.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.422 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.12 -170.8 24.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.18 -28.72 8.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.74 178.3 5.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -64.81 170.64 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 12.2 pt -152.98 136.18 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.655 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.84 112.2 4.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.511 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.401 ' HB3' ' HB3' ' A' ' 93' ' ' TRP . 37.6 p-90 -117.17 156.98 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.221 0.534 . . . . 0.0 111.811 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.99 153.35 40.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.286 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 mm -115.46 151.27 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.578 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -147.5 130.51 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.531 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.3 p -120.41 154.7 34.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 p -52.0 -30.27 24.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -139.07 117.8 12.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.69 17.11 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -108.74 -49.58 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -76.3 -50.51 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.52 148.41 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -136.53 107.35 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.89 118.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -142.17 136.46 14.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.93 132.77 28.11 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.575 -1.427 . . . . 0.0 112.05 -0.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.4 -45.57 9.13 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.404 2.069 . . . . 0.0 112.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 p -133.36 148.75 51.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.82 175.29 46.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 t -116.21 108.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mp -80.29 158.83 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.31 170.13 5.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.62 110.57 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.647 2.231 . . . . 0.0 112.259 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.66 37.0 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.29 142.28 31.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.219 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -102.57 143.16 32.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.78 148.5 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.49 143.82 32.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.31 156.34 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.649 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.79 113.95 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.294 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 29' ' ' TYR . 7.3 p -114.16 88.14 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.94 146.48 33.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.6 107.5 9.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.74 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 146.17 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.037 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 p -56.75 164.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -178.65 -173.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -116.15 109.52 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.97 16.94 13.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.457 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.47 -24.94 29.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.9 p -147.01 44.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.35 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.73 134.71 55.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.71 69.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -155.68 28.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -130.35 6.45 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.617 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.87 119.3 34.12 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.45 136.0 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.056 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 89' ' ' ILE . 7.8 mt -98.69 165.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.2 m -137.75 123.07 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.871 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.79 112.2 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.54 155.01 35.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.445 ' CH2' ' CG ' ' A' ' 116' ' ' ARG . 11.4 p90 -157.59 147.28 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.452 HG23 ' CE1' ' A' ' 109' ' ' PHE . 0.6 OUTLIER -141.25 134.12 28.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -52.52 125.2 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 43.7 p -66.6 151.63 96.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.7 165.05 28.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.536 2.158 . . . . 0.0 112.148 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.93 117.44 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.43 51.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.234 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.43 166.08 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 0.0 111.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.09 164.31 25.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.314 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.94 69.42 9.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.63 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.08 122.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.88 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.2 122.28 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -117.23 150.52 38.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.91 -19.02 45.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.41 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.83 -23.66 66.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 0.0 111.234 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.16 -13.95 43.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.452 ' CE1' HG23 ' A' ' 94' ' ' THR . 5.3 m-85 -102.53 -22.71 13.98 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 111.191 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -107.9 33.67 3.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.906 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.52 -140.4 6.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.473 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.89 149.42 21.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.61 -166.0 16.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.469 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.27 152.47 48.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.24 136.15 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.445 ' CG ' ' CH2' ' A' ' 93' ' ' TRP . 12.4 tpt180 -99.4 152.86 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.92 137.71 9.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.07 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -145.21 132.23 20.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -91.56 133.86 35.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.82 117.8 61.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.668 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.37 128.7 19.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.354 2.036 . . . . 0.0 112.359 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 32.5 mm -92.54 148.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.225 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.21 160.2 40.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.657 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -132.15 110.74 10.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.207 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.43 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 2.8 t30 -99.29 132.24 44.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.633 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.941 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.788 0.327 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -108.03 -179.15 3.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.832 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 24.2 p -53.16 151.18 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.82 107.56 5.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.02 166.16 21.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.391 2.06 . . . . 0.0 112.263 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.13 97.18 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.54 2.16 . . . . 0.0 112.308 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 131.72 27.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -57.91 108.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.1 pt -68.7 123.46 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 145.19 55.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.657 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.34 136.07 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.234 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -140.66 105.64 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.78 161.57 41.2 Favored 'Cis proline' 0 C--N 1.35 0.658 0 C-N-CA 123.854 -1.311 . . . . 0.0 112.461 0.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.8 t -92.37 -26.06 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.112 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.67 49.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.68 106.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -129.58 120.12 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 45.9 t -109.27 92.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.573 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.471 ' HA ' ' CE2' ' B' ' 29' ' ' TYR . 21.0 m-85 -52.91 96.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.495 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -67.17 141.35 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.441 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -49.14 169.47 0.16 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.805 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 64.6 Cg_endo -91.13 166.82 28.77 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.948 0.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -108.83 31.23 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.719 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.55 3.71 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.429 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -164.38 151.27 11.37 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.5 109.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.4 110.49 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.9 m -93.45 110.72 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.047 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.471 ' CE2' ' HA ' ' B' ' 19' ' ' PHE . 79.6 m-85 -88.93 121.82 31.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -77.87 131.36 37.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.454 HD11 HG22 ' B' ' 31' ' ' ILE . 16.2 mt -113.77 152.03 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.486 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -113.08 121.53 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.524 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 39.2 mt -125.3 150.24 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.567 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 53.6 m -148.9 145.11 27.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.423 . . . . 0.0 111.437 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -88.89 106.66 18.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.265 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.43 20.34 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.4 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.93 -170.87 24.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.554 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.12 -28.54 9.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.93 178.21 5.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -64.72 170.7 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.438 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 12.1 pt -152.95 136.09 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.623 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.66 112.17 4.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -117.21 157.03 26.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.209 0.528 . . . . 0.0 111.861 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.05 153.48 40.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.257 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 mm -115.49 151.51 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -147.76 130.46 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.516 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 35.4 p -120.42 154.7 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.923 0.392 . . . . 0.0 111.12 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -52.07 -30.11 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -139.18 117.65 12.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.54 17.26 7.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.26 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -108.84 -49.63 3.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -76.25 -50.5 14.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.62 148.32 24.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.999 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -136.49 107.11 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.62 118.66 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.2 136.32 14.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.05 132.75 28.1 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.603 -1.416 . . . . 0.0 112.079 -0.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.54 -45.31 9.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.449 2.1 . . . . 0.0 112.191 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -133.48 148.56 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.766 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.64 175.23 46.33 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.526 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -116.17 108.35 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 111.09 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 mp -80.13 158.81 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.21 170.11 6.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.7 110.33 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.637 2.225 . . . . 0.0 112.3 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.89 36.97 9.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.18 142.31 31.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.272 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -102.74 143.03 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.71 148.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.065 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.32 143.9 32.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.993 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.29 156.41 31.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.701 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.87 113.88 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.237 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.428 ' CG1' ' HB2' ' B' ' 29' ' ' TYR . 7.2 p -114.1 87.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.968 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.78 146.57 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.69 107.62 9.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.708 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.78 146.2 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -56.75 164.32 1.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -178.61 -173.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -116.3 109.31 17.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.93 17.16 12.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.492 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.68 -24.92 28.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.056 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 59.7 p -146.94 44.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.58 22.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.841 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -64.12 134.7 55.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.64 69.74 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -155.64 29.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -130.41 6.34 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.629 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.75 119.24 33.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.826 0.346 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.39 136.09 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.431 HD11 HG22 ' B' ' 89' ' ' ILE . 7.9 mt -98.82 165.53 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 58.7 m -137.81 122.84 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.51 112.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.52 154.81 36.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.833 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.446 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 11.4 p90 -157.42 147.14 20.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.449 HG23 ' CE1' ' B' ' 109' ' ' PHE . 0.6 OUTLIER -141.06 134.11 29.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -52.44 125.37 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 43.8 p -66.86 151.6 96.69 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.63 165.01 28.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.586 2.19 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.91 117.39 1.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.38 47.63 50.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.218 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.52 166.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 111.324 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.21 164.22 25.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.88 69.51 9.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.585 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.99 122.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.12 122.17 6.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -116.98 150.56 38.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -19.01 44.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.332 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.76 -23.73 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.773 0.321 . . . . 0.0 111.242 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.19 -13.85 42.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.449 ' CE1' HG23 ' B' ' 94' ' ' THR . 5.3 m-85 -102.55 -22.75 13.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -107.82 33.58 4.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.33 -140.35 6.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.83 149.36 21.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.39 -165.95 17.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.555 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.3 152.35 48.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 110.954 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.16 136.12 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.446 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 12.4 tpt180 -99.38 152.79 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.78 137.8 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.796 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -91.44 133.78 35.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.71 117.72 62.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.656 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.37 128.76 19.94 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.389 2.06 . . . . 0.0 112.294 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 31.9 mm -92.63 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.17 160.2 40.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.726 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -132.1 110.78 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.231 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.426 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 2.9 t30 -99.46 132.19 44.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.623 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.955 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.771 0.32 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -94.95 82.33 3.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.2 m -82.9 172.37 12.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 m -140.64 136.16 16.27 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.03 168.3 25.13 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.556 2.17 . . . . 0.0 112.247 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.07 124.0 10.91 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.481 2.121 . . . . 0.0 112.266 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 111.09 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -54.07 120.23 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.65 130.67 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.46 151.18 27.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.587 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.09 149.59 46.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 111.303 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -141.28 108.89 6.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.454 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.6 159.72 51.33 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 124.038 -1.234 . . . . 0.0 112.501 0.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.15 -3.57 12.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -120.43 -48.48 2.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -170.38 141.24 1.96 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 tt -109.07 144.83 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.605 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.426 ' CB ' ' HB3' ' A' ' 123' ' ' GLU . 10.2 p -125.11 101.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.774 0.321 . . . . 0.0 111.653 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' CD1' ' A' ' 29' ' ' TYR . 30.8 m-85 -58.11 111.15 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.463 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -72.22 139.77 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -57.55 167.42 1.34 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.844 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -89.99 163.12 34.9 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.734 0.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -101.31 28.83 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.13 5.81 46.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.06 156.12 41.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.778 0.323 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -76.35 108.1 9.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.89 136.34 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.79 106.94 17.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 39.5 m-85 -91.94 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -79.96 154.05 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 32' ' ' LYS . 26.0 mt -130.32 147.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.793 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' N ' HG21 ' A' ' 31' ' ' ILE . 27.2 tttt -100.98 126.98 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.185 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.6 mt -124.16 159.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.5 m -156.28 153.7 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.419 ' OD1' ' CD1' ' A' ' 41' ' ' ILE . 13.3 t30 -112.61 76.01 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.752 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.62 -30.98 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.954 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.07 174.43 3.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.354 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.01 35.14 4.84 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.553 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.22 171.54 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -74.61 152.35 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 ' CD1' ' OD1' ' A' ' 35' ' ' ASN . 8.7 pt -149.82 142.53 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 111.554 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.94 107.97 3.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.455 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.5 p-90 -109.48 157.56 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.171 0.51 . . . . 0.0 111.756 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.13 155.56 41.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.485 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.424 ' CD1' HG21 ' A' ' 91' ' ' ILE . 6.2 mm -121.64 144.93 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.8 135.86 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.917 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 p -118.69 156.73 28.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.006 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.8 p -49.87 -64.27 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 114.17 25.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.99 22.5 5.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -42.89 5.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -95.14 -51.34 4.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.8 mt -76.13 140.18 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.9 125.02 28.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.38 140.72 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -168.02 127.06 1.01 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.71 132.6 24.12 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 123.937 -1.276 . . . . 0.0 111.977 -0.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.96 -44.15 52.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.46 2.106 . . . . 0.0 112.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 104' ' ' PHE . 3.5 m -139.38 141.4 37.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.711 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.38 155.84 26.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.548 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.78 115.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 0.0 111.019 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.42 156.41 19.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -110.97 178.53 0.97 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.805 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.1 Cg_exo -58.21 110.24 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.533 2.155 . . . . 0.0 112.282 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.68 40.65 29.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.67 155.64 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -114.23 143.98 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.874 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 m -133.61 151.55 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.73 141.47 30.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.092 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -125.52 161.27 27.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.565 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.73 132.19 23.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.304 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.11 90.37 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.046 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 148.4 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.98 152.58 42.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -105.84 137.24 44.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.019 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -59.97 145.86 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -165.56 -166.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -114.6 118.52 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.46 19.22 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.07 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -142.66 46.5 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.008 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -143.03 147.74 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.57 150.81 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.433 HD21 ' CD1' ' A' ' 124' ' ' TYR . 49.6 mt -128.29 29.08 5.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.16 32.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.03 -19.09 12.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.389 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.57 117.79 23.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.2 137.77 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.3 mt -108.13 166.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 m -153.1 123.6 7.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.424 HG21 ' CD1' ' A' ' 45' ' ' ILE . 3.6 mp -112.69 122.5 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 135.78 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.747 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -141.1 145.1 35.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 111.026 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 109' ' ' PHE . 5.0 t -131.27 149.67 52.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -51.52 135.91 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.81 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 129.77 65.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.472 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 53.0 Cg_exo -55.03 159.9 8.88 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.411 2.074 . . . . 0.0 112.245 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -51.68 124.95 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.998 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.78 42.52 78.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.53 143.31 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.073 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.33 164.36 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 69.51 9.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.599 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.95 129.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.738 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE2' ' SG ' ' A' ' 59' ' ' CYS . 34.8 t80 -49.04 128.14 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -120.01 150.66 40.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -86.07 -36.6 19.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.74 -19.66 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.283 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.472 ' CD1' ' CD ' ' A' ' 97' ' ' PRO . 18.2 m0 -53.58 -22.28 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 94' ' ' THR . 57.1 m-85 -88.81 -33.81 17.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.983 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.41 51.73 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.954 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -133.27 -120.1 2.08 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.565 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -109.27 143.41 38.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.41 -171.3 19.31 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.579 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.84 145.51 43.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.65 150.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.53 139.89 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -128.44 146.53 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.46 159.61 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -129.06 147.81 50.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.477 . . . . 0.0 111.369 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -138.34 86.73 16.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 147.64 92.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.654 2.236 . . . . 0.0 112.613 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.2 mm -100.67 152.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 18' ' ' VAL . 6.9 tp10 -141.45 154.54 45.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.979 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 2.3 m-85 -113.51 126.86 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.168 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.55 82.05 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.772 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.981 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -95.17 82.45 3.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 68.8 m -82.97 172.6 12.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.803 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -140.85 136.0 15.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.92 168.22 25.31 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.496 2.131 . . . . 0.0 112.27 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.09 123.85 10.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.514 2.143 . . . . 0.0 112.24 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.69 111.16 0.85 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.614 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -54.01 120.13 5.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.849 0.356 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.53 130.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.49 151.35 27.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.552 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.33 149.48 45.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 111.255 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -141.05 108.94 6.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.576 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.59 159.83 50.96 Favored 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.902 -1.291 . . . . 0.0 112.504 0.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.18 -3.36 12.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.721 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -120.49 -48.66 2.28 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.823 0.345 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -170.3 141.46 2.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.355 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -109.43 144.8 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.568 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.433 ' CB ' ' HB3' ' B' ' 123' ' ' GLU . 10.4 p -125.09 101.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.857 0.361 . . . . 0.0 111.693 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.474 ' CD2' ' CD1' ' B' ' 29' ' ' TYR . 30.6 m-85 -58.21 111.02 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.405 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -72.08 139.69 48.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.269 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -57.4 167.52 1.25 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.868 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 69.7 Cg_endo -89.9 163.17 35.29 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.77 0.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -101.42 28.78 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.028 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.18 5.67 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.421 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.88 156.36 42.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.703 0.287 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -76.5 108.16 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.97 136.6 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.95 106.97 17.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.474 ' CD1' ' CD2' ' B' ' 19' ' ' PHE . 39.7 m-85 -91.97 113.45 25.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.65 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -79.73 154.07 28.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.382 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.426 HG21 ' N ' ' B' ' 32' ' ' LYS . 25.9 mt -130.4 147.03 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.783 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.426 ' N ' HG21 ' B' ' 31' ' ' ILE . 27.4 tttt -100.83 126.94 47.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.226 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 13.8 mt -124.02 159.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -156.45 153.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.071 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.426 ' OD1' ' CD1' ' B' ' 41' ' ' ILE . 13.4 t30 -112.76 75.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.789 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.59 -30.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.998 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.3 174.61 3.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 35.36 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.33 171.72 18.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -74.77 152.45 39.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.426 ' CD1' ' OD1' ' B' ' 35' ' ' ASN . 8.5 pt -149.91 142.52 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.39 . . . . 0.0 111.582 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.92 107.96 3.51 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.408 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.4 ' CZ2' ' HA3' ' B' ' 60' ' ' GLY . 37.6 p-90 -109.35 157.51 18.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.204 0.526 . . . . 0.0 111.729 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.46 41.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.401 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' B' ' 91' ' ' ILE . 6.2 mm -121.65 144.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 111.298 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.74 136.13 20.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 2.7 p -119.04 156.77 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.928 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 4.4 p -49.94 -64.12 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.2 114.19 25.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.94 22.6 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -42.93 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.768 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -95.15 -51.47 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.12 140.17 41.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.82 125.29 29.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.53 140.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.985 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -168.17 126.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.6 132.5 23.64 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.948 -0.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.87 -44.06 53.36 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.39 2.06 . . . . 0.0 112.233 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . 0.446 ' SG ' ' CE2' ' B' ' 104' ' ' PHE . 3.5 m -139.59 141.22 37.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.4 ' HA3' ' CZ2' ' B' ' 43' ' ' TRP . . . -153.27 155.81 26.37 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.626 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.74 115.53 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 111.088 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.29 156.75 19.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.455 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.2 OUTLIER -111.29 178.61 0.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 32.2 Cg_exo -58.33 110.21 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 0.0 112.282 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.83 40.72 28.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 155.62 18.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.027 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -114.34 143.77 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 m -133.4 151.8 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.02 141.19 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.179 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -125.19 161.27 27.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.704 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.77 132.25 23.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.283 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.15 90.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.13 148.44 48.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.94 152.55 42.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.823 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -105.82 137.32 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -60.02 145.97 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -165.68 -166.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -114.38 118.66 34.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.6 19.0 15.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 -28.29 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -142.46 46.37 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -142.77 147.93 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.64 151.04 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' B' ' 124' ' ' TYR . 49.0 mt -128.53 29.23 5.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.38 32.91 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.01 -18.98 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.66 117.59 23.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.02 137.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 6.2 mt -107.98 166.55 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 8.3 m -153.14 123.45 7.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.886 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.422 HG21 ' CD1' ' B' ' 45' ' ' ILE . 3.6 mp -112.58 122.51 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.254 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.13 135.99 51.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.764 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -141.32 145.12 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.989 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.453 HG23 ' CD1' ' B' ' 109' ' ' PHE . 5.0 t -131.22 149.88 52.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -51.59 136.09 27.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.22 129.84 65.13 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . 0.47 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 53.0 Cg_exo -55.1 159.93 9.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.444 2.096 . . . . 0.0 112.235 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.84 124.94 13.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.01 42.34 80.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.54 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.45 143.07 50.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.09 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.22 164.42 7.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.084 0.468 . . . . 0.0 111.266 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.84 69.28 9.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.575 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.7 129.41 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.825 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.446 ' CE2' ' SG ' ' B' ' 59' ' ' CYS . 34.9 t80 -49.02 128.09 15.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.012 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.07 150.52 40.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -85.9 -36.66 19.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.59 -19.68 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.306 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.47 ' CD1' ' CD ' ' B' ' 97' ' ' PRO . 18.2 m0 -53.62 -22.4 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.104 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.453 ' CD1' HG23 ' B' ' 94' ' ' THR . 57.6 m-85 -88.68 -33.78 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.76 0.314 . . . . 0.0 110.948 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -99.57 51.72 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -133.22 -120.39 2.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.424 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -109.12 143.49 38.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.51 -171.29 19.22 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.528 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.85 145.49 43.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 43.6 t -91.68 150.01 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.64 139.72 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.766 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.22 146.54 50.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.41 159.44 43.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -128.9 147.83 50.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.381 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -138.25 86.75 16.67 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.38 147.76 92.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.586 2.191 . . . . 0.0 112.576 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 28.8 mm -100.72 152.2 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.433 ' HB3' ' CB ' ' B' ' 18' ' ' VAL . 7.1 tp10 -141.63 154.52 45.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.896 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 124' ' ' TYR . 2.4 m-85 -113.56 126.96 55.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.67 81.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.913 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.52 139.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.69 168.89 18.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.2 103.12 4.08 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.41 160.24 32.3 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.544 2.163 . . . . 0.0 112.382 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.95 110.39 3.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.526 2.151 . . . . 0.0 112.261 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.94 132.81 28.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 36.2 m-20 -55.78 140.41 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG23 ' CD1' ' A' ' 41' ' ' ILE . 9.2 pt -102.78 146.34 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.2 142.85 27.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.91 151.54 51.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.024 0.44 . . . . 0.0 111.16 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -135.67 111.5 10.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.528 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.97 165.09 43.11 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.958 -1.268 . . . . 0.0 112.609 0.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.9 t -45.57 -70.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.431 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -154.76 39.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.007 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 137.9 4.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.242 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 12.3 tt -148.2 138.34 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.795 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 123' ' ' GLU . 48.2 t -119.11 116.23 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 111.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.38 95.9 2.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.349 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -70.55 135.8 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.594 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -74.8 172.6 8.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.381 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 92.3 Cg_endo -82.12 163.87 75.32 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 124.275 -1.135 . . . . 0.0 113.065 0.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.06 45.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -124.97 8.11 8.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.464 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.64 8.38 3.07 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HG3' ' CG2' ' A' ' 76' ' ' THR . 15.0 mttt 62.5 137.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -140.17 95.81 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.945 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -76.16 118.21 18.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.416 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 95.7 m-85 -101.79 111.71 24.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -84.2 135.38 34.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.454 HD11 HG22 ' A' ' 31' ' ' ILE . 42.3 mt -112.92 138.0 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.686 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 125.66 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.408 HD12 ' CE ' ' A' ' 70' ' ' MET . 14.3 mt -120.63 155.0 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.2 m -150.64 158.32 44.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 111.221 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.29 108.95 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.738 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 8' ' ' ASP . . . -95.37 22.42 6.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.094 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.57 -152.07 10.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.613 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.9 -19.43 4.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.696 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.04 152.73 39.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.318 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 168.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.752 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 9' ' ' ILE . 25.1 pt -155.34 149.05 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.642 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.49 112.62 3.88 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.13 161.52 13.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 0.0 111.85 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 151.28 37.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.115 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 45' ' ' ILE . 18.5 mm -115.1 144.18 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 111.891 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.07 143.98 46.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 76.9 p -138.68 150.63 46.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.069 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.0 78.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -137.51 114.49 10.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.7 mtp -90.46 10.57 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.567 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.12 -35.48 10.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.927 0.394 . . . . 0.0 110.626 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HD3' ' CG ' ' A' ' 77' ' ' PHE . 2.5 ttm180 -94.55 -25.5 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.779 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.17 141.1 50.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.8 p -133.8 110.98 10.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.42 121.79 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.027 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -142.2 131.02 11.97 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.948 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.8 140.81 67.66 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.658 -1.392 . . . . 0.0 112.154 -0.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.25 -39.65 12.7 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 21.9 m -138.19 167.12 22.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.26 -168.73 41.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.731 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -150.6 138.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.64 0.257 . . . . 0.0 110.832 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.19 151.35 51.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.403 . . . . 0.0 111.146 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 1.1 m-20 -84.11 178.01 2.65 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 27.7 Cg_exo -62.45 127.48 21.0 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.736 2.291 . . . . 0.0 112.422 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER 81.61 -7.98 1.39 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.035 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.34 156.74 25.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.6 149.74 51.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.976 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.62 152.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 mt -104.85 138.49 41.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.408 ' CE ' HD12 ' A' ' 33' ' ' ILE . 43.1 mtm -129.21 154.12 47.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.77 117.61 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.312 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 72' ' ' VAL . 7.5 p -106.31 86.84 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.9 131.29 42.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.63 97.55 5.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.732 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -51.94 148.92 5.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.17 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.427 ' CG2' ' HG3' ' A' ' 26' ' ' LYS . 3.2 p -64.23 138.37 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.405 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 21.7 p90 -154.21 -173.69 4.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -105.68 109.47 21.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.02 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.414 ' CB ' HD23 ' A' ' 126' ' ' LEU . . . -95.43 18.89 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.81 -24.15 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -139.17 52.13 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -141.6 176.16 9.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.63 112.24 25.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD12 ' CD2' ' A' ' 124' ' ' TYR . 22.9 mt -134.25 60.38 1.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -141.98 17.31 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.352 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.08 10.02 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.77 137.25 39.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -163.4 133.86 4.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 89' ' ' ILE . 56.7 mt -96.74 112.09 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.6 m -93.98 122.49 36.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.49 109.93 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.884 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.04 131.73 55.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.976 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.405 ' CZ2' ' HD3' ' A' ' 116' ' ' ARG . 5.9 p90 -136.5 141.81 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.42 HG21 ' CE1' ' A' ' 109' ' ' PHE . 1.3 t -131.85 144.55 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.76 143.05 26.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 144.13 57.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.7 159.17 53.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.562 2.175 . . . . 0.0 112.165 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -51.45 124.06 11.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.05 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.38 35.96 91.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.57 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.15 135.92 56.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.814 0.34 . . . . 0.0 111.096 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.09 164.48 0.63 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.146 0.498 . . . . 0.0 111.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.39 70.2 7.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.567 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.38 139.04 0.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -50.49 139.25 16.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.449 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 1.2 mmp_? -129.97 148.57 51.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -32.62 39.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.6 -9.48 58.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.449 ' CD2' ' HB2' ' A' ' 105' ' ' ARG . 17.6 m0 -62.66 -18.49 62.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.57 0.224 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.42 ' CE1' HG21 ' A' ' 94' ' ' THR . 10.6 m-85 -104.9 28.59 7.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.745 0.307 . . . . 0.0 110.795 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -150.38 32.9 0.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -121.21 -142.5 6.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.431 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.7 141.27 29.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.856 0.36 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.34 -179.9 20.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.66 149.2 33.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.411 HG12 ' CD2' ' A' ' 109' ' ' PHE . 11.0 t -106.43 130.25 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.405 ' HD3' ' CZ2' ' A' ' 93' ' ' TRP . 13.6 mtt-85 -94.31 135.11 36.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -123.55 118.68 27.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.93 162.97 17.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -140.87 143.22 34.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.6 mt -124.6 104.65 30.8 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.678 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.93 138.7 87.17 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.489 2.126 . . . . 0.0 112.453 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 14.1 mm -113.93 104.91 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.958 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' O ' ' CG1' ' A' ' 18' ' ' VAL . 4.2 mt-10 -97.05 117.92 32.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.464 ' CD2' HD12 ' A' ' 84' ' ' LEU . 11.6 m-85 -81.8 99.39 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.8 83.65 1.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.007 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.414 HD23 ' CB ' ' A' ' 79' ' ' ALA . 30.6 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.816 0.341 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.44 139.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.55 168.78 18.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.946 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 26.8 m -146.2 103.01 4.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.25 160.32 32.79 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.547 2.165 . . . . 0.0 112.382 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.96 110.35 3.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.536 2.157 . . . . 0.0 112.249 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.86 132.86 27.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' B' ' 36' ' ' ALA . 37.2 m-20 -55.77 140.43 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.401 HG23 ' CD1' ' B' ' 41' ' ' ILE . 9.4 pt -102.82 146.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.209 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.26 142.97 26.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.01 151.38 51.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -135.6 111.42 10.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.12 164.96 44.42 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.958 -1.267 . . . . 0.0 112.607 0.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.5 t -45.43 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.476 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -154.75 39.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.044 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.8 137.86 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.262 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 12.4 tt -148.24 138.25 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' B' ' 123' ' ' GLU . 48.0 t -118.99 116.29 50.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.526 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.55 95.98 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -70.51 135.85 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.48 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -74.77 172.52 8.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.48 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -82.23 164.13 74.53 Favored 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.257 -1.143 . . . . 0.0 112.975 0.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.31 45.35 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.403 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 70.7 m-20 -124.95 7.93 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.36 8.29 3.13 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . 0.436 ' HG3' ' CG2' ' B' ' 76' ' ' THR . 15.1 mttt 62.7 138.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.661 0.267 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -140.53 95.76 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -76.05 118.47 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.423 ' HB2' ' CG1' ' B' ' 72' ' ' VAL . 95.9 m-85 -102.04 111.87 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -84.49 135.46 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.225 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.511 HD11 HG22 ' B' ' 31' ' ' ILE . 41.8 mt -112.92 138.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.715 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 125.59 54.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.961 0.41 . . . . 0.0 111.186 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.413 HD12 ' CE ' ' B' ' 70' ' ' MET . 14.1 mt -120.6 155.0 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.872 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.4 m -150.65 158.42 44.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.057 0.456 . . . . 0.0 111.279 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.24 109.13 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.705 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' B' ' 8' ' ' ASP . . . -95.56 22.49 7.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.53 -151.99 9.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.93 -19.52 4.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.61 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.2 152.68 39.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.993 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 168.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.687 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.401 ' CD1' HG23 ' B' ' 9' ' ' ILE . 24.8 pt -155.29 149.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.622 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.65 112.86 3.92 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.31 161.52 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.279 0.561 . . . . 0.0 111.935 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.03 151.45 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.146 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.23 144.1 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 111.876 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.04 143.84 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.34 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 74.7 p -138.58 150.73 46.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.017 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -36.04 78.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -137.56 114.55 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 42.5 mtp -90.53 10.76 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.46 -35.09 10.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 0.0 110.604 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.4 ' HD3' ' CG ' ' B' ' 77' ' ' PHE . 2.5 ttm180 -94.87 -25.5 16.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.23 141.01 50.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 97.7 p -133.81 110.67 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.2 121.71 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -142.1 131.0 12.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.86 140.94 68.56 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.068 -0.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.46 -39.44 12.5 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.109 . . . . 0.0 112.247 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 22.5 m -138.36 167.11 22.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.28 -168.74 41.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.682 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -150.7 138.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.674 0.274 . . . . 0.0 110.769 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.34 151.48 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.211 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.442 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 1.1 m-20 -84.25 177.82 2.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 27.8 Cg_exo -62.26 127.18 20.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.787 2.325 . . . . 0.0 112.435 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER 81.95 -8.26 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.977 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.16 156.84 25.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.55 149.85 51.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.81 152.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 12.6 mt -104.72 138.3 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' MET . . . . . 0.413 ' CE ' HD12 ' B' ' 33' ' ' ILE . 43.1 mtm -128.98 154.16 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.87 117.6 13.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' B' ' 29' ' ' TYR . 7.3 p -106.46 86.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.98 131.2 41.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 p -123.39 97.59 5.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.702 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -52.17 148.92 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.058 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.436 ' CG2' ' HG3' ' B' ' 26' ' ' LYS . 3.2 p -64.3 138.31 58.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.4 ' CG ' ' HD3' ' B' ' 52' ' ' ARG . 21.3 p90 -154.12 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -105.73 109.67 21.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.953 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.76 19.23 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.428 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.35 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.3 p -139.2 52.21 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -141.65 175.92 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.51 111.95 24.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.468 HD12 ' CD2' ' B' ' 124' ' ' TYR . 22.4 mt -134.04 60.54 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -142.03 17.27 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.1 10.09 2.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.89 137.27 39.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -163.45 133.88 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 55.8 mt -96.78 112.03 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 88.5 m -93.87 122.53 36.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.333 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.62 109.83 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.877 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -111.92 131.8 55.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.403 ' CZ2' ' HD3' ' B' ' 116' ' ' ARG . 5.8 p90 -136.62 141.84 43.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.023 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.417 HG21 ' CE1' ' B' ' 109' ' ' PHE . 1.3 t -131.86 144.5 50.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.66 142.96 26.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.12 144.34 58.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.93 159.2 53.98 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.658 2.239 . . . . 0.0 112.215 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -51.46 123.83 10.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.45 35.94 91.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.05 136.04 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.754 0.311 . . . . 0.0 111.077 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.38 164.24 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.218 0.532 . . . . 0.0 111.277 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 70.27 7.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.653 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.33 138.95 0.09 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.39 138.91 16.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.451 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 1.2 mmp_? -129.69 148.48 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -32.51 40.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.73 -9.22 58.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.649 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.451 ' CD2' ' HB2' ' B' ' 105' ' ' ARG . 17.9 m0 -62.86 -18.63 63.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.658 0.266 . . . . 0.0 111.256 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.421 ' CD2' HG12 ' B' ' 115' ' ' VAL . 10.6 m-85 -104.69 28.46 7.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.36 . . . . 0.0 110.891 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -150.28 32.75 0.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.97 -142.62 6.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.485 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.65 141.22 29.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.31 -179.69 20.44 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.81 149.24 33.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.421 HG12 ' CD2' ' B' ' 109' ' ' PHE . 11.1 t -106.41 130.36 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.403 ' HD3' ' CZ2' ' B' ' 93' ' ' TRP . 13.8 mtt-85 -94.46 134.86 36.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.076 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -123.43 118.59 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.82 163.06 17.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.754 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -141.08 143.23 34.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.142 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mt -124.51 104.49 31.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.82 138.76 86.98 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.503 2.135 . . . . 0.0 112.429 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 13.8 mm -113.95 104.8 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.946 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.411 ' O ' ' CG1' ' B' ' 18' ' ' VAL . 4.1 mt-10 -96.95 117.77 31.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.981 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.468 ' CD2' HD12 ' B' ' 84' ' ' LEU . 11.1 m-85 -81.76 99.2 8.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.68 83.63 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.054 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.9 mt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.908 179.751 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.74 155.18 27.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 t -102.09 -56.48 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.809 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 5' ' ' PRO . 6.6 p -177.7 141.11 0.44 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.948 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HD2' ' CG2' ' A' ' 4' ' ' VAL . 50.0 Cg_exo -53.17 147.58 34.53 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.603 2.202 . . . . 0.0 112.323 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.65 106.29 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.621 2.214 . . . . 0.0 112.24 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.65 129.91 49.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -55.0 128.87 35.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.2 138.69 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.318 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 149.73 39.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.693 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.29 149.87 35.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.962 0.411 . . . . 0.0 111.094 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -144.86 107.17 4.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.662 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.87 154.64 61.49 Favored 'Cis proline' 0 C--N 1.352 0.717 0 C-N-CA 123.748 -1.355 . . . . 0.0 112.457 0.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.2 m -59.45 -53.11 61.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -160.05 39.89 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.47 111.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.085 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.403 ' CG2' HD11 ' A' ' 122' ' ' ILE . 15.9 tt -129.9 134.01 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.941 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 123' ' ' GLU . 6.1 p -130.69 110.63 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -57.34 154.37 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.968 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.14 120.13 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.372 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -50.33 169.01 0.21 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 61.4 Cg_endo -72.7 163.44 88.73 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.443 0.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 24.4 m-85 -111.63 34.92 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.017 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.76 4.5 25.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.72 131.63 20.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.826 0.346 . . . . 0.0 110.74 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -51.77 122.58 8.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -118.39 150.22 39.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.642 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.72 109.83 14.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -98.33 116.59 30.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.406 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -81.4 130.6 35.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 12.2 mt -110.77 143.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.527 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 131.6 46.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 111.47 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 64.2 mt -125.93 154.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.639 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.421 HG21 ' N ' ' A' ' 35' ' ' ASN . 53.2 m -153.21 156.65 38.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 111.328 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' N ' HG21 ' A' ' 34' ' ' THR . 47.5 t30 -105.66 109.31 21.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.532 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.61 21.64 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.89 -145.47 13.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.545 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.79 -39.39 0.29 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -103.36 159.34 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -52.04 158.68 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.77 117.18 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 111.545 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.0 116.91 4.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.906 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.466 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 26.2 p-90 -113.78 154.9 26.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.597 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.61 156.33 45.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 45' ' ' ILE . 2.3 mp -118.08 147.29 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.434 . . . . 0.0 111.742 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -145.27 131.26 19.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 p -113.19 150.09 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -36.2 47.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.07 115.81 11.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.8 mmm -93.31 21.86 5.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.45 -37.22 7.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -101.99 -27.94 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.013 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.5 150.16 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.61 109.75 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.76 144.47 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -159.27 136.38 6.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.52 144.54 81.34 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.66 -1.392 . . . . 0.0 112.236 0.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 -4.85 15.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.589 2.192 . . . . 0.0 112.96 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -171.87 161.67 5.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 169.96 157.75 12.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.608 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 t -94.14 134.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -108.89 132.87 53.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -88.87 168.37 15.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 25.3 Cg_endo -62.12 113.59 1.95 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.538 2.158 . . . . 0.0 112.359 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.7 30.89 2.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.67 148.37 24.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.792 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' CG ' ' OG1' ' A' ' 34' ' ' THR . 42.0 mttt -115.64 121.87 43.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 14.0 p -112.4 146.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.73 147.12 23.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.253 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.4 ttp -129.47 156.93 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.494 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.42 122.38 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.591 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -111.91 115.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.27 129.26 46.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.6 t -116.18 127.57 54.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.66 147.99 31.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.111 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -62.65 161.02 12.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -176.68 -175.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 111.02 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.43 108.65 20.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.28 18.7 6.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.453 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.48 -38.4 12.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.3 p -131.31 44.31 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.074 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -138.13 177.25 8.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.3 149.66 21.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 47.5 mt -139.46 29.37 2.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.54 26.59 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.53 -12.51 9.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.53 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.77 120.33 24.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.94 134.52 17.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.91 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.12 165.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 92.4 m -136.73 118.77 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.951 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -116.59 108.88 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.78 156.71 24.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -155.81 141.11 17.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.6 t -138.57 154.65 48.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -68.0 128.81 37.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.9 p -70.38 139.81 87.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.784 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 72.1 Cg_exo -48.25 164.22 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.417 2.078 . . . . 0.0 112.35 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.26 99.73 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.64 45.3 94.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.473 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.17 -85.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.744 0.307 . . . . 0.0 111.102 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.38 1.51 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.126 0.489 . . . . 0.0 111.277 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 70.45 10.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.67 124.26 0.05 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.451 ' HA ' ' CZ3' ' A' ' 108' ' ' TRP . 31.7 t80 -56.46 145.03 28.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -135.31 156.36 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.14 30.32 1.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -116.96 -34.14 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.958 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CD1' ' CD ' ' A' ' 97' ' ' PRO . 24.7 m0 -59.3 -29.71 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.403 ' CD2' HG22 ' A' ' 115' ' ' VAL . 4.6 m-85 -85.45 -44.24 12.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -93.51 53.74 1.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.29 -157.3 9.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.535 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.13 154.63 41.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.823 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.08 -162.45 13.14 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.649 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.96 111.25 9.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.403 HG22 ' CD2' ' A' ' 109' ' ' PHE . 7.4 p -111.54 130.74 64.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -104.04 154.5 19.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.824 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -132.47 141.93 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.74 163.07 24.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.7 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -141.03 124.24 16.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.033 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.37 117.24 57.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.772 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.89 137.38 32.07 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.33 2.02 . . . . 0.0 112.236 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.403 HD11 ' CG2' ' A' ' 17' ' ' ILE . 8.7 mm -105.68 136.06 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 2.2 mt-10 -124.95 157.94 34.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 88.0 m-85 -120.62 96.68 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.241 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.424 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 66.4 t30 -79.2 81.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.894 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.898 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.897 0.379 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.67 155.14 27.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 21.2 t -101.92 -56.61 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.428 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 6.6 p -177.77 141.13 0.44 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.944 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.428 ' HD2' ' CG2' ' B' ' 4' ' ' VAL . 51.2 Cg_exo -53.2 147.59 34.81 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.601 2.201 . . . . 0.0 112.249 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.81 106.4 1.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.541 2.161 . . . . 0.0 112.248 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.82 129.76 48.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.443 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -54.78 128.63 33.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.84 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.12 138.89 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.88 149.81 39.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.38 149.92 35.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -144.88 107.34 4.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.648 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' LYS . 26.4 Cg_endo -61.72 154.72 60.44 Favored 'Cis proline' 0 C--N 1.351 0.668 0 C-N-CA 123.802 -1.333 . . . . 0.0 112.391 0.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.9 m -59.58 -53.13 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.9 39.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' B' ' 13' ' ' PRO . 0.3 OUTLIER -163.47 111.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.063 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.02 133.99 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' B' ' 123' ' ' GLU . 6.1 p -130.67 110.76 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.284 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 21.6 m-85 -57.37 154.39 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.92 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.36 119.95 37.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -50.13 169.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.928 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 60.5 Cg_endo -72.55 163.67 87.83 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.598 -1.417 . . . . 0.0 112.385 0.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 24.4 m-85 -111.76 34.7 4.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.6 4.61 26.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.312 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -144.74 131.55 20.16 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.831 0.348 . . . . 0.0 110.85 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -51.64 122.73 8.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.038 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -118.67 150.08 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.552 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.56 109.97 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 111.217 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.408 ' CE1' ' CD1' ' B' ' 19' ' ' PHE . 15.0 m-85 -98.5 116.42 30.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -81.25 130.49 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.484 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 12.1 mt -110.81 143.48 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 131.68 46.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 0.0 111.508 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.428 ' HB ' ' CG1' ' B' ' 68' ' ' VAL . 64.4 mt -126.03 154.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.645 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' THR . . . . . 0.422 HG21 ' N ' ' B' ' 35' ' ' ASN . 53.2 m -153.13 156.66 39.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 111.285 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.422 ' N ' HG21 ' B' ' 34' ' ' THR . 47.6 t30 -105.64 109.45 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.479 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -94.65 21.51 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.231 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.87 -145.5 13.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.67 -39.44 0.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.577 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -103.13 159.36 15.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -52.16 158.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.55 117.19 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.607 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.98 116.89 4.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.876 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.471 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 26.1 p-90 -113.74 154.89 26.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.648 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.58 156.4 45.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.419 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' B' ' 45' ' ' ILE . 2.3 mp -118.06 147.33 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.976 0.417 . . . . 0.0 111.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -145.39 131.14 19.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 68.8 p -113.15 150.14 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.069 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.94 -36.09 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.809 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.18 115.77 11.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 79.2 mmm -93.33 22.09 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.942 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -37.33 7.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 ttp85 -101.9 -27.93 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.42 150.26 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.85 110.02 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.04 144.61 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.37 136.35 6.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.85 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 144.53 81.31 Favored 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.688 -1.38 . . . . 0.0 112.3 -0.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.0 -4.68 15.47 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.947 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -172.01 161.63 5.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 169.91 157.86 12.89 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.656 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.09 134.05 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.794 0.33 . . . . 0.0 110.998 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 tp -108.89 132.53 53.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.019 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.436 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -88.54 168.34 16.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 24.9 Cg_endo -62.05 113.45 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.509 2.139 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.94 30.6 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 148.37 24.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.416 ' CG ' ' OG1' ' B' ' 34' ' ' THR . 42.1 mttt -115.73 121.83 43.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 13.8 p -112.41 146.15 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.85 147.27 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.194 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 13.4 ttp -129.58 156.92 43.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.471 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.32 122.71 16.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.578 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.6 p -112.3 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.658 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.62 129.1 46.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 111.297 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.01 127.7 55.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.751 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.81 148.05 31.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -62.84 160.97 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.763 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -176.53 -175.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.37 108.66 20.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.39 18.9 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.456 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.56 -38.54 12.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 111.086 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.0 p -131.2 44.31 2.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -138.06 177.32 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -91.35 149.62 21.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.4 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 47.6 mt -139.5 29.41 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.37 26.31 1.98 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.972 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.18 -12.62 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.64 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.61 120.22 24.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.946 0.403 . . . . 0.0 111.104 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.78 134.6 17.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.911 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.23 165.56 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.983 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 93.8 m -136.64 118.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.993 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -116.58 108.9 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -114.78 156.56 24.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -155.62 141.05 17.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 13.7 t -138.55 154.61 48.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -67.97 128.91 38.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 21.2 p -70.45 139.8 86.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . 0.481 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 70.9 Cg_exo -48.2 164.08 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.541 2.161 . . . . 0.0 112.303 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.11 99.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.53 45.47 94.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.22 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 70.32 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.75 124.27 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.817 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.452 ' HA ' ' CZ3' ' B' ' 108' ' ' TRP . 30.5 t80 -56.49 145.07 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -135.43 156.38 49.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.19 30.48 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -116.99 -34.2 4.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CD1' ' CD ' ' B' ' 97' ' ' PRO . 25.0 m0 -59.23 -29.84 67.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.406 ' CD2' HG22 ' B' ' 115' ' ' VAL . 4.6 m-85 -85.48 -43.91 13.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -93.79 53.84 1.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.45 -157.12 9.63 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.566 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.3 154.71 41.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.08 -162.52 13.12 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.664 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.95 111.41 9.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' B' ' 109' ' ' PHE . 7.4 p -111.65 130.7 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -103.9 154.53 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -132.56 142.05 48.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.91 162.93 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -140.94 124.36 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.36 117.45 57.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.734 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 137.39 31.76 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.365 2.044 . . . . 0.0 112.225 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 8.8 mm -105.66 136.13 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.359 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . 2.2 mt-10 -124.96 158.08 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.445 ' HB3' ' CE2' ' B' ' 23' ' ' TYR . 87.8 m-85 -120.73 96.54 5.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.422 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 66.4 t30 -79.14 81.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 37.1 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.828 -179.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.878 0.37 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.38 86.91 1.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -171.25 44.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.9 m -52.0 144.71 19.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.222 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.43 167.36 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.537 2.158 . . . . 0.0 112.327 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.15 146.69 82.41 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.527 2.151 . . . . 0.0 112.223 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.28 113.01 3.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.528 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -48.1 121.56 4.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 0.0 111.067 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.421 HG12 ' CE2' ' A' ' 93' ' ' TRP . 5.0 pt -93.21 147.02 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -92.67 145.34 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.57 154.15 51.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.136 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' O ' ' CG2' ' A' ' 31' ' ' ILE . 13.6 mm-40 -139.97 127.93 12.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.389 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.78 163.97 77.55 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.697 0.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.4 -53.21 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.725 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -178.3 50.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.165 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -169.92 107.15 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.174 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -120.95 150.22 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 123' ' ' GLU . 42.4 t -132.99 95.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.0 111.641 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -54.8 97.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.265 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -59.09 151.39 22.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -64.2 169.69 4.42 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.656 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 66.8 Cg_endo -93.11 164.12 23.14 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.502 -1.041 . . . . 0.0 112.789 0.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.01 37.29 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.695 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.64 -5.87 13.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.59 -161.43 1.29 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.838 0.351 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.39 142.39 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -159.56 91.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.466 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.5 m -83.3 143.83 30.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.511 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -121.48 130.3 53.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.176 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.35 133.89 42.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.04 0.448 . . . . 0.0 111.671 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 31' ' ' ILE . 9.4 mm -99.99 149.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.05 126.38 46.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.277 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.5 mt -125.09 153.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 78.5 m -154.49 155.27 34.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -102.86 81.74 2.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.091 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.75 -23.4 17.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.96 -160.26 7.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.625 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.06 0.94 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.7 139.15 12.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.19 138.59 16.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 pt -137.62 174.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.461 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.94 98.16 0.34 Allowed Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.684 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.455 ' CZ3' ' CD1' ' A' ' 45' ' ' ILE . 30.1 p-90 -92.43 155.68 17.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.126 0.489 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.3 158.12 43.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.446 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -125.32 149.68 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.001 0.429 . . . . 0.0 111.723 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -159.66 131.31 6.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.484 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -109.79 158.39 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.307 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -29.89 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.45 117.8 23.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.18 18.19 7.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -109.4 -43.74 4.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.6 -58.97 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mt -83.9 140.79 31.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.09 107.46 5.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.011 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 HG12 ' CG2' ' A' ' 45' ' ' ILE . 3.2 m -74.42 152.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -168.52 113.27 0.56 Allowed Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.35 141.11 70.79 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.304 0.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.59 -3.87 14.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.544 2.162 . . . . 0.0 112.747 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.2 p -170.42 147.6 3.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.792 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.23 175.32 43.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 t -106.2 122.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.175 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.16 125.27 38.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.74 161.42 61.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.95 100.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.561 2.174 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt 69.47 45.21 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -107.61 154.13 21.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.957 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -110.77 137.14 48.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.988 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.42 145.56 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.91 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.1 117.14 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.429 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 1.8 tmm? -101.66 147.93 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -113.92 140.91 47.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.439 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.0 t -124.95 84.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.23 129.42 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.05 122.07 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -92.31 138.76 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.844 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.38 162.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -169.21 -161.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.19 119.89 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.6 19.42 20.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.39 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.35 -31.01 12.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.3 p -136.87 44.77 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.07 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -144.31 139.81 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.93 146.59 17.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.975 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 16.2 mt -130.86 32.24 4.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.26 27.89 1.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -127.68 6.19 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.654 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.04 119.99 39.14 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.47 131.23 14.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.291 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.6 mt -84.67 162.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.51 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.2 m -138.66 137.36 36.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 0.0 111.375 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.6 mt -120.53 146.94 24.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.606 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 4.4 mt-10 -149.28 111.59 4.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.192 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.421 ' CE2' HG12 ' A' ' 9' ' ' ILE . 7.8 p90 -123.79 138.53 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.46 130.39 26.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.976 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -54.03 125.03 17.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -67.05 144.68 98.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 163.05 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.433 2.089 . . . . 0.0 112.204 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.46 118.39 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.983 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.37 46.12 52.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.47 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.83 151.13 46.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.12 164.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.284 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 71.13 5.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.6 142.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.763 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.36 134.44 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 155.22 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.986 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -93.4 -6.74 46.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.653 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.81 -17.59 35.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.546 0.213 . . . . 0.0 111.464 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.36 -16.15 32.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.294 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 1.5 m-85 -126.89 37.55 4.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -151.46 43.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.49 -117.96 0.61 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.617 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -97.97 156.18 16.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.989 0.423 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.11 135.75 5.37 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.579 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -77.25 130.89 37.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 t -122.28 117.1 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.34 147.24 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.415 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.436 ' HB3' ' CG ' ' A' ' 92' ' ' GLU . 12.8 ptp180 -143.93 153.84 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.045 0.45 . . . . 0.0 111.507 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -147.73 131.78 17.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.29 134.13 48.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.132 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.79 137.7 19.83 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.5 138.73 17.66 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.542 2.161 . . . . 0.0 112.597 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.409 HG21 HD11 ' A' ' 122' ' ' ILE . 11.5 mm -101.52 146.56 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.029 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . 2.7 mt-10 -132.67 163.72 28.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.466 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 71.5 m-85 -126.37 131.5 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.195 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.408 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 4.2 t30 -120.18 115.16 23.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.913 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.793 0.33 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.35 86.88 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -171.25 44.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.6 m -51.99 144.85 19.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.174 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.52 167.43 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.566 2.177 . . . . 0.0 112.22 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 146.76 82.39 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.554 2.169 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.23 113.21 3.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.451 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -48.24 121.72 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.415 HG12 ' CE2' ' B' ' 93' ' ' TRP . 5.1 pt -93.34 146.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -92.83 145.45 24.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.768 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.62 154.24 51.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.098 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.407 ' O ' ' CG2' ' B' ' 31' ' ' ILE . 13.5 mm-40 -139.95 127.94 12.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.9 163.77 78.48 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.047 -1.231 . . . . 0.0 112.695 0.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.23 -53.25 4.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.694 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -178.32 50.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.141 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -170.04 106.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.7 150.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' B' ' 123' ' ' GLU . 42.2 t -133.07 95.35 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.705 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -54.89 96.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.309 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -59.01 151.21 22.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.761 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -63.97 169.72 4.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.602 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 65.5 Cg_endo -93.14 164.07 23.07 Favored 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.476 -1.052 . . . . 0.0 112.834 0.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -102.87 37.23 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.705 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 -5.87 14.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.231 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.58 -161.33 1.27 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.847 0.356 . . . . 0.0 110.957 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.54 142.27 27.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -159.28 91.07 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.42 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 31.1 m -83.38 143.88 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.562 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -121.65 130.12 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.159 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.07 133.78 42.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.949 0.404 . . . . 0.0 111.688 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.43 HD11 HG22 ' B' ' 31' ' ' ILE . 9.6 mm -99.9 149.65 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.89 126.52 46.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 37.8 mt -125.18 153.83 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.909 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 82.1 m -154.46 155.23 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.075 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -102.9 81.67 2.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.73 -23.26 16.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 -160.43 7.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.29 0.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.511 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.83 138.99 12.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.775 0.321 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.18 138.67 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 pt -137.76 174.1 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.418 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.95 98.35 0.34 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.643 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.459 ' CZ3' ' CD1' ' B' ' 45' ' ' ILE . 29.9 p-90 -92.46 155.82 17.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 111.816 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.47 157.88 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' B' ' 45' ' ' ILE . 1.0 OUTLIER -125.12 149.46 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.7 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -159.41 131.35 6.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 24.1 p -109.9 158.43 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.93 -29.93 22.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.57 117.91 23.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.27 18.25 7.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -109.3 -43.98 4.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.847 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.35 -59.1 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.68 140.7 31.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.22 107.37 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' B' ' 45' ' ' ILE . 3.2 m -74.26 152.16 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.133 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -168.41 113.16 0.57 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.738 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.28 141.09 70.71 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.791 -1.337 . . . . 0.0 112.417 0.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.52 -4.11 14.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.529 2.153 . . . . 0.0 112.723 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.3 p -170.25 147.44 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.04 175.38 43.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 6.6 t -106.33 122.28 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.143 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.72 125.34 38.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.85 161.47 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.93 100.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.574 2.183 . . . . 0.0 112.382 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt 69.29 45.44 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -107.79 154.23 21.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.886 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -110.89 137.14 48.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.4 145.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.23 117.19 33.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' MET . . . . . 0.43 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 1.8 tmm? -101.68 147.81 26.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.431 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.43 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -113.83 140.98 47.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 111.443 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 43.6 t -124.98 84.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.84 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.15 129.48 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.21 121.86 36.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.01 138.76 31.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.44 162.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -169.18 -161.98 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.08 119.99 37.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.54 19.19 20.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.29 -31.09 12.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 73.6 p -136.8 44.8 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -144.49 139.8 28.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.86 146.68 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 16.1 mt -130.91 32.23 4.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.27 28.27 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -127.95 6.17 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.19 120.36 39.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.748 0.309 . . . . 0.0 110.757 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.79 131.0 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.255 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 37.2 mt -84.5 161.88 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.585 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 73.6 m -138.49 137.5 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 111.301 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -120.59 146.95 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.684 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 4.3 mt-10 -149.34 111.54 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.868 0.366 . . . . 0.0 111.135 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.415 ' CE2' HG12 ' B' ' 9' ' ' ILE . 7.9 p90 -123.74 138.59 54.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.6 130.18 25.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.997 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -53.78 125.03 16.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.9 p -67.09 144.86 98.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.86 163.03 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.536 2.157 . . . . 0.0 112.162 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.49 118.63 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.031 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.1 46.1 50.98 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.442 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.9 151.26 46.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.17 164.32 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.314 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.54 71.27 5.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.35 142.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.09 134.34 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.14 155.36 31.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -93.51 -6.7 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.691 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.87 -17.49 35.44 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.602 0.239 . . . . 0.0 111.518 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.44 -16.07 32.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.323 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 1.5 m-85 -126.88 37.37 4.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 110.972 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -151.42 43.13 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.57 -117.96 0.61 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.579 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -98.05 156.25 16.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.984 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.18 135.6 5.32 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.538 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -77.09 131.17 38.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 t -122.59 117.13 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.36 147.22 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.511 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . 0.425 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 12.7 ptp180 -143.87 153.86 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 111.469 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -147.72 131.79 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -104.25 134.27 47.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.159 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.92 137.57 19.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.36 138.42 17.66 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.589 2.193 . . . . 0.0 112.616 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.413 HG21 HD11 ' B' ' 122' ' ' ILE . 11.8 mm -101.19 146.82 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.419 ' HB2' ' CG2' ' B' ' 18' ' ' VAL . 2.7 mt-10 -132.93 163.8 28.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 70.1 m-85 -126.48 131.31 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.404 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 4.2 t30 -119.8 115.17 23.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.879 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.851 0.358 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -138.44 126.97 23.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.12 -178.42 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.968 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.66 153.11 42.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 158.75 54.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.531 2.154 . . . . 0.0 112.308 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.09 120.94 9.16 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.75 143.66 35.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.379 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -61.84 114.06 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 3.0 pt -73.31 142.51 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.095 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.77 139.09 31.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.76 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 149.49 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -142.66 105.41 5.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.755 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 155.14 54.13 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 123.844 -1.315 . . . . 0.0 112.348 0.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.9 -44.34 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.931 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.02 44.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.984 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.76 109.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -130.76 142.82 42.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.77 99.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.513 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 19.8 m-85 -52.58 121.65 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.89 131.15 34.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.452 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -55.53 168.18 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.803 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.452 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 93.2 Cg_endo -83.67 163.89 68.86 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.674 0.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.1 25.46 10.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.847 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.32 7.96 45.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.483 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -140.73 175.44 9.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -103.1 112.6 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.08 147.62 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 128.62 56.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 19' ' ' PHE . 65.6 m-85 -92.23 119.74 32.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.744 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -78.46 132.77 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.1 mt -120.84 148.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.519 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.45 125.52 54.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 111.355 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 mt -122.93 151.42 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.508 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 99.5 m -147.92 155.66 41.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -98.28 75.65 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.62 -26.27 13.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.105 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.49 -148.97 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.33 3.78 4.79 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.108 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -138.0 172.91 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.907 0.354 . . . . 0.0 110.831 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -70.22 155.45 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.673 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.423 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 20.8 pt -149.31 134.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 111.794 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.04 113.17 4.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.487 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -108.58 160.36 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.309 0.576 . . . . 0.0 111.919 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.65 22.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.967 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.7 mm -115.49 139.07 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.724 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.85 129.6 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.673 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.0 p -107.71 148.36 29.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -54.21 -27.71 36.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -125.61 104.37 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.51 24.94 6.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -106.57 -44.67 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.779 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.95 -40.0 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.81 150.23 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.16 177.04 11.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.97 154.44 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -161.85 128.67 2.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.07 133.26 27.0 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 123.892 -1.295 . . . . 0.0 111.945 -0.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.91 -47.7 25.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.381 2.054 . . . . 0.0 112.102 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.0 p -136.27 165.83 24.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.668 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.26 -167.77 37.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.566 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.25 125.35 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.339 . . . . 0.0 111.118 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD1' ' CG1' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -103.21 160.25 14.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -110.55 172.32 3.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.424 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 36.6 Cg_exo -60.84 116.23 3.22 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.618 2.212 . . . . 0.0 112.354 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.94 27.57 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.231 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -103.59 148.24 26.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.476 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.78 136.82 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.223 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.404 ' CG1' ' CD1' ' A' ' 62' ' ' LEU . 11.8 p -125.88 155.2 35.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.4 mt -103.63 141.13 36.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 4.3 mtm -124.2 155.7 38.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.802 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.41 121.68 31.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.168 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.95 100.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -65.87 117.68 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.984 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.5 m -123.03 116.18 23.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.66 151.92 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.1 p -53.94 167.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -177.59 -164.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -130.88 98.14 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.04 -22.47 61.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.41 -39.0 31.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.9 p -129.82 47.09 2.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -143.24 151.79 40.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.06 147.99 47.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 23.2 mt -125.95 24.09 7.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.27 28.53 1.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.771 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -124.94 7.4 8.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.46 123.88 48.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.23 148.15 35.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 67.9 mt -118.58 108.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 120.8 33.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.28 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.38 100.21 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.911 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 11.5 mt-10 -97.66 157.8 15.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -163.64 142.36 7.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.039 0.447 . . . . 0.0 111.145 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.5 t -143.06 131.34 22.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -48.05 146.5 2.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.473 HG21 ' CZ3' ' A' ' 108' ' ' TRP . 1.7 p -90.22 140.92 27.32 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.18 160.72 3.04 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.496 2.13 . . . . 0.0 111.91 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.42 117.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.49 48.98 33.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.401 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.49 48.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 111.438 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.7 165.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.129 0.49 . . . . 0.0 111.554 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.12 73.81 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.45 152.35 3.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.881 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -64.25 153.09 39.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.835 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 2.4 mmt180 -142.88 150.25 39.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.032 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 106' ' ' ARG . 8.0 ttp-105 -102.58 25.78 8.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.69 -29.68 7.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.477 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 23.2 m0 -62.56 -27.57 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -82.85 -40.79 19.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -61.31 -29.11 69.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.807 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.31 146.8 44.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.464 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -84.72 114.47 22.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.883 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.13 135.11 4.9 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.619 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.419 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.3 mtm 54.99 102.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 114' ' ' MET . 7.5 p 169.98 98.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.93 160.41 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.133 0.492 . . . . 0.0 111.597 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.409 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 4.8 ptp85 -141.41 104.54 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.751 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -92.17 166.45 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -128.55 152.23 48.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.939 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.99 93.13 17.64 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.04 133.1 53.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.622 2.215 . . . . 0.0 112.471 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 12.9 mm -99.08 146.05 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -138.36 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.285 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 13.4 m-85 -119.26 137.51 53.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -121.36 78.93 1.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.983 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.834 0.349 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -138.42 126.96 23.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.13 -178.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.7 153.03 42.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.53 158.77 54.96 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.567 2.178 . . . . 0.0 112.245 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.04 121.03 9.31 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.498 2.132 . . . . 0.0 112.283 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.96 143.74 36.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.337 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -61.94 114.03 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 3.0 pt -73.26 142.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -86.62 139.1 31.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.92 149.57 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -142.84 105.44 5.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.627 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 154.85 54.33 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.894 -1.294 . . . . 0.0 112.317 0.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.41 -44.5 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.93 44.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.69 109.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.147 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -130.57 142.84 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -139.81 99.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 111.503 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.439 ' HA ' ' CZ ' ' B' ' 29' ' ' TYR . 19.8 m-85 -52.54 121.59 7.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.442 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -86.7 131.02 34.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 111.325 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -55.33 168.25 0.6 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 94.8 Cg_endo -83.6 163.81 69.3 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.925 -1.281 . . . . 0.0 112.669 0.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.05 25.46 10.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.951 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.3 7.89 45.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.363 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -140.71 175.19 9.81 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -102.74 112.55 25.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.2 147.63 51.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 128.62 56.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.439 ' CZ ' ' HA ' ' B' ' 19' ' ' PHE . 66.9 m-85 -92.14 119.66 32.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.35 132.72 37.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.4 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 11.0 mt -120.78 148.53 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.55 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.39 125.47 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.506 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.1 mt -122.87 151.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.564 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 99.3 m -147.88 155.49 41.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 0.0 111.553 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -98.2 75.83 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.86 -25.92 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.171 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.69 -149.05 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.444 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.26 3.68 4.81 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.93 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -137.9 172.77 12.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.94 0.37 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -69.97 155.48 40.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.599 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 20.5 pt -149.36 134.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 0.0 111.781 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.06 113.34 4.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.426 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -108.72 160.24 16.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 0.0 111.866 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 144.9 22.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.033 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 11.9 mm -115.76 139.04 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 111.689 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.76 130.04 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.599 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 71.4 p -108.23 148.09 30.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.061 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -53.82 -27.98 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.963 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -125.37 104.73 8.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.89 25.07 6.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -106.54 -44.92 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.65 -39.97 6.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.88 150.25 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.18 177.05 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.89 154.68 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -162.16 128.64 2.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.09 133.27 27.09 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.888 -1.297 . . . . 0.0 111.96 0.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.0 -47.61 25.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.372 2.048 . . . . 0.0 112.123 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 11.7 p -136.33 165.6 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.05 -167.74 37.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.559 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.28 125.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 111.046 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.401 ' CD1' ' CG1' ' B' ' 68' ' ' VAL . 0.2 OUTLIER -103.13 160.18 14.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' B' ' 35' ' ' ASN . 0.4 OUTLIER -110.58 172.4 3.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.747 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.415 ' CD ' ' HB3' ' B' ' 63' ' ' ASP . 36.4 Cg_exo -60.88 116.35 3.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.622 2.215 . . . . 0.0 112.363 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.81 27.83 4.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -103.86 148.23 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.45 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 136.91 55.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' B' ' 62' ' ' LEU . 12.0 p -125.98 155.29 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.035 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -103.77 141.28 36.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 4.2 mtm -124.36 155.64 38.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.47 121.77 31.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.201 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.02 100.25 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.015 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.5 m -66.03 117.54 8.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.84 116.13 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.73 151.77 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 7.2 p -53.8 167.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -177.8 -164.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -130.61 98.29 4.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.22 -22.43 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.34 -39.13 30.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.5 p -129.65 47.02 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -143.17 151.81 41.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -71.02 148.38 47.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 23.4 mt -126.26 24.08 6.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.31 28.45 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.738 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -124.9 7.51 8.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.614 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.48 123.78 48.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.06 148.34 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 67.4 mt -118.67 108.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.926 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.48 120.67 33.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.29 100.13 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . 0.412 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 11.4 mt-10 -97.52 157.85 15.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -163.69 142.19 7.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 111.183 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 1.6 t -142.89 131.48 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.657 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -48.35 146.44 2.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.474 HG21 ' CZ3' ' B' ' 108' ' ' TRP . 1.7 p -90.09 140.86 27.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.85 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.04 160.77 2.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.471 2.114 . . . . 0.0 112.025 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.62 117.61 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.6 48.85 34.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.375 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.36 48.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.83 165.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.176 0.512 . . . . 0.0 111.483 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.13 73.73 1.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.769 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.39 152.26 3.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.06 153.11 38.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.475 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 2.4 mmt180 -142.94 150.08 39.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.94 0.4 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.424 ' HB3' ' NH1' ' B' ' 106' ' ' ARG . 8.1 ttp-105 -102.43 25.66 8.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -29.56 7.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.475 ' CE2' ' HB2' ' B' ' 105' ' ' ARG . 23.4 m0 -62.78 -27.35 69.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -82.99 -40.64 19.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -61.46 -29.11 69.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.824 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.27 146.87 44.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.443 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -84.83 114.45 22.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.863 0.363 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.07 135.12 4.91 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.77 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.422 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 4.3 mtm 54.93 102.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' B' ' 114' ' ' MET . 7.4 p 169.88 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.081 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.84 160.55 14.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.158 0.504 . . . . 0.0 111.542 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . 0.412 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 4.6 ptp85 -141.51 104.25 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -92.04 166.47 12.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 111.132 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -128.51 152.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.91 93.17 17.84 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.11 133.23 54.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 12.9 mm -99.19 146.16 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.044 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -138.38 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 13.7 m-85 -119.35 137.12 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.996 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -121.09 79.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.816 0.341 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -119.33 130.11 55.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 t -163.48 -77.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG2' ' HD2' ' A' ' 5' ' ' PRO . 7.3 p -178.85 138.11 0.34 Allowed Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' HD2' ' CG2' ' A' ' 4' ' ' VAL . 73.1 Cg_endo -76.04 160.83 36.39 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.398 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.62 132.85 26.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.552 2.168 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.05 -142.78 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.565 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -130.8 136.97 49.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.456 HG22 ' CD1' ' A' ' 93' ' ' TRP . 23.0 pt -93.93 153.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.42 133.05 49.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.658 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.7 p -126.42 155.16 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -139.97 114.54 7.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.84 161.63 67.5 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.924 -1.282 . . . . 0.0 112.497 0.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -50.13 70.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.177 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -167.76 46.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.084 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -162.9 106.96 1.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.931 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.1 tt -131.19 125.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.129 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.428 HG22 ' CB ' ' A' ' 123' ' ' GLU . 7.5 p -122.04 101.57 10.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.186 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 22.9 m-85 -47.32 162.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.567 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -122.85 119.4 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.969 0.414 . . . . 0.0 111.545 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.66 0.13 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.755 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 77.6 Cg_endo -76.84 164.27 87.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.764 0.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.82 40.92 2.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -108.14 6.8 27.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.4 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.49 -160.99 1.23 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.797 0.332 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.26 112.34 24.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -112.48 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.52 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 113.78 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.429 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 8.7 m-85 -105.51 112.64 25.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.259 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -84.13 145.09 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.638 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.423 HD13 ' CE ' ' A' ' 70' ' ' MET . 3.7 mt -116.12 145.43 21.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.383 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -94.32 129.67 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.962 0.411 . . . . 0.0 111.528 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.6 mt -128.55 151.76 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.705 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.412 HG21 ' N ' ' A' ' 35' ' ' ASN . 54.1 m -152.33 155.83 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' N ' HG21 ' A' ' 34' ' ' THR . 1.3 m-20 -94.61 100.79 12.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.48 18.03 6.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.512 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.11 -149.83 19.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.07 -26.75 2.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -125.55 162.39 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.855 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -52.06 168.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.465 HD11 ' CD1' ' A' ' 93' ' ' TRP . 13.9 pt -154.22 129.97 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.635 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.03 106.43 2.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.517 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.18 156.52 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.158 0.504 . . . . 0.0 111.909 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.64 154.72 40.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.036 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.4 mm -127.73 137.96 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 111.72 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -142.36 129.55 20.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.643 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.9 p -104.25 157.26 17.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.111 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.27 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -143.0 118.33 10.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.17 17.81 6.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.272 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -110.05 -39.22 5.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.365 . . . . 0.0 110.952 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.42 -27.06 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.7 mt -116.62 149.72 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -138.83 144.16 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.25 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.02 120.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.731 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.18 136.49 24.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 132.49 27.26 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.632 -1.404 . . . . 0.0 112.0 0.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.39 -39.38 44.3 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.334 2.023 . . . . 0.0 112.112 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.24 163.58 35.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.87 154.68 10.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.82 122.34 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.757 0.313 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -98.42 149.27 22.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.46 167.99 12.89 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.76 121.44 9.17 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.632 2.222 . . . . 0.0 112.384 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.85 18.43 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 152.76 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -122.3 153.02 39.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.63 152.9 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.84 91.93 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.251 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.423 ' CE ' HD13 ' A' ' 31' ' ' ILE . 35.4 ttp -72.7 158.95 34.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.615 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.417 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -124.41 129.82 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.9 93.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.992 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.96 127.61 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.43 101.73 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.753 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.0 145.24 44.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.129 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.39 162.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CZ ' ' CE2' ' A' ' 124' ' ' TYR . 0.5 OUTLIER -168.55 -163.14 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.88 119.14 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.58 18.36 20.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.506 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.95 -23.07 15.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.19 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.9 p -141.44 49.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.1 147.77 21.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -60.61 139.04 57.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 75.2 mt -116.29 27.08 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -146.63 27.59 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.608 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.72 -29.33 9.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.78 132.93 53.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.903 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -148.5 145.61 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.39 115.62 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.935 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 81.1 m -96.4 124.42 40.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.32 113.26 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -110.85 155.49 22.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.465 ' CD1' HD11 ' A' ' 41' ' ' ILE . 6.6 p90 -154.81 129.16 9.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.782 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 4.4 t -130.37 135.08 47.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.4 138.64 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.0 p -76.92 138.79 65.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.36 165.3 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.478 2.119 . . . . 0.0 112.043 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -50.35 105.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.63 48.67 49.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.36 -79.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.404 ' CB ' ' NH1' ' A' ' 105' ' ' ARG . . . 179.5 164.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 111.298 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -92.43 70.29 5.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.22 142.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.761 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -51.69 138.08 23.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.404 ' NH1' ' CB ' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -126.2 149.7 48.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -99.57 25.21 7.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 110' ' ' GLN . 6.8 pt-20 -116.94 -16.54 10.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.409 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -69.27 -19.23 63.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 111.344 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 3.2 m-85 -110.32 31.49 5.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.734 0.302 . . . . 0.0 111.261 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -115.55 -21.92 9.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.393 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.51 -179.64 41.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.683 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -97.85 126.43 43.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 0.0 110.753 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.57 -171.18 45.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.265 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER 58.5 163.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.955 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.423 ' CB ' ' O ' ' A' ' 114' ' ' MET . 3.8 t 82.84 111.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.238 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.13 151.75 21.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.607 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.99 140.38 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 0.0 111.276 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -126.17 162.12 26.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.546 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -130.88 152.52 50.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.25 95.73 9.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.729 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.61 127.41 20.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.468 2.112 . . . . 0.0 112.213 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 mm -96.16 154.54 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.428 ' CB ' HG22 ' A' ' 18' ' ' VAL . 93.2 mt-10 -145.66 163.18 35.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.467 ' CE2' ' CZ ' ' A' ' 77' ' ' PHE . 33.7 m-85 -125.35 120.9 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.065 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -100.73 88.98 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.947 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.962 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.775 0.321 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.46 130.09 55.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 13.3 t -163.59 -77.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.431 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 7.3 p -178.84 138.11 0.34 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.149 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.431 ' HD2' ' CG2' ' B' ' 4' ' ' VAL . 73.1 Cg_endo -75.96 160.73 36.73 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.639 2.226 . . . . 0.0 112.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.57 132.78 26.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.527 2.151 . . . . 0.0 112.302 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -142.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -130.69 137.16 49.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.452 HG22 ' CD1' ' B' ' 93' ' ' TRP . 22.9 pt -94.15 153.01 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.183 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.35 132.98 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -126.42 155.18 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.142 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -139.89 114.49 7.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.588 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.88 161.46 68.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.607 0.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -50.15 70.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -167.78 46.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -162.87 106.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 tt -131.15 125.42 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.102 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' B' ' 123' ' ' GLU . 7.6 p -122.1 101.64 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.494 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 22.9 m-85 -47.4 162.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.576 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -122.94 119.31 30.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.558 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -49.07 170.54 0.13 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.755 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 72.2 Cg_endo -76.78 164.34 87.63 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.749 0.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.89 40.95 2.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.789 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.34 7.16 27.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.479 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.74 -160.98 1.23 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.833 0.349 . . . . 0.0 110.779 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.4 112.65 25.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . 0.407 ' HB3' ' CZ ' ' B' ' 29' ' ' TYR . 0.3 OUTLIER -112.54 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 113.59 27.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.487 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 8.6 m-85 -105.3 112.65 25.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.259 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -84.08 144.96 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.691 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.429 HD13 ' CE ' ' B' ' 70' ' ' MET . 3.8 mt -116.09 145.36 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.408 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -94.28 129.63 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.977 0.418 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 58.5 mt -128.54 151.65 35.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' THR . . . . . 0.409 HG21 ' N ' ' B' ' 35' ' ' ASN . 54.0 m -152.23 155.73 38.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 111.398 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.409 ' N ' HG21 ' B' ' 34' ' ' THR . 1.3 m-20 -94.64 100.76 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.59 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.36 18.01 6.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.04 -149.73 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.52 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.19 -26.79 2.85 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.49 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -125.63 162.3 25.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -51.85 168.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.47 HD11 ' CD1' ' B' ' 93' ' ' TRP . 14.0 pt -154.13 129.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 111.66 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.01 106.45 2.67 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.511 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.28 156.56 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.54 . . . . 0.0 111.85 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -148.57 155.04 40.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.963 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 mm -127.92 137.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -142.39 129.48 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.606 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 43.8 p -104.13 157.35 17.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.53 -27.6 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.98 118.18 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.713 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.1 17.8 6.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -110.18 -39.04 5.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.48 -27.11 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.7 mt -116.59 149.86 38.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.797 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -139.01 144.3 38.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.27 120.99 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -135.24 136.5 24.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.11 132.44 27.1 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.046 -0.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.37 -39.59 44.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.401 2.067 . . . . 0.0 112.088 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.1 p -146.06 163.51 35.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.344 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.94 154.56 10.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.835 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.65 122.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 111.001 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -98.58 149.39 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.54 168.06 12.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.94 121.37 9.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 112.356 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.9 18.64 9.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.94 21.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.328 . . . . 0.0 110.767 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -122.43 152.99 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.58 152.92 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.016 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.81 92.02 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.232 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' MET . . . . . 0.429 ' CE ' HD13 ' B' ' 31' ' ' ILE . 35.7 ttp -72.78 158.99 34.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.425 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -124.6 129.68 51.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.72 93.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.91 127.49 32.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.28 101.94 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.24 145.11 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.11 162.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.456 ' CZ ' ' CE2' ' B' ' 124' ' ' TYR . 0.5 OUTLIER -168.57 -163.06 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.896 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.95 119.21 38.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.71 18.31 20.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.526 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.22 15.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.7 p -141.3 49.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.22 147.68 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -60.56 139.1 57.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 76.1 mt -116.38 27.23 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.109 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -146.66 27.38 1.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.7 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.63 -29.22 9.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.93 132.88 53.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.945 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -148.45 145.5 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.996 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.32 115.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.013 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 81.7 m -96.23 124.45 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.6 mp -116.33 113.23 42.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.812 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -110.71 155.47 22.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.47 ' CD1' HD11 ' B' ' 41' ' ' ILE . 6.8 p90 -154.9 128.79 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.407 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 4.3 t -129.94 135.01 47.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.25 138.69 44.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 68.7 p -77.07 138.79 64.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 165.08 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.525 2.15 . . . . 0.0 112.057 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -50.21 105.41 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.56 48.85 48.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.395 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.65 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 0.0 111.24 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . 0.409 ' CB ' ' NH1' ' B' ' 105' ' ' ARG . . . 179.53 164.76 1.04 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.168 0.509 . . . . 0.0 111.307 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -92.54 70.36 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.699 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.17 141.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.686 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -51.8 137.88 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.409 ' NH1' ' CB ' ' B' ' 101' ' ' ALA . 0.0 OUTLIER -125.96 149.76 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -99.46 25.11 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.188 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' B' ' 110' ' ' GLN . 6.7 pt-20 -116.9 -16.64 10.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.45 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -69.2 -19.27 63.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.605 0.24 . . . . 0.0 111.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 3.1 m-85 -110.26 31.56 5.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.308 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' B' ' 107' ' ' GLU . 0.0 OUTLIER -115.67 -22.0 9.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.356 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.51 -179.74 42.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.641 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.67 126.44 43.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 110.746 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.6 -171.32 45.26 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.292 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.428 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 0.3 OUTLIER 58.63 163.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 111.015 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.428 ' CB ' ' O ' ' B' ' 114' ' ' MET . 3.9 t 82.82 112.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.248 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.23 151.75 21.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.93 140.13 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 111.315 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -126.1 162.17 25.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -131.0 152.63 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.095 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.29 95.87 9.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.646 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.66 127.49 20.81 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.439 2.093 . . . . 0.0 112.132 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 13.1 mm -96.3 154.52 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.268 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.426 ' CB ' HG22 ' B' ' 18' ' ' VAL . 93.0 mt-10 -145.63 163.31 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.456 ' CE2' ' CZ ' ' B' ' 77' ' ' PHE . 33.8 m-85 -125.27 121.26 33.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -101.1 88.87 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.948 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.908 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.819 0.342 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.19 169.46 10.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.59 147.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.35 148.85 59.43 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.87 146.1 82.16 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.596 2.197 . . . . 0.0 112.275 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.63 149.51 55.28 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -165.51 1.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -111.23 111.88 23.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.88 147.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.58 149.69 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.799 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.36 151.5 45.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.56 107.71 3.81 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.37 157.38 62.06 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.347 0.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.05 -20.15 12.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.277 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -94.71 -45.93 7.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 111.096 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.78 -176.66 0.24 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.4 tt -144.33 156.28 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 123' ' ' GLU . 3.6 p -133.09 92.43 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 19.2 m-30 -50.78 113.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.668 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -79.14 136.21 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -50.89 168.52 0.24 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.684 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 2.0 Cg_endo -82.58 163.76 73.94 Favored 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.255 -1.144 . . . . 0.0 112.364 0.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -106.33 26.61 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -110.68 7.1 22.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.106 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -141.46 134.14 28.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.788 0.328 . . . . 0.0 111.034 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -55.42 107.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -116.66 124.15 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.8 113.21 25.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.985 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 85.5 m-85 -89.73 99.33 12.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.489 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -66.68 153.32 43.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.577 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mt -139.27 148.73 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HB2' ' CG ' ' B' ' 22' ' ' PRO . 25.3 ttmt -104.91 140.48 38.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.41 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.419 ' HB ' ' CG1' ' A' ' 68' ' ' VAL . 46.7 mt -131.54 154.03 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.779 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.0 m -145.47 155.59 43.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.029 0.442 . . . . 0.0 111.189 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.42 ' ND2' HG12 ' A' ' 41' ' ' ILE . 36.0 t-20 -104.08 102.27 12.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.42 21.32 6.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.29 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.85 -122.86 4.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.542 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.36 -42.0 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.563 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -113.26 166.6 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.44 156.3 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.42 HG12 ' ND2' ' A' ' 35' ' ' ASN . 21.9 pt -143.82 174.01 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.33 100.03 0.46 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.918 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 -92.12 159.35 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 111.712 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.64 130.73 11.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.514 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 HD11 HG22 ' A' ' 45' ' ' ILE . 5.6 mm -100.31 141.09 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.732 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -142.0 131.99 24.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.575 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.1 p -107.46 156.97 18.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.41 . . . . 0.0 111.399 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -29.16 3.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.38 122.77 13.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.65 -8.62 59.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.417 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.17 -41.19 13.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 110.604 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -84.8 -59.28 2.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.65 134.12 37.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.706 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 m -127.49 109.13 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -68.29 156.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -170.09 113.85 0.48 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.3 149.58 92.19 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.112 -1.203 . . . . 0.0 112.278 0.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.88 -15.31 21.12 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 0.0 112.586 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -179.49 153.26 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.83 167.73 40.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.791 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 t -98.36 120.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.402 ' CD2' ' HB2' ' A' ' 35' ' ' ASN . 4.5 tp -96.98 162.93 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -115.17 170.97 4.92 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.19 111.13 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.576 2.184 . . . . 0.0 112.419 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.27 39.79 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -106.74 154.31 21.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.894 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.38 38.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 10.5 p -138.39 143.36 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.937 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.23 151.64 23.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -133.47 161.56 34.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.764 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.98 118.24 7.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.268 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -107.82 86.51 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.992 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.16 145.57 53.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 43.2 t -136.19 102.96 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.18 150.16 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -67.4 112.46 4.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -123.58 178.02 5.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.93 89.97 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.18 -26.57 39.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.87 -49.12 59.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.7 p -125.61 50.63 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.068 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -136.28 162.34 33.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -80.12 130.2 35.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.2 mt -125.9 52.91 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -112.77 -23.66 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -65.46 -91.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.448 ' CB ' ' HB ' ' A' ' 122' ' ' ILE . 2.1 p-10 41.66 84.64 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.573 0.225 . . . . 0.0 111.513 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -167.4 135.17 2.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.607 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.403 HD13 ' CD1' ' A' ' 122' ' ' ILE . 28.1 mt -119.81 163.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.874 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.2 m -149.59 114.63 5.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.963 0.411 . . . . 0.0 111.363 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.37 98.7 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.955 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.89 137.9 40.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -139.08 150.3 45.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.242 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.446 HG23 ' CE1' ' A' ' 109' ' ' PHE . 4.4 t -147.6 132.24 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -53.33 147.79 9.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 p -98.2 142.87 25.27 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.751 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.13 160.62 3.07 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.377 2.051 . . . . 0.0 112.039 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -47.03 116.28 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.175 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.4 50.77 23.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.42 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 62.74 7.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.727 0.299 . . . . 0.0 111.549 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.42 164.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.612 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -104.55 73.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.57 147.83 0.18 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.71 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.41 150.39 48.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.48 146.85 38.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.14 -23.77 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.22 -22.26 64.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.162 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.83 -30.07 71.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 94' ' ' THR . 9.2 m-85 -85.5 -26.35 26.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.989 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -110.02 58.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.27 -138.2 2.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.72 146.26 23.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.822 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.3 130.9 6.69 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.397 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt -67.57 152.25 45.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.1 t -128.44 128.3 68.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -96.8 152.61 18.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.03 130.08 18.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.042 0.449 . . . . 0.0 111.585 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.74 162.74 16.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.033 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -131.95 149.34 52.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 0.0 111.48 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 mt -143.26 98.47 5.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.656 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -57.91 151.04 59.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.703 2.269 . . . . 0.0 112.795 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 87' ' ' ASP . 43.9 mm -101.46 158.26 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.018 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -140.08 153.66 46.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.902 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -119.81 113.54 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -102.94 82.63 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.975 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.11 169.66 10.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.38 147.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.62 148.96 60.61 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.07 146.22 81.47 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.531 2.154 . . . . 0.0 112.215 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.73 149.54 54.75 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.576 2.184 . . . . 0.0 112.335 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.68 -165.53 1.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.17 111.85 23.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.814 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.89 147.54 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.49 149.52 21.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.19 151.55 45.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.6 107.63 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.33 157.6 61.28 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.824 -1.323 . . . . 0.0 112.377 0.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.39 -20.24 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.231 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -94.67 -46.09 7.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.891 0.376 . . . . 0.0 111.068 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.89 -176.46 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 tt -144.69 156.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.244 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.432 ' CG2' ' HB3' ' B' ' 123' ' ' GLU . 3.5 p -133.22 92.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.566 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 19.0 m-30 -50.87 112.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.74 136.22 37.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.303 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -50.88 168.62 0.24 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.795 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 1.9 Cg_endo -82.54 163.73 74.1 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 124.276 -1.135 . . . . 0.0 112.476 0.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.35 26.43 9.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -110.43 6.97 22.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.125 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -141.4 134.22 28.82 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 120.787 0.327 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -55.38 107.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -116.67 124.13 48.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.716 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.75 113.23 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.566 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 85.8 m-85 -89.86 99.44 12.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.471 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -66.73 153.43 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.578 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mt -139.43 148.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -105.03 140.54 38.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.443 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.405 ' HB ' ' CG1' ' B' ' 68' ' ' VAL . 46.1 mt -131.45 154.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.828 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.7 m -145.47 155.72 43.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.998 0.428 . . . . 0.0 111.208 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.426 ' ND2' HG12 ' B' ' 41' ' ' ILE . 36.1 t-20 -104.26 102.38 12.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.535 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.44 21.23 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.293 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.89 -122.78 4.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.444 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.33 -42.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -113.2 166.63 11.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.49 156.45 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.426 HG12 ' ND2' ' B' ' 35' ' ' ASN . 21.5 pt -143.92 174.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.35 100.0 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.883 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -92.01 159.4 15.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.234 0.54 . . . . 0.0 111.651 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.73 130.81 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.414 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.43 HD11 HG22 ' B' ' 45' ' ' ILE . 5.6 mm -100.34 141.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 111.717 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -142.08 131.94 24.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.513 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 11.4 p -107.52 156.88 18.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 111.316 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -29.02 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.014 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.57 122.82 12.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.77 -8.59 59.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.455 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.12 -41.23 13.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -84.66 -59.59 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.778 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -94.48 134.1 37.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.756 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -127.46 109.01 11.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.07 156.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.071 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -169.96 113.87 0.48 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.32 149.81 92.62 Favored 'Cis proline' 0 C--N 1.351 0.667 0 C-N-CA 124.014 -1.244 . . . . 0.0 112.249 0.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.92 -15.45 20.95 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 112.546 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p -179.52 153.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.538 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.46 168.17 41.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.696 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 26.3 t -98.7 121.12 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.011 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.412 ' CD2' ' HB2' ' B' ' 35' ' ' ASN . 4.6 tp -96.98 163.13 13.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.427 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.4 OUTLIER -115.36 171.08 4.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.29 111.32 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.571 2.181 . . . . 0.0 112.349 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.04 39.87 9.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.427 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.6 OUTLIER -106.87 154.38 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.799 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.6 38.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.405 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 10.5 p -138.63 143.36 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.28 151.62 23.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -133.39 161.6 34.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.728 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.96 118.29 7.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.309 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 t -108.03 86.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.35 145.44 53.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.033 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.7 t -136.07 103.19 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.26 150.32 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -67.64 112.47 4.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -123.47 178.17 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.97 89.91 3.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.1 -26.74 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.028 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.18 57.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 61.3 p -125.65 50.56 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.066 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.12 162.46 32.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -80.15 130.22 35.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 12.6 mt -125.82 52.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -112.51 -23.43 10.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -65.64 -91.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.779 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' B' ' 122' ' ' ILE . 2.1 p-10 41.51 84.59 0.02 OUTLIER 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.76 0.314 . . . . 0.0 111.564 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 6.3 mtm-85 -167.25 135.17 2.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.643 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' B' ' 122' ' ' ILE . 29.0 mt -119.8 163.69 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.795 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 21.8 m -149.5 114.79 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.939 0.4 . . . . 0.0 111.247 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.7 mp -110.47 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.861 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 137.79 40.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.832 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -138.97 150.29 45.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.434 HG23 ' CE1' ' B' ' 109' ' ' PHE . 4.6 t -147.7 132.07 17.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -53.19 147.62 9.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -98.08 142.83 25.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.18 160.62 3.14 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.428 2.085 . . . . 0.0 112.022 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -46.98 116.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.58 50.78 24.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.364 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.04 62.81 7.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.726 0.298 . . . . 0.0 111.562 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.36 164.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.24 0.543 . . . . 0.0 111.663 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -104.48 73.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.49 147.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.3 150.44 48.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 146.84 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.677 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.1 -23.68 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.162 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.33 -22.17 64.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.149 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -62.98 -30.08 71.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.062 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.434 ' CE1' HG23 ' B' ' 94' ' ' THR . 9.2 m-85 -85.31 -26.48 26.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -109.96 58.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.952 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.41 -138.16 2.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.453 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.64 146.42 23.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.819 0.342 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.15 130.56 6.63 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.597 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt -67.13 152.23 46.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 t -128.5 128.32 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -96.82 152.56 18.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.604 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.06 130.06 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.449 . . . . 0.0 111.546 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.78 162.73 16.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.966 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -131.96 149.19 52.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 0.0 111.498 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 mt -143.25 98.46 5.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.665 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.77 151.03 58.68 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.789 2.326 . . . . 0.0 112.642 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.44 ' HB ' ' CB ' ' B' ' 87' ' ' ASP . 43.7 mm -101.47 158.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.968 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.432 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . 0.8 OUTLIER -140.0 153.67 46.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.891 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -119.84 113.51 20.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -102.96 82.86 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.819 0.343 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 68.39 123.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -69.52 -55.71 9.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.718 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.42 ' CG2' ' HD2' ' A' ' 5' ' ' PRO . 7.4 p 179.42 138.26 0.28 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 4' ' ' VAL . 72.8 Cg_endo -77.27 166.78 25.76 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.664 2.243 . . . . 0.0 112.416 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.52 109.75 2.7 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.607 2.204 . . . . 0.0 112.226 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.45 135.75 47.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.505 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.25 152.49 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.3 pt -118.0 147.16 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.63 140.9 31.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.578 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.79 139.12 47.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.188 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -137.25 110.07 9.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.54 167.52 32.84 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.672 0.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -43.08 -68.41 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.429 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.11 43.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.69 123.54 3.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.037 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.55 151.89 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.61 100.15 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.39 113.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -81.21 132.87 35.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.11 0.14 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.857 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 72.1 Cg_endo -76.72 167.74 79.16 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.733 0.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.4 m-85 -115.85 31.54 6.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.013 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.6 6.59 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.271 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -149.76 -178.57 6.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.14 107.95 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -111.16 132.98 53.87 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.4 m -107.15 135.78 48.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -116.88 121.81 42.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.02 150.88 45.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.435 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 31' ' ' ILE . 15.0 mt -133.43 153.96 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.702 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.24 135.25 53.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.409 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 69.4 mt -145.46 121.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.669 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -118.19 153.46 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 111.108 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -94.54 81.68 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.95 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.43 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.92 -154.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.629 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.72 -19.33 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.743 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -132.61 167.16 20.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.009 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -49.78 164.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.811 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 pt -156.74 132.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.798 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.13 109.48 3.83 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -99.51 159.3 15.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.988 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.77 155.05 44.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.408 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.1 mm -117.24 132.37 67.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 111.586 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 150.8 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.737 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 p -143.27 153.71 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -41.97 95.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.62 114.87 15.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.68 20.6 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -97.14 -31.69 12.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -113.37 -19.25 11.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.3 mt -108.11 132.45 53.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.05 107.74 5.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.73 127.12 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.032 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.22 130.96 22.8 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.1 142.86 76.05 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.875 -1.302 . . . . 0.0 112.022 0.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.22 -31.7 43.93 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.434 2.089 . . . . 0.0 112.036 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -145.91 -177.93 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.495 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.27 -171.0 39.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.596 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.31 129.47 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.4 153.55 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.141 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -90.05 168.1 15.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.934 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.79 133.69 46.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.497 2.131 . . . . 0.0 112.231 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 tttm 77.7 12.07 1.99 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.841 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -108.51 142.98 38.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.187 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.27 161.21 13.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.193 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.8 t -135.62 141.93 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.063 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.03 118.95 33.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.946 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.8 mtm -112.46 158.21 20.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.71 102.23 6.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.22 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.05 109.43 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.809 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.2 m -91.24 129.88 37.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.302 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 41.0 t -114.99 150.82 35.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.9 154.58 21.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.119 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.9 p -58.59 161.03 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.418 ' CZ ' ' HB1' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -173.53 -165.63 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.94 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 92.4 m-20 -121.92 82.86 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB1' ' CZ ' ' A' ' 77' ' ' PHE . . . -57.24 -22.11 38.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.216 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.296 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.4 p -141.56 43.13 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.168 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 19.6 mm-40 -122.52 6.5 9.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.26 140.01 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.23 24.46 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -142.26 28.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.767 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.21 9.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.02 126.91 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.84 139.63 26.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.5 mt -107.35 122.36 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.615 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.0 m -110.56 118.66 36.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.487 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.15 154.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -149.71 101.72 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -122.14 137.9 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.997 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 115' ' ' VAL . 0.8 OUTLIER -134.37 148.97 50.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.029 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -60.22 144.16 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -85.77 150.89 54.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.418 ' HG2' ' CB ' ' A' ' 100' ' ' ALA . 39.3 Cg_endo -67.04 163.63 33.22 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.5 2.133 . . . . 0.0 112.059 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -47.18 116.45 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.21 46.64 56.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.688 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.418 ' CB ' ' HG2' ' A' ' 97' ' ' PRO . . . -65.13 150.65 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.113 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.41 165.03 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.142 0.496 . . . . 0.0 111.282 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.9 71.33 7.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.621 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.02 140.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.05 120.21 9.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.16 156.16 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.024 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.77 -27.16 16.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -18.22 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.339 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.85 -16.25 57.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.428 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 2.5 m-85 -125.67 50.71 1.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.04 24.65 4.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.97 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.26 -171.29 12.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.1 146.27 29.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.764 0.316 . . . . 0.0 110.631 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.14 179.17 25.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.273 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.403 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 2.9 mtt 59.3 162.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.0 110.883 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.43 ' CG1' ' HB ' ' A' ' 94' ' ' THR . 3.3 t 81.76 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.118 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.28 26.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.773 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.76 139.39 46.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.004 0.43 . . . . 0.0 111.174 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -125.37 166.77 15.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.489 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -121.69 152.05 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -141.31 88.56 9.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 141.8 47.29 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.566 2.177 . . . . 0.0 112.633 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.37 138.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.817 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.62 159.18 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.264 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.478 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 97.7 m-85 -122.8 113.07 18.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 60.4 t30 -95.15 90.57 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.917 -179.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.846 0.355 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 68.51 123.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -69.58 -55.66 9.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.722 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.432 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 7.4 p 179.33 138.24 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.079 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.432 ' HD2' ' CG2' ' B' ' 4' ' ' VAL . 71.7 Cg_endo -77.25 166.78 25.78 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.613 2.209 . . . . 0.0 112.37 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.45 109.75 2.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.508 2.139 . . . . 0.0 112.33 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.38 135.8 47.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -49.31 152.45 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 111.017 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 11.2 pt -117.99 147.2 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.66 140.82 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.63 139.53 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -137.62 109.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.561 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.46 167.29 33.23 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.996 -1.252 . . . . 0.0 112.636 0.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.3 m -43.01 -68.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.469 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.24 43.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.63 123.19 3.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.402 ' CG2' HD11 ' B' ' 122' ' ' ILE . 13.0 tt -131.19 151.68 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -138.36 100.13 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.602 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.38 113.19 1.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -81.06 132.73 35.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -49.15 170.12 0.14 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 72.6 Cg_endo -76.71 167.84 78.86 Favored 'Cis proline' 0 C--N 1.35 0.628 0 C-N-CA 123.898 -1.293 . . . . 0.0 112.699 0.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . 0.478 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.5 m-85 -115.87 31.49 6.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.031 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.63 6.65 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.3 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -149.78 -178.69 6.6 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.75 0.31 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.07 108.08 20.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.942 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -111.43 132.78 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 94.9 m -106.89 135.96 47.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -116.91 122.09 43.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.29 150.85 44.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.443 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.456 HD11 HG22 ' B' ' 31' ' ' ILE . 15.0 mt -133.48 153.8 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.662 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.09 135.32 53.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.439 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 68.5 mt -145.48 121.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.73 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.6 m -118.32 153.47 33.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -94.52 81.63 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.74 -15.91 59.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.473 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.04 -154.19 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.84 -19.43 5.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.639 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mtp85 -132.72 167.29 20.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -49.86 164.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 31.3 pt -156.6 132.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.746 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.01 109.22 3.78 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.475 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.46 159.22 15.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.241 0.543 . . . . 0.0 111.899 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.7 155.08 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 25.4 mm -117.24 132.4 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.928 0.394 . . . . 0.0 111.576 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.07 150.65 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.809 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 31.5 p -143.16 153.75 43.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.008 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.6 -42.01 95.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.61 114.85 15.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.64 20.68 7.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -97.21 -31.58 12.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -113.38 -19.34 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -108.06 132.51 53.48 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.09 107.57 5.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.56 127.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -131.32 130.96 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.16 142.76 75.74 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.001 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.11 -31.87 44.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.491 2.127 . . . . 0.0 111.97 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 p -145.75 -177.98 5.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.424 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.26 -170.89 39.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.37 129.47 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.45 153.57 43.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.193 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.407 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.2 p30 -90.2 168.0 15.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.836 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 30.9 Cg_exo -61.71 133.71 46.66 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.455 2.103 . . . . 0.0 112.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.8 tttm 77.53 12.42 2.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.882 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -108.73 142.96 38.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.12 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.19 161.24 13.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.183 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.61 141.65 41.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.097 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 mt -117.78 118.99 33.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.016 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 9.7 mtm -112.53 158.07 20.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.63 102.12 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.284 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -87.88 109.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 43.0 m -91.32 130.06 37.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.1 t -115.09 150.9 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.681 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.98 154.66 21.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.7 p -58.67 160.87 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.413 ' CZ ' ' HB1' ' B' ' 79' ' ' ALA . 0.7 OUTLIER -173.38 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 92.4 m-20 -121.91 82.77 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' B' ' 77' ' ' PHE . . . -57.26 -22.12 39.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.232 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.335 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -141.72 43.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' B' ' 78' ' ' ASN . 19.8 mm-40 -122.58 6.29 9.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.627 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.41 140.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.52 24.31 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -142.01 28.33 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.12 9.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.06 126.86 35.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.82 139.79 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 78.2 mt -107.65 122.16 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.631 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 64.0 m -110.17 118.77 37.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.369 . . . . 0.0 111.512 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.38 154.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.7 101.7 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -122.17 137.77 54.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.034 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' B' ' 115' ' ' VAL . 0.8 OUTLIER -134.26 149.2 50.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.004 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.46 143.99 52.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 70.7 p -85.59 150.89 54.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . 0.411 ' HG2' ' CB ' ' B' ' 100' ' ' ALA . 39.8 Cg_endo -67.03 163.54 33.54 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.63 2.22 . . . . 0.0 111.996 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -47.1 116.53 1.4 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.12 46.56 56.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.78 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.411 ' CB ' ' HG2' ' B' ' 97' ' ' PRO . . . -65.01 150.69 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.48 164.96 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.462 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -89.78 71.24 7.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.99 140.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.84 120.22 9.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.22 156.2 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.94 -26.86 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.996 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -18.39 65.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.303 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.6 -16.39 56.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.405 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 2.4 m-85 -125.67 50.73 1.8 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.673 0.273 . . . . 0.0 111.05 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.03 24.52 4.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.988 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.21 -171.31 12.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.93 146.26 29.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.81 0.338 . . . . 0.0 110.673 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.09 179.27 25.32 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.348 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.411 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 2.9 mtt 59.23 162.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' B' ' 94' ' ' THR . 3.3 t 81.72 117.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.53 148.08 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.45 139.55 46.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.994 0.426 . . . . 0.0 111.199 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -125.43 166.72 16.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.595 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -121.77 151.78 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.076 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -140.99 88.56 10.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.17 141.49 48.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.632 2.222 . . . . 0.0 112.607 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.402 HD11 ' CG2' ' B' ' 17' ' ' ILE . 7.4 mm -107.09 138.36 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.752 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -131.68 159.06 39.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 111.256 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.478 ' HB3' ' CE2' ' B' ' 23' ' ' TYR . 97.5 m-85 -122.78 113.04 18.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 60.4 t30 -95.03 90.58 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.4 ' CD2' ' CE2' ' B' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.13 84.5 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.997 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -152.81 140.4 19.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.44 115.19 11.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.095 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.29 160.33 3.5 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.369 2.046 . . . . 0.0 112.35 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.9 123.18 8.74 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.557 2.171 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.69 138.32 46.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -59.03 130.65 48.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.27 120.34 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.225 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 146.75 24.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.631 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.78 153.44 49.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.888 0.375 . . . . 0.0 111.218 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -144.85 108.94 4.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.657 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.0 165.18 37.32 Favored 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.842 -1.316 . . . . 0.0 112.664 0.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -45.13 -59.61 2.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.418 ' HA ' ' CD2' ' A' ' 120' ' ' LEU . 22.9 pt20 -170.9 45.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.15 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -178.52 132.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 18.7 tt -132.28 153.85 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.1 t -120.78 92.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.674 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.14 95.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.283 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.81 139.39 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.579 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -76.56 175.23 4.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.586 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 40.6 Cg_endo -66.7 165.58 64.44 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.683 0.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CE2' HD22 ' A' ' 126' ' ' LEU . 23.1 m-85 -108.63 43.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.937 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -123.06 7.21 9.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.323 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.17 142.14 48.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.3 115.63 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.05 103.3 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -84.76 102.47 13.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -89.48 117.91 28.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.659 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.39 135.43 33.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.5 mt -119.98 133.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -97.93 139.18 34.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 111.342 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -133.02 146.22 32.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.652 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.41 HG21 ' N ' ' A' ' 35' ' ' ASN . 55.4 m -150.09 156.53 41.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 0.0 111.212 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.41 ' N ' HG21 ' A' ' 34' ' ' THR . 18.4 t30 -97.89 111.07 23.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.727 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.51 19.45 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.396 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.21 -140.49 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.566 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.44 53.19 0.47 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -175.97 177.12 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.432 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 25.5 ttm-85 -77.61 151.15 34.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 pt -146.58 167.47 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 111.38 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.64 106.14 0.63 Allowed Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.585 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -104.42 160.41 14.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.259 0.552 . . . . 0.0 111.75 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.65 143.11 17.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.461 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.3 mm -99.4 154.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.008 0.432 . . . . 0.0 111.634 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.53 132.08 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.4 149.7 42.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.77 -32.14 69.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.96 109.21 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.732 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.69 24.88 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.013 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.54 -55.38 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.23 -28.23 27.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.46 156.69 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.982 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.44 141.33 28.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 56' ' ' ASP . 2.2 p -139.21 161.07 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.966 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -176.49 131.06 0.37 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.813 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.17 148.71 92.58 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.186 0.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.6 -12.8 24.76 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.599 2.2 . . . . 0.0 112.847 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.54 172.75 0.72 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.45 174.48 38.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.449 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.432 ' CG1' ' HG2' ' A' ' 40' ' ' ARG . 21.7 t -107.12 114.42 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -87.53 169.54 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.072 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.412 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -129.89 176.3 2.94 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.792 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.6 Cg_exo -61.24 114.45 2.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.633 2.222 . . . . 0.0 112.291 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.69 32.28 13.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.411 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -97.9 148.0 23.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -113.53 156.2 24.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.84 144.76 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.04 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.51 137.07 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.0 158.76 34.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.03 35.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.187 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.03 91.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.895 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -82.77 151.67 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.48 116.61 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.11 142.78 58.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 p -56.55 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -133.43 -168.89 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -121.31 119.8 33.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.46 18.92 15.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.47 -24.44 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.229 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.3 p -143.1 41.63 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.036 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -138.33 159.59 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -89.2 134.19 34.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.9 mt -123.62 56.09 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.48 25.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -134.02 6.58 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.637 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.57 108.21 19.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.812 0.339 . . . . 0.0 110.824 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.08 136.1 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.101 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.8 mt -94.87 163.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 m -144.87 123.96 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.51 98.1 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.85 136.93 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.675 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' A' ' 116' ' ' ARG . 6.6 p90 -145.52 143.69 30.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.161 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -141.46 143.48 33.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.78 122.48 14.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.0 p -52.93 145.05 24.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.79 160.53 43.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.534 2.156 . . . . 0.0 112.292 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.4 119.16 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.7 41.5 97.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.763 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.33 139.57 49.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.8 164.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 0.0 111.403 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 70.32 7.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.45 131.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -51.25 152.01 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.33 152.09 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -91.77 -23.71 19.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.069 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -18.91 65.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.39 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 34.6 m0 -60.18 -16.14 30.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.276 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -126.34 40.22 3.77 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.819 0.342 . . . . 0.0 110.89 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.71 28.51 8.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.07 -179.16 40.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.04 156.28 27.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.952 0.406 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.65 81.01 0.32 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.622 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.2 mmt 55.05 106.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p 176.84 115.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.431 ' HD3' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -102.23 154.14 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -139.73 96.82 3.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.029 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.34 162.42 18.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -140.56 126.52 19.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.067 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.418 ' CD2' ' HA ' ' A' ' 15' ' ' GLN . 1.4 mt -110.85 100.52 46.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.42 144.13 74.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.604 2.203 . . . . 0.0 112.529 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.475 HD11 HG22 ' A' ' 122' ' ' ILE . 8.2 mm -110.53 93.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.68 140.81 32.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -103.7 104.43 14.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.66 82.45 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.407 HD22 ' CE2' ' A' ' 23' ' ' TYR . 34.7 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.892 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.812 0.339 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.11 84.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -152.81 140.44 19.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.6 114.99 11.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.17 160.36 3.35 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.397 2.065 . . . . 0.0 112.303 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.02 123.27 8.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.186 . . . . 0.0 112.286 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.7 138.33 46.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.567 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -58.95 130.75 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.839 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.37 120.51 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.85 146.89 24.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.537 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.93 153.3 49.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.204 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -144.72 108.99 4.77 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.07 165.17 37.76 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.611 0.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -45.02 -59.55 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 0.409 ' HA ' ' CD2' ' B' ' 120' ' ' LEU . 22.9 pt20 -170.95 44.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.148 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -178.49 132.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.41 . . . . 0.0 111.254 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 18.5 tt -132.25 154.0 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.721 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 57.5 t -120.98 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.812 0.339 . . . . 0.0 111.579 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -57.21 95.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.277 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.581 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -76.49 175.28 4.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 40.2 Cg_endo -66.51 165.73 62.55 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.951 -1.271 . . . . 0.0 112.786 -0.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . 0.41 ' CE2' HD22 ' B' ' 126' ' ' LEU . 23.1 m-85 -108.9 43.69 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.959 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.89 6.98 9.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.361 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.0 142.06 48.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.849 0.357 . . . . 0.0 110.972 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -65.16 115.44 5.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -115.91 103.16 10.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.749 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -84.53 102.37 12.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.083 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -89.51 117.87 28.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.725 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.26 135.36 33.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.332 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 22.6 mt -119.93 133.12 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.681 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -97.99 138.96 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.38 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -132.9 146.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' THR . . . . . 0.42 HG21 ' N ' ' B' ' 35' ' ' ASN . 55.1 m -150.13 156.41 41.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.276 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.42 ' N ' HG21 ' B' ' 34' ' ' THR . 18.4 t30 -97.71 111.08 23.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.51 19.34 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.2 -140.26 9.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.6 53.16 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -175.92 177.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.432 ' HG2' ' CG1' ' B' ' 61' ' ' VAL . 25.9 ttm-85 -77.66 151.17 34.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 4.3 pt -146.66 167.37 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 111.428 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.56 106.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.568 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 34.0 p-90 -104.53 160.57 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 111.703 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -157.87 142.92 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.461 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 14.2 mm -99.11 154.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.694 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.75 131.94 15.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.25 149.57 42.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.066 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.6 -32.33 68.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.75 109.18 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.66 24.71 5.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -55.3 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.36 -28.24 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.33 156.64 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.5 141.36 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' B' ' 56' ' ' ASP . 2.2 p -139.29 160.96 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.197 0.522 . . . . 0.0 111.004 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . 0.464 ' N ' ' CG2' ' B' ' 55' ' ' VAL . 0.5 OUTLIER -176.43 131.08 0.38 Allowed Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.826 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.17 148.6 92.31 Favored 'Cis proline' 0 C--N 1.352 0.731 0 C-N-CA 123.691 -1.379 . . . . 0.0 112.314 -0.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.49 -12.63 24.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.617 2.211 . . . . 0.0 112.916 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.37 172.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.33 174.4 38.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.556 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.432 ' CG1' ' HG2' ' B' ' 40' ' ' ARG . 21.7 t -106.99 114.64 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.066 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 tp -87.78 169.35 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.411 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.3 OUTLIER -129.76 176.26 2.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 34.2 Cg_exo -61.17 114.4 2.18 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.665 2.244 . . . . 0.0 112.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.72 32.27 13.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.411 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -97.79 148.2 23.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -113.69 156.27 24.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.93 144.72 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.52 137.1 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.08 158.83 34.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.829 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.43 146.76 35.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.78 90.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -82.76 151.47 26.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.32 116.48 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.07 142.76 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -56.58 128.07 34.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.39 -168.8 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.02 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -121.45 119.71 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.35 18.93 15.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.38 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.53 -24.47 20.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.8 p -143.14 41.8 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -138.54 159.47 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -89.1 134.06 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 9.0 mt -123.45 55.98 1.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.44 25.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -133.76 6.33 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.687 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.54 108.05 19.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.797 0.332 . . . . 0.0 110.864 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.0 136.27 26.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.03 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.93 163.92 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -144.95 123.89 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.1 mp -115.51 98.05 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.007 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.77 136.94 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.431 ' CZ3' ' HB3' ' B' ' 116' ' ' ARG . 6.7 p90 -145.53 143.7 30.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 2.5 t -141.49 143.51 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.82 122.38 14.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 12.0 p -52.76 144.94 23.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.81 160.67 42.72 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.617 2.211 . . . . 0.0 112.22 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.43 119.1 3.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.085 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.66 41.92 97.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.587 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.63 139.7 49.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 111.048 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.09 164.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.342 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 70.46 7.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.651 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.51 131.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -51.21 151.98 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.21 152.26 50.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -92.21 -23.49 19.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.056 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -19.0 65.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.348 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 34.0 m0 -60.09 -16.36 31.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.213 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -126.25 40.55 3.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 28.43 8.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.761 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.08 -179.09 40.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.596 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.07 156.16 27.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.912 0.387 . . . . 0.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.66 81.04 0.32 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.585 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 5.1 mmt 55.16 106.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.978 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p 176.72 115.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.431 ' HB3' ' CZ3' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -102.33 154.21 19.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -139.71 96.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.032 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 162.52 18.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -140.59 126.63 19.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.409 ' CD2' ' HA ' ' B' ' 15' ' ' GLN . 1.4 mt -110.98 100.53 46.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.4 144.15 73.94 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.425 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.48 HD11 HG22 ' B' ' 122' ' ' ILE . 8.3 mm -110.49 93.71 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.195 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.78 141.06 32.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.0 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -103.9 104.43 14.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.137 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.8 82.38 5.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.41 HD22 ' CE2' ' B' ' 23' ' ' TYR . 34.2 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.896 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.796 0.332 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -118.89 79.46 1.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.31 173.07 6.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.831 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.97 129.31 15.93 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.173 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.62 172.11 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.519 2.146 . . . . 0.0 112.215 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.97 119.2 5.9 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.594 2.196 . . . . 0.0 112.284 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.64 131.6 40.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.5 113.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.2 pt -85.12 124.64 40.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.072 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -67.7 138.09 56.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.831 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.52 153.37 51.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.48 102.49 4.66 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.853 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.18 157.51 46.39 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.311 -0.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.59 -10.82 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.763 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.05 -61.5 1.67 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.909 0.385 . . . . 0.0 111.069 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -143.86 175.19 10.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.236 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 ' CG2' HD11 ' A' ' 122' ' ' ILE . 19.5 tt -148.11 123.16 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.729 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -113.41 118.01 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.457 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 29' ' ' TYR . 48.4 m-85 -77.12 96.03 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.48 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -70.36 131.95 44.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.535 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -58.39 169.19 1.04 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.736 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 67.8 Cg_endo -89.1 160.27 38.72 Favored 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.296 -1.127 . . . . 0.0 112.803 0.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -97.88 46.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.924 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.7 9.0 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.43 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.34 -5.87 7.7 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.59 134.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -153.32 101.27 2.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.2 m -75.12 102.71 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 36.9 m-85 -74.09 116.06 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.21 121.09 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -104.47 126.79 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.006 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.38 124.69 36.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 mt -119.29 158.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.3 m -162.0 153.07 17.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -95.87 108.79 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.628 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.34 22.11 5.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.87 -147.29 20.54 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.569 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.71 -25.38 2.86 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.686 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.85 167.45 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 110.99 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.43 162.34 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.553 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 8.3 pt -150.24 137.86 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.828 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.47 111.21 4.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.599 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.439 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 27.5 p-90 -105.22 157.86 16.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.116 0.484 . . . . 0.0 111.772 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.65 148.89 33.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 mm -121.67 150.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -151.75 135.93 16.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.681 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.36 154.53 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -62.42 -32.67 73.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.014 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.15 108.23 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.962 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.09 25.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.765 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.07 -38.11 6.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.775 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.29 -32.01 7.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.82 118.33 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.673 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.6 m -122.15 106.8 11.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.91 154.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.21 129.88 0.55 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.171 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.56 131.67 22.12 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.942 -1.274 . . . . 0.0 111.88 -0.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.23 -48.43 15.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.407 2.071 . . . . 0.0 112.051 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.3 p -135.96 -178.84 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.53 -168.22 33.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.64 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -144.75 142.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -134.04 136.91 44.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.033 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -64.77 -179.66 0.32 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.968 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 29.6 Cg_exo -61.52 116.18 3.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.585 2.19 . . . . 0.0 112.435 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.52 29.8 2.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.412 ' CB ' ' HB2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -90.53 153.26 20.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.636 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -115.29 142.57 46.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.264 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.3 129.82 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.775 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.74 141.19 30.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 36.4 ttp -127.58 158.04 38.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.601 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.88 151.05 45.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.391 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.7 84.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.015 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.67 133.74 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 87.86 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.807 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.28 152.67 2.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -66.87 117.64 9.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -137.9 -163.99 1.54 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.62 139.04 43.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.712 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.56 18.64 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.509 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.33 15.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.02 47.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -138.29 165.82 25.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.15 127.0 18.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.5 84.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.997 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.53 25.16 7.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.178 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 73.27 93.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -70.37 147.61 49.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -142.35 137.37 30.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.418 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 78.8 mt -110.32 94.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.2 140.24 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 89' ' ' ILE . 3.9 mp -132.96 111.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.006 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.91 124.43 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.027 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.469 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 11.7 p90 -133.5 142.08 48.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -141.3 144.99 34.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -60.74 131.36 50.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 p -73.61 142.45 80.8 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.01 162.74 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.475 2.116 . . . . 0.0 112.16 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.44 118.31 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.95 45.65 70.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.265 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.75 167.71 7.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.211 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.11 163.67 27.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.34 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.44 69.83 8.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.13 146.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -69.8 116.72 10.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.99 155.14 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -84.01 -26.04 29.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -22.66 66.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -59.35 -17.7 31.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 2.7 m-85 -124.85 38.63 4.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 110.801 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -117.71 35.25 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.921 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.7 174.63 24.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.638 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.8 140.2 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 110.589 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.41 172.28 44.77 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.25 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.422 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER 58.82 164.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 110.904 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.427 ' CG2' ' HB ' ' A' ' 94' ' ' THR . 5.1 t 82.55 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.252 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.469 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 5.7 tpt180 -106.83 144.27 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -134.04 103.5 5.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 131.49 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.544 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.17 143.36 30.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.9 94.98 42.96 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.506 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.13 139.2 62.8 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.632 2.221 . . . . 0.0 112.58 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 17' ' ' ILE . 7.6 mm -114.51 111.9 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.96 127.91 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -89.39 107.4 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.27 76.89 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.946 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.745 0.307 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -118.81 79.38 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.27 173.14 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.803 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.96 129.4 15.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.73 172.23 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.469 2.113 . . . . 0.0 112.149 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.1 119.33 6.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.566 2.177 . . . . 0.0 112.256 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.67 131.4 40.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.293 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -48.13 113.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 111.019 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.469 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.2 pt -85.13 124.54 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -67.65 138.1 56.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.43 153.34 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.4 102.4 4.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.12 157.71 45.69 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.777 -1.343 . . . . 0.0 112.222 0.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.73 -10.78 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.729 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.06 -61.58 1.66 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.886 0.374 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -143.8 174.96 10.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.232 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.402 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 19.5 tt -147.94 123.23 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 44.4 t -113.49 117.96 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.53 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.461 ' CE2' ' CD1' ' B' ' 29' ' ' TYR . 48.3 m-85 -77.08 95.98 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.531 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -70.28 131.84 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.629 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -58.39 169.24 1.03 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.68 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 67.7 Cg_endo -89.12 160.23 38.62 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.712 0.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -97.92 46.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.882 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.87 8.98 4.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.345 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -5.97 7.74 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.68 134.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.768 0.318 . . . . 0.0 110.596 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.39 101.35 2.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -75.24 102.75 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CD1' ' CE2' ' B' ' 19' ' ' PHE . 36.9 m-85 -74.17 116.0 14.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -94.18 121.02 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 64.3 mt -104.37 126.85 59.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.45 124.8 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 13.7 mt -119.35 158.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.953 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.9 m -162.0 153.17 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -95.99 108.91 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.44 22.03 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.147 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.78 -147.46 20.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.573 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.59 -25.36 2.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.685 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 167.46 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.937 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.55 162.32 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.538 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 8.2 pt -150.22 137.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.401 . . . . 0.0 111.878 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.46 111.15 4.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.568 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.441 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 27.6 p-90 -105.09 157.85 16.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 111.763 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.68 148.97 33.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -121.71 150.67 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 111.679 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -151.8 136.1 16.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.51 154.42 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.387 . . . . 0.0 111.15 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 68.6 p -62.35 -32.76 73.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.03 108.13 13.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.006 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 30.7 mmm -102.92 25.13 9.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.13 -38.17 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.773 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.23 -32.0 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.79 118.63 36.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.667 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m -122.4 106.71 11.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.192 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.85 154.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.27 129.87 0.54 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.61 131.66 22.15 Favored 'Cis proline' 0 C--N 1.35 0.636 0 C-N-CA 123.932 -1.278 . . . . 0.0 111.887 -0.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.23 -48.5 15.61 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.327 2.018 . . . . 0.0 112.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p -135.8 -178.69 5.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.48 -168.32 33.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.651 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.76 142.86 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' B' ' 62' ' ' LEU . 0.4 OUTLIER -134.28 136.76 43.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.966 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -64.57 -179.73 0.32 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 29.6 Cg_exo -61.62 116.35 3.37 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.547 2.165 . . . . 0.0 112.377 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.44 29.75 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.407 ' CB ' ' HB2' ' B' ' 62' ' ' LEU . 0.5 OUTLIER -90.43 153.36 20.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.637 179.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -115.38 142.71 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.264 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.34 129.71 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.815 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.7 141.36 30.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.236 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 36.5 ttp -127.79 158.08 38.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.04 151.01 45.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.354 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.6 84.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.77 133.59 55.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.3 t -141.49 87.83 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.15 152.67 2.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.8 p -66.84 117.97 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -138.2 -164.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.57 139.14 43.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.69 18.64 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.508 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.83 -26.28 15.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 111.033 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -150.02 48.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.49 165.79 25.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.14 126.96 17.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 88.0 mt -151.47 84.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.44 25.11 7.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.216 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 73.49 93.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.894 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.42 147.63 49.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -142.39 137.3 30.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' B' ' 91' ' ' ILE . 77.9 mt -110.23 94.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.19 140.22 38.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.417 ' CD1' ' O ' ' B' ' 89' ' ' ILE . 3.9 mp -133.02 111.24 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.937 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.93 124.29 50.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.021 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 11.8 p90 -133.44 142.05 48.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.423 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 0.7 OUTLIER -141.26 145.07 35.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -60.74 131.35 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 3.9 p -73.6 142.36 80.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.05 162.49 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.512 2.141 . . . . 0.0 112.101 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.17 118.23 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.98 45.71 70.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.239 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.76 167.87 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 163.76 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.268 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 69.86 8.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.617 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.3 147.2 0.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.801 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.32 116.7 10.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.892 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.94 154.99 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -83.71 -26.43 29.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -22.68 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -59.45 -17.56 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.249 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 2.7 m-85 -124.88 38.55 4.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.891 0.377 . . . . 0.0 110.814 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -117.66 35.28 4.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.65 174.7 23.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.544 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.88 140.17 32.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 110.656 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.44 172.29 44.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.157 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.417 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 0.0 OUTLIER 58.81 164.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.409 . . . . 0.0 110.897 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.423 ' CG2' ' HB ' ' B' ' 94' ' ' THR . 5.1 t 82.57 129.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.23 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.474 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 5.7 tpt180 -106.84 144.29 33.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.42 55.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -100.08 143.4 30.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.228 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.07 95.11 43.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.383 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 139.21 64.26 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.638 2.225 . . . . 0.0 112.548 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 7.6 mm -114.41 111.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.6 128.05 56.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.098 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -89.63 107.4 19.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.2 76.86 9.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.832 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.1 177.15 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p 61.41 144.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' CG2' ' HD2' ' A' ' 5' ' ' PRO . 8.6 p -149.78 137.77 11.88 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HD2' ' CG2' ' A' ' 4' ' ' VAL . 51.0 Cg_endo -68.82 142.02 50.98 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.522 2.148 . . . . 0.0 112.277 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.06 138.72 28.63 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.422 2.081 . . . . 0.0 112.342 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 111.84 2.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.541 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 8.3 p-10 -46.95 140.38 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.678 0.275 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.477 HG12 ' CE2' ' A' ' 93' ' ' TRP . 1.3 pt -116.71 147.12 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.39 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.2 145.03 25.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.17 144.0 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.297 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -133.05 111.46 13.14 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.59 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.84 161.81 60.19 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.928 -1.28 . . . . 0.0 112.446 0.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -20.48 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.385 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.56 -49.35 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.901 0.381 . . . . 0.0 111.205 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 152.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.429 ' CG2' HD11 ' A' ' 122' ' ' ILE . 12.3 tt -105.95 153.21 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.415 ' CG2' ' HB3' ' A' ' 123' ' ' GLU . 8.0 p -136.19 100.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.418 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.12 114.26 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.542 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.92 142.1 38.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.287 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -66.39 170.6 5.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.732 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 6.9 Cg_exo -73.96 167.04 80.69 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.514 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -110.99 32.84 4.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -117.41 7.22 12.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.25 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.76 149.82 48.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.926 0.393 . . . . 0.0 110.961 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -67.5 107.95 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -108.01 138.09 44.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.846 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.16 112.86 24.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.094 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -105.03 108.5 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -79.76 151.08 30.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.407 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.422 HG21 ' N ' ' A' ' 32' ' ' LYS . 29.1 mm -126.06 150.06 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.713 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.422 ' N ' HG21 ' A' ' 31' ' ' ILE . 12.2 ttmm -104.85 120.57 41.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.93 0.395 . . . . 0.0 111.298 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.5 mt -121.9 130.06 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.717 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.425 HG21 ' N ' ' A' ' 35' ' ' ASN . 53.5 m -139.76 155.02 47.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.148 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.425 ' N ' HG21 ' A' ' 34' ' ' THR . 11.4 t-20 -92.46 114.24 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.763 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 8' ' ' ASP . . . -91.35 18.53 7.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.387 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.09 -141.43 6.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.52 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.43 52.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -174.59 164.78 3.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.776 0.322 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.18 137.09 46.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.733 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.431 ' CD1' HG23 ' A' ' 9' ' ' ILE . 2.5 pt -139.11 114.86 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.33 122.67 9.78 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.919 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -114.63 157.9 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 111.458 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.73 135.96 14.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.693 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.5 mm -93.06 141.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.472 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.26 133.03 15.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.58 160.37 32.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 111.139 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.73 -47.83 41.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -114.29 112.56 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 23.48 6.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.988 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -45.78 3.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -81.99 -50.82 8.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -76.21 154.08 35.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -143.84 110.9 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.774 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.04 146.71 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -164.26 123.75 1.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 135.42 38.59 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.774 -1.344 . . . . 0.0 112.08 0.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.48 -10.64 23.98 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 0.0 112.74 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 p -162.53 165.47 26.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.33 -154.78 25.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.542 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 t -135.02 149.26 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.79 123.41 47.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -77.02 168.27 29.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.73 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 36.3 Cg_endo -65.25 116.46 3.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.573 2.182 . . . . 0.0 112.454 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt 62.09 28.61 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -101.34 150.06 23.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.127 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 30.0 mttt -111.19 154.84 23.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.94 142.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.003 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.67 136.06 36.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 159.09 25.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.69 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.78 124.75 34.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.37 93.86 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.6 p -86.33 154.15 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.0 p -133.14 108.54 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.24 145.49 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.4 p -61.05 142.0 56.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.821 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.06 -169.92 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -116.44 111.77 20.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.41 20.37 11.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.35 -28.84 14.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.202 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.7 p -142.16 46.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -147.16 144.43 28.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.79 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -71.95 150.78 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.425 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 54.8 mt -132.95 66.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -157.48 31.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.025 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -132.72 6.35 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.649 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.91 117.19 33.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -149.02 134.19 18.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 62.2 mt -86.96 161.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.05 110.89 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.105 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.05 111.95 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' CG ' ' CB ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -113.72 131.61 56.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.969 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.477 ' CE2' HG12 ' A' ' 9' ' ' ILE . 17.8 p90 -141.67 150.48 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.6 t -154.34 154.61 33.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.49 153.51 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.408 HG23 ' CZ2' ' A' ' 108' ' ' TRP . 0.6 OUTLIER -101.41 133.06 21.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.786 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.03 158.2 11.91 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.461 2.108 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -52.73 124.21 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.85 32.19 70.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.386 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 96' ' ' THR . . . -62.03 -18.28 60.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.581 0.229 . . . . 0.0 111.452 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 73.01 166.06 0.3 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.359 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -87.22 71.29 10.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.22 129.42 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.46 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 77.5 t80 -56.94 150.32 16.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.4 155.24 45.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -93.05 22.33 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.35 -6.3 17.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.6 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.46 ' CH2' ' HA ' ' A' ' 104' ' ' PHE . 8.8 m0 -91.14 19.65 5.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.626 0.25 . . . . 0.0 111.057 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -144.64 21.27 1.66 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.758 0.313 . . . . 0.0 111.151 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -105.02 26.9 8.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.936 0.398 . . . . 0.0 110.586 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.63 67.95 1.07 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.346 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.98 118.61 28.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.752 0.311 . . . . 0.0 110.854 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 50.32 -98.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.407 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.9 ptp -168.2 110.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.73 0.3 . . . . 0.0 110.949 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.6 t -82.64 143.14 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.36 125.36 50.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.438 ' CB ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -135.5 153.72 51.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.31 135.5 48.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -96.18 129.48 43.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.261 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.9 mt -111.43 98.7 41.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.652 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.92 150.14 10.22 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.66 2.24 . . . . 0.0 112.596 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.429 HD11 ' CG2' ' A' ' 17' ' ' ILE . 37.5 mm -100.87 149.84 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.962 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 29.3 mt-10 -133.22 156.93 46.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.009 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 84' ' ' LEU . 54.6 m-85 -123.81 105.23 9.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.974 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -87.49 81.38 7.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.759 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.903 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.819 0.342 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.06 177.41 7.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p 61.15 144.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.423 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 8.6 p -149.77 137.71 11.83 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.135 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.423 ' HD2' ' CG2' ' B' ' 4' ' ' VAL . 51.6 Cg_endo -68.7 142.06 51.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.504 2.136 . . . . 0.0 112.214 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 138.94 29.14 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.5 2.133 . . . . 0.0 112.289 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.28 112.05 2.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' B' ' 36' ' ' ALA . 8.2 p-10 -47.0 140.34 4.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 111.089 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.477 HG12 ' CE2' ' B' ' 93' ' ' TRP . 1.3 pt -116.42 147.25 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.53 144.92 25.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.0 144.16 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.1 111.52 13.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.86 162.01 59.65 Favored 'Cis proline' 0 C--N 1.351 0.669 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.42 0.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -20.38 11.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.57 -49.47 4.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.07 152.26 1.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.425 ' CG2' HD11 ' B' ' 122' ' ' ILE . 12.4 tt -105.88 153.19 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' B' ' 123' ' ' GLU . 7.9 p -136.23 100.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.99 114.21 3.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.75 142.37 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -66.53 170.34 5.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.663 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 6.7 Cg_exo -74.21 167.09 80.78 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.559 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -111.04 32.99 4.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -117.54 7.19 12.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.211 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.67 150.14 48.32 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -67.84 107.88 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.87 138.17 44.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 112.88 24.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.14 108.51 20.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -79.51 150.99 31.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.435 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.421 HG21 ' N ' ' B' ' 32' ' ' LYS . 29.0 mm -126.1 150.15 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.689 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.437 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 12.0 ttmm -104.89 120.51 41.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.318 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -121.85 130.13 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.739 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' THR . . . . . 0.426 HG21 ' N ' ' B' ' 35' ' ' ASN . 52.9 m -139.8 155.12 47.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.426 ' N ' HG21 ' B' ' 34' ' ' THR . 11.4 t-20 -92.53 114.32 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.692 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' B' ' 8' ' ' ASP . . . -91.41 18.71 6.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.356 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.18 -141.46 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.564 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.25 51.85 0.55 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -174.32 164.84 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.15 137.12 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.434 ' CD1' HG23 ' B' ' 9' ' ' ILE . 2.5 pt -139.05 115.14 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.317 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.58 122.56 9.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.922 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -114.56 157.98 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.91 136.0 14.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.657 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 41.7 mm -93.13 141.92 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.5 133.1 15.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.754 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.73 160.45 32.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.06 0.457 . . . . 0.0 111.084 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -47.7 43.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -114.33 112.63 23.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 23.38 6.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -45.82 3.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.87 -50.97 8.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.13 154.26 35.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.143 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 9.7 m -144.03 110.81 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.07 146.53 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.213 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -164.19 123.74 1.31 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.26 135.33 38.02 Favored 'Cis proline' 0 C--N 1.352 0.748 0 C-N-CA 123.756 -1.352 . . . . 0.0 112.137 0.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.4 -10.45 23.96 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.507 2.138 . . . . 0.0 112.744 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 24.3 p -162.75 165.44 25.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.31 -154.93 26.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 t -134.88 149.28 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.789 0.328 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.88 123.28 46.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.99 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.43 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 0.6 OUTLIER -76.84 168.26 29.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.703 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 36.5 Cg_endo -65.25 116.56 3.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.587 2.191 . . . . 0.0 112.381 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt 62.04 28.55 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' B' ' 67' ' ' LYS . 0.2 OUTLIER -101.24 150.3 23.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . 0.411 ' N ' ' HG3' ' B' ' 66' ' ' GLU . 30.1 mttt -111.44 154.84 24.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.99 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.6 p -149.94 142.88 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.968 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.66 135.95 36.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.28 159.18 25.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.92 124.59 33.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.317 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 31.0 t -126.27 93.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -86.44 154.26 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 p -133.25 108.42 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -53.23 145.41 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.969 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.5 p -61.04 141.88 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.97 -169.8 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -116.54 111.55 20.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.29 20.54 11.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.41 -29.15 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 60.0 p -141.96 46.74 1.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -147.19 144.41 28.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -71.87 150.97 43.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.448 ' HB3' ' CE1' ' B' ' 124' ' ' TYR . 55.6 mt -133.16 67.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.784 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -157.51 32.08 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -132.8 6.31 3.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.615 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.81 117.27 33.96 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.878 0.37 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -149.11 134.08 18.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 61.9 mt -86.77 161.09 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.99 111.01 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.12 111.92 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . 0.43 ' CG ' ' CB ' ' B' ' 117' ' ' ARG . 0.4 OUTLIER -113.68 131.63 56.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.477 ' CE2' HG12 ' B' ' 9' ' ' ILE . 18.0 p90 -141.59 150.74 42.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 11.5 t -154.55 154.68 33.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.56 153.49 4.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.966 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.4 HG23 ' CZ2' ' B' ' 108' ' ' TRP . 0.6 OUTLIER -101.37 132.99 21.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.0 158.17 11.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.5 2.133 . . . . 0.0 112.316 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -52.67 124.29 13.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.57 32.41 71.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.427 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -62.06 -18.35 60.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.611 0.243 . . . . 0.0 111.511 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 73.29 166.2 0.3 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.215 0.531 . . . . 0.0 111.231 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -87.49 71.45 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.78 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.35 129.36 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.461 ' HA ' ' CH2' ' B' ' 108' ' ' TRP . 77.3 t80 -56.83 150.29 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.45 155.13 45.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.973 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -92.93 22.32 5.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.159 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.33 -6.44 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.636 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.461 ' CH2' ' HA ' ' B' ' 104' ' ' PHE . 9.0 m0 -91.1 19.61 5.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.66 0.266 . . . . 0.0 111.069 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -144.58 21.1 1.67 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.746 0.307 . . . . 0.0 111.203 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -104.89 26.88 8.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.973 0.415 . . . . 0.0 110.551 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.58 68.15 1.08 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.257 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.09 118.7 28.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.743 0.306 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 50.03 -98.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.519 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 2.8 ptp -168.22 110.12 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.893 0.377 . . . . 0.0 110.937 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 19.3 t -82.57 143.26 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.59 125.27 50.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . 0.43 ' CB ' ' CG ' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -135.4 153.63 51.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.181 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.24 135.6 48.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.623 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -96.23 129.36 43.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.293 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 79.1 mt -111.3 98.75 41.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.681 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.94 150.17 10.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.638 2.225 . . . . 0.0 112.518 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.425 HD11 ' CG2' ' B' ' 17' ' ' ILE . 36.9 mm -100.92 149.9 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.006 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.412 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . 30.4 mt-10 -133.23 156.87 46.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' B' ' 84' ' ' LEU . 55.5 m-85 -123.82 105.09 9.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -87.33 81.42 7.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.789 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.95 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.886 0.374 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 61.23 114.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -88.0 -179.63 6.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -81.25 141.88 50.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.71 168.03 25.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.569 2.18 . . . . 0.0 112.325 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.67 157.87 51.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.296 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.09 129.6 9.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -50.77 129.99 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HG12 ' CZ2' ' A' ' 93' ' ' TRP . 1.1 pt -99.16 120.22 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.426 ' ND2' ' HB ' ' A' ' 34' ' ' THR . 1.1 p30 -81.8 142.52 32.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.826 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -136.95 155.72 49.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.45 106.58 4.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.02 154.47 48.54 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.508 0.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -50.36 11.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.199 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -159.49 41.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.117 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -153.53 92.9 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.33 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 10.4 tt -123.28 130.78 74.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.599 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.43 HG22 ' CB ' ' A' ' 123' ' ' GLU . 7.4 p -138.97 113.98 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.516 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -71.84 104.6 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.376 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 153.52 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.595 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -77.11 170.35 16.77 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.655 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 96.1 Cg_endo -79.07 166.77 78.23 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.786 0.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' CD2' ' A' ' 126' ' ' LEU . 22.3 m-85 -106.84 50.03 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.871 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.53 -3.33 10.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.309 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -137.5 150.31 47.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.844 0.354 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.82 110.72 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.25 83.49 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 114.94 10.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.81 132.92 42.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.15 138.89 38.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.96 145.18 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.442 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.86 138.85 39.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 mt -121.04 157.92 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.64 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.426 ' HB ' ' ND2' ' A' ' 10' ' ' ASN . 88.8 m -162.12 148.53 13.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -121.03 84.63 2.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 110.495 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.42 -27.32 0.68 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.56 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.65 154.08 1.4 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.685 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.71 54.83 0.93 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.435 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 154.89 4.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -65.79 148.37 51.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.5 pt -145.47 165.55 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.07 106.51 0.91 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 62.5 p-90 -104.29 157.58 17.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.227 0.537 . . . . 0.0 112.183 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 153.44 40.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.357 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' CD1' HG12 ' A' ' 91' ' ' ILE . 11.9 mm -119.92 145.36 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.979 0.419 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.69 134.83 20.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.683 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.1 p -112.36 153.74 26.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.071 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -26.17 18.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.721 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.68 114.16 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.3 19.84 5.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.285 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -96.33 -44.27 7.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.87 -50.7 4.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.96 153.76 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.27 151.25 28.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.017 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.8 150.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.786 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.15 115.71 0.62 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.51 139.56 61.34 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.219 -0.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 -32.94 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.655 2.237 . . . . 0.0 112.185 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 m -139.68 155.59 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 179.28 159.29 23.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.419 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 10.6 p -96.1 114.6 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.217 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.91 166.07 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 3.9 m-20 -119.18 166.21 15.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.781 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.01 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.752 2.301 . . . . 0.0 112.518 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 70.18 38.92 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 155.56 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.996 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.11 136.48 50.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG22 ' CZ2' ' A' ' 43' ' ' TRP . 5.9 m -122.33 129.16 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.039 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 127.04 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.793 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.47 159.03 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.0 155.33 26.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.48 82.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.792 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -53.24 136.32 36.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.196 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 51.2 m -152.62 82.11 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.04 150.16 45.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.85 162.16 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -167.56 -169.51 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -102.33 114.53 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.98 22.19 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.407 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.84 -32.16 12.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.0 p -142.91 56.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.61 179.84 4.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.68 82.42 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.002 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.455 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 8.3 mt -117.11 67.76 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.417 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -85.94 -27.97 24.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 85' ' ' ASN . 3.0 m-80 178.54 -49.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.324 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.09 147.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -155.45 132.74 10.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.161 0.505 . . . . 0.0 111.938 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 57.5 mt -101.15 102.18 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.71 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -83.75 138.12 33.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.091 0.472 . . . . 0.0 111.675 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 45' ' ' ILE . 12.9 mt -122.4 123.6 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -120.09 112.43 19.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.485 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 10.6 p90 -126.87 128.74 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.437 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 1.4 t -127.87 148.99 50.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.393 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -52.03 147.55 7.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.8 p -84.64 134.69 41.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.6 161.44 2.96 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.31 2.006 . . . . 0.0 111.94 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -50.81 125.39 13.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.76 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.21 48.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.241 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.62 143.32 57.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 111.241 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.14 164.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.267 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -88.4 69.82 9.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.61 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 179.16 137.69 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.802 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -54.97 145.75 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.435 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 5.2 mmt180 -131.74 150.71 52.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.09 -25.46 23.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.936 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.86 -14.97 59.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.502 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.435 ' CD2' ' HB2' ' A' ' 105' ' ' ARG . 19.0 m0 -55.45 -20.43 12.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.281 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -95.41 38.87 1.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.739 0.304 . . . . 0.0 111.07 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -156.0 30.44 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.13 -154.52 7.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.554 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.35 155.48 25.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.35 -156.39 15.69 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.551 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.33 146.95 43.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 110.863 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.437 ' CG2' ' HB ' ' A' ' 94' ' ' THR . 25.5 t -122.6 130.22 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.485 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 10.5 mtt180 -103.09 137.38 41.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.17 102.42 6.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.22 170.84 8.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.583 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.8 122.86 13.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.98 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 106.26 38.33 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.663 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.2 138.63 82.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.514 2.143 . . . . 0.0 112.79 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 5.0 mm -110.97 150.81 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.591 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' CB ' HG22 ' A' ' 18' ' ' VAL . 67.6 mt-10 -141.53 140.87 33.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 0.0 111.423 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CE1' ' HB3' ' A' ' 84' ' ' LEU . 38.4 m-85 -101.66 96.82 7.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.11 94.79 3.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.429 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 42.0 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.818 0.342 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 61.24 114.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 66.6 m -87.96 -179.65 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 m -81.17 141.9 50.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.203 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.8 168.02 25.68 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.637 2.224 . . . . 0.0 112.267 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.68 157.88 51.5 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.596 2.197 . . . . 0.0 112.24 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.18 129.7 9.22 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -50.88 129.99 24.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.412 HG12 ' CZ2' ' B' ' 93' ' ' TRP . 1.1 pt -99.11 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.007 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.434 ' ND2' ' HB ' ' B' ' 34' ' ' THR . 1.1 p30 -81.85 142.66 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.843 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 16.0 p -137.02 155.83 49.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.27 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.6 106.55 4.34 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.649 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.02 154.4 48.53 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.613 0.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -50.27 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.185 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -159.67 41.89 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -153.51 92.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.301 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.465 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 10.5 tt -123.19 130.89 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.434 HG22 ' CB ' ' B' ' 123' ' ' GLU . 7.6 p -138.97 113.84 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.568 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -71.76 104.69 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.3 153.32 42.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.439 . . . . 0.0 111.525 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -76.9 170.32 16.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.672 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 97.1 Cg_endo -78.97 166.97 77.93 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.027 -1.239 . . . . 0.0 112.759 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' B' ' 126' ' ' LEU . 22.2 m-85 -106.98 49.89 0.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.872 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.48 -3.16 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.304 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -137.57 150.36 47.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.82 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 110.75 3.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.19 83.84 1.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 85.6 m -72.27 114.77 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.62 133.0 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.29 138.93 38.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.406 ' N ' HD11 ' B' ' 31' ' ' ILE . 5.3 mp -131.92 145.31 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.549 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.07 138.5 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.941 0.4 . . . . 0.0 111.481 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 47.4 mt -120.79 157.67 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.659 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' THR . . . . . 0.434 ' HB ' ' ND2' ' B' ' 10' ' ' ASN . 87.7 m -161.93 148.5 13.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -120.95 84.6 2.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.513 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.47 -27.34 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.77 153.8 1.54 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.657 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.44 55.0 0.95 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 154.97 4.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.8 0.333 . . . . 0.0 110.827 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -65.9 148.23 52.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.737 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 pt -145.16 165.57 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 111.586 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -125.15 106.21 0.89 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 62.7 p-90 -104.27 157.37 17.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.217 0.532 . . . . 0.0 112.207 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.88 153.38 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.422 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.423 ' CD1' HG12 ' B' ' 91' ' ' ILE . 12.3 mm -119.88 145.51 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.81 134.74 20.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 36.7 p -112.27 153.52 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.22 -26.21 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.739 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.65 114.15 7.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.23 19.85 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -96.32 -44.38 7.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.741 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.83 -50.79 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.88 154.01 30.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.5 151.11 28.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.7 150.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.09 115.86 0.62 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.47 139.6 61.5 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.098 -0.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.41 -32.84 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.547 2.165 . . . . 0.0 112.102 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.64 155.58 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.479 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 179.4 159.5 23.55 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.411 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 p -96.29 114.79 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.211 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.08 166.19 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.43 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 3.8 m-20 -119.29 166.2 15.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.685 2.257 . . . . 0.0 112.483 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? 69.81 39.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.67 155.47 24.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.02 136.39 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.99 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.445 HG22 ' CZ2' ' B' ' 43' ' ' TRP . 6.0 m -122.27 128.76 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.16 126.84 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.28 158.97 37.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.83 155.36 25.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.52 82.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.759 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 15.1 m -52.94 136.29 34.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.158 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 50.9 m -152.65 82.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.66 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.13 150.07 46.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.84 162.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -167.56 -169.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -102.46 114.63 28.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.1 22.22 5.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.344 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.03 -31.95 12.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.223 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.4 p -143.16 56.18 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -123.74 179.93 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.73 82.46 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.453 ' HB3' ' CE1' ' B' ' 124' ' ' TYR . 8.1 mt -117.08 67.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.73 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 0.7 OUTLIER -85.97 -28.05 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 85' ' ' ASN . 2.9 m-80 178.61 -49.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.01 147.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 -155.5 132.67 10.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 111.869 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 56.8 mt -101.11 102.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.744 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 20.3 m -83.73 137.89 33.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.187 0.518 . . . . 0.0 111.654 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.423 HG12 ' CD1' ' B' ' 45' ' ' ILE . 13.0 mt -122.32 123.47 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.269 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -119.99 112.48 19.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 10.5 p90 -126.84 128.79 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.573 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 1.4 t -128.02 148.91 50.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.391 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -51.91 147.73 6.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -84.75 134.71 41.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.63 161.57 2.91 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.384 2.056 . . . . 0.0 111.867 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -50.87 125.37 13.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.09 48.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.203 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.51 143.11 57.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 0.0 111.34 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.65 164.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.288 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -88.61 69.82 8.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.53 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? 179.2 137.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.812 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -55.34 145.95 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.991 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 5.0 mmt180 -131.93 150.71 52.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.22 -25.25 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.007 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.93 -15.14 59.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.454 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.441 ' CD2' ' HB2' ' B' ' 105' ' ' ARG . 19.0 m0 -55.27 -20.45 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.613 0.245 . . . . 0.0 111.25 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -95.55 39.13 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 111.104 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -156.19 30.44 0.34 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.23 -154.66 7.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.518 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.26 155.41 26.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.871 0.367 . . . . 0.0 110.953 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.35 -156.35 15.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.31 146.89 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' B' ' 94' ' ' THR . 25.5 t -122.5 130.45 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.479 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 10.5 mtt180 -103.18 137.51 41.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.734 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.31 102.3 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.411 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.11 170.91 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.578 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -142.78 123.02 13.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.53 106.2 38.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.677 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.14 138.81 83.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.62 2.213 . . . . 0.0 112.77 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.465 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 5.0 mm -111.21 150.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.513 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.434 ' CB ' HG22 ' B' ' 18' ' ' VAL . 67.6 mt-10 -141.79 140.59 33.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 111.442 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' B' ' 84' ' ' LEU . 37.5 m-85 -101.44 96.68 7.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.94 94.88 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' B' ' 23' ' ' TYR . 41.3 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.822 0.344 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -34.44 78.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -147.7 -79.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.99 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.4 m -154.08 108.27 2.46 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.118 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.03 171.38 11.36 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.498 2.132 . . . . 0.0 112.277 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.29 135.51 46.96 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.568 2.178 . . . . 0.0 112.173 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.3 122.91 16.17 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.273 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.7 108.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.36 145.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.317 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.5 146.7 23.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.576 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.07 155.9 49.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.24 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -153.96 106.23 2.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.645 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.73 161.97 45.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.474 0.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.3 -10.96 11.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.616 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.28 -56.35 2.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.879 0.371 . . . . 0.0 111.18 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.89 -175.43 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tt -150.26 136.34 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 123' ' ' GLU . 7.3 p -126.19 107.94 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.711 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -65.13 119.99 11.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -84.37 134.95 34.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 111.654 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -51.74 170.5 0.21 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.683 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 89.1 Cg_endo -80.13 164.11 81.07 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 124.065 -1.223 . . . . 0.0 112.721 0.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 20.2 m-85 -109.62 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.81 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.22 5.65 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.155 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.67 129.09 25.93 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 0.0 110.773 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.79 106.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -105.61 150.3 25.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.44 97.97 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -87.23 125.52 34.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.4 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -94.97 130.68 41.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.6 mt -97.84 150.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.663 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -104.6 134.27 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.361 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.8 mt -136.87 154.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.1 m -153.83 158.35 40.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.061 0.458 . . . . 0.0 111.238 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 20.4 t-20 -107.85 114.04 27.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.544 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.02 19.91 6.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.424 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.3 -177.26 19.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.632 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.45 19.63 26.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.71 161.94 37.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -65.67 164.11 15.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 pt -149.19 142.0 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.403 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.42 100.98 2.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.731 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -105.71 149.76 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.047 0.451 . . . . 0.0 111.528 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.57 132.23 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.597 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 9.2 mm -92.75 151.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.268 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -138.63 138.2 37.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -124.25 148.97 46.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -55.7 -40.08 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -127.52 118.17 23.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.73 16.72 7.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.408 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -110.88 -31.63 7.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -23.11 14.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 mt -126.85 138.75 53.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.988 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 m -149.5 116.7 6.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.43 153.48 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -145.65 123.3 6.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.0 144.93 77.32 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.498 0.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.21 -13.63 40.26 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.584 2.19 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.61 130.75 0.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 110.586 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.21 -178.82 25.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.668 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 61' ' ' VAL . 10.5 p -114.34 111.52 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.56 145.48 31.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 2.8 m-20 -101.81 171.88 4.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' O ' ' CD ' ' A' ' 65' ' ' LYS . 42.3 Cg_exo -57.06 127.87 27.54 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.527 2.151 . . . . 0.0 112.505 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CD ' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 46.89 34.86 2.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.4 136.64 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.67 113.82 27.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.057 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.87 155.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.87 119.3 26.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.83 164.66 13.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.46 155.46 30.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.399 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.5 t -129.68 104.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.798 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 125.69 32.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.8 p -129.6 98.19 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.712 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.84 153.9 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -64.62 151.16 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.481 ' CZ ' ' CD2' ' A' ' 124' ' ' TYR . 3.5 p90 -148.58 -161.44 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.089 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.09 93.47 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.23 -19.02 64.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.58 -28.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.788 0.328 . . . . 0.0 111.462 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 71.7 p -143.56 59.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 81' ' ' THR . 47.1 mt-10 -159.24 160.31 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -82.76 153.16 25.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.414 HD21 ' CD1' ' A' ' 124' ' ' TYR . 12.5 mt -128.43 38.36 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.67 30.04 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.16 -45.37 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.39 138.47 54.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 132.3 3.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.82 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 78.4 mt -107.73 121.93 61.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' A' ' 118' ' ' LYS . 4.0 m -103.79 138.76 39.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 91' ' ' ILE . 4.0 mp -118.16 124.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 122.01 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.407 ' CZ2' ' HB2' ' A' ' 116' ' ' ARG . 6.2 p90 -130.94 143.66 50.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.429 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 1.3 t -145.18 120.57 10.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -43.22 142.83 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.595 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.9 p -82.01 146.06 54.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.953 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.69 165.92 14.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.547 2.164 . . . . 0.0 112.158 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -45.16 114.38 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.498 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.73 49.67 16.16 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.902 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.6 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 172.68 163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.074 0.464 . . . . 0.0 111.243 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.49 69.51 9.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.518 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.21 128.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.735 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -48.97 131.28 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.994 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -121.47 150.33 41.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 27.16 7.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.27 -1.09 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.787 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -92.47 19.87 6.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.588 0.232 . . . . 0.0 111.193 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -115.24 -23.39 8.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.28 . . . . 0.0 111.306 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -59.99 -32.28 70.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.092 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.4 146.35 40.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.566 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -91.96 150.29 21.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.777 0.323 . . . . 0.0 110.789 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.61 -77.5 1.91 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.264 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.444 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 1.4 mpt? -47.58 169.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.976 0.417 . . . . 0.0 111.226 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.444 ' CB ' ' O ' ' A' ' 114' ' ' MET . 4.5 t 87.07 106.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.39 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.407 ' HB2' ' CZ2' ' A' ' 93' ' ' TRP . 48.0 mtt-85 -98.87 146.14 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.67 156.78 17.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.385 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.419 ' O ' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -145.18 161.74 38.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.524 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.93 148.97 34.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.33 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.6 mt -151.17 86.36 4.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.569 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.1 158.77 3.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.697 2.265 . . . . 0.0 112.66 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.1 mm -114.53 145.72 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.048 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -139.06 165.12 27.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 111.037 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 90.1 m-85 -132.59 108.2 8.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.993 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.18 83.18 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.6 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.831 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.776 0.322 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -34.64 78.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -147.58 -79.38 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 16.3 m -154.2 108.24 2.44 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.92 171.47 11.1 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.483 2.122 . . . . 0.0 112.308 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.27 135.47 46.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.206 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.35 122.98 16.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.306 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -50.67 108.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.25 145.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.67 146.64 24.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.559 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.88 156.09 48.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.232 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -154.18 106.32 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.661 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.76 162.06 45.87 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.872 -1.304 . . . . 0.0 112.381 0.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -11.02 11.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.23 -56.31 2.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 111.204 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -154.9 -175.3 5.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 tt -150.44 136.36 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.638 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' B' ' 123' ' ' GLU . 7.3 p -126.25 107.86 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.702 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -65.19 119.96 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.3 134.99 34.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -51.72 170.52 0.21 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.637 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -80.19 164.12 80.87 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.704 0.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 20.2 m-85 -109.58 47.42 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.29 5.62 5.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.66 128.97 25.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.768 0.318 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.7 106.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.65 150.33 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.676 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.49 97.87 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.091 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.04 125.52 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.546 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -94.95 130.64 41.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 28.7 mt -97.89 150.54 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -104.6 134.48 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 23.8 mt -137.01 154.92 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.818 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -153.93 158.2 40.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.145 0.497 . . . . 0.0 111.251 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -107.75 114.05 27.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.493 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.19 20.09 6.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.365 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.61 -177.58 18.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.32 19.92 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.613 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.89 162.07 37.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.734 0.302 . . . . 0.0 110.788 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -65.86 164.09 15.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.664 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 pt -149.18 141.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.429 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.26 101.12 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.696 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -105.85 149.71 26.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 111.516 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.46 132.38 19.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.673 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 9.1 mm -92.77 151.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.323 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -138.7 138.29 37.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 30.6 p -124.29 149.19 46.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.2 p -55.95 -40.14 72.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -127.4 117.97 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.853 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.51 16.62 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.383 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -110.77 -31.7 7.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -23.19 14.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 34.9 mt -126.75 138.75 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.963 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 36.7 m -149.39 116.73 6.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -94.52 153.47 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -145.64 123.41 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.98 145.03 77.62 Favored 'Cis proline' 0 C--N 1.351 0.67 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.481 -0.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.2 -13.63 40.29 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.15 . . . . 0.0 112.524 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.6 130.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.613 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.12 -178.79 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.606 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' B' ' 61' ' ' VAL . 10.3 p -114.41 111.37 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.38 145.56 31.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.021 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.8 171.79 5.01 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.417 ' O ' ' CD ' ' B' ' 65' ' ' LYS . 41.5 Cg_exo -56.91 127.94 27.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.546 2.164 . . . . 0.0 112.558 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.417 ' CD ' ' O ' ' B' ' 64' ' ' PRO . 0.0 OUTLIER 46.72 34.8 2.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.623 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.32 136.77 40.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 113.9 27.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.014 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.92 155.22 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.96 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.95 119.21 26.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.022 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.75 164.7 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.722 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -118.55 155.29 31.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.54 104.72 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.776 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.34 125.19 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.977 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 1.7 p -129.11 98.1 4.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 153.89 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -64.73 151.11 45.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.76 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.483 ' CZ ' ' CD2' ' B' ' 124' ' ' TYR . 3.5 p90 -148.52 -161.55 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.999 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.05 93.41 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.17 64.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.45 -29.23 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.751 0.31 . . . . 0.0 111.404 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -143.28 59.33 1.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -159.22 160.34 35.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -82.82 153.36 25.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.416 HD21 ' CD1' ' B' ' 124' ' ' TYR . 12.4 mt -128.53 38.24 4.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.52 30.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.41 -45.19 3.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.48 138.53 54.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 132.26 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 77.6 mt -107.73 121.81 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' B' ' 118' ' ' LYS . 4.0 m -103.77 138.84 39.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.416 HD11 ' N ' ' B' ' 91' ' ' ILE . 4.0 mp -118.26 124.33 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.31 121.95 37.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.409 ' CZ2' ' HB2' ' B' ' 116' ' ' ARG . 6.2 p90 -130.91 143.7 50.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.091 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.438 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 1.3 t -145.18 120.5 10.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -43.24 142.87 0.94 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.513 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 6.9 p -81.99 146.03 54.59 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 165.76 15.12 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.597 2.198 . . . . 0.0 112.168 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -44.9 114.5 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.537 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.55 49.63 15.5 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.905 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -51.35 -76.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.035 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 172.38 163.57 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 111.161 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.55 69.41 9.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.4 128.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -48.98 131.24 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.065 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -121.41 150.28 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 26.93 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -113.08 -1.01 14.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.789 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -92.67 20.15 6.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.703 0.287 . . . . 0.0 111.185 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.48 -23.57 8.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.179 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -59.92 -32.08 70.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.105 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.68 146.38 41.64 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -92.04 150.32 21.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.815 0.341 . . . . 0.0 110.713 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.65 -77.46 1.91 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.37 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.437 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 1.4 mpt? -47.65 169.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.041 0.448 . . . . 0.0 111.246 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.438 ' CG2' ' HB ' ' B' ' 94' ' ' THR . 4.5 t 87.06 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.318 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.409 ' HB2' ' CZ2' ' B' ' 93' ' ' TRP . 48.2 mtt-85 -99.05 146.23 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.78 156.73 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' B' ' 90' ' ' THR . 0.0 OUTLIER -145.11 161.73 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.481 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -144.96 148.95 34.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 35.1 mt -151.11 86.44 4.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.582 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.09 158.94 2.94 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.691 2.261 . . . . 0.0 112.683 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 25.3 mm -114.74 145.73 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.002 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.435 ' HB3' ' CG2' ' B' ' 18' ' ' VAL . 0.3 OUTLIER -139.08 165.0 28.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.056 0.455 . . . . 0.0 111.093 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' B' ' 77' ' ' PHE . 90.0 m-85 -132.51 108.09 8.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.976 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.05 83.23 3.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.906 179.897 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 53.99 91.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.02 -176.26 3.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.002 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 m -54.78 156.92 5.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.85 171.48 15.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.58 2.187 . . . . 0.0 112.243 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.27 138.83 62.94 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.532 2.155 . . . . 0.0 112.303 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.15 -152.92 0.41 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -112.06 151.84 28.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.765 0.316 . . . . 0.0 110.885 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.433 HG22 ' CD1' ' A' ' 93' ' ' TRP . 1.1 pp -110.75 127.55 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.157 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.19 152.48 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.0 143.03 30.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.95 111.08 24.59 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.51 168.53 24.73 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.09 -1.213 . . . . 0.0 112.828 0.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -38.9 -48.76 1.61 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.99 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 177.22 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.033 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.57 112.19 16.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.1 tt -113.22 130.06 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.426 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 38.8 t -105.37 87.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.879 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -51.81 101.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.356 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -72.13 137.82 47.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.539 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -70.2 169.34 13.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 72.6 Cg_endo -76.11 166.23 83.41 Favored 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.641 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 17.2 m-85 -108.14 30.41 6.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.14 7.38 36.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.353 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -135.18 154.64 51.55 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.859 0.361 . . . . 0.0 111.101 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -71.34 131.98 44.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -140.24 93.15 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.78 111.4 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -98.09 106.42 18.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -79.37 121.29 24.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -109.81 125.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.21 155.42 16.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -133.89 154.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.404 HG21 ' N ' ' A' ' 35' ' ' ASN . 53.9 m -144.84 151.69 39.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.404 ' N ' HG21 ' A' ' 34' ' ' THR . 14.0 t-20 -98.51 105.48 17.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.673 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.88 20.93 6.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.28 20.26 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.469 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.81 40.34 2.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 175.87 161.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -55.15 169.85 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.706 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 pt -158.92 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.82 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.16 107.08 2.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.444 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 51.3 p-90 -103.76 159.37 15.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 112.033 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.73 145.06 30.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.449 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 13.1 mm -123.9 151.11 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.033 0.444 . . . . 0.0 111.553 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.38 163.41 39.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.1 p -139.37 149.82 44.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.984 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.42 -31.06 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.967 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -136.1 117.74 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.03 16.56 8.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.327 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -54.84 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.93 -40.14 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 122.4 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.638 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.12 107.84 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.207 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.53 129.12 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.029 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -140.28 140.92 24.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.06 153.37 97.47 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.917 -1.285 . . . . 0.0 112.265 0.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.55 -11.68 26.45 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.589 2.193 . . . . 0.0 112.662 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.4 p -172.68 158.77 4.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.903 0.382 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 175.86 148.04 6.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.69 128.02 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 165.32 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -117.41 169.59 7.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.32 112.96 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.584 2.189 . . . . 0.0 112.515 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 62.56 34.86 14.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.282 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -102.19 154.61 18.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.43 160.28 16.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.436 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.01 151.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.698 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.2 125.13 53.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 ttm -121.61 158.54 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.75 38.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.507 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 54.6 t -114.05 91.73 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.749 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.38 129.41 39.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.247 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 10.7 t -130.56 140.16 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.1 151.97 26.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 p -55.6 111.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.918 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 23' ' ' TYR . 27.2 p90 -118.82 -172.43 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.98 126.93 52.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.17 19.01 21.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.329 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.28 -25.19 21.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -135.64 29.23 3.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.53 129.2 20.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.69 146.94 29.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.1 mt -117.31 41.44 2.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.847 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.35 25.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -118.26 -15.1 9.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.468 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.98 114.52 13.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.841 0.353 . . . . 0.0 111.013 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.19 135.52 21.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.436 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 15.6 mt -98.46 107.63 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -71.03 121.12 17.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.06 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 45' ' ' ILE . 14.2 mm -109.86 149.76 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.816 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -148.23 159.92 43.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.488 ' CZ2' ' HB3' ' A' ' 116' ' ' ARG . 10.0 p90 -177.91 123.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 134.75 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -56.34 112.78 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.441 HG23 ' CH2' ' A' ' 108' ' ' TRP . 8.1 p -58.72 148.22 68.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.22 164.68 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.628 2.219 . . . . 0.0 112.316 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.48 115.54 1.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.292 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.04 47.81 32.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.732 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.09 166.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 110.955 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.49 16.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.097 0.475 . . . . 0.0 111.404 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 70.96 8.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.643 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 132.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.838 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -53.25 152.45 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 13.3 mmm180 -136.91 145.25 44.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.35 -27.71 19.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.55 -18.76 65.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.441 ' CH2' HG23 ' A' ' 96' ' ' THR . 26.5 m0 -56.58 -20.35 20.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.307 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -116.54 43.44 2.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 111.049 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -112.81 -30.59 7.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.809 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.83 145.7 15.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.533 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 155.71 27.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 0.0 110.891 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.08 -92.32 0.28 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.553 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -99.36 106.52 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.62 127.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.488 ' HB3' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -119.07 157.87 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.94 124.61 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.35 131.76 40.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.762 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.1 122.65 39.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.075 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 mt -81.72 133.42 52.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.547 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.35 134.94 11.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.611 2.207 . . . . 0.0 112.697 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.426 ' O ' ' CE1' ' A' ' 124' ' ' TYR . 7.5 mm -108.06 82.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.016 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 162.06 26.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' A' ' 122' ' ' ILE . 57.5 m-85 -131.08 100.75 5.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.901 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.426 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 28.6 t30 -80.07 81.5 6.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.919 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.837 0.351 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 53.97 91.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.96 -176.3 3.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 m -54.75 156.92 5.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.81 171.56 15.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.604 2.203 . . . . 0.0 112.277 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.33 139.07 63.75 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.317 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.41 -152.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.21 151.76 29.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.831 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.436 HG22 ' CD1' ' B' ' 93' ' ' TRP . 1.1 pp -110.62 127.28 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.0 152.5 41.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.09 142.95 30.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 0.0 111.488 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.89 111.0 24.77 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.38 168.48 24.26 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.9 0.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.7 t -38.85 -48.76 1.59 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.98 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 177.21 -50.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -79.58 112.14 16.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 7.7 tt -113.33 130.18 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 39.2 t -105.3 87.31 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.934 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -51.37 100.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.423 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -71.97 137.73 47.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.48 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -70.15 169.27 13.93 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.697 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 72.1 Cg_endo -76.16 166.27 83.27 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.736 0.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . 0.42 ' HB3' ' CE1' ' B' ' 77' ' ' PHE . 17.1 m-85 -108.22 30.38 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.09 7.46 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -135.27 154.63 51.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.341 . . . . 0.0 111.12 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -71.37 132.12 44.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -140.31 93.24 2.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.85 111.48 11.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.984 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -98.06 106.5 18.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -79.45 121.51 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.12 125.32 67.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.29 155.43 16.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.268 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 33.8 mt -133.99 153.83 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.617 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' THR . . . . . 0.427 HG21 ' N ' ' B' ' 35' ' ' ASN . 54.1 m -144.75 151.74 39.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 111.474 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.427 ' N ' HG21 ' B' ' 34' ' ' THR . 14.2 t-20 -98.63 105.54 17.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.616 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.83 20.85 6.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.308 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.54 -161.12 20.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.89 40.28 2.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.531 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 175.89 161.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -55.21 169.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.607 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 3.7 pt -158.92 115.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 0.0 111.864 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.06 107.18 2.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.478 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 51.2 p-90 -103.87 159.22 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.51 145.11 30.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.353 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.43 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 13.0 mm -123.89 150.94 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 111.627 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.23 163.51 38.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.552 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 24.3 p -139.5 149.69 44.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.27 -31.24 13.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.008 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -135.89 117.74 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.0 16.48 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.78 -55.03 2.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 110.506 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.82 -40.3 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.88 122.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.711 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.06 108.2 13.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -97.83 129.09 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.027 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -140.21 140.92 24.68 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.0 153.46 97.64 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.199 0.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.72 -11.52 26.03 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.52 2.146 . . . . 0.0 112.582 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 20.1 p -172.74 158.67 4.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 175.98 147.99 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.51 128.1 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.91 165.37 11.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.807 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.437 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.9 OUTLIER -117.54 169.63 7.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.451 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.43 112.66 1.19 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.645 2.23 . . . . 0.0 112.534 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp 62.8 34.99 14.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.197 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.437 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -102.19 154.64 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.51 160.38 16.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.344 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.15 151.88 15.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.629 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -111.2 125.12 53.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.311 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 2.1 ttm -121.7 158.62 28.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.523 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.8 38.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.489 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.17 91.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.651 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.29 129.36 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 10.8 t -130.67 140.0 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -110.04 152.24 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.038 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.3 p -55.8 112.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' B' ' 23' ' ' TYR . 27.5 p90 -119.02 -172.39 2.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.005 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.0 127.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.71 21.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.13 -25.13 22.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 111.121 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.8 p -135.69 29.23 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.037 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.42 129.35 20.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.87 146.94 30.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 29.1 mt -117.32 41.57 2.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.42 24.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -118.0 -15.28 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.561 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.94 114.6 13.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.888 0.375 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.2 135.53 21.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.43 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 15.7 mt -98.52 107.65 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -70.97 121.1 17.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.128 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' B' ' 45' ' ' ILE . 14.4 mm -109.89 149.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.907 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -148.12 159.98 43.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.016 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.475 ' CZ2' ' HB3' ' B' ' 116' ' ' ARG . 10.1 p90 -177.94 123.57 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.908 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.79 134.66 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -56.56 112.57 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.438 HG23 ' CH2' ' B' ' 108' ' ' TRP . 8.0 p -58.4 147.94 66.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.01 164.68 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.602 2.201 . . . . 0.0 112.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.51 115.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.208 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.98 47.77 31.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.825 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 166.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.019 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.75 164.63 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.179 0.514 . . . . 0.0 111.342 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 71.03 7.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.608 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.91 132.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.07 152.27 4.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 13.3 mmm180 -136.77 145.28 44.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -27.89 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.49 -18.5 65.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.279 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.438 ' CH2' HG23 ' B' ' 96' ' ' THR . 26.1 m0 -56.86 -20.22 21.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.73 43.76 2.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.981 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -113.01 -30.67 6.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.794 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.92 145.72 15.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.98 155.78 27.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.892 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.1 -92.39 0.28 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.536 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -99.35 106.52 18.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.866 0.365 . . . . 0.0 110.983 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.59 127.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.475 ' HB3' ' CZ2' ' B' ' 93' ' ' TRP . 0.1 OUTLIER -119.09 157.94 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.04 124.86 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.057 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.56 131.75 40.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.401 ' N ' ' ND2' ' B' ' 119' ' ' ASN . 0.7 OUTLIER -96.08 122.55 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 mt -81.66 133.31 52.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.665 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -79.16 134.95 11.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.622 2.215 . . . . 0.0 112.661 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.428 ' O ' ' CE1' ' B' ' 124' ' ' TYR . 7.6 mm -108.23 82.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.44 161.89 26.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.154 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' B' ' 122' ' ' ILE . 58.6 m-85 -130.89 101.0 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.433 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 28.9 t30 -80.58 81.55 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.908 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.805 0.336 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.03 137.16 32.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.024 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -125.87 132.67 52.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.74 141.35 37.8 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.193 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.71 159.79 51.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.496 2.13 . . . . 0.0 112.367 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.25 116.13 4.56 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.572 2.181 . . . . 0.0 112.266 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.38 114.07 3.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.546 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.75 146.33 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pt -110.8 146.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -96.01 141.18 29.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.47 145.36 50.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.157 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.4 118.13 12.59 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.33 157.27 72.63 Favored 'Cis proline' 0 C--N 1.352 0.74 0 C-N-CA 124.22 -1.158 . . . . 0.0 112.644 0.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.11 -33.11 75.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -179.47 51.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.743 0.306 . . . . 0.0 111.32 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -174.21 108.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.313 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 tt -131.08 155.25 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 73.8 t -135.5 96.14 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.678 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE2' ' CG2' ' A' ' 122' ' ' ILE . 18.8 m-85 -63.28 100.12 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -69.67 151.4 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.493 . . . . 0.0 111.89 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -48.64 170.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 80.1 Cg_endo -87.62 169.02 39.76 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.241 -1.149 . . . . 0.0 112.961 0.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' A' ' 125' ' ' ASN . 21.7 m-30 -110.42 18.97 19.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.185 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -104.1 3.21 32.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.983 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.64 -171.49 3.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.697 0.284 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -99.13 105.56 17.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.35 121.46 38.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -106.55 107.51 18.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.49 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -97.2 126.19 42.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.155 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -86.89 141.1 29.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.814 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.424 HG21 ' N ' ' A' ' 32' ' ' LYS . 17.1 mt -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.575 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' N ' HG21 ' A' ' 31' ' ' ILE . 8.4 mttm -102.89 119.38 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -117.34 145.85 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.2 m -147.61 158.42 44.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 111.323 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -111.26 113.56 26.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.457 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.32 23.18 6.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.72 -158.66 23.63 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.531 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.61 18.7 5.4 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.617 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.87 159.74 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -57.3 151.64 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.666 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt -150.36 121.34 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.861 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 168.5 54.31 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -166.03 155.21 11.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.523 0.662 . . . . 0.0 112.109 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.78 156.78 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.061 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.7 mm -121.51 136.19 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.948 0.404 . . . . 0.0 111.796 -179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 126.18 17.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.519 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.0 p -112.25 162.08 15.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.195 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.49 -28.2 1.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.282 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.42 120.5 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.7 11.34 27.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.486 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.62 -54.12 2.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 110.679 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.96 -28.19 60.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mt -115.22 122.08 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.46 157.84 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.94 155.04 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.875 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.87 109.17 0.65 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.1 140.79 67.96 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.83 -1.321 . . . . 0.0 112.32 0.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.41 -24.89 30.77 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.406 2.071 . . . . 0.0 112.209 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.9 p -151.91 172.85 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.78 -163.33 35.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.648 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 t -137.88 152.57 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 111.2 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.432 ' CD1' HG23 ' A' ' 68' ' ' VAL . 5.7 mp -124.52 161.45 26.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.409 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.6 p30 -115.03 170.53 5.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.744 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 49.4 Cg_exo -56.7 114.0 1.72 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.485 2.124 . . . . 0.0 112.562 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.02 39.24 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.546 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.35 139.31 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.52 112.3 21.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG23 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -101.75 149.12 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.29 127.18 43.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.765 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.43 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 54.0 ttp -113.7 161.38 17.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.082 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.43 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -129.48 141.4 51.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.094 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.07 101.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.8 145.98 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 142.63 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.691 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.9 143.07 26.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.005 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -57.07 161.47 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.145 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -172.27 -160.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -127.29 94.4 3.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.21 -22.18 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.33 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.78 -43.95 94.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -131.27 60.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -158.28 162.14 37.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -70.43 152.24 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.4 mt -138.26 23.26 2.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.061 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -145.54 27.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.971 0.415 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.38 -28.46 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.101 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.53 124.63 24.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.81 132.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 66.6 mt -94.47 127.88 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.8 m -112.58 104.58 12.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.43 148.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 4.9 mt-10 -144.77 154.27 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.294 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -162.42 149.46 13.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.0 141.84 25.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.779 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.02 139.5 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 p -92.6 146.65 32.73 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.2 163.4 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.518 2.145 . . . . 0.0 112.107 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.16 112.32 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.979 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.56 47.1 58.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.72 155.46 19.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 111.21 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.68 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.29 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -88.42 69.76 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.618 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -173.01 124.69 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -52.31 125.76 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.22 149.77 27.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -21.89 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 110' ' ' GLN . 24.3 pt-20 -73.77 -9.74 58.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.633 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -69.31 -29.59 67.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -105.78 37.2 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 1.3 pp0? -120.46 25.64 9.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.922 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.28 150.41 20.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.583 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.47 156.8 25.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.93 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.74 -83.07 0.32 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.594 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -114.34 104.34 11.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.926 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 115' ' ' VAL . 7.4 p 175.36 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.664 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -107.26 155.84 19.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.991 0.424 . . . . 0.0 111.157 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.409 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -145.71 132.64 20.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.952 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 152.22 33.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -102.86 156.37 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.809 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.51 129.33 19.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.56 128.07 6.75 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.645 2.23 . . . . 0.0 112.2 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 122' ' ' ILE . 11.6 mm -100.0 138.86 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.513 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.51 160.08 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.284 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -123.11 117.74 26.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.42 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 38.2 t30 -114.8 141.48 47.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.49 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.6 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.856 -179.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.835 0.35 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.09 137.26 32.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 31.4 t -125.9 132.76 52.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.72 141.44 38.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.83 159.73 51.68 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.52 2.146 . . . . 0.0 112.27 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.26 116.0 4.51 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.519 2.146 . . . . 0.0 112.349 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.99 114.28 3.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.09 146.21 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 pt -110.57 146.11 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.21 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.87 141.16 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.664 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.46 145.5 50.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.401 ' HG2' ' HB3' ' A' ' 22' ' ' PRO . 32.8 mt-30 -135.62 117.97 12.31 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.534 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 157.18 72.3 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 124.217 -1.159 . . . . 0.0 112.729 0.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.01 -33.1 75.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.444 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -179.6 51.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 0.0 111.301 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -174.54 108.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.388 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.9 tt -131.02 155.55 42.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.409 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 74.2 t -135.82 96.19 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.737 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' B' ' 122' ' ' ILE . 18.8 m-85 -63.36 100.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.086 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -69.64 151.21 46.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.151 0.501 . . . . 0.0 111.869 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.481 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -48.35 170.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.481 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 73.9 Cg_endo -87.73 168.76 39.75 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 124.312 -1.12 . . . . 0.0 112.94 0.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' B' ' 125' ' ' ASN . 21.9 m-30 -110.15 18.85 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -103.99 3.22 33.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.927 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.55 -171.38 3.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.771 0.32 . . . . 0.0 110.555 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -99.29 105.52 17.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.34 121.65 38.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.373 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.4 m -106.63 107.8 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.413 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.46 126.43 42.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.094 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -87.05 141.21 28.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.743 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.427 HG21 ' N ' ' B' ' 32' ' ' LYS . 18.0 mt -113.68 154.63 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.478 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.427 ' N ' HG21 ' B' ' 31' ' ' ILE . 8.4 mttm -102.81 119.58 39.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 111.479 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 75.2 mt -117.48 145.88 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.585 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 53.5 m -147.69 158.41 44.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.365 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -111.17 113.77 26.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 23.01 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.67 -158.36 23.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.577 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.57 18.38 5.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.658 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.65 159.84 42.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.779 0.323 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 3.5 mpp_? -57.29 151.87 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.644 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 pt -150.61 121.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.322 . . . . 0.0 111.804 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.25 168.66 54.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.451 -0.88 . . . . 0.0 110.906 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -166.05 155.31 11.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.536 0.668 . . . . 0.0 112.075 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.9 156.91 43.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.057 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 mm -121.63 136.22 59.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.905 0.383 . . . . 0.0 111.848 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.33 126.09 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.505 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 34.8 p -112.23 162.25 15.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.249 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -28.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.41 120.55 23.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.73 11.46 26.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.467 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -54.23 2.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.355 . . . . 0.0 110.704 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -74.71 -28.32 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.804 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 mt -115.06 122.08 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.829 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.36 157.88 26.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.254 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 155.06 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.98 109.11 0.64 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.02 140.73 67.73 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.404 0.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.35 -24.81 31.16 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.458 2.105 . . . . 0.0 112.242 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.0 p -152.01 172.74 15.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.647 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.03 -163.64 35.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.597 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.64 152.74 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 111.115 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.43 ' CD1' HG23 ' B' ' 68' ' ' VAL . 5.5 mp -124.82 161.43 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.403 ' HB2' ' CD ' ' B' ' 64' ' ' PRO . 1.6 p30 -114.98 170.55 5.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.403 ' CD ' ' HB2' ' B' ' 63' ' ' ASP . 51.7 Cg_exo -56.82 113.97 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.562 2.175 . . . . 0.0 112.568 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.1 39.25 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.486 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.42 139.33 46.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.262 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.63 112.22 20.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.786 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.43 HG23 ' CD1' ' B' ' 62' ' ' LEU . 27.4 m -101.77 149.3 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.359 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.37 127.24 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' MET . . . . . 0.429 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 53.8 ttp -113.63 161.35 17.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.429 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -129.46 141.54 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.25 101.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.9 145.99 32.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.06 142.68 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.669 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.94 143.11 26.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 4.2 p -57.08 161.71 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -172.33 -160.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.76 94.69 4.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.35 -22.47 66.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.99 93.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.301 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 80.6 p -131.26 60.37 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -158.5 161.96 37.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -70.25 151.88 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 12.2 mt -137.97 23.34 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -145.45 27.55 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.58 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.26 -28.48 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -70.44 124.48 24.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 132.67 21.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.061 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 66.6 mt -94.41 127.96 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 87.3 m -112.63 104.7 12.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.46 148.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.627 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . 0.411 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 4.9 mt-10 -144.84 154.36 42.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -162.53 149.52 13.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.028 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.407 HG23 ' CZ ' ' B' ' 109' ' ' PHE . 0.0 OUTLIER -148.05 141.83 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.08 139.38 28.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.7 p -92.53 146.61 32.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.27 163.03 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.607 2.205 . . . . 0.0 112.175 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.71 112.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.34 47.59 55.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 155.55 20.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.95 163.97 2.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.373 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -88.0 69.68 9.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.62 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -172.98 124.68 0.43 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -52.39 125.65 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 149.85 27.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -21.74 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' B' ' 110' ' ' GLN . 24.3 pt-20 -73.9 -9.62 58.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.69 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -69.34 -29.62 67.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.687 0.279 . . . . 0.0 111.021 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.407 ' CZ ' HG23 ' B' ' 94' ' ' THR . 15.0 m-85 -105.84 37.16 2.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.811 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' B' ' 107' ' ' GLU . 1.3 pp0? -120.44 25.58 9.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.23 150.76 20.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.603 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.72 156.82 24.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.68 -83.23 0.32 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.595 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -114.0 104.31 12.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 111.097 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' B' ' 115' ' ' VAL . 7.4 p 175.41 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 32.4 mtt180 -107.12 155.79 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.168 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . 0.411 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -145.82 132.47 19.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.976 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 152.24 33.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -102.73 156.53 17.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.797 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.67 129.2 19.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.102 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.37 128.09 6.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.458 2.105 . . . . 0.0 112.167 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.421 HD11 HG22 ' B' ' 122' ' ' ILE . 11.6 mm -99.94 138.73 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.38 160.14 22.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -123.14 117.82 26.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 111.569 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.418 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 38.1 t30 -114.82 141.72 47.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.522 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.836 -179.987 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.907 0.384 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -99.87 88.76 3.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.35 176.31 10.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.61 157.79 81.8 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.26 153.33 7.14 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.652 2.235 . . . . 0.0 112.451 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.07 159.85 51.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.648 2.232 . . . . 0.0 112.262 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.37 -146.56 5.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.604 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.3 137.72 54.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.418 HG22 ' NE1' ' A' ' 93' ' ' TRP . 1.1 pt -113.19 149.79 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.236 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 153.45 20.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.603 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -144.98 152.48 40.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.273 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -137.71 116.47 9.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.488 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.02 154.25 76.81 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.963 -1.265 . . . . 0.0 112.484 0.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.9 9.1 38.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.688 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.17 -59.57 1.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -169.37 173.38 6.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -121.51 155.23 25.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.018 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 44.7 t -118.15 85.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.634 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 29' ' ' TYR . 5.2 m-30 -49.7 102.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -73.3 135.6 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -54.15 170.33 0.32 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.695 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 98.4 Cg_endo -78.6 168.47 75.08 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.837 0.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.2 m-85 -112.98 29.93 7.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.01 6.44 12.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.05 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -140.82 157.83 44.83 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.39 114.05 14.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -115.67 149.82 37.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.5 m -114.98 126.92 55.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.471 ' CZ ' ' CG ' ' A' ' 19' ' ' PHE . 42.9 m-85 -107.18 128.68 54.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.506 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -90.98 115.17 27.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.455 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.05 143.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.565 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.72 140.95 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 111.626 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.5 mt -134.49 152.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.481 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 35' ' ' ASN . 49.5 m -152.59 158.78 42.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.24 0.543 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.419 ' N ' HG21 ' A' ' 34' ' ' THR . 52.4 t30 -112.76 107.37 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.29 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.97 -4.29 49.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.661 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 -173.15 49.54 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.34 22.46 10.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -145.16 -179.65 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.94 155.81 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.9 pt -148.86 170.88 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.985 0.422 . . . . 0.0 111.304 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.56 108.17 0.98 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.402 ' HA ' ' O ' ' A' ' 92' ' ' GLU . 30.6 p-90 -104.8 157.83 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 112.023 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.33 157.65 41.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.431 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 2.7 mp -121.86 142.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.908 0.385 . . . . 0.0 111.939 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.31 125.87 14.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.6 p -102.03 158.34 16.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.226 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.24 -33.83 3.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.051 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -137.86 123.87 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.36 8.3 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.474 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.65 -47.54 5.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.752 0.31 . . . . 0.0 110.864 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -82.14 -53.61 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.739 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 mt -91.07 155.36 18.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.816 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.6 152.38 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 153.6 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.83 110.28 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.31 140.72 60.82 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.722 -1.366 . . . . 0.0 112.344 0.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.23 -6.11 16.9 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.556 2.171 . . . . 0.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 p -174.76 171.4 3.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.726 0.298 . . . . 0.0 110.683 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.03 171.75 38.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.634 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.09 120.51 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 0.0 111.116 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -94.37 159.42 15.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.956 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -115.44 167.25 10.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 9.9 Cg_endo -53.28 109.47 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.68 2.253 . . . . 0.0 112.411 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? 62.47 46.85 5.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.42 153.74 25.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -121.12 142.6 49.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.4 m -143.45 149.67 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.009 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.8 tp -96.67 153.51 17.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.988 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.8 ttm -134.16 148.28 50.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.0 129.8 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 97.78 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.68 125.42 29.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.73 147.8 31.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -101.1 142.17 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -55.74 148.91 15.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CD2' ' N ' ' A' ' 78' ' ' ASN . 35.3 p90 -161.79 -164.67 1.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.421 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 3.6 m-80 -125.9 113.15 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB1' ' CE2' ' A' ' 77' ' ' PHE . . . -97.38 21.5 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.278 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.01 -23.52 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.2 p -138.51 40.4 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -151.51 145.15 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -61.36 147.14 45.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' HB3' ' CD2' ' A' ' 124' ' ' TYR . 11.0 mt -130.51 63.85 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -160.06 27.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -129.05 4.91 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.685 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.91 111.58 23.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -146.13 132.73 19.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.279 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.431 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 63.0 mt -94.18 130.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -106.3 126.19 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.18 116.76 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.9 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -118.31 159.55 23.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.006 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.418 ' NE1' HG22 ' A' ' 9' ' ' ILE . 9.4 p90 -155.96 130.59 9.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.426 ' HB ' ' CG2' ' A' ' 115' ' ' VAL . 0.7 OUTLIER -128.06 140.82 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -53.77 137.09 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.0 p -80.47 149.92 69.4 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.18 163.99 2.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 112.08 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -50.67 108.24 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.937 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.96 47.74 59.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.435 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.69 173.1 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.368 . . . . 0.0 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.5 164.66 26.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.1 70.08 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 178.8 136.81 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -53.97 149.09 9.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -138.73 148.16 43.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -18.95 62.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.34 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.13 -6.79 45.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.831 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 48.7 m0 -87.55 13.25 10.56 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.494 0.187 . . . . 0.0 111.448 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 108' ' ' TRP . 49.3 m-85 -154.19 30.9 0.44 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.872 0.367 . . . . 0.0 110.613 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.407 ' HG3' ' N ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -110.99 -26.47 9.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.071 -179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 110' ' ' GLN . . . -83.73 171.17 48.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -96.07 145.71 25.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.314 . . . . 0.0 110.486 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.98 176.4 48.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.191 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.422 ' O ' ' CB ' ' A' ' 115' ' ' VAL . 12.5 mmt 59.22 166.69 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.073 0.463 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' CG2' ' HB ' ' A' ' 94' ' ' THR . 3.4 t 82.92 116.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.139 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -92.23 146.32 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.5 134.03 54.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.53 161.18 29.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.624 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -131.08 154.32 48.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 95.1 5.48 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.756 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -52.13 150.99 17.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.692 2.262 . . . . 0.0 112.678 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.0 mm -108.63 149.51 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -131.45 164.43 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.43 . . . . 0.0 110.983 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.467 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -130.28 114.35 15.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.242 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.432 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 25.4 t30 -103.16 80.72 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.815 -179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.842 0.353 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -99.91 88.6 3.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.21 176.17 10.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.47 157.87 81.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.211 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.38 153.28 7.48 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.625 2.217 . . . . 0.0 112.408 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.01 159.54 52.13 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.11 -146.83 5.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.614 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.1 137.56 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.826 0.346 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.428 HG22 ' NE1' ' B' ' 93' ' ' TRP . 1.1 pt -113.18 149.73 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.22 153.34 20.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.712 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -144.82 152.32 40.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -137.51 116.43 10.04 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.467 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.05 154.22 76.95 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.016 -1.244 . . . . 0.0 112.58 0.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.89 9.15 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.737 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.36 -59.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.802 0.334 . . . . 0.0 111.168 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -169.55 173.4 6.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.011 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -121.66 155.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 45.1 t -118.23 84.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.476 ' CG ' ' CZ ' ' B' ' 29' ' ' TYR . 5.2 m-30 -49.51 102.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.602 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -73.37 135.5 44.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.446 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -53.91 170.44 0.3 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.787 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.455 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 97.0 Cg_endo -78.45 168.61 74.95 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.723 0.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.2 m-85 -113.11 29.85 7.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.956 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.91 6.72 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.132 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.09 157.82 44.77 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.25 114.02 14.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.092 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -115.86 149.63 38.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -114.87 126.76 55.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 111.246 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.476 ' CZ ' ' CG ' ' B' ' 19' ' ' PHE . 43.4 m-85 -106.92 128.68 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.476 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -91.07 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -103.84 142.91 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.545 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.58 140.91 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 61.6 mt -134.5 152.96 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' THR . . . . . 0.419 HG21 ' N ' ' B' ' 35' ' ' ASN . 49.5 m -152.61 158.96 43.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.413 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . 0.419 ' N ' HG21 ' B' ' 34' ' ' THR . 52.3 t30 -112.94 107.39 15.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.313 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.0 -4.1 48.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.82 -173.1 49.54 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.453 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.4 22.43 10.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -145.03 -179.53 6.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.366 . . . . 0.0 110.829 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.04 155.9 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 21.2 pt -148.88 170.82 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.385 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.41 107.88 0.96 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 30.8 p-90 -104.7 157.67 17.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 112.093 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.5 41.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.231 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.44 ' CD1' ' N ' ' B' ' 45' ' ' ILE . 2.7 mp -121.67 142.81 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.012 0.434 . . . . 0.0 111.924 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.51 125.86 14.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 56.2 p -101.97 158.6 16.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.23 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.46 -33.79 4.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.067 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -137.81 123.78 20.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.24 8.33 16.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.487 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -47.39 5.07 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.752 0.311 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 mtt-85 -82.18 -53.69 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 mt -91.05 155.59 18.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.778 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.7 152.26 29.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.027 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.15 153.58 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.02 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.75 110.35 0.35 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.38 140.69 60.86 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.29 0.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.18 -6.16 16.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.595 2.197 . . . . 0.0 112.846 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 3.8 p -174.75 171.42 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.716 0.293 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.01 171.83 38.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.556 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.18 120.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -94.2 159.43 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.442 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -115.48 167.31 10.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 9.8 Cg_endo -53.36 109.46 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.643 2.228 . . . . 0.0 112.434 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? 62.62 46.74 5.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.35 153.62 25.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -121.01 142.47 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.42 149.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.65 153.41 17.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 3.8 ttm -134.03 148.38 51.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.08 129.8 55.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.038 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 97.94 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.2 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.35 29.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.826 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 38.6 t -108.56 147.66 31.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.977 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -101.09 142.23 32.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -55.85 148.75 16.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.039 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' B' ' 78' ' ' ASN . 35.2 p90 -161.53 -164.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . 0.427 ' N ' ' CD2' ' B' ' 77' ' ' PHE . 3.6 m-80 -125.96 113.05 16.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . 0.41 ' HB1' ' CE2' ' B' ' 77' ' ' PHE . . . -97.28 21.56 9.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.399 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.85 -23.57 12.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.29 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 58.3 p -138.58 40.54 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.311 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -151.74 145.13 24.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -61.35 147.28 45.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' B' ' 124' ' ' TYR . 11.4 mt -130.5 63.58 1.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -159.93 27.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -129.33 4.92 5.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.765 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.93 111.57 23.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.645 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -146.04 132.73 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.27 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.437 HG23 HD11 ' B' ' 89' ' ' ILE . 62.5 mt -94.23 130.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 99.5 m -106.31 125.86 51.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.86 116.92 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.54 159.5 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.428 ' NE1' HG22 ' B' ' 9' ' ' ILE . 9.2 p90 -155.96 130.68 9.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.435 ' HB ' ' CG2' ' B' ' 115' ' ' VAL . 0.7 OUTLIER -128.15 140.85 51.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -53.83 137.37 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 59.1 p -80.69 149.92 68.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.14 164.24 1.87 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.539 2.159 . . . . 0.0 112.074 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.01 108.31 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.98 47.62 59.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.462 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.51 172.98 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.53 164.69 26.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.275 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.11 69.76 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.17 137.12 0.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.835 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -54.12 148.97 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -138.61 148.15 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.301 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.2 -6.54 43.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.798 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.473 ' O ' ' CD1' ' B' ' 109' ' ' PHE . 48.8 m0 -87.75 13.38 10.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.527 0.203 . . . . 0.0 111.467 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.473 ' CD1' ' O ' ' B' ' 108' ' ' TRP . 49.3 m-85 -154.33 31.06 0.43 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.853 0.359 . . . . 0.0 110.589 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' B' ' 111' ' ' GLY . 0.0 OUTLIER -111.32 -26.23 9.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.055 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . 0.421 ' N ' ' HG3' ' B' ' 110' ' ' GLN . . . -83.95 171.15 48.43 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.591 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -96.01 145.61 25.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.583 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.93 176.52 48.3 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.149 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.421 ' O ' ' CB ' ' B' ' 115' ' ' VAL . 12.5 mmt 59.25 166.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.435 ' CG2' ' HB ' ' B' ' 94' ' ' THR . 3.4 t 83.06 116.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -91.94 146.26 23.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.764 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.57 134.13 54.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.56 161.01 29.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -130.84 154.32 48.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.48 95.11 5.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.72 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -52.17 151.11 17.66 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.681 2.254 . . . . 0.0 112.639 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 19.9 mm -108.68 149.34 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.993 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -131.31 164.41 25.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.022 0.439 . . . . 0.0 111.02 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' B' ' 84' ' ' LEU . 89.4 m-85 -130.23 114.28 15.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.249 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.422 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 24.6 t30 -103.34 80.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 43.4 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.856 -179.911 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -148.18 -60.17 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 1.6 m -162.98 -79.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 3' ' ' SER . 5.2 m 43.96 101.34 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.944 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.59 128.32 12.54 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.567 2.178 . . . . 0.0 112.258 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.05 140.6 80.2 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.367 2.045 . . . . 0.0 112.229 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.8 132.36 46.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.537 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -51.22 128.76 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 pp -102.35 142.84 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.22 150.02 35.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -142.2 150.05 40.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.994 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -146.13 104.51 4.12 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.758 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.409 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 31.6 Cg_endo -63.7 159.94 64.69 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.465 0.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.37 -18.24 12.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.81 -46.78 4.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' PRO . 31.5 pttt -172.73 -179.13 2.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 14.2 tt -135.93 138.72 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.031 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.4 t -121.94 91.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -59.96 102.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.554 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.88 138.43 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.462 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -60.22 167.71 2.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.716 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 7.7 Cg_endo -88.05 164.8 43.31 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 124.415 -1.077 . . . . 0.0 112.484 0.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 38.6 m-85 -101.19 47.52 0.91 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.964 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.71 1.78 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.485 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -139.35 152.09 46.88 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.839 0.352 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -63.01 121.19 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.781 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -112.86 99.98 8.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.067 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.4 m -99.76 109.59 22.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.437 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 60.4 m-85 -92.09 163.85 13.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.1 0.476 . . . . 0.0 111.222 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -118.09 109.19 16.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.738 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.411 ' CG1' ' HE1' ' A' ' 70' ' ' MET . 8.9 mm -91.1 141.9 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.94 128.63 56.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.3 mt -128.9 153.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.6 m -148.82 157.71 43.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 111.275 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -104.4 73.84 1.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.982 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.71 -26.09 61.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.09 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.15 -62.49 5.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.57 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.5 21.67 4.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.682 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -149.7 159.3 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.44 149.03 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 pt -154.37 167.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.63 100.14 0.48 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.87 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -95.57 157.04 16.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.11 128.94 10.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.686 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.01 142.67 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 111.469 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -145.23 132.84 20.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.572 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.71 155.14 29.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.042 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -65.45 -35.21 80.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.76 112.76 17.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.2 21.63 9.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -46.3 6.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -106.11 -33.07 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 mt -95.96 131.92 41.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.43 167.18 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 56' ' ' ASP . 2.5 p -151.99 160.53 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.315 0.578 . . . . 0.0 111.004 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.457 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 23.1 t70 -165.42 125.98 1.31 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.65 143.54 77.4 Favored 'Cis proline' 0 C--N 1.352 0.75 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.303 -0.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.03 4.89 6.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 113.035 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.7 p -179.71 158.28 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.09 164.7 30.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.627 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.08 117.51 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 111.127 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.49 160.8 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.966 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.452 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -109.99 178.62 0.97 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 22.5 Cg_exo -65.35 105.72 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.737 2.291 . . . . 0.0 112.649 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 72.08 22.65 3.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.256 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.2 150.08 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -116.63 132.29 56.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.82 143.46 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.905 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.1 126.04 54.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.411 ' HE1' ' CG1' ' A' ' 31' ' ' ILE . 25.9 ptt? -122.68 168.13 12.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.56 137.43 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.747 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 29' ' ' TYR . 8.8 p -115.41 96.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 144.19 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 t -138.76 81.93 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -51.88 153.48 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -65.65 122.53 17.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 8.8 p90 -130.91 179.32 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.84 127.28 56.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.8 18.35 6.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.513 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.93 -29.36 13.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.9 p -136.15 42.72 2.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -143.16 133.37 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -52.55 134.24 35.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.433 HD23 ' CG ' ' A' ' 124' ' ' TYR . 16.8 mt -121.88 21.38 10.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -144.07 21.78 1.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -132.32 4.03 3.99 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.694 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -96.75 118.86 34.13 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 110.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.7 133.11 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.7 mt -85.3 164.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.593 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 121.39 12.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 111.405 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.03 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.793 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -99.63 122.47 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.444 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 5.6 p90 -133.59 143.7 48.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.3 136.75 33.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -50.1 144.66 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.29 139.42 41.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.71 160.82 47.04 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -48.73 129.33 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.169 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.94 38.06 94.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.647 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 134.09 45.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.63 163.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.144 0.497 . . . . 0.0 111.289 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.29 6.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.54 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.01 145.55 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.812 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.43 115.77 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 0.5 OUTLIER -106.06 153.75 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.827 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -87.19 -27.42 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.68 -33.2 72.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.48 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 54.0 m0 -53.54 -31.85 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -87.11 -33.17 19.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -103.0 37.23 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.943 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.8 -146.06 5.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.433 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -90.24 154.8 19.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.357 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.85 -174.24 16.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.455 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.19 132.66 56.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.74 125.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.25 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.444 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -97.05 108.05 20.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -103.26 115.89 31.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.03 157.69 16.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.433 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.31 126.01 17.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.394 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.6 114.46 47.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.15 145.56 79.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.1 mm -95.03 151.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.852 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.6 156.68 48.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.433 ' CG ' HD23 ' A' ' 84' ' ' LEU . 6.5 m-85 -127.69 104.93 8.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.98 78.46 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.664 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.922 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.824 0.345 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -148.01 -60.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.412 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 1.5 m -163.12 -79.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.836 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 3' ' ' SER . 5.2 m 43.85 101.42 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.873 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.6 128.26 12.47 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.571 2.181 . . . . 0.0 112.256 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.93 140.39 79.19 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.462 2.108 . . . . 0.0 112.272 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.75 132.36 46.76 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.414 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -51.07 128.96 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.6 pp -102.46 142.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.31 150.1 35.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.7 p -142.26 149.98 40.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -146.07 104.48 4.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.66 160.24 63.66 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.399 0.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -18.45 12.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.69 -46.55 4.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.77 0.319 . . . . 0.0 111.274 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 31.3 pttt -172.87 -179.29 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.1 tt -135.72 138.82 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.059 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 62.5 t -122.09 91.47 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.23 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -59.91 102.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.562 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.85 138.58 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.468 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -60.4 167.73 2.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.717 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 7.8 Cg_endo -88.16 164.51 42.98 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.385 -1.09 . . . . 0.0 112.544 0.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . 0.403 ' CD1' ' CE1' ' B' ' 77' ' ' PHE . 39.4 m-85 -100.9 47.64 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.061 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.68 1.67 11.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.44 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -139.21 152.11 47.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -63.01 121.16 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.724 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -112.86 100.16 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.996 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -99.9 109.85 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.627 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.436 ' HB2' ' CG1' ' B' ' 72' ' ' VAL . 59.9 m-85 -92.29 163.85 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 111.133 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -118.12 109.04 15.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.704 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.415 ' CG1' ' HE1' ' B' ' 70' ' ' MET . 9.0 mm -91.05 141.95 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.02 128.53 56.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 36.0 mt -128.86 153.34 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 59.5 m -148.77 157.53 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -104.3 73.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.926 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.79 -25.93 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.112 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.4 -62.32 5.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.572 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.58 21.53 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.651 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 mtm-85 -149.63 159.32 44.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.4 148.87 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.725 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.22 167.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.992 0.425 . . . . 0.0 111.522 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.54 100.11 0.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.839 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -95.56 157.07 16.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 111.589 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.23 129.04 10.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.713 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 25.6 mm -93.05 142.6 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 111.472 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -145.23 132.77 20.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.651 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.58 155.18 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 3.0 p -65.5 -35.27 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.7 112.76 17.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.29 21.77 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.97 -46.29 6.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -106.17 -33.27 7.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -95.71 131.83 41.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.796 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.47 167.05 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' B' ' 56' ' ' ASP . 2.5 p -151.79 160.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . 0.463 ' N ' ' CG2' ' B' ' 55' ' ' VAL . 22.9 t70 -165.46 126.03 1.31 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.54 143.6 77.73 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.831 -1.32 . . . . 0.0 112.252 -0.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.88 4.72 6.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.618 2.212 . . . . 0.0 113.095 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 9.6 p -179.7 158.23 0.79 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.14 164.74 30.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.603 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.2 t -100.19 117.65 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 111.087 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -90.53 160.97 15.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -110.14 178.39 1.02 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.804 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 22.3 Cg_exo -65.11 106.03 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 71.81 22.5 3.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.363 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.1 150.2 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -116.69 132.19 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.68 143.64 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.922 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.3 125.88 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' MET . . . . . 0.415 ' HE1' ' CG1' ' B' ' 31' ' ' ILE . 25.9 ptt? -122.45 168.32 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.77 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.65 137.48 53.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.721 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' B' ' 29' ' ' TYR . 8.9 p -115.51 96.23 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.722 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 144.14 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 t -138.76 81.88 1.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.732 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.7 153.4 2.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -65.7 122.62 17.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CE1' ' CD1' ' B' ' 23' ' ' TYR . 9.2 p90 -130.97 179.22 6.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.93 127.32 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.69 18.07 6.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.599 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.76 -29.3 13.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.6 p -136.14 42.67 2.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -143.14 133.41 24.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -52.6 134.32 35.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.007 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.442 HD23 ' CG ' ' B' ' 124' ' ' TYR . 16.9 mt -121.95 21.29 10.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -143.95 21.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.897 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -132.28 4.1 4.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.733 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.74 118.99 34.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.731 0.3 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.72 133.3 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 18.2 mt -85.43 164.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.524 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.47 121.59 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.09 92.04 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.811 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -99.77 122.56 42.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.458 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 5.6 p90 -133.76 143.8 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.856 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 137.18 33.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.785 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -50.29 144.96 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.54 139.5 41.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.68 161.01 46.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.535 2.157 . . . . 0.0 112.32 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -48.9 129.27 17.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.89 38.16 94.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.65 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 134.16 45.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.09 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.57 163.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.127 0.489 . . . . 0.0 111.331 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.43 6.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.634 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.81 145.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.44 115.73 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.481 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 0.5 OUTLIER -105.95 153.56 21.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.04 -27.43 23.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.69 -33.07 72.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CE2' ' HB2' ' B' ' 105' ' ' ARG . 54.0 m0 -53.69 -31.79 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.937 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -87.17 -33.29 19.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -102.75 37.08 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.75 -146.18 5.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.59 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -90.22 154.58 19.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.947 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.95 -174.39 16.92 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.97 132.74 56.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.836 0.35 . . . . 0.0 110.808 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.88 125.29 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.458 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -97.33 107.88 20.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -102.99 115.91 31.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.26 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 157.59 16.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.444 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -141.34 125.9 17.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.53 114.55 47.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.3 145.52 78.1 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.406 2.07 . . . . 0.0 112.645 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 40.7 mm -94.97 151.51 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.887 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.7 156.59 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.442 ' CG ' HD23 ' B' ' 84' ' ' LEU . 6.4 m-85 -127.47 105.05 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.038 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.2 78.57 9.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.834 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.14 156.15 42.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.2 t -87.65 168.78 12.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.59 157.68 39.58 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.057 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.9 146.84 97.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.527 2.151 . . . . 0.0 112.188 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.15 142.98 47.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.562 2.175 . . . . 0.0 112.295 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.13 126.13 13.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.444 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -52.73 121.9 8.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.442 HG12 ' CE2' ' A' ' 93' ' ' TRP . 1.1 pt -94.49 128.98 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.02 146.62 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.741 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.21 138.69 35.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.065 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -136.11 112.1 10.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.723 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.09 154.55 70.02 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.401 0.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.45 -38.94 88.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.116 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.04 49.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -169.16 118.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.26 147.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.43 99.72 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 111.603 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 19.2 m-30 -51.51 108.18 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.74 137.15 40.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -59.85 167.09 2.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 83.3 Cg_endo -86.68 161.61 52.65 Favored 'Cis proline' 0 C--N 1.348 0.548 0 C-N-CA 124.013 -1.244 . . . . 0.0 112.583 0.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.97 29.51 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -107.07 7.06 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.533 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -148.68 147.83 29.35 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -56.98 117.99 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 112.16 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.9 m -102.7 114.2 28.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.001 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.567 ' CE1' ' CD1' ' A' ' 19' ' ' PHE . 4.9 m-85 -96.01 122.08 38.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -81.1 132.51 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.41 HG21 ' N ' ' A' ' 32' ' ' LYS . 32.2 mm -114.65 152.49 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.924 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' N ' HG21 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -113.27 127.73 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.238 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -131.54 130.3 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.79 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.9 m -142.15 156.61 45.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.215 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -100.08 113.75 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.23 20.23 6.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.344 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.65 -140.39 9.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.583 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.31 29.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -155.89 148.39 23.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.434 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 5.7 ttp180 -54.67 159.24 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.1 pt -154.2 166.45 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.041 0.448 . . . . 0.0 111.577 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.19 109.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.597 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -104.21 161.67 13.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.226 0.536 . . . . 0.0 111.79 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.36 151.29 26.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.28 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.438 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 20.0 mm -122.14 140.4 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' CG ' ' HB ' ' A' ' 90' ' ' THR . 21.5 ptmt -142.14 131.28 23.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.1 p -114.03 154.81 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.068 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.06 -37.09 73.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -124.89 112.16 16.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.2 -37.53 9.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.759 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -32.38 7.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.81 141.87 29.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.72 132.48 27.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.09 128.0 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -145.71 129.52 8.55 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.52 133.35 28.03 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.153 -0.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.33 -46.81 29.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.388 2.059 . . . . 0.0 112.232 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.83 150.3 36.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.728 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.74 -172.03 27.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.598 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.434 ' CG1' ' HG2' ' A' ' 40' ' ' ARG . 6.0 t -123.16 114.49 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.842 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.86 161.44 17.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.028 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -121.23 178.39 1.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.675 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 33.5 Cg_exo -61.55 108.89 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.623 2.215 . . . . 0.0 112.323 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.72 34.45 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.06 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 151.23 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.798 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -106.44 156.81 18.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 59.4 t -148.74 147.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.202 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mt -112.55 135.63 53.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.686 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 157.74 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.3 123.03 26.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.97 85.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.192 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.73 131.62 49.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.939 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.5 t -123.53 87.59 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.91 149.42 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.001 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 p -63.93 135.88 56.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CD2' ' HB2' ' A' ' 83' ' ' ASP . 26.4 p90 -145.35 -164.5 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -127.15 131.48 50.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.61 19.97 13.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.376 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.68 -37.48 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.287 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 77.6 p -138.65 25.03 2.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 81' ' ' THR . 28.4 mt-10 -161.13 161.87 31.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER 59.63 166.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.957 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.469 HD21 ' CE1' ' A' ' 124' ' ' TYR . 6.2 mt 84.18 54.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ASN . 1.1 p30 -125.4 27.36 6.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.964 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 85' ' ' ASN . 10.7 m-20 82.37 97.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.753 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.7 139.2 53.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.92 132.89 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.438 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 8.4 mt -83.67 166.03 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.744 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.408 ' HB ' ' CG ' ' A' ' 46' ' ' LYS . 2.5 m -140.63 117.56 11.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 111.057 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.408 HG13 ' CD1' ' A' ' 45' ' ' ILE . 3.3 mp -108.34 103.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.79 140.45 48.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.48 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 9.4 p90 -149.94 141.47 23.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.009 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.427 HG23 ' CD1' ' A' ' 109' ' ' PHE . 4.0 t -132.43 147.43 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.992 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.4 137.86 28.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.446 ' CG2' ' CH2' ' A' ' 108' ' ' TRP . 3.0 p -82.38 143.36 48.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -55.87 160.73 9.42 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.495 2.13 . . . . 0.0 112.071 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.8 121.38 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.41 42.56 65.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.09 160.64 17.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.401 . . . . 0.0 111.149 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.85 164.37 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.218 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -88.12 70.17 9.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.583 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.23 134.98 0.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.829 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.12 145.04 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.466 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 3.0 mmt180 -124.8 152.31 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -80.7 -44.55 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.046 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.51 -14.07 62.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.526 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CG ' ' HB2' ' A' ' 105' ' ' ARG . 5.0 m0 -51.49 -24.57 5.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.333 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.427 ' CD1' HG23 ' A' ' 94' ' ' THR . 19.9 m-85 -99.2 -27.36 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.4 23.53 4.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.985 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.68 -70.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.221 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.54 112.88 7.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.951 0.405 . . . . 0.0 110.254 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.37 -73.61 0.29 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.994 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 8.1 mtt -43.89 109.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.377 . . . . 0.0 111.492 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.06 124.31 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.48 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -87.65 141.25 28.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.168 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.41 129.2 39.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.766 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -126.22 162.83 24.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -143.7 142.82 31.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -128.56 95.75 31.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.67 135.61 70.47 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 17.4 mm -97.24 144.76 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -132.39 163.67 28.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.685 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.469 ' CE1' HD21 ' A' ' 84' ' ' LEU . 1.8 m-85 -126.08 125.7 43.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.319 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -114.76 80.93 1.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.841 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.924 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.779 0.323 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.26 155.97 42.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -87.48 168.63 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.45 157.74 39.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.97 146.83 97.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.559 2.173 . . . . 0.0 112.261 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 142.87 47.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 112.35 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.99 125.86 12.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.524 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -52.71 121.73 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.438 HG12 ' CE2' ' B' ' 93' ' ' TRP . 1.1 pt -94.28 129.13 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.2 146.84 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.684 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.4 138.91 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.038 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -136.22 112.13 10.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.08 154.59 69.98 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 123.99 -1.254 . . . . 0.0 112.43 0.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.29 -39.25 89.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.949 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.85 49.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -169.29 118.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.04 148.18 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 7.4 p -139.62 99.72 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 19.5 m-30 -51.6 108.1 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.465 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.83 137.16 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.367 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -59.69 167.08 2.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.859 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 81.9 Cg_endo -86.7 161.64 52.5 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.976 -1.26 . . . . 0.0 112.613 0.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.0 29.62 3.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -107.09 6.99 29.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.474 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -148.75 147.83 29.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.01 117.76 4.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.97 112.2 22.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -102.75 114.33 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' B' ' 19' ' ' PHE . 5.1 m-85 -96.1 121.9 38.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.814 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -80.95 132.44 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.061 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.414 HG21 ' N ' ' B' ' 32' ' ' LYS . 32.2 mm -114.6 152.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.414 ' N ' HG21 ' B' ' 31' ' ' ILE . 0.8 OUTLIER -113.34 127.87 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.62 130.37 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.794 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 51.1 m -142.13 156.69 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.19 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -100.22 113.71 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.892 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.18 20.19 6.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.43 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.61 -140.33 9.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.535 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.27 29.45 0.97 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -155.91 148.31 23.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.768 0.318 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . 0.437 ' HG2' ' CG1' ' B' ' 61' ' ' VAL . 5.6 ttp180 -54.52 159.12 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 12.3 pt -154.19 166.4 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.592 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.14 109.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.566 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -104.26 161.66 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.299 0.571 . . . . 0.0 111.789 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.23 151.43 26.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.352 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.438 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 20.5 mm -122.32 140.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 0.0 111.637 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.409 ' CG ' ' HB ' ' B' ' 90' ' ' THR . 21.5 ptmt -142.23 131.07 22.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.641 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 67.8 p -113.92 154.84 26.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.144 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.05 -37.21 73.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -124.85 112.13 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.26 -37.15 9.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.767 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -32.22 7.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.9 141.58 29.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 132.46 27.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.022 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.08 127.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.047 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.47 129.54 8.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.68 133.46 28.72 Favored 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.731 -1.362 . . . . 0.0 112.092 0.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.35 -46.78 29.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.355 2.037 . . . . 0.0 112.286 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.3 p -144.84 150.18 36.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.732 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.64 -172.1 27.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.586 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' B' ' 40' ' ' ARG . 5.9 t -123.02 114.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.78 161.24 17.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.071 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.446 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -121.01 178.32 1.21 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.797 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 30.7 Cg_exo -61.5 108.98 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.653 2.235 . . . . 0.0 112.355 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.53 34.75 9.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.9 151.04 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -106.49 156.71 18.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 59.1 t -148.71 147.31 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.234 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.9 mt -112.43 135.69 52.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.63 157.73 34.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 111.126 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.25 123.08 26.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.01 85.49 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.261 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 131.83 50.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 t -123.75 87.58 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.89 149.54 2.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 p -63.93 135.99 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' B' ' 83' ' ' ASP . 26.5 p90 -145.57 -164.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -127.11 131.31 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.95 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.384 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.63 -37.62 5.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 111.265 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 77.9 p -138.54 25.1 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' B' ' 81' ' ' THR . 28.5 mt-10 -161.03 161.83 31.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . 0.482 ' HB2' ' CD2' ' B' ' 77' ' ' PHE . 0.6 OUTLIER 59.56 166.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 110.95 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.479 HD21 ' CE1' ' B' ' 124' ' ' TYR . 6.2 mt 84.3 54.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.492 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' B' ' 86' ' ' ASN . 1.2 p30 -125.65 27.48 6.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.946 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' B' ' 85' ' ' ASN . 10.9 m-20 82.31 97.15 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.76 139.29 53.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.88 132.93 4.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.438 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 8.8 mt -83.73 166.23 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' THR . . . . . 0.409 ' HB ' ' CG ' ' B' ' 46' ' ' LYS . 2.5 m -140.79 117.38 10.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.962 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . 0.411 HG13 ' CD1' ' B' ' 45' ' ' ILE . 3.4 mp -108.22 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.73 140.56 48.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . 0.468 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 9.5 p90 -149.91 141.6 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' THR . . . . . 0.436 HG23 ' CD1' ' B' ' 109' ' ' PHE . 4.0 t -132.63 147.24 52.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -52.32 138.03 27.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.446 ' CG2' ' CH2' ' B' ' 108' ' ' TRP . 3.1 p -82.5 143.37 47.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.8 160.72 9.28 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 121.48 5.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.21 42.67 63.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.46 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.12 160.55 18.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 111.134 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.79 164.22 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.27 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -87.94 70.15 9.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.634 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.27 134.91 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.836 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -58.89 144.96 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.481 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 3.0 mmt180 -124.81 152.15 44.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -80.57 -44.54 18.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.613 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CG ' ' HB2' ' B' ' 105' ' ' ARG . 4.9 m0 -51.63 -24.44 5.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.78 0.324 . . . . 0.0 110.96 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . 0.436 ' CD1' HG23 ' B' ' 94' ' ' THR . 19.8 m-85 -99.29 -27.11 13.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -93.66 23.73 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.88 -70.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.245 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.48 112.88 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.843 0.354 . . . . 0.0 110.228 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.45 -73.47 0.3 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.962 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 8.4 mtt -44.14 109.81 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.93 0.395 . . . . 0.0 111.482 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.1 124.34 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . 0.468 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -87.75 141.21 28.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.47 129.08 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -125.97 162.82 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -143.77 142.79 31.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.842 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.7 mp -128.55 95.81 31.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.61 135.57 70.34 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.629 2.219 . . . . 0.0 112.146 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 17.5 mm -97.27 144.5 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.277 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -132.3 163.62 28.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . 0.479 ' CE1' HD21 ' B' ' 84' ' ' LEU . 1.8 m-85 -125.93 125.92 43.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.286 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -114.93 81.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.986 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.743 0.306 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -137.12 133.62 35.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.22 86.17 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.984 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.43 ' CG2' ' HD2' ' A' ' 5' ' ' PRO . 6.8 p -142.29 140.62 19.42 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.02 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.43 ' HD2' ' CG2' ' A' ' 4' ' ' VAL . 75.2 Cg_exo -49.6 142.15 24.9 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.461 2.107 . . . . 0.0 112.285 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.83 156.41 9.34 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.489 2.126 . . . . 0.0 112.331 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.52 122.86 23.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.43 115.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.38 138.09 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.85 146.43 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -135.65 149.67 49.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 111.153 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -135.4 116.37 11.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.483 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.51 163.81 63.74 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.514 0.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 t -44.6 -62.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.383 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.16 48.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.949 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 104.89 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 8.2 tt -131.93 145.31 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.478 ' CG1' ' CG1' ' B' ' 18' ' ' VAL . 6.6 p -150.6 121.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -72.65 113.9 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -81.89 134.61 35.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . . . -65.68 170.72 4.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.805 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HA ' ' CB ' ' A' ' 21' ' ' ALA . 62.5 Cg_endo -73.19 164.99 85.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.766 -1.348 . . . . 0.0 112.675 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -107.27 46.65 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -115.11 -4.77 12.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.406 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -123.08 144.47 49.28 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.94 126.78 31.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.85 155.43 41.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.52 116.06 16.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -102.42 116.12 31.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -92.49 131.7 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.433 ' HB ' ' CG ' ' A' ' 70' ' ' MET . 5.3 mm -107.55 143.25 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.525 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -104.65 119.91 40.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.397 . . . . 0.0 111.242 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -112.88 153.79 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.748 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.69 155.86 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.143 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -102.48 109.9 21.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.582 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.15 19.19 6.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.493 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.63 -143.53 12.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.457 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.54 20.73 2.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 159.86 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -55.85 152.36 10.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.728 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.69 116.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.38 115.47 5.11 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.841 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.468 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 67.4 p-90 -118.06 158.86 24.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.122 0.487 . . . . 0.0 111.566 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.6 152.99 31.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.566 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 mm -104.02 154.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.424 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -155.65 132.64 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.678 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.27 160.16 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.161 0.505 . . . . 0.0 111.272 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.13 -55.16 36.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.44 113.16 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.59 22.05 5.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -113.23 -58.57 2.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.915 0.388 . . . . 0.0 110.788 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -33.2 63.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.779 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -98.02 145.88 26.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.689 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.92 147.11 36.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.03 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' CG2' ' N ' ' A' ' 56' ' ' ASP . 2.3 p -139.98 160.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.26 0.552 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.46 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 9.8 t70 -172.92 129.04 0.55 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.06 146.71 86.74 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.217 -0.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.95 -0.42 10.65 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.66 2.24 . . . . 0.0 113.151 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.55 177.1 0.36 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.822 0.344 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 154.71 167.37 16.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.64 128.93 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 111.115 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.86 123.06 46.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -79.72 171.54 12.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 114.54 2.31 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.618 2.212 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.49 28.49 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.293 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.4 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -96.75 148.27 23.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.768 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 128.38 52.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.117 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.38 138.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.033 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.58 123.54 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.433 ' CG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.24 163.06 17.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 154.58 51.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -134.37 89.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.702 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 p -74.0 139.44 44.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m -131.05 149.38 52.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.659 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.76 148.73 24.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 111.196 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -71.49 127.65 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.756 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.69 -173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.006 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -129.59 121.46 27.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.99 -21.01 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.39 65.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.38 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.9 p -141.15 67.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.304 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -150.19 171.92 16.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.65 136.53 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.0 mt -152.78 86.51 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.46 22.43 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.265 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER 73.83 93.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.174 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.1 152.54 43.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.354 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -157.8 131.02 7.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.706 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mm -85.1 163.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.317 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 78.2 m -144.2 118.92 9.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.88 0.371 . . . . 0.0 111.493 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.13 97.16 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.76 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.38 133.95 48.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.101 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -138.66 154.89 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.31 151.41 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -55.71 150.88 11.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.43 HG23 ' CZ2' ' A' ' 108' ' ' TRP . 0.6 OUTLIER -96.07 142.17 24.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.0 156.59 61.73 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.609 2.206 . . . . 0.0 112.279 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -50.16 128.24 18.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.993 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.83 34.46 87.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.39 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.35 127.04 29.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.153 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.88 166.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.249 0.547 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -85.89 70.85 10.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.0 128.77 0.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -52.11 151.31 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.22 155.77 49.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.039 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.46 -34.44 16.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.99 -24.98 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.43 ' CZ2' HG23 ' A' ' 96' ' ' THR . 21.9 m0 -50.05 -34.7 22.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.985 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -94.12 -32.93 13.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.999 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.5 49.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.93 -132.65 2.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.503 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.25 151.32 22.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.91 0.386 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.37 138.37 9.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.508 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt -72.29 130.38 40.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 t -109.06 125.23 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.234 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.1 142.45 27.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.93 97.77 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.04 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -87.27 159.34 18.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.76 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.6 120.25 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.885 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.7 mt -94.73 135.18 24.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.76 130.42 5.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.664 2.243 . . . . 0.0 112.627 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 3.4 mm -114.04 119.54 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.419 ' CB ' HG22 ' A' ' 18' ' ' VAL . 45.7 mt-10 -117.82 157.53 26.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.533 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.37 109.06 18.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.959 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -83.13 81.56 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.5 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.869 -179.907 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.852 0.358 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -137.03 133.73 35.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.14 85.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.048 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.439 ' CG2' ' HD2' ' B' ' 5' ' ' PRO . 6.6 p -142.17 140.69 19.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' PRO . . . . . 0.439 ' HD2' ' CG2' ' B' ' 4' ' ' VAL . 73.4 Cg_exo -49.47 142.06 24.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.537 2.158 . . . . 0.0 112.257 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.83 156.51 9.19 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.532 2.155 . . . . 0.0 112.281 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.63 122.88 23.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.536 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -52.44 115.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.84 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.32 137.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.78 146.47 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 149.55 49.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -135.4 116.45 11.99 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 163.65 63.67 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.533 0.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.5 t -44.48 -62.42 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.462 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -173.26 48.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.996 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.05 104.82 2.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.479 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 8.3 tt -131.96 145.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.478 ' CG1' ' CG1' ' A' ' 18' ' ' VAL . 6.8 p -150.88 121.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -72.49 113.62 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.704 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -81.58 134.41 35.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' B' ' 22' ' ' PRO . . . -65.59 170.85 4.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' B' ' 21' ' ' ALA . 64.8 Cg_endo -73.12 164.92 85.66 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.866 -1.306 . . . . 0.0 112.723 0.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -107.24 46.67 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -115.15 -4.6 12.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.395 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.27 144.44 49.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.913 0.387 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.9 126.68 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.992 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.84 155.37 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.44 115.96 16.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -102.36 116.23 32.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.659 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -92.74 131.5 37.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.254 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.435 ' HB ' ' CG ' ' B' ' 70' ' ' MET . 5.2 mm -107.31 143.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.616 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -104.59 120.09 40.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.267 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 mt -113.09 153.73 14.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.78 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.72 155.98 34.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 111.17 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -102.64 109.89 21.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.24 19.37 5.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.48 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.74 -143.64 12.84 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.432 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.44 20.81 2.23 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.52 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.74 160.08 37.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.855 0.359 . . . . 0.0 110.808 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -56.04 152.65 10.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.61 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.93 116.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.445 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.67 115.5 5.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.878 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 67.5 p-90 -118.18 158.75 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.101 0.477 . . . . 0.0 111.495 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.43 153.2 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.527 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 mm -104.2 154.26 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.431 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -155.61 132.73 10.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.677 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.3 160.35 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.0 111.251 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.39 -54.88 40.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.7 113.23 26.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.771 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.56 21.97 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -113.2 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -33.16 63.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.16 145.74 26.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.77 146.96 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' B' ' 56' ' ' ASP . 2.3 p -139.74 160.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.295 0.569 . . . . 0.0 110.922 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . 0.457 ' N ' ' CG2' ' B' ' 55' ' ' VAL . 9.8 t70 -172.69 128.98 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.793 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.07 146.72 86.8 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.293 -0.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.03 -0.46 10.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.678 2.252 . . . . 0.0 113.084 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.64 177.07 0.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 154.8 167.21 16.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.65 129.02 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.99 123.19 46.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.951 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.404 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.2 OUTLIER -79.74 171.47 12.34 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.81 114.45 2.29 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.591 2.194 . . . . 0.0 112.346 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.61 28.31 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.228 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.404 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.2 OUTLIER -96.54 148.37 22.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.766 179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 128.45 52.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.08 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.48 138.49 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.51 123.51 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.01 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' MET . . . . . 0.435 ' CG ' ' HB ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -119.22 163.08 17.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.962 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.72 51.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.435 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -134.58 89.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.589 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 20.5 p -74.06 139.38 44.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.99 149.35 52.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.588 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.59 148.86 24.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.252 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -71.52 127.72 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.78 -173.85 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.957 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.52 121.54 27.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.21 -20.8 66.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.306 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.9 -43.45 66.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -140.97 67.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.274 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -150.28 171.82 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.059 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.56 136.35 45.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 55.7 mt -152.59 86.48 1.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.5 22.43 12.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.238 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' B' ' 86' ' ' ASN . 0.3 OUTLIER 73.74 93.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.16 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.37 152.27 43.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.349 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -157.44 131.01 7.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 7.1 mm -85.1 163.36 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 81.9 m -144.08 118.88 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.389 . . . . 0.0 111.492 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.06 97.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.718 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -104.5 133.91 48.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.02 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -138.68 154.91 48.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.12 151.32 36.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -55.63 150.85 11.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.009 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' THR . . . . . 0.424 HG23 ' CZ2' ' B' ' 108' ' ' TRP . 0.6 OUTLIER -96.04 142.19 24.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 156.48 62.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.206 . . . . 0.0 112.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -50.09 128.25 18.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.74 34.54 87.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.371 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.42 126.99 29.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.66 166.72 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.381 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -86.0 70.88 10.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.02 128.81 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -52.11 151.25 3.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.15 155.7 49.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.39 -34.35 16.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.02 -25.04 68.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' TRP . . . . . 0.424 ' CZ2' HG23 ' B' ' 96' ' ' THR . 22.3 m0 -49.93 -34.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.043 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.11 -33.09 13.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.985 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.41 49.25 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.88 -132.76 2.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.41 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -100.97 151.64 21.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.93 138.45 9.49 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.569 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt -72.49 130.3 40.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 12.4 t -108.78 125.32 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.254 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.24 142.51 27.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.99 97.61 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.074 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -87.08 159.26 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.48 120.29 11.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.6 mt -94.77 135.21 23.99 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.772 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.81 130.45 5.04 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.665 2.243 . . . . 0.0 112.814 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 3.4 mm -114.08 119.39 61.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.623 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.422 ' CB ' HG22 ' B' ' 18' ' ' VAL . 45.1 mt-10 -117.72 157.49 26.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 111.48 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.36 109.13 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -83.28 81.62 8.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.847 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.527 0.167 0 CA-C-O 120.683 0.201 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.13 97.02 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.621 2.214 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.56 131.46 26.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 9.0 m-20 -57.74 109.03 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.1 pt -68.72 123.37 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.74 145.37 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.51 136.24 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.241 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' B' ' 22' ' ' PRO . 14.7 mt-30 -140.85 105.57 6.28 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.66 161.48 40.68 Favored 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.506 0.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.3 t -92.36 -26.07 18.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.71 49.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.53 107.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 17' ' ' ILE . 12.9 tt -129.7 120.1 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 125' ' ' ASN . 46.0 t -109.27 92.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.564 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 20.9 m-85 -52.74 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -67.18 141.41 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.431 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.13 169.42 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.821 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.774 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 66.3 Cg_endo -91.1 166.97 28.8 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.371 -1.096 . . . . 0.0 112.974 0.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.431 ' O ' ' HB ' ' A' ' 76' ' ' THR . 22.3 m-85 -108.87 31.1 5.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.755 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.37 3.61 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.399 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.601 ' N ' HG22 ' A' ' 76' ' ' THR . 3.3 t70 -164.31 151.49 11.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.821 0.343 . . . . 0.0 110.78 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.65 109.11 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.49 110.46 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.669 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 83.0 m -93.43 110.85 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 19' ' ' PHE . 79.6 m-85 -89.02 121.8 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -77.9 131.43 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.435 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.675 HD12 ' HE3' ' A' ' 70' ' ' MET . 16.0 mt -113.89 151.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -112.93 121.76 45.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 111.482 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.602 HD11 ' CE ' ' A' ' 70' ' ' MET . 39.3 mt -125.45 150.19 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.505 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.81 145.37 27.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.42 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.13 106.69 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.279 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.51 20.68 5.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.422 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.12 -170.8 24.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.18 -28.72 8.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.74 178.3 5.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.446 ' HB2' HG12 ' A' ' 61' ' ' VAL . 4.0 ptp180 -64.81 170.64 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 12.2 pt -152.98 136.18 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.655 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.84 112.2 4.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.511 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.472 ' HE1' HD13 ' A' ' 62' ' ' LEU . 37.6 p-90 -117.17 156.98 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.221 0.534 . . . . 0.0 111.811 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.99 153.35 40.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.286 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 mm -115.46 151.27 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.578 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -147.5 130.51 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.531 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.527 HG22 HG23 ' A' ' 89' ' ' ILE . 36.3 p -120.41 154.7 34.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 p -52.0 -30.27 24.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -139.07 117.8 12.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.69 17.11 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -108.74 -49.58 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -76.3 -50.51 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.52 148.41 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -136.53 107.35 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.89 118.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -142.17 136.46 14.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.93 132.77 28.11 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.575 -1.427 . . . . 0.0 112.05 -0.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.4 -45.57 9.13 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.404 2.069 . . . . 0.0 112.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 p -133.36 148.75 51.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.82 175.29 46.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 40' ' ' ARG . 4.9 t -116.21 108.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.597 HD11 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -80.29 158.83 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.31 170.13 5.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.62 110.57 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.647 2.231 . . . . 0.0 112.259 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.66 37.0 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.29 142.28 31.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.219 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -102.57 143.16 32.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.597 HG11 HD11 ' A' ' 62' ' ' LEU . 8.9 p -141.78 148.5 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 31' ' ' ILE . 1.4 mm? -104.49 143.82 32.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.675 ' HE3' HD12 ' A' ' 31' ' ' ILE . 3.1 ttp -120.31 156.34 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.649 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.669 ' HB1' ' CG2' ' A' ' 28' ' ' THR . . . -130.79 113.95 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.294 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 72' ' ' VAL . 7.3 p -114.16 88.14 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.94 146.48 33.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.6 107.5 9.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.74 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 146.17 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.037 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 25' ' ' ASP . 5.3 p -56.75 164.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -178.65 -173.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -116.15 109.52 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.97 16.94 13.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.457 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.47 -24.94 29.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.9 p -147.01 44.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.35 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.73 134.71 55.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.626 HD13 ' HB2' ' A' ' 124' ' ' TYR . 91.4 mt -127.71 69.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -155.68 28.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -130.35 6.45 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.617 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.87 119.3 34.12 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.45 136.0 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.056 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.872 HG13 HD11 ' A' ' 122' ' ' ILE . 7.8 mt -98.69 165.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 89' ' ' ILE . 58.2 m -137.75 123.07 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.871 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 91' ' ' ILE . 3.3 mp -121.79 112.2 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.54 155.01 35.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.461 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 11.4 p90 -157.59 147.28 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.469 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -141.25 134.12 28.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -52.52 125.2 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.404 ' OG1' ' HG3' ' A' ' 40' ' ' ARG . 43.7 p -66.6 151.63 96.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.7 165.05 28.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.536 2.158 . . . . 0.0 112.148 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.93 117.44 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.43 51.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.234 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.43 166.08 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 0.0 111.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.09 164.31 25.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.314 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.94 69.42 9.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.63 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.08 122.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.88 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.2 122.28 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -117.23 150.52 38.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.91 -19.02 45.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.41 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.83 -23.66 66.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 0.0 111.234 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.16 -13.95 43.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 C--N 1.333 -0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 111.191 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.823 0.344 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' A' ' 94' ' ' THR . 12.6 t -115.24 136.15 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.461 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 12.4 tpt180 -99.4 152.86 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.92 137.71 9.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.07 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -145.21 132.23 20.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -91.56 133.86 35.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.82 117.8 61.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.668 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.37 128.7 19.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.354 2.036 . . . . 0.0 112.359 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.872 HD11 HG13 ' A' ' 89' ' ' ILE . 32.5 mm -92.54 148.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.225 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.54 ' HB3' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.21 160.2 40.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.657 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.626 ' HB2' HD13 ' A' ' 84' ' ' LEU . 81.3 m-85 -132.15 110.74 10.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.207 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.671 ' HB2' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -99.29 132.24 44.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.633 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.941 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.718 0.216 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.13 97.18 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.54 2.16 . . . . 0.0 112.308 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 131.72 27.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 9.1 m-20 -57.91 108.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.889 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.1 pt -68.7 123.46 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 145.19 55.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.657 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.34 136.07 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.234 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -140.66 105.64 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.78 161.57 41.2 Favored 'Cis proline' 0 C--N 1.35 0.658 0 C-N-CA 123.854 -1.311 . . . . 0.0 112.461 0.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.8 t -92.37 -26.06 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.112 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.67 49.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.68 106.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 17' ' ' ILE . 13.0 tt -129.58 120.12 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' B' ' 125' ' ' ASN . 45.9 t -109.27 92.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.573 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.484 ' HA ' ' CE2' ' B' ' 29' ' ' TYR . 21.0 m-85 -52.91 96.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.495 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -67.17 141.35 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.441 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.14 169.47 0.16 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.805 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.782 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 64.6 Cg_endo -91.13 166.82 28.77 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.948 0.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.434 ' O ' ' HB ' ' B' ' 76' ' ' THR . 22.3 m-85 -108.83 31.23 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.719 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.55 3.71 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.429 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ASP . . . . . 0.6 ' N ' HG22 ' B' ' 76' ' ' THR . 3.3 t70 -164.38 151.27 11.37 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.5 109.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.4 110.49 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.674 ' CG2' ' HB1' ' B' ' 71' ' ' ALA . 88.9 m -93.45 110.72 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.047 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.507 ' O ' HG12 ' B' ' 72' ' ' VAL . 79.6 m-85 -88.93 121.82 31.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' B' ' 70' ' ' MET . 37.9 m80 -77.87 131.36 37.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.659 HD12 ' HE3' ' B' ' 70' ' ' MET . 16.2 mt -113.77 152.03 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.486 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -113.08 121.53 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.524 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.601 HD11 ' CE ' ' B' ' 70' ' ' MET . 39.2 mt -125.3 150.24 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.567 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 53.6 m -148.9 145.11 27.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.423 . . . . 0.0 111.437 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -88.89 106.66 18.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.265 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.43 20.34 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.4 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.93 -170.87 24.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.554 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.12 -28.54 9.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.93 178.21 5.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.461 ' HB2' HG12 ' B' ' 61' ' ' VAL . 3.9 ptp180 -64.72 170.7 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.851 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.438 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 12.1 pt -152.95 136.09 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.623 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.66 112.17 4.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.471 ' HE1' HD13 ' B' ' 62' ' ' LEU . 38.1 p-90 -117.21 157.03 26.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.209 0.528 . . . . 0.0 111.861 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.05 153.48 40.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.257 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 mm -115.49 151.51 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -147.76 130.46 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.516 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.522 HG22 HG23 ' B' ' 89' ' ' ILE . 35.4 p -120.42 154.7 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.923 0.392 . . . . 0.0 111.12 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -52.07 -30.11 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -139.18 117.65 12.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.54 17.26 7.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.26 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -108.84 -49.63 3.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -76.25 -50.5 14.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.62 148.32 24.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.999 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -136.49 107.11 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.62 118.66 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.2 136.32 14.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.05 132.75 28.1 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.603 -1.416 . . . . 0.0 112.079 -0.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.54 -45.31 9.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.449 2.1 . . . . 0.0 112.191 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -133.48 148.56 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.766 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.64 175.23 46.33 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.526 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' B' ' 40' ' ' ARG . 5.0 t -116.17 108.35 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.597 HD11 HG11 ' B' ' 68' ' ' VAL . 1.1 mp -80.13 158.81 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.21 170.11 6.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.7 110.33 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.637 2.225 . . . . 0.0 112.3 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.89 36.97 9.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.402 ' HG2' ' HG ' ' B' ' 62' ' ' LEU . 0.4 OUTLIER -100.18 142.31 31.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.272 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -102.74 143.03 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.597 HG11 HD11 ' B' ' 62' ' ' LEU . 9.0 p -141.71 148.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.065 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.513 HD13 ' O ' ' B' ' 31' ' ' ILE . 1.4 mm? -104.32 143.9 32.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.659 ' HE3' HD12 ' B' ' 31' ' ' ILE . 3.1 ttp -120.29 156.41 31.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.701 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.674 ' HB1' ' CG2' ' B' ' 28' ' ' THR . . . -130.87 113.88 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.237 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.649 ' O ' HG13 ' B' ' 72' ' ' VAL . 7.2 p -114.1 87.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.968 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 28' ' ' THR . 0.2 OUTLIER -78.78 146.57 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.69 107.62 9.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.708 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.78 146.2 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.6 HG22 ' N ' ' B' ' 25' ' ' ASP . 5.4 p -56.75 164.32 1.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -178.61 -173.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -116.3 109.31 17.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.93 17.16 12.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.492 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.68 -24.92 28.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.056 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 59.7 p -146.94 44.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.58 22.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.841 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -64.12 134.7 55.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' B' ' 124' ' ' TYR . 90.9 mt -127.64 69.74 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -155.64 29.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -130.41 6.34 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.629 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.75 119.24 33.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.826 0.346 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.39 136.09 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.871 HG13 HD11 ' B' ' 122' ' ' ILE . 7.9 mt -98.82 165.53 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.47 ' H ' HG22 ' B' ' 89' ' ' ILE . 58.7 m -137.81 122.84 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.47 HD12 ' N ' ' B' ' 91' ' ' ILE . 3.3 mp -121.51 112.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.52 154.81 36.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.833 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.469 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 11.4 p90 -157.42 147.14 20.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.464 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -141.06 134.11 29.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.407 ' HA ' HG22 ' B' ' 41' ' ' ILE . 0.4 OUTLIER -52.44 125.37 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.405 ' OG1' ' HG3' ' B' ' 40' ' ' ARG . 43.8 p -66.86 151.6 96.69 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.63 165.01 28.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.586 2.19 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.91 117.39 1.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.38 47.63 50.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.218 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.52 166.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 111.324 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.21 164.22 25.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.88 69.51 9.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.585 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.99 122.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.12 122.17 6.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -116.98 150.56 38.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -19.01 44.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.332 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.76 -23.73 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.773 0.321 . . . . 0.0 111.242 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.19 -13.85 42.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.772 0.32 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.464 HG13 ' HB ' ' B' ' 94' ' ' THR . 12.7 t -115.16 136.12 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.469 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 12.4 tpt180 -99.38 152.79 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.78 137.8 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.796 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -91.44 133.78 35.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.71 117.72 62.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.656 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.37 128.76 19.94 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.389 2.06 . . . . 0.0 112.294 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.871 HD11 HG13 ' B' ' 89' ' ' ILE . 31.9 mm -92.63 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.537 ' HB3' HG13 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -140.17 160.2 40.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.726 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.612 ' CB ' HD13 ' B' ' 84' ' ' LEU . 80.9 m-85 -132.1 110.78 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.231 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.671 ' HB2' HG12 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -99.46 132.19 44.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.623 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.955 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.659 0.191 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.07 124.0 10.91 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.481 2.121 . . . . 0.0 112.266 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 111.09 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -54.07 120.23 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.65 130.67 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.46 151.18 27.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.587 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.09 149.59 46.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 111.303 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 31' ' ' ILE . 5.4 mt-30 -141.28 108.89 6.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.454 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.6 159.72 51.33 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 124.038 -1.234 . . . . 0.0 112.501 0.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.15 -3.57 12.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -120.43 -48.48 2.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -170.38 141.24 1.96 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 tt -109.07 144.83 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.605 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.893 HG11 HG11 ' B' ' 18' ' ' VAL . 10.2 p -125.11 101.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.774 0.321 . . . . 0.0 111.653 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' CD1' ' A' ' 29' ' ' TYR . 30.8 m-85 -58.11 111.15 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.463 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -72.22 139.77 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.736 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -57.55 167.42 1.34 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.844 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.736 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -89.99 163.12 34.9 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.734 0.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -101.31 28.83 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.13 5.81 46.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.06 156.12 41.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.778 0.323 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -76.35 108.1 9.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.89 136.34 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.79 106.94 17.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 39.5 m-85 -91.94 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -79.96 154.05 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 12' ' ' GLN . 26.0 mt -130.32 147.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.793 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -100.98 126.98 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.185 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.7 HD11 ' CE ' ' A' ' 70' ' ' MET . 13.6 mt -124.16 159.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 33' ' ' ILE . 98.5 m -156.28 153.7 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' OD1' HD13 ' A' ' 41' ' ' ILE . 13.3 t30 -112.61 76.01 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.752 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.62 -30.98 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.954 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.07 174.43 3.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.354 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.01 35.14 4.84 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.553 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.22 171.54 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -74.61 152.35 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.449 HD13 ' OD1' ' A' ' 35' ' ' ASN . 8.7 pt -149.82 142.53 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 111.554 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -98.94 107.97 3.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.455 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CD1' HD12 ' A' ' 62' ' ' LEU . 37.5 p-90 -109.48 157.56 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.171 0.51 . . . . 0.0 111.756 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.592 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -148.13 155.56 41.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.485 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.671 HD12 HG13 ' A' ' 91' ' ' ILE . 6.2 mm -121.64 144.93 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.8 135.86 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.917 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.415 HG22 HG23 ' A' ' 89' ' ' ILE . 2.6 p -118.69 156.73 28.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.006 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.8 p -49.87 -64.27 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 114.17 25.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.99 22.5 5.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -42.89 5.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -95.14 -51.34 4.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.8 mt -76.13 140.18 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.9 125.02 28.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.38 140.72 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -168.02 127.06 1.01 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 11.9 Cg_exo -70.71 132.6 24.12 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 123.937 -1.276 . . . . 0.0 111.977 -0.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 52.3 Cg_exo -54.96 -44.15 52.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.46 2.106 . . . . 0.0 112.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 104' ' ' PHE . 3.5 m -139.38 141.4 37.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.711 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.38 155.84 26.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.548 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.78 115.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 0.0 111.019 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -87.42 156.41 19.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -110.97 178.53 0.97 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.805 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.1 Cg_exo -58.21 110.24 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.533 2.155 . . . . 0.0 112.282 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.68 40.65 29.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.67 155.64 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -114.23 143.98 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.874 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.456 HG23 ' HB ' ' A' ' 33' ' ' ILE . 8.1 m -133.61 151.55 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.73 141.47 30.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.092 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.7 ' CE ' HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -125.52 161.27 27.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.565 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.73 132.19 23.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.304 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.11 90.37 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.046 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 148.4 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.98 152.58 42.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -105.84 137.24 44.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.019 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 76' ' ' THR . 3.8 p -59.97 145.86 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -165.56 -166.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -114.6 118.52 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.46 19.22 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.07 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -142.66 46.5 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.008 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -143.03 147.74 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.57 150.81 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' A' ' 124' ' ' TYR . 49.6 mt -128.29 29.08 5.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.16 32.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -111.03 -19.09 12.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.389 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.57 117.79 23.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.2 137.77 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 90' ' ' THR . 6.3 mt -108.13 166.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.488 ' H ' HG22 ' A' ' 89' ' ' ILE . 8.4 m -153.1 123.6 7.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.809 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.671 HG13 HD12 ' A' ' 45' ' ' ILE . 3.6 mp -112.69 122.5 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 135.78 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.747 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 10.9 p90 -141.1 145.1 35.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 111.026 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.428 HG21 ' HA ' ' A' ' 109' ' ' PHE . 5.0 t -131.27 149.67 52.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -51.52 135.91 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.81 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 129.77 65.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.472 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 53.0 Cg_exo -55.03 159.9 8.88 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.411 2.074 . . . . 0.0 112.245 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -51.68 124.95 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.998 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.78 42.52 78.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HB1' ' CZ2' ' A' ' 108' ' ' TRP . . . -59.53 143.31 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.073 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.33 164.36 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 69.51 9.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.599 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.95 129.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.738 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE2' ' SG ' ' A' ' 59' ' ' CYS . 34.8 t80 -49.04 128.14 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -120.01 150.66 40.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -86.07 -36.6 19.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.74 -19.66 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.283 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.484 ' CZ2' ' HB1' ' A' ' 100' ' ' ALA . 18.2 m0 -53.58 -22.28 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.428 ' HA ' HG21 ' A' ' 94' ' ' THR . 57.1 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.983 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.855 0.359 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.65 150.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.53 139.89 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -128.44 146.53 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.46 159.61 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.734 ' O ' HD22 ' A' ' 120' ' ' LEU . 87.3 m-20 -129.06 147.81 50.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.477 . . . . 0.0 111.369 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 119' ' ' ASN . 1.9 mm? -138.34 86.73 16.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 147.64 92.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.654 2.236 . . . . 0.0 112.613 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.2 mm -100.67 152.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HB3' ' CB ' ' A' ' 18' ' ' VAL . 6.9 tp10 -141.45 154.54 45.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.979 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' A' ' 84' ' ' LEU . 2.3 m-85 -113.51 126.86 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.168 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HB2' HG22 ' A' ' 18' ' ' VAL . 10.0 t30 -109.55 82.05 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.772 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.981 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.707 0.211 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.09 123.85 10.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.514 2.143 . . . . 0.0 112.24 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.69 111.16 0.85 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.614 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -54.01 120.13 5.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.849 0.356 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.53 130.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.49 151.35 27.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.552 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.33 149.48 45.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 111.255 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.451 ' O ' HG23 ' B' ' 31' ' ' ILE . 5.4 mt-30 -141.05 108.94 6.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.576 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.59 159.83 50.96 Favored 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.902 -1.291 . . . . 0.0 112.504 0.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.18 -3.36 12.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.721 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -120.49 -48.66 2.28 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.823 0.345 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -170.3 141.46 2.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.355 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -109.43 144.8 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.568 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.893 HG11 HG11 ' A' ' 18' ' ' VAL . 10.4 p -125.09 101.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.857 0.361 . . . . 0.0 111.693 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.474 ' CD2' ' CD1' ' B' ' 29' ' ' TYR . 30.6 m-85 -58.21 111.02 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.405 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -72.08 139.69 48.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.269 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -57.4 167.52 1.25 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.868 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.715 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 69.7 Cg_endo -89.9 163.17 35.29 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.77 0.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -101.42 28.78 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.028 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.18 5.67 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.421 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.88 156.36 42.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.703 0.287 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -76.5 108.16 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.97 136.6 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.95 106.97 17.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.474 ' CD1' ' CD2' ' B' ' 19' ' ' PHE . 39.7 m-85 -91.97 113.45 25.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.65 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -79.73 154.07 28.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.382 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.451 HG23 ' O ' ' B' ' 12' ' ' GLN . 25.9 mt -130.4 147.03 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.783 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -100.83 126.94 47.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.226 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.712 HD11 ' CE ' ' B' ' 70' ' ' MET . 13.8 mt -124.02 159.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.487 ' N ' HG22 ' B' ' 33' ' ' ILE . 98.1 m -156.45 153.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.071 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.437 ' OD1' HD13 ' B' ' 41' ' ' ILE . 13.4 t30 -112.76 75.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.789 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.59 -30.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.998 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.3 174.61 3.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 35.36 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.33 171.72 18.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -74.77 152.45 39.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.437 HD13 ' OD1' ' B' ' 35' ' ' ASN . 8.5 pt -149.91 142.52 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.39 . . . . 0.0 111.582 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.92 107.96 3.51 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.408 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.464 ' CD1' HD12 ' B' ' 62' ' ' LEU . 37.6 p-90 -109.35 157.51 18.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.204 0.526 . . . . 0.0 111.729 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.58 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -148.1 155.46 41.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.401 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.68 HD12 HG13 ' B' ' 91' ' ' ILE . 6.2 mm -121.65 144.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 111.298 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.74 136.13 20.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.42 HG22 HG23 ' B' ' 89' ' ' ILE . 2.7 p -119.04 156.77 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 4.4 p -49.94 -64.12 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.2 114.19 25.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.94 22.6 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -42.93 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.768 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -95.15 -51.47 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.12 140.17 41.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.82 125.29 29.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.53 140.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.985 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -168.17 126.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.6 132.5 23.64 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.948 -0.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.87 -44.06 53.36 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.39 2.06 . . . . 0.0 112.233 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' B' ' 104' ' ' PHE . 3.5 m -139.59 141.22 37.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.27 155.81 26.37 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.626 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.74 115.53 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 111.088 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.464 HD12 ' CD1' ' B' ' 43' ' ' TRP . 0.4 OUTLIER -87.29 156.75 19.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.455 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.2 OUTLIER -111.29 178.61 0.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 32.2 Cg_exo -58.33 110.21 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 0.0 112.282 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.83 40.72 28.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 155.62 18.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.027 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -114.34 143.77 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' B' ' 33' ' ' ILE . 8.6 m -133.4 151.8 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.02 141.19 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.179 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.712 ' CE ' HD11 ' B' ' 33' ' ' ILE . 0.6 OUTLIER -125.19 161.27 27.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.704 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.77 132.25 23.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.283 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.15 90.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.13 148.44 48.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.94 152.55 42.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.823 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -105.82 137.32 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -60.02 145.97 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -165.68 -166.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -114.38 118.66 34.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.6 19.0 15.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 -28.29 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -142.46 46.37 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -142.77 147.93 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.64 151.04 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.482 HD22 ' CG ' ' B' ' 124' ' ' TYR . 49.0 mt -128.53 29.23 5.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.38 32.91 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -111.01 -18.98 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.66 117.59 23.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.02 137.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.482 HG22 ' H ' ' B' ' 90' ' ' THR . 6.2 mt -107.98 166.55 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.482 ' H ' HG22 ' B' ' 89' ' ' ILE . 8.3 m -153.14 123.45 7.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.68 HG13 HD12 ' B' ' 45' ' ' ILE . 3.6 mp -112.58 122.51 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.254 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.13 135.99 51.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.764 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' B' ' 43' ' ' TRP . 10.9 p90 -141.32 145.12 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.419 HG21 ' HA ' ' B' ' 109' ' ' PHE . 5.0 t -131.22 149.88 52.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -51.59 136.09 27.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.22 129.84 65.13 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' PRO . . . . . 0.47 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 53.0 Cg_exo -55.1 159.93 9.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.444 2.096 . . . . 0.0 112.235 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.84 124.94 13.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.01 42.34 80.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.54 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.48 ' HB1' ' CZ2' ' B' ' 108' ' ' TRP . . . -59.45 143.07 50.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.09 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.22 164.42 7.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.084 0.468 . . . . 0.0 111.266 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.84 69.28 9.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.575 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.7 129.41 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.825 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.428 ' CE2' ' SG ' ' B' ' 59' ' ' CYS . 34.9 t80 -49.02 128.09 15.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.012 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.07 150.52 40.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -85.9 -36.66 19.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.59 -19.68 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.306 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.48 ' CZ2' ' HB1' ' B' ' 100' ' ' ALA . 18.2 m0 -53.62 -22.4 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.104 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.419 ' HA ' HG21 ' B' ' 94' ' ' THR . 57.6 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.76 0.314 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.897 0.38 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 43.6 t -91.68 150.01 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.64 139.72 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.766 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.22 146.54 50.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.41 159.44 43.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.732 ' O ' HD22 ' B' ' 120' ' ' LEU . 87.2 m-20 -128.9 147.83 50.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.381 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.732 HD22 ' O ' ' B' ' 119' ' ' ASN . 1.9 mm? -138.25 86.75 16.67 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.38 147.76 92.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.586 2.191 . . . . 0.0 112.576 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 28.8 mm -100.72 152.2 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.442 ' HB3' ' CB ' ' B' ' 18' ' ' VAL . 7.1 tp10 -141.63 154.52 45.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.896 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.482 ' CG ' HD22 ' B' ' 84' ' ' LEU . 2.4 m-85 -113.56 126.96 55.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.492 ' HB2' HG22 ' B' ' 18' ' ' VAL . 10.0 t30 -109.67 81.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.913 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo . . . . . 0 N--CA 1.465 -0.193 0 CA-C-O 120.722 0.218 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' CG ' ' HG3' ' A' ' 116' ' ' ARG . 65.4 Cg_endo -73.95 110.39 3.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.526 2.151 . . . . 0.0 112.261 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.94 132.81 28.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.957 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.2 m-20 -55.78 140.41 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.632 HG23 ' NE1' ' A' ' 93' ' ' TRP . 9.2 pt -102.78 146.34 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.2 142.85 27.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.91 151.54 51.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.024 0.44 . . . . 0.0 111.16 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -135.67 111.5 10.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.528 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.97 165.09 43.11 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.958 -1.268 . . . . 0.0 112.609 0.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.9 t -45.57 -70.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.431 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.797 ' HA ' HD22 ' A' ' 120' ' ' LEU . 4.4 mt-30 -154.76 39.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.007 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 137.9 4.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.242 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 12.3 tt -148.2 138.34 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.795 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 123' ' ' GLU . 48.2 t -119.11 116.23 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 111.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.38 95.9 2.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.349 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -70.55 135.8 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.594 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.867 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -74.8 172.6 8.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.381 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.867 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 92.3 Cg_endo -82.12 163.87 75.32 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 124.275 -1.135 . . . . 0.0 113.065 0.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.06 45.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 76' ' ' THR . 70.8 m-20 -124.97 8.11 8.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.64 8.38 3.07 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.454 ' HG3' ' CG2' ' A' ' 76' ' ' THR . 15.0 mttt 62.5 137.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -140.17 95.81 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.945 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -76.16 118.21 18.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.748 ' O ' HG12 ' A' ' 72' ' ' VAL . 95.7 m-85 -101.79 111.71 24.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -84.2 135.38 34.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.3 mt -112.92 138.0 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.686 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 125.66 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.655 HD11 ' CE ' ' A' ' 70' ' ' MET . 14.3 mt -120.63 155.0 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.426 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.2 m -150.64 158.32 44.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 111.221 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -96.29 108.95 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.738 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.957 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -95.37 22.42 6.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.094 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.57 -152.07 10.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.613 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.9 -19.43 4.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.696 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.04 152.73 39.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.318 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 168.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.752 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.744 HD12 ' CD1' ' A' ' 93' ' ' TRP . 25.1 pt -155.34 149.05 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.642 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.49 112.62 3.88 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.13 161.52 13.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 0.0 111.85 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 151.28 37.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.115 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.1 144.18 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 111.891 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.07 143.98 46.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 89' ' ' ILE . 76.9 p -138.68 150.63 46.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.069 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.0 78.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -137.51 114.49 10.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.7 mtp -90.46 10.57 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.567 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.12 -35.48 10.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.927 0.394 . . . . 0.0 110.626 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HD3' ' CG ' ' A' ' 77' ' ' PHE . 2.5 ttm180 -94.55 -25.5 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.779 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.17 141.1 50.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.8 p -133.8 110.98 10.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.42 121.79 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.027 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -142.2 131.02 11.97 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.948 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.8 140.81 67.66 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.658 -1.392 . . . . 0.0 112.154 -0.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.25 -39.65 12.7 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 21.9 m -138.19 167.12 22.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.26 -168.73 41.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.731 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 41' ' ' ILE . 11.7 p -150.6 138.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.64 0.257 . . . . 0.0 110.832 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 66' ' ' GLU . 1.1 pt? -134.19 151.35 51.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.403 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 1.1 m-20 -84.11 178.01 2.65 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 27.7 Cg_exo -62.45 127.48 21.0 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.736 2.291 . . . . 0.0 112.422 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER 81.61 -7.98 1.39 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.035 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.519 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -81.34 156.74 25.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.6 149.74 51.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.976 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.62 152.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 mt -104.85 138.49 41.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 33' ' ' ILE . 43.1 mtm -129.21 154.12 47.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.77 117.61 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.312 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 29' ' ' TYR . 7.5 p -106.31 86.84 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.9 131.29 42.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.63 97.55 5.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.732 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -51.94 148.92 5.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.17 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' A' ' 26' ' ' LYS . 3.2 p -64.23 138.37 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 21.7 p90 -154.21 -173.69 4.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -105.68 109.47 21.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.02 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -95.43 18.89 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.81 -24.15 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -139.17 52.13 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -141.6 176.16 9.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.63 112.24 25.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.538 HD13 ' CD2' ' A' ' 124' ' ' TYR . 22.9 mt -134.25 60.38 1.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -141.98 17.31 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.352 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.08 10.02 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.77 137.25 39.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HA ' HG12 ' A' ' 122' ' ' ILE . 13.6 ptt180 -163.4 133.86 4.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 47' ' ' THR . 56.7 mt -96.74 112.09 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 118' ' ' LYS . 87.6 m -93.98 122.49 36.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.4 mp -111.49 109.93 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.884 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.04 131.73 55.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.976 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.744 ' CD1' HD12 ' A' ' 41' ' ' ILE . 5.9 p90 -136.5 141.81 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 1.3 t -131.85 144.55 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.76 143.05 26.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 144.13 57.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 43.3 Cg_endo -67.7 159.17 53.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.562 2.175 . . . . 0.0 112.165 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -51.45 124.06 11.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.05 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.38 35.96 91.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.57 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -65.15 135.92 56.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.814 0.34 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.09 164.48 0.63 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.146 0.498 . . . . 0.0 111.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.39 70.2 7.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.567 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.38 139.04 0.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -50.49 139.25 16.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 1.2 mmp_? -129.97 148.57 51.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -32.62 39.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.6 -9.48 58.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.46 ' CG ' ' HB2' ' A' ' 105' ' ' ARG . 17.6 m0 -62.66 -18.49 62.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.57 0.224 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 94' ' ' THR . 10.6 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.745 0.307 . . . . 0.0 110.795 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 94' ' ' THR . 11.0 t -106.43 130.25 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.426 ' HD3' ' CZ2' ' A' ' 93' ' ' TRP . 13.6 mtt-85 -94.31 135.11 36.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -123.55 118.68 27.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -117.93 162.97 17.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.814 ' C ' HD23 ' A' ' 120' ' ' LEU . 3.0 p30 -140.87 143.22 34.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 119' ' ' ASN . 4.6 mt -124.6 104.65 30.8 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.678 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.93 138.7 87.17 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.489 2.126 . . . . 0.0 112.453 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 14.1 mm -113.93 104.91 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.958 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.739 ' O ' HG13 ' A' ' 18' ' ' VAL . 4.2 mt-10 -97.05 117.92 32.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 84' ' ' LEU . 11.6 m-85 -81.8 99.39 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.407 ' HB2' HG12 ' A' ' 18' ' ' VAL . 1.4 m-20 -73.8 83.65 1.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.007 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 79' ' ' ALA . 30.6 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.749 0.229 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.402 ' CG ' ' HG3' ' B' ' 116' ' ' ARG . 66.4 Cg_endo -73.96 110.35 3.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.536 2.157 . . . . 0.0 112.249 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.86 132.86 27.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.958 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 37.2 m-20 -55.77 140.43 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.625 HG23 ' NE1' ' B' ' 93' ' ' TRP . 9.4 pt -102.82 146.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.209 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.26 142.97 26.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.01 151.38 51.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -135.6 111.42 10.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.12 164.96 44.42 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.958 -1.267 . . . . 0.0 112.607 0.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.5 t -45.43 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.476 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.815 ' HA ' HD22 ' B' ' 120' ' ' LEU . 4.4 mt-30 -154.75 39.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.044 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.8 137.86 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.262 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 12.4 tt -148.24 138.25 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.725 HG13 ' O ' ' B' ' 123' ' ' GLU . 48.0 t -118.99 116.29 50.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.526 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.55 95.98 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -70.51 135.85 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.889 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -74.77 172.52 8.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.889 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -82.23 164.13 74.53 Favored 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.257 -1.143 . . . . 0.0 112.975 0.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.31 45.35 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 70.7 m-20 -124.95 7.93 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.36 8.29 3.13 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' B' ' 76' ' ' THR . 15.1 mttt 62.7 138.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.661 0.267 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -140.53 95.76 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -76.05 118.47 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.734 ' O ' HG12 ' B' ' 72' ' ' VAL . 95.9 m-85 -102.04 111.87 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -84.49 135.46 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.225 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 41.8 mt -112.92 138.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.715 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 125.59 54.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.961 0.41 . . . . 0.0 111.186 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.666 HD11 ' CE ' ' B' ' 70' ' ' MET . 14.1 mt -120.6 155.0 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.872 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 33' ' ' ILE . 52.4 m -150.65 158.42 44.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.057 0.456 . . . . 0.0 111.279 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -96.24 109.13 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.705 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.958 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -95.56 22.49 7.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.53 -151.99 9.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.93 -19.52 4.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.61 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.2 152.68 39.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.993 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 168.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.687 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.761 HD12 ' CD1' ' B' ' 93' ' ' TRP . 24.8 pt -155.29 149.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.622 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -106.65 112.86 3.92 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.31 161.52 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.279 0.561 . . . . 0.0 111.935 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.03 151.45 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.146 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.23 144.1 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 111.876 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.04 143.84 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.34 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.475 HG22 HG12 ' B' ' 89' ' ' ILE . 74.7 p -138.58 150.73 46.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.017 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -36.04 78.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.56 114.55 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 42.5 mtp -90.53 10.76 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.46 -35.09 10.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 0.0 110.604 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.411 ' HD3' ' CG ' ' B' ' 77' ' ' PHE . 2.5 ttm180 -94.87 -25.5 16.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.23 141.01 50.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 97.7 p -133.81 110.67 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.2 121.71 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -142.1 131.0 12.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.86 140.94 68.56 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.068 -0.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.46 -39.44 12.5 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.109 . . . . 0.0 112.247 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 22.5 m -138.36 167.11 22.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.28 -168.74 41.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.682 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.648 HG23 ' O ' ' B' ' 41' ' ' ILE . 11.8 p -150.7 138.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.674 0.274 . . . . 0.0 110.769 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.522 HD12 ' O ' ' B' ' 66' ' ' GLU . 1.1 pt? -134.34 151.48 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.211 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.442 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 1.1 m-20 -84.25 177.82 2.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 27.8 Cg_exo -62.26 127.18 20.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.787 2.325 . . . . 0.0 112.435 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER 81.95 -8.26 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.977 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.522 ' O ' HD12 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -81.16 156.84 25.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.55 149.85 51.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.81 152.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 12.6 mt -104.72 138.3 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.666 ' CE ' HD11 ' B' ' 33' ' ' ILE . 43.1 mtm -128.98 154.16 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.87 117.6 13.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.734 HG12 ' O ' ' B' ' 29' ' ' TYR . 7.3 p -106.46 86.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.98 131.2 41.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 p -123.39 97.59 5.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.702 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -52.17 148.92 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.058 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' B' ' 26' ' ' LYS . 3.2 p -64.3 138.31 58.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.411 ' CG ' ' HD3' ' B' ' 52' ' ' ARG . 21.3 p90 -154.12 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' B' ' 82' ' ' GLU . 42.3 m-80 -105.73 109.67 21.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.953 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.76 19.23 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.428 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.35 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.3 p -139.2 52.21 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' B' ' 78' ' ' ASN . 8.6 mm-40 -141.65 175.92 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.51 111.95 24.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' B' ' 124' ' ' TYR . 22.4 mt -134.04 60.54 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -142.03 17.27 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.1 10.09 2.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.89 137.27 39.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -163.45 133.88 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.475 HG12 HG22 ' B' ' 47' ' ' THR . 55.8 mt -96.78 112.03 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 118' ' ' LYS . 88.5 m -93.87 122.53 36.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.333 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.454 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.4 mp -111.62 109.83 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.877 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -111.92 131.8 55.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.761 ' CD1' HD12 ' B' ' 41' ' ' ILE . 5.8 p90 -136.62 141.84 43.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.023 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.549 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 1.3 t -131.86 144.5 50.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.66 142.96 26.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.12 144.34 58.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' PRO . . . . . 0.444 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 41.5 Cg_endo -67.93 159.2 53.98 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.658 2.239 . . . . 0.0 112.215 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -51.46 123.83 10.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.45 35.94 91.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -65.05 136.04 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.754 0.311 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.38 164.24 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.218 0.532 . . . . 0.0 111.277 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 70.27 7.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.653 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.33 138.95 0.09 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.39 138.91 16.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.466 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 1.2 mmp_? -129.69 148.48 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -32.51 40.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.73 -9.22 58.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.649 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.466 ' CG ' ' HB2' ' B' ' 105' ' ' ARG . 17.9 m0 -62.86 -18.63 63.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.658 0.266 . . . . 0.0 111.256 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' B' ' 94' ' ' THR . 10.6 m-85 . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.36 . . . . 0.0 110.891 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' B' ' 94' ' ' THR . 11.1 t -106.41 130.36 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.425 ' HD3' ' CZ2' ' B' ' 93' ' ' TRP . 13.8 mtt-85 -94.46 134.86 36.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.076 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -123.43 118.59 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.548 ' O ' HG23 ' B' ' 90' ' ' THR . 0.0 OUTLIER -117.82 163.06 17.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.754 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.816 ' C ' HD23 ' B' ' 120' ' ' LEU . 3.1 p30 -141.08 143.23 34.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.142 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.816 HD23 ' C ' ' B' ' 119' ' ' ASN . 4.5 mt -124.51 104.49 31.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.82 138.76 86.98 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.503 2.135 . . . . 0.0 112.429 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 13.8 mm -113.95 104.8 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.946 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.725 ' O ' HG13 ' B' ' 18' ' ' VAL . 4.1 mt-10 -96.95 117.77 31.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.981 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.54 ' CD2' HD13 ' B' ' 84' ' ' LEU . 11.1 m-85 -81.76 99.2 8.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.41 ' HB2' HG12 ' B' ' 18' ' ' VAL . 1.4 m-20 -73.68 83.63 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.054 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.9 mt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.908 179.751 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.683 0.201 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.65 106.29 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.621 2.214 . . . . 0.0 112.24 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.65 129.91 49.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.2 m-20 -55.0 128.87 35.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.857 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.2 138.69 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.318 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 149.73 39.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.693 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.29 149.87 35.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.962 0.411 . . . . 0.0 111.094 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.9 mm-40 -144.86 107.17 4.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.662 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.87 154.64 61.49 Favored 'Cis proline' 0 C--N 1.352 0.717 0 C-N-CA 123.748 -1.355 . . . . 0.0 112.457 0.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.2 m -59.45 -53.11 61.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -160.05 39.89 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.47 111.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.085 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -129.9 134.01 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.941 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.721 HG23 ' HB3' ' A' ' 123' ' ' GLU . 6.1 p -130.69 110.63 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -57.34 154.37 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.968 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.14 120.13 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.372 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -50.33 169.01 0.21 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.848 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 61.4 Cg_endo -72.7 163.44 88.73 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.443 0.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 24.4 m-85 -111.63 34.92 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.017 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.76 4.5 25.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.72 131.63 20.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.826 0.346 . . . . 0.0 110.74 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -51.77 122.58 8.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -118.39 150.22 39.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.642 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.72 109.83 14.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.643 ' O ' HG12 ' A' ' 72' ' ' VAL . 14.6 m-85 -98.33 116.59 30.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.406 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -81.4 130.6 35.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.739 HD12 ' HE3' ' A' ' 70' ' ' MET . 12.2 mt -110.77 143.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.527 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 131.6 46.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 111.47 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.441 HD11 ' CE ' ' A' ' 70' ' ' MET . 64.2 mt -125.93 154.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.639 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.2 m -153.21 156.65 38.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 111.328 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -105.66 109.31 21.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -94.61 21.64 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.89 -145.47 13.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.545 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.79 -39.39 0.29 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -103.36 159.34 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -52.04 158.68 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.77 117.18 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 111.545 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.0 116.91 4.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.906 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.896 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 26.2 p-90 -113.78 154.9 26.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.597 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.61 156.33 45.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.896 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 2.3 mp -118.08 147.29 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.434 . . . . 0.0 111.742 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -145.27 131.26 19.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 p -113.19 150.09 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.567 HG23 ' HG3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -51.86 -36.2 47.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.07 115.81 11.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.8 mmm -93.31 21.86 5.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.411 ' HB2' ' NH1' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -104.45 -37.22 7.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.869 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -101.99 -27.94 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.013 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.5 150.16 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.61 109.75 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.76 144.47 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -159.27 136.38 6.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.52 144.54 81.34 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.66 -1.392 . . . . 0.0 112.236 0.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 -4.85 15.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.589 2.192 . . . . 0.0 112.96 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -171.87 161.67 5.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 169.96 157.75 12.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.608 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 t -94.14 134.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 tp -108.89 132.87 53.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.441 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -88.87 168.37 15.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 25.3 Cg_endo -62.12 113.59 1.95 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.538 2.158 . . . . 0.0 112.359 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.7 30.89 2.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.67 148.37 24.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.792 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' CG ' ' OG1' ' A' ' 34' ' ' THR . 42.0 mttt -115.64 121.87 43.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 14.0 p -112.4 146.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.73 147.12 23.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.253 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.739 ' HE3' HD12 ' A' ' 31' ' ' ILE . 13.4 ttp -129.47 156.93 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.494 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.42 122.38 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.591 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 29' ' ' TYR . 12.6 p -111.91 115.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.27 129.26 46.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.6 t -116.18 127.57 54.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.66 147.99 31.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.111 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 76' ' ' THR . 2.7 p -62.65 161.02 12.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -176.68 -175.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 111.02 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.43 108.65 20.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.28 18.7 6.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.453 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.48 -38.4 12.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.3 p -131.31 44.31 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.074 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -138.13 177.25 8.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.833 ' O ' HD23 ' A' ' 84' ' ' LEU . 96.9 m-20 -91.3 149.66 21.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.988 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 83' ' ' ASP . 47.5 mt -139.46 29.37 2.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.54 26.59 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.53 -12.51 9.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.53 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.77 120.33 24.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.567 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.8 OUTLIER -149.94 134.52 17.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.91 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.696 HG13 HD11 ' A' ' 122' ' ' ILE . 5.8 mt -98.12 165.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.575 HG21 ' HD2' ' A' ' 117' ' ' ARG . 92.4 m -136.73 118.77 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.951 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.8 mp -116.59 108.88 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.78 156.71 24.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -155.81 141.11 17.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.587 ' HB ' HG23 ' A' ' 115' ' ' VAL . 13.6 t -138.57 154.65 48.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -68.0 128.81 37.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.45 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 20.9 p -70.38 139.81 87.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.784 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 72.1 Cg_exo -48.25 164.22 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.417 2.078 . . . . 0.0 112.35 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.26 99.73 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.64 45.3 94.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.473 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.17 -85.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.744 0.307 . . . . 0.0 111.102 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.38 1.51 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.126 0.489 . . . . 0.0 111.277 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 70.45 10.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.67 124.26 0.05 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.463 ' HA ' ' CZ3' ' A' ' 108' ' ' TRP . 31.7 t80 -56.46 145.03 28.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -135.31 156.36 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.14 30.32 1.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -116.96 -34.14 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.958 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CD1' ' CD ' ' A' ' 97' ' ' PRO . 24.7 m0 -59.3 -29.71 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 115' ' ' VAL . 4.6 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 109' ' ' PHE . 7.4 p -111.54 130.74 64.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -104.04 154.5 19.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.824 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.575 ' HD2' HG21 ' A' ' 90' ' ' THR . 1.4 ttp85 -132.47 141.93 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -126.74 163.07 24.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.7 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -141.03 124.24 16.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.033 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.37 117.24 57.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.772 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.89 137.38 32.07 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.33 2.02 . . . . 0.0 112.236 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.696 HD11 HG13 ' A' ' 89' ' ' ILE . 8.7 mm -105.68 136.06 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.721 ' HB3' HG23 ' A' ' 18' ' ' VAL . 2.2 mt-10 -124.95 157.94 34.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 88.0 m-85 -120.62 96.68 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.241 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.424 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 2.3 t-20 -79.2 81.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.894 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.898 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.526 0.125 0 CA-C-O 120.748 0.228 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.81 106.4 1.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.541 2.161 . . . . 0.0 112.248 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.82 129.76 48.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.443 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.726 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 8.4 m-20 -54.78 128.63 33.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.84 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.12 138.89 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.88 149.81 39.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.38 149.92 35.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.532 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.8 mm-40 -144.88 107.34 4.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.648 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' LYS . 26.4 Cg_endo -61.72 154.72 60.44 Favored 'Cis proline' 0 C--N 1.351 0.668 0 C-N-CA 123.802 -1.333 . . . . 0.0 112.391 0.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.9 m -59.58 -53.13 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.9 39.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' B' ' 13' ' ' PRO . 0.3 OUTLIER -163.47 111.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.063 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.02 133.99 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.732 HG23 ' HB3' ' B' ' 123' ' ' GLU . 6.1 p -130.67 110.76 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.284 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 21.6 m-85 -57.37 154.39 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.92 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.36 119.95 37.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.827 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -50.13 169.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.928 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.827 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 60.5 Cg_endo -72.55 163.67 87.83 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.598 -1.417 . . . . 0.0 112.385 0.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 24.4 m-85 -111.76 34.7 4.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.6 4.61 26.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.312 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -144.74 131.55 20.16 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.831 0.348 . . . . 0.0 110.85 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -51.64 122.73 8.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.038 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -118.67 150.08 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.552 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.56 109.97 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 111.217 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 72' ' ' VAL . 15.0 m-85 -98.5 116.42 30.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -81.25 130.49 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.484 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.757 HD12 ' HE3' ' B' ' 70' ' ' MET . 12.1 mt -110.81 143.48 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 131.68 46.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 0.0 111.508 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.438 HD11 ' CE ' ' B' ' 70' ' ' MET . 64.4 mt -126.03 154.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.645 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' B' ' 33' ' ' ILE . 53.2 m -153.13 156.66 39.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 111.285 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -105.64 109.45 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.479 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -94.65 21.51 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.231 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.87 -145.5 13.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.67 -39.44 0.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.577 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -103.13 159.36 15.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -52.16 158.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.55 117.19 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.607 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.98 116.89 4.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.876 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.92 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 26.1 p-90 -113.74 154.89 26.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.648 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.58 156.4 45.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.419 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.92 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 2.3 mp -118.06 147.33 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.976 0.417 . . . . 0.0 111.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -145.39 131.14 19.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 68.8 p -113.15 150.14 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.069 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.581 HG23 ' HG3' ' B' ' 88' ' ' ARG . 0.8 OUTLIER -51.94 -36.09 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.809 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.18 115.77 11.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 79.2 mmm -93.33 22.09 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.942 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' B' ' 51' ' ' ARG . 0.1 OUTLIER -104.65 -37.33 7.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 ttp85 -101.9 -27.93 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.42 150.26 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.85 110.02 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.04 144.61 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.37 136.35 6.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.85 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 144.53 81.31 Favored 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.688 -1.38 . . . . 0.0 112.3 -0.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.0 -4.68 15.47 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.947 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -172.01 161.63 5.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 169.91 157.86 12.89 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.656 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.09 134.05 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.794 0.33 . . . . 0.0 110.998 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' B' ' 62' ' ' LEU . 5.6 tp -108.89 132.53 53.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -88.54 168.34 16.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 24.9 Cg_endo -62.05 113.45 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.509 2.139 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.94 30.6 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 148.37 24.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.416 ' CG ' ' OG1' ' B' ' 34' ' ' THR . 42.1 mttt -115.73 121.83 43.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 13.8 p -112.41 146.15 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.85 147.27 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.194 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.757 ' HE3' HD12 ' B' ' 31' ' ' ILE . 13.4 ttp -129.58 156.92 43.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.471 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.32 122.71 16.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.578 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 29' ' ' TYR . 12.6 p -112.3 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.658 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.62 129.1 46.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 111.297 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.01 127.7 55.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.751 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.81 148.05 31.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -62.84 160.97 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.763 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -176.53 -175.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.37 108.66 20.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.39 18.9 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.456 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.56 -38.54 12.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 111.086 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.0 p -131.2 44.31 2.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -138.06 177.32 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.827 ' O ' HD23 ' B' ' 84' ' ' LEU . 97.2 m-20 -91.35 149.62 21.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.827 HD23 ' O ' ' B' ' 83' ' ' ASP . 47.6 mt -139.5 29.41 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.37 26.31 1.98 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.972 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.18 -12.62 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.64 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.61 120.22 24.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.946 0.403 . . . . 0.0 111.104 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.581 ' HG3' HG23 ' B' ' 48' ' ' THR . 0.8 OUTLIER -149.78 134.6 17.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.911 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.706 HG13 HD11 ' B' ' 122' ' ' ILE . 5.8 mt -98.23 165.56 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.983 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.584 HG21 ' HD2' ' B' ' 117' ' ' ARG . 93.8 m -136.64 118.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.447 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.8 mp -116.58 108.9 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -114.78 156.56 24.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -155.62 141.05 17.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.578 ' HB ' HG23 ' B' ' 115' ' ' VAL . 13.7 t -138.55 154.61 48.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -67.97 128.91 38.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.458 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 21.2 p -70.45 139.8 86.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' PRO . . . . . 0.481 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 70.9 Cg_exo -48.2 164.08 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.541 2.161 . . . . 0.0 112.303 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.11 99.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.53 45.47 94.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.22 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 70.32 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.75 124.27 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.817 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.464 ' HA ' ' CZ3' ' B' ' 108' ' ' TRP . 30.5 t80 -56.49 145.07 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -135.43 156.38 49.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.19 30.48 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -116.99 -34.2 4.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CD1' ' CD ' ' B' ' 97' ' ' PRO . 25.0 m0 -59.23 -29.84 67.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.58 ' CD2' HG21 ' B' ' 115' ' ' VAL . 4.6 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.58 HG21 ' CD2' ' B' ' 109' ' ' PHE . 7.4 p -111.65 130.7 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -103.9 154.53 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.584 ' HD2' HG21 ' B' ' 90' ' ' THR . 1.4 ttp85 -132.56 142.05 48.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.91 162.93 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -140.94 124.36 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.36 117.45 57.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.734 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 137.39 31.76 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.365 2.044 . . . . 0.0 112.225 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.706 HD11 HG13 ' B' ' 89' ' ' ILE . 8.8 mm -105.66 136.13 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.732 ' HB3' HG23 ' B' ' 18' ' ' VAL . 2.2 mt-10 -124.96 158.08 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.443 ' HB3' ' CE2' ' B' ' 23' ' ' TYR . 87.8 m-85 -120.73 96.54 5.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.422 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 2.3 t-20 -79.14 81.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 37.1 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.828 -179.919 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo . . . . . 0 N--CA 1.465 -0.148 0 CA-C-O 120.775 0.24 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.15 146.69 82.41 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.527 2.151 . . . . 0.0 112.223 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.28 113.01 3.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.528 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 14.7 m-20 -48.1 121.56 4.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 0.0 111.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.434 HG12 ' CE2' ' A' ' 93' ' ' TRP . 5.0 pt -93.21 147.02 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -92.67 145.34 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.57 154.15 51.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.136 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.629 ' O ' HG23 ' A' ' 31' ' ' ILE . 13.6 mm-40 -139.97 127.93 12.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.389 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.706 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 51.0 Cg_endo -68.78 163.97 77.55 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.697 0.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.4 -53.21 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.725 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HG3' ' HG ' ' A' ' 120' ' ' LEU . 2.2 tt0 -178.3 50.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.165 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -169.92 107.15 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.174 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -120.95 150.22 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 123' ' ' GLU . 42.4 t -132.99 95.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.0 111.641 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -54.8 97.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.265 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -59.09 151.39 22.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -64.2 169.69 4.42 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.656 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.754 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 66.8 Cg_endo -93.11 164.12 23.14 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.502 -1.041 . . . . 0.0 112.789 0.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.01 37.29 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.695 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.64 -5.87 13.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.59 -161.43 1.29 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.838 0.351 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.39 142.39 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -159.56 91.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.466 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.699 HG23 ' C ' ' A' ' 72' ' ' VAL . 31.5 m -83.3 143.83 30.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.511 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -121.48 130.3 53.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.176 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.35 133.89 42.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.04 0.448 . . . . 0.0 111.671 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 12' ' ' GLN . 9.4 mm -99.99 149.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.05 126.38 46.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.277 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 34' ' ' THR . 37.5 mt -125.09 153.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 33' ' ' ILE . 78.5 m -154.49 155.27 34.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.787 ' HB2' HD12 ' A' ' 62' ' ' LEU . 64.8 t30 -102.86 81.74 2.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -54.75 -23.4 17.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.96 -160.26 7.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.625 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.06 0.94 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.7 139.15 12.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.19 138.59 16.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 95' ' ' ASN . 1.2 pt -137.62 174.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -132.94 98.16 0.34 Allowed Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.684 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.982 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 30.1 p-90 -92.43 155.68 17.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.126 0.489 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.3 158.12 43.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.446 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.982 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -125.32 149.68 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.001 0.429 . . . . 0.0 111.723 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -159.66 131.31 6.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.484 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -109.79 158.39 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.307 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -29.89 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.45 117.8 23.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.18 18.19 7.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -109.4 -43.74 4.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.6 -58.97 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mt -83.9 140.79 31.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.09 107.46 5.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.011 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.812 HG11 ' CG2' ' A' ' 45' ' ' ILE . 3.2 m -74.42 152.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -168.52 113.27 0.56 Allowed Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.35 141.11 70.79 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.304 0.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HB3' HG23 ' A' ' 55' ' ' VAL . 73.6 Cg_endo -75.59 -3.87 14.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.544 2.162 . . . . 0.0 112.747 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.2 p -170.42 147.6 3.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.792 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.23 175.32 43.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 41' ' ' ILE . 6.4 t -106.2 122.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -94.16 125.27 38.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 4.7 m-20 -81.74 161.42 61.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.95 100.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.561 2.174 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt 69.47 45.21 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' HD11 ' A' ' 62' ' ' LEU . 3.4 tp10 -107.61 154.13 21.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -110.77 137.14 48.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.988 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.673 ' CG1' HD21 ' A' ' 62' ' ' LEU . 7.7 p -136.42 145.56 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.91 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.1 117.14 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.419 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 1.8 tmm? -101.66 147.93 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.419 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -113.92 140.91 47.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.439 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.699 ' C ' HG23 ' A' ' 28' ' ' THR . 44.0 t -124.95 84.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -57.23 129.42 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.05 122.07 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -92.31 138.76 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.844 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.38 162.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -169.21 -161.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.19 119.89 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.6 19.42 20.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.39 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.35 -31.01 12.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.3 p -136.87 44.77 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.07 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -144.31 139.81 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.509 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.2 m-20 -54.93 146.59 17.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 83' ' ' ASP . 16.2 mt -130.86 32.24 4.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.26 27.89 1.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -127.68 6.19 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.654 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.04 119.99 39.14 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 122' ' ' ILE . 0.8 OUTLIER -150.47 131.23 14.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.291 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.917 HG13 HD11 ' A' ' 122' ' ' ILE . 37.6 mt -84.67 162.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.51 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.525 ' N ' HG22 ' A' ' 89' ' ' ILE . 78.2 m -138.66 137.36 36.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 0.0 111.375 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.6 mt -120.53 146.94 24.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.606 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 4.4 mt-10 -149.28 111.59 4.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.192 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.434 ' CE2' HG12 ' A' ' 9' ' ' ILE . 7.8 p90 -123.79 138.53 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.491 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -139.46 130.39 26.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 41' ' ' ILE . 21.1 p30 -54.03 125.03 17.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -67.05 144.68 98.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 163.05 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.433 2.089 . . . . 0.0 112.204 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.46 118.39 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.983 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.37 46.12 52.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.47 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.83 151.13 46.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.12 164.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.284 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 71.13 5.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 178.6 142.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.763 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.36 134.44 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 155.22 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.986 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -93.4 -6.74 46.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.653 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.81 -17.59 35.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.546 0.213 . . . . 0.0 111.464 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.36 -16.15 32.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.294 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 1.5 m-85 . . . . . 0 C--N 1.332 -0.166 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 t -122.28 117.1 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.34 147.24 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.415 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.457 ' HB3' ' CG ' ' A' ' 92' ' ' GLU . 12.8 ptp180 -143.93 153.84 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.045 0.45 . . . . 0.0 111.507 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -147.73 131.78 17.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.409 ' OD1' HG23 ' A' ' 90' ' ' THR . 2.3 m-20 -104.29 134.13 48.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.132 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HG ' ' HG3' ' A' ' 15' ' ' GLN . 6.1 mp -107.79 137.7 19.83 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.5 138.73 17.66 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.542 2.161 . . . . 0.0 112.597 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.917 HD11 HG13 ' A' ' 89' ' ' ILE . 11.5 mm -101.52 146.56 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.029 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.813 ' HB2' HG22 ' A' ' 18' ' ' VAL . 2.7 mt-10 -132.67 163.72 28.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 71.5 m-85 -126.37 131.5 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.195 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.665 ' HB2' HG12 ' A' ' 18' ' ' VAL . 4.2 t30 -120.18 115.16 23.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 8.1 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo . . . . . 0 CA--C 1.528 0.184 0 CA-C-O 120.744 0.227 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 146.76 82.39 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.554 2.169 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.23 113.21 3.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.451 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.557 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 15.3 m-20 -48.24 121.72 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' B' ' 93' ' ' TRP . 5.1 pt -93.34 146.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -92.83 145.45 24.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.768 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.62 154.24 51.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.098 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.63 ' O ' HG23 ' B' ' 31' ' ' ILE . 13.5 mm-40 -139.95 127.94 12.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 51.1 Cg_endo -68.9 163.77 78.48 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.047 -1.231 . . . . 0.0 112.695 0.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.23 -53.25 4.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.694 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.41 ' HG3' ' HG ' ' B' ' 120' ' ' LEU . 2.2 tt0 -178.32 50.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.141 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -170.04 106.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.7 150.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' B' ' 123' ' ' GLU . 42.2 t -133.07 95.35 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.705 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -54.89 96.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.309 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -59.01 151.21 22.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.761 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.767 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -63.97 169.72 4.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.602 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.767 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 65.5 Cg_endo -93.14 164.07 23.07 Favored 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.476 -1.052 . . . . 0.0 112.834 0.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -102.87 37.23 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.705 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 -5.87 14.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.231 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.58 -161.33 1.27 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.847 0.356 . . . . 0.0 110.957 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.54 142.27 27.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -159.28 91.07 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.42 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.699 HG23 ' C ' ' B' ' 72' ' ' VAL . 31.1 m -83.38 143.88 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.562 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -121.65 130.12 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.159 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.07 133.78 42.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.949 0.404 . . . . 0.0 111.688 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.63 HG23 ' O ' ' B' ' 12' ' ' GLN . 9.6 mm -99.9 149.65 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.89 126.52 46.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 34' ' ' THR . 37.8 mt -125.18 153.83 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.909 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' B' ' 33' ' ' ILE . 82.1 m -154.46 155.23 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.075 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.768 ' HB2' HD12 ' B' ' 62' ' ' LEU . 64.6 t30 -102.9 81.67 2.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -54.73 -23.26 16.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 -160.43 7.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.29 0.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.511 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.83 138.99 12.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.775 0.321 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.18 138.67 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' B' ' 95' ' ' ASN . 1.2 pt -137.76 174.1 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -132.95 98.35 0.34 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.643 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.964 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 29.9 p-90 -92.46 155.82 17.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 111.816 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.47 157.88 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.964 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -125.12 149.46 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.7 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -159.41 131.35 6.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 24.1 p -109.9 158.43 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.93 -29.93 22.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.57 117.91 23.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.27 18.25 7.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -109.3 -43.98 4.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.847 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.35 -59.1 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.68 140.7 31.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.22 107.37 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.821 HG11 ' CG2' ' B' ' 45' ' ' ILE . 3.2 m -74.26 152.16 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.133 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -168.41 113.16 0.57 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.738 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.28 141.09 70.71 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.791 -1.337 . . . . 0.0 112.417 0.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HB3' HG23 ' B' ' 55' ' ' VAL . 73.6 Cg_endo -75.52 -4.11 14.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.529 2.153 . . . . 0.0 112.723 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.3 p -170.25 147.44 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.04 175.38 43.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.479 HG13 ' O ' ' B' ' 41' ' ' ILE . 6.6 t -106.33 122.28 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.143 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.768 HD12 ' HB2' ' B' ' 35' ' ' ASN . 0.2 OUTLIER -93.72 125.34 38.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' B' ' 66' ' ' GLU . 4.7 m-20 -81.85 161.47 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.93 100.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.574 2.183 . . . . 0.0 112.382 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt 69.29 45.44 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.509 ' O ' HD11 ' B' ' 62' ' ' LEU . 3.4 tp10 -107.79 154.23 21.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -110.89 137.14 48.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.668 ' CG1' HD21 ' B' ' 62' ' ' LEU . 7.5 p -136.4 145.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.23 117.19 33.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.421 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 1.8 tmm? -101.68 147.81 26.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.431 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -113.83 140.98 47.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 111.443 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.699 ' C ' HG23 ' B' ' 28' ' ' THR . 43.6 t -124.98 84.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.84 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' SER . . . . . 0.508 ' N ' HG23 ' B' ' 28' ' ' THR . 0.4 OUTLIER -57.15 129.48 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.21 121.86 36.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.01 138.76 31.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.44 162.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -169.18 -161.98 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.08 119.99 37.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.54 19.19 20.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.29 -31.09 12.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 73.6 p -136.8 44.8 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -144.49 139.8 28.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.513 ' O ' HD23 ' B' ' 84' ' ' LEU . 1.1 m-20 -54.86 146.68 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.513 HD23 ' O ' ' B' ' 83' ' ' ASP . 16.1 mt -130.91 32.23 4.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.27 28.27 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -127.95 6.17 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.19 120.36 39.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.748 0.309 . . . . 0.0 110.757 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.424 ' HA ' HG12 ' B' ' 122' ' ' ILE . 0.8 OUTLIER -150.79 131.0 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.255 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.931 HG13 HD11 ' B' ' 122' ' ' ILE . 37.2 mt -84.5 161.88 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.585 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.528 ' N ' HG22 ' B' ' 89' ' ' ILE . 73.6 m -138.49 137.5 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -120.59 146.95 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.684 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 4.3 mt-10 -149.34 111.54 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.868 0.366 . . . . 0.0 111.135 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.429 ' CE2' HG12 ' B' ' 9' ' ' ILE . 7.9 p90 -123.74 138.59 54.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 0.7 OUTLIER -139.6 130.18 25.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.997 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.592 ' HA ' HG22 ' B' ' 41' ' ' ILE . 21.2 p30 -53.78 125.03 16.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.9 p -67.09 144.86 98.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.86 163.03 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.536 2.157 . . . . 0.0 112.162 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.49 118.63 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.031 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.1 46.1 50.98 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.442 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.9 151.26 46.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.17 164.32 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.314 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.54 71.27 5.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 178.35 142.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.09 134.34 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.14 155.36 31.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -93.51 -6.7 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.691 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.87 -17.49 35.44 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.602 0.239 . . . . 0.0 111.518 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.44 -16.07 32.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.323 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 1.5 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 110.972 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 t -122.59 117.13 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.36 147.22 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.511 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.447 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 12.7 ptp180 -143.87 153.86 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 111.469 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -147.72 131.79 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.422 ' OD1' HG23 ' B' ' 90' ' ' THR . 2.3 m-20 -104.25 134.27 47.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.159 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.41 ' HG ' ' HG3' ' B' ' 15' ' ' GLN . 6.0 mp -107.92 137.57 19.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.36 138.42 17.66 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.589 2.193 . . . . 0.0 112.616 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.931 HD11 HG13 ' B' ' 89' ' ' ILE . 11.8 mm -101.19 146.82 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.819 ' HB2' HG22 ' B' ' 18' ' ' VAL . 2.7 mt-10 -132.93 163.8 28.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.478 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 70.1 m-85 -126.48 131.31 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.651 ' HB2' HG12 ' B' ' 18' ' ' VAL . 4.2 t30 -119.8 115.17 23.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 8.2 mt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.732 0.222 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.09 120.94 9.16 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.75 143.66 35.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.379 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.694 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 73.8 m-20 -61.84 114.06 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 3.0 pt -73.31 142.51 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.095 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.411 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 2.0 m120 -86.77 139.09 31.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.76 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 149.49 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 83.4 mm-40 -142.66 105.41 5.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.755 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 155.14 54.13 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 123.844 -1.315 . . . . 0.0 112.348 0.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.9 -44.34 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.931 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.02 44.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.984 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.76 109.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.604 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.8 tt -130.76 142.82 42.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.722 HG11 HG11 ' B' ' 18' ' ' VAL . 7.3 p -139.77 99.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.513 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 19.8 m-85 -52.58 121.65 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.89 131.15 34.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -55.53 168.18 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.803 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 93.2 Cg_endo -83.67 163.89 68.86 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.674 0.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.1 25.46 10.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.847 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.32 7.96 45.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.483 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.478 ' N ' HG22 ' A' ' 76' ' ' THR . 14.2 p-10 -140.73 175.44 9.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -103.1 112.6 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.08 147.62 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 128.62 56.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 19' ' ' PHE . 65.6 m-85 -92.23 119.74 32.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.744 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -78.46 132.77 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.693 HD11 ' CG2' ' A' ' 72' ' ' VAL . 11.1 mt -120.84 148.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.519 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -112.45 125.52 54.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 111.355 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.506 HD11 ' CE ' ' A' ' 70' ' ' MET . 30.3 mt -122.93 151.42 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.508 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 10' ' ' ASN . 99.5 m -147.92 155.66 41.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -98.28 75.65 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -52.62 -26.27 13.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.105 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.49 -148.97 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.33 3.78 4.79 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.108 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -138.0 172.91 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.907 0.354 . . . . 0.0 110.831 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 86.9 mtm180 -70.22 155.45 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.673 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.614 HD12 ' CD1' ' A' ' 93' ' ' TRP . 20.8 pt -149.31 134.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 111.794 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.04 113.17 4.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.487 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.443 ' HE1' HD12 ' A' ' 62' ' ' LEU . 62.1 p-90 -108.58 160.36 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.309 0.576 . . . . 0.0 111.919 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.65 22.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.967 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.696 ' CD1' HG23 ' A' ' 91' ' ' ILE . 11.7 mm -115.49 139.07 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.724 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.85 129.6 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.673 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 89' ' ' ILE . 70.0 p -107.71 148.36 29.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -54.21 -27.71 36.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -125.61 104.37 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.51 24.94 6.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -106.57 -44.67 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.779 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.95 -40.0 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.81 150.23 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.16 177.04 11.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.97 154.44 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -161.85 128.67 2.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 11.3 Cg_exo -71.07 133.26 27.0 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 123.892 -1.295 . . . . 0.0 111.945 -0.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 53.2 Cg_exo -54.91 -47.7 25.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.381 2.054 . . . . 0.0 112.102 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.0 p -136.27 165.83 24.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.668 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.26 -167.77 37.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.566 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 61' ' ' VAL . 11.8 p -138.25 125.35 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.339 . . . . 0.0 111.118 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.951 HD11 ' CG1' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -103.21 160.25 14.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB3' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -110.55 172.32 3.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.435 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 36.6 Cg_exo -60.84 116.23 3.22 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.618 2.212 . . . . 0.0 112.354 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 69.94 27.57 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.231 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' O ' HD23 ' A' ' 62' ' ' LEU . 2.0 mt-10 -103.59 148.24 26.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.476 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.78 136.82 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.223 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.951 ' CG1' HD11 ' A' ' 62' ' ' LEU . 11.8 p -125.88 155.2 35.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' N ' HG22 ' A' ' 68' ' ' VAL . 83.4 mt -103.63 141.13 36.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.596 ' HE3' HD12 ' A' ' 31' ' ' ILE . 4.3 mtm -124.2 155.7 38.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.41 121.68 31.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.168 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.693 ' CG2' HD11 ' A' ' 31' ' ' ILE . 21.9 t -95.95 100.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -65.87 117.68 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.984 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.5 m -123.03 116.18 23.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.66 151.92 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 25' ' ' ASP . 7.1 p -53.94 167.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 79' ' ' ALA . 34.1 p90 -177.59 -164.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -130.88 98.14 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . . . -72.04 -22.47 61.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.41 -39.0 31.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.9 p -129.82 47.09 2.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -143.24 151.79 40.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.06 147.99 47.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 23.2 mt -125.95 24.09 7.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.27 28.53 1.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.771 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.94 7.4 8.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.46 123.88 48.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.23 148.15 35.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.651 HG13 HD11 ' A' ' 122' ' ' ILE . 67.9 mt -118.58 108.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 120.8 33.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.28 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.696 HG23 ' CD1' ' A' ' 45' ' ' ILE . 4.3 mp -111.38 100.21 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.911 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.408 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 11.5 mt-10 -97.66 157.8 15.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.614 ' CD1' HD12 ' A' ' 41' ' ' ILE . 10.2 p90 -163.64 142.36 7.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.039 0.447 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 115' ' ' VAL . 1.5 t -143.06 131.34 22.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.05 146.5 2.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.837 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 1.7 p -90.22 140.92 27.32 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.423 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 52.9 Cg_exo -52.18 160.72 3.04 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.496 2.13 . . . . 0.0 111.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.42 117.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.49 48.98 33.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.401 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.49 48.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 111.438 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.7 165.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.129 0.49 . . . . 0.0 111.554 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.12 73.81 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.45 152.35 3.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.881 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -64.25 153.09 39.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.835 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 2.4 mmt180 -142.88 150.25 39.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.032 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 106' ' ' ARG . 8.0 ttp-105 -102.58 25.78 8.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.69 -29.68 7.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.837 ' CZ3' HG22 ' A' ' 96' ' ' THR . 23.2 m0 -62.56 -27.57 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.3 mtm . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.5 p 169.98 98.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.93 160.41 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.133 0.492 . . . . 0.0 111.597 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.408 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 4.8 ptp85 -141.41 104.54 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.751 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -92.17 166.45 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -128.55 152.23 48.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.939 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.99 93.13 17.64 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.04 133.1 53.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.622 2.215 . . . . 0.0 112.471 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.651 HD11 HG13 ' A' ' 89' ' ' ILE . 12.9 mm -99.08 146.05 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.494 ' C ' HG23 ' A' ' 18' ' ' VAL . 36.2 mt-10 -138.36 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.285 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 13.4 m-85 -119.26 137.51 53.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -121.36 78.93 1.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.983 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.528 0.193 0 CA-C-O 120.75 0.229 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.04 121.03 9.31 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.498 2.132 . . . . 0.0 112.283 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.96 143.74 36.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.337 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 73.8 m-20 -61.94 114.03 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 3.0 pt -73.26 142.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.411 ' HB2' ' HB ' ' B' ' 34' ' ' THR . 2.0 m120 -86.62 139.1 31.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.92 149.57 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -142.84 105.44 5.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.627 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 154.85 54.33 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.894 -1.294 . . . . 0.0 112.317 0.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.41 -44.5 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.93 44.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.69 109.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.147 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.609 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.8 tt -130.57 142.84 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.722 HG11 HG11 ' A' ' 18' ' ' VAL . 7.3 p -139.81 99.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 111.503 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.452 ' HA ' ' CZ ' ' B' ' 29' ' ' TYR . 19.8 m-85 -52.54 121.59 7.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.442 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -86.7 131.02 34.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 111.325 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.792 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -55.33 168.25 0.6 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.792 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 94.8 Cg_endo -83.6 163.81 69.3 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.925 -1.281 . . . . 0.0 112.669 0.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.05 25.46 10.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.951 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.3 7.89 45.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.363 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ASP . . . . . 0.483 ' N ' HG22 ' B' ' 76' ' ' THR . 14.4 p-10 -140.71 175.19 9.81 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -102.74 112.55 25.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.2 147.63 51.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 128.62 56.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.452 ' CZ ' ' HA ' ' B' ' 19' ' ' PHE . 66.9 m-85 -92.14 119.66 32.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.35 132.72 37.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.4 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.69 HD11 ' CG2' ' B' ' 72' ' ' VAL . 11.0 mt -120.78 148.53 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.55 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.39 125.47 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.506 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.503 HD11 ' CE ' ' B' ' 70' ' ' MET . 30.1 mt -122.87 151.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.564 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' B' ' 10' ' ' ASN . 99.3 m -147.88 155.49 41.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 0.0 111.553 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -98.2 75.83 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -52.86 -25.92 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.171 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.69 -149.05 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.444 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.26 3.68 4.81 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.93 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -137.9 172.77 12.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.94 0.37 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' B' ' 62' ' ' LEU . 87.0 mtm180 -69.97 155.48 40.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.599 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.631 HD12 ' CD1' ' B' ' 93' ' ' TRP . 20.5 pt -149.36 134.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 0.0 111.781 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.06 113.34 4.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.426 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.44 ' HE1' HD12 ' B' ' 62' ' ' LEU . 61.8 p-90 -108.72 160.24 16.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 0.0 111.866 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 144.9 22.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.033 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.707 ' CD1' HG23 ' B' ' 91' ' ' ILE . 11.9 mm -115.76 139.04 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 111.689 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.76 130.04 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.599 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.524 HG22 HG12 ' B' ' 89' ' ' ILE . 71.4 p -108.23 148.09 30.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.061 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -53.82 -27.98 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.963 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -125.37 104.73 8.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.89 25.07 6.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -106.54 -44.92 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.65 -39.97 6.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.88 150.25 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.18 177.05 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.89 154.68 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -162.16 128.64 2.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' B' ' 58' ' ' PRO . 11.4 Cg_exo -71.09 133.27 27.09 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.888 -1.297 . . . . 0.0 111.96 0.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' B' ' 57' ' ' PRO . 53.1 Cg_exo -55.0 -47.61 25.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.372 2.048 . . . . 0.0 112.123 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 11.7 p -136.33 165.6 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.05 -167.74 37.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.559 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.451 ' O ' HG13 ' B' ' 61' ' ' VAL . 11.9 p -138.28 125.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 111.046 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.944 HD11 ' CG1' ' B' ' 68' ' ' VAL . 0.2 OUTLIER -103.13 160.18 14.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.426 ' HB3' ' CD ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER -110.58 172.4 3.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.747 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.426 ' CD ' ' HB3' ' B' ' 63' ' ' ASP . 36.4 Cg_exo -60.88 116.35 3.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.622 2.215 . . . . 0.0 112.363 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.81 27.83 4.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.452 ' O ' HD23 ' B' ' 62' ' ' LEU . 2.0 mt-10 -103.86 148.23 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.45 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 136.91 55.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.944 ' CG1' HD11 ' B' ' 62' ' ' LEU . 12.0 p -125.98 155.29 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.035 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.447 ' N ' HG22 ' B' ' 68' ' ' VAL . 83.1 mt -103.77 141.28 36.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.597 ' HE3' HD12 ' B' ' 31' ' ' ILE . 4.2 mtm -124.36 155.64 38.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.47 121.77 31.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.201 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.69 ' CG2' HD11 ' B' ' 31' ' ' ILE . 21.9 t -96.02 100.25 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.015 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.5 m -66.03 117.54 8.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.84 116.13 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.73 151.77 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.483 HG22 ' N ' ' B' ' 25' ' ' ASP . 7.2 p -53.8 167.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' B' ' 79' ' ' ALA . 34.2 p90 -177.8 -164.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -130.61 98.29 4.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' B' ' 77' ' ' PHE . . . -72.22 -22.43 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.34 -39.13 30.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.5 p -129.65 47.02 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -143.17 151.81 41.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -71.02 148.38 47.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 23.4 mt -126.26 24.08 6.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.31 28.45 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.738 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.9 7.51 8.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.614 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.48 123.78 48.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.06 148.34 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.651 HG13 HD11 ' B' ' 122' ' ' ILE . 67.4 mt -118.67 108.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.48 120.67 33.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.707 HG23 ' CD1' ' B' ' 45' ' ' ILE . 4.3 mp -111.29 100.13 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.411 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 11.4 mt-10 -97.52 157.85 15.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.631 ' CD1' HD12 ' B' ' 41' ' ' ILE . 10.0 p90 -163.69 142.19 7.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 111.183 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 t -142.89 131.48 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.657 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.35 146.44 2.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.845 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 1.7 p -90.09 140.86 27.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.85 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' PRO . . . . . 0.421 ' HD2' ' NE1' ' B' ' 108' ' ' TRP . 53.4 Cg_exo -52.04 160.77 2.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.471 2.114 . . . . 0.0 112.025 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.62 117.61 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.6 48.85 34.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.375 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.36 48.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.83 165.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.176 0.512 . . . . 0.0 111.483 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.13 73.73 1.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.769 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.39 152.26 3.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.06 153.11 38.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 2.4 mmt180 -142.94 150.08 39.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.94 0.4 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.437 ' HB3' ' NH1' ' B' ' 106' ' ' ARG . 8.1 ttp-105 -102.43 25.66 8.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -29.56 7.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.845 ' CZ3' HG22 ' B' ' 96' ' ' THR . 23.4 m0 -62.78 -27.35 69.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 114' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 4.3 mtm . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.608 ' O ' HG13 ' B' ' 115' ' ' VAL . 7.4 p 169.88 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.081 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.84 160.55 14.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.158 0.504 . . . . 0.0 111.542 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.411 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 4.6 ptp85 -141.51 104.25 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -92.04 166.47 12.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 111.132 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -128.51 152.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.91 93.17 17.84 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.11 133.23 54.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.651 HD11 HG13 ' B' ' 89' ' ' ILE . 12.9 mm -99.19 146.16 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.504 ' C ' HG23 ' B' ' 18' ' ' VAL . 35.8 mt-10 -138.38 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 13.7 m-85 -119.35 137.12 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.996 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -121.09 79.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.463 -0.272 0 CA-C-O 120.658 0.191 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.62 132.85 26.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.552 2.168 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.05 -142.78 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.565 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.904 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 5.4 t0 -130.8 136.97 49.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 93' ' ' TRP . 23.0 pt -93.93 153.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.42 133.05 49.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.658 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.7 p -126.42 155.16 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HD3' ' B' ' 22' ' ' PRO . 28.8 mm-40 -139.97 114.54 7.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.84 161.63 67.5 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.924 -1.282 . . . . 0.0 112.497 0.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -50.13 70.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.177 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -167.76 46.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.084 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -162.9 106.96 1.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.931 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 17' ' ' ILE . 11.1 tt -131.19 125.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.129 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.5 p -122.04 101.57 10.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.186 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 22.9 m-85 -47.32 162.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.567 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -122.85 119.4 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.969 0.414 . . . . 0.0 111.545 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.87 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.66 0.13 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.755 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.87 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 77.6 Cg_endo -76.84 164.27 87.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.764 0.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.82 40.92 2.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -108.14 6.8 27.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.4 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.49 -160.99 1.23 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.797 0.332 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.26 112.34 24.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -112.48 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.52 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 113.78 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.429 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 8.7 m-85 -105.51 112.64 25.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.259 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.13 145.09 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.638 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.425 HD12 ' CE ' ' A' ' 70' ' ' MET . 3.7 mt -116.12 145.43 21.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.383 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' CD ' ' HG3' ' B' ' 22' ' ' PRO . 6.9 tttt -94.32 129.67 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.962 0.411 . . . . 0.0 111.528 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.6 mt -128.55 151.76 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.705 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -152.33 155.83 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' OD1' HD11 ' A' ' 41' ' ' ILE . 1.3 m-20 -94.61 100.79 12.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -90.48 18.03 6.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.512 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.11 -149.83 19.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.07 -26.75 2.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -125.55 162.39 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.855 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -52.06 168.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.449 HD12 ' CD1' ' A' ' 93' ' ' TRP . 13.9 pt -154.22 129.97 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.635 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.03 106.43 2.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.517 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.18 156.52 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.158 0.504 . . . . 0.0 111.909 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.455 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -148.64 154.72 40.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.036 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG13 ' A' ' 91' ' ' ILE . 9.4 mm -127.73 137.96 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 111.72 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -142.36 129.55 20.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.643 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 HG12 ' A' ' 89' ' ' ILE . 43.9 p -104.25 157.26 17.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.111 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.27 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -143.0 118.33 10.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.17 17.81 6.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.272 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -110.05 -39.22 5.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.365 . . . . 0.0 110.952 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.42 -27.06 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.466 HD11 ' OD2' ' A' ' 87' ' ' ASP . 1.7 mt -116.62 149.72 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -138.83 144.16 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.25 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -133.02 120.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.731 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.18 136.49 24.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 132.49 27.26 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.632 -1.404 . . . . 0.0 112.0 0.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.39 -39.38 44.3 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.334 2.023 . . . . 0.0 112.112 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.24 163.58 35.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.87 154.68 10.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.82 122.34 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.757 0.313 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 68' ' ' VAL . 3.7 tp -98.42 149.27 22.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.46 167.99 12.89 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.76 121.44 9.17 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.632 2.222 . . . . 0.0 112.384 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.85 18.43 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 152.76 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -122.3 153.02 39.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' CG1' HD11 ' A' ' 62' ' ' LEU . 3.2 m -147.63 152.9 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.84 91.93 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.251 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.449 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 35.4 ttp -72.7 158.95 34.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.615 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -124.41 129.82 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.9 93.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.992 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.96 127.61 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.43 101.73 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.753 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.0 145.24 44.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.129 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.39 162.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CZ ' ' CE2' ' A' ' 124' ' ' TYR . 0.5 OUTLIER -168.55 -163.14 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.88 119.14 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.58 18.36 20.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.506 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.95 -23.07 15.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.19 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.9 p -141.44 49.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.1 147.77 21.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -60.61 139.04 57.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 75.2 mt -116.29 27.08 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -146.63 27.59 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.608 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.72 -29.33 9.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 53' ' ' LEU . 1.4 m-20 -62.78 132.93 53.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.903 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -148.5 145.61 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 47' ' ' THR . 71.5 mt -121.39 115.62 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.935 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 118' ' ' LYS . 81.1 m -96.4 124.42 40.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.604 HD13 HD13 ' A' ' 120' ' ' LEU . 4.6 mp -116.32 113.26 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -110.85 155.49 22.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CD1' HD12 ' A' ' 41' ' ' ILE . 6.6 p90 -154.81 129.16 9.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.782 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.72 ' CB ' HG22 ' A' ' 115' ' ' VAL . 4.4 t -130.37 135.08 47.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.4 138.64 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.0 p -76.92 138.79 65.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.36 165.3 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.478 2.119 . . . . 0.0 112.043 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -50.35 105.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.63 48.67 49.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.36 -79.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.404 ' CB ' ' NH1' ' A' ' 105' ' ' ARG . . . 179.5 164.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 111.298 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -92.43 70.29 5.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.22 142.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.761 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -51.69 138.08 23.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.2 149.7 48.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -99.57 25.21 7.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.413 ' HG2' ' HG2' ' A' ' 105' ' ' ARG . 6.8 pt-20 -116.94 -16.54 10.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.409 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -69.27 -19.23 63.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 111.344 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 3.2 m-85 . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.734 0.302 . . . . 0.0 111.261 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.567 ' C ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.992 0.425 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.72 HG22 ' CB ' ' A' ' 94' ' ' THR . 3.8 t 82.84 111.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.238 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.13 151.75 21.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.607 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.99 140.38 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 0.0 111.276 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 90' ' ' THR . 5.3 tttp -126.17 162.12 26.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.546 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -130.88 152.52 50.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.604 HD13 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -139.25 95.73 9.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.729 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 120' ' ' LEU . 26.5 Cg_endo -62.61 127.41 20.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.468 2.112 . . . . 0.0 112.213 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 mm -96.16 154.54 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 93.2 mt-10 -145.66 163.18 35.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.467 ' CE2' ' CZ ' ' A' ' 77' ' ' PHE . 33.7 m-85 -125.35 120.9 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.065 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -100.73 88.98 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.947 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.962 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.73 0.221 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.57 132.78 26.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.527 2.151 . . . . 0.0 112.302 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -142.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.879 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 5.5 t0 -130.69 137.16 49.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' B' ' 93' ' ' TRP . 22.9 pt -94.15 153.01 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.183 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.35 132.98 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -126.42 155.18 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.142 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -139.89 114.49 7.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.588 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.88 161.46 68.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.607 0.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -50.15 70.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -167.78 46.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -162.87 106.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.422 ' O ' HG23 ' B' ' 17' ' ' ILE . 10.9 tt -131.15 125.42 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.659 ' O ' HG13 ' B' ' 18' ' ' VAL . 7.6 p -122.1 101.64 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.494 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 22.9 m-85 -47.4 162.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.576 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -122.94 119.31 30.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.558 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.843 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.07 170.54 0.13 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.755 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.843 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.2 Cg_endo -76.78 164.34 87.63 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.749 0.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.89 40.95 2.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.789 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.34 7.16 27.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.479 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.74 -160.98 1.23 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.833 0.349 . . . . 0.0 110.779 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.4 112.65 25.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' HIS . . . . . 0.424 ' HB3' ' CZ ' ' B' ' 29' ' ' TYR . 0.3 OUTLIER -112.54 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 113.59 27.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.487 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 8.6 m-85 -105.3 112.65 25.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.259 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.08 144.96 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.691 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.429 HD12 ' CE ' ' B' ' 70' ' ' MET . 3.8 mt -116.09 145.36 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.408 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -94.28 129.63 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.977 0.418 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 58.5 mt -128.54 151.65 35.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -152.23 155.73 38.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 111.398 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.431 ' OD1' HD11 ' B' ' 41' ' ' ILE . 1.3 m-20 -94.64 100.76 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.59 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -90.36 18.01 6.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.04 -149.73 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.52 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.19 -26.79 2.85 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.49 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -125.63 162.3 25.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -51.85 168.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' B' ' 93' ' ' TRP . 14.0 pt -154.13 129.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 111.66 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.01 106.45 2.67 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.511 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.28 156.56 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.54 . . . . 0.0 111.85 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.464 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -148.57 155.04 40.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.963 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.599 HD12 HG13 ' B' ' 91' ' ' ILE . 9.3 mm -127.92 137.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -142.39 129.48 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.606 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.541 HG22 HG12 ' B' ' 89' ' ' ILE . 43.8 p -104.13 157.35 17.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.53 -27.6 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.98 118.18 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.713 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.1 17.8 6.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -110.18 -39.04 5.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.48 -27.11 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.454 HD11 ' OD2' ' B' ' 87' ' ' ASP . 1.7 mt -116.59 149.86 38.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -139.01 144.3 38.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.513 HG11 HG21 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -133.27 120.99 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -135.24 136.5 24.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.11 132.44 27.1 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.046 -0.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.37 -39.59 44.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.401 2.067 . . . . 0.0 112.088 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.1 p -146.06 163.51 35.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.344 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.94 154.56 10.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.835 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.65 122.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 111.001 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.514 HD11 ' CG1' ' B' ' 68' ' ' VAL . 3.7 tp -98.58 149.39 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.54 168.06 12.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.94 121.37 9.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 112.356 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.9 18.64 9.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.94 21.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.328 . . . . 0.0 110.767 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -122.43 152.99 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.514 ' CG1' HD11 ' B' ' 62' ' ' LEU . 3.1 m -147.58 152.92 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.016 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.81 92.02 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.232 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.444 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 35.7 ttp -72.78 158.99 34.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.444 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -124.6 129.68 51.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.72 93.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.91 127.49 32.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.28 101.94 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.24 145.11 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.11 162.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.456 ' CZ ' ' CE2' ' B' ' 124' ' ' TYR . 0.5 OUTLIER -168.57 -163.06 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.896 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.95 119.21 38.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.71 18.31 20.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.526 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.22 15.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.7 p -141.3 49.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.22 147.68 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -60.56 139.1 57.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 76.1 mt -116.38 27.23 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.109 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -146.66 27.38 1.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.7 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.63 -29.22 9.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ASP . . . . . 0.454 ' OD2' HD11 ' B' ' 53' ' ' LEU . 1.4 m-20 -62.93 132.88 53.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -148.45 145.5 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.996 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.541 HG12 HG22 ' B' ' 47' ' ' THR . 71.5 mt -121.32 115.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.013 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.439 HG23 ' O ' ' B' ' 118' ' ' LYS . 81.7 m -96.23 124.45 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.599 HG13 HD12 ' B' ' 45' ' ' ILE . 4.6 mp -116.33 113.23 42.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.812 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -110.71 155.47 22.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.452 ' CD1' HD12 ' B' ' 41' ' ' ILE . 6.8 p90 -154.9 128.79 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.734 ' CB ' HG22 ' B' ' 115' ' ' VAL . 4.3 t -129.94 135.01 47.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.25 138.69 44.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 68.7 p -77.07 138.79 64.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 165.08 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.525 2.15 . . . . 0.0 112.057 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -50.21 105.41 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.56 48.85 48.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.395 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.65 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 0.0 111.24 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.409 ' CB ' ' NH1' ' B' ' 105' ' ' ARG . . . 179.53 164.76 1.04 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.168 0.509 . . . . 0.0 111.307 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -92.54 70.36 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.699 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.17 141.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.686 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -51.8 137.88 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HG2' ' HG2' ' B' ' 107' ' ' GLU . 0.0 OUTLIER -125.96 149.76 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -99.46 25.11 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.188 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' GLU . . . . . 0.412 ' HG2' ' HG2' ' B' ' 105' ' ' ARG . 6.7 pt-20 -116.9 -16.64 10.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.45 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -69.2 -19.27 63.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.605 0.24 . . . . 0.0 111.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.308 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' MET . . . . . 0.581 ' C ' HG23 ' B' ' 115' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.941 0.4 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.734 HG22 ' CB ' ' B' ' 94' ' ' THR . 3.9 t 82.82 112.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.248 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.23 151.75 21.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.93 140.13 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 111.315 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.439 ' O ' HG23 ' B' ' 90' ' ' THR . 5.2 tttp -126.1 162.17 25.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -131.0 152.63 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.095 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.596 HD13 HD13 ' B' ' 91' ' ' ILE . 0.3 OUTLIER -139.29 95.87 9.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.646 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.66 127.49 20.81 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.439 2.093 . . . . 0.0 112.132 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 13.1 mm -96.3 154.52 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.268 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -145.63 163.31 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.456 ' CE2' ' CZ ' ' B' ' 77' ' ' PHE . 33.8 m-85 -125.27 121.26 33.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -101.1 88.87 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.948 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.908 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.749 0.229 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ARG . 58.5 Cg_endo -71.63 149.51 55.28 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -165.51 1.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.67 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 1.4 m-20 -111.23 111.88 23.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.88 147.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.58 149.69 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.799 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.36 151.5 45.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.56 107.71 3.81 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.37 157.38 62.06 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.347 0.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.441 ' C ' HD21 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -112.05 -20.15 12.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.277 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.48 ' C ' HD23 ' A' ' 120' ' ' LEU . 37.9 mt-30 -94.71 -45.93 7.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 111.096 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.78 -176.66 0.24 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 122' ' ' ILE . 17.4 tt -144.33 156.28 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' A' ' 123' ' ' GLU . 3.6 p -133.09 92.43 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 19.2 m-30 -50.78 113.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.668 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -79.14 136.21 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.804 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -50.89 168.52 0.24 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.684 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.804 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 2.0 Cg_endo -82.58 163.76 73.94 Favored 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.255 -1.144 . . . . 0.0 112.364 0.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -106.33 26.61 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -110.68 7.1 22.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.106 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -141.46 134.14 28.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.788 0.328 . . . . 0.0 111.034 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -55.42 107.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -116.66 124.15 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.416 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -99.8 113.21 25.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.985 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 85.5 m-85 -89.73 99.33 12.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.489 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -66.68 153.32 43.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.577 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mt -139.27 148.73 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' CB ' ' HG3' ' B' ' 22' ' ' PRO . 25.3 ttmt -104.91 140.48 38.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.41 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 34' ' ' THR . 46.7 mt -131.54 154.03 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.779 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.435 ' N ' HG22 ' A' ' 33' ' ' ILE . 55.0 m -145.47 155.59 43.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.029 0.442 . . . . 0.0 111.189 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.865 ' HB2' HD23 ' A' ' 62' ' ' LEU . 36.0 t-20 -104.08 102.27 12.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -93.42 21.32 6.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.85 -122.86 4.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.542 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.36 -42.0 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.563 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -113.26 166.6 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.44 156.3 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.417 HG12 ' ND2' ' A' ' 35' ' ' ASN . 21.9 pt -143.82 174.01 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -130.33 100.03 0.46 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.918 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 -92.12 159.35 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 111.712 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.64 130.73 11.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.514 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.429 ' CG2' HG11 ' A' ' 55' ' ' VAL . 5.6 mm -100.31 141.09 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.732 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -142.0 131.99 24.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.575 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 55' ' ' VAL . 11.1 p -107.46 156.97 18.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.41 . . . . 0.0 111.399 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -48.32 -29.16 3.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.057 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.38 122.77 13.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.65 -8.62 59.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.417 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.17 -41.19 13.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 110.604 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -84.8 -59.28 2.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.65 134.12 37.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.706 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 m -127.49 109.13 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 47' ' ' THR . 16.0 m -68.29 156.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 32.5 t0 -170.09 113.85 0.48 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.3 149.58 92.19 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.112 -1.203 . . . . 0.0 112.278 0.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.88 -15.31 21.12 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 0.0 112.586 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -179.49 153.26 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.83 167.73 40.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.791 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 t -98.36 120.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.865 HD23 ' HB2' ' A' ' 35' ' ' ASN . 4.5 tp -96.98 162.93 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.418 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -115.17 170.97 4.92 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.19 111.13 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.576 2.184 . . . . 0.0 112.419 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.27 39.79 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -106.74 154.31 21.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.894 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.38 38.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 10.5 p -138.39 143.36 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.937 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.23 151.64 23.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.411 ' CE ' HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -133.47 161.56 34.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.764 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -146.98 118.24 7.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.268 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -107.82 86.51 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.992 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.16 145.57 53.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 43.2 t -136.19 102.96 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.18 150.16 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -67.4 112.46 4.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HE2' ' HB2' ' A' ' 79' ' ' ALA . 44.8 p90 -123.58 178.02 5.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.93 89.97 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . . . -55.18 -26.57 39.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.87 -49.12 59.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.7 p -125.61 50.63 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.068 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -136.28 162.34 33.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -80.12 130.2 35.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.501 HD22 ' CE2' ' A' ' 124' ' ' TYR . 12.2 mt -125.9 52.91 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -112.77 -23.66 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.495 ' HB3' HG21 ' A' ' 48' ' ' THR . 15.0 m120 -65.46 -91.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.842 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 122' ' ' ILE . 2.1 p-10 41.66 84.64 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.573 0.225 . . . . 0.0 111.513 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB2' HG23 ' A' ' 48' ' ' THR . 6.2 mtm-85 -167.4 135.17 2.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.607 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 122' ' ' ILE . 28.1 mt -119.81 163.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.874 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.53 ' N ' HG22 ' A' ' 89' ' ' ILE . 22.2 m -149.59 114.63 5.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.963 0.411 . . . . 0.0 111.363 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 120' ' ' LEU . 4.7 mp -110.37 98.7 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.955 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.89 137.9 40.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.0 p90 -139.08 150.3 45.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.242 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.598 ' HB ' HG13 ' A' ' 115' ' ' VAL . 4.4 t -147.6 132.24 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -53.33 147.79 9.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 p -98.2 142.87 25.27 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.751 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.13 160.62 3.07 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.377 2.051 . . . . 0.0 112.039 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -47.03 116.28 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.175 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.4 50.77 23.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.42 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 62.74 7.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.727 0.299 . . . . 0.0 111.549 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.42 164.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.612 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -104.55 73.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.57 147.83 0.18 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.71 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.41 150.39 48.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.48 146.85 38.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.14 -23.77 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.22 -22.26 64.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.162 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.83 -30.07 71.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' A' ' 115' ' ' VAL . 9.2 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.989 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.598 HG13 ' HB ' ' A' ' 94' ' ' THR . 14.1 t -128.44 128.3 68.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HB2' ' HG2' ' A' ' 6' ' ' PRO . 1.2 ttt180 -96.8 152.61 18.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.582 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.03 130.08 18.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.042 0.449 . . . . 0.0 111.585 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -115.74 162.74 16.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.033 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -131.95 149.34 52.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 0.0 111.48 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 91' ' ' ILE . 2.1 mt -143.26 98.47 5.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 37.2 Cg_exo -57.91 151.04 59.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.703 2.269 . . . . 0.0 112.795 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 89' ' ' ILE . 43.9 mm -101.46 158.26 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.018 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.67 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -140.08 153.66 46.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.902 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.501 ' CE2' HD22 ' A' ' 84' ' ' LEU . 31.7 m-85 -119.81 113.54 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -102.94 82.63 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.975 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 CA--C 1.528 0.191 0 CA-C-O 120.702 0.209 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.412 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 59.4 Cg_endo -71.73 149.54 54.75 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.576 2.184 . . . . 0.0 112.335 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.68 -165.53 1.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.5 m-20 -111.17 111.85 23.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.89 147.54 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.49 149.52 21.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.19 151.55 45.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.6 107.63 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 28.3 Cg_endo -62.33 157.6 61.28 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.824 -1.323 . . . . 0.0 112.377 0.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' SER . . . . . 0.434 ' C ' HD21 ' B' ' 120' ' ' LEU . 0.0 OUTLIER -112.39 -20.24 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.231 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.485 ' C ' HD23 ' B' ' 120' ' ' LEU . 37.9 mt-30 -94.67 -46.09 7.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.891 0.376 . . . . 0.0 111.068 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.89 -176.46 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' B' ' 122' ' ' ILE . 17.5 tt -144.69 156.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.244 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.642 HG23 ' HB3' ' B' ' 123' ' ' GLU . 3.5 p -133.22 92.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.566 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 19.0 m-30 -50.87 112.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.74 136.22 37.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.303 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.771 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -50.88 168.62 0.24 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.795 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.771 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 1.9 Cg_endo -82.54 163.73 74.1 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 124.276 -1.135 . . . . 0.0 112.476 0.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.35 26.43 9.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -110.43 6.97 22.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.125 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -141.4 134.22 28.82 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 120.787 0.327 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -55.38 107.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -116.67 124.13 48.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.716 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.404 ' CG2' ' HB1' ' B' ' 71' ' ' ALA . 0.2 OUTLIER -99.75 113.23 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.566 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 85.8 m-85 -89.86 99.44 12.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.471 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -66.73 153.43 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.578 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mt -139.43 148.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 25.4 ttmt -105.03 140.54 38.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.443 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.436 HG22 ' N ' ' B' ' 34' ' ' THR . 46.1 mt -131.45 154.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.828 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.7 m -145.47 155.72 43.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.998 0.428 . . . . 0.0 111.208 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.897 ' HB2' HD23 ' B' ' 62' ' ' LEU . 36.1 t-20 -104.26 102.38 12.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.535 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -93.44 21.23 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.293 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.89 -122.78 4.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.444 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.33 -42.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -113.2 166.63 11.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.49 156.45 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.422 HG12 ' ND2' ' B' ' 35' ' ' ASN . 21.5 pt -143.92 174.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.35 100.0 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.883 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -92.01 159.4 15.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.234 0.54 . . . . 0.0 111.651 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.73 130.81 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.414 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.438 ' CG2' HG11 ' B' ' 55' ' ' VAL . 5.6 mm -100.34 141.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 111.717 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -142.08 131.94 24.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.513 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.445 HG23 HG13 ' B' ' 55' ' ' VAL . 11.4 p -107.52 156.88 18.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 111.316 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.541 HG23 ' HB2' ' B' ' 88' ' ' ARG . 0.0 OUTLIER -48.32 -29.02 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.57 122.82 12.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.77 -8.59 59.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.455 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.12 -41.23 13.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -84.66 -59.59 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.778 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -94.48 134.1 37.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.756 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -127.46 109.01 11.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.445 HG13 HG23 ' B' ' 47' ' ' THR . 16.1 m -68.07 156.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.071 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' B' ' 71' ' ' ALA . 32.9 t0 -169.96 113.87 0.48 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.32 149.81 92.62 Favored 'Cis proline' 0 C--N 1.351 0.667 0 C-N-CA 124.014 -1.244 . . . . 0.0 112.249 0.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.92 -15.45 20.95 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 112.546 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p -179.52 153.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.538 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.46 168.17 41.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.696 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 26.3 t -98.7 121.12 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.011 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.897 HD23 ' HB2' ' B' ' 35' ' ' ASN . 4.6 tp -96.98 163.13 13.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.4 OUTLIER -115.36 171.08 4.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.29 111.32 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.571 2.181 . . . . 0.0 112.349 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.04 39.87 9.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.42 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.6 OUTLIER -106.87 154.38 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.799 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.6 38.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 10.5 p -138.63 143.36 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.28 151.62 23.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.413 ' CE ' HD11 ' B' ' 33' ' ' ILE . 0.7 OUTLIER -133.39 161.6 34.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.728 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' B' ' 56' ' ' ASP . . . -146.96 118.29 7.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.309 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 t -108.03 86.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.35 145.44 53.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.033 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.7 t -136.07 103.19 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.26 150.32 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -67.64 112.47 4.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.472 ' HE2' ' HB2' ' B' ' 79' ' ' ALA . 44.7 p90 -123.47 178.17 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.97 89.91 3.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.472 ' HB2' ' HE2' ' B' ' 77' ' ' PHE . . . -55.1 -26.74 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.028 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.18 57.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 61.3 p -125.65 50.56 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.066 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.12 162.46 32.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -80.15 130.22 35.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.502 HD22 ' CE2' ' B' ' 124' ' ' TYR . 12.6 mt -125.82 52.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -112.51 -23.43 10.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.492 ' HB3' HG21 ' B' ' 48' ' ' THR . 14.9 m120 -65.64 -91.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.779 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ASP . . . . . 0.446 ' CB ' ' HB ' ' B' ' 122' ' ' ILE . 2.1 p-10 41.51 84.59 0.02 OUTLIER 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.76 0.314 . . . . 0.0 111.564 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.541 ' HB2' HG23 ' B' ' 48' ' ' THR . 6.3 mtm-85 -167.25 135.17 2.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.643 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.805 HD11 HD11 ' B' ' 122' ' ' ILE . 29.0 mt -119.8 163.69 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.795 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.537 ' N ' HG22 ' B' ' 89' ' ' ILE . 21.8 m -149.5 114.79 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.939 0.4 . . . . 0.0 111.247 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.513 ' CD1' HD12 ' B' ' 120' ' ' LEU . 4.7 mp -110.47 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.861 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 137.79 40.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.832 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -138.97 150.29 45.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.597 ' HB ' HG13 ' B' ' 115' ' ' VAL . 4.6 t -147.7 132.07 17.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -53.19 147.62 9.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -98.08 142.83 25.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.18 160.62 3.14 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.428 2.085 . . . . 0.0 112.022 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -46.98 116.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.58 50.78 24.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.364 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.04 62.81 7.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.726 0.298 . . . . 0.0 111.562 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.36 164.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.24 0.543 . . . . 0.0 111.663 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -104.48 73.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.49 147.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.3 150.44 48.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 146.84 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.677 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.1 -23.68 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.162 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.33 -22.17 64.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.149 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -62.98 -30.08 71.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.062 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' B' ' 115' ' ' VAL . 9.2 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.983 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.597 HG13 ' HB ' ' B' ' 94' ' ' THR . 13.7 t -128.5 128.32 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.412 ' HB2' ' HG2' ' B' ' 6' ' ' PRO . 1.2 ttt180 -96.82 152.56 18.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.604 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.06 130.06 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.449 . . . . 0.0 111.546 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 90' ' ' THR . 0.0 OUTLIER -115.78 162.73 16.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.966 179.24 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -131.96 149.19 52.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 0.0 111.498 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.513 HD12 ' CD1' ' B' ' 91' ' ' ILE . 2.1 mt -143.25 98.46 5.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.665 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 88' ' ' ARG . 38.0 Cg_exo -57.77 151.03 58.68 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.789 2.326 . . . . 0.0 112.642 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.805 HD11 HD11 ' B' ' 89' ' ' ILE . 43.7 mm -101.47 158.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.968 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.642 ' HB3' HG23 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -140.0 153.67 46.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.891 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.502 ' CE2' HD22 ' B' ' 84' ' ' LEU . 32.1 m-85 -119.84 113.51 20.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -102.96 82.86 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.684 0.202 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.52 109.75 2.7 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.607 2.204 . . . . 0.0 112.226 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.45 135.75 47.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.505 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.2 m-20 -49.25 152.49 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 33' ' ' ILE . 11.3 pt -118.0 147.16 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.63 140.9 31.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.578 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.79 139.12 47.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.188 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -137.25 110.07 9.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 28.8 Cg_endo -62.54 167.52 32.84 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.672 0.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -43.08 -68.41 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.429 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.11 43.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.69 123.54 3.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.037 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.55 151.89 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.4 p -138.61 100.15 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.39 113.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -81.21 132.87 35.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.862 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.11 0.14 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.857 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.862 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 72.1 Cg_endo -76.72 167.74 79.16 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.733 0.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.4 m-85 -115.85 31.54 6.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.013 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.6 6.59 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.271 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.556 ' N ' HG22 ' A' ' 76' ' ' THR . 11.0 m-20 -149.76 -178.57 6.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.14 107.95 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -111.16 132.98 53.87 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.545 HG21 ' HB1' ' A' ' 71' ' ' ALA . 95.4 m -107.15 135.78 48.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.78 ' O ' HG12 ' A' ' 72' ' ' VAL . 6.3 m-85 -116.88 121.81 42.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.642 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.02 150.88 45.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.435 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -133.43 153.96 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.702 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.24 135.25 53.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.409 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 9' ' ' ILE . 69.4 mt -145.46 121.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -118.19 153.46 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 111.108 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.624 ' ND2' HD13 ' A' ' 41' ' ' ILE . 3.7 t-20 -94.54 81.68 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.95 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -63.8 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.43 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.92 -154.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.629 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.72 -19.33 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.743 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -132.61 167.16 20.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.009 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 41' ' ' ILE . 37.6 mtp180 -49.78 164.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.811 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.624 HD13 ' ND2' ' A' ' 35' ' ' ASN . 31.2 pt -156.74 132.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.798 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 60' ' ' GLY . . . -94.13 109.48 3.83 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -99.51 159.3 15.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.988 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.77 155.05 44.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.408 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.464 ' CG2' HG21 ' A' ' 55' ' ' VAL . 25.1 mm -117.24 132.37 67.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 111.586 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 150.8 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.737 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 p -143.27 153.71 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -41.97 95.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.62 114.87 15.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.68 20.6 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -97.14 -31.69 12.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -113.37 -19.25 11.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.3 mt -108.11 132.45 53.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.05 107.74 5.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -100.73 127.12 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.032 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.22 130.96 22.8 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.1 142.86 76.05 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.875 -1.302 . . . . 0.0 112.022 0.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.22 -31.7 43.93 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.434 2.089 . . . . 0.0 112.036 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -145.91 -177.93 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.495 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.404 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . 164.27 -171.0 39.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.596 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.31 129.47 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.604 HD13 HG23 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.4 153.55 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.141 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.2 p30 -90.05 168.1 15.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 32.3 Cg_exo -61.79 133.69 46.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.497 2.131 . . . . 0.0 112.231 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 tttm 77.7 12.07 1.99 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.841 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -108.51 142.98 38.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.187 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.27 161.21 13.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.193 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG23 HD13 ' A' ' 62' ' ' LEU . 41.8 t -135.62 141.93 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.03 118.95 33.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.946 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.533 ' SD ' HD12 ' A' ' 33' ' ' ILE . 9.8 mtm -112.46 158.21 20.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 28' ' ' THR . . . -126.71 102.23 6.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.22 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 29' ' ' TYR . 7.4 p -88.05 109.43 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.809 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.2 m -91.24 129.88 37.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.302 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 41.0 t -114.99 150.82 35.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.9 154.58 21.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.119 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 25' ' ' ASP . 3.9 p -58.59 161.03 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -173.53 -165.63 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.94 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 92.4 m-20 -121.92 82.86 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 77' ' ' PHE . . . -57.24 -22.11 38.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.216 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.296 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.4 p -141.56 43.13 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.168 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 19.6 mm-40 -122.52 6.5 9.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.26 140.01 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' A' ' 124' ' ' TYR . 2.2 mt -115.23 24.46 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -142.26 28.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.767 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.21 9.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.02 126.91 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.84 139.63 26.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.5 mt -107.35 122.36 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.615 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 118' ' ' LYS . 68.0 m -110.56 118.66 36.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.487 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.15 154.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -149.71 101.72 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.512 ' NE1' HG23 ' A' ' 9' ' ' ILE . 15.1 p90 -122.14 137.9 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.997 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.732 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -134.37 148.97 50.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.029 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -60.22 144.16 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -85.77 150.89 54.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 39.3 Cg_endo -67.04 163.63 33.22 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.5 2.133 . . . . 0.0 112.059 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -47.18 116.45 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.21 46.64 56.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.688 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.688 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -65.13 150.65 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.113 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.41 165.03 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.142 0.496 . . . . 0.0 111.282 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.9 71.33 7.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.621 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.02 140.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.05 120.21 9.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HG2' ' HG2' ' A' ' 107' ' ' GLU . 0.9 OUTLIER -101.16 156.16 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.024 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.77 -27.16 16.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.434 ' HG2' ' HG2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -65.16 -18.22 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.339 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.85 -16.25 57.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.428 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 2.5 m-85 . . . . . 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.596 ' C ' HG23 ' A' ' 115' ' ' VAL . 2.9 mtt . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 121.03 0.443 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.732 HG13 ' HB ' ' A' ' 94' ' ' THR . 3.3 t 81.76 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.118 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.28 26.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.773 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.76 139.39 46.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.004 0.43 . . . . 0.0 111.174 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 90' ' ' THR . 26.0 mtpp -125.37 166.77 15.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.489 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -121.69 152.05 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -141.31 88.56 9.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 141.8 47.29 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.566 2.177 . . . . 0.0 112.633 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.37 138.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.817 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.6 mm-40 -131.62 159.18 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.264 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.571 ' HB2' HD22 ' A' ' 84' ' ' LEU . 97.7 m-85 -122.8 113.07 18.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 60.4 t30 -95.15 90.57 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' A' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.465 -0.15 0 CA-C-O 120.729 0.22 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.45 109.75 2.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.508 2.139 . . . . 0.0 112.33 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.38 135.8 47.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 2.1 m-20 -49.31 152.45 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 111.017 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.585 HD12 HG23 ' B' ' 33' ' ' ILE . 11.2 pt -117.99 147.2 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.66 140.82 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.63 139.53 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -137.62 109.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.561 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.564 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 28.7 Cg_endo -62.46 167.29 33.23 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.996 -1.252 . . . . 0.0 112.636 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.3 m -43.01 -68.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.469 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.24 43.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.63 123.19 3.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.19 151.68 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.61 ' O ' HG13 ' B' ' 18' ' ' VAL . 7.4 p -138.36 100.13 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.602 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.38 113.19 1.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASN . . . . . 0.401 HD21 HG13 ' A' ' 18' ' ' VAL . 6.6 m-80 -81.06 132.73 35.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.315 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.856 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.15 170.12 0.14 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.856 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.6 Cg_endo -76.71 167.84 78.86 Favored 'Cis proline' 0 C--N 1.35 0.628 0 C-N-CA 123.898 -1.293 . . . . 0.0 112.699 0.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.5 m-85 -115.87 31.49 6.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.031 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.63 6.65 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.3 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ASP . . . . . 0.559 ' N ' HG22 ' B' ' 76' ' ' THR . 11.2 m-20 -149.78 -178.69 6.6 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.75 0.31 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.07 108.08 20.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.942 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -111.43 132.78 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' THR . . . . . 0.54 HG21 ' HB1' ' B' ' 71' ' ' ALA . 94.9 m -106.89 135.96 47.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.785 ' O ' HG12 ' B' ' 72' ' ' VAL . 6.5 m-85 -116.91 122.09 43.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.29 150.85 44.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.443 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -133.48 153.8 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.662 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.09 135.32 53.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.439 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.585 HG23 HD12 ' B' ' 9' ' ' ILE . 68.5 mt -145.48 121.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.6 m -118.32 153.47 33.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.63 ' ND2' HD13 ' B' ' 41' ' ' ILE . 3.8 t-20 -94.52 81.63 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -63.74 -15.91 59.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.473 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.04 -154.19 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.84 -19.43 5.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.639 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mtp85 -132.72 167.29 20.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.402 ' O ' HG23 ' B' ' 41' ' ' ILE . 37.8 mtp180 -49.86 164.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.63 HD13 ' ND2' ' B' ' 35' ' ' ASN . 31.3 pt -156.6 132.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.746 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.01 109.22 3.78 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.475 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.46 159.22 15.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.241 0.543 . . . . 0.0 111.899 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.7 155.08 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' HG21 ' B' ' 55' ' ' VAL . 25.4 mm -117.24 132.4 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.928 0.394 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.07 150.65 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.809 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 31.5 p -143.16 153.75 43.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.008 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.6 -42.01 95.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.61 114.85 15.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.64 20.68 7.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ARG . . . . . 0.401 ' HG3' ' HG2' ' B' ' 52' ' ' ARG . 3.4 ptp180 -97.21 -31.58 12.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.401 ' HG2' ' HG3' ' B' ' 51' ' ' ARG . 1.4 ptt180 -113.38 -19.34 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -108.06 132.51 53.48 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.09 107.57 5.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -100.56 127.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -131.32 130.96 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.16 142.76 75.74 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.001 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.11 -31.87 44.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.491 2.127 . . . . 0.0 111.97 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 p -145.75 -177.98 5.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.424 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.26 -170.89 39.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.37 129.47 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.589 HD13 HG23 ' B' ' 68' ' ' VAL . 1.0 OUTLIER -125.45 153.57 43.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.193 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.2 p30 -90.2 168.0 15.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.836 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 30.9 Cg_exo -61.71 133.71 46.66 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.455 2.103 . . . . 0.0 112.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.8 tttm 77.53 12.42 2.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.882 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 1.2 tp10 -108.73 142.96 38.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.12 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.19 161.24 13.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.183 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.589 HG23 HD13 ' B' ' 62' ' ' LEU . 41.5 t -135.61 141.65 41.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.097 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 mt -117.78 118.99 33.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.016 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.547 ' SD ' HD12 ' B' ' 33' ' ' ILE . 9.7 mtm -112.53 158.07 20.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' B' ' 28' ' ' THR . . . -126.63 102.12 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.284 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.785 HG12 ' O ' ' B' ' 29' ' ' TYR . 7.3 p -87.88 109.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 43.0 m -91.32 130.06 37.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.1 t -115.09 150.9 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.681 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.98 154.66 21.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.559 HG22 ' N ' ' B' ' 25' ' ' ASP . 3.7 p -58.67 160.87 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' B' ' 79' ' ' ALA . 0.7 OUTLIER -173.38 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 92.4 m-20 -121.91 82.77 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.509 ' HB2' ' CZ ' ' B' ' 77' ' ' PHE . . . -57.26 -22.12 39.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.232 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.335 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -141.72 43.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' B' ' 78' ' ' ASN . 19.8 mm-40 -122.58 6.29 9.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.627 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.41 140.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' B' ' 124' ' ' TYR . 2.2 mt -115.52 24.31 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -142.01 28.33 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.12 9.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.06 126.86 35.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.82 139.79 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 78.2 mt -107.65 122.16 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.631 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.489 HG23 ' O ' ' B' ' 118' ' ' LYS . 64.0 m -110.17 118.77 37.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.369 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.38 154.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.7 101.7 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.506 ' NE1' HG23 ' B' ' 9' ' ' ILE . 15.3 p90 -122.17 137.77 54.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.034 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.718 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.8 OUTLIER -134.26 149.2 50.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.004 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.46 143.99 52.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 70.7 p -85.59 150.89 54.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 39.8 Cg_endo -67.03 163.54 33.54 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.63 2.22 . . . . 0.0 111.996 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -47.1 116.53 1.4 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.12 46.56 56.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.78 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.681 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -65.01 150.69 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.48 164.96 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.462 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -89.78 71.24 7.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.99 140.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.84 120.22 9.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.419 ' HG2' ' HG2' ' B' ' 107' ' ' GLU . 0.9 OUTLIER -101.22 156.2 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.94 -26.86 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.996 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -65.3 -18.39 65.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.303 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.6 -16.39 56.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.405 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 2.4 m-85 . . . . . 0 C--N 1.332 -0.165 0 CA-C-O 120.673 0.273 . . . . 0.0 111.05 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' MET . . . . . 0.597 ' C ' HG23 ' B' ' 115' ' ' VAL . 2.9 mtt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.718 HG13 ' HB ' ' B' ' 94' ' ' THR . 3.3 t 81.72 117.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.53 148.08 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.45 139.55 46.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.994 0.426 . . . . 0.0 111.199 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 90' ' ' THR . 25.9 mtpp -125.43 166.72 16.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.595 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -121.77 151.78 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.076 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -140.99 88.56 10.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.17 141.49 48.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.632 2.222 . . . . 0.0 112.607 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.09 138.36 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.597 ' C ' HG23 ' B' ' 18' ' ' VAL . 1.6 mm-40 -131.68 159.06 39.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 111.256 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.578 ' HB2' HD22 ' B' ' 84' ' ' LEU . 97.5 m-85 -122.78 113.04 18.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 60.4 t30 -95.03 90.58 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' B' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.674 0.197 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.9 123.18 8.74 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.557 2.171 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.69 138.32 46.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.3 m-20 -59.03 130.65 48.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.27 120.34 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.225 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 146.75 24.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.631 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.78 153.44 49.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.888 0.375 . . . . 0.0 111.218 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.1 mt-30 -144.85 108.94 4.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.0 165.18 37.32 Favored 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.842 -1.316 . . . . 0.0 112.664 0.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -45.13 -59.61 2.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.934 ' HA ' HD22 ' A' ' 120' ' ' LEU . 22.9 pt20 -170.9 45.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.15 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -178.52 132.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 29' ' ' TYR . 18.7 tt -132.28 153.85 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 125' ' ' ASN . 57.1 t -120.78 92.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.674 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.14 95.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.283 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.81 139.39 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.579 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.913 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -76.56 175.23 4.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.586 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.913 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 40.6 Cg_endo -66.7 165.58 64.44 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.683 0.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.63 43.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -123.06 7.21 9.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.323 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.17 142.14 48.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.3 115.63 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.05 103.3 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -84.76 102.47 13.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 17' ' ' ILE . 93.5 m-85 -89.48 117.91 28.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.39 135.43 33.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 12' ' ' GLN . 22.5 mt -119.98 133.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -97.93 139.18 34.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 111.342 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -133.02 146.22 32.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.652 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.4 m -150.09 156.53 41.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 0.0 111.212 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' HB2' HD23 ' A' ' 62' ' ' LEU . 18.4 t30 -97.89 111.07 23.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.727 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.51 19.45 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.21 -140.49 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.566 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.44 53.19 0.47 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -175.97 177.12 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.445 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 25.5 ttm-85 -77.61 151.15 34.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 62' ' ' LEU . 4.3 pt -146.58 167.47 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 111.38 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -132.64 106.14 0.63 Allowed Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.585 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -104.42 160.41 14.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.259 0.552 . . . . 0.0 111.75 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . . . -157.65 143.11 17.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.461 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.426 HD12 HG13 ' A' ' 91' ' ' ILE . 14.3 mm -99.4 154.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.008 0.432 . . . . 0.0 111.634 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.53 132.08 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.4 149.7 42.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.77 -32.14 69.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.96 109.21 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.732 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.69 24.88 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.013 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.54 -55.38 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.23 -28.23 27.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.46 156.69 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.982 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.44 141.33 28.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.2 p -139.21 161.07 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.966 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -176.49 131.06 0.37 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.813 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.17 148.71 92.58 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.186 0.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.6 -12.8 24.76 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.599 2.2 . . . . 0.0 112.847 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.54 172.75 0.72 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.45 174.48 38.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.449 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' HG2' ' A' ' 40' ' ' ARG . 21.7 t -107.12 114.42 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 35' ' ' ASN . 3.7 tp -87.53 169.54 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.072 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.412 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -129.89 176.3 2.94 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.792 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.6 Cg_exo -61.24 114.45 2.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.633 2.222 . . . . 0.0 112.291 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.69 32.28 13.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -97.9 148.0 23.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -113.53 156.2 24.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.84 144.76 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.04 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.51 137.07 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.0 158.76 34.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.03 35.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.187 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.03 91.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.895 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -82.77 151.67 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.48 116.61 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.11 142.78 58.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 p -56.55 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -133.43 -168.89 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -121.31 119.8 33.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 84' ' ' LEU . . . -98.46 18.92 15.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.47 -24.44 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.229 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.3 p -143.1 41.63 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.036 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -138.33 159.59 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.653 ' O ' HD23 ' A' ' 84' ' ' LEU . 22.6 t0 -89.2 134.19 34.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.9 mt -123.62 56.09 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.48 25.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -134.02 6.58 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.637 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.57 108.21 19.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.812 0.339 . . . . 0.0 110.824 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.08 136.1 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.101 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.805 HG13 HD11 ' A' ' 122' ' ' ILE . 12.8 mt -94.87 163.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.5 ' N ' HG22 ' A' ' 89' ' ' ILE . 10.0 m -144.87 123.96 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.128 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.1 mp -115.51 98.1 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.85 136.93 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.675 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' ' 116' ' ' ARG . 6.6 p90 -145.52 143.69 30.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.161 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -141.46 143.48 33.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.78 122.48 14.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.582 HG22 ' CH2' ' A' ' 108' ' ' TRP . 12.0 p -52.93 145.05 24.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 37.1 Cg_endo -65.79 160.53 43.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.534 2.156 . . . . 0.0 112.292 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.4 119.16 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.7 41.5 97.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.763 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.674 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -71.33 139.57 49.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.8 164.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 0.0 111.403 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 70.32 7.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.45 131.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 73.5 t80 -51.25 152.01 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.33 152.09 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -91.77 -23.71 19.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.069 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -18.91 65.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.39 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CH2' HG22 ' A' ' 96' ' ' THR . 34.6 m0 -60.18 -16.14 30.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.276 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.819 0.342 . . . . 0.0 110.89 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.2 mmt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.2 p 176.84 115.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.446 ' HB3' ' CZ3' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -102.23 154.14 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -139.73 96.82 3.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.029 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.34 162.42 18.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.648 ' C ' HD23 ' A' ' 120' ' ' LEU . 67.2 m-80 -140.56 126.52 19.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.934 HD22 ' HA ' ' A' ' 15' ' ' GLN . 1.4 mt -110.85 100.52 46.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.42 144.13 74.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.604 2.203 . . . . 0.0 112.529 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.805 HD11 HG13 ' A' ' 89' ' ' ILE . 8.2 mm -110.53 93.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.68 140.81 32.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD2' HD13 ' A' ' 84' ' ' LEU . 21.3 m-85 -103.7 104.43 14.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.046 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.524 ' HB2' HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -78.66 82.45 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.711 0.213 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.02 123.27 8.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.186 . . . . 0.0 112.286 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.7 138.33 46.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.567 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 11.5 m-20 -58.95 130.75 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.37 120.51 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.85 146.89 24.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.537 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.93 153.3 49.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.204 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.612 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.2 mt-30 -144.72 108.99 4.77 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.07 165.17 37.76 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.611 0.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -45.02 -59.55 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.942 ' HA ' HD22 ' B' ' 120' ' ' LEU . 22.9 pt20 -170.95 44.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.148 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -178.49 132.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.41 . . . . 0.0 111.254 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' B' ' 29' ' ' TYR . 18.5 tt -132.25 154.0 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.721 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' B' ' 125' ' ' ASN . 57.5 t -120.98 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.812 0.339 . . . . 0.0 111.579 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -57.21 95.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.277 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.581 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.931 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -76.49 175.28 4.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.931 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 40.2 Cg_endo -66.51 165.73 62.55 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.951 -1.271 . . . . 0.0 112.786 -0.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 43.69 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.89 6.98 9.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.361 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.0 142.06 48.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.849 0.357 . . . . 0.0 110.972 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -65.16 115.44 5.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -115.91 103.16 10.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.749 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -84.53 102.37 12.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.083 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.439 ' CD1' HD11 ' B' ' 17' ' ' ILE . 93.8 m-85 -89.51 117.87 28.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.725 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.26 135.36 33.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.332 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.612 HG23 ' O ' ' B' ' 12' ' ' GLN . 22.6 mt -119.93 133.12 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.681 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -97.99 138.96 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.38 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -132.9 146.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 55.1 m -150.13 156.41 41.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.276 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.537 ' HB2' HD23 ' B' ' 62' ' ' LEU . 18.4 t30 -97.71 111.08 23.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.51 19.34 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.2 -140.26 9.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.6 53.16 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -175.92 177.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.448 ' HG2' ' CG1' ' B' ' 61' ' ' VAL . 25.9 ttm-85 -77.66 151.17 34.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.438 ' O ' HG13 ' B' ' 61' ' ' VAL . 4.3 pt -146.66 167.37 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 111.428 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -132.56 106.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.568 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 34.0 p-90 -104.53 160.57 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 111.703 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' B' ' 104' ' ' PHE . . . -157.87 142.92 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.461 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.423 HD12 HG13 ' B' ' 91' ' ' ILE . 14.2 mm -99.11 154.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.694 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.75 131.94 15.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.25 149.57 42.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.066 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.6 -32.33 68.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.75 109.18 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.66 24.71 5.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -55.3 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.36 -28.24 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.33 156.64 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.5 141.36 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.491 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.2 p -139.29 160.96 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.197 0.522 . . . . 0.0 111.004 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ASP . . . . . 0.491 ' N ' HG22 ' B' ' 55' ' ' VAL . 0.5 OUTLIER -176.43 131.08 0.38 Allowed Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.826 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.17 148.6 92.31 Favored 'Cis proline' 0 C--N 1.352 0.731 0 C-N-CA 123.691 -1.379 . . . . 0.0 112.314 -0.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.49 -12.63 24.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.617 2.211 . . . . 0.0 112.916 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.37 172.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.33 174.4 38.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.556 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' B' ' 40' ' ' ARG . 21.7 t -106.99 114.64 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.066 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 35' ' ' ASN . 3.7 tp -87.78 169.35 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.408 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.3 OUTLIER -129.76 176.26 2.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 34.2 Cg_exo -61.17 114.4 2.18 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.665 2.244 . . . . 0.0 112.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.72 32.27 13.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -97.79 148.2 23.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -113.69 156.27 24.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.93 144.72 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.52 137.1 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.08 158.83 34.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.829 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.43 146.76 35.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.78 90.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -82.76 151.47 26.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.32 116.48 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.07 142.76 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -56.58 128.07 34.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.39 -168.8 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.02 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -121.45 119.71 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' B' ' 84' ' ' LEU . . . -98.35 18.93 15.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.38 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.53 -24.47 20.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.8 p -143.14 41.8 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -138.54 159.47 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.644 ' O ' HD23 ' B' ' 84' ' ' LEU . 22.6 t0 -89.1 134.06 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.644 HD23 ' O ' ' B' ' 83' ' ' ASP . 9.0 mt -123.45 55.98 1.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.44 25.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -133.76 6.33 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.687 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.54 108.05 19.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.797 0.332 . . . . 0.0 110.864 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.0 136.27 26.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.03 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.813 HG13 HD11 ' B' ' 122' ' ' ILE . 12.6 mt -94.93 163.92 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.494 ' N ' HG22 ' B' ' 89' ' ' ILE . 9.7 m -144.95 123.89 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.538 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.1 mp -115.51 98.05 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.007 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.77 136.94 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.451 ' CZ3' ' HB3' ' B' ' 116' ' ' ARG . 6.7 p90 -145.53 143.7 30.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 2.5 t -141.49 143.51 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.82 122.38 14.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.576 HG22 ' CH2' ' B' ' 108' ' ' TRP . 12.0 p -52.76 144.94 23.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 37.2 Cg_endo -65.81 160.67 42.72 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.617 2.211 . . . . 0.0 112.22 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.43 119.1 3.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.085 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.66 41.92 97.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.587 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.659 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -71.63 139.7 49.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 111.048 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.09 164.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.342 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 70.46 7.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.651 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.51 131.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' B' ' 44' ' ' ALA . 74.1 t80 -51.21 151.98 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.21 152.26 50.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -92.21 -23.49 19.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.056 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -19.0 65.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.348 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.576 ' CH2' HG22 ' B' ' 96' ' ' THR . 34.0 m0 -60.09 -16.36 31.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.213 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 5.1 mmt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.816 0.341 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.521 ' O ' HG13 ' B' ' 115' ' ' VAL . 7.2 p 176.72 115.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.451 ' HB3' ' CZ3' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -102.33 154.21 19.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -139.71 96.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.032 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 162.52 18.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.649 ' C ' HD23 ' B' ' 120' ' ' LEU . 67.2 m-80 -140.59 126.63 19.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.942 HD22 ' HA ' ' B' ' 15' ' ' GLN . 1.4 mt -110.98 100.53 46.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.4 144.15 73.94 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.425 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.813 HD11 HG13 ' B' ' 89' ' ' ILE . 8.3 mm -110.49 93.71 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.195 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.78 141.06 32.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.0 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.406 ' CD2' HD13 ' B' ' 84' ' ' LEU . 21.3 m-85 -103.9 104.43 14.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.516 ' HB2' HG12 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -78.8 82.38 5.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.896 -179.917 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.661 0.192 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.97 119.2 5.9 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.594 2.196 . . . . 0.0 112.284 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.64 131.6 40.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.757 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 5.8 m-20 -48.5 113.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.2 pt -85.12 124.64 40.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.072 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -67.7 138.09 56.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.831 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.52 153.37 51.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.48 102.49 4.66 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.853 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.44 ' HG3' ' HB ' ' A' ' 17' ' ' ILE . 20.2 Cg_endo -60.18 157.51 46.39 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.311 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.59 -10.82 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.763 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.05 -61.5 1.67 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.909 0.385 . . . . 0.0 111.069 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 13' ' ' PRO . 7.2 mttm -143.86 175.19 10.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.236 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' ILE . 19.5 tt -148.11 123.16 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.729 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 123' ' ' GLU . 44.8 t -113.41 118.01 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.457 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 29' ' ' TYR . 48.4 m-85 -77.12 96.03 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.48 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -70.36 131.95 44.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.535 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.745 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -58.39 169.19 1.04 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.736 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.745 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 67.8 Cg_endo -89.1 160.27 38.72 Favored 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.296 -1.127 . . . . 0.0 112.803 0.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.411 ' OH ' ' HB2' ' A' ' 19' ' ' PHE . 32.6 m-85 -97.88 46.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.924 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 76' ' ' THR . 11.1 t70 -132.7 9.0 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.43 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.34 -5.87 7.7 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.59 134.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.32 101.27 2.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.2 m -75.12 102.71 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 36.9 m-85 -74.09 116.06 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.21 121.09 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.614 HD12 ' HE3' ' A' ' 70' ' ' MET . 64.7 mt -104.47 126.79 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.38 124.69 36.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.499 HD11 ' CE ' ' A' ' 70' ' ' MET . 13.5 mt -119.29 158.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 33' ' ' ILE . 55.3 m -162.0 153.07 17.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -95.87 108.79 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.628 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -93.34 22.11 5.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.87 -147.29 20.54 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.569 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.71 -25.38 2.86 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.686 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -122.85 167.45 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 110.99 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.43 162.34 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.553 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 8.3 pt -150.24 137.86 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.828 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.47 111.21 4.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.599 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.439 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 27.5 p-90 -105.22 157.86 16.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.116 0.484 . . . . 0.0 111.772 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.65 148.89 33.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.47 HD13 HG23 ' A' ' 91' ' ' ILE . 15.5 mm -121.67 150.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -151.75 135.93 16.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.681 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.36 154.53 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -62.42 -32.67 73.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.014 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.15 108.23 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.962 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.09 25.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.765 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.07 -38.11 6.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.775 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.29 -32.01 7.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.82 118.33 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.673 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.6 m -122.15 106.8 11.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.91 154.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.21 129.88 0.55 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.171 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 10.3 Cg_exo -71.56 131.67 22.12 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.942 -1.274 . . . . 0.0 111.88 -0.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 32.0 Cg_exo -58.23 -48.43 15.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.407 2.071 . . . . 0.0 112.051 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.3 p -135.96 -178.84 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.53 -168.22 33.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.64 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -144.75 142.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -134.04 136.91 44.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.033 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -64.77 -179.66 0.32 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.968 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 29.6 Cg_exo -61.52 116.18 3.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.585 2.19 . . . . 0.0 112.435 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.52 29.8 2.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' CB ' ' HB2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -90.53 153.26 20.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.636 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -115.29 142.57 46.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.264 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.3 129.82 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.775 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.74 141.19 30.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.614 ' HE3' HD12 ' A' ' 31' ' ' ILE . 36.4 ttp -127.58 158.04 38.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.88 151.05 45.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.391 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.7 84.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.015 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.67 133.74 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 87.86 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.807 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.28 152.67 2.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 2.7 p -66.87 117.64 9.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -137.9 -163.99 1.54 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.62 139.04 43.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.712 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.56 18.64 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.509 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.33 15.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.02 47.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -138.29 165.82 25.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.15 127.0 18.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.5 84.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.997 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.53 25.16 7.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.178 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 73.27 93.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -70.37 147.61 49.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -142.35 137.37 30.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.418 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 78.8 mt -110.32 94.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.664 HG23 ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -78.2 140.24 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 45' ' ' ILE . 3.9 mp -132.96 111.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.006 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.91 124.43 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.027 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 11.7 p90 -133.5 142.08 48.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.678 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -141.3 144.99 34.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -60.74 131.36 50.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 p -73.61 142.45 80.8 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.01 162.74 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.475 2.116 . . . . 0.0 112.16 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.44 118.31 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.95 45.65 70.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.265 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.75 167.71 7.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.211 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.11 163.67 27.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.34 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.44 69.83 8.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.13 146.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -69.8 116.72 10.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.99 155.14 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -84.01 -26.04 29.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -22.66 66.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -59.35 -17.7 31.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 94' ' ' THR . 2.7 m-85 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.538 ' C ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 120.959 0.409 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 94' ' ' THR . 5.1 t 82.55 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.252 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.472 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 5.7 tpt180 -106.83 144.27 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -134.04 103.5 5.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 131.49 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.544 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.664 ' OD1' HG23 ' A' ' 90' ' ' THR . 1.5 m-80 -100.17 143.36 30.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.9 94.98 42.96 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.506 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.13 139.2 62.8 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.632 2.221 . . . . 0.0 112.58 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 7.6 mm -114.51 111.9 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.705 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -112.96 127.91 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -89.39 107.4 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.27 76.89 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.946 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo . . . . . 0 C--O 1.231 0.137 0 CA-C-O 120.731 0.221 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.1 119.33 6.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.566 2.177 . . . . 0.0 112.256 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.67 131.4 40.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.293 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.749 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 5.8 m-20 -48.13 113.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 111.019 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.469 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.2 pt -85.13 124.54 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -67.65 138.1 56.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.43 153.34 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.4 102.4 4.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.433 ' HG3' ' HB ' ' B' ' 17' ' ' ILE . 19.1 Cg_endo -60.12 157.71 45.69 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.777 -1.343 . . . . 0.0 112.222 0.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.73 -10.78 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.729 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.06 -61.58 1.66 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.886 0.374 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' B' ' 13' ' ' PRO . 7.5 mttm -143.8 174.96 10.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.232 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.454 ' O ' HG23 ' B' ' 17' ' ' ILE . 19.5 tt -147.94 123.23 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.698 HG13 ' O ' ' B' ' 123' ' ' GLU . 44.4 t -113.49 117.96 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.53 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.461 ' CE2' ' CD1' ' B' ' 29' ' ' TYR . 48.3 m-85 -77.08 95.98 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.531 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -70.28 131.84 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.629 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.766 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -58.39 169.24 1.03 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.68 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.766 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 67.7 Cg_endo -89.12 160.23 38.62 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.712 0.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' B' ' 19' ' ' PHE . 32.5 m-85 -97.92 46.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.882 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 11.1 t70 -132.87 8.98 4.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.345 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -5.97 7.74 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.68 134.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.768 0.318 . . . . 0.0 110.596 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.39 101.35 2.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -75.24 102.75 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CD1' ' CE2' ' B' ' 19' ' ' PHE . 36.9 m-85 -74.17 116.0 14.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' B' ' 70' ' ' MET . 12.2 m80 -94.18 121.02 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.621 HD12 ' HE3' ' B' ' 70' ' ' MET . 64.3 mt -104.37 126.85 59.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.45 124.8 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.508 HD11 ' CE ' ' B' ' 70' ' ' MET . 13.7 mt -119.35 158.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.953 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.435 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.9 m -162.0 153.17 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -95.99 108.91 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -93.44 22.03 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.147 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.78 -147.46 20.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.573 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.59 -25.36 2.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.685 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' B' ' 64' ' ' PRO . 0.0 OUTLIER -122.8 167.46 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.937 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.55 162.32 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.538 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 8.2 pt -150.22 137.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.401 . . . . 0.0 111.878 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -99.46 111.15 4.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.568 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.441 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 27.6 p-90 -105.09 157.85 16.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 111.763 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.68 148.97 33.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.484 HD13 HG23 ' B' ' 91' ' ' ILE . 15.6 mm -121.71 150.67 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 111.679 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -151.8 136.1 16.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.51 154.42 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.387 . . . . 0.0 111.15 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 68.6 p -62.35 -32.76 73.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.03 108.13 13.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.006 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 30.7 mmm -102.92 25.13 9.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.13 -38.17 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.773 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.23 -32.0 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.79 118.63 36.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.667 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m -122.4 106.71 11.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.192 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.85 154.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.27 129.87 0.54 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.61 131.66 22.15 Favored 'Cis proline' 0 C--N 1.35 0.636 0 C-N-CA 123.932 -1.278 . . . . 0.0 111.887 -0.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.23 -48.5 15.61 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.327 2.018 . . . . 0.0 112.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p -135.8 -178.69 5.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.48 -168.32 33.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.651 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.76 142.86 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.733 ' N ' HD23 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -134.28 136.76 43.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.966 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -64.57 -179.73 0.32 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 29.6 Cg_exo -61.62 116.35 3.37 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.547 2.165 . . . . 0.0 112.377 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.44 29.75 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' B' ' 62' ' ' LEU . 0.5 OUTLIER -90.43 153.36 20.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.637 179.57 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -115.38 142.71 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.264 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.34 129.71 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.815 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.7 141.36 30.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.236 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.621 ' HE3' HD12 ' B' ' 31' ' ' ILE . 36.5 ttp -127.79 158.08 38.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.04 151.01 45.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.354 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.6 84.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.77 133.59 55.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.3 t -141.49 87.83 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.15 152.67 2.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' B' ' 24' ' ' ASP . 2.8 p -66.84 117.97 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -138.2 -164.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.57 139.14 43.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.69 18.64 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.508 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.83 -26.28 15.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 111.033 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -150.02 48.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.49 165.79 25.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.14 126.96 17.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 88.0 mt -151.47 84.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.44 25.11 7.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.216 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 73.49 93.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.894 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.42 147.63 49.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -142.39 137.3 30.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' B' ' 91' ' ' ILE . 77.9 mt -110.23 94.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.676 HG23 ' OD1' ' B' ' 119' ' ' ASN . 0.2 OUTLIER -78.19 140.22 38.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.484 HG23 HD13 ' B' ' 45' ' ' ILE . 3.9 mp -133.02 111.24 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.937 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.93 124.29 50.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.021 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 11.8 p90 -133.44 142.05 48.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.666 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.7 OUTLIER -141.26 145.07 35.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -60.74 131.35 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 3.9 p -73.6 142.36 80.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.05 162.49 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.512 2.141 . . . . 0.0 112.101 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.17 118.23 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.98 45.71 70.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.239 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.76 167.87 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 163.76 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.268 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 69.86 8.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.617 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.3 147.2 0.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.801 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.32 116.7 10.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.892 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.94 154.99 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -83.71 -26.43 29.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -22.68 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -59.45 -17.56 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.249 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.573 ' CZ ' HG22 ' B' ' 94' ' ' THR . 2.7 m-85 . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.891 0.377 . . . . 0.0 110.814 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 114' ' ' MET . . . . . 0.542 ' C ' HG23 ' B' ' 115' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.96 0.409 . . . . 0.0 110.897 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.666 HG13 ' HB ' ' B' ' 94' ' ' THR . 5.1 t 82.57 129.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.23 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.474 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 5.7 tpt180 -106.84 144.29 33.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.42 55.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.676 ' OD1' HG23 ' B' ' 90' ' ' THR . 1.5 m-80 -100.08 143.4 30.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.228 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.07 95.11 43.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.383 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 139.21 64.26 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.638 2.225 . . . . 0.0 112.548 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 7.6 mm -114.41 111.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.698 ' O ' HG13 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -112.6 128.05 56.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.098 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -89.63 107.4 19.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.2 76.86 9.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.832 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 CA--C 1.528 0.204 0 CA-C-O 120.602 0.168 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.06 138.72 28.63 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.422 2.081 . . . . 0.0 112.342 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 111.84 2.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.541 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.837 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.3 p-10 -46.95 140.38 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.678 0.275 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 93' ' ' TRP . 1.3 pt -116.71 147.12 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.39 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.2 145.03 25.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.17 144.0 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.297 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -133.05 111.46 13.14 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.59 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 31' ' ' ILE . 32.0 Cg_endo -63.84 161.81 60.19 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.928 -1.28 . . . . 0.0 112.446 0.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -20.48 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.385 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.56 -49.35 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.901 0.381 . . . . 0.0 111.205 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 152.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.605 ' CG2' HD13 ' A' ' 122' ' ' ILE . 12.3 tt -105.95 153.21 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 123' ' ' GLU . 8.0 p -136.19 100.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.418 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.12 114.26 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.542 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.92 142.1 38.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.287 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -66.39 170.6 5.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.732 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 6.9 Cg_exo -73.96 167.04 80.69 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.514 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -110.99 32.84 4.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -117.41 7.22 12.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.25 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.76 149.82 48.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.926 0.393 . . . . 0.0 110.961 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -67.5 107.95 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -108.01 138.09 44.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.846 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.16 112.86 24.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.094 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -105.03 108.5 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -79.76 151.08 30.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.407 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.543 HD12 ' HD2' ' A' ' 13' ' ' PRO . 29.1 mm -126.06 150.06 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.713 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HB2' ' HG3' ' B' ' 22' ' ' PRO . 12.2 ttmm -104.85 120.57 41.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.93 0.395 . . . . 0.0 111.298 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.5 mt -121.9 130.06 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.717 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.5 m -139.76 155.02 47.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.148 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.46 114.24 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.763 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.837 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.35 18.53 7.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.387 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.09 -141.43 6.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.52 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.43 52.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -174.59 164.78 3.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.776 0.322 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.18 137.09 46.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.733 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.415 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 2.5 pt -139.11 114.86 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.33 122.67 9.78 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.919 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.83 ' CD1' HD23 ' A' ' 62' ' ' LEU . 29.4 p-90 -114.63 157.9 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 111.458 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.73 135.96 14.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.693 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.008 HG21 HG11 ' A' ' 55' ' ' VAL . 41.5 mm -93.06 141.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.472 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.26 133.03 15.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.58 160.37 32.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 111.139 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.73 -47.83 41.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -114.29 112.56 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 23.48 6.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.988 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -45.78 3.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -81.99 -50.82 8.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -76.21 154.08 35.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -143.84 110.9 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.774 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.008 HG11 HG21 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -100.04 146.71 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -164.26 123.75 1.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 135.42 38.59 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.774 -1.344 . . . . 0.0 112.08 0.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.48 -10.64 23.98 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 0.0 112.74 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 p -162.53 165.47 26.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.33 -154.78 25.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.542 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 t -135.02 149.26 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' CD1' ' A' ' 43' ' ' TRP . 0.9 OUTLIER -116.79 123.41 47.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -77.02 168.27 29.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.73 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 36.3 Cg_endo -65.25 116.46 3.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.573 2.182 . . . . 0.0 112.454 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt 62.09 28.61 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -101.34 150.06 23.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.127 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 30.0 mttt -111.19 154.84 23.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.614 HG11 HD21 ' A' ' 62' ' ' LEU . 8.9 p -149.94 142.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.003 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.67 136.06 36.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 159.09 25.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.69 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.78 124.75 34.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 55' ' ' VAL . 33.3 t -126.37 93.86 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.6 p -86.33 154.15 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.0 p -133.14 108.54 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.24 145.49 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 76' ' ' THR . 3.4 p -61.05 142.0 56.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.821 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.06 -169.92 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -116.44 111.77 20.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.41 20.37 11.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.35 -28.84 14.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.202 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.7 p -142.16 46.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -147.16 144.43 28.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.79 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.416 ' O ' HD23 ' A' ' 84' ' ' LEU . 17.4 m-20 -71.95 150.78 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 54.8 mt -132.95 66.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -157.48 31.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.025 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -132.72 6.35 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.649 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.91 117.19 33.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -149.02 134.19 18.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 122' ' ' ILE . 62.2 mt -86.96 161.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.543 ' N ' HG22 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -148.05 110.89 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.105 -179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 91' ' ' ILE . 3.6 mp -102.05 111.95 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' CG ' ' CB ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -113.72 131.61 56.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.969 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.498 ' CE2' HG12 ' A' ' 9' ' ' ILE . 17.8 p90 -141.67 150.48 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.67 ' HB ' HG13 ' A' ' 115' ' ' VAL . 11.6 t -154.34 154.61 33.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.49 153.51 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -101.41 133.06 21.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.786 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.03 158.2 11.91 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.461 2.108 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -52.73 124.21 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.85 32.19 70.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.386 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 101' ' ' ALA . . . -62.03 -18.28 60.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.581 0.229 . . . . 0.0 111.452 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 100' ' ' ALA . . . 73.01 166.06 0.3 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.359 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -87.22 71.29 10.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.22 129.42 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 77.5 t80 -56.94 150.32 16.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.4 155.24 45.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -93.05 22.33 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.35 -6.3 17.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.6 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.471 ' CH2' ' HA ' ' A' ' 104' ' ' PHE . 8.8 m0 -91.14 19.65 5.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.626 0.25 . . . . 0.0 111.057 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 C--N 1.333 -0.132 0 CA-C-O 120.758 0.313 . . . . 0.0 111.151 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.9 ptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.73 0.3 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.67 HG13 ' HB ' ' A' ' 94' ' ' THR . 19.6 t -82.64 143.14 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.36 125.36 50.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.438 ' CB ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -135.5 153.72 51.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.31 135.5 48.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.521 ' CG ' HG23 ' A' ' 90' ' ' THR . 5.6 m-80 -96.18 129.48 43.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.261 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.9 mt -111.43 98.7 41.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.652 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.92 150.14 10.22 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.66 2.24 . . . . 0.0 112.596 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 89' ' ' ILE . 37.5 mm -100.87 149.84 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.962 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.76 ' HB3' HG23 ' A' ' 18' ' ' VAL . 29.3 mt-10 -133.22 156.93 46.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.009 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 84' ' ' LEU . 54.6 m-85 -123.81 105.23 9.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.974 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.411 ' ND2' HG12 ' B' ' 18' ' ' VAL . 5.7 t30 -87.49 81.38 7.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.759 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.903 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 CA--C 1.527 0.128 0 CA-C-O 120.663 0.193 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 138.94 29.14 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.5 2.133 . . . . 0.0 112.289 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.28 112.05 2.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.842 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 8.2 p-10 -47.0 140.34 4.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 111.089 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' B' ' 93' ' ' TRP . 1.3 pt -116.42 147.25 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.53 144.92 25.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.0 144.16 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.1 111.52 13.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' B' ' 31' ' ' ILE . 32.7 Cg_endo -63.86 162.01 59.65 Favored 'Cis proline' 0 C--N 1.351 0.669 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.42 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -20.38 11.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.57 -49.47 4.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.07 152.26 1.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.605 ' CG2' HD13 ' B' ' 122' ' ' ILE . 12.4 tt -105.88 153.19 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.752 HG23 ' HB3' ' B' ' 123' ' ' GLU . 7.9 p -136.23 100.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.99 114.21 3.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.75 142.37 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -66.53 170.34 5.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.663 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.876 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 6.7 Cg_exo -74.21 167.09 80.78 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.559 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -111.04 32.99 4.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -117.54 7.19 12.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.211 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.67 150.14 48.32 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -67.84 107.88 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.87 138.17 44.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 112.88 24.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.14 108.51 20.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -79.51 150.99 31.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.435 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.551 HD12 ' HD2' ' B' ' 13' ' ' PRO . 29.0 mm -126.1 150.15 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.689 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.455 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 12.0 ttmm -104.89 120.51 41.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.318 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -121.85 130.13 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.739 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -139.8 155.12 47.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 11.4 t-20 -92.53 114.32 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.692 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.41 18.71 6.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.356 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.18 -141.46 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.564 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.25 51.85 0.55 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -174.32 164.84 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.15 137.12 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' B' ' 9' ' ' ILE . 2.5 pt -139.05 115.14 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.317 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -71.58 122.56 9.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.922 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.848 ' CD1' HD23 ' B' ' 62' ' ' LEU . 29.5 p-90 -114.56 157.98 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.91 136.0 14.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.657 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.996 HG21 HG11 ' B' ' 55' ' ' VAL . 41.7 mm -93.13 141.92 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.5 133.1 15.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.754 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.73 160.45 32.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.06 0.457 . . . . 0.0 111.084 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -47.7 43.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -114.33 112.63 23.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 23.38 6.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -45.82 3.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.87 -50.97 8.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.13 154.26 35.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.143 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 9.7 m -144.03 110.81 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.996 HG11 HG21 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -100.07 146.53 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.213 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -164.19 123.74 1.31 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.26 135.33 38.02 Favored 'Cis proline' 0 C--N 1.352 0.748 0 C-N-CA 123.756 -1.352 . . . . 0.0 112.137 0.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.4 -10.45 23.96 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.507 2.138 . . . . 0.0 112.744 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 24.3 p -162.75 165.44 25.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.31 -154.93 26.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 t -134.88 149.28 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.789 0.328 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.848 HD23 ' CD1' ' B' ' 43' ' ' TRP . 0.9 OUTLIER -116.88 123.28 46.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.99 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 0.6 OUTLIER -76.84 168.26 29.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.703 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 36.5 Cg_endo -65.25 116.56 3.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.587 2.191 . . . . 0.0 112.381 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt 62.04 28.55 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' B' ' 67' ' ' LYS . 0.2 OUTLIER -101.24 150.3 23.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 67' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 66' ' ' GLU . 30.1 mttt -111.44 154.84 24.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.99 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.608 HG11 HD21 ' B' ' 62' ' ' LEU . 8.6 p -149.94 142.88 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.968 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.66 135.95 36.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.28 159.18 25.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.92 124.59 33.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.317 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.72 HG22 HG12 ' B' ' 55' ' ' VAL . 31.0 t -126.27 93.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -86.44 154.26 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 p -133.25 108.42 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -53.23 145.41 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.969 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.5 p -61.04 141.88 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.97 -169.8 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -116.54 111.55 20.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.29 20.54 11.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.41 -29.15 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 60.0 p -141.96 46.74 1.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -147.19 144.41 28.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.411 ' O ' HD23 ' B' ' 84' ' ' LEU . 16.8 m-20 -71.87 150.97 43.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.453 ' HB3' ' CE1' ' B' ' 124' ' ' TYR . 55.6 mt -133.16 67.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.784 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -157.51 32.08 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -132.8 6.31 3.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.615 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.81 117.27 33.96 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.878 0.37 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -149.11 134.08 18.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.635 HG13 HD11 ' B' ' 122' ' ' ILE . 61.9 mt -86.77 161.09 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.548 ' N ' HG22 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -147.99 111.01 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.593 HD12 ' N ' ' B' ' 91' ' ' ILE . 3.7 mp -102.12 111.92 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 0.4 OUTLIER -113.68 131.63 56.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.498 ' CE2' HG12 ' B' ' 9' ' ' ILE . 18.0 p90 -141.59 150.74 42.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.678 ' HB ' HG13 ' B' ' 115' ' ' VAL . 11.5 t -154.55 154.68 33.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.56 153.49 4.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.966 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.408 ' HB ' ' CB ' ' B' ' 100' ' ' ALA . 0.6 OUTLIER -101.37 132.99 21.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 96' ' ' THR . 53.1 Cg_exo -55.0 158.17 11.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.5 2.133 . . . . 0.0 112.316 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -52.67 124.29 13.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.57 32.41 71.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.427 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' B' ' 101' ' ' ALA . . . -62.06 -18.35 60.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.611 0.243 . . . . 0.0 111.511 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 100' ' ' ALA . . . 73.29 166.2 0.3 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.215 0.531 . . . . 0.0 111.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -87.49 71.45 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.78 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.35 129.36 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.472 ' HA ' ' CH2' ' B' ' 108' ' ' TRP . 77.3 t80 -56.83 150.29 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.45 155.13 45.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.973 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -92.93 22.32 5.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.159 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.33 -6.44 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.636 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.472 ' CH2' ' HA ' ' B' ' 104' ' ' PHE . 9.0 m0 -91.1 19.61 5.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.66 0.266 . . . . 0.0 111.069 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.746 0.307 . . . . 0.0 111.203 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.893 0.377 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' B' ' 94' ' ' THR . 19.3 t -82.57 143.26 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.59 125.27 50.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.437 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -135.4 153.63 51.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.181 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.24 135.6 48.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.623 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.523 ' CG ' HG23 ' B' ' 90' ' ' THR . 5.7 m-80 -96.23 129.36 43.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.293 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 79.1 mt -111.3 98.75 41.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.681 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.94 150.17 10.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.638 2.225 . . . . 0.0 112.518 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.635 HD11 HG13 ' B' ' 89' ' ' ILE . 36.9 mm -100.92 149.9 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.006 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' B' ' 18' ' ' VAL . 30.4 mt-10 -133.23 156.87 46.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' B' ' 84' ' ' LEU . 55.5 m-85 -123.82 105.09 9.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.514 ' ND2' HG12 ' A' ' 18' ' ' VAL . 5.5 t30 -87.33 81.42 7.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.789 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.95 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 N--CA 1.465 -0.166 0 CA-C-O 120.697 0.207 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HG2' ' HG3' ' A' ' 116' ' ' ARG . 60.6 Cg_endo -72.67 157.87 51.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.296 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 37' ' ' GLY . . . -82.09 129.6 9.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -50.77 129.99 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -99.16 120.22 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -81.8 142.52 32.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -136.95 155.72 49.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.45 106.58 4.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.02 154.47 48.54 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.508 0.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -50.36 11.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.199 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -159.49 41.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.117 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -153.53 92.9 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.33 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.722 ' CG2' HD13 ' A' ' 122' ' ' ILE . 10.4 tt -123.28 130.78 74.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.599 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.004 HG11 HG11 ' B' ' 18' ' ' VAL . 7.4 p -138.97 113.98 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.516 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -71.84 104.6 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.376 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 153.52 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.595 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.826 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -77.11 170.35 16.77 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.655 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.826 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 96.1 Cg_endo -79.07 166.77 78.23 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.786 0.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' CD2' ' A' ' 126' ' ' LEU . 22.3 m-85 -106.84 50.03 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.871 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.53 -3.33 10.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.309 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -137.5 150.31 47.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.844 0.354 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.82 110.72 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.25 83.49 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 114.94 10.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.81 132.92 42.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.15 138.89 38.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.96 145.18 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.442 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.86 138.85 39.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 34' ' ' THR . 47.0 mt -121.04 157.92 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.64 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 33' ' ' ILE . 88.8 m -162.12 148.53 13.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB3' HD11 ' A' ' 41' ' ' ILE . 23.8 p-10 -121.03 84.63 2.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 110.495 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.42 -27.32 0.68 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.56 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 7' ' ' GLY . . . -47.65 154.08 1.4 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.685 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.71 54.83 0.93 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.435 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 154.89 4.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -65.79 148.37 51.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 61' ' ' VAL . 26.5 pt -145.47 165.55 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -125.07 106.51 0.91 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 62.5 p-90 -104.29 157.58 17.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.227 0.537 . . . . 0.0 112.183 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 153.44 40.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.357 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.409 ' CD1' HG12 ' A' ' 91' ' ' ILE . 11.9 mm -119.92 145.36 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.979 0.419 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.69 134.83 20.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.683 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 89' ' ' ILE . 37.1 p -112.36 153.74 26.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -26.17 18.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.721 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.68 114.16 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.3 19.84 5.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.285 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -96.33 -44.27 7.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.87 -50.7 4.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.463 HD22 ' SG ' ' A' ' 74' ' ' CYS . 13.2 mt -78.96 153.76 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.27 151.25 28.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.017 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.8 150.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.786 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.15 115.71 0.62 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.51 139.56 61.34 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.219 -0.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 -32.94 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.655 2.237 . . . . 0.0 112.185 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 m -139.68 155.59 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 179.28 159.29 23.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.419 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 61' ' ' VAL . 10.6 p -96.1 114.6 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.217 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.91 166.07 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.428 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 3.9 m-20 -119.18 166.21 15.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.781 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.01 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.752 2.301 . . . . 0.0 112.518 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 70.18 38.92 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 34' ' ' THR . 0.1 OUTLIER -112.33 155.56 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.996 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.11 136.48 50.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.33 129.16 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 127.04 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.793 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.47 159.03 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.0 155.33 26.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.48 82.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.792 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -53.24 136.32 36.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.196 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.463 ' SG ' HD22 ' A' ' 53' ' ' LEU . 51.2 m -152.62 82.11 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.04 150.16 45.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.85 162.16 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -167.56 -169.51 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -102.33 114.53 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.98 22.19 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.407 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.84 -32.16 12.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.0 p -142.91 56.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.61 179.84 4.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.551 ' C ' HD23 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -100.68 82.42 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.002 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.75 HD13 ' CD2' ' A' ' 124' ' ' TYR . 8.3 mt -117.11 67.76 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.94 -27.97 24.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.54 -49.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.324 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.09 147.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -155.45 132.74 10.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.161 0.505 . . . . 0.0 111.938 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.446 HG12 HG22 ' A' ' 47' ' ' THR . 57.5 mt -101.15 102.18 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.71 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -83.75 138.12 33.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.091 0.472 . . . . 0.0 111.675 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 45' ' ' ILE . 12.9 mt -122.4 123.6 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 44.6 mt-10 -120.09 112.43 19.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 10.6 p90 -126.87 128.74 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.752 ' HB ' HG22 ' A' ' 115' ' ' VAL . 1.4 t -127.87 148.99 50.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.393 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -52.03 147.55 7.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.557 HG22 ' CH2' ' A' ' 108' ' ' TRP . 4.8 p -84.64 134.69 41.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.6 161.44 2.96 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.31 2.006 . . . . 0.0 111.94 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -50.81 125.39 13.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.76 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.21 48.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.241 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' THR . . . -66.62 143.32 57.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 111.241 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.14 164.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.267 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -88.4 69.82 9.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.61 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 179.16 137.69 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.802 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -54.97 145.75 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 5.2 mmt180 -131.74 150.71 52.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.09 -25.46 23.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.936 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.86 -14.97 59.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.502 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.557 ' CH2' HG22 ' A' ' 96' ' ' THR . 19.0 m0 -55.45 -20.43 12.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.281 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.739 0.304 . . . . 0.0 111.07 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.86 0.362 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.752 HG22 ' HB ' ' A' ' 94' ' ' THR . 25.5 t -122.6 130.22 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.504 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 10.5 mtt180 -103.09 137.38 41.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.17 102.42 6.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.22 170.84 8.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.583 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.8 122.86 13.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.98 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 106.26 38.33 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.663 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.2 138.63 82.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.514 2.143 . . . . 0.0 112.79 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 17' ' ' ILE . 5.0 mm -110.97 150.81 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.591 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 18' ' ' VAL . 67.6 mt-10 -141.53 140.87 33.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 0.0 111.423 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.75 ' CD2' HD13 ' A' ' 84' ' ' LEU . 38.4 m-85 -101.66 96.82 7.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.11 94.79 3.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.429 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 42.0 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 CA--C 1.527 0.144 0 CA-C-O 120.74 0.225 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.402 ' HG2' ' HG3' ' B' ' 116' ' ' ARG . 60.3 Cg_endo -72.68 157.88 51.5 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.596 2.197 . . . . 0.0 112.24 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.18 129.7 9.22 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -50.88 129.99 24.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' B' ' 35' ' ' ASN . 1.1 pt -99.11 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.007 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.406 ' ND2' ' HB ' ' B' ' 34' ' ' THR . 1.1 p30 -81.85 142.66 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.843 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 16.0 p -137.02 155.83 49.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.27 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.6 106.55 4.34 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.649 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.02 154.4 48.53 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.613 0.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -50.27 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.185 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -159.67 41.89 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -153.51 92.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.301 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.721 ' CG2' HD13 ' B' ' 122' ' ' ILE . 10.5 tt -123.19 130.89 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 1.004 HG11 HG11 ' A' ' 18' ' ' VAL . 7.6 p -138.97 113.84 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.568 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -71.76 104.69 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.3 153.32 42.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.439 . . . . 0.0 111.525 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.832 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -76.9 170.32 16.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.672 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.832 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 97.1 Cg_endo -78.97 166.97 77.93 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.027 -1.239 . . . . 0.0 112.759 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' B' ' 126' ' ' LEU . 22.2 m-85 -106.98 49.89 0.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.872 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.48 -3.16 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.304 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -137.57 150.36 47.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.82 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 110.75 3.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.19 83.84 1.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 85.6 m -72.27 114.77 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.62 133.0 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.29 138.93 38.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.92 145.31 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.07 138.5 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.941 0.4 . . . . 0.0 111.481 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.479 HG22 ' N ' ' B' ' 34' ' ' THR . 47.4 mt -120.79 157.67 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.659 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.479 ' N ' HG22 ' B' ' 33' ' ' ILE . 87.7 m -161.93 148.5 13.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' B' ' 41' ' ' ILE . 23.8 p-10 -120.95 84.6 2.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.513 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.47 -27.34 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.77 153.8 1.54 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.657 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.44 55.0 0.95 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 154.97 4.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.8 0.333 . . . . 0.0 110.827 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -65.9 148.23 52.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.737 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.595 ' O ' HG23 ' B' ' 61' ' ' VAL . 26.6 pt -145.16 165.57 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 111.586 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -125.15 106.21 0.89 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 62.7 p-90 -104.27 157.37 17.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.217 0.532 . . . . 0.0 112.207 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.88 153.38 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.422 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.414 ' CD1' HG12 ' B' ' 91' ' ' ILE . 12.3 mm -119.88 145.51 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.81 134.74 20.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.455 HG22 HG12 ' B' ' 89' ' ' ILE . 36.7 p -112.27 153.52 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.22 -26.21 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.739 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.65 114.15 7.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.23 19.85 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -96.32 -44.38 7.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.741 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.83 -50.79 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.466 HD22 ' SG ' ' B' ' 74' ' ' CYS . 13.3 mt -78.88 154.01 30.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.5 151.11 28.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.7 150.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.09 115.86 0.62 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.47 139.6 61.5 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.098 -0.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.41 -32.84 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.547 2.165 . . . . 0.0 112.102 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.64 155.58 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.479 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 179.4 159.5 23.55 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.411 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 41' ' ' ILE . 10.5 p -96.29 114.79 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.211 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.08 166.19 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.428 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 3.8 m-20 -119.29 166.2 15.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.685 2.257 . . . . 0.0 112.483 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? 69.81 39.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.434 ' O ' HG23 ' B' ' 34' ' ' THR . 0.1 OUTLIER -112.67 155.47 24.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.02 136.39 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.99 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -122.27 128.76 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.16 126.84 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.28 158.97 37.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.83 155.36 25.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.52 82.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.759 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 15.1 m -52.94 136.29 34.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.158 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.466 ' SG ' HD22 ' B' ' 53' ' ' LEU . 50.9 m -152.65 82.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.66 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.13 150.07 46.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.84 162.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -167.56 -169.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -102.46 114.63 28.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.1 22.22 5.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.344 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.03 -31.95 12.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.223 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.4 p -143.16 56.18 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -123.74 179.93 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.545 ' C ' HD23 ' B' ' 84' ' ' LEU . 1.0 OUTLIER -100.73 82.46 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.749 HD13 ' CD2' ' B' ' 124' ' ' TYR . 8.1 mt -117.08 67.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.73 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -28.05 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.61 -49.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.01 147.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 -155.5 132.67 10.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 111.869 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.455 HG12 HG22 ' B' ' 47' ' ' THR . 56.8 mt -101.11 102.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.744 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 20.3 m -83.73 137.89 33.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.187 0.518 . . . . 0.0 111.654 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' B' ' 45' ' ' ILE . 13.0 mt -122.32 123.47 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.269 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 44.4 mt-10 -119.99 112.48 19.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.499 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 10.5 p90 -126.84 128.79 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.573 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.751 ' HB ' HG22 ' B' ' 115' ' ' VAL . 1.4 t -128.02 148.91 50.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.391 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -51.91 147.73 6.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.569 HG22 ' CH2' ' B' ' 108' ' ' TRP . 4.6 p -84.75 134.71 41.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.63 161.57 2.91 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.384 2.056 . . . . 0.0 111.867 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -50.87 125.37 13.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.09 48.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.203 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' B' ' 96' ' ' THR . . . -66.51 143.11 57.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 0.0 111.34 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.65 164.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.288 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -88.61 69.82 8.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.53 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? 179.2 137.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.812 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -55.34 145.95 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.991 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.448 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 5.0 mmt180 -131.93 150.71 52.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.22 -25.25 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.007 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.93 -15.14 59.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.454 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.569 ' CH2' HG22 ' B' ' 96' ' ' THR . 19.0 m0 -55.27 -20.45 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.613 0.245 . . . . 0.0 111.25 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 111.104 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.789 0.328 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.751 HG22 ' HB ' ' B' ' 94' ' ' THR . 25.5 t -122.5 130.45 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.499 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 10.5 mtt180 -103.18 137.51 41.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.734 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.31 102.3 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.411 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.11 170.91 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.578 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -142.78 123.02 13.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.53 106.2 38.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.677 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.14 138.81 83.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.62 2.213 . . . . 0.0 112.77 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.721 HD13 ' CG2' ' B' ' 17' ' ' ILE . 5.0 mm -111.21 150.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.513 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.574 ' O ' HG23 ' B' ' 18' ' ' VAL . 67.6 mt-10 -141.79 140.59 33.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 111.442 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.749 ' CD2' HD13 ' B' ' 84' ' ' LEU . 37.5 m-85 -101.44 96.68 7.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.94 94.88 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' B' ' 23' ' ' TYR . 41.3 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 CA--C 1.527 0.147 0 CA-C-O 120.666 0.194 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.29 135.51 46.96 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.568 2.178 . . . . 0.0 112.173 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.3 122.91 16.17 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.273 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.7 108.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.36 145.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.317 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.5 146.7 23.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.576 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.07 155.9 49.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.24 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -153.96 106.23 2.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.645 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.73 161.97 45.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.474 0.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.3 -10.96 11.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.616 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.503 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -108.28 -56.35 2.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.879 0.371 . . . . 0.0 111.18 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.89 -175.43 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.492 ' CG2' HD13 ' A' ' 122' ' ' ILE . 9.5 tt -150.26 136.34 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 123' ' ' GLU . 7.3 p -126.19 107.94 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.711 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -65.13 119.99 11.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -84.37 134.95 34.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 111.654 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -51.74 170.5 0.21 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.683 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 89.1 Cg_endo -80.13 164.11 81.07 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 124.065 -1.223 . . . . 0.0 112.721 0.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.519 ' CE2' HD23 ' A' ' 126' ' ' LEU . 20.2 m-85 -109.62 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.81 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.22 5.65 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.155 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.67 129.09 25.93 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 0.0 110.773 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.79 106.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -105.61 150.3 25.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.44 97.97 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -87.23 125.52 34.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.4 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 71' ' ' ALA . 12.3 m80 -94.97 130.68 41.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' HE3' ' A' ' 70' ' ' MET . 28.6 mt -97.84 150.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -104.6 134.27 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.361 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 70' ' ' MET . 23.8 mt -136.87 154.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.1 m -153.83 158.35 40.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.061 0.458 . . . . 0.0 111.238 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 20.4 t-20 -107.85 114.04 27.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.544 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.02 19.91 6.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.424 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.3 -177.26 19.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.632 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.45 19.63 26.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.71 161.94 37.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -65.67 164.11 15.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 pt -149.19 142.0 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.403 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -102.42 100.98 2.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.731 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.406 ' CD1' HD12 ' A' ' 62' ' ' LEU . 63.0 p-90 -105.71 149.76 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.047 0.451 . . . . 0.0 111.528 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.57 132.23 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.597 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 9.2 mm -92.75 151.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.268 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -138.63 138.2 37.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -124.25 148.97 46.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -55.7 -40.08 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -127.52 118.17 23.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.73 16.72 7.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.408 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -110.88 -31.63 7.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -23.11 14.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 74' ' ' CYS . 34.9 mt -126.85 138.75 53.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 m -149.5 116.7 6.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 71' ' ' ALA . 2.7 t -94.43 153.48 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -145.65 123.3 6.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.0 144.93 77.32 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.498 0.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.21 -13.63 40.26 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.584 2.19 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.61 130.75 0.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 110.586 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.21 -178.82 25.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.668 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 61' ' ' VAL . 10.5 p -114.34 111.52 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.482 HD23 ' HG3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -80.56 145.48 31.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 2.8 m-20 -101.81 171.88 4.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' O ' ' CD ' ' A' ' 65' ' ' LYS . 42.3 Cg_exo -57.06 127.87 27.54 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.527 2.151 . . . . 0.0 112.505 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CD ' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 46.89 34.86 2.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.482 ' HG3' HD23 ' A' ' 62' ' ' LEU . 1.4 tp10 -101.4 136.64 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.67 113.82 27.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.057 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.87 155.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.87 119.3 26.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.662 ' HE3' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -112.83 164.66 13.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -118.46 155.46 30.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.5 t -129.68 104.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.798 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 125.69 32.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HA ' HD23 ' A' ' 53' ' ' LEU . 1.8 p -129.6 98.19 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.712 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.84 153.9 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 76' ' ' THR . 2.3 p -64.62 151.16 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.481 ' CZ ' ' CD2' ' A' ' 124' ' ' TYR . 3.5 p90 -148.58 -161.44 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.089 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.09 93.47 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -68.23 -19.02 64.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.58 -28.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.788 0.328 . . . . 0.0 111.462 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 71.7 p -143.56 59.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 81' ' ' THR . 47.1 mt-10 -159.24 160.31 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -82.76 153.16 25.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' A' ' 124' ' ' TYR . 12.5 mt -128.43 38.36 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.67 30.04 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.16 -45.37 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.39 138.47 54.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 132.3 3.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.82 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 78.4 mt -107.73 121.93 61.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 118' ' ' LYS . 4.0 m -103.79 138.76 39.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.0 mp -118.16 124.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 122.01 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.428 ' CZ2' ' HB2' ' A' ' 116' ' ' ARG . 6.2 p90 -130.94 143.66 50.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.724 ' CB ' HG22 ' A' ' 115' ' ' VAL . 1.3 t -145.18 120.57 10.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.22 142.83 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.595 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.534 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 6.9 p -82.01 146.06 54.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.953 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.69 165.92 14.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.547 2.164 . . . . 0.0 112.158 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -45.16 114.38 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.498 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.73 49.67 16.16 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.902 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -51.6 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 100' ' ' ALA . . . 172.68 163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.074 0.464 . . . . 0.0 111.243 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.49 69.51 9.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.518 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.21 128.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.735 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -48.97 131.28 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.994 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 108' ' ' TRP . 6.6 ttm180 -121.47 150.33 41.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 27.16 7.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.27 -1.09 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.787 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.534 ' CZ3' HG22 ' A' ' 96' ' ' THR . 7.2 m0 -92.47 19.87 6.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.588 0.232 . . . . 0.0 111.193 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.28 . . . . 0.0 111.306 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.608 ' C ' HG23 ' A' ' 115' ' ' VAL . 1.4 mpt? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.976 0.417 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.724 HG22 ' CB ' ' A' ' 94' ' ' THR . 4.5 t 87.07 106.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.39 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 93' ' ' TRP . 48.0 mtt-85 -98.87 146.14 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.67 156.78 17.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.385 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -145.18 161.74 38.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.524 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.93 148.97 34.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.33 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 15' ' ' GLN . 34.6 mt -151.17 86.36 4.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.569 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.1 158.77 3.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.697 2.265 . . . . 0.0 112.66 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.492 HD13 ' CG2' ' A' ' 17' ' ' ILE . 25.1 mm -114.53 145.72 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.048 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.739 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -139.06 165.12 27.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 111.037 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 90.1 m-85 -132.59 108.2 8.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.993 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -96.18 83.18 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 29.6 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.831 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.684 0.202 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.27 135.47 46.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.206 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.35 122.98 16.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.306 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -50.67 108.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.25 145.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.67 146.64 24.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.559 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.88 156.09 48.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.232 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -154.18 106.32 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.661 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.76 162.06 45.87 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.872 -1.304 . . . . 0.0 112.381 0.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -11.02 11.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.502 ' O ' HD23 ' B' ' 120' ' ' LEU . 0.1 OUTLIER -108.23 -56.31 2.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 111.204 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -154.9 -175.3 5.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.491 ' CG2' HD13 ' B' ' 122' ' ' ILE . 9.5 tt -150.44 136.36 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.638 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' B' ' 123' ' ' GLU . 7.3 p -126.25 107.86 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.702 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -65.19 119.96 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.3 134.99 34.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.847 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -51.72 170.52 0.21 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.637 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.847 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -80.19 164.12 80.87 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.704 0.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.524 ' CE2' HD23 ' B' ' 126' ' ' LEU . 20.2 m-85 -109.58 47.42 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.29 5.62 5.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.66 128.97 25.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.768 0.318 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.7 106.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.65 150.33 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.676 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.49 97.87 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.091 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.04 125.52 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.546 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.425 ' NE2' ' HB2' ' B' ' 71' ' ' ALA . 12.8 m80 -94.95 130.64 41.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.657 HD12 ' HE3' ' B' ' 70' ' ' MET . 28.7 mt -97.89 150.54 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -104.6 134.48 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.461 HD11 ' SD ' ' B' ' 70' ' ' MET . 23.8 mt -137.01 154.92 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.818 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.442 ' N ' HG22 ' B' ' 33' ' ' ILE . 52.9 m -153.93 158.2 40.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.145 0.497 . . . . 0.0 111.251 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 20.4 t-20 -107.75 114.05 27.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.493 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.19 20.09 6.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.365 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.61 -177.58 18.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.32 19.92 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.613 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.89 162.07 37.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.734 0.302 . . . . 0.0 110.788 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -65.86 164.09 15.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.664 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 pt -149.18 141.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.429 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.26 101.12 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.696 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -105.85 149.71 26.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 111.516 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.46 132.38 19.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.673 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 9.1 mm -92.77 151.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.323 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -138.7 138.29 37.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 30.6 p -124.29 149.19 46.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.2 p -55.95 -40.14 72.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -127.4 117.97 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.853 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.51 16.62 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.383 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -110.77 -31.7 7.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -23.19 14.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' B' ' 74' ' ' CYS . 34.9 mt -126.75 138.75 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.963 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 36.7 m -149.39 116.73 6.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.496 HG13 ' O ' ' B' ' 71' ' ' ALA . 2.7 t -94.52 153.47 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -145.64 123.41 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.98 145.03 77.62 Favored 'Cis proline' 0 C--N 1.351 0.67 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.481 -0.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.2 -13.63 40.29 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.15 . . . . 0.0 112.524 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.6 130.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.613 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.12 -178.79 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.606 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.627 ' O ' HG13 ' B' ' 61' ' ' VAL . 10.3 p -114.41 111.37 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.465 HD23 ' HG3' ' B' ' 66' ' ' GLU . 0.2 OUTLIER -80.38 145.56 31.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.021 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' B' ' 35' ' ' ASN . 2.9 m-20 -101.8 171.79 5.01 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.417 ' O ' ' CD ' ' B' ' 65' ' ' LYS . 41.5 Cg_exo -56.91 127.94 27.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.546 2.164 . . . . 0.0 112.558 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.417 ' CD ' ' O ' ' B' ' 64' ' ' PRO . 0.0 OUTLIER 46.72 34.8 2.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.623 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.465 ' HG3' HD23 ' B' ' 62' ' ' LEU . 1.4 tp10 -101.32 136.77 40.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 113.9 27.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.014 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.92 155.22 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.96 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.95 119.21 26.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.022 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.657 ' HE3' HD12 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -112.75 164.7 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.722 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.496 ' O ' HG13 ' B' ' 55' ' ' VAL . . . -118.55 155.29 31.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.54 104.72 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.776 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.34 125.19 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.977 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' CYS . . . . . 0.477 ' HA ' HD23 ' B' ' 53' ' ' LEU . 1.7 p -129.11 98.1 4.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 153.89 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -64.73 151.11 45.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.76 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.483 ' CZ ' ' CD2' ' B' ' 124' ' ' TYR . 3.5 p90 -148.52 -161.55 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.999 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.05 93.41 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.458 ' HB3' HD21 ' B' ' 126' ' ' LEU . . . -68.08 -19.17 64.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.45 -29.23 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.751 0.31 . . . . 0.0 111.404 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -143.28 59.33 1.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -159.22 160.34 35.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -82.82 153.36 25.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' B' ' 124' ' ' TYR . 12.4 mt -128.53 38.24 4.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.52 30.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.41 -45.19 3.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.48 138.53 54.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 132.26 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 77.6 mt -107.73 121.81 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.619 HG23 ' O ' ' B' ' 118' ' ' LYS . 4.0 m -103.77 138.84 39.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.556 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.0 mp -118.26 124.33 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.31 121.95 37.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' B' ' 116' ' ' ARG . 6.2 p90 -130.91 143.7 50.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.091 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.72 ' CB ' HG22 ' B' ' 115' ' ' VAL . 1.3 t -145.18 120.5 10.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.24 142.87 0.94 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.513 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.519 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 6.9 p -81.99 146.03 54.59 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 165.76 15.12 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.597 2.198 . . . . 0.0 112.168 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -44.9 114.5 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.537 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.55 49.63 15.5 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.905 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' B' ' 101' ' ' ALA . . . -51.35 -76.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.035 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' B' ' 100' ' ' ALA . . . 172.38 163.57 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 111.161 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.55 69.41 9.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.4 128.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -48.98 131.24 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.065 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HB2' ' CZ2' ' B' ' 108' ' ' TRP . 6.6 ttm180 -121.41 150.28 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 26.93 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -113.08 -1.01 14.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.789 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.519 ' CZ3' HG22 ' B' ' 96' ' ' THR . 7.0 m0 -92.67 20.15 6.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.703 0.287 . . . . 0.0 111.185 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.179 -179.811 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 114' ' ' MET . . . . . 0.595 ' C ' HG23 ' B' ' 115' ' ' VAL . 1.4 mpt? . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.041 0.448 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.72 HG22 ' CB ' ' B' ' 94' ' ' THR . 4.5 t 87.06 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.318 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.427 ' HB2' ' CZ2' ' B' ' 93' ' ' TRP . 48.2 mtt-85 -99.05 146.23 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.78 156.73 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.619 ' O ' HG23 ' B' ' 90' ' ' THR . 0.0 OUTLIER -145.11 161.73 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.481 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -144.96 148.95 34.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.502 HD23 ' O ' ' B' ' 15' ' ' GLN . 35.1 mt -151.11 86.44 4.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.09 158.94 2.94 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.691 2.261 . . . . 0.0 112.683 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.491 HD13 ' CG2' ' B' ' 17' ' ' ILE . 25.3 mm -114.74 145.73 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.002 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.743 ' HB3' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -139.08 165.0 28.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.056 0.455 . . . . 0.0 111.093 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' B' ' 77' ' ' PHE . 90.0 m-85 -132.51 108.09 8.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.976 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.05 83.23 3.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.569 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 30.3 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.906 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 CA--C 1.527 0.14 0 CA-C-O 120.752 0.23 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.27 138.83 62.94 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.532 2.155 . . . . 0.0 112.303 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.15 -152.92 0.41 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.0 m-20 -112.06 151.84 28.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.765 0.316 . . . . 0.0 110.885 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.75 127.55 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.157 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.409 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -73.19 152.48 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.0 143.03 30.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.95 111.08 24.59 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.51 168.53 24.73 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.09 -1.213 . . . . 0.0 112.828 0.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -38.9 -48.76 1.61 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.99 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.6 ' CG ' HD22 ' A' ' 120' ' ' LEU . 1.1 tm0? 177.22 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.033 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.57 112.19 16.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.58 HD13 ' CE1' ' A' ' 19' ' ' PHE . 8.1 tt -113.22 130.06 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 38.8 t -105.37 87.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.879 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 17' ' ' ILE . 6.9 m-85 -51.81 101.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 21.8 m-80 -72.13 137.82 47.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.539 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.845 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -70.2 169.34 13.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.845 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 72.6 Cg_endo -76.11 166.23 83.41 Favored 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.641 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 17.2 m-85 -108.14 30.41 6.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.14 7.38 36.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.353 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -135.18 154.64 51.55 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.859 0.361 . . . . 0.0 111.101 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -71.34 131.98 44.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -140.24 93.15 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.78 111.4 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CD2' HD11 ' A' ' 17' ' ' ILE . 76.2 m-85 -98.09 106.42 18.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' B' ' 22' ' ' PRO . 7.7 m80 -79.37 121.29 24.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -109.81 125.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HG3' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -95.21 155.42 16.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 34' ' ' THR . 34.0 mt -133.89 154.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.9 m -144.84 151.69 39.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' HB2' HD22 ' A' ' 62' ' ' LEU . 14.0 t-20 -98.51 105.48 17.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.673 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -92.88 20.93 6.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.28 20.26 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.469 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.81 40.34 2.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 175.87 161.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 41' ' ' ILE . 13.5 ptp180 -55.15 169.85 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.706 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 40' ' ' ARG . 3.7 pt -158.92 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.82 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.16 107.08 2.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.444 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.543 ' CD1' HD12 ' A' ' 62' ' ' LEU . 51.3 p-90 -103.76 159.37 15.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 112.033 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -145.73 145.06 30.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.449 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 91' ' ' ILE . 13.1 mm -123.9 151.11 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.033 0.444 . . . . 0.0 111.553 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.38 163.41 39.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.504 HG22 HG12 ' A' ' 89' ' ' ILE . 24.1 p -139.37 149.82 44.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.984 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -50.42 -31.06 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.967 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -136.1 117.74 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.03 16.56 8.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.327 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -54.84 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.93 -40.14 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 122.4 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.638 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.12 107.84 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.207 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 72' ' ' VAL . 2.6 m -97.53 129.12 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.029 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -140.28 140.92 24.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.06 153.37 97.47 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.917 -1.285 . . . . 0.0 112.265 0.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.55 -11.68 26.45 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.589 2.193 . . . . 0.0 112.662 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.4 p -172.68 158.77 4.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.903 0.382 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 175.86 148.04 6.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.69 128.02 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.543 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -97.84 165.32 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -117.41 169.59 7.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.32 112.96 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.584 2.189 . . . . 0.0 112.515 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 62.56 34.86 14.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.282 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.512 ' O ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -102.19 154.61 18.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.43 160.28 16.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.436 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.01 151.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.698 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 ' HG3' ' A' ' 32' ' ' LYS . 12.4 tp -111.2 125.13 53.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 ttm -121.61 158.54 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.75 38.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.507 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 55' ' ' VAL . 54.6 t -114.05 91.73 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.749 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.38 129.41 39.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.247 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 10.7 t -130.56 140.16 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.1 151.97 26.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 p -55.6 111.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.918 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 23' ' ' TYR . 27.2 p90 -118.82 -172.43 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.98 126.93 52.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 84' ' ' LEU . . . -105.17 19.01 21.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.329 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.28 -25.19 21.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -135.64 29.23 3.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.53 129.2 20.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.69 146.94 29.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 79' ' ' ALA . 29.1 mt -117.31 41.44 2.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.35 25.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' HG21 ' A' ' 48' ' ' THR . 24.0 m120 -118.26 -15.1 9.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.468 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.98 114.52 13.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.841 0.353 . . . . 0.0 111.013 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.19 135.52 21.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.504 HG12 HG22 ' A' ' 47' ' ' THR . 15.6 mt -98.46 107.63 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -71.03 121.12 17.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.06 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 45' ' ' ILE . 14.2 mm -109.86 149.76 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.816 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -148.23 159.92 43.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.496 ' CZ2' ' HB3' ' A' ' 116' ' ' ARG . 10.0 p90 -177.91 123.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 134.75 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -56.34 112.78 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 p -58.72 148.22 68.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.942 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.22 164.68 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.628 2.219 . . . . 0.0 112.316 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.48 115.54 1.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.292 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.04 47.81 32.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.732 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.09 166.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 110.955 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.49 16.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.097 0.475 . . . . 0.0 111.404 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 70.96 8.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.643 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 132.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.838 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -53.25 152.45 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 13.3 mmm180 -136.91 145.25 44.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.35 -27.71 19.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.55 -18.76 65.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.407 ' CD2' ' HB2' ' A' ' 105' ' ' ARG . 26.5 m0 -56.58 -20.35 20.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.307 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 111.049 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.62 127.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.496 ' HB3' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -119.07 157.87 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.94 124.61 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.35 131.76 40.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.762 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.1 122.65 39.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.075 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.6 HD22 ' CG ' ' A' ' 15' ' ' GLN . 1.5 mt -81.72 133.42 52.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.547 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HD3' ' NE2' ' A' ' 15' ' ' GLN . 94.9 Cg_endo -79.35 134.94 11.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.611 2.207 . . . . 0.0 112.697 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 89' ' ' ILE . 7.5 mm -108.06 82.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.016 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 162.06 26.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' A' ' 122' ' ' ILE . 57.5 m-85 -131.08 100.75 5.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.901 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.446 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 28.6 t30 -80.07 81.5 6.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.919 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 CA-C-O 120.731 0.221 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.33 139.07 63.75 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.317 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.41 -152.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.561 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.9 m-20 -112.21 151.76 29.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.831 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.62 127.28 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ASN . . . . . 0.413 ' HB2' ' HB ' ' B' ' 34' ' ' THR . 1.0 OUTLIER -73.0 152.5 41.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.09 142.95 30.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 0.0 111.488 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.89 111.0 24.77 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.38 168.48 24.26 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.9 0.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.7 t -38.85 -48.76 1.59 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.98 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.604 ' CG ' HD22 ' B' ' 120' ' ' LEU . 1.1 tm0? 177.21 -50.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 111.008 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -79.58 112.14 16.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.585 HD13 ' CE1' ' B' ' 19' ' ' PHE . 7.7 tt -113.33 130.18 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 39.2 t -105.3 87.31 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.934 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CE1' HD13 ' B' ' 17' ' ' ILE . 6.8 m-85 -51.37 100.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.423 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -71.97 137.73 47.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.48 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.844 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -70.15 169.27 13.93 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.697 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.844 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.1 Cg_endo -76.16 166.27 83.27 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.736 0.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.425 ' HB3' ' CE1' ' B' ' 77' ' ' PHE . 17.1 m-85 -108.22 30.38 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.09 7.46 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -135.27 154.63 51.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.341 . . . . 0.0 111.12 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -71.37 132.12 44.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -140.31 93.24 2.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.85 111.48 11.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.984 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD2' HD11 ' B' ' 17' ' ' ILE . 76.0 m-85 -98.06 106.5 18.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -79.45 121.51 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.12 125.32 67.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.513 ' HG3' HD12 ' B' ' 69' ' ' LEU . 0.1 OUTLIER -95.29 155.43 16.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.268 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.417 HG22 ' N ' ' B' ' 34' ' ' THR . 33.8 mt -133.99 153.83 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.1 m -144.75 151.74 39.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 111.474 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.551 ' HB2' HD22 ' B' ' 62' ' ' LEU . 14.2 t-20 -98.63 105.54 17.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.616 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -92.83 20.85 6.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.308 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.54 -161.12 20.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.89 40.28 2.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.531 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 175.89 161.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.541 ' O ' HG23 ' B' ' 41' ' ' ILE . 13.5 ptp180 -55.21 169.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.607 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.541 HG23 ' O ' ' B' ' 40' ' ' ARG . 3.7 pt -158.92 115.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 0.0 111.864 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.06 107.18 2.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.478 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.534 ' CD1' HD12 ' B' ' 62' ' ' LEU . 51.2 p-90 -103.87 159.22 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.723 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -145.51 145.11 30.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.353 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.769 HD12 HD12 ' B' ' 91' ' ' ILE . 13.0 mm -123.89 150.94 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 111.627 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.23 163.51 38.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.552 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.496 HG22 HG12 ' B' ' 89' ' ' ILE . 24.3 p -139.5 149.69 44.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.465 HG21 ' O ' ' B' ' 86' ' ' ASN . 0.7 OUTLIER -50.27 -31.24 13.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.008 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -135.89 117.74 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.0 16.48 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.78 -55.03 2.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 110.506 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.82 -40.3 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.88 122.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.711 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.06 108.2 13.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.433 HG12 HG22 ' B' ' 72' ' ' VAL . 2.6 m -97.83 129.09 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.027 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -140.21 140.92 24.68 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.0 153.46 97.64 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.199 0.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.72 -11.52 26.03 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.52 2.146 . . . . 0.0 112.582 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 20.1 p -172.74 158.67 4.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 175.98 147.99 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.51 128.1 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' B' ' 35' ' ' ASN . 0.1 OUTLIER -97.91 165.37 11.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.807 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.9 OUTLIER -117.54 169.63 7.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.451 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.43 112.66 1.19 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.645 2.23 . . . . 0.0 112.534 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp 62.8 34.99 14.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.197 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.512 ' O ' HD21 ' B' ' 62' ' ' LEU . 0.0 OUTLIER -102.19 154.64 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.51 160.38 16.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.344 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.15 151.88 15.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.629 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.513 HD12 ' HG3' ' B' ' 32' ' ' LYS . 12.4 tp -111.2 125.12 53.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.311 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 2.1 ttm -121.7 158.62 28.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.523 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.8 38.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.489 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.433 HG22 HG12 ' B' ' 55' ' ' VAL . 54.4 t -114.17 91.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.651 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.29 129.36 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 10.8 t -130.67 140.0 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -110.04 152.24 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.038 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.3 p -55.8 112.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' B' ' 23' ' ' TYR . 27.5 p90 -119.02 -172.39 2.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.005 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.0 127.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' B' ' 84' ' ' LEU . . . -105.05 18.71 21.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.13 -25.13 22.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 111.121 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.8 p -135.69 29.23 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.037 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.42 129.35 20.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.87 146.94 30.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' B' ' 79' ' ' ALA . 29.1 mt -117.32 41.57 2.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.42 24.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.465 ' O ' HG21 ' B' ' 48' ' ' THR . 23.9 m120 -118.0 -15.28 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.561 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.94 114.6 13.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.888 0.375 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.2 135.53 21.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.496 HG12 HG22 ' B' ' 47' ' ' THR . 15.7 mt -98.52 107.65 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -70.97 121.1 17.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.128 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.769 HD12 HD12 ' B' ' 45' ' ' ILE . 14.4 mm -109.89 149.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.907 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -148.12 159.98 43.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.016 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' B' ' 116' ' ' ARG . 10.1 p90 -177.94 123.57 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.908 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.79 134.66 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -56.56 112.57 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.0 p -58.4 147.94 66.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.01 164.68 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.602 2.201 . . . . 0.0 112.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.51 115.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.208 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.98 47.77 31.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.825 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 166.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.019 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.75 164.63 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.179 0.514 . . . . 0.0 111.342 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 71.03 7.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.608 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.91 132.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.07 152.27 4.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 13.3 mmm180 -136.77 145.28 44.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -27.89 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.49 -18.5 65.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.279 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.412 ' CD2' ' HB2' ' B' ' 105' ' ' ARG . 26.1 m0 -56.86 -20.22 21.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.981 -179.904 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 114' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.7 mpt? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.866 0.365 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' B' ' 114' ' ' MET . 7.4 p 175.59 127.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.483 ' HB3' ' CZ2' ' B' ' 93' ' ' TRP . 0.1 OUTLIER -119.09 157.94 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.04 124.86 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.057 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.56 131.75 40.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.08 122.55 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.604 HD22 ' CG ' ' B' ' 15' ' ' GLN . 1.5 mt -81.66 133.31 52.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.665 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.416 ' HD3' ' NE2' ' B' ' 15' ' ' GLN . 91.6 Cg_endo -79.16 134.95 11.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.622 2.215 . . . . 0.0 112.661 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.492 HD11 HG13 ' B' ' 89' ' ' ILE . 7.6 mm -108.23 82.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.44 161.89 26.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.154 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' B' ' 122' ' ' ILE . 58.6 m-85 -130.89 101.0 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.455 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 28.9 t30 -80.58 81.55 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.908 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.527 0.166 0 CA-C-O 120.677 0.199 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.25 116.13 4.56 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.572 2.181 . . . . 0.0 112.266 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.38 114.07 3.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.546 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.75 146.33 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pt -110.8 146.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -96.01 141.18 29.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.47 145.36 50.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.157 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.4 118.13 12.59 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.33 157.27 72.63 Favored 'Cis proline' 0 C--N 1.352 0.74 0 C-N-CA 124.22 -1.158 . . . . 0.0 112.644 0.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.11 -33.11 75.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.411 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 2.8 tt0 -179.47 51.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.743 0.306 . . . . 0.0 111.32 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -174.21 108.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.313 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.9 tt -131.08 155.25 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 123' ' ' GLU . 73.8 t -135.5 96.14 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.678 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE2' ' CG2' ' A' ' 122' ' ' ILE . 18.8 m-85 -63.28 100.12 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -69.67 151.4 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.493 . . . . 0.0 111.89 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.802 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -48.64 170.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.802 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 80.1 Cg_endo -87.62 169.02 39.76 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.241 -1.149 . . . . 0.0 112.961 0.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' A' ' 125' ' ' ASN . 21.7 m-30 -110.42 18.97 19.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.185 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -104.1 3.21 32.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.983 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.64 -171.49 3.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.697 0.284 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -99.13 105.56 17.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.35 121.46 38.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -106.55 107.51 18.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.49 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -97.2 126.19 42.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.155 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -86.89 141.1 29.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.814 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 32' ' ' LYS . 17.1 mt -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.575 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 31' ' ' ILE . 8.4 mttm -102.89 119.38 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -117.34 145.85 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.2 m -147.61 158.42 44.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 111.323 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -111.26 113.56 26.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.457 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.32 23.18 6.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.72 -158.66 23.63 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.531 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.61 18.7 5.4 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.617 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.87 159.74 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.5 mpp_? -57.3 151.64 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.666 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt -150.36 121.34 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.861 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 168.5 54.31 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -166.03 155.21 11.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.523 0.662 . . . . 0.0 112.109 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.78 156.78 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.061 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.474 ' CG2' HG11 ' A' ' 55' ' ' VAL . 15.7 mm -121.51 136.19 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.948 0.404 . . . . 0.0 111.796 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 126.18 17.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.519 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.0 p -112.25 162.08 15.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.195 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.49 -28.2 1.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.282 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.42 120.5 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.7 11.34 27.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.486 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.62 -54.12 2.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 110.679 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.96 -28.19 60.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mt -115.22 122.08 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.46 157.84 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG11 ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -123.94 155.04 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.875 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 9.0 t70 -166.87 109.17 0.65 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 73.1 Cg_endo -76.1 140.79 67.96 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.83 -1.321 . . . . 0.0 112.32 0.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.41 -24.89 30.77 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.406 2.071 . . . . 0.0 112.209 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.9 p -151.91 172.85 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.78 -163.33 35.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.648 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 t -137.88 152.57 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 111.2 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.555 HD11 HG21 ' A' ' 68' ' ' VAL . 5.7 mp -124.52 161.45 26.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.6 p30 -115.03 170.53 5.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.744 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 49.4 Cg_exo -56.7 114.0 1.72 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.485 2.124 . . . . 0.0 112.562 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.02 39.24 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.546 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.35 139.31 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.52 112.3 21.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.555 HG21 HD11 ' A' ' 62' ' ' LEU . 27.3 m -101.75 149.12 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.29 127.18 43.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.765 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.448 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 54.0 ttp -113.7 161.38 17.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.082 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.448 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -129.48 141.4 51.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.094 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.07 101.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.8 145.98 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 142.63 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.691 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.9 143.07 26.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.005 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -57.07 161.47 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.145 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -172.27 -160.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -127.29 94.4 3.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.21 -22.18 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.33 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.78 -43.95 94.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -131.27 60.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -158.28 162.14 37.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -70.43 152.24 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.585 HD22 ' CB ' ' A' ' 124' ' ' TYR . 12.4 mt -138.26 23.26 2.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -145.54 27.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.971 0.415 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.38 -28.46 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.101 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.53 124.63 24.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.81 132.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.654 HG13 HD11 ' A' ' 122' ' ' ILE . 66.6 mt -94.47 127.88 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.8 m -112.58 104.58 12.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 91' ' ' ILE . 4.3 mp -87.43 148.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.404 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 4.9 mt-10 -144.77 154.27 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.294 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -162.42 149.46 13.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.621 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -148.0 141.84 25.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.779 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.02 139.5 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 p -92.6 146.65 32.73 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.2 163.4 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.518 2.145 . . . . 0.0 112.107 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.16 112.32 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.979 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.56 47.1 58.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.72 155.46 19.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 111.21 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.68 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.29 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -88.42 69.76 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.618 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -173.01 124.69 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -52.31 125.76 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.22 149.77 27.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -21.89 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -73.77 -9.74 58.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.633 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -69.31 -29.59 67.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.621 ' CZ ' HG22 ' A' ' 94' ' ' THR . 15.0 m-85 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 1.6 mpt? . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.926 0.393 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.4 p 175.36 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.664 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -107.26 155.84 19.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.991 0.424 . . . . 0.0 111.157 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.404 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -145.71 132.64 20.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.952 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 152.22 33.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 120' ' ' LEU . 16.8 m-20 -102.86 156.37 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.809 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 119' ' ' ASN . 5.0 mp -134.51 129.33 19.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.56 128.07 6.75 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.645 2.23 . . . . 0.0 112.2 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.654 HD11 HG13 ' A' ' 89' ' ' ILE . 11.6 mm -100.0 138.86 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.513 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.562 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -119.51 160.08 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.284 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CB ' HD22 ' A' ' 84' ' ' LEU . 38.7 m-85 -123.11 117.74 26.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 38.2 t30 -114.8 141.48 47.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.49 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 32.6 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 CA--C 1.527 0.151 0 CA-C-O 120.699 0.208 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.26 116.0 4.51 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.519 2.146 . . . . 0.0 112.349 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.99 114.28 3.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.09 146.21 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 pt -110.57 146.11 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.21 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.87 141.16 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.664 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.46 145.5 50.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.41 ' HB3' ' CG ' ' A' ' 22' ' ' PRO . 32.8 mt-30 -135.62 117.97 12.31 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.534 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 157.18 72.3 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 124.217 -1.159 . . . . 0.0 112.729 0.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.01 -33.1 75.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.444 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 120' ' ' LEU . 2.7 tt0 -179.6 51.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' B' ' 121' ' ' PRO . 1.4 ptpt -174.54 108.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.388 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.429 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.9 tt -131.02 155.55 42.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' B' ' 123' ' ' GLU . 74.2 t -135.82 96.19 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.737 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' B' ' 122' ' ' ILE . 18.8 m-85 -63.36 100.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.086 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -69.64 151.21 46.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.151 0.501 . . . . 0.0 111.869 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.82 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -48.35 170.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.82 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 73.9 Cg_endo -87.73 168.76 39.75 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 124.312 -1.12 . . . . 0.0 112.94 0.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' B' ' 125' ' ' ASN . 21.9 m-30 -110.15 18.85 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -103.99 3.22 33.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.927 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.55 -171.38 3.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.771 0.32 . . . . 0.0 110.555 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -99.29 105.52 17.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.34 121.65 38.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.373 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.4 m -106.63 107.8 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.413 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.46 126.43 42.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.094 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -87.05 141.21 28.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.743 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.422 HG22 ' N ' ' B' ' 32' ' ' LYS . 18.0 mt -113.68 154.63 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.478 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.422 ' N ' HG22 ' B' ' 31' ' ' ILE . 8.4 mttm -102.81 119.58 39.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 111.479 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 75.2 mt -117.48 145.88 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.585 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.4 HG22 ' N ' ' B' ' 35' ' ' ASN . 53.5 m -147.69 158.41 44.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.365 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.4 ' N ' HG22 ' B' ' 34' ' ' THR . 7.0 t-20 -111.17 113.77 26.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 23.01 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.67 -158.36 23.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.577 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.57 18.38 5.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.658 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.65 159.84 42.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.779 0.323 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' B' ' 62' ' ' LEU . 3.5 mpp_? -57.29 151.87 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 pt -150.61 121.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.322 . . . . 0.0 111.804 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' B' ' 93' ' ' TRP . . . -74.25 168.66 54.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.451 -0.88 . . . . 0.0 110.906 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -166.05 155.31 11.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.536 0.668 . . . . 0.0 112.075 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.9 156.91 43.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.057 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.473 ' CG2' HG11 ' B' ' 55' ' ' VAL . 15.1 mm -121.63 136.22 59.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.905 0.383 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.33 126.09 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.505 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 34.8 p -112.23 162.25 15.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.249 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -28.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.41 120.55 23.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.73 11.46 26.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.467 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -54.23 2.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.355 . . . . 0.0 110.704 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -74.71 -28.32 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.804 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 mt -115.06 122.08 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.829 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.36 157.88 26.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.254 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.473 HG11 ' CG2' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -123.99 155.06 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' B' ' 57' ' ' PRO . 9.0 t70 -166.98 109.11 0.64 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' B' ' 56' ' ' ASP . 72.7 Cg_endo -76.02 140.73 67.73 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.404 0.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.35 -24.81 31.16 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.458 2.105 . . . . 0.0 112.242 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.0 p -152.01 172.74 15.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.647 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.03 -163.64 35.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.597 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.64 152.74 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 111.115 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.563 HD11 HG21 ' B' ' 68' ' ' VAL . 5.5 mp -124.82 161.43 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.6 p30 -114.98 170.55 5.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 51.7 Cg_exo -56.82 113.97 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.562 2.175 . . . . 0.0 112.568 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.1 39.25 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.486 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -111.42 139.33 46.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.262 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.63 112.22 20.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.786 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.563 HG21 HD11 ' B' ' 62' ' ' LEU . 27.4 m -101.77 149.3 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.359 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.37 127.24 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.443 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 53.8 ttp -113.63 161.35 17.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.443 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -129.46 141.54 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.25 101.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.9 145.99 32.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.06 142.68 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.669 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.94 143.11 26.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 4.2 p -57.08 161.71 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -172.33 -160.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.76 94.69 4.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.35 -22.47 66.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.99 93.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.301 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 80.6 p -131.26 60.37 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -158.5 161.96 37.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -70.25 151.88 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' B' ' 124' ' ' TYR . 12.2 mt -137.97 23.34 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.088 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -145.45 27.55 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.58 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.26 -28.48 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -70.44 124.48 24.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 132.67 21.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.061 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.661 HG13 HD11 ' B' ' 122' ' ' ILE . 66.6 mt -94.41 127.96 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 87.3 m -112.63 104.7 12.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.528 HD12 ' H ' ' B' ' 91' ' ' ILE . 4.3 mp -87.46 148.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.627 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.4 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 4.9 mt-10 -144.84 154.36 42.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.405 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 4.3 p90 -162.53 149.52 13.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.028 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.617 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 0.0 OUTLIER -148.05 141.83 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.08 139.38 28.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.7 p -92.53 146.61 32.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.27 163.03 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.607 2.205 . . . . 0.0 112.175 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.71 112.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.34 47.59 55.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 155.55 20.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.95 163.97 2.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.373 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -88.0 69.68 9.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.62 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -172.98 124.68 0.43 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -52.39 125.65 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 149.85 27.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -21.74 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -73.9 -9.62 58.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.69 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -69.34 -29.62 67.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.687 0.279 . . . . 0.0 111.021 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.617 ' CZ ' HG22 ' B' ' 94' ' ' THR . 15.0 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.811 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.229 0.019 0 CA-C-O 120.883 0.373 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.664 ' O ' HG13 ' B' ' 115' ' ' VAL . 7.4 p 175.41 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 32.4 mtt180 -107.12 155.79 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.168 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 117' ' ' ARG . . . . . 0.4 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -145.82 132.47 19.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.976 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 152.24 33.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.626 ' O ' HD12 ' B' ' 120' ' ' LEU . 17.1 m-20 -102.73 156.53 17.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.797 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 119' ' ' ASN . 5.0 mp -134.67 129.2 19.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.102 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' B' ' 16' ' ' LYS . 96.1 Cg_endo -80.37 128.09 6.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.458 2.105 . . . . 0.0 112.167 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.661 HD11 HG13 ' B' ' 89' ' ' ILE . 11.6 mm -99.94 138.73 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.564 ' HB3' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -119.38 160.14 22.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.584 ' CB ' HD22 ' B' ' 84' ' ' LEU . 38.5 m-85 -123.14 117.82 26.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 111.569 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.433 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 38.1 t30 -114.82 141.72 47.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.522 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 32.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.836 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo . . . . . 0 C--O 1.232 0.204 0 CA-C-O 120.707 0.211 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HG2' ' HG2' ' A' ' 116' ' ' ARG . 57.3 Cg_endo -71.07 159.85 51.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.648 2.232 . . . . 0.0 112.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.37 -146.56 5.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.604 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -125.3 137.72 54.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG23 ' NE1' ' A' ' 93' ' ' TRP . 1.1 pt -113.19 149.79 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.236 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 153.45 20.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.603 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -144.98 152.48 40.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.273 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -137.71 116.47 9.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.488 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.02 154.25 76.81 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.963 -1.265 . . . . 0.0 112.484 0.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.9 9.1 38.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.688 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.17 -59.57 1.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 121' ' ' PRO . 12.8 pttm -169.37 173.38 6.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -121.51 155.23 25.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.018 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 44.7 t -118.15 85.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.634 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 29' ' ' TYR . 5.2 m-30 -49.7 102.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -73.3 135.6 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.837 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -54.15 170.33 0.32 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.695 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.837 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 98.4 Cg_endo -78.6 168.47 75.08 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.837 0.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.2 m-85 -112.98 29.93 7.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.01 6.44 12.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.05 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -140.82 157.83 44.83 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.39 114.05 14.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -115.67 149.82 37.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.5 m -114.98 126.92 55.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.471 ' CZ ' ' CG ' ' A' ' 19' ' ' PHE . 42.9 m-85 -107.18 128.68 54.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.506 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -90.98 115.17 27.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.455 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.05 143.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.565 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.72 140.95 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 111.626 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.55 HD11 ' HE2' ' A' ' 70' ' ' MET . 61.5 mt -134.49 152.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.481 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 33' ' ' ILE . 49.5 m -152.59 158.78 42.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.24 0.543 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.768 ' HB2' HD23 ' A' ' 62' ' ' LEU . 52.4 t30 -112.76 107.37 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.29 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -78.97 -4.29 49.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.661 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 -173.15 49.54 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.34 22.46 10.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -145.16 -179.65 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.94 155.81 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.428 HD13 ' OD1' ' A' ' 35' ' ' ASN . 20.9 pt -148.86 170.88 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.985 0.422 . . . . 0.0 111.304 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.56 108.17 0.98 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.724 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 30.6 p-90 -104.8 157.83 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 112.023 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.33 157.65 41.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 55' ' ' VAL . 2.7 mp -121.86 142.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.908 0.385 . . . . 0.0 111.939 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.31 125.87 14.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.737 HG22 HG12 ' A' ' 89' ' ' ILE . 55.6 p -102.03 158.34 16.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.226 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -46.24 -33.83 3.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.051 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -137.86 123.87 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.36 8.3 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.474 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.65 -47.54 5.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.752 0.31 . . . . 0.0 110.864 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -82.14 -53.61 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.739 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.728 HD12 ' HB ' ' A' ' 47' ' ' THR . 14.8 mt -91.07 155.36 18.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.816 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.6 152.38 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -119.15 153.6 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -172.83 110.28 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.31 140.72 60.82 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.722 -1.366 . . . . 0.0 112.344 0.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.23 -6.11 16.9 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.556 2.171 . . . . 0.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 p -174.76 171.4 3.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.726 0.298 . . . . 0.0 110.683 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.03 171.75 38.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.634 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.09 120.51 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 0.0 111.116 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.768 HD23 ' HB2' ' A' ' 35' ' ' ASN . 5.5 tp -94.37 159.42 15.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.45 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -115.44 167.25 10.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 9.9 Cg_endo -53.28 109.47 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.68 2.253 . . . . 0.0 112.411 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? 62.47 46.85 5.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.42 153.74 25.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -121.12 142.6 49.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.403 HG13 HD11 ' A' ' 62' ' ' LEU . 35.4 m -143.45 149.67 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.009 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 69' ' ' LEU . 10.8 tp -96.67 153.51 17.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.988 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.55 ' HE2' HD11 ' A' ' 33' ' ' ILE . 3.8 ttm -134.16 148.28 50.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -111.0 129.8 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 97.78 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.68 125.42 29.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.73 147.8 31.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -101.1 142.17 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -55.74 148.91 15.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 79' ' ' ALA . 35.3 p90 -161.79 -164.67 1.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.421 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 3.6 m-80 -125.9 113.15 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . . . -97.38 21.5 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.278 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.01 -23.52 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.2 p -138.51 40.4 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -151.51 145.15 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -61.36 147.14 45.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.48 ' HB3' ' CD2' ' A' ' 124' ' ' TYR . 11.0 mt -130.51 63.85 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -160.06 27.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.526 ' O ' HG21 ' A' ' 48' ' ' THR . 24.2 m-80 -129.05 4.91 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.685 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.91 111.58 23.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -146.13 132.73 19.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.279 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.737 HG12 HG22 ' A' ' 47' ' ' THR . 63.0 mt -94.18 130.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 118' ' ' LYS . 99.5 m -106.3 126.19 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.0 mp -115.18 116.76 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.9 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' OE2' HG22 ' A' ' 90' ' ' THR . 0.1 OUTLIER -118.31 159.55 23.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.006 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.406 ' NE1' HG23 ' A' ' 9' ' ' ILE . 9.4 p90 -155.96 130.59 9.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.693 ' HB ' HG22 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -128.06 140.82 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -53.77 137.09 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.0 p -80.47 149.92 69.4 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.18 163.99 2.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 112.08 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -50.67 108.24 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.937 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.96 47.74 59.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.435 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.69 173.1 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.368 . . . . 0.0 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.5 164.66 26.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.1 70.08 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 178.8 136.81 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -53.97 149.09 9.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -138.73 148.16 43.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -18.95 62.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.34 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.13 -6.79 45.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.831 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 48.7 m0 -87.55 13.25 10.56 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.494 0.187 . . . . 0.0 111.448 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 115' ' ' VAL . 49.3 m-85 . . . . . 0 C--N 1.333 -0.131 0 CA-C-O 120.872 0.367 . . . . 0.0 110.613 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.6 ' C ' HG23 ' A' ' 115' ' ' VAL . 12.5 mmt . . . . . 0 CA--C 1.521 -0.169 0 CA-C-O 121.073 0.463 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 94' ' ' THR . 3.4 t 82.92 116.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.139 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HG2' ' HG2' ' A' ' 6' ' ' PRO . 27.0 mmt-85 -92.23 146.32 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.5 134.03 54.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -127.53 161.18 29.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.624 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -131.08 154.32 48.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 95.1 5.48 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.756 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 58.5 Cg_exo -52.13 150.99 17.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.692 2.262 . . . . 0.0 112.678 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.0 mm -108.63 149.51 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HB3' HG13 ' A' ' 18' ' ' VAL . 1.7 tt0 -131.45 164.43 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.43 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -130.28 114.35 15.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.242 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.457 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 4.8 t-20 -103.16 80.72 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 43.9 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.815 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo . . . . . 0 CA--C 1.528 0.197 0 CA-C-O 120.698 0.208 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.01 159.54 52.13 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.11 -146.83 5.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.614 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.0 OUTLIER -125.1 137.56 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.826 0.346 . . . . 0.0 110.867 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.421 HG23 ' NE1' ' B' ' 93' ' ' TRP . 1.1 pt -113.18 149.73 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.22 153.34 20.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.712 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -144.82 152.32 40.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -137.51 116.43 10.04 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.467 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.05 154.22 76.95 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.016 -1.244 . . . . 0.0 112.58 0.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.89 9.15 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.737 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.401 ' O ' ' HD2' ' B' ' 121' ' ' PRO . 0.6 OUTLIER -127.36 -59.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.802 0.334 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 121' ' ' PRO . 12.7 pttm -169.55 173.4 6.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.011 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -121.66 155.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 45.1 t -118.23 84.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.476 ' CG ' ' CZ ' ' B' ' 29' ' ' TYR . 5.2 m-30 -49.51 102.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.602 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -73.37 135.5 44.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.446 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.856 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -53.91 170.44 0.3 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.787 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.856 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 97.0 Cg_endo -78.45 168.61 74.95 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.723 0.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.2 m-85 -113.11 29.85 7.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.956 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.91 6.72 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.132 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.09 157.82 44.77 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.25 114.02 14.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.092 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -115.86 149.63 38.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -114.87 126.76 55.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 111.246 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.476 ' CZ ' ' CG ' ' B' ' 19' ' ' PHE . 43.4 m-85 -106.92 128.68 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.476 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -91.07 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -103.84 142.91 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.545 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.58 140.91 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.551 HD11 ' HE2' ' B' ' 70' ' ' MET . 61.6 mt -134.5 152.96 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.408 ' N ' HG22 ' B' ' 33' ' ' ILE . 49.5 m -152.61 158.96 43.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.413 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.764 ' HB2' HD23 ' B' ' 62' ' ' LEU . 52.3 t30 -112.94 107.39 15.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.313 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -79.0 -4.1 48.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.82 -173.1 49.54 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.453 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.4 22.43 10.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -145.03 -179.53 6.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.366 . . . . 0.0 110.829 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.04 155.9 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.428 HD13 ' OD1' ' B' ' 35' ' ' ASN . 21.2 pt -148.88 170.82 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.41 107.88 0.96 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.727 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 30.8 p-90 -104.7 157.67 17.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 112.093 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.5 41.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.231 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.739 ' HB ' HG11 ' B' ' 55' ' ' VAL . 2.7 mp -121.67 142.81 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.012 0.434 . . . . 0.0 111.924 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.51 125.86 14.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.751 HG22 HG12 ' B' ' 89' ' ' ILE . 56.2 p -101.97 158.6 16.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.23 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.533 HG21 ' O ' ' B' ' 86' ' ' ASN . 0.1 OUTLIER -46.46 -33.79 4.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.067 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -137.81 123.78 20.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.24 8.33 16.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.487 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -47.39 5.07 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.752 0.311 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 mtt-85 -82.18 -53.69 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LEU . . . . . 0.719 HD12 ' HB ' ' B' ' 47' ' ' THR . 15.2 mt -91.05 155.59 18.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.778 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.7 152.26 29.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.027 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.739 HG11 ' HB ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -119.15 153.58 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.02 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 56' ' ' ASP . . . . . 0.666 ' O ' ' HB3' ' B' ' 71' ' ' ALA . 0.5 OUTLIER -172.75 110.35 0.35 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.38 140.69 60.86 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.29 0.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.18 -6.16 16.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.595 2.197 . . . . 0.0 112.846 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 3.8 p -174.75 171.42 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.716 0.293 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.01 171.83 38.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.556 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.18 120.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.764 HD23 ' HB2' ' B' ' 35' ' ' ASN . 5.5 tp -94.2 159.43 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.448 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -115.48 167.31 10.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 9.8 Cg_endo -53.36 109.46 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.643 2.228 . . . . 0.0 112.434 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? 62.62 46.74 5.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.35 153.62 25.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -121.01 142.47 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.42 149.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.65 153.41 17.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.551 ' HE2' HD11 ' B' ' 33' ' ' ILE . 3.8 ttm -134.03 148.38 51.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' B' ' 56' ' ' ASP . . . -111.08 129.8 55.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.038 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 97.94 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.2 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.35 29.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.826 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 38.6 t -108.56 147.66 31.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.977 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -101.09 142.23 32.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -55.85 148.75 16.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.039 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' B' ' 79' ' ' ALA . 35.2 p90 -161.53 -164.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ASN . . . . . 0.427 ' N ' ' CD2' ' B' ' 77' ' ' PHE . 3.6 m-80 -125.96 113.05 16.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' B' ' 77' ' ' PHE . . . -97.28 21.56 9.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.399 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.85 -23.57 12.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.29 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 58.3 p -138.58 40.54 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.311 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -151.74 145.13 24.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -61.35 147.28 45.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.477 ' HB3' ' CD2' ' B' ' 124' ' ' TYR . 11.4 mt -130.5 63.58 1.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -159.93 27.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.533 ' O ' HG21 ' B' ' 48' ' ' THR . 24.2 m-80 -129.33 4.92 5.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.765 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.93 111.57 23.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.645 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -146.04 132.73 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.27 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.751 HG12 HG22 ' B' ' 47' ' ' THR . 62.5 mt -94.23 130.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.633 HG23 ' O ' ' B' ' 118' ' ' LYS . 99.5 m -106.31 125.86 51.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.548 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.0 mp -114.86 116.92 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.918 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.476 ' OE2' HG22 ' B' ' 90' ' ' THR . 0.1 OUTLIER -118.54 159.5 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.421 ' NE1' HG23 ' B' ' 9' ' ' ILE . 9.2 p90 -155.96 130.68 9.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.674 ' HB ' HG22 ' B' ' 115' ' ' VAL . 0.7 OUTLIER -128.15 140.85 51.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -53.83 137.37 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 59.1 p -80.69 149.92 68.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.14 164.24 1.87 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.539 2.159 . . . . 0.0 112.074 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.01 108.31 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.98 47.62 59.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.462 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.51 172.98 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.53 164.69 26.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.275 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.11 69.76 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.17 137.12 0.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.835 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -54.12 148.97 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -138.61 148.15 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.301 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.2 -6.54 43.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.798 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.473 ' O ' ' CD1' ' B' ' 109' ' ' PHE . 48.8 m0 -87.75 13.38 10.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.527 0.203 . . . . 0.0 111.467 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.585 ' CE2' HG11 ' B' ' 115' ' ' VAL . 49.3 m-85 . . . . . 0 C--N 1.333 -0.139 0 CA-C-O 120.853 0.359 . . . . 0.0 110.589 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 114' ' ' MET . . . . . 0.592 ' C ' HG23 ' B' ' 115' ' ' VAL . 12.5 mmt . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' B' ' 94' ' ' THR . 3.4 t 83.06 116.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -91.94 146.26 23.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.764 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.57 134.13 54.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 118' ' ' LYS . . . . . 0.633 ' O ' HG23 ' B' ' 90' ' ' THR . 0.2 OUTLIER -127.56 161.01 29.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -130.84 154.32 48.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.48 95.11 5.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.72 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' B' ' 15' ' ' GLN . 59.1 Cg_exo -52.17 151.11 17.66 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.681 2.254 . . . . 0.0 112.639 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 19.9 mm -108.68 149.34 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.993 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.424 ' HB3' HG13 ' B' ' 18' ' ' VAL . 1.7 tt0 -131.31 164.41 25.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.022 0.439 . . . . 0.0 111.02 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' B' ' 84' ' ' LEU . 89.4 m-85 -130.23 114.28 15.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.249 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.445 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 4.8 t-20 -103.34 80.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 43.4 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.7 Cg_endo . . . . . 0 CA--C 1.529 0.27 0 CA-C-O 120.56 0.15 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 52.5 Cg_exo -55.05 140.6 80.2 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.367 2.045 . . . . 0.0 112.229 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.8 132.36 46.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.537 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 26.6 m-20 -51.22 128.76 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.454 HD12 HG23 ' A' ' 11' ' ' THR . 1.6 pp -102.35 142.84 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.22 150.02 35.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.454 HG23 HD12 ' A' ' 9' ' ' ILE . 1.7 p -142.2 150.05 40.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -146.13 104.51 4.12 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.758 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 31' ' ' ILE . 31.6 Cg_endo -63.7 159.94 64.69 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.465 0.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.37 -18.24 12.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.81 -46.78 4.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' PRO . 31.5 pttt -172.73 -179.13 2.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.2 tt -135.93 138.72 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.031 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.512 HG22 ' CB ' ' A' ' 123' ' ' GLU . 61.4 t -121.94 91.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -59.96 102.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.554 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.88 138.43 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.462 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -60.22 167.71 2.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.716 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 7.7 Cg_endo -88.05 164.8 43.31 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 124.415 -1.077 . . . . 0.0 112.484 0.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 38.6 m-85 -101.19 47.52 0.91 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.964 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.71 1.78 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.485 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' C ' HG22 ' A' ' 76' ' ' THR . 49.7 p-10 -139.35 152.09 46.88 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.839 0.352 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -63.01 121.19 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.781 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -112.86 99.98 8.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.067 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.4 m -99.76 109.59 22.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.448 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 60.4 m-85 -92.09 163.85 13.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.1 0.476 . . . . 0.0 111.222 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -118.09 109.19 16.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.738 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 ' HD2' ' A' ' 13' ' ' PRO . 8.9 mm -91.1 141.9 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.94 128.63 56.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 34' ' ' THR . 36.3 mt -128.9 153.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 33' ' ' ILE . 58.6 m -148.82 157.71 43.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 111.275 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.635 ' HB2' HD23 ' A' ' 62' ' ' LEU . 11.4 t-20 -104.4 73.84 1.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -57.71 -26.09 61.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.15 -62.49 5.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.57 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.5 21.67 4.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.682 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -149.7 159.3 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.44 149.03 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 pt -154.37 167.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.63 100.14 0.48 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.87 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -95.57 157.04 16.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . . . -153.11 128.94 10.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.01 142.67 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 111.469 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -145.23 132.84 20.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.572 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.71 155.14 29.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.042 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -65.45 -35.21 80.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.76 112.76 17.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.2 21.63 9.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -46.3 6.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -106.11 -33.07 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 mt -95.96 131.92 41.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.43 167.18 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.5 p -151.99 160.53 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.315 0.578 . . . . 0.0 111.004 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 55' ' ' VAL . 23.1 t70 -165.42 125.98 1.31 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.65 143.54 77.4 Favored 'Cis proline' 0 C--N 1.352 0.75 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.303 -0.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.03 4.89 6.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 113.035 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.7 p -179.71 158.28 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.09 164.7 30.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.627 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.08 117.51 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 111.127 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 35' ' ' ASN . 5.0 tp -90.49 160.8 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.452 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -109.99 178.62 0.97 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 22.5 Cg_exo -65.35 105.72 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.737 2.291 . . . . 0.0 112.649 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 72.08 22.65 3.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.256 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -87.2 150.08 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -116.63 132.29 56.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.82 143.46 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.905 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.1 126.04 54.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.428 ' HE2' HG21 ' A' ' 31' ' ' ILE . 25.9 ptt? -122.68 168.13 12.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.56 137.43 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.747 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.677 ' O ' HG13 ' A' ' 72' ' ' VAL . 8.8 p -115.41 96.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 144.19 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 t -138.76 81.93 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -51.88 153.48 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.446 HG22 ' C ' ' A' ' 25' ' ' ASP . 2.4 p -65.65 122.53 17.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 8.8 p90 -130.91 179.32 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.84 127.28 56.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.8 18.35 6.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.513 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.93 -29.36 13.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.9 p -136.15 42.72 2.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -143.16 133.37 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -52.55 134.24 35.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.488 HD22 ' CG ' ' A' ' 124' ' ' TYR . 16.8 mt -121.88 21.38 10.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -144.07 21.78 1.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -132.32 4.03 3.99 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.694 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -96.75 118.86 34.13 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 110.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.7 133.11 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 90' ' ' THR . 17.7 mt -85.3 164.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.507 ' N ' HG22 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -143.47 121.39 12.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 111.405 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.03 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.793 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -99.63 122.47 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 5.6 p90 -133.59 143.7 48.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.3 136.75 33.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -50.1 144.66 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.29 139.42 41.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.71 160.82 47.04 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -48.73 129.33 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.169 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.94 38.06 94.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.647 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 134.09 45.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.63 163.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.144 0.497 . . . . 0.0 111.289 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.29 6.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.54 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.01 145.55 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.812 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 44' ' ' ALA . 71.8 t80 -57.43 115.77 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 0.5 OUTLIER -106.06 153.75 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.827 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -87.19 -27.42 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.68 -33.2 72.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 54.0 m0 -53.54 -31.85 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.74 125.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.25 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -97.05 108.05 20.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -103.26 115.89 31.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.03 157.69 16.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.433 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.31 126.01 17.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.394 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.6 114.46 47.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.15 145.56 79.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.495 HD13 ' CG2' ' A' ' 17' ' ' ILE . 40.1 mm -95.03 151.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.852 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.512 ' CB ' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -136.6 156.68 48.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.488 ' CG ' HD22 ' A' ' 84' ' ' LEU . 6.5 m-85 -127.69 104.93 8.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.98 78.46 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.664 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.922 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 CA--C 1.529 0.236 0 CA-C-O 120.513 0.131 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.93 140.39 79.19 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.462 2.108 . . . . 0.0 112.272 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.75 132.36 46.76 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.414 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 27.5 m-20 -51.07 128.96 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.461 HD12 HG23 ' B' ' 11' ' ' THR . 1.6 pp -102.46 142.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.31 150.1 35.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' THR . . . . . 0.461 HG23 HD12 ' B' ' 9' ' ' ILE . 1.7 p -142.26 149.98 40.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -146.07 104.48 4.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' B' ' 31' ' ' ILE . 32.2 Cg_endo -63.66 160.24 63.66 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.399 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -18.45 12.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.69 -46.55 4.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.77 0.319 . . . . 0.0 111.274 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' B' ' 13' ' ' PRO . 31.3 pttt -172.87 -179.29 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.1 tt -135.72 138.82 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.059 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' B' ' 123' ' ' GLU . 62.5 t -122.09 91.47 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.23 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -59.91 102.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.562 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.85 138.58 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.468 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -60.4 167.73 2.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.717 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.752 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 7.8 Cg_endo -88.16 164.51 42.98 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.385 -1.09 . . . . 0.0 112.544 0.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' TYR . . . . . 0.403 ' CD1' ' CE1' ' B' ' 77' ' ' PHE . 39.4 m-85 -100.9 47.64 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.061 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.68 1.67 11.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.44 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ASP . . . . . 0.454 ' C ' HG22 ' B' ' 76' ' ' THR . 50.0 p-10 -139.21 152.11 47.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -63.01 121.16 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.724 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -112.86 100.16 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.996 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -99.9 109.85 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.627 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.447 ' HB2' ' CG1' ' B' ' 72' ' ' VAL . 59.9 m-85 -92.29 163.85 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 111.133 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -118.12 109.04 15.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.704 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.522 HD12 ' HD2' ' B' ' 13' ' ' PRO . 9.0 mm -91.05 141.95 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.02 128.53 56.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.414 HG22 ' N ' ' B' ' 34' ' ' THR . 36.0 mt -128.86 153.34 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' THR . . . . . 0.414 ' N ' HG22 ' B' ' 33' ' ' ILE . 59.5 m -148.77 157.53 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.642 ' HB2' HD23 ' B' ' 62' ' ' LEU . 11.3 t-20 -104.3 73.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.926 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -57.79 -25.93 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.4 -62.32 5.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.572 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.58 21.53 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.651 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 mtm-85 -149.63 159.32 44.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.4 148.87 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.725 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.22 167.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.992 0.425 . . . . 0.0 111.522 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.54 100.11 0.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.839 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -95.56 157.07 16.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 111.589 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' B' ' 104' ' ' PHE . . . -153.23 129.04 10.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.713 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 25.6 mm -93.05 142.6 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 111.472 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -145.23 132.77 20.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.651 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.58 155.18 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 3.0 p -65.5 -35.27 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.7 112.76 17.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.29 21.77 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.97 -46.29 6.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -106.17 -33.27 7.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -95.71 131.83 41.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.796 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.47 167.05 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.504 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.5 p -151.79 160.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' ASP . . . . . 0.504 ' N ' HG22 ' B' ' 55' ' ' VAL . 22.9 t70 -165.46 126.03 1.31 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.54 143.6 77.73 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.831 -1.32 . . . . 0.0 112.252 -0.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.88 4.72 6.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.618 2.212 . . . . 0.0 113.095 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 9.6 p -179.7 158.23 0.79 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.14 164.74 30.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.603 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.2 t -100.19 117.65 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 111.087 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' B' ' 35' ' ' ASN . 5.0 tp -90.53 160.97 15.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -110.14 178.39 1.02 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.804 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 22.3 Cg_exo -65.11 106.03 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 71.81 22.5 3.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.363 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -87.1 150.2 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -116.69 132.19 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.68 143.64 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.922 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.3 125.88 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.403 ' HE2' HG21 ' B' ' 31' ' ' ILE . 25.9 ptt? -122.45 168.32 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.77 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.65 137.48 53.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.721 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.672 ' O ' HG13 ' B' ' 72' ' ' VAL . 8.9 p -115.51 96.23 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.722 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 144.14 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 t -138.76 81.88 1.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.732 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.7 153.4 2.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.454 HG22 ' C ' ' B' ' 25' ' ' ASP . 2.4 p -65.7 122.62 17.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CE1' ' CD1' ' B' ' 23' ' ' TYR . 9.2 p90 -130.97 179.22 6.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.93 127.32 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.69 18.07 6.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.599 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.76 -29.3 13.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.6 p -136.14 42.67 2.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -143.14 133.41 24.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -52.6 134.32 35.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.007 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' B' ' 124' ' ' TYR . 16.9 mt -121.95 21.29 10.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -143.95 21.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.897 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -132.28 4.1 4.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.733 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.74 118.99 34.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.731 0.3 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.72 133.3 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.5 HG22 ' N ' ' B' ' 90' ' ' THR . 18.2 mt -85.43 164.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.524 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.5 ' N ' HG22 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -143.47 121.59 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.09 92.04 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.811 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -99.77 122.56 42.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.459 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 5.6 p90 -133.76 143.8 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.856 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 137.18 33.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.785 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -50.29 144.96 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.54 139.5 41.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.68 161.01 46.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.535 2.157 . . . . 0.0 112.32 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -48.9 129.27 17.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.89 38.16 94.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.65 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 134.16 45.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.09 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.57 163.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.127 0.489 . . . . 0.0 111.331 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.43 6.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.634 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.81 145.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' B' ' 44' ' ' ALA . 71.8 t80 -57.44 115.73 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 0.5 OUTLIER -105.95 153.56 21.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.04 -27.43 23.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.69 -33.07 72.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' B' ' 105' ' ' ARG . 54.0 m0 -53.69 -31.79 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.937 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.836 0.35 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.88 125.29 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.459 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -97.33 107.88 20.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -102.99 115.91 31.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.26 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 157.59 16.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.444 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -141.34 125.9 17.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.53 114.55 47.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.3 145.52 78.1 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.406 2.07 . . . . 0.0 112.645 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.495 HD13 ' CG2' ' B' ' 17' ' ' ILE . 40.7 mm -94.97 151.51 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.887 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.503 ' CB ' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -136.7 156.59 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' B' ' 84' ' ' LEU . 6.4 m-85 -127.47 105.05 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.038 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.2 78.57 9.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.834 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo . . . . . 0 CA--C 1.527 0.156 0 CA-C-O 120.776 0.24 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.15 142.98 47.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.562 2.175 . . . . 0.0 112.295 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.13 126.13 13.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.444 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 16.8 m-20 -52.73 121.9 8.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.573 HG22 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -94.49 128.98 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.02 146.62 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.741 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.21 138.69 35.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.065 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -136.11 112.1 10.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.723 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.09 154.55 70.02 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.401 0.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.45 -38.94 88.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.116 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.04 49.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -169.16 118.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.26 147.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.704 HG11 HG11 ' B' ' 18' ' ' VAL . 7.4 p -139.43 99.72 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 111.603 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 19.2 m-30 -51.51 108.18 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.74 137.15 40.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -59.85 167.09 2.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.732 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 83.3 Cg_endo -86.68 161.61 52.65 Favored 'Cis proline' 0 C--N 1.348 0.548 0 C-N-CA 124.013 -1.244 . . . . 0.0 112.583 0.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.97 29.51 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -107.07 7.06 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.533 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -148.68 147.83 29.35 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -56.98 117.99 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 112.16 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.9 m -102.7 114.2 28.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.001 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.567 ' CE1' ' CD1' ' A' ' 19' ' ' PHE . 4.9 m-85 -96.01 122.08 38.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -81.1 132.51 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.65 152.49 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HB2' ' HG3' ' B' ' 22' ' ' PRO . 0.8 OUTLIER -113.27 127.73 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.238 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -131.54 130.3 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.79 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.9 m -142.15 156.61 45.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.215 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.573 ' HA ' HG22 ' A' ' 9' ' ' ILE . 25.9 t-20 -100.08 113.75 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -92.23 20.23 6.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.344 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.65 -140.39 9.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.583 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.31 29.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -155.89 148.39 23.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.574 ' HG2' HG12 ' A' ' 61' ' ' VAL . 5.7 ttp180 -54.67 159.24 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 61' ' ' VAL . 12.1 pt -154.2 166.45 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.041 0.448 . . . . 0.0 111.577 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.19 109.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.597 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -104.21 161.67 13.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.226 0.536 . . . . 0.0 111.79 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.36 151.29 26.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.28 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.723 HD12 HG13 ' A' ' 91' ' ' ILE . 20.0 mm -122.14 140.4 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.14 131.28 23.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.507 HG22 HG12 ' A' ' 89' ' ' ILE . 67.1 p -114.03 154.81 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.068 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.06 -37.09 73.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -124.89 112.16 16.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.2 -37.53 9.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.759 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -32.38 7.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.81 141.87 29.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.72 132.48 27.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -115.09 128.0 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -145.71 129.52 8.55 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 58.8 Cg_endo -71.52 133.35 28.03 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.153 -0.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 51.4 Cg_exo -55.33 -46.81 29.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.388 2.059 . . . . 0.0 112.232 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.83 150.3 36.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.728 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.74 -172.03 27.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.598 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.574 HG12 ' HG2' ' A' ' 40' ' ' ARG . 6.0 t -123.16 114.49 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.842 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.433 HD21 HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -87.86 161.44 17.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.028 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -121.23 178.39 1.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.675 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 33.5 Cg_exo -61.55 108.89 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.623 2.215 . . . . 0.0 112.323 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.72 34.45 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.06 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -95.74 151.23 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.798 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -106.44 156.81 18.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 HD21 ' A' ' 62' ' ' LEU . 59.4 t -148.74 147.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 69' ' ' LEU . 2.8 mt -112.55 135.63 53.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.686 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 157.74 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.3 123.03 26.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.97 85.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.192 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.73 131.62 49.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.939 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.5 t -123.53 87.59 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.91 149.42 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.001 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 76' ' ' THR . 2.9 p -63.93 135.88 56.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 83' ' ' ASP . 26.4 p90 -145.35 -164.5 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -127.15 131.48 50.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.61 19.97 13.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.376 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.68 -37.48 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.287 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 77.6 p -138.65 25.03 2.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 81' ' ' THR . 28.4 mt-10 -161.13 161.87 31.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER 59.63 166.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.957 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.64 HD23 ' CE1' ' A' ' 124' ' ' TYR . 6.2 mt 84.18 54.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ASN . 1.1 p30 -125.4 27.36 6.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.964 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 85' ' ' ASN . 10.7 m-20 82.37 97.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.753 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.7 139.2 53.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.92 132.89 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 122' ' ' ILE . 8.4 mt -83.67 166.03 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.744 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 89' ' ' ILE . 2.5 m -140.63 117.56 11.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 111.057 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.723 HG13 HD12 ' A' ' 45' ' ' ILE . 3.3 mp -108.34 103.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.79 140.45 48.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.49 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 9.4 p90 -149.94 141.47 23.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.009 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.552 HG21 ' O ' ' A' ' 108' ' ' TRP . 4.0 t -132.43 147.43 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.992 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -52.4 137.86 28.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.663 HG22 ' CH2' ' A' ' 108' ' ' TRP . 3.0 p -82.38 143.36 48.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 47.2 Cg_exo -55.87 160.73 9.42 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.495 2.13 . . . . 0.0 112.071 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.8 121.38 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.41 42.56 65.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.09 160.64 17.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.401 . . . . 0.0 111.149 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.85 164.37 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.218 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -88.12 70.17 9.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.583 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.23 134.98 0.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.829 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.12 145.04 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.488 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 3.0 mmt180 -124.8 152.31 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -80.7 -44.55 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.046 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.51 -14.07 62.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.526 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.663 ' CH2' HG22 ' A' ' 96' ' ' THR . 5.0 m0 -51.49 -24.57 5.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.333 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 8.1 mtt . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.891 0.377 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.06 124.31 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.49 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -87.65 141.25 28.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.168 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.41 129.2 39.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.766 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -126.22 162.83 24.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.596 ' O ' HD12 ' A' ' 120' ' ' LEU . 53.2 m-80 -143.7 142.82 31.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 119' ' ' ASN . 8.6 mp -128.56 95.75 31.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.67 135.61 70.47 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.516 HD11 HG13 ' A' ' 89' ' ' ILE . 17.4 mm -97.24 144.76 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 18' ' ' VAL . 8.9 mt-10 -132.39 163.67 28.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.685 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.64 ' CE1' HD23 ' A' ' 84' ' ' LEU . 1.8 m-85 -126.08 125.7 43.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.319 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -114.76 80.93 1.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.841 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.924 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.752 0.23 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 142.87 47.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 112.35 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.99 125.86 12.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.524 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 16.5 m-20 -52.71 121.73 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.934 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' B' ' 35' ' ' ASN . 1.1 pt -94.28 129.13 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.2 146.84 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.684 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.4 138.91 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.038 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -136.22 112.13 10.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.08 154.59 69.98 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 123.99 -1.254 . . . . 0.0 112.43 0.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.29 -39.25 89.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.949 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.85 49.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -169.29 118.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.04 148.18 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.704 HG11 HG11 ' A' ' 18' ' ' VAL . 7.4 p -139.62 99.72 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 19.5 m-30 -51.6 108.1 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.465 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.83 137.16 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.367 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -59.69 167.08 2.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.859 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.727 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 81.9 Cg_endo -86.7 161.64 52.5 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.976 -1.26 . . . . 0.0 112.613 0.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.0 29.62 3.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -107.09 6.99 29.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.474 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -148.75 147.83 29.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.01 117.76 4.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.97 112.2 22.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -102.75 114.33 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' B' ' 19' ' ' PHE . 5.1 m-85 -96.1 121.9 38.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.814 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -80.95 132.44 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.061 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.6 152.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -113.34 127.87 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.62 130.37 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.794 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 51.1 m -142.13 156.69 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.19 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' B' ' 9' ' ' ILE . 26.1 t-20 -100.22 113.71 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.892 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -92.18 20.19 6.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.43 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.61 -140.33 9.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.535 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.27 29.45 0.97 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -155.91 148.31 23.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.768 0.318 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ARG . . . . . 0.572 ' HG2' HG12 ' B' ' 61' ' ' VAL . 5.6 ttp180 -54.52 159.12 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.431 ' O ' HG13 ' B' ' 61' ' ' VAL . 12.3 pt -154.19 166.4 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.592 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.14 109.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.566 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -104.26 161.66 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.299 0.571 . . . . 0.0 111.789 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.23 151.43 26.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.352 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.73 HD12 HG13 ' B' ' 91' ' ' ILE . 20.5 mm -122.32 140.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 0.0 111.637 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.23 131.07 22.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.641 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' THR . . . . . 0.527 HG22 HG12 ' B' ' 89' ' ' ILE . 67.8 p -113.92 154.84 26.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.144 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.05 -37.21 73.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -124.85 112.13 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.26 -37.15 9.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.767 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -32.22 7.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.9 141.58 29.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 132.46 27.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.022 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.48 HG11 HG21 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -115.08 127.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.047 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.47 129.54 8.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' B' ' 58' ' ' PRO . 58.7 Cg_endo -71.68 133.46 28.72 Favored 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.731 -1.362 . . . . 0.0 112.092 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 57' ' ' PRO . 50.7 Cg_exo -55.35 -46.78 29.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.355 2.037 . . . . 0.0 112.286 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.3 p -144.84 150.18 36.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.732 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.64 -172.1 27.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.586 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.572 HG12 ' HG2' ' B' ' 40' ' ' ARG . 5.9 t -123.02 114.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.436 HD21 HG23 ' B' ' 68' ' ' VAL . 0.4 OUTLIER -87.78 161.24 17.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.071 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.446 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -121.01 178.32 1.21 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.797 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 64' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 30.7 Cg_exo -61.5 108.98 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.653 2.235 . . . . 0.0 112.355 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.53 34.75 9.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -95.9 151.04 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -106.49 156.71 18.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' VAL . . . . . 0.436 HG23 HD21 ' B' ' 62' ' ' LEU . 59.1 t -148.71 147.31 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.234 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' B' ' 69' ' ' LEU . 2.9 mt -112.43 135.69 52.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.63 157.73 34.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 111.126 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.25 123.08 26.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.01 85.49 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.261 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 131.83 50.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 t -123.75 87.58 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.89 149.54 2.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 p -63.93 135.99 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' PHE . . . . . 0.496 ' CD2' ' HB2' ' B' ' 83' ' ' ASP . 26.5 p90 -145.57 -164.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -127.11 131.31 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.95 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.384 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.63 -37.62 5.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 111.265 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 77.9 p -138.54 25.1 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' B' ' 81' ' ' THR . 28.5 mt-10 -161.03 161.83 31.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ASP . . . . . 0.496 ' HB2' ' CD2' ' B' ' 77' ' ' PHE . 0.6 OUTLIER 59.56 166.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 110.95 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.628 HD23 ' CE1' ' B' ' 124' ' ' TYR . 6.2 mt 84.3 54.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.492 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' B' ' 86' ' ' ASN . 1.2 p30 -125.65 27.48 6.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.946 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' B' ' 85' ' ' ASN . 10.9 m-20 82.31 97.15 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.76 139.29 53.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.88 132.93 4.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.527 HG12 HG22 ' B' ' 47' ' ' THR . 8.8 mt -83.73 166.23 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.473 ' H ' HG22 ' B' ' 89' ' ' ILE . 2.5 m -140.79 117.38 10.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.962 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ILE . . . . . 0.73 HG13 HD12 ' B' ' 45' ' ' ILE . 3.4 mp -108.22 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.73 140.56 48.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 9.5 p90 -149.91 141.6 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.558 HG21 ' O ' ' B' ' 108' ' ' TRP . 4.0 t -132.63 147.24 52.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ASN . . . . . 0.415 ' HA ' HG22 ' B' ' 41' ' ' ILE . 0.7 OUTLIER -52.32 138.03 27.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.67 HG22 ' CH2' ' B' ' 108' ' ' TRP . 3.1 p -82.5 143.37 47.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.8 160.72 9.28 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 121.48 5.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.21 42.67 63.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.46 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.12 160.55 18.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 111.134 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.79 164.22 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.27 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -87.94 70.15 9.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.634 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.27 134.91 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.836 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -58.89 144.96 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ARG . . . . . 0.499 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 3.0 mmt180 -124.81 152.15 44.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -80.57 -44.54 18.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.613 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.67 ' CH2' HG22 ' B' ' 96' ' ' THR . 4.9 m0 -51.63 -24.44 5.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.78 0.324 . . . . 0.0 110.96 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 8.4 mtt . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.93 0.395 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.1 124.34 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' ARG . . . . . 0.479 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -87.75 141.21 28.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.47 129.08 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -125.97 162.82 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.598 ' O ' HD12 ' B' ' 120' ' ' LEU . 54.0 m-80 -143.77 142.79 31.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.842 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.598 HD12 ' O ' ' B' ' 119' ' ' ASN . 8.7 mp -128.55 95.81 31.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.61 135.57 70.34 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.629 2.219 . . . . 0.0 112.146 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.516 HD11 HG13 ' B' ' 89' ' ' ILE . 17.5 mm -97.27 144.5 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.277 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' B' ' 18' ' ' VAL . 9.2 mt-10 -132.3 163.62 28.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' TYR . . . . . 0.628 ' CE1' HD23 ' B' ' 84' ' ' LEU . 1.8 m-85 -125.93 125.92 43.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.286 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -114.93 81.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.986 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 75.2 Cg_exo . . . . . 0 CA--C 1.528 0.19 0 CA-C-O 120.623 0.176 . . . . 0.0 112.285 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 51.4 Cg_exo -52.83 156.41 9.34 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.489 2.126 . . . . 0.0 112.331 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.52 122.86 23.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.5 m-20 -52.43 115.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.38 138.09 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.85 146.43 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -135.65 149.67 49.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 111.153 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.561 ' O ' HG23 ' A' ' 31' ' ' ILE . 38.9 mt-30 -135.4 116.37 11.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.51 163.81 63.74 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.514 0.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 t -44.6 -62.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.383 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.41 ' HA ' HD22 ' A' ' 120' ' ' LEU . 2.2 tt0 -173.16 48.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 104.89 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 8.2 tt -131.93 145.31 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 123' ' ' GLU . 6.6 p -150.6 121.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -72.65 113.9 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -81.89 134.61 35.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -65.68 170.72 4.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.805 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.841 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 62.5 Cg_endo -73.19 164.99 85.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.766 -1.348 . . . . 0.0 112.675 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -107.27 46.65 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -115.11 -4.77 12.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.406 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -123.08 144.47 49.28 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.94 126.78 31.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.85 155.43 41.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.52 116.06 16.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -102.42 116.12 31.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -92.49 131.7 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 12' ' ' GLN . 5.3 mm -107.55 143.25 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.525 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -104.65 119.91 40.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.397 . . . . 0.0 111.242 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -112.88 153.79 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.748 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.69 155.86 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.143 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -102.48 109.9 21.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.582 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.15 19.19 6.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.63 -143.53 12.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.457 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.54 20.73 2.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 159.86 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' C ' ' HG1' ' A' ' 96' ' ' THR . 15.2 mtm180 -55.85 152.36 10.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.728 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.69 116.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.38 115.47 5.11 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.841 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.545 ' CD1' HD12 ' A' ' 62' ' ' LEU . 67.4 p-90 -118.06 158.86 24.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.122 0.487 . . . . 0.0 111.566 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.6 152.99 31.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.566 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.432 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 5.9 mm -104.02 154.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.424 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -155.65 132.64 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.678 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.27 160.16 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.161 0.505 . . . . 0.0 111.272 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.13 -55.16 36.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.44 113.16 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.59 22.05 5.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -113.23 -58.57 2.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.915 0.388 . . . . 0.0 110.788 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -33.2 63.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.779 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -98.02 145.88 26.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.689 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.92 147.11 36.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.03 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.3 p -139.98 160.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.26 0.552 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 55' ' ' VAL . 9.8 t70 -172.92 129.04 0.55 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.06 146.71 86.74 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.217 -0.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.95 -0.42 10.65 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.66 2.24 . . . . 0.0 113.151 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.55 177.1 0.36 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.822 0.344 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 154.71 167.37 16.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.64 128.93 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 111.115 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.545 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.86 123.06 46.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.72 171.54 12.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 114.54 2.31 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.618 2.212 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.49 28.49 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.293 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.75 148.27 23.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.768 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 128.38 52.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.117 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.38 138.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.033 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.58 123.54 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.448 ' CG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.24 163.06 17.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 154.58 51.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -134.37 89.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.702 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 p -74.0 139.44 44.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m -131.05 149.38 52.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.659 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.76 148.73 24.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 111.196 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -71.49 127.65 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.756 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.69 -173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.006 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -129.59 121.46 27.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.484 ' CB ' HD11 ' A' ' 126' ' ' LEU . . . -65.99 -21.01 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.39 65.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.38 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.9 p -141.15 67.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.304 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -150.19 171.92 16.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.65 136.53 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.0 mt -152.78 86.51 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.46 22.43 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.265 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.83 93.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.1 152.54 43.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.354 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.418 ' HA ' HG12 ' A' ' 122' ' ' ILE . 2.6 ptm180 -157.8 131.02 7.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.706 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 90' ' ' THR . 7.1 mm -85.1 163.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.317 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 89' ' ' ILE . 78.2 m -144.2 118.92 9.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.88 0.371 . . . . 0.0 111.493 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.13 97.16 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.76 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.38 133.95 48.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.101 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -138.66 154.89 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.682 ' HB ' HG13 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -147.31 151.41 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -55.71 150.88 11.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.521 HG22 ' CZ2' ' A' ' 108' ' ' TRP . 0.6 OUTLIER -96.07 142.17 24.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.0 156.59 61.73 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.609 2.206 . . . . 0.0 112.279 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -50.16 128.24 18.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.993 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.83 34.46 87.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.39 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.35 127.04 29.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.153 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.88 166.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.249 0.547 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -85.89 70.85 10.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.0 128.77 0.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -52.11 151.31 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.22 155.77 49.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.039 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.46 -34.44 16.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.99 -24.98 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.521 ' CZ2' HG22 ' A' ' 96' ' ' THR . 21.9 m0 -50.05 -34.7 22.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.985 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.667 ' CD2' HG11 ' A' ' 115' ' ' VAL . 4.9 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.999 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.758 0.313 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.682 HG13 ' HB ' ' A' ' 94' ' ' THR . 12.7 t -109.06 125.23 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.234 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.1 142.45 27.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.93 97.77 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.04 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -87.27 159.34 18.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.76 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.6 120.25 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.885 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 15' ' ' GLN . 4.7 mt -94.73 135.18 24.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.76 130.42 5.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.664 2.243 . . . . 0.0 112.627 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 3.4 mm -114.04 119.54 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 18' ' ' VAL . 45.7 mt-10 -117.82 157.53 26.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.533 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.37 109.06 18.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.959 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -83.13 81.56 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 79' ' ' ALA . 67.5 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 73.4 Cg_exo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.602 0.168 . . . . 0.0 112.257 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 5' ' ' PRO . 51.8 Cg_exo -52.83 156.51 9.19 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.532 2.155 . . . . 0.0 112.281 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.63 122.88 23.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.536 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 2.5 m-20 -52.44 115.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.84 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.32 137.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.78 146.47 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 149.55 49.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.572 ' O ' HG23 ' B' ' 31' ' ' ILE . 38.8 mt-30 -135.4 116.45 11.99 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 163.65 63.67 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.533 0.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.5 t -44.48 -62.42 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.462 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.41 ' HA ' HD22 ' B' ' 120' ' ' LEU . 2.2 tt0 -173.26 48.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.996 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.05 104.82 2.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.479 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 8.3 tt -131.96 145.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.762 HG23 ' O ' ' B' ' 123' ' ' GLU . 6.8 p -150.88 121.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -72.49 113.62 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.704 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -81.58 134.41 35.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.868 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -65.59 170.85 4.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' PRO . . . . . 0.868 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 64.8 Cg_endo -73.12 164.92 85.66 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.866 -1.306 . . . . 0.0 112.723 0.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -107.24 46.67 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -115.15 -4.6 12.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.395 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.27 144.44 49.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.913 0.387 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.9 126.68 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.992 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.84 155.37 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.44 115.96 16.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -102.36 116.23 32.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.659 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -92.74 131.5 37.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.254 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.572 HG23 ' O ' ' B' ' 12' ' ' GLN . 5.2 mm -107.31 143.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.616 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -104.59 120.09 40.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.267 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 mt -113.09 153.73 14.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.78 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.72 155.98 34.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 111.17 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -102.64 109.89 21.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.24 19.37 5.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.48 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.74 -143.64 12.84 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.432 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.44 20.81 2.23 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.52 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.74 160.08 37.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.855 0.359 . . . . 0.0 110.808 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -56.04 152.65 10.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.61 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.93 116.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.445 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.67 115.5 5.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.878 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.552 ' CD1' HD12 ' B' ' 62' ' ' LEU . 67.5 p-90 -118.18 158.75 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.101 0.477 . . . . 0.0 111.495 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.43 153.2 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.527 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.436 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 5.9 mm -104.2 154.26 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.431 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -155.61 132.73 10.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.677 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.3 160.35 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.0 111.251 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.39 -54.88 40.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.7 113.23 26.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.771 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.56 21.97 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -113.2 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -33.16 63.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.16 145.74 26.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.77 146.96 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.479 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.3 p -139.74 160.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.295 0.569 . . . . 0.0 110.922 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' ASP . . . . . 0.479 ' N ' HG22 ' B' ' 55' ' ' VAL . 9.8 t70 -172.69 128.98 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.793 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.07 146.72 86.8 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.293 -0.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.03 -0.46 10.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.678 2.252 . . . . 0.0 113.084 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.64 177.07 0.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 154.8 167.21 16.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.65 129.02 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.552 HD12 ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -103.99 123.19 46.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.951 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.74 171.47 12.34 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.81 114.45 2.29 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.591 2.194 . . . . 0.0 112.346 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.61 28.31 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.228 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 148.37 22.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.766 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 128.45 52.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.08 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.48 138.49 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.51 123.51 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.01 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' MET . . . . . 0.449 ' CG ' ' HB ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -119.22 163.08 17.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.962 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.72 51.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.435 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -134.58 89.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.589 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 20.5 p -74.06 139.38 44.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.99 149.35 52.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.588 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.59 148.86 24.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.252 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -71.52 127.72 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.78 -173.85 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.957 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.52 121.54 27.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ALA . . . . . 0.48 ' CB ' HD11 ' B' ' 126' ' ' LEU . . . -66.21 -20.8 66.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.306 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.9 -43.45 66.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -140.97 67.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.274 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -150.28 171.82 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.059 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.56 136.35 45.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 55.7 mt -152.59 86.48 1.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.5 22.43 12.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.238 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.74 93.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.37 152.27 43.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.349 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.426 ' HA ' HG12 ' B' ' 122' ' ' ILE . 2.6 ptm180 -157.44 131.01 7.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.515 HG22 ' N ' ' B' ' 90' ' ' THR . 7.1 mm -85.1 163.36 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.515 ' N ' HG22 ' B' ' 89' ' ' ILE . 81.9 m -144.08 118.88 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.389 . . . . 0.0 111.492 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.06 97.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.718 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -104.5 133.91 48.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.02 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -138.68 154.91 48.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' THR . . . . . 0.673 ' HB ' HG13 ' B' ' 115' ' ' VAL . 1.0 OUTLIER -147.12 151.32 36.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -55.63 150.85 11.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.009 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' THR . . . . . 0.521 HG22 ' CZ2' ' B' ' 108' ' ' TRP . 0.6 OUTLIER -96.04 142.19 24.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 156.48 62.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.206 . . . . 0.0 112.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -50.09 128.25 18.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.74 34.54 87.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.371 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.42 126.99 29.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.66 166.72 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.381 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -86.0 70.88 10.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.02 128.81 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -52.11 151.25 3.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.15 155.7 49.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.39 -34.35 16.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.02 -25.04 68.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' TRP . . . . . 0.521 ' CZ2' HG22 ' B' ' 96' ' ' THR . 22.3 m0 -49.93 -34.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.043 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' B' ' 115' ' ' VAL . 4.7 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.985 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.673 HG13 ' HB ' ' B' ' 94' ' ' THR . 12.4 t -108.78 125.32 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.254 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.24 142.51 27.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.99 97.61 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.074 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -87.08 159.26 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.48 120.29 11.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' B' ' 15' ' ' GLN . 4.6 mt -94.77 135.21 23.99 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.81 130.45 5.04 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.665 2.243 . . . . 0.0 112.814 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 3.4 mm -114.08 119.39 61.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.623 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.762 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.1 mt-10 -117.72 157.49 26.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 111.48 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.36 109.13 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -83.28 81.62 8.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' B' ' 79' ' ' ALA . 67.9 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.796 0.332 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -108.09 -179.14 3.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.3 p -53.2 151.04 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.63 107.58 5.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.137 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.98 166.21 21.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.387 2.058 . . . . 0.0 112.28 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.13 97.02 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.621 2.214 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.56 131.46 26.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 9.0 m-20 -57.74 109.03 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.1 pt -68.72 123.37 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.74 145.37 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.51 136.24 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.241 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' B' ' 22' ' ' PRO . 14.7 mt-30 -140.85 105.57 6.28 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.66 161.48 40.68 Favored 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.506 0.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.3 t -92.36 -26.07 18.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.71 49.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.53 107.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 17' ' ' ILE . 12.9 tt -129.7 120.1 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 125' ' ' ASN . 46.0 t -109.27 92.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.564 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 20.9 m-85 -52.74 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -67.18 141.41 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.431 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.13 169.42 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.821 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.774 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 66.3 Cg_endo -91.1 166.97 28.8 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.371 -1.096 . . . . 0.0 112.974 0.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.431 ' O ' ' HB ' ' A' ' 76' ' ' THR . 22.3 m-85 -108.87 31.1 5.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.755 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.37 3.61 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.399 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.601 ' N ' HG22 ' A' ' 76' ' ' THR . 3.3 t70 -164.31 151.49 11.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.821 0.343 . . . . 0.0 110.78 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.65 109.11 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.49 110.46 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.669 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 83.0 m -93.43 110.85 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 19' ' ' PHE . 79.6 m-85 -89.02 121.8 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -77.9 131.43 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.435 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.675 HD12 ' HE3' ' A' ' 70' ' ' MET . 16.0 mt -113.89 151.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -112.93 121.76 45.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 111.482 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.602 HD11 ' CE ' ' A' ' 70' ' ' MET . 39.3 mt -125.45 150.19 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.505 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.81 145.37 27.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.42 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.13 106.69 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.279 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.51 20.68 5.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.422 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.12 -170.8 24.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.18 -28.72 8.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.74 178.3 5.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.446 ' HB2' HG12 ' A' ' 61' ' ' VAL . 4.0 ptp180 -64.81 170.64 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 12.2 pt -152.98 136.18 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.655 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.84 112.2 4.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.511 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.472 ' HE1' HD13 ' A' ' 62' ' ' LEU . 37.6 p-90 -117.17 156.98 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.221 0.534 . . . . 0.0 111.811 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.99 153.35 40.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.286 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 mm -115.46 151.27 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.578 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -147.5 130.51 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.531 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.527 HG22 HG23 ' A' ' 89' ' ' ILE . 36.3 p -120.41 154.7 34.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 p -52.0 -30.27 24.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -139.07 117.8 12.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.69 17.11 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -108.74 -49.58 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -76.3 -50.51 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.52 148.41 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -136.53 107.35 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.89 118.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -142.17 136.46 14.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.93 132.77 28.11 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.575 -1.427 . . . . 0.0 112.05 -0.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.4 -45.57 9.13 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.404 2.069 . . . . 0.0 112.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 p -133.36 148.75 51.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.82 175.29 46.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 40' ' ' ARG . 4.9 t -116.21 108.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.597 HD11 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -80.29 158.83 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.31 170.13 5.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.62 110.57 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.647 2.231 . . . . 0.0 112.259 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.66 37.0 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.29 142.28 31.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.219 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -102.57 143.16 32.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.597 HG11 HD11 ' A' ' 62' ' ' LEU . 8.9 p -141.78 148.5 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 31' ' ' ILE . 1.4 mm? -104.49 143.82 32.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.675 ' HE3' HD12 ' A' ' 31' ' ' ILE . 3.1 ttp -120.31 156.34 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.649 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.669 ' HB1' ' CG2' ' A' ' 28' ' ' THR . . . -130.79 113.95 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.294 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 72' ' ' VAL . 7.3 p -114.16 88.14 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.94 146.48 33.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.6 107.5 9.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.74 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 146.17 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.037 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 25' ' ' ASP . 5.3 p -56.75 164.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -178.65 -173.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -116.15 109.52 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.97 16.94 13.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.457 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.47 -24.94 29.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.9 p -147.01 44.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.35 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.73 134.71 55.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.626 HD13 ' HB2' ' A' ' 124' ' ' TYR . 91.4 mt -127.71 69.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -155.68 28.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -130.35 6.45 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.617 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.87 119.3 34.12 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.45 136.0 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.056 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.872 HG13 HD11 ' A' ' 122' ' ' ILE . 7.8 mt -98.69 165.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 89' ' ' ILE . 58.2 m -137.75 123.07 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.871 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 91' ' ' ILE . 3.3 mp -121.79 112.2 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.54 155.01 35.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.461 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 11.4 p90 -157.59 147.28 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.469 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -141.25 134.12 28.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.4 OUTLIER -52.52 125.2 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.404 ' OG1' ' HG3' ' A' ' 40' ' ' ARG . 43.7 p -66.6 151.63 96.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.7 165.05 28.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.536 2.158 . . . . 0.0 112.148 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.93 117.44 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.43 51.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.234 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.43 166.08 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 0.0 111.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.09 164.31 25.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.314 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.94 69.42 9.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.63 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.08 122.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.88 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.2 122.28 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -117.23 150.52 38.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.91 -19.02 45.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.41 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.83 -23.66 66.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 0.0 111.234 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.16 -13.95 43.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -102.53 -22.71 13.98 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 111.191 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -107.9 33.67 3.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.906 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.52 -140.4 6.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.473 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.89 149.42 21.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.61 -166.0 16.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.469 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.27 152.47 48.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' A' ' 94' ' ' THR . 12.6 t -115.24 136.15 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.461 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 12.4 tpt180 -99.4 152.86 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.92 137.71 9.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.07 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -145.21 132.23 20.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -91.56 133.86 35.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.82 117.8 61.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.668 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.37 128.7 19.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.354 2.036 . . . . 0.0 112.359 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.872 HD11 HG13 ' A' ' 89' ' ' ILE . 32.5 mm -92.54 148.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.225 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.54 ' HB3' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.21 160.2 40.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.657 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.626 ' HB2' HD13 ' A' ' 84' ' ' LEU . 81.3 m-85 -132.15 110.74 10.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.207 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.671 ' HB2' HG12 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -99.29 132.24 44.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.633 179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.941 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.788 0.327 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -108.03 -179.15 3.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.832 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 24.2 p -53.16 151.18 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.82 107.56 5.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.02 166.16 21.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.391 2.06 . . . . 0.0 112.263 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.13 97.18 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.54 2.16 . . . . 0.0 112.308 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 131.72 27.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 9.1 m-20 -57.91 108.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.889 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.1 pt -68.7 123.46 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 145.19 55.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.657 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.34 136.07 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.234 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -140.66 105.64 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.78 161.57 41.2 Favored 'Cis proline' 0 C--N 1.35 0.658 0 C-N-CA 123.854 -1.311 . . . . 0.0 112.461 0.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.8 t -92.37 -26.06 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.112 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.67 49.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.68 106.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.529 ' O ' HG23 ' B' ' 17' ' ' ILE . 13.0 tt -129.58 120.12 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' B' ' 125' ' ' ASN . 45.9 t -109.27 92.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.573 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.484 ' HA ' ' CE2' ' B' ' 29' ' ' TYR . 21.0 m-85 -52.91 96.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.495 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -67.17 141.35 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.441 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.14 169.47 0.16 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.805 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.782 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 64.6 Cg_endo -91.13 166.82 28.77 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.948 0.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.434 ' O ' ' HB ' ' B' ' 76' ' ' THR . 22.3 m-85 -108.83 31.23 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.719 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.55 3.71 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.429 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ASP . . . . . 0.6 ' N ' HG22 ' B' ' 76' ' ' THR . 3.3 t70 -164.38 151.27 11.37 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.5 109.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.4 110.49 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.674 ' CG2' ' HB1' ' B' ' 71' ' ' ALA . 88.9 m -93.45 110.72 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.047 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.507 ' O ' HG12 ' B' ' 72' ' ' VAL . 79.6 m-85 -88.93 121.82 31.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' B' ' 70' ' ' MET . 37.9 m80 -77.87 131.36 37.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.659 HD12 ' HE3' ' B' ' 70' ' ' MET . 16.2 mt -113.77 152.03 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.486 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -113.08 121.53 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.524 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.601 HD11 ' CE ' ' B' ' 70' ' ' MET . 39.2 mt -125.3 150.24 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.567 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 53.6 m -148.9 145.11 27.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.423 . . . . 0.0 111.437 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -88.89 106.66 18.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.265 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.43 20.34 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.4 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.93 -170.87 24.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.554 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.12 -28.54 9.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.93 178.21 5.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.461 ' HB2' HG12 ' B' ' 61' ' ' VAL . 3.9 ptp180 -64.72 170.7 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.851 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.438 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 12.1 pt -152.95 136.09 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.623 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.66 112.17 4.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.471 ' HE1' HD13 ' B' ' 62' ' ' LEU . 38.1 p-90 -117.21 157.03 26.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.209 0.528 . . . . 0.0 111.861 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.05 153.48 40.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.257 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 mm -115.49 151.51 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -147.76 130.46 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.516 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.522 HG22 HG23 ' B' ' 89' ' ' ILE . 35.4 p -120.42 154.7 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.923 0.392 . . . . 0.0 111.12 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -52.07 -30.11 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -139.18 117.65 12.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.54 17.26 7.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.26 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -108.84 -49.63 3.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -76.25 -50.5 14.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.62 148.32 24.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.999 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -136.49 107.11 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.62 118.66 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.2 136.32 14.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.05 132.75 28.1 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.603 -1.416 . . . . 0.0 112.079 -0.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.54 -45.31 9.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.449 2.1 . . . . 0.0 112.191 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -133.48 148.56 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.766 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.64 175.23 46.33 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.526 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' B' ' 40' ' ' ARG . 5.0 t -116.17 108.35 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.597 HD11 HG11 ' B' ' 68' ' ' VAL . 1.1 mp -80.13 158.81 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.21 170.11 6.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.7 110.33 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.637 2.225 . . . . 0.0 112.3 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.89 36.97 9.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.402 ' HG2' ' HG ' ' B' ' 62' ' ' LEU . 0.4 OUTLIER -100.18 142.31 31.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.272 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -102.74 143.03 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.597 HG11 HD11 ' B' ' 62' ' ' LEU . 9.0 p -141.71 148.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.065 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.513 HD13 ' O ' ' B' ' 31' ' ' ILE . 1.4 mm? -104.32 143.9 32.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.659 ' HE3' HD12 ' B' ' 31' ' ' ILE . 3.1 ttp -120.29 156.41 31.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.701 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.674 ' HB1' ' CG2' ' B' ' 28' ' ' THR . . . -130.87 113.88 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.237 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.649 ' O ' HG13 ' B' ' 72' ' ' VAL . 7.2 p -114.1 87.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.968 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 28' ' ' THR . 0.2 OUTLIER -78.78 146.57 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.69 107.62 9.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.708 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.78 146.2 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.6 HG22 ' N ' ' B' ' 25' ' ' ASP . 5.4 p -56.75 164.32 1.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -178.61 -173.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -116.3 109.31 17.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.93 17.16 12.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.492 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.68 -24.92 28.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.056 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 59.7 p -146.94 44.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.58 22.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.841 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -64.12 134.7 55.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' B' ' 124' ' ' TYR . 90.9 mt -127.64 69.74 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -155.64 29.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -130.41 6.34 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.629 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.75 119.24 33.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.826 0.346 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.39 136.09 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.871 HG13 HD11 ' B' ' 122' ' ' ILE . 7.9 mt -98.82 165.53 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.47 ' H ' HG22 ' B' ' 89' ' ' ILE . 58.7 m -137.81 122.84 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.47 HD12 ' N ' ' B' ' 91' ' ' ILE . 3.3 mp -121.51 112.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.52 154.81 36.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.833 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.469 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 11.4 p90 -157.42 147.14 20.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.464 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -141.06 134.11 29.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.407 ' HA ' HG22 ' B' ' 41' ' ' ILE . 0.4 OUTLIER -52.44 125.37 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.405 ' OG1' ' HG3' ' B' ' 40' ' ' ARG . 43.8 p -66.86 151.6 96.69 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.63 165.01 28.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.586 2.19 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.91 117.39 1.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.38 47.63 50.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.218 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.52 166.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 111.324 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.21 164.22 25.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.88 69.51 9.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.585 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.99 122.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.12 122.17 6.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -116.98 150.56 38.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -19.01 44.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.332 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.76 -23.73 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.773 0.321 . . . . 0.0 111.242 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.19 -13.85 42.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -102.55 -22.75 13.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -107.82 33.58 4.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.33 -140.35 6.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.83 149.36 21.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.39 -165.95 17.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.555 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.3 152.35 48.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 110.954 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.464 HG13 ' HB ' ' B' ' 94' ' ' THR . 12.7 t -115.16 136.12 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.469 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 12.4 tpt180 -99.38 152.79 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.78 137.8 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.796 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -91.44 133.78 35.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.71 117.72 62.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.656 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.37 128.76 19.94 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.389 2.06 . . . . 0.0 112.294 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.871 HD11 HG13 ' B' ' 89' ' ' ILE . 31.9 mm -92.63 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.537 ' HB3' HG13 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -140.17 160.2 40.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.726 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.612 ' CB ' HD13 ' B' ' 84' ' ' LEU . 80.9 m-85 -132.1 110.78 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.231 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.671 ' HB2' HG12 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -99.46 132.19 44.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.623 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.955 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.771 0.32 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -94.95 82.33 3.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.2 m -82.9 172.37 12.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 m -140.64 136.16 16.27 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.03 168.3 25.13 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.556 2.17 . . . . 0.0 112.247 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.07 124.0 10.91 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.481 2.121 . . . . 0.0 112.266 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 111.09 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -54.07 120.23 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.65 130.67 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.46 151.18 27.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.587 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.09 149.59 46.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 111.303 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 31' ' ' ILE . 5.4 mt-30 -141.28 108.89 6.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.454 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.6 159.72 51.33 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 124.038 -1.234 . . . . 0.0 112.501 0.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.15 -3.57 12.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -120.43 -48.48 2.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -170.38 141.24 1.96 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 tt -109.07 144.83 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.605 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.893 HG11 HG11 ' B' ' 18' ' ' VAL . 10.2 p -125.11 101.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.774 0.321 . . . . 0.0 111.653 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' CD1' ' A' ' 29' ' ' TYR . 30.8 m-85 -58.11 111.15 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.463 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -72.22 139.77 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.736 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -57.55 167.42 1.34 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.844 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.736 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -89.99 163.12 34.9 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.734 0.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -101.31 28.83 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.13 5.81 46.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.06 156.12 41.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.778 0.323 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -76.35 108.1 9.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.89 136.34 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.79 106.94 17.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 39.5 m-85 -91.94 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -79.96 154.05 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 12' ' ' GLN . 26.0 mt -130.32 147.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.793 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -100.98 126.98 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.185 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.7 HD11 ' CE ' ' A' ' 70' ' ' MET . 13.6 mt -124.16 159.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 33' ' ' ILE . 98.5 m -156.28 153.7 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' OD1' HD13 ' A' ' 41' ' ' ILE . 13.3 t30 -112.61 76.01 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.752 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.62 -30.98 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.954 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.07 174.43 3.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.354 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.01 35.14 4.84 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.553 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.22 171.54 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -74.61 152.35 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.449 HD13 ' OD1' ' A' ' 35' ' ' ASN . 8.7 pt -149.82 142.53 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 111.554 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -98.94 107.97 3.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.455 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CD1' HD12 ' A' ' 62' ' ' LEU . 37.5 p-90 -109.48 157.56 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.171 0.51 . . . . 0.0 111.756 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.592 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -148.13 155.56 41.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.485 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.671 HD12 HG13 ' A' ' 91' ' ' ILE . 6.2 mm -121.64 144.93 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.8 135.86 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.917 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.415 HG22 HG23 ' A' ' 89' ' ' ILE . 2.6 p -118.69 156.73 28.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.006 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.8 p -49.87 -64.27 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 114.17 25.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.99 22.5 5.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -42.89 5.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -95.14 -51.34 4.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.8 mt -76.13 140.18 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.9 125.02 28.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.38 140.72 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -168.02 127.06 1.01 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 11.9 Cg_exo -70.71 132.6 24.12 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 123.937 -1.276 . . . . 0.0 111.977 -0.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 52.3 Cg_exo -54.96 -44.15 52.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.46 2.106 . . . . 0.0 112.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 104' ' ' PHE . 3.5 m -139.38 141.4 37.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.711 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.38 155.84 26.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.548 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.78 115.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 0.0 111.019 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -87.42 156.41 19.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -110.97 178.53 0.97 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.805 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.1 Cg_exo -58.21 110.24 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.533 2.155 . . . . 0.0 112.282 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.68 40.65 29.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.67 155.64 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -114.23 143.98 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.874 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.456 HG23 ' HB ' ' A' ' 33' ' ' ILE . 8.1 m -133.61 151.55 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.73 141.47 30.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.092 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.7 ' CE ' HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -125.52 161.27 27.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.565 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.73 132.19 23.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.304 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.11 90.37 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.046 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 148.4 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.98 152.58 42.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -105.84 137.24 44.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.019 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 76' ' ' THR . 3.8 p -59.97 145.86 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -165.56 -166.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -114.6 118.52 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.46 19.22 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.07 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -142.66 46.5 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.008 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -143.03 147.74 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.57 150.81 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' A' ' 124' ' ' TYR . 49.6 mt -128.29 29.08 5.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.16 32.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -111.03 -19.09 12.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.389 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.57 117.79 23.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.2 137.77 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 90' ' ' THR . 6.3 mt -108.13 166.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.488 ' H ' HG22 ' A' ' 89' ' ' ILE . 8.4 m -153.1 123.6 7.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.809 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.671 HG13 HD12 ' A' ' 45' ' ' ILE . 3.6 mp -112.69 122.5 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 135.78 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.747 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 10.9 p90 -141.1 145.1 35.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 111.026 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.428 HG21 ' HA ' ' A' ' 109' ' ' PHE . 5.0 t -131.27 149.67 52.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -51.52 135.91 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.81 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 129.77 65.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.472 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 53.0 Cg_exo -55.03 159.9 8.88 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.411 2.074 . . . . 0.0 112.245 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -51.68 124.95 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.998 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.78 42.52 78.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HB1' ' CZ2' ' A' ' 108' ' ' TRP . . . -59.53 143.31 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.073 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.33 164.36 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 69.51 9.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.599 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.95 129.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.738 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE2' ' SG ' ' A' ' 59' ' ' CYS . 34.8 t80 -49.04 128.14 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -120.01 150.66 40.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -86.07 -36.6 19.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.74 -19.66 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.283 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.484 ' CZ2' ' HB1' ' A' ' 100' ' ' ALA . 18.2 m0 -53.58 -22.28 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.428 ' HA ' HG21 ' A' ' 94' ' ' THR . 57.1 m-85 -88.81 -33.81 17.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.983 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.41 51.73 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.954 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -133.27 -120.1 2.08 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.565 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -109.27 143.41 38.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.41 -171.3 19.31 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.579 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.84 145.51 43.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.65 150.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.53 139.89 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -128.44 146.53 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.46 159.61 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.734 ' O ' HD22 ' A' ' 120' ' ' LEU . 87.3 m-20 -129.06 147.81 50.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.477 . . . . 0.0 111.369 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 119' ' ' ASN . 1.9 mm? -138.34 86.73 16.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 147.64 92.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.654 2.236 . . . . 0.0 112.613 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.2 mm -100.67 152.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HB3' ' CB ' ' A' ' 18' ' ' VAL . 6.9 tp10 -141.45 154.54 45.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.979 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' A' ' 84' ' ' LEU . 2.3 m-85 -113.51 126.86 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.168 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HB2' HG22 ' A' ' 18' ' ' VAL . 10.0 t30 -109.55 82.05 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.772 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.981 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -95.17 82.45 3.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 68.8 m -82.97 172.6 12.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.803 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -140.85 136.0 15.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.92 168.22 25.31 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.496 2.131 . . . . 0.0 112.27 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.09 123.85 10.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.514 2.143 . . . . 0.0 112.24 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.69 111.16 0.85 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.614 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -54.01 120.13 5.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.849 0.356 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.53 130.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.49 151.35 27.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.552 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.33 149.48 45.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 111.255 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.451 ' O ' HG23 ' B' ' 31' ' ' ILE . 5.4 mt-30 -141.05 108.94 6.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.576 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.59 159.83 50.96 Favored 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.902 -1.291 . . . . 0.0 112.504 0.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.18 -3.36 12.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.721 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -120.49 -48.66 2.28 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.823 0.345 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -170.3 141.46 2.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.355 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -109.43 144.8 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.568 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.893 HG11 HG11 ' A' ' 18' ' ' VAL . 10.4 p -125.09 101.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.857 0.361 . . . . 0.0 111.693 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.474 ' CD2' ' CD1' ' B' ' 29' ' ' TYR . 30.6 m-85 -58.21 111.02 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.405 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -72.08 139.69 48.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.269 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -57.4 167.52 1.25 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.868 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.715 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 69.7 Cg_endo -89.9 163.17 35.29 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.77 0.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -101.42 28.78 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.028 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.18 5.67 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.421 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.88 156.36 42.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.703 0.287 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -76.5 108.16 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.97 136.6 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.95 106.97 17.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.474 ' CD1' ' CD2' ' B' ' 19' ' ' PHE . 39.7 m-85 -91.97 113.45 25.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.65 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -79.73 154.07 28.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.382 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.451 HG23 ' O ' ' B' ' 12' ' ' GLN . 25.9 mt -130.4 147.03 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.783 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -100.83 126.94 47.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.226 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.712 HD11 ' CE ' ' B' ' 70' ' ' MET . 13.8 mt -124.02 159.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.487 ' N ' HG22 ' B' ' 33' ' ' ILE . 98.1 m -156.45 153.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.071 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.437 ' OD1' HD13 ' B' ' 41' ' ' ILE . 13.4 t30 -112.76 75.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.789 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.59 -30.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.998 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.3 174.61 3.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 35.36 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.33 171.72 18.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -74.77 152.45 39.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.437 HD13 ' OD1' ' B' ' 35' ' ' ASN . 8.5 pt -149.91 142.52 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.39 . . . . 0.0 111.582 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.92 107.96 3.51 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.408 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.464 ' CD1' HD12 ' B' ' 62' ' ' LEU . 37.6 p-90 -109.35 157.51 18.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.204 0.526 . . . . 0.0 111.729 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.58 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -148.1 155.46 41.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.401 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.68 HD12 HG13 ' B' ' 91' ' ' ILE . 6.2 mm -121.65 144.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 111.298 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.74 136.13 20.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.42 HG22 HG23 ' B' ' 89' ' ' ILE . 2.7 p -119.04 156.77 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 4.4 p -49.94 -64.12 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.2 114.19 25.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.94 22.6 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -42.93 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.768 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -95.15 -51.47 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.12 140.17 41.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.82 125.29 29.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.53 140.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.985 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -168.17 126.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.6 132.5 23.64 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.948 -0.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.87 -44.06 53.36 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.39 2.06 . . . . 0.0 112.233 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' B' ' 104' ' ' PHE . 3.5 m -139.59 141.22 37.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.27 155.81 26.37 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.626 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.74 115.53 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 111.088 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.464 HD12 ' CD1' ' B' ' 43' ' ' TRP . 0.4 OUTLIER -87.29 156.75 19.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.455 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.2 OUTLIER -111.29 178.61 0.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 32.2 Cg_exo -58.33 110.21 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 0.0 112.282 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.83 40.72 28.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 155.62 18.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.027 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -114.34 143.77 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' B' ' 33' ' ' ILE . 8.6 m -133.4 151.8 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.02 141.19 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.179 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.712 ' CE ' HD11 ' B' ' 33' ' ' ILE . 0.6 OUTLIER -125.19 161.27 27.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.704 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.77 132.25 23.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.283 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.15 90.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.13 148.44 48.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.94 152.55 42.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.823 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -105.82 137.32 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -60.02 145.97 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -165.68 -166.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -114.38 118.66 34.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.6 19.0 15.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 -28.29 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -142.46 46.37 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -142.77 147.93 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.64 151.04 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.482 HD22 ' CG ' ' B' ' 124' ' ' TYR . 49.0 mt -128.53 29.23 5.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.38 32.91 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -111.01 -18.98 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.66 117.59 23.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.02 137.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.482 HG22 ' H ' ' B' ' 90' ' ' THR . 6.2 mt -107.98 166.55 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.482 ' H ' HG22 ' B' ' 89' ' ' ILE . 8.3 m -153.14 123.45 7.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.68 HG13 HD12 ' B' ' 45' ' ' ILE . 3.6 mp -112.58 122.51 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.254 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.13 135.99 51.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.764 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' B' ' 43' ' ' TRP . 10.9 p90 -141.32 145.12 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.419 HG21 ' HA ' ' B' ' 109' ' ' PHE . 5.0 t -131.22 149.88 52.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -51.59 136.09 27.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.22 129.84 65.13 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' PRO . . . . . 0.47 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 53.0 Cg_exo -55.1 159.93 9.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.444 2.096 . . . . 0.0 112.235 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.84 124.94 13.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.01 42.34 80.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.54 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.48 ' HB1' ' CZ2' ' B' ' 108' ' ' TRP . . . -59.45 143.07 50.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.09 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.22 164.42 7.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.084 0.468 . . . . 0.0 111.266 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.84 69.28 9.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.575 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.7 129.41 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.825 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.428 ' CE2' ' SG ' ' B' ' 59' ' ' CYS . 34.9 t80 -49.02 128.09 15.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.012 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.07 150.52 40.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -85.9 -36.66 19.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.59 -19.68 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.306 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.48 ' CZ2' ' HB1' ' B' ' 100' ' ' ALA . 18.2 m0 -53.62 -22.4 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.104 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.419 ' HA ' HG21 ' B' ' 94' ' ' THR . 57.6 m-85 -88.68 -33.78 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.76 0.314 . . . . 0.0 110.948 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -99.57 51.72 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -133.22 -120.39 2.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.424 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -109.12 143.49 38.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.51 -171.29 19.22 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.528 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.85 145.49 43.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 43.6 t -91.68 150.01 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.64 139.72 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.766 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.22 146.54 50.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.41 159.44 43.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.732 ' O ' HD22 ' B' ' 120' ' ' LEU . 87.2 m-20 -128.9 147.83 50.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.381 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.732 HD22 ' O ' ' B' ' 119' ' ' ASN . 1.9 mm? -138.25 86.75 16.67 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.38 147.76 92.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.586 2.191 . . . . 0.0 112.576 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 28.8 mm -100.72 152.2 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.442 ' HB3' ' CB ' ' B' ' 18' ' ' VAL . 7.1 tp10 -141.63 154.52 45.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.896 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.482 ' CG ' HD22 ' B' ' 84' ' ' LEU . 2.4 m-85 -113.56 126.96 55.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.492 ' HB2' HG22 ' B' ' 18' ' ' VAL . 10.0 t30 -109.67 81.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.913 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.52 139.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.69 168.89 18.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.642 ' O ' HG23 ' A' ' 4' ' ' VAL . 26.9 m -146.2 103.12 4.08 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.41 160.24 32.3 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.544 2.163 . . . . 0.0 112.382 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' CG ' ' HG3' ' A' ' 116' ' ' ARG . 65.4 Cg_endo -73.95 110.39 3.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.526 2.151 . . . . 0.0 112.261 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.94 132.81 28.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.957 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.2 m-20 -55.78 140.41 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.632 HG23 ' NE1' ' A' ' 93' ' ' TRP . 9.2 pt -102.78 146.34 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.2 142.85 27.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.91 151.54 51.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.024 0.44 . . . . 0.0 111.16 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -135.67 111.5 10.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.528 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.97 165.09 43.11 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.958 -1.268 . . . . 0.0 112.609 0.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.9 t -45.57 -70.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.431 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.797 ' HA ' HD22 ' A' ' 120' ' ' LEU . 4.4 mt-30 -154.76 39.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.007 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 137.9 4.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.242 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 12.3 tt -148.2 138.34 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.795 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 123' ' ' GLU . 48.2 t -119.11 116.23 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 111.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.38 95.9 2.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.349 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -70.55 135.8 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.594 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.867 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -74.8 172.6 8.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.381 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.867 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 92.3 Cg_endo -82.12 163.87 75.32 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 124.275 -1.135 . . . . 0.0 113.065 0.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.06 45.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 76' ' ' THR . 70.8 m-20 -124.97 8.11 8.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.64 8.38 3.07 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.454 ' HG3' ' CG2' ' A' ' 76' ' ' THR . 15.0 mttt 62.5 137.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -140.17 95.81 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.945 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -76.16 118.21 18.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.748 ' O ' HG12 ' A' ' 72' ' ' VAL . 95.7 m-85 -101.79 111.71 24.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -84.2 135.38 34.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.3 mt -112.92 138.0 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.686 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 125.66 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.655 HD11 ' CE ' ' A' ' 70' ' ' MET . 14.3 mt -120.63 155.0 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.426 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.2 m -150.64 158.32 44.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 111.221 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -96.29 108.95 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.738 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.957 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -95.37 22.42 6.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.094 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.57 -152.07 10.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.613 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.9 -19.43 4.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.696 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.04 152.73 39.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.318 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 168.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.752 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.744 HD12 ' CD1' ' A' ' 93' ' ' TRP . 25.1 pt -155.34 149.05 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.642 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.49 112.62 3.88 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.13 161.52 13.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 0.0 111.85 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 151.28 37.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.115 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.1 144.18 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 111.891 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.07 143.98 46.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 89' ' ' ILE . 76.9 p -138.68 150.63 46.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.069 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.0 78.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -137.51 114.49 10.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.7 mtp -90.46 10.57 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.567 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.12 -35.48 10.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.927 0.394 . . . . 0.0 110.626 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HD3' ' CG ' ' A' ' 77' ' ' PHE . 2.5 ttm180 -94.55 -25.5 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.779 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.17 141.1 50.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.8 p -133.8 110.98 10.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.42 121.79 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.027 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -142.2 131.02 11.97 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.948 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.8 140.81 67.66 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.658 -1.392 . . . . 0.0 112.154 -0.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.25 -39.65 12.7 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 21.9 m -138.19 167.12 22.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.26 -168.73 41.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.731 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 41' ' ' ILE . 11.7 p -150.6 138.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.64 0.257 . . . . 0.0 110.832 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 66' ' ' GLU . 1.1 pt? -134.19 151.35 51.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.403 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 1.1 m-20 -84.11 178.01 2.65 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 27.7 Cg_exo -62.45 127.48 21.0 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.736 2.291 . . . . 0.0 112.422 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER 81.61 -7.98 1.39 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.035 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.519 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -81.34 156.74 25.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.6 149.74 51.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.976 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.62 152.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 mt -104.85 138.49 41.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 33' ' ' ILE . 43.1 mtm -129.21 154.12 47.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.77 117.61 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.312 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 29' ' ' TYR . 7.5 p -106.31 86.84 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.9 131.29 42.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.63 97.55 5.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.732 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -51.94 148.92 5.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.17 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' A' ' 26' ' ' LYS . 3.2 p -64.23 138.37 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 21.7 p90 -154.21 -173.69 4.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -105.68 109.47 21.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.02 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -95.43 18.89 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.81 -24.15 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -139.17 52.13 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -141.6 176.16 9.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.63 112.24 25.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.538 HD13 ' CD2' ' A' ' 124' ' ' TYR . 22.9 mt -134.25 60.38 1.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -141.98 17.31 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.352 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.08 10.02 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.77 137.25 39.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HA ' HG12 ' A' ' 122' ' ' ILE . 13.6 ptt180 -163.4 133.86 4.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 47' ' ' THR . 56.7 mt -96.74 112.09 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 118' ' ' LYS . 87.6 m -93.98 122.49 36.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.4 mp -111.49 109.93 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.884 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.04 131.73 55.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.976 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.744 ' CD1' HD12 ' A' ' 41' ' ' ILE . 5.9 p90 -136.5 141.81 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 1.3 t -131.85 144.55 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.76 143.05 26.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 144.13 57.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 43.3 Cg_endo -67.7 159.17 53.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.562 2.175 . . . . 0.0 112.165 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -51.45 124.06 11.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.05 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.38 35.96 91.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.57 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -65.15 135.92 56.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.814 0.34 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.09 164.48 0.63 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.146 0.498 . . . . 0.0 111.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.39 70.2 7.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.567 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.38 139.04 0.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -50.49 139.25 16.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 1.2 mmp_? -129.97 148.57 51.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -32.62 39.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.6 -9.48 58.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.46 ' CG ' ' HB2' ' A' ' 105' ' ' ARG . 17.6 m0 -62.66 -18.49 62.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.57 0.224 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 94' ' ' THR . 10.6 m-85 -104.9 28.59 7.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.745 0.307 . . . . 0.0 110.795 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -150.38 32.9 0.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -121.21 -142.5 6.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.431 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.7 141.27 29.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.856 0.36 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.34 -179.9 20.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.66 149.2 33.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 94' ' ' THR . 11.0 t -106.43 130.25 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.426 ' HD3' ' CZ2' ' A' ' 93' ' ' TRP . 13.6 mtt-85 -94.31 135.11 36.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -123.55 118.68 27.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -117.93 162.97 17.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.814 ' C ' HD23 ' A' ' 120' ' ' LEU . 3.0 p30 -140.87 143.22 34.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 119' ' ' ASN . 4.6 mt -124.6 104.65 30.8 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.678 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.93 138.7 87.17 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.489 2.126 . . . . 0.0 112.453 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 14.1 mm -113.93 104.91 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.958 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.739 ' O ' HG13 ' A' ' 18' ' ' VAL . 4.2 mt-10 -97.05 117.92 32.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 84' ' ' LEU . 11.6 m-85 -81.8 99.39 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' HB2' HG12 ' A' ' 18' ' ' VAL . 1.4 m-20 -73.8 83.65 1.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.007 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 79' ' ' ALA . 30.6 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.816 0.341 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.44 139.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.55 168.78 18.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.946 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.639 ' O ' HG23 ' B' ' 4' ' ' VAL . 26.8 m -146.2 103.01 4.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.25 160.32 32.79 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.547 2.165 . . . . 0.0 112.382 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.402 ' CG ' ' HG3' ' B' ' 116' ' ' ARG . 66.4 Cg_endo -73.96 110.35 3.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.536 2.157 . . . . 0.0 112.249 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.86 132.86 27.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.958 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 37.2 m-20 -55.77 140.43 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.625 HG23 ' NE1' ' B' ' 93' ' ' TRP . 9.4 pt -102.82 146.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.209 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.26 142.97 26.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.01 151.38 51.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -135.6 111.42 10.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.12 164.96 44.42 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.958 -1.267 . . . . 0.0 112.607 0.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.5 t -45.43 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.476 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.815 ' HA ' HD22 ' B' ' 120' ' ' LEU . 4.4 mt-30 -154.75 39.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.044 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.8 137.86 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.262 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 12.4 tt -148.24 138.25 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.725 HG13 ' O ' ' B' ' 123' ' ' GLU . 48.0 t -118.99 116.29 50.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.526 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.55 95.98 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -70.51 135.85 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.889 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -74.77 172.52 8.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.889 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -82.23 164.13 74.53 Favored 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.257 -1.143 . . . . 0.0 112.975 0.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.31 45.35 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 70.7 m-20 -124.95 7.93 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.36 8.29 3.13 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' B' ' 76' ' ' THR . 15.1 mttt 62.7 138.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.661 0.267 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -140.53 95.76 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -76.05 118.47 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.734 ' O ' HG12 ' B' ' 72' ' ' VAL . 95.9 m-85 -102.04 111.87 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -84.49 135.46 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.225 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 41.8 mt -112.92 138.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.715 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 125.59 54.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.961 0.41 . . . . 0.0 111.186 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.666 HD11 ' CE ' ' B' ' 70' ' ' MET . 14.1 mt -120.6 155.0 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.872 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 33' ' ' ILE . 52.4 m -150.65 158.42 44.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.057 0.456 . . . . 0.0 111.279 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -96.24 109.13 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.705 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.958 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -95.56 22.49 7.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.53 -151.99 9.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.93 -19.52 4.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.61 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.2 152.68 39.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.993 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 168.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.687 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.761 HD12 ' CD1' ' B' ' 93' ' ' TRP . 24.8 pt -155.29 149.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.622 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -106.65 112.86 3.92 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.31 161.52 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.279 0.561 . . . . 0.0 111.935 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.03 151.45 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.146 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.23 144.1 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 111.876 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.04 143.84 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.34 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.475 HG22 HG12 ' B' ' 89' ' ' ILE . 74.7 p -138.58 150.73 46.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.017 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -36.04 78.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -137.56 114.55 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 42.5 mtp -90.53 10.76 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.46 -35.09 10.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 0.0 110.604 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.411 ' HD3' ' CG ' ' B' ' 77' ' ' PHE . 2.5 ttm180 -94.87 -25.5 16.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.23 141.01 50.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 97.7 p -133.81 110.67 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.2 121.71 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -142.1 131.0 12.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.86 140.94 68.56 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.068 -0.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.46 -39.44 12.5 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.109 . . . . 0.0 112.247 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 22.5 m -138.36 167.11 22.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.28 -168.74 41.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.682 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.648 HG23 ' O ' ' B' ' 41' ' ' ILE . 11.8 p -150.7 138.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.674 0.274 . . . . 0.0 110.769 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.522 HD12 ' O ' ' B' ' 66' ' ' GLU . 1.1 pt? -134.34 151.48 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.211 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.442 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 1.1 m-20 -84.25 177.82 2.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 27.8 Cg_exo -62.26 127.18 20.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.787 2.325 . . . . 0.0 112.435 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER 81.95 -8.26 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.977 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.522 ' O ' HD12 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -81.16 156.84 25.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.55 149.85 51.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.81 152.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 12.6 mt -104.72 138.3 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.666 ' CE ' HD11 ' B' ' 33' ' ' ILE . 43.1 mtm -128.98 154.16 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.87 117.6 13.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.734 HG12 ' O ' ' B' ' 29' ' ' TYR . 7.3 p -106.46 86.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.98 131.2 41.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 p -123.39 97.59 5.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.702 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -52.17 148.92 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.058 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' B' ' 26' ' ' LYS . 3.2 p -64.3 138.31 58.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.411 ' CG ' ' HD3' ' B' ' 52' ' ' ARG . 21.3 p90 -154.12 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' B' ' 82' ' ' GLU . 42.3 m-80 -105.73 109.67 21.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.953 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.76 19.23 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.428 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.35 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.3 p -139.2 52.21 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' B' ' 78' ' ' ASN . 8.6 mm-40 -141.65 175.92 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.51 111.95 24.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' B' ' 124' ' ' TYR . 22.4 mt -134.04 60.54 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -142.03 17.27 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.1 10.09 2.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.89 137.27 39.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -163.45 133.88 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.475 HG12 HG22 ' B' ' 47' ' ' THR . 55.8 mt -96.78 112.03 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 118' ' ' LYS . 88.5 m -93.87 122.53 36.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.333 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.454 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.4 mp -111.62 109.83 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.877 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -111.92 131.8 55.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.761 ' CD1' HD12 ' B' ' 41' ' ' ILE . 5.8 p90 -136.62 141.84 43.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.023 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.549 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 1.3 t -131.86 144.5 50.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.66 142.96 26.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.12 144.34 58.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' PRO . . . . . 0.444 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 41.5 Cg_endo -67.93 159.2 53.98 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.658 2.239 . . . . 0.0 112.215 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -51.46 123.83 10.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.45 35.94 91.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -65.05 136.04 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.754 0.311 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.38 164.24 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.218 0.532 . . . . 0.0 111.277 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 70.27 7.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.653 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.33 138.95 0.09 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.39 138.91 16.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.466 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 1.2 mmp_? -129.69 148.48 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -32.51 40.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.73 -9.22 58.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.649 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.466 ' CG ' ' HB2' ' B' ' 105' ' ' ARG . 17.9 m0 -62.86 -18.63 63.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.658 0.266 . . . . 0.0 111.256 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' B' ' 94' ' ' THR . 10.6 m-85 -104.69 28.46 7.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.36 . . . . 0.0 110.891 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -150.28 32.75 0.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.97 -142.62 6.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.485 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.65 141.22 29.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.31 -179.69 20.44 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.81 149.24 33.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' B' ' 94' ' ' THR . 11.1 t -106.41 130.36 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.425 ' HD3' ' CZ2' ' B' ' 93' ' ' TRP . 13.8 mtt-85 -94.46 134.86 36.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.076 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -123.43 118.59 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.548 ' O ' HG23 ' B' ' 90' ' ' THR . 0.0 OUTLIER -117.82 163.06 17.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.754 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.816 ' C ' HD23 ' B' ' 120' ' ' LEU . 3.1 p30 -141.08 143.23 34.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.142 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.816 HD23 ' C ' ' B' ' 119' ' ' ASN . 4.5 mt -124.51 104.49 31.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.82 138.76 86.98 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.503 2.135 . . . . 0.0 112.429 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 13.8 mm -113.95 104.8 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.946 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.725 ' O ' HG13 ' B' ' 18' ' ' VAL . 4.1 mt-10 -96.95 117.77 31.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.981 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.54 ' CD2' HD13 ' B' ' 84' ' ' LEU . 11.1 m-85 -81.76 99.2 8.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.41 ' HB2' HG12 ' B' ' 18' ' ' VAL . 1.4 m-20 -73.68 83.63 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.054 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.9 mt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.908 179.751 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.74 155.18 27.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 t -102.09 -56.48 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.809 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.532 HG23 ' HD2' ' A' ' 5' ' ' PRO . 6.6 p -177.7 141.11 0.44 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.948 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 4' ' ' VAL . 50.0 Cg_exo -53.17 147.58 34.53 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.603 2.202 . . . . 0.0 112.323 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.65 106.29 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.621 2.214 . . . . 0.0 112.24 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.65 129.91 49.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.2 m-20 -55.0 128.87 35.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.857 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.2 138.69 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.318 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 149.73 39.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.693 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.29 149.87 35.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.962 0.411 . . . . 0.0 111.094 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.9 mm-40 -144.86 107.17 4.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.662 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.87 154.64 61.49 Favored 'Cis proline' 0 C--N 1.352 0.717 0 C-N-CA 123.748 -1.355 . . . . 0.0 112.457 0.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.2 m -59.45 -53.11 61.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -160.05 39.89 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.47 111.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.085 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -129.9 134.01 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.941 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.721 HG23 ' HB3' ' A' ' 123' ' ' GLU . 6.1 p -130.69 110.63 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -57.34 154.37 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.968 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.14 120.13 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.372 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -50.33 169.01 0.21 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.848 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 61.4 Cg_endo -72.7 163.44 88.73 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.443 0.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 24.4 m-85 -111.63 34.92 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.017 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.76 4.5 25.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.72 131.63 20.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.826 0.346 . . . . 0.0 110.74 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -51.77 122.58 8.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -118.39 150.22 39.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.642 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.72 109.83 14.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.643 ' O ' HG12 ' A' ' 72' ' ' VAL . 14.6 m-85 -98.33 116.59 30.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.406 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -81.4 130.6 35.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.739 HD12 ' HE3' ' A' ' 70' ' ' MET . 12.2 mt -110.77 143.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.527 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 131.6 46.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 111.47 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.441 HD11 ' CE ' ' A' ' 70' ' ' MET . 64.2 mt -125.93 154.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.639 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.2 m -153.21 156.65 38.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 111.328 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -105.66 109.31 21.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -94.61 21.64 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.89 -145.47 13.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.545 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.79 -39.39 0.29 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -103.36 159.34 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -52.04 158.68 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.77 117.18 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 111.545 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.0 116.91 4.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.906 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.896 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 26.2 p-90 -113.78 154.9 26.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.597 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.61 156.33 45.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.896 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 2.3 mp -118.08 147.29 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.434 . . . . 0.0 111.742 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -145.27 131.26 19.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 p -113.19 150.09 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.567 HG23 ' HG3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -51.86 -36.2 47.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.07 115.81 11.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.8 mmm -93.31 21.86 5.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.411 ' HB2' ' NH1' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -104.45 -37.22 7.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.869 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -101.99 -27.94 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.013 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.5 150.16 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.61 109.75 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.76 144.47 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -159.27 136.38 6.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.52 144.54 81.34 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.66 -1.392 . . . . 0.0 112.236 0.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 -4.85 15.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.589 2.192 . . . . 0.0 112.96 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -171.87 161.67 5.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 169.96 157.75 12.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.608 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 t -94.14 134.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 62' ' ' LEU . 5.5 tp -108.89 132.87 53.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.441 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -88.87 168.37 15.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 25.3 Cg_endo -62.12 113.59 1.95 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.538 2.158 . . . . 0.0 112.359 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.7 30.89 2.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.67 148.37 24.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.792 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' CG ' ' OG1' ' A' ' 34' ' ' THR . 42.0 mttt -115.64 121.87 43.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 14.0 p -112.4 146.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.73 147.12 23.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.253 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.739 ' HE3' HD12 ' A' ' 31' ' ' ILE . 13.4 ttp -129.47 156.93 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.494 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.42 122.38 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.591 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 29' ' ' TYR . 12.6 p -111.91 115.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.27 129.26 46.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.6 t -116.18 127.57 54.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.66 147.99 31.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.111 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 76' ' ' THR . 2.7 p -62.65 161.02 12.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -176.68 -175.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 111.02 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.43 108.65 20.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.28 18.7 6.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.453 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.48 -38.4 12.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.3 p -131.31 44.31 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.074 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -138.13 177.25 8.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.833 ' O ' HD23 ' A' ' 84' ' ' LEU . 96.9 m-20 -91.3 149.66 21.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.988 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 83' ' ' ASP . 47.5 mt -139.46 29.37 2.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.54 26.59 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.53 -12.51 9.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.53 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.77 120.33 24.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.567 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.8 OUTLIER -149.94 134.52 17.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.91 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.696 HG13 HD11 ' A' ' 122' ' ' ILE . 5.8 mt -98.12 165.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.575 HG21 ' HD2' ' A' ' 117' ' ' ARG . 92.4 m -136.73 118.77 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.951 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.8 mp -116.59 108.88 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.78 156.71 24.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -155.81 141.11 17.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.587 ' HB ' HG23 ' A' ' 115' ' ' VAL . 13.6 t -138.57 154.65 48.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -68.0 128.81 37.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.45 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 20.9 p -70.38 139.81 87.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.784 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 72.1 Cg_exo -48.25 164.22 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.417 2.078 . . . . 0.0 112.35 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.26 99.73 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.64 45.3 94.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.473 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.17 -85.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.744 0.307 . . . . 0.0 111.102 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.38 1.51 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.126 0.489 . . . . 0.0 111.277 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 70.45 10.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.67 124.26 0.05 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.463 ' HA ' ' CZ3' ' A' ' 108' ' ' TRP . 31.7 t80 -56.46 145.03 28.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -135.31 156.36 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.14 30.32 1.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -116.96 -34.14 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.958 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CD1' ' CD ' ' A' ' 97' ' ' PRO . 24.7 m0 -59.3 -29.71 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 115' ' ' VAL . 4.6 m-85 -85.45 -44.24 12.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -93.51 53.74 1.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.29 -157.3 9.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.535 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.13 154.63 41.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.823 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.08 -162.45 13.14 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.649 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.96 111.25 9.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 109' ' ' PHE . 7.4 p -111.54 130.74 64.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -104.04 154.5 19.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.824 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.575 ' HD2' HG21 ' A' ' 90' ' ' THR . 1.4 ttp85 -132.47 141.93 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -126.74 163.07 24.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.7 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -141.03 124.24 16.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.033 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.37 117.24 57.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.772 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.89 137.38 32.07 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.33 2.02 . . . . 0.0 112.236 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.696 HD11 HG13 ' A' ' 89' ' ' ILE . 8.7 mm -105.68 136.06 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.721 ' HB3' HG23 ' A' ' 18' ' ' VAL . 2.2 mt-10 -124.95 157.94 34.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 88.0 m-85 -120.62 96.68 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.241 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.424 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 2.3 t-20 -79.2 81.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.894 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.898 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.897 0.379 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.67 155.14 27.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 21.2 t -101.92 -56.61 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.556 HG23 ' HD2' ' B' ' 5' ' ' PRO . 6.6 p -177.77 141.13 0.44 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.944 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.556 ' HD2' HG23 ' B' ' 4' ' ' VAL . 51.2 Cg_exo -53.2 147.59 34.81 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.601 2.201 . . . . 0.0 112.249 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.81 106.4 1.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.541 2.161 . . . . 0.0 112.248 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.82 129.76 48.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.443 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.726 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 8.4 m-20 -54.78 128.63 33.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.84 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.12 138.89 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.88 149.81 39.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.38 149.92 35.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.532 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.8 mm-40 -144.88 107.34 4.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.648 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' LYS . 26.4 Cg_endo -61.72 154.72 60.44 Favored 'Cis proline' 0 C--N 1.351 0.668 0 C-N-CA 123.802 -1.333 . . . . 0.0 112.391 0.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.9 m -59.58 -53.13 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.9 39.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' B' ' 13' ' ' PRO . 0.3 OUTLIER -163.47 111.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.063 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.02 133.99 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.732 HG23 ' HB3' ' B' ' 123' ' ' GLU . 6.1 p -130.67 110.76 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.284 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 21.6 m-85 -57.37 154.39 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.92 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.36 119.95 37.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.827 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -50.13 169.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.928 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.827 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 60.5 Cg_endo -72.55 163.67 87.83 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.598 -1.417 . . . . 0.0 112.385 0.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 24.4 m-85 -111.76 34.7 4.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.6 4.61 26.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.312 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -144.74 131.55 20.16 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.831 0.348 . . . . 0.0 110.85 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -51.64 122.73 8.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.038 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -118.67 150.08 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.552 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.56 109.97 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 111.217 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 72' ' ' VAL . 15.0 m-85 -98.5 116.42 30.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -81.25 130.49 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.484 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.757 HD12 ' HE3' ' B' ' 70' ' ' MET . 12.1 mt -110.81 143.48 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 131.68 46.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 0.0 111.508 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.438 HD11 ' CE ' ' B' ' 70' ' ' MET . 64.4 mt -126.03 154.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.645 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' B' ' 33' ' ' ILE . 53.2 m -153.13 156.66 39.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 111.285 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -105.64 109.45 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.479 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -94.65 21.51 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.231 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.87 -145.5 13.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.67 -39.44 0.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.577 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -103.13 159.36 15.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -52.16 158.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.55 117.19 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.607 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.98 116.89 4.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.876 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.92 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 26.1 p-90 -113.74 154.89 26.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.648 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.58 156.4 45.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.419 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.92 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 2.3 mp -118.06 147.33 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.976 0.417 . . . . 0.0 111.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -145.39 131.14 19.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 68.8 p -113.15 150.14 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.069 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.581 HG23 ' HG3' ' B' ' 88' ' ' ARG . 0.8 OUTLIER -51.94 -36.09 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.809 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.18 115.77 11.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 79.2 mmm -93.33 22.09 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.942 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' B' ' 51' ' ' ARG . 0.1 OUTLIER -104.65 -37.33 7.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 ttp85 -101.9 -27.93 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.42 150.26 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.85 110.02 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.04 144.61 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.37 136.35 6.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.85 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 144.53 81.31 Favored 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.688 -1.38 . . . . 0.0 112.3 -0.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.0 -4.68 15.47 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.947 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -172.01 161.63 5.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 169.91 157.86 12.89 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.656 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.09 134.05 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.794 0.33 . . . . 0.0 110.998 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' B' ' 62' ' ' LEU . 5.6 tp -108.89 132.53 53.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -88.54 168.34 16.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 24.9 Cg_endo -62.05 113.45 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.509 2.139 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.94 30.6 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 148.37 24.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.416 ' CG ' ' OG1' ' B' ' 34' ' ' THR . 42.1 mttt -115.73 121.83 43.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 13.8 p -112.41 146.15 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.85 147.27 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.194 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.757 ' HE3' HD12 ' B' ' 31' ' ' ILE . 13.4 ttp -129.58 156.92 43.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.471 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.32 122.71 16.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.578 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 29' ' ' TYR . 12.6 p -112.3 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.658 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.62 129.1 46.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 111.297 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.01 127.7 55.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.751 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.81 148.05 31.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -62.84 160.97 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.763 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -176.53 -175.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.37 108.66 20.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.39 18.9 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.456 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.56 -38.54 12.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 111.086 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.0 p -131.2 44.31 2.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -138.06 177.32 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.827 ' O ' HD23 ' B' ' 84' ' ' LEU . 97.2 m-20 -91.35 149.62 21.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.827 HD23 ' O ' ' B' ' 83' ' ' ASP . 47.6 mt -139.5 29.41 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.37 26.31 1.98 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.972 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.18 -12.62 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.64 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.61 120.22 24.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.946 0.403 . . . . 0.0 111.104 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.581 ' HG3' HG23 ' B' ' 48' ' ' THR . 0.8 OUTLIER -149.78 134.6 17.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.911 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.706 HG13 HD11 ' B' ' 122' ' ' ILE . 5.8 mt -98.23 165.56 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.983 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.584 HG21 ' HD2' ' B' ' 117' ' ' ARG . 93.8 m -136.64 118.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.447 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.8 mp -116.58 108.9 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -114.78 156.56 24.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -155.62 141.05 17.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.578 ' HB ' HG23 ' B' ' 115' ' ' VAL . 13.7 t -138.55 154.61 48.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -67.97 128.91 38.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.458 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 21.2 p -70.45 139.8 86.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' PRO . . . . . 0.481 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 70.9 Cg_exo -48.2 164.08 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.541 2.161 . . . . 0.0 112.303 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.11 99.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.53 45.47 94.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.22 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 70.32 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.75 124.27 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.817 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.464 ' HA ' ' CZ3' ' B' ' 108' ' ' TRP . 30.5 t80 -56.49 145.07 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -135.43 156.38 49.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.19 30.48 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -116.99 -34.2 4.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CD1' ' CD ' ' B' ' 97' ' ' PRO . 25.0 m0 -59.23 -29.84 67.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.58 ' CD2' HG21 ' B' ' 115' ' ' VAL . 4.6 m-85 -85.48 -43.91 13.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -93.79 53.84 1.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.45 -157.12 9.63 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.566 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.3 154.71 41.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.08 -162.52 13.12 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.664 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.95 111.41 9.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.58 HG21 ' CD2' ' B' ' 109' ' ' PHE . 7.4 p -111.65 130.7 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -103.9 154.53 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.584 ' HD2' HG21 ' B' ' 90' ' ' THR . 1.4 ttp85 -132.56 142.05 48.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.91 162.93 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -140.94 124.36 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.36 117.45 57.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.734 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 137.39 31.76 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.365 2.044 . . . . 0.0 112.225 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.706 HD11 HG13 ' B' ' 89' ' ' ILE . 8.8 mm -105.66 136.13 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.732 ' HB3' HG23 ' B' ' 18' ' ' VAL . 2.2 mt-10 -124.96 158.08 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.443 ' HB3' ' CE2' ' B' ' 23' ' ' TYR . 87.8 m-85 -120.73 96.54 5.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.422 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 2.3 t-20 -79.14 81.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 37.1 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.828 -179.919 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.878 0.37 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.38 86.91 1.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -171.25 44.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.9 m -52.0 144.71 19.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.222 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.43 167.36 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.537 2.158 . . . . 0.0 112.327 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.15 146.69 82.41 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.527 2.151 . . . . 0.0 112.223 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.28 113.01 3.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.528 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 14.7 m-20 -48.1 121.56 4.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 0.0 111.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.434 HG12 ' CE2' ' A' ' 93' ' ' TRP . 5.0 pt -93.21 147.02 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -92.67 145.34 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.57 154.15 51.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.136 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.629 ' O ' HG23 ' A' ' 31' ' ' ILE . 13.6 mm-40 -139.97 127.93 12.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.389 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.706 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 51.0 Cg_endo -68.78 163.97 77.55 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.697 0.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.4 -53.21 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.725 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HG3' ' HG ' ' A' ' 120' ' ' LEU . 2.2 tt0 -178.3 50.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.165 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -169.92 107.15 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.174 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -120.95 150.22 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 123' ' ' GLU . 42.4 t -132.99 95.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.0 111.641 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -54.8 97.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.265 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -59.09 151.39 22.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -64.2 169.69 4.42 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.656 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.754 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 66.8 Cg_endo -93.11 164.12 23.14 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.502 -1.041 . . . . 0.0 112.789 0.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.01 37.29 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.695 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.64 -5.87 13.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.59 -161.43 1.29 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.838 0.351 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.39 142.39 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -159.56 91.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.466 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.699 HG23 ' C ' ' A' ' 72' ' ' VAL . 31.5 m -83.3 143.83 30.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.511 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -121.48 130.3 53.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.176 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.35 133.89 42.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.04 0.448 . . . . 0.0 111.671 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 12' ' ' GLN . 9.4 mm -99.99 149.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.05 126.38 46.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.277 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 34' ' ' THR . 37.5 mt -125.09 153.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 33' ' ' ILE . 78.5 m -154.49 155.27 34.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.787 ' HB2' HD12 ' A' ' 62' ' ' LEU . 64.8 t30 -102.86 81.74 2.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -54.75 -23.4 17.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.96 -160.26 7.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.625 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.06 0.94 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.7 139.15 12.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.19 138.59 16.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 95' ' ' ASN . 1.2 pt -137.62 174.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -132.94 98.16 0.34 Allowed Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.684 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.982 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 30.1 p-90 -92.43 155.68 17.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.126 0.489 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.3 158.12 43.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.446 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.982 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -125.32 149.68 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.001 0.429 . . . . 0.0 111.723 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -159.66 131.31 6.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.484 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -109.79 158.39 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.307 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -29.89 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.45 117.8 23.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.18 18.19 7.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -109.4 -43.74 4.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.6 -58.97 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mt -83.9 140.79 31.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.09 107.46 5.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.011 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.812 HG11 ' CG2' ' A' ' 45' ' ' ILE . 3.2 m -74.42 152.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -168.52 113.27 0.56 Allowed Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.35 141.11 70.79 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.304 0.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HB3' HG23 ' A' ' 55' ' ' VAL . 73.6 Cg_endo -75.59 -3.87 14.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.544 2.162 . . . . 0.0 112.747 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.2 p -170.42 147.6 3.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.792 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.23 175.32 43.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 41' ' ' ILE . 6.4 t -106.2 122.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -94.16 125.27 38.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 4.7 m-20 -81.74 161.42 61.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.95 100.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.561 2.174 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt 69.47 45.21 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' HD11 ' A' ' 62' ' ' LEU . 3.4 tp10 -107.61 154.13 21.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -110.77 137.14 48.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.988 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.673 ' CG1' HD21 ' A' ' 62' ' ' LEU . 7.7 p -136.42 145.56 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.91 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.1 117.14 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.419 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 1.8 tmm? -101.66 147.93 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.419 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -113.92 140.91 47.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.439 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.699 ' C ' HG23 ' A' ' 28' ' ' THR . 44.0 t -124.95 84.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -57.23 129.42 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.05 122.07 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -92.31 138.76 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.844 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.38 162.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -169.21 -161.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.19 119.89 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.6 19.42 20.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.39 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.35 -31.01 12.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.3 p -136.87 44.77 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.07 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -144.31 139.81 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.509 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.2 m-20 -54.93 146.59 17.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 83' ' ' ASP . 16.2 mt -130.86 32.24 4.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.26 27.89 1.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -127.68 6.19 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.654 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.04 119.99 39.14 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 122' ' ' ILE . 0.8 OUTLIER -150.47 131.23 14.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.291 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.917 HG13 HD11 ' A' ' 122' ' ' ILE . 37.6 mt -84.67 162.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.51 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.525 ' N ' HG22 ' A' ' 89' ' ' ILE . 78.2 m -138.66 137.36 36.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 0.0 111.375 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.6 mt -120.53 146.94 24.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.606 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 4.4 mt-10 -149.28 111.59 4.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.192 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.434 ' CE2' HG12 ' A' ' 9' ' ' ILE . 7.8 p90 -123.79 138.53 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.491 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -139.46 130.39 26.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 41' ' ' ILE . 21.1 p30 -54.03 125.03 17.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -67.05 144.68 98.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 163.05 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.433 2.089 . . . . 0.0 112.204 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.46 118.39 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.983 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.37 46.12 52.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.47 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.83 151.13 46.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.12 164.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.284 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 71.13 5.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 178.6 142.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.763 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.36 134.44 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 155.22 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.986 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -93.4 -6.74 46.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.653 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.81 -17.59 35.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.546 0.213 . . . . 0.0 111.464 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.36 -16.15 32.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.294 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 1.5 m-85 -126.89 37.55 4.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -151.46 43.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.49 -117.96 0.61 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.617 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -97.97 156.18 16.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.989 0.423 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.11 135.75 5.37 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.579 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -77.25 130.89 37.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 t -122.28 117.1 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.34 147.24 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.415 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.457 ' HB3' ' CG ' ' A' ' 92' ' ' GLU . 12.8 ptp180 -143.93 153.84 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.045 0.45 . . . . 0.0 111.507 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -147.73 131.78 17.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.409 ' OD1' HG23 ' A' ' 90' ' ' THR . 2.3 m-20 -104.29 134.13 48.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.132 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HG ' ' HG3' ' A' ' 15' ' ' GLN . 6.1 mp -107.79 137.7 19.83 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.5 138.73 17.66 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.542 2.161 . . . . 0.0 112.597 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.917 HD11 HG13 ' A' ' 89' ' ' ILE . 11.5 mm -101.52 146.56 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.029 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.813 ' HB2' HG22 ' A' ' 18' ' ' VAL . 2.7 mt-10 -132.67 163.72 28.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 71.5 m-85 -126.37 131.5 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.195 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.665 ' HB2' HG12 ' A' ' 18' ' ' VAL . 4.2 t30 -120.18 115.16 23.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 8.1 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.793 0.33 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.35 86.88 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -171.25 44.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.6 m -51.99 144.85 19.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.174 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.52 167.43 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.566 2.177 . . . . 0.0 112.22 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 146.76 82.39 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.554 2.169 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.23 113.21 3.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.451 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.557 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 15.3 m-20 -48.24 121.72 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' B' ' 93' ' ' TRP . 5.1 pt -93.34 146.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -92.83 145.45 24.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.768 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.62 154.24 51.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.098 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.63 ' O ' HG23 ' B' ' 31' ' ' ILE . 13.5 mm-40 -139.95 127.94 12.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 51.1 Cg_endo -68.9 163.77 78.48 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.047 -1.231 . . . . 0.0 112.695 0.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.23 -53.25 4.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.694 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.41 ' HG3' ' HG ' ' B' ' 120' ' ' LEU . 2.2 tt0 -178.32 50.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.141 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -170.04 106.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.7 150.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' B' ' 123' ' ' GLU . 42.2 t -133.07 95.35 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.705 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -54.89 96.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.309 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -59.01 151.21 22.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.761 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.767 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -63.97 169.72 4.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.602 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.767 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 65.5 Cg_endo -93.14 164.07 23.07 Favored 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.476 -1.052 . . . . 0.0 112.834 0.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -102.87 37.23 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.705 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 -5.87 14.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.231 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.58 -161.33 1.27 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.847 0.356 . . . . 0.0 110.957 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.54 142.27 27.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -159.28 91.07 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.42 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.699 HG23 ' C ' ' B' ' 72' ' ' VAL . 31.1 m -83.38 143.88 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.562 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -121.65 130.12 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.159 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.07 133.78 42.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.949 0.404 . . . . 0.0 111.688 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.63 HG23 ' O ' ' B' ' 12' ' ' GLN . 9.6 mm -99.9 149.65 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.89 126.52 46.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 34' ' ' THR . 37.8 mt -125.18 153.83 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.909 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' B' ' 33' ' ' ILE . 82.1 m -154.46 155.23 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.075 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.768 ' HB2' HD12 ' B' ' 62' ' ' LEU . 64.6 t30 -102.9 81.67 2.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -54.73 -23.26 16.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 -160.43 7.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.29 0.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.511 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.83 138.99 12.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.775 0.321 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.18 138.67 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' B' ' 95' ' ' ASN . 1.2 pt -137.76 174.1 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -132.95 98.35 0.34 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.643 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.964 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 29.9 p-90 -92.46 155.82 17.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 111.816 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.47 157.88 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.964 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -125.12 149.46 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.7 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -159.41 131.35 6.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 24.1 p -109.9 158.43 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.93 -29.93 22.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.57 117.91 23.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.27 18.25 7.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -109.3 -43.98 4.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.847 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.35 -59.1 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.68 140.7 31.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.22 107.37 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.821 HG11 ' CG2' ' B' ' 45' ' ' ILE . 3.2 m -74.26 152.16 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.133 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -168.41 113.16 0.57 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.738 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.28 141.09 70.71 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.791 -1.337 . . . . 0.0 112.417 0.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HB3' HG23 ' B' ' 55' ' ' VAL . 73.6 Cg_endo -75.52 -4.11 14.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.529 2.153 . . . . 0.0 112.723 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.3 p -170.25 147.44 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.04 175.38 43.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.479 HG13 ' O ' ' B' ' 41' ' ' ILE . 6.6 t -106.33 122.28 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.143 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.768 HD12 ' HB2' ' B' ' 35' ' ' ASN . 0.2 OUTLIER -93.72 125.34 38.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' B' ' 66' ' ' GLU . 4.7 m-20 -81.85 161.47 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.93 100.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.574 2.183 . . . . 0.0 112.382 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt 69.29 45.44 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.509 ' O ' HD11 ' B' ' 62' ' ' LEU . 3.4 tp10 -107.79 154.23 21.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -110.89 137.14 48.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.668 ' CG1' HD21 ' B' ' 62' ' ' LEU . 7.5 p -136.4 145.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.23 117.19 33.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.421 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 1.8 tmm? -101.68 147.81 26.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.431 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -113.83 140.98 47.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 111.443 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.699 ' C ' HG23 ' B' ' 28' ' ' THR . 43.6 t -124.98 84.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.84 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' SER . . . . . 0.508 ' N ' HG23 ' B' ' 28' ' ' THR . 0.4 OUTLIER -57.15 129.48 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.21 121.86 36.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.01 138.76 31.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.44 162.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -169.18 -161.98 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.08 119.99 37.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.54 19.19 20.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.29 -31.09 12.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 73.6 p -136.8 44.8 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -144.49 139.8 28.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.513 ' O ' HD23 ' B' ' 84' ' ' LEU . 1.1 m-20 -54.86 146.68 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.513 HD23 ' O ' ' B' ' 83' ' ' ASP . 16.1 mt -130.91 32.23 4.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.27 28.27 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -127.95 6.17 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.19 120.36 39.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.748 0.309 . . . . 0.0 110.757 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.424 ' HA ' HG12 ' B' ' 122' ' ' ILE . 0.8 OUTLIER -150.79 131.0 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.255 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.931 HG13 HD11 ' B' ' 122' ' ' ILE . 37.2 mt -84.5 161.88 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.585 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.528 ' N ' HG22 ' B' ' 89' ' ' ILE . 73.6 m -138.49 137.5 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -120.59 146.95 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.684 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 4.3 mt-10 -149.34 111.54 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.868 0.366 . . . . 0.0 111.135 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.429 ' CE2' HG12 ' B' ' 9' ' ' ILE . 7.9 p90 -123.74 138.59 54.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 0.7 OUTLIER -139.6 130.18 25.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.997 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.592 ' HA ' HG22 ' B' ' 41' ' ' ILE . 21.2 p30 -53.78 125.03 16.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.9 p -67.09 144.86 98.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.86 163.03 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.536 2.157 . . . . 0.0 112.162 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.49 118.63 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.031 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.1 46.1 50.98 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.442 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.9 151.26 46.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.17 164.32 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.314 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.54 71.27 5.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 178.35 142.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.09 134.34 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.14 155.36 31.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -93.51 -6.7 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.691 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.87 -17.49 35.44 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.602 0.239 . . . . 0.0 111.518 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.44 -16.07 32.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.323 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 1.5 m-85 -126.88 37.37 4.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 110.972 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -151.42 43.13 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.57 -117.96 0.61 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.579 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -98.05 156.25 16.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.984 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.18 135.6 5.32 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.538 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -77.09 131.17 38.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 t -122.59 117.13 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.36 147.22 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.511 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.447 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 12.7 ptp180 -143.87 153.86 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 111.469 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -147.72 131.79 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.422 ' OD1' HG23 ' B' ' 90' ' ' THR . 2.3 m-20 -104.25 134.27 47.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.159 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.41 ' HG ' ' HG3' ' B' ' 15' ' ' GLN . 6.0 mp -107.92 137.57 19.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.36 138.42 17.66 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.589 2.193 . . . . 0.0 112.616 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.931 HD11 HG13 ' B' ' 89' ' ' ILE . 11.8 mm -101.19 146.82 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.819 ' HB2' HG22 ' B' ' 18' ' ' VAL . 2.7 mt-10 -132.93 163.8 28.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.478 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 70.1 m-85 -126.48 131.31 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.651 ' HB2' HG12 ' B' ' 18' ' ' VAL . 4.2 t30 -119.8 115.17 23.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 8.2 mt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.851 0.358 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -138.44 126.97 23.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.12 -178.42 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.968 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.66 153.11 42.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 158.75 54.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.531 2.154 . . . . 0.0 112.308 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.09 120.94 9.16 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.75 143.66 35.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.379 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.694 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 73.8 m-20 -61.84 114.06 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 3.0 pt -73.31 142.51 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.095 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.411 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 2.0 m120 -86.77 139.09 31.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.76 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 149.49 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 83.4 mm-40 -142.66 105.41 5.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.755 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 155.14 54.13 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 123.844 -1.315 . . . . 0.0 112.348 0.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.9 -44.34 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.931 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.02 44.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.984 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.76 109.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.604 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.8 tt -130.76 142.82 42.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.722 HG11 HG11 ' B' ' 18' ' ' VAL . 7.3 p -139.77 99.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.513 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 19.8 m-85 -52.58 121.65 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.89 131.15 34.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -55.53 168.18 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.803 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 93.2 Cg_endo -83.67 163.89 68.86 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.674 0.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.1 25.46 10.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.847 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.32 7.96 45.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.483 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.478 ' N ' HG22 ' A' ' 76' ' ' THR . 14.2 p-10 -140.73 175.44 9.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -103.1 112.6 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.08 147.62 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 128.62 56.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 19' ' ' PHE . 65.6 m-85 -92.23 119.74 32.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.744 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -78.46 132.77 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.693 HD11 ' CG2' ' A' ' 72' ' ' VAL . 11.1 mt -120.84 148.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.519 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -112.45 125.52 54.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 111.355 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.506 HD11 ' CE ' ' A' ' 70' ' ' MET . 30.3 mt -122.93 151.42 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.508 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 10' ' ' ASN . 99.5 m -147.92 155.66 41.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -98.28 75.65 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -52.62 -26.27 13.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.105 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.49 -148.97 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.33 3.78 4.79 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.108 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -138.0 172.91 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.907 0.354 . . . . 0.0 110.831 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 86.9 mtm180 -70.22 155.45 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.673 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.614 HD12 ' CD1' ' A' ' 93' ' ' TRP . 20.8 pt -149.31 134.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 111.794 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.04 113.17 4.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.487 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.443 ' HE1' HD12 ' A' ' 62' ' ' LEU . 62.1 p-90 -108.58 160.36 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.309 0.576 . . . . 0.0 111.919 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.65 22.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.967 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.696 ' CD1' HG23 ' A' ' 91' ' ' ILE . 11.7 mm -115.49 139.07 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.724 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.85 129.6 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.673 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 89' ' ' ILE . 70.0 p -107.71 148.36 29.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -54.21 -27.71 36.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -125.61 104.37 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.51 24.94 6.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -106.57 -44.67 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.779 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.95 -40.0 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.81 150.23 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.16 177.04 11.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.97 154.44 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -161.85 128.67 2.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 11.3 Cg_exo -71.07 133.26 27.0 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 123.892 -1.295 . . . . 0.0 111.945 -0.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 53.2 Cg_exo -54.91 -47.7 25.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.381 2.054 . . . . 0.0 112.102 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.0 p -136.27 165.83 24.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.668 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.26 -167.77 37.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.566 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 61' ' ' VAL . 11.8 p -138.25 125.35 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.339 . . . . 0.0 111.118 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.951 HD11 ' CG1' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -103.21 160.25 14.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB3' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -110.55 172.32 3.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 36.6 Cg_exo -60.84 116.23 3.22 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.618 2.212 . . . . 0.0 112.354 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 69.94 27.57 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.231 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' O ' HD23 ' A' ' 62' ' ' LEU . 2.0 mt-10 -103.59 148.24 26.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.476 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.78 136.82 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.223 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.951 ' CG1' HD11 ' A' ' 62' ' ' LEU . 11.8 p -125.88 155.2 35.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' N ' HG22 ' A' ' 68' ' ' VAL . 83.4 mt -103.63 141.13 36.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.596 ' HE3' HD12 ' A' ' 31' ' ' ILE . 4.3 mtm -124.2 155.7 38.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.41 121.68 31.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.168 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.693 ' CG2' HD11 ' A' ' 31' ' ' ILE . 21.9 t -95.95 100.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -65.87 117.68 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.984 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.5 m -123.03 116.18 23.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.66 151.92 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 25' ' ' ASP . 7.1 p -53.94 167.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 79' ' ' ALA . 34.1 p90 -177.59 -164.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -130.88 98.14 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . . . -72.04 -22.47 61.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.41 -39.0 31.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.9 p -129.82 47.09 2.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -143.24 151.79 40.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.06 147.99 47.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 23.2 mt -125.95 24.09 7.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.27 28.53 1.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.771 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.94 7.4 8.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.46 123.88 48.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.23 148.15 35.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.651 HG13 HD11 ' A' ' 122' ' ' ILE . 67.9 mt -118.58 108.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 120.8 33.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.28 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.696 HG23 ' CD1' ' A' ' 45' ' ' ILE . 4.3 mp -111.38 100.21 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.911 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.408 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 11.5 mt-10 -97.66 157.8 15.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.614 ' CD1' HD12 ' A' ' 41' ' ' ILE . 10.2 p90 -163.64 142.36 7.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.039 0.447 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 115' ' ' VAL . 1.5 t -143.06 131.34 22.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.05 146.5 2.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.837 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 1.7 p -90.22 140.92 27.32 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.423 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 52.9 Cg_exo -52.18 160.72 3.04 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.496 2.13 . . . . 0.0 111.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.42 117.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.49 48.98 33.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.401 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.49 48.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 111.438 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.7 165.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.129 0.49 . . . . 0.0 111.554 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.12 73.81 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.45 152.35 3.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.881 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -64.25 153.09 39.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.835 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 2.4 mmt180 -142.88 150.25 39.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.032 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.443 ' NH1' ' HB3' ' A' ' 106' ' ' ARG . 8.0 ttp-105 -102.58 25.78 8.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.69 -29.68 7.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.837 ' CZ3' HG22 ' A' ' 96' ' ' THR . 23.2 m0 -62.56 -27.57 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -82.85 -40.79 19.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -61.31 -29.11 69.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.807 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.31 146.8 44.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.464 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -84.72 114.47 22.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.883 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.13 135.11 4.9 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.619 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.3 mtm 54.99 102.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.5 p 169.98 98.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.93 160.41 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.133 0.492 . . . . 0.0 111.597 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 4.8 ptp85 -141.41 104.54 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.751 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -92.17 166.45 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -128.55 152.23 48.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.939 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.99 93.13 17.64 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.04 133.1 53.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.622 2.215 . . . . 0.0 112.471 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.651 HD11 HG13 ' A' ' 89' ' ' ILE . 12.9 mm -99.08 146.05 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.494 ' C ' HG23 ' A' ' 18' ' ' VAL . 36.2 mt-10 -138.36 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.285 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 13.4 m-85 -119.26 137.51 53.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -121.36 78.93 1.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.983 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.834 0.349 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -138.42 126.96 23.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.13 -178.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.7 153.03 42.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.53 158.77 54.96 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.567 2.178 . . . . 0.0 112.245 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.04 121.03 9.31 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.498 2.132 . . . . 0.0 112.283 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.96 143.74 36.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.337 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 73.8 m-20 -61.94 114.03 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 3.0 pt -73.26 142.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.411 ' HB2' ' HB ' ' B' ' 34' ' ' THR . 2.0 m120 -86.62 139.1 31.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.92 149.57 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -142.84 105.44 5.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.627 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 154.85 54.33 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.894 -1.294 . . . . 0.0 112.317 0.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.41 -44.5 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.93 44.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.69 109.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.147 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.609 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.8 tt -130.57 142.84 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.722 HG11 HG11 ' A' ' 18' ' ' VAL . 7.3 p -139.81 99.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 111.503 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.452 ' HA ' ' CZ ' ' B' ' 29' ' ' TYR . 19.8 m-85 -52.54 121.59 7.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.442 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -86.7 131.02 34.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 111.325 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.792 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -55.33 168.25 0.6 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.792 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 94.8 Cg_endo -83.6 163.81 69.3 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.925 -1.281 . . . . 0.0 112.669 0.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.05 25.46 10.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.951 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.3 7.89 45.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.363 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ASP . . . . . 0.483 ' N ' HG22 ' B' ' 76' ' ' THR . 14.4 p-10 -140.71 175.19 9.81 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -102.74 112.55 25.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.2 147.63 51.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 128.62 56.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.452 ' CZ ' ' HA ' ' B' ' 19' ' ' PHE . 66.9 m-85 -92.14 119.66 32.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.35 132.72 37.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.4 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.69 HD11 ' CG2' ' B' ' 72' ' ' VAL . 11.0 mt -120.78 148.53 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.55 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.39 125.47 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.506 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.503 HD11 ' CE ' ' B' ' 70' ' ' MET . 30.1 mt -122.87 151.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.564 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' B' ' 10' ' ' ASN . 99.3 m -147.88 155.49 41.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 0.0 111.553 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -98.2 75.83 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -52.86 -25.92 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.171 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.69 -149.05 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.444 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.26 3.68 4.81 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.93 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -137.9 172.77 12.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.94 0.37 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' B' ' 62' ' ' LEU . 87.0 mtm180 -69.97 155.48 40.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.599 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.631 HD12 ' CD1' ' B' ' 93' ' ' TRP . 20.5 pt -149.36 134.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 0.0 111.781 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.06 113.34 4.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.426 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.44 ' HE1' HD12 ' B' ' 62' ' ' LEU . 61.8 p-90 -108.72 160.24 16.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 0.0 111.866 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 144.9 22.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.033 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.707 ' CD1' HG23 ' B' ' 91' ' ' ILE . 11.9 mm -115.76 139.04 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 111.689 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.76 130.04 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.599 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.524 HG22 HG12 ' B' ' 89' ' ' ILE . 71.4 p -108.23 148.09 30.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.061 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -53.82 -27.98 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.963 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -125.37 104.73 8.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.89 25.07 6.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -106.54 -44.92 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.65 -39.97 6.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.88 150.25 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.18 177.05 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.89 154.68 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -162.16 128.64 2.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' B' ' 58' ' ' PRO . 11.4 Cg_exo -71.09 133.27 27.09 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.888 -1.297 . . . . 0.0 111.96 0.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' B' ' 57' ' ' PRO . 53.1 Cg_exo -55.0 -47.61 25.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.372 2.048 . . . . 0.0 112.123 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 11.7 p -136.33 165.6 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.05 -167.74 37.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.559 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.451 ' O ' HG13 ' B' ' 61' ' ' VAL . 11.9 p -138.28 125.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 111.046 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.944 HD11 ' CG1' ' B' ' 68' ' ' VAL . 0.2 OUTLIER -103.13 160.18 14.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.426 ' HB3' ' CD ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER -110.58 172.4 3.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.747 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.426 ' CD ' ' HB3' ' B' ' 63' ' ' ASP . 36.4 Cg_exo -60.88 116.35 3.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.622 2.215 . . . . 0.0 112.363 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.81 27.83 4.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.452 ' O ' HD23 ' B' ' 62' ' ' LEU . 2.0 mt-10 -103.86 148.23 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.45 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 136.91 55.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.944 ' CG1' HD11 ' B' ' 62' ' ' LEU . 12.0 p -125.98 155.29 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.035 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.447 ' N ' HG22 ' B' ' 68' ' ' VAL . 83.1 mt -103.77 141.28 36.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.597 ' HE3' HD12 ' B' ' 31' ' ' ILE . 4.2 mtm -124.36 155.64 38.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.47 121.77 31.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.201 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.69 ' CG2' HD11 ' B' ' 31' ' ' ILE . 21.9 t -96.02 100.25 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.015 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.5 m -66.03 117.54 8.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.84 116.13 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.73 151.77 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.483 HG22 ' N ' ' B' ' 25' ' ' ASP . 7.2 p -53.8 167.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' B' ' 79' ' ' ALA . 34.2 p90 -177.8 -164.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -130.61 98.29 4.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' B' ' 77' ' ' PHE . . . -72.22 -22.43 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.34 -39.13 30.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.5 p -129.65 47.02 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -143.17 151.81 41.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -71.02 148.38 47.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 23.4 mt -126.26 24.08 6.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.31 28.45 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.738 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -124.9 7.51 8.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.614 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.48 123.78 48.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.06 148.34 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.651 HG13 HD11 ' B' ' 122' ' ' ILE . 67.4 mt -118.67 108.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.48 120.67 33.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.707 HG23 ' CD1' ' B' ' 45' ' ' ILE . 4.3 mp -111.29 100.13 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.411 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 11.4 mt-10 -97.52 157.85 15.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.631 ' CD1' HD12 ' B' ' 41' ' ' ILE . 10.0 p90 -163.69 142.19 7.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 111.183 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 t -142.89 131.48 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.657 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.35 146.44 2.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.845 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 1.7 p -90.09 140.86 27.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.85 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' PRO . . . . . 0.421 ' HD2' ' NE1' ' B' ' 108' ' ' TRP . 53.4 Cg_exo -52.04 160.77 2.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.471 2.114 . . . . 0.0 112.025 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.62 117.61 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.6 48.85 34.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.375 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.36 48.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.83 165.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.176 0.512 . . . . 0.0 111.483 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.13 73.73 1.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.769 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.39 152.26 3.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.06 153.11 38.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 2.4 mmt180 -142.94 150.08 39.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.94 0.4 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.437 ' HB3' ' NH1' ' B' ' 106' ' ' ARG . 8.1 ttp-105 -102.43 25.66 8.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -29.56 7.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.845 ' CZ3' HG22 ' B' ' 96' ' ' THR . 23.4 m0 -62.78 -27.35 69.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -82.99 -40.64 19.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -61.46 -29.11 69.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.824 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.27 146.87 44.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.443 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -84.83 114.45 22.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.863 0.363 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.07 135.12 4.91 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.77 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 4.3 mtm 54.93 102.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.608 ' O ' HG13 ' B' ' 115' ' ' VAL . 7.4 p 169.88 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.081 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.84 160.55 14.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.158 0.504 . . . . 0.0 111.542 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.411 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 4.6 ptp85 -141.51 104.25 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -92.04 166.47 12.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 111.132 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -128.51 152.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.91 93.17 17.84 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.11 133.23 54.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.651 HD11 HG13 ' B' ' 89' ' ' ILE . 12.9 mm -99.19 146.16 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.504 ' C ' HG23 ' B' ' 18' ' ' VAL . 35.8 mt-10 -138.38 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 13.7 m-85 -119.35 137.12 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.996 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -121.09 79.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.816 0.341 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -119.33 130.11 55.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 t -163.48 -77.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.558 HG23 ' HD2' ' A' ' 5' ' ' PRO . 7.3 p -178.85 138.11 0.34 Allowed Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.558 ' HD2' HG23 ' A' ' 4' ' ' VAL . 73.1 Cg_endo -76.04 160.83 36.39 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.398 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.62 132.85 26.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.552 2.168 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.05 -142.78 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.565 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.904 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 5.4 t0 -130.8 136.97 49.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 93' ' ' TRP . 23.0 pt -93.93 153.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.42 133.05 49.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.658 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.7 p -126.42 155.16 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HD3' ' B' ' 22' ' ' PRO . 28.8 mm-40 -139.97 114.54 7.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.84 161.63 67.5 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.924 -1.282 . . . . 0.0 112.497 0.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -50.13 70.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.177 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -167.76 46.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.084 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -162.9 106.96 1.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.931 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 17' ' ' ILE . 11.1 tt -131.19 125.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.129 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.5 p -122.04 101.57 10.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.186 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 22.9 m-85 -47.32 162.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.567 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -122.85 119.4 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.969 0.414 . . . . 0.0 111.545 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.87 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.66 0.13 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.755 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.87 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 77.6 Cg_endo -76.84 164.27 87.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.764 0.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.82 40.92 2.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -108.14 6.8 27.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.4 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.49 -160.99 1.23 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.797 0.332 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.26 112.34 24.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -112.48 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.52 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 113.78 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.429 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 8.7 m-85 -105.51 112.64 25.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.259 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.13 145.09 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.638 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.425 HD12 ' CE ' ' A' ' 70' ' ' MET . 3.7 mt -116.12 145.43 21.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.383 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' CD ' ' HG3' ' B' ' 22' ' ' PRO . 6.9 tttt -94.32 129.67 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.962 0.411 . . . . 0.0 111.528 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.6 mt -128.55 151.76 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.705 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -152.33 155.83 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' OD1' HD11 ' A' ' 41' ' ' ILE . 1.3 m-20 -94.61 100.79 12.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -90.48 18.03 6.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.512 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.11 -149.83 19.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.07 -26.75 2.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -125.55 162.39 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.855 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -52.06 168.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.449 HD12 ' CD1' ' A' ' 93' ' ' TRP . 13.9 pt -154.22 129.97 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.635 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.03 106.43 2.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.517 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.18 156.52 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.158 0.504 . . . . 0.0 111.909 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.455 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -148.64 154.72 40.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.036 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG13 ' A' ' 91' ' ' ILE . 9.4 mm -127.73 137.96 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 111.72 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -142.36 129.55 20.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.643 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 HG12 ' A' ' 89' ' ' ILE . 43.9 p -104.25 157.26 17.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.111 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.27 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -143.0 118.33 10.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.17 17.81 6.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.272 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -110.05 -39.22 5.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.365 . . . . 0.0 110.952 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.42 -27.06 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.466 HD11 ' OD2' ' A' ' 87' ' ' ASP . 1.7 mt -116.62 149.72 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -138.83 144.16 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.25 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -133.02 120.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.731 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.18 136.49 24.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 132.49 27.26 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.632 -1.404 . . . . 0.0 112.0 0.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.39 -39.38 44.3 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.334 2.023 . . . . 0.0 112.112 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.24 163.58 35.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.87 154.68 10.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.82 122.34 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.757 0.313 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 68' ' ' VAL . 3.7 tp -98.42 149.27 22.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.46 167.99 12.89 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.76 121.44 9.17 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.632 2.222 . . . . 0.0 112.384 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.85 18.43 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 152.76 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -122.3 153.02 39.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' CG1' HD11 ' A' ' 62' ' ' LEU . 3.2 m -147.63 152.9 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.84 91.93 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.251 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.449 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 35.4 ttp -72.7 158.95 34.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.615 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -124.41 129.82 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.9 93.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.992 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.96 127.61 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.43 101.73 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.753 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.0 145.24 44.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.129 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.39 162.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CZ ' ' CE2' ' A' ' 124' ' ' TYR . 0.5 OUTLIER -168.55 -163.14 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.88 119.14 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.58 18.36 20.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.506 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.95 -23.07 15.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.19 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.9 p -141.44 49.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.1 147.77 21.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -60.61 139.04 57.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 75.2 mt -116.29 27.08 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -146.63 27.59 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.608 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.72 -29.33 9.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 53' ' ' LEU . 1.4 m-20 -62.78 132.93 53.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.903 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -148.5 145.61 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 47' ' ' THR . 71.5 mt -121.39 115.62 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.935 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 118' ' ' LYS . 81.1 m -96.4 124.42 40.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.604 HD13 HD13 ' A' ' 120' ' ' LEU . 4.6 mp -116.32 113.26 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -110.85 155.49 22.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CD1' HD12 ' A' ' 41' ' ' ILE . 6.6 p90 -154.81 129.16 9.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.782 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.72 ' CB ' HG22 ' A' ' 115' ' ' VAL . 4.4 t -130.37 135.08 47.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.4 138.64 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.0 p -76.92 138.79 65.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.36 165.3 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.478 2.119 . . . . 0.0 112.043 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -50.35 105.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.63 48.67 49.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.36 -79.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.404 ' CB ' ' NH1' ' A' ' 105' ' ' ARG . . . 179.5 164.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 111.298 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -92.43 70.29 5.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.22 142.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.761 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -51.69 138.08 23.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.2 149.7 48.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -99.57 25.21 7.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 110' ' ' GLN . 6.8 pt-20 -116.94 -16.54 10.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.409 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -69.27 -19.23 63.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 111.344 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 3.2 m-85 -110.32 31.49 5.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.734 0.302 . . . . 0.0 111.261 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -115.55 -21.92 9.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.393 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.51 -179.64 41.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.683 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -97.85 126.43 43.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 0.0 110.753 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.57 -171.18 45.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.265 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.567 ' C ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER 58.5 163.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.955 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.72 HG22 ' CB ' ' A' ' 94' ' ' THR . 3.8 t 82.84 111.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.238 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.13 151.75 21.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.607 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.99 140.38 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 0.0 111.276 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 90' ' ' THR . 5.3 tttp -126.17 162.12 26.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.546 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -130.88 152.52 50.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.604 HD13 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -139.25 95.73 9.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.729 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 120' ' ' LEU . 26.5 Cg_endo -62.61 127.41 20.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.468 2.112 . . . . 0.0 112.213 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 mm -96.16 154.54 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 93.2 mt-10 -145.66 163.18 35.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.467 ' CE2' ' CZ ' ' A' ' 77' ' ' PHE . 33.7 m-85 -125.35 120.9 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.065 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -100.73 88.98 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.947 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.962 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.775 0.321 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.46 130.09 55.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 13.3 t -163.59 -77.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.559 HG23 ' HD2' ' B' ' 5' ' ' PRO . 7.3 p -178.84 138.11 0.34 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.149 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' B' ' 4' ' ' VAL . 73.1 Cg_endo -75.96 160.73 36.73 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.639 2.226 . . . . 0.0 112.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.57 132.78 26.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.527 2.151 . . . . 0.0 112.302 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -142.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.879 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 5.5 t0 -130.69 137.16 49.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' B' ' 93' ' ' TRP . 22.9 pt -94.15 153.01 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.183 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.35 132.98 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -126.42 155.18 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.142 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -139.89 114.49 7.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.588 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.88 161.46 68.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.607 0.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -50.15 70.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -167.78 46.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -162.87 106.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.422 ' O ' HG23 ' B' ' 17' ' ' ILE . 10.9 tt -131.15 125.42 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.659 ' O ' HG13 ' B' ' 18' ' ' VAL . 7.6 p -122.1 101.64 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.494 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 22.9 m-85 -47.4 162.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.576 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -122.94 119.31 30.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.558 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.843 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.07 170.54 0.13 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.755 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.843 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.2 Cg_endo -76.78 164.34 87.63 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.749 0.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.89 40.95 2.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.789 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.34 7.16 27.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.479 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.74 -160.98 1.23 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.833 0.349 . . . . 0.0 110.779 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.4 112.65 25.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' HIS . . . . . 0.424 ' HB3' ' CZ ' ' B' ' 29' ' ' TYR . 0.3 OUTLIER -112.54 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 113.59 27.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.487 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 8.6 m-85 -105.3 112.65 25.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.259 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.08 144.96 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.691 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.429 HD12 ' CE ' ' B' ' 70' ' ' MET . 3.8 mt -116.09 145.36 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.408 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -94.28 129.63 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.977 0.418 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 58.5 mt -128.54 151.65 35.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -152.23 155.73 38.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 111.398 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.431 ' OD1' HD11 ' B' ' 41' ' ' ILE . 1.3 m-20 -94.64 100.76 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.59 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -90.36 18.01 6.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.04 -149.73 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.52 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.19 -26.79 2.85 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.49 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -125.63 162.3 25.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -51.85 168.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' B' ' 93' ' ' TRP . 14.0 pt -154.13 129.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 111.66 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.01 106.45 2.67 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.511 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.28 156.56 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.54 . . . . 0.0 111.85 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.464 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -148.57 155.04 40.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.963 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.599 HD12 HG13 ' B' ' 91' ' ' ILE . 9.3 mm -127.92 137.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -142.39 129.48 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.606 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.541 HG22 HG12 ' B' ' 89' ' ' ILE . 43.8 p -104.13 157.35 17.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.53 -27.6 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.98 118.18 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.713 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.1 17.8 6.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -110.18 -39.04 5.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.48 -27.11 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.454 HD11 ' OD2' ' B' ' 87' ' ' ASP . 1.7 mt -116.59 149.86 38.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -139.01 144.3 38.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.513 HG11 HG21 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -133.27 120.99 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -135.24 136.5 24.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.11 132.44 27.1 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.046 -0.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.37 -39.59 44.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.401 2.067 . . . . 0.0 112.088 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.1 p -146.06 163.51 35.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.344 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.94 154.56 10.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.835 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.65 122.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 111.001 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.514 HD11 ' CG1' ' B' ' 68' ' ' VAL . 3.7 tp -98.58 149.39 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.54 168.06 12.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.94 121.37 9.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 112.356 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.9 18.64 9.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.94 21.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.328 . . . . 0.0 110.767 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -122.43 152.99 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.514 ' CG1' HD11 ' B' ' 62' ' ' LEU . 3.1 m -147.58 152.92 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.016 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.81 92.02 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.232 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.444 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 35.7 ttp -72.78 158.99 34.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.444 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -124.6 129.68 51.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.72 93.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.91 127.49 32.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.28 101.94 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.24 145.11 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.11 162.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.456 ' CZ ' ' CE2' ' B' ' 124' ' ' TYR . 0.5 OUTLIER -168.57 -163.06 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.896 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.95 119.21 38.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.71 18.31 20.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.526 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.22 15.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.7 p -141.3 49.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.22 147.68 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -60.56 139.1 57.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 76.1 mt -116.38 27.23 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.109 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -146.66 27.38 1.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.7 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.63 -29.22 9.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ASP . . . . . 0.454 ' OD2' HD11 ' B' ' 53' ' ' LEU . 1.4 m-20 -62.93 132.88 53.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -148.45 145.5 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.996 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.541 HG12 HG22 ' B' ' 47' ' ' THR . 71.5 mt -121.32 115.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.013 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.439 HG23 ' O ' ' B' ' 118' ' ' LYS . 81.7 m -96.23 124.45 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.599 HG13 HD12 ' B' ' 45' ' ' ILE . 4.6 mp -116.33 113.23 42.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.812 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -110.71 155.47 22.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.452 ' CD1' HD12 ' B' ' 41' ' ' ILE . 6.8 p90 -154.9 128.79 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.734 ' CB ' HG22 ' B' ' 115' ' ' VAL . 4.3 t -129.94 135.01 47.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.25 138.69 44.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 68.7 p -77.07 138.79 64.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 165.08 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.525 2.15 . . . . 0.0 112.057 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -50.21 105.41 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.56 48.85 48.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.395 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.65 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 0.0 111.24 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.409 ' CB ' ' NH1' ' B' ' 105' ' ' ARG . . . 179.53 164.76 1.04 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.168 0.509 . . . . 0.0 111.307 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -92.54 70.36 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.699 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.17 141.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.686 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -51.8 137.88 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HG2' ' HG2' ' B' ' 107' ' ' GLU . 0.0 OUTLIER -125.96 149.76 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -99.46 25.11 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.188 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' B' ' 110' ' ' GLN . 6.7 pt-20 -116.9 -16.64 10.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.45 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -69.2 -19.27 63.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.605 0.24 . . . . 0.0 111.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 3.1 m-85 -110.26 31.56 5.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.308 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' B' ' 107' ' ' GLU . 0.0 OUTLIER -115.67 -22.0 9.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.356 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.51 -179.74 42.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.641 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.67 126.44 43.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 110.746 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.6 -171.32 45.26 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.292 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.581 ' C ' HG23 ' B' ' 115' ' ' VAL . 0.3 OUTLIER 58.63 163.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 111.015 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.734 HG22 ' CB ' ' B' ' 94' ' ' THR . 3.9 t 82.82 112.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.248 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.23 151.75 21.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.93 140.13 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 111.315 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.439 ' O ' HG23 ' B' ' 90' ' ' THR . 5.2 tttp -126.1 162.17 25.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -131.0 152.63 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.095 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.596 HD13 HD13 ' B' ' 91' ' ' ILE . 0.3 OUTLIER -139.29 95.87 9.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.646 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.66 127.49 20.81 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.439 2.093 . . . . 0.0 112.132 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 13.1 mm -96.3 154.52 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.268 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -145.63 163.31 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.456 ' CE2' ' CZ ' ' B' ' 77' ' ' PHE . 33.8 m-85 -125.27 121.26 33.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -101.1 88.87 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.948 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.908 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.819 0.342 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.19 169.46 10.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.59 147.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.35 148.85 59.43 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.87 146.1 82.16 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.596 2.197 . . . . 0.0 112.275 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ARG . 58.5 Cg_endo -71.63 149.51 55.28 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -165.51 1.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.67 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 1.4 m-20 -111.23 111.88 23.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.88 147.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.58 149.69 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.799 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.36 151.5 45.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.56 107.71 3.81 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.37 157.38 62.06 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.347 0.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.441 ' C ' HD21 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -112.05 -20.15 12.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.277 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.48 ' C ' HD23 ' A' ' 120' ' ' LEU . 37.9 mt-30 -94.71 -45.93 7.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 111.096 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.78 -176.66 0.24 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 122' ' ' ILE . 17.4 tt -144.33 156.28 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' A' ' 123' ' ' GLU . 3.6 p -133.09 92.43 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 19.2 m-30 -50.78 113.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.668 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -79.14 136.21 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.804 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -50.89 168.52 0.24 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.684 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.804 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 2.0 Cg_endo -82.58 163.76 73.94 Favored 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.255 -1.144 . . . . 0.0 112.364 0.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -106.33 26.61 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -110.68 7.1 22.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.106 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -141.46 134.14 28.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.788 0.328 . . . . 0.0 111.034 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -55.42 107.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -116.66 124.15 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.416 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -99.8 113.21 25.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.985 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 85.5 m-85 -89.73 99.33 12.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.489 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -66.68 153.32 43.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.577 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mt -139.27 148.73 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' CB ' ' HG3' ' B' ' 22' ' ' PRO . 25.3 ttmt -104.91 140.48 38.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.41 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 34' ' ' THR . 46.7 mt -131.54 154.03 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.779 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.435 ' N ' HG22 ' A' ' 33' ' ' ILE . 55.0 m -145.47 155.59 43.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.029 0.442 . . . . 0.0 111.189 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.865 ' HB2' HD23 ' A' ' 62' ' ' LEU . 36.0 t-20 -104.08 102.27 12.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -93.42 21.32 6.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.85 -122.86 4.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.542 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.36 -42.0 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.563 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -113.26 166.6 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.44 156.3 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.417 HG12 ' ND2' ' A' ' 35' ' ' ASN . 21.9 pt -143.82 174.01 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -130.33 100.03 0.46 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.918 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 -92.12 159.35 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 111.712 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.64 130.73 11.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.514 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.429 ' CG2' HG11 ' A' ' 55' ' ' VAL . 5.6 mm -100.31 141.09 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.732 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -142.0 131.99 24.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.575 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 55' ' ' VAL . 11.1 p -107.46 156.97 18.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.41 . . . . 0.0 111.399 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -48.32 -29.16 3.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.057 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.38 122.77 13.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.65 -8.62 59.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.417 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.17 -41.19 13.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 110.604 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -84.8 -59.28 2.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.65 134.12 37.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.706 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 m -127.49 109.13 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 47' ' ' THR . 16.0 m -68.29 156.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 32.5 t0 -170.09 113.85 0.48 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.3 149.58 92.19 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.112 -1.203 . . . . 0.0 112.278 0.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.88 -15.31 21.12 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 0.0 112.586 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -179.49 153.26 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.83 167.73 40.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.791 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 t -98.36 120.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.865 HD23 ' HB2' ' A' ' 35' ' ' ASN . 4.5 tp -96.98 162.93 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -115.17 170.97 4.92 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.19 111.13 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.576 2.184 . . . . 0.0 112.419 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.27 39.79 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -106.74 154.31 21.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.894 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.38 38.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 10.5 p -138.39 143.36 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.937 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.23 151.64 23.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.411 ' CE ' HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -133.47 161.56 34.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.764 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -146.98 118.24 7.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.268 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -107.82 86.51 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.992 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.16 145.57 53.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 43.2 t -136.19 102.96 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.18 150.16 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -67.4 112.46 4.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HE2' ' HB2' ' A' ' 79' ' ' ALA . 44.8 p90 -123.58 178.02 5.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.93 89.97 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . . . -55.18 -26.57 39.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.87 -49.12 59.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.7 p -125.61 50.63 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.068 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -136.28 162.34 33.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -80.12 130.2 35.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.501 HD22 ' CE2' ' A' ' 124' ' ' TYR . 12.2 mt -125.9 52.91 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -112.77 -23.66 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' HB3' HG21 ' A' ' 48' ' ' THR . 15.0 m120 -65.46 -91.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.842 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 122' ' ' ILE . 2.1 p-10 41.66 84.64 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.573 0.225 . . . . 0.0 111.513 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB2' HG23 ' A' ' 48' ' ' THR . 6.2 mtm-85 -167.4 135.17 2.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.607 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 122' ' ' ILE . 28.1 mt -119.81 163.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.874 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.53 ' N ' HG22 ' A' ' 89' ' ' ILE . 22.2 m -149.59 114.63 5.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.963 0.411 . . . . 0.0 111.363 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 120' ' ' LEU . 4.7 mp -110.37 98.7 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.955 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.89 137.9 40.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.0 p90 -139.08 150.3 45.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.242 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.598 ' HB ' HG13 ' A' ' 115' ' ' VAL . 4.4 t -147.6 132.24 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -53.33 147.79 9.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 p -98.2 142.87 25.27 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.751 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.13 160.62 3.07 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.377 2.051 . . . . 0.0 112.039 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -47.03 116.28 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.175 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.4 50.77 23.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.42 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 62.74 7.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.727 0.299 . . . . 0.0 111.549 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.42 164.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.612 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -104.55 73.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.57 147.83 0.18 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.71 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.41 150.39 48.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.48 146.85 38.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.14 -23.77 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.22 -22.26 64.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.162 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.83 -30.07 71.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' A' ' 115' ' ' VAL . 9.2 m-85 -85.5 -26.35 26.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.989 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -110.02 58.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.27 -138.2 2.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.72 146.26 23.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.822 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.3 130.9 6.69 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.397 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt -67.57 152.25 45.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.598 HG13 ' HB ' ' A' ' 94' ' ' THR . 14.1 t -128.44 128.3 68.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HB2' ' HG2' ' A' ' 6' ' ' PRO . 1.2 ttt180 -96.8 152.61 18.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.582 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.03 130.08 18.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.042 0.449 . . . . 0.0 111.585 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -115.74 162.74 16.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.033 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -131.95 149.34 52.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 0.0 111.48 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 91' ' ' ILE . 2.1 mt -143.26 98.47 5.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 37.2 Cg_exo -57.91 151.04 59.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.703 2.269 . . . . 0.0 112.795 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 89' ' ' ILE . 43.9 mm -101.46 158.26 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.018 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.67 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -140.08 153.66 46.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.902 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.501 ' CE2' HD22 ' A' ' 84' ' ' LEU . 31.7 m-85 -119.81 113.54 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -102.94 82.63 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.975 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.11 169.66 10.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.38 147.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.62 148.96 60.61 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.07 146.22 81.47 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.531 2.154 . . . . 0.0 112.215 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.412 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 59.4 Cg_endo -71.73 149.54 54.75 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.576 2.184 . . . . 0.0 112.335 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.68 -165.53 1.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.5 m-20 -111.17 111.85 23.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.89 147.54 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.49 149.52 21.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.19 151.55 45.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.6 107.63 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 28.3 Cg_endo -62.33 157.6 61.28 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.824 -1.323 . . . . 0.0 112.377 0.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' SER . . . . . 0.434 ' C ' HD21 ' B' ' 120' ' ' LEU . 0.0 OUTLIER -112.39 -20.24 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.231 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.485 ' C ' HD23 ' B' ' 120' ' ' LEU . 37.9 mt-30 -94.67 -46.09 7.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.891 0.376 . . . . 0.0 111.068 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.89 -176.46 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' B' ' 122' ' ' ILE . 17.5 tt -144.69 156.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.244 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.642 HG23 ' HB3' ' B' ' 123' ' ' GLU . 3.5 p -133.22 92.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.566 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 19.0 m-30 -50.87 112.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.74 136.22 37.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.303 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.771 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -50.88 168.62 0.24 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.795 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.771 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 1.9 Cg_endo -82.54 163.73 74.1 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 124.276 -1.135 . . . . 0.0 112.476 0.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.35 26.43 9.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -110.43 6.97 22.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.125 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -141.4 134.22 28.82 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 120.787 0.327 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -55.38 107.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -116.67 124.13 48.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.716 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.404 ' CG2' ' HB1' ' B' ' 71' ' ' ALA . 0.2 OUTLIER -99.75 113.23 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.566 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 85.8 m-85 -89.86 99.44 12.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.471 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -66.73 153.43 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.578 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mt -139.43 148.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 25.4 ttmt -105.03 140.54 38.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.443 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.436 HG22 ' N ' ' B' ' 34' ' ' THR . 46.1 mt -131.45 154.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.828 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.7 m -145.47 155.72 43.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.998 0.428 . . . . 0.0 111.208 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.897 ' HB2' HD23 ' B' ' 62' ' ' LEU . 36.1 t-20 -104.26 102.38 12.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.535 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -93.44 21.23 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.293 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.89 -122.78 4.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.444 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.33 -42.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -113.2 166.63 11.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.49 156.45 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.422 HG12 ' ND2' ' B' ' 35' ' ' ASN . 21.5 pt -143.92 174.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.35 100.0 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.883 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -92.01 159.4 15.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.234 0.54 . . . . 0.0 111.651 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.73 130.81 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.414 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.438 ' CG2' HG11 ' B' ' 55' ' ' VAL . 5.6 mm -100.34 141.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 111.717 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -142.08 131.94 24.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.513 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.445 HG23 HG13 ' B' ' 55' ' ' VAL . 11.4 p -107.52 156.88 18.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 111.316 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.541 HG23 ' HB2' ' B' ' 88' ' ' ARG . 0.0 OUTLIER -48.32 -29.02 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.57 122.82 12.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.77 -8.59 59.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.455 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.12 -41.23 13.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -84.66 -59.59 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.778 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -94.48 134.1 37.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.756 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -127.46 109.01 11.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.445 HG13 HG23 ' B' ' 47' ' ' THR . 16.1 m -68.07 156.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.071 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' B' ' 71' ' ' ALA . 32.9 t0 -169.96 113.87 0.48 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.32 149.81 92.62 Favored 'Cis proline' 0 C--N 1.351 0.667 0 C-N-CA 124.014 -1.244 . . . . 0.0 112.249 0.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.92 -15.45 20.95 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 112.546 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p -179.52 153.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.538 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.46 168.17 41.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.696 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 26.3 t -98.7 121.12 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.011 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.897 HD23 ' HB2' ' B' ' 35' ' ' ASN . 4.6 tp -96.98 163.13 13.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.4 OUTLIER -115.36 171.08 4.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.29 111.32 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.571 2.181 . . . . 0.0 112.349 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.04 39.87 9.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.42 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.6 OUTLIER -106.87 154.38 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.799 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.6 38.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 10.5 p -138.63 143.36 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.28 151.62 23.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.413 ' CE ' HD11 ' B' ' 33' ' ' ILE . 0.7 OUTLIER -133.39 161.6 34.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.728 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' B' ' 56' ' ' ASP . . . -146.96 118.29 7.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.309 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 t -108.03 86.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.35 145.44 53.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.033 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.7 t -136.07 103.19 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.26 150.32 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -67.64 112.47 4.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.472 ' HE2' ' HB2' ' B' ' 79' ' ' ALA . 44.7 p90 -123.47 178.17 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.97 89.91 3.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.472 ' HB2' ' HE2' ' B' ' 77' ' ' PHE . . . -55.1 -26.74 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.028 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.18 57.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 61.3 p -125.65 50.56 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.066 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.12 162.46 32.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -80.15 130.22 35.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.502 HD22 ' CE2' ' B' ' 124' ' ' TYR . 12.6 mt -125.82 52.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -112.51 -23.43 10.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.492 ' HB3' HG21 ' B' ' 48' ' ' THR . 14.9 m120 -65.64 -91.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.779 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ASP . . . . . 0.446 ' CB ' ' HB ' ' B' ' 122' ' ' ILE . 2.1 p-10 41.51 84.59 0.02 OUTLIER 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.76 0.314 . . . . 0.0 111.564 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.541 ' HB2' HG23 ' B' ' 48' ' ' THR . 6.3 mtm-85 -167.25 135.17 2.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.643 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.805 HD11 HD11 ' B' ' 122' ' ' ILE . 29.0 mt -119.8 163.69 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.795 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.537 ' N ' HG22 ' B' ' 89' ' ' ILE . 21.8 m -149.5 114.79 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.939 0.4 . . . . 0.0 111.247 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.513 ' CD1' HD12 ' B' ' 120' ' ' LEU . 4.7 mp -110.47 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.861 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 137.79 40.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.832 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -138.97 150.29 45.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.597 ' HB ' HG13 ' B' ' 115' ' ' VAL . 4.6 t -147.7 132.07 17.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -53.19 147.62 9.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -98.08 142.83 25.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.18 160.62 3.14 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.428 2.085 . . . . 0.0 112.022 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -46.98 116.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.58 50.78 24.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.364 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.04 62.81 7.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.726 0.298 . . . . 0.0 111.562 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.36 164.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.24 0.543 . . . . 0.0 111.663 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -104.48 73.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.49 147.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.3 150.44 48.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 146.84 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.677 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.1 -23.68 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.162 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.33 -22.17 64.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.149 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -62.98 -30.08 71.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.062 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' B' ' 115' ' ' VAL . 9.2 m-85 -85.31 -26.48 26.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -109.96 58.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.952 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.41 -138.16 2.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.453 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.64 146.42 23.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.819 0.342 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.15 130.56 6.63 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.597 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt -67.13 152.23 46.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.597 HG13 ' HB ' ' B' ' 94' ' ' THR . 13.7 t -128.5 128.32 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.412 ' HB2' ' HG2' ' B' ' 6' ' ' PRO . 1.2 ttt180 -96.82 152.56 18.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.604 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.06 130.06 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.449 . . . . 0.0 111.546 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 90' ' ' THR . 0.0 OUTLIER -115.78 162.73 16.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.966 179.24 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -131.96 149.19 52.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 0.0 111.498 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.513 HD12 ' CD1' ' B' ' 91' ' ' ILE . 2.1 mt -143.25 98.46 5.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.665 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 88' ' ' ARG . 38.0 Cg_exo -57.77 151.03 58.68 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.789 2.326 . . . . 0.0 112.642 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.805 HD11 HD11 ' B' ' 89' ' ' ILE . 43.7 mm -101.47 158.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.968 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.642 ' HB3' HG23 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -140.0 153.67 46.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.891 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.502 ' CE2' HD22 ' B' ' 84' ' ' LEU . 32.1 m-85 -119.84 113.51 20.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -102.96 82.86 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.819 0.343 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 68.39 123.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -69.52 -55.71 9.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.718 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.548 HG23 ' HD2' ' A' ' 5' ' ' PRO . 7.4 p 179.42 138.26 0.28 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 4' ' ' VAL . 72.8 Cg_endo -77.27 166.78 25.76 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.664 2.243 . . . . 0.0 112.416 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.52 109.75 2.7 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.607 2.204 . . . . 0.0 112.226 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.45 135.75 47.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.505 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.2 m-20 -49.25 152.49 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 33' ' ' ILE . 11.3 pt -118.0 147.16 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.63 140.9 31.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.578 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.79 139.12 47.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.188 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -137.25 110.07 9.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 28.8 Cg_endo -62.54 167.52 32.84 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.672 0.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -43.08 -68.41 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.429 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.11 43.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.69 123.54 3.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.037 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.55 151.89 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.4 p -138.61 100.15 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.39 113.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -81.21 132.87 35.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.862 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.11 0.14 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.857 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.862 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 72.1 Cg_endo -76.72 167.74 79.16 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.733 0.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.4 m-85 -115.85 31.54 6.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.013 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.6 6.59 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.271 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.556 ' N ' HG22 ' A' ' 76' ' ' THR . 11.0 m-20 -149.76 -178.57 6.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.14 107.95 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -111.16 132.98 53.87 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.545 HG21 ' HB1' ' A' ' 71' ' ' ALA . 95.4 m -107.15 135.78 48.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.78 ' O ' HG12 ' A' ' 72' ' ' VAL . 6.3 m-85 -116.88 121.81 42.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.642 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.02 150.88 45.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.435 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -133.43 153.96 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.702 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.24 135.25 53.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.409 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 9' ' ' ILE . 69.4 mt -145.46 121.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -118.19 153.46 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 111.108 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.624 ' ND2' HD13 ' A' ' 41' ' ' ILE . 3.7 t-20 -94.54 81.68 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.95 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -63.8 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.43 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.92 -154.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.629 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.72 -19.33 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.743 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -132.61 167.16 20.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.009 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 41' ' ' ILE . 37.6 mtp180 -49.78 164.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.811 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.624 HD13 ' ND2' ' A' ' 35' ' ' ASN . 31.2 pt -156.74 132.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.798 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 60' ' ' GLY . . . -94.13 109.48 3.83 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -99.51 159.3 15.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.988 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.77 155.05 44.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.408 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.464 ' CG2' HG21 ' A' ' 55' ' ' VAL . 25.1 mm -117.24 132.37 67.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 111.586 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 150.8 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.737 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 p -143.27 153.71 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -41.97 95.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.62 114.87 15.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.68 20.6 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -97.14 -31.69 12.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -113.37 -19.25 11.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.3 mt -108.11 132.45 53.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.05 107.74 5.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -100.73 127.12 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.032 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.22 130.96 22.8 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.1 142.86 76.05 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.875 -1.302 . . . . 0.0 112.022 0.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.22 -31.7 43.93 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.434 2.089 . . . . 0.0 112.036 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -145.91 -177.93 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.495 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . 164.27 -171.0 39.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.596 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.31 129.47 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.604 HD13 HG23 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.4 153.55 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.141 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.2 p30 -90.05 168.1 15.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 32.3 Cg_exo -61.79 133.69 46.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.497 2.131 . . . . 0.0 112.231 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 tttm 77.7 12.07 1.99 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.841 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -108.51 142.98 38.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.187 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.27 161.21 13.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.193 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG23 HD13 ' A' ' 62' ' ' LEU . 41.8 t -135.62 141.93 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.03 118.95 33.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.946 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.533 ' SD ' HD12 ' A' ' 33' ' ' ILE . 9.8 mtm -112.46 158.21 20.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 28' ' ' THR . . . -126.71 102.23 6.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.22 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 29' ' ' TYR . 7.4 p -88.05 109.43 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.809 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.2 m -91.24 129.88 37.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.302 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 41.0 t -114.99 150.82 35.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.9 154.58 21.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.119 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 25' ' ' ASP . 3.9 p -58.59 161.03 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -173.53 -165.63 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.94 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 92.4 m-20 -121.92 82.86 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 77' ' ' PHE . . . -57.24 -22.11 38.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.216 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.296 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.4 p -141.56 43.13 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.168 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 19.6 mm-40 -122.52 6.5 9.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.26 140.01 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' A' ' 124' ' ' TYR . 2.2 mt -115.23 24.46 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -142.26 28.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.767 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.21 9.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.02 126.91 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.84 139.63 26.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.5 mt -107.35 122.36 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.615 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 118' ' ' LYS . 68.0 m -110.56 118.66 36.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.487 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.15 154.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -149.71 101.72 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.512 ' NE1' HG23 ' A' ' 9' ' ' ILE . 15.1 p90 -122.14 137.9 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.997 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.732 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -134.37 148.97 50.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.029 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -60.22 144.16 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -85.77 150.89 54.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 39.3 Cg_endo -67.04 163.63 33.22 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.5 2.133 . . . . 0.0 112.059 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -47.18 116.45 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.21 46.64 56.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.688 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.688 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -65.13 150.65 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.113 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.41 165.03 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.142 0.496 . . . . 0.0 111.282 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.9 71.33 7.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.621 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.02 140.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.05 120.21 9.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HG2' ' HG2' ' A' ' 107' ' ' GLU . 0.9 OUTLIER -101.16 156.16 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.024 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.77 -27.16 16.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.434 ' HG2' ' HG2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -65.16 -18.22 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.339 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.85 -16.25 57.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.428 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 109' ' ' PHE . 2.5 m-85 -125.67 50.71 1.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -133.04 24.65 4.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.97 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.26 -171.29 12.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.1 146.27 29.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.764 0.316 . . . . 0.0 110.631 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.14 179.17 25.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.273 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.596 ' C ' HG23 ' A' ' 115' ' ' VAL . 2.9 mtt 59.3 162.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.0 110.883 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.732 HG13 ' HB ' ' A' ' 94' ' ' THR . 3.3 t 81.76 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.118 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.28 26.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.773 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.76 139.39 46.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.004 0.43 . . . . 0.0 111.174 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 90' ' ' THR . 26.0 mtpp -125.37 166.77 15.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.489 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -121.69 152.05 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -141.31 88.56 9.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 141.8 47.29 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.566 2.177 . . . . 0.0 112.633 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.37 138.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.817 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.6 mm-40 -131.62 159.18 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.264 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.571 ' HB2' HD22 ' A' ' 84' ' ' LEU . 97.7 m-85 -122.8 113.07 18.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 60.4 t30 -95.15 90.57 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' A' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.846 0.355 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 68.51 123.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -69.58 -55.66 9.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.722 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.561 HG23 ' HD2' ' B' ' 5' ' ' PRO . 7.4 p 179.33 138.24 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.079 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.561 ' HD2' HG23 ' B' ' 4' ' ' VAL . 71.7 Cg_endo -77.25 166.78 25.78 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.613 2.209 . . . . 0.0 112.37 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.45 109.75 2.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.508 2.139 . . . . 0.0 112.33 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.38 135.8 47.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 2.1 m-20 -49.31 152.45 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 111.017 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.585 HD12 HG23 ' B' ' 33' ' ' ILE . 11.2 pt -117.99 147.2 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.66 140.82 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.63 139.53 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -137.62 109.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.561 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.564 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 28.7 Cg_endo -62.46 167.29 33.23 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.996 -1.252 . . . . 0.0 112.636 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.3 m -43.01 -68.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.469 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.24 43.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.63 123.19 3.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.19 151.68 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.61 ' O ' HG13 ' B' ' 18' ' ' VAL . 7.4 p -138.36 100.13 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.602 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.38 113.19 1.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASN . . . . . 0.401 HD21 HG13 ' A' ' 18' ' ' VAL . 6.6 m-80 -81.06 132.73 35.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.315 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.856 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.15 170.12 0.14 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.856 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.6 Cg_endo -76.71 167.84 78.86 Favored 'Cis proline' 0 C--N 1.35 0.628 0 C-N-CA 123.898 -1.293 . . . . 0.0 112.699 0.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.5 m-85 -115.87 31.49 6.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.031 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.63 6.65 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.3 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ASP . . . . . 0.559 ' N ' HG22 ' B' ' 76' ' ' THR . 11.2 m-20 -149.78 -178.69 6.6 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.75 0.31 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.07 108.08 20.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.942 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -111.43 132.78 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' THR . . . . . 0.54 HG21 ' HB1' ' B' ' 71' ' ' ALA . 94.9 m -106.89 135.96 47.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.785 ' O ' HG12 ' B' ' 72' ' ' VAL . 6.5 m-85 -116.91 122.09 43.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.29 150.85 44.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.443 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -133.48 153.8 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.662 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.09 135.32 53.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.439 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.585 HG23 HD12 ' B' ' 9' ' ' ILE . 68.5 mt -145.48 121.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.6 m -118.32 153.47 33.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.63 ' ND2' HD13 ' B' ' 41' ' ' ILE . 3.8 t-20 -94.52 81.63 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -63.74 -15.91 59.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.473 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.04 -154.19 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.84 -19.43 5.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.639 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mtp85 -132.72 167.29 20.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.402 ' O ' HG23 ' B' ' 41' ' ' ILE . 37.8 mtp180 -49.86 164.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.63 HD13 ' ND2' ' B' ' 35' ' ' ASN . 31.3 pt -156.6 132.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.746 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.01 109.22 3.78 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.475 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.46 159.22 15.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.241 0.543 . . . . 0.0 111.899 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.7 155.08 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' HG21 ' B' ' 55' ' ' VAL . 25.4 mm -117.24 132.4 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.928 0.394 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.07 150.65 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.809 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 31.5 p -143.16 153.75 43.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.008 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.6 -42.01 95.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.61 114.85 15.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.64 20.68 7.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ARG . . . . . 0.401 ' HG3' ' HG2' ' B' ' 52' ' ' ARG . 3.4 ptp180 -97.21 -31.58 12.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.401 ' HG2' ' HG3' ' B' ' 51' ' ' ARG . 1.4 ptt180 -113.38 -19.34 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -108.06 132.51 53.48 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.09 107.57 5.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -100.56 127.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -131.32 130.96 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.16 142.76 75.74 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.001 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.11 -31.87 44.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.491 2.127 . . . . 0.0 111.97 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 p -145.75 -177.98 5.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.424 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.26 -170.89 39.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.37 129.47 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.589 HD13 HG23 ' B' ' 68' ' ' VAL . 1.0 OUTLIER -125.45 153.57 43.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.193 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.2 p30 -90.2 168.0 15.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.836 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 30.9 Cg_exo -61.71 133.71 46.66 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.455 2.103 . . . . 0.0 112.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.8 tttm 77.53 12.42 2.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.882 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 1.2 tp10 -108.73 142.96 38.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.12 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.19 161.24 13.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.183 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.589 HG23 HD13 ' B' ' 62' ' ' LEU . 41.5 t -135.61 141.65 41.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.097 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 mt -117.78 118.99 33.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.016 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.547 ' SD ' HD12 ' B' ' 33' ' ' ILE . 9.7 mtm -112.53 158.07 20.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' B' ' 28' ' ' THR . . . -126.63 102.12 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.284 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.785 HG12 ' O ' ' B' ' 29' ' ' TYR . 7.3 p -87.88 109.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 43.0 m -91.32 130.06 37.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.1 t -115.09 150.9 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.681 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.98 154.66 21.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.559 HG22 ' N ' ' B' ' 25' ' ' ASP . 3.7 p -58.67 160.87 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' B' ' 79' ' ' ALA . 0.7 OUTLIER -173.38 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 92.4 m-20 -121.91 82.77 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.509 ' HB2' ' CZ ' ' B' ' 77' ' ' PHE . . . -57.26 -22.12 39.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.232 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.335 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -141.72 43.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' B' ' 78' ' ' ASN . 19.8 mm-40 -122.58 6.29 9.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.627 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.41 140.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' B' ' 124' ' ' TYR . 2.2 mt -115.52 24.31 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -142.01 28.33 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.12 9.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.06 126.86 35.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.82 139.79 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 78.2 mt -107.65 122.16 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.631 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.489 HG23 ' O ' ' B' ' 118' ' ' LYS . 64.0 m -110.17 118.77 37.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.369 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.38 154.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.7 101.7 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.506 ' NE1' HG23 ' B' ' 9' ' ' ILE . 15.3 p90 -122.17 137.77 54.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.034 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.718 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.8 OUTLIER -134.26 149.2 50.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.004 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.46 143.99 52.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 70.7 p -85.59 150.89 54.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 39.8 Cg_endo -67.03 163.54 33.54 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.63 2.22 . . . . 0.0 111.996 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -47.1 116.53 1.4 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.12 46.56 56.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.78 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.681 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -65.01 150.69 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.48 164.96 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.462 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -89.78 71.24 7.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.99 140.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.84 120.22 9.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.419 ' HG2' ' HG2' ' B' ' 107' ' ' GLU . 0.9 OUTLIER -101.22 156.2 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.94 -26.86 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.996 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -65.3 -18.39 65.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.303 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.6 -16.39 56.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.405 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 2.4 m-85 -125.67 50.73 1.8 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.673 0.273 . . . . 0.0 111.05 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' B' ' 107' ' ' GLU . 0.0 OUTLIER -133.03 24.52 4.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.988 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.21 -171.31 12.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.93 146.26 29.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.81 0.338 . . . . 0.0 110.673 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.09 179.27 25.32 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.348 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.597 ' C ' HG23 ' B' ' 115' ' ' VAL . 2.9 mtt 59.23 162.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.718 HG13 ' HB ' ' B' ' 94' ' ' THR . 3.3 t 81.72 117.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.53 148.08 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.45 139.55 46.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.994 0.426 . . . . 0.0 111.199 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 90' ' ' THR . 25.9 mtpp -125.43 166.72 16.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.595 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -121.77 151.78 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.076 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -140.99 88.56 10.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.17 141.49 48.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.632 2.222 . . . . 0.0 112.607 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.09 138.36 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.597 ' C ' HG23 ' B' ' 18' ' ' VAL . 1.6 mm-40 -131.68 159.06 39.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 111.256 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.578 ' HB2' HD22 ' B' ' 84' ' ' LEU . 97.5 m-85 -122.78 113.04 18.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 60.4 t30 -95.03 90.58 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' B' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.13 84.5 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.997 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -152.81 140.4 19.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 4' ' ' VAL . 31.1 m -135.44 115.19 11.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.095 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.29 160.33 3.5 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.369 2.046 . . . . 0.0 112.35 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.9 123.18 8.74 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.557 2.171 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.69 138.32 46.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.3 m-20 -59.03 130.65 48.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.27 120.34 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.225 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 146.75 24.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.631 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.78 153.44 49.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.888 0.375 . . . . 0.0 111.218 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.1 mt-30 -144.85 108.94 4.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.0 165.18 37.32 Favored 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.842 -1.316 . . . . 0.0 112.664 0.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -45.13 -59.61 2.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.934 ' HA ' HD22 ' A' ' 120' ' ' LEU . 22.9 pt20 -170.9 45.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.15 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -178.52 132.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 29' ' ' TYR . 18.7 tt -132.28 153.85 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 125' ' ' ASN . 57.1 t -120.78 92.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.674 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.14 95.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.283 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.81 139.39 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.579 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.913 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -76.56 175.23 4.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.586 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.913 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 40.6 Cg_endo -66.7 165.58 64.44 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.683 0.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.63 43.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -123.06 7.21 9.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.323 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.17 142.14 48.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.3 115.63 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.05 103.3 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -84.76 102.47 13.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 17' ' ' ILE . 93.5 m-85 -89.48 117.91 28.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.39 135.43 33.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 12' ' ' GLN . 22.5 mt -119.98 133.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -97.93 139.18 34.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 111.342 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -133.02 146.22 32.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.652 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.4 m -150.09 156.53 41.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 0.0 111.212 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' HB2' HD23 ' A' ' 62' ' ' LEU . 18.4 t30 -97.89 111.07 23.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.727 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.51 19.45 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.21 -140.49 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.566 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.44 53.19 0.47 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -175.97 177.12 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.445 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 25.5 ttm-85 -77.61 151.15 34.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 62' ' ' LEU . 4.3 pt -146.58 167.47 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 111.38 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -132.64 106.14 0.63 Allowed Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.585 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -104.42 160.41 14.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.259 0.552 . . . . 0.0 111.75 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . . . -157.65 143.11 17.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.461 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.426 HD12 HG13 ' A' ' 91' ' ' ILE . 14.3 mm -99.4 154.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.008 0.432 . . . . 0.0 111.634 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.53 132.08 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.4 149.7 42.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.77 -32.14 69.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.96 109.21 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.732 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.69 24.88 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.013 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.54 -55.38 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.23 -28.23 27.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.46 156.69 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.982 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.44 141.33 28.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.2 p -139.21 161.07 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.966 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -176.49 131.06 0.37 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.813 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.17 148.71 92.58 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.186 0.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.6 -12.8 24.76 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.599 2.2 . . . . 0.0 112.847 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.54 172.75 0.72 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.45 174.48 38.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.449 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' HG2' ' A' ' 40' ' ' ARG . 21.7 t -107.12 114.42 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 35' ' ' ASN . 3.7 tp -87.53 169.54 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.072 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.412 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -129.89 176.3 2.94 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.792 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.6 Cg_exo -61.24 114.45 2.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.633 2.222 . . . . 0.0 112.291 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.69 32.28 13.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -97.9 148.0 23.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -113.53 156.2 24.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.84 144.76 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.04 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.51 137.07 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.0 158.76 34.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.03 35.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.187 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.03 91.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.895 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -82.77 151.67 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.48 116.61 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.11 142.78 58.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 p -56.55 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -133.43 -168.89 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -121.31 119.8 33.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 84' ' ' LEU . . . -98.46 18.92 15.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.47 -24.44 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.229 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.3 p -143.1 41.63 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.036 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -138.33 159.59 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.653 ' O ' HD23 ' A' ' 84' ' ' LEU . 22.6 t0 -89.2 134.19 34.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.9 mt -123.62 56.09 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.48 25.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -134.02 6.58 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.637 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.57 108.21 19.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.812 0.339 . . . . 0.0 110.824 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.08 136.1 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.101 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.805 HG13 HD11 ' A' ' 122' ' ' ILE . 12.8 mt -94.87 163.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.5 ' N ' HG22 ' A' ' 89' ' ' ILE . 10.0 m -144.87 123.96 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.128 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.1 mp -115.51 98.1 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.85 136.93 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.675 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' ' 116' ' ' ARG . 6.6 p90 -145.52 143.69 30.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.161 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -141.46 143.48 33.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.78 122.48 14.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.582 HG22 ' CH2' ' A' ' 108' ' ' TRP . 12.0 p -52.93 145.05 24.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 37.1 Cg_endo -65.79 160.53 43.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.534 2.156 . . . . 0.0 112.292 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.4 119.16 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.7 41.5 97.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.763 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.674 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -71.33 139.57 49.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.8 164.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 0.0 111.403 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 70.32 7.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.45 131.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 73.5 t80 -51.25 152.01 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.33 152.09 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -91.77 -23.71 19.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.069 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -18.91 65.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.39 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CH2' HG22 ' A' ' 96' ' ' THR . 34.6 m0 -60.18 -16.14 30.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.276 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -126.34 40.22 3.77 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.819 0.342 . . . . 0.0 110.89 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.71 28.51 8.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.07 -179.16 40.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.04 156.28 27.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.952 0.406 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.65 81.01 0.32 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.622 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.2 mmt 55.05 106.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.2 p 176.84 115.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.446 ' HB3' ' CZ3' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -102.23 154.14 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -139.73 96.82 3.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.029 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.34 162.42 18.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.648 ' C ' HD23 ' A' ' 120' ' ' LEU . 67.2 m-80 -140.56 126.52 19.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.934 HD22 ' HA ' ' A' ' 15' ' ' GLN . 1.4 mt -110.85 100.52 46.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.42 144.13 74.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.604 2.203 . . . . 0.0 112.529 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.805 HD11 HG13 ' A' ' 89' ' ' ILE . 8.2 mm -110.53 93.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.68 140.81 32.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD2' HD13 ' A' ' 84' ' ' LEU . 21.3 m-85 -103.7 104.43 14.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.046 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.524 ' HB2' HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -78.66 82.45 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.812 0.339 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.11 84.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -152.81 140.44 19.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.532 ' O ' HG23 ' B' ' 4' ' ' VAL . 31.3 m -135.6 114.99 11.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.17 160.36 3.35 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.397 2.065 . . . . 0.0 112.303 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.02 123.27 8.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.186 . . . . 0.0 112.286 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.7 138.33 46.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.567 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 11.5 m-20 -58.95 130.75 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.37 120.51 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.85 146.89 24.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.537 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.93 153.3 49.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.204 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.612 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.2 mt-30 -144.72 108.99 4.77 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.07 165.17 37.76 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.611 0.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -45.02 -59.55 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.942 ' HA ' HD22 ' B' ' 120' ' ' LEU . 22.9 pt20 -170.95 44.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.148 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -178.49 132.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.41 . . . . 0.0 111.254 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' B' ' 29' ' ' TYR . 18.5 tt -132.25 154.0 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.721 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' B' ' 125' ' ' ASN . 57.5 t -120.98 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.812 0.339 . . . . 0.0 111.579 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -57.21 95.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.277 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.581 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.931 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -76.49 175.28 4.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.931 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 40.2 Cg_endo -66.51 165.73 62.55 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.951 -1.271 . . . . 0.0 112.786 -0.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 43.69 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.89 6.98 9.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.361 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.0 142.06 48.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.849 0.357 . . . . 0.0 110.972 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -65.16 115.44 5.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -115.91 103.16 10.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.749 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -84.53 102.37 12.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.083 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.439 ' CD1' HD11 ' B' ' 17' ' ' ILE . 93.8 m-85 -89.51 117.87 28.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.725 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.26 135.36 33.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.332 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.612 HG23 ' O ' ' B' ' 12' ' ' GLN . 22.6 mt -119.93 133.12 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.681 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -97.99 138.96 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.38 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -132.9 146.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 55.1 m -150.13 156.41 41.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.276 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.537 ' HB2' HD23 ' B' ' 62' ' ' LEU . 18.4 t30 -97.71 111.08 23.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.51 19.34 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.2 -140.26 9.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.6 53.16 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -175.92 177.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.448 ' HG2' ' CG1' ' B' ' 61' ' ' VAL . 25.9 ttm-85 -77.66 151.17 34.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.438 ' O ' HG13 ' B' ' 61' ' ' VAL . 4.3 pt -146.66 167.37 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 111.428 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -132.56 106.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.568 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 34.0 p-90 -104.53 160.57 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 111.703 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' B' ' 104' ' ' PHE . . . -157.87 142.92 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.461 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.423 HD12 HG13 ' B' ' 91' ' ' ILE . 14.2 mm -99.11 154.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.694 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.75 131.94 15.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.25 149.57 42.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.066 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.6 -32.33 68.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.75 109.18 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.66 24.71 5.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -55.3 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.36 -28.24 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.33 156.64 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.5 141.36 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.491 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.2 p -139.29 160.96 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.197 0.522 . . . . 0.0 111.004 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ASP . . . . . 0.491 ' N ' HG22 ' B' ' 55' ' ' VAL . 0.5 OUTLIER -176.43 131.08 0.38 Allowed Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.826 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.17 148.6 92.31 Favored 'Cis proline' 0 C--N 1.352 0.731 0 C-N-CA 123.691 -1.379 . . . . 0.0 112.314 -0.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.49 -12.63 24.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.617 2.211 . . . . 0.0 112.916 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.37 172.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.33 174.4 38.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.556 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' B' ' 40' ' ' ARG . 21.7 t -106.99 114.64 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.066 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 35' ' ' ASN . 3.7 tp -87.78 169.35 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.408 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.3 OUTLIER -129.76 176.26 2.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 34.2 Cg_exo -61.17 114.4 2.18 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.665 2.244 . . . . 0.0 112.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.72 32.27 13.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -97.79 148.2 23.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -113.69 156.27 24.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.93 144.72 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.52 137.1 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.08 158.83 34.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.829 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.43 146.76 35.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.78 90.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -82.76 151.47 26.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.32 116.48 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.07 142.76 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -56.58 128.07 34.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.39 -168.8 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.02 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -121.45 119.71 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' B' ' 84' ' ' LEU . . . -98.35 18.93 15.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.38 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.53 -24.47 20.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.8 p -143.14 41.8 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -138.54 159.47 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.644 ' O ' HD23 ' B' ' 84' ' ' LEU . 22.6 t0 -89.1 134.06 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.644 HD23 ' O ' ' B' ' 83' ' ' ASP . 9.0 mt -123.45 55.98 1.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.44 25.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -133.76 6.33 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.687 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.54 108.05 19.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.797 0.332 . . . . 0.0 110.864 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.0 136.27 26.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.03 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.813 HG13 HD11 ' B' ' 122' ' ' ILE . 12.6 mt -94.93 163.92 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.494 ' N ' HG22 ' B' ' 89' ' ' ILE . 9.7 m -144.95 123.89 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.538 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.1 mp -115.51 98.05 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.007 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.77 136.94 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.451 ' CZ3' ' HB3' ' B' ' 116' ' ' ARG . 6.7 p90 -145.53 143.7 30.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 2.5 t -141.49 143.51 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.82 122.38 14.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.576 HG22 ' CH2' ' B' ' 108' ' ' TRP . 12.0 p -52.76 144.94 23.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 37.2 Cg_endo -65.81 160.67 42.72 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.617 2.211 . . . . 0.0 112.22 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.43 119.1 3.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.085 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.66 41.92 97.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.587 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.659 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -71.63 139.7 49.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 111.048 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.09 164.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.342 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 70.46 7.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.651 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.51 131.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' B' ' 44' ' ' ALA . 74.1 t80 -51.21 151.98 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.21 152.26 50.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -92.21 -23.49 19.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.056 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -19.0 65.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.348 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.576 ' CH2' HG22 ' B' ' 96' ' ' THR . 34.0 m0 -60.09 -16.36 31.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.213 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -126.25 40.55 3.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 28.43 8.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.761 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.08 -179.09 40.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.596 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.07 156.16 27.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.912 0.387 . . . . 0.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.66 81.04 0.32 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.585 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 5.1 mmt 55.16 106.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.978 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.521 ' O ' HG13 ' B' ' 115' ' ' VAL . 7.2 p 176.72 115.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.451 ' HB3' ' CZ3' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -102.33 154.21 19.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -139.71 96.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.032 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 162.52 18.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.649 ' C ' HD23 ' B' ' 120' ' ' LEU . 67.2 m-80 -140.59 126.63 19.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.942 HD22 ' HA ' ' B' ' 15' ' ' GLN . 1.4 mt -110.98 100.53 46.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.4 144.15 73.94 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.425 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.813 HD11 HG13 ' B' ' 89' ' ' ILE . 8.3 mm -110.49 93.71 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.195 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.78 141.06 32.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.0 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.406 ' CD2' HD13 ' B' ' 84' ' ' LEU . 21.3 m-85 -103.9 104.43 14.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.516 ' HB2' HG12 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -78.8 82.38 5.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.896 -179.917 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.796 0.332 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -118.89 79.46 1.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.31 173.07 6.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.831 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 2.2 m -137.97 129.31 15.93 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.173 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 4' ' ' VAL . 44.3 Cg_exo -56.62 172.11 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.519 2.146 . . . . 0.0 112.215 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.97 119.2 5.9 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.594 2.196 . . . . 0.0 112.284 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.64 131.6 40.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.757 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 5.8 m-20 -48.5 113.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.2 pt -85.12 124.64 40.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.072 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -67.7 138.09 56.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.831 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.52 153.37 51.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.48 102.49 4.66 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.853 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.44 ' HG3' ' HB ' ' A' ' 17' ' ' ILE . 20.2 Cg_endo -60.18 157.51 46.39 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.311 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.59 -10.82 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.763 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.05 -61.5 1.67 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.909 0.385 . . . . 0.0 111.069 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 13' ' ' PRO . 7.2 mttm -143.86 175.19 10.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.236 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' ILE . 19.5 tt -148.11 123.16 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.729 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 123' ' ' GLU . 44.8 t -113.41 118.01 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.457 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 29' ' ' TYR . 48.4 m-85 -77.12 96.03 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.48 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -70.36 131.95 44.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.535 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.745 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -58.39 169.19 1.04 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.736 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.745 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 67.8 Cg_endo -89.1 160.27 38.72 Favored 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.296 -1.127 . . . . 0.0 112.803 0.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.411 ' OH ' ' HB2' ' A' ' 19' ' ' PHE . 32.6 m-85 -97.88 46.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.924 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 76' ' ' THR . 11.1 t70 -132.7 9.0 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.43 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.34 -5.87 7.7 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.59 134.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.32 101.27 2.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.2 m -75.12 102.71 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 36.9 m-85 -74.09 116.06 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.21 121.09 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.614 HD12 ' HE3' ' A' ' 70' ' ' MET . 64.7 mt -104.47 126.79 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.38 124.69 36.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.499 HD11 ' CE ' ' A' ' 70' ' ' MET . 13.5 mt -119.29 158.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 33' ' ' ILE . 55.3 m -162.0 153.07 17.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -95.87 108.79 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.628 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -93.34 22.11 5.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.87 -147.29 20.54 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.569 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.71 -25.38 2.86 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.686 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -122.85 167.45 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 110.99 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.43 162.34 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.553 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 8.3 pt -150.24 137.86 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.828 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.47 111.21 4.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.599 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.439 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 27.5 p-90 -105.22 157.86 16.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.116 0.484 . . . . 0.0 111.772 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.65 148.89 33.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.47 HD13 HG23 ' A' ' 91' ' ' ILE . 15.5 mm -121.67 150.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -151.75 135.93 16.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.681 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.36 154.53 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -62.42 -32.67 73.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.014 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.15 108.23 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.962 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.09 25.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.765 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.07 -38.11 6.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.775 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.29 -32.01 7.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.82 118.33 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.673 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.6 m -122.15 106.8 11.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.91 154.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.21 129.88 0.55 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.171 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 10.3 Cg_exo -71.56 131.67 22.12 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.942 -1.274 . . . . 0.0 111.88 -0.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 32.0 Cg_exo -58.23 -48.43 15.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.407 2.071 . . . . 0.0 112.051 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.3 p -135.96 -178.84 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.53 -168.22 33.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.64 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -144.75 142.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -134.04 136.91 44.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.033 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -64.77 -179.66 0.32 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.968 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 29.6 Cg_exo -61.52 116.18 3.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.585 2.19 . . . . 0.0 112.435 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.52 29.8 2.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' CB ' ' HB2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -90.53 153.26 20.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.636 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -115.29 142.57 46.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.264 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.3 129.82 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.775 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.74 141.19 30.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.614 ' HE3' HD12 ' A' ' 31' ' ' ILE . 36.4 ttp -127.58 158.04 38.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.88 151.05 45.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.391 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.7 84.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.015 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.67 133.74 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 87.86 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.807 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.28 152.67 2.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 2.7 p -66.87 117.64 9.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -137.9 -163.99 1.54 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.62 139.04 43.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.712 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.56 18.64 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.509 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.33 15.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.02 47.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -138.29 165.82 25.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.15 127.0 18.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.5 84.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.997 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.53 25.16 7.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.178 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 73.27 93.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -70.37 147.61 49.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -142.35 137.37 30.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.418 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 78.8 mt -110.32 94.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.664 HG23 ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -78.2 140.24 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 45' ' ' ILE . 3.9 mp -132.96 111.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.006 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.91 124.43 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.027 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 11.7 p90 -133.5 142.08 48.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.678 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -141.3 144.99 34.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -60.74 131.36 50.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 p -73.61 142.45 80.8 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.01 162.74 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.475 2.116 . . . . 0.0 112.16 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.44 118.31 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.95 45.65 70.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.265 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.75 167.71 7.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.211 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.11 163.67 27.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.34 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.44 69.83 8.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.13 146.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -69.8 116.72 10.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.99 155.14 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -84.01 -26.04 29.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -22.66 66.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -59.35 -17.7 31.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 94' ' ' THR . 2.7 m-85 -124.85 38.63 4.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 110.801 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -117.71 35.25 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.921 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.7 174.63 24.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.638 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.8 140.2 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 110.589 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.41 172.28 44.77 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.25 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.538 ' C ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER 58.82 164.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 110.904 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 94' ' ' THR . 5.1 t 82.55 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.252 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.472 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 5.7 tpt180 -106.83 144.27 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -134.04 103.5 5.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 131.49 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.544 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.664 ' OD1' HG23 ' A' ' 90' ' ' THR . 1.5 m-80 -100.17 143.36 30.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.9 94.98 42.96 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.506 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.13 139.2 62.8 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.632 2.221 . . . . 0.0 112.58 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 7.6 mm -114.51 111.9 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.705 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -112.96 127.91 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -89.39 107.4 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.27 76.89 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.946 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.745 0.307 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -118.81 79.38 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.27 173.14 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.803 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.96 129.4 15.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.73 172.23 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.469 2.113 . . . . 0.0 112.149 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.1 119.33 6.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.566 2.177 . . . . 0.0 112.256 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.67 131.4 40.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.293 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.749 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 5.8 m-20 -48.13 113.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 111.019 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.469 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.2 pt -85.13 124.54 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -67.65 138.1 56.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.43 153.34 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.4 102.4 4.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.433 ' HG3' ' HB ' ' B' ' 17' ' ' ILE . 19.1 Cg_endo -60.12 157.71 45.69 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.777 -1.343 . . . . 0.0 112.222 0.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.73 -10.78 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.729 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.06 -61.58 1.66 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.886 0.374 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' B' ' 13' ' ' PRO . 7.5 mttm -143.8 174.96 10.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.232 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.454 ' O ' HG23 ' B' ' 17' ' ' ILE . 19.5 tt -147.94 123.23 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.698 HG13 ' O ' ' B' ' 123' ' ' GLU . 44.4 t -113.49 117.96 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.53 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.461 ' CE2' ' CD1' ' B' ' 29' ' ' TYR . 48.3 m-85 -77.08 95.98 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.531 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -70.28 131.84 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.629 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.766 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -58.39 169.24 1.03 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.68 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.766 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 67.7 Cg_endo -89.12 160.23 38.62 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.712 0.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' B' ' 19' ' ' PHE . 32.5 m-85 -97.92 46.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.882 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 11.1 t70 -132.87 8.98 4.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.345 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -5.97 7.74 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.68 134.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.768 0.318 . . . . 0.0 110.596 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.39 101.35 2.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -75.24 102.75 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CD1' ' CE2' ' B' ' 19' ' ' PHE . 36.9 m-85 -74.17 116.0 14.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' B' ' 70' ' ' MET . 12.2 m80 -94.18 121.02 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.621 HD12 ' HE3' ' B' ' 70' ' ' MET . 64.3 mt -104.37 126.85 59.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.45 124.8 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.508 HD11 ' CE ' ' B' ' 70' ' ' MET . 13.7 mt -119.35 158.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.953 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.435 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.9 m -162.0 153.17 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -95.99 108.91 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -93.44 22.03 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.147 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.78 -147.46 20.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.573 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.59 -25.36 2.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.685 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' B' ' 64' ' ' PRO . 0.0 OUTLIER -122.8 167.46 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.937 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.55 162.32 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.538 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 8.2 pt -150.22 137.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.401 . . . . 0.0 111.878 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -99.46 111.15 4.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.568 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.441 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 27.6 p-90 -105.09 157.85 16.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 111.763 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.68 148.97 33.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.484 HD13 HG23 ' B' ' 91' ' ' ILE . 15.6 mm -121.71 150.67 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 111.679 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -151.8 136.1 16.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.51 154.42 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.387 . . . . 0.0 111.15 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 68.6 p -62.35 -32.76 73.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.03 108.13 13.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.006 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 30.7 mmm -102.92 25.13 9.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.13 -38.17 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.773 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.23 -32.0 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.79 118.63 36.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.667 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m -122.4 106.71 11.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.192 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.85 154.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.27 129.87 0.54 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.61 131.66 22.15 Favored 'Cis proline' 0 C--N 1.35 0.636 0 C-N-CA 123.932 -1.278 . . . . 0.0 111.887 -0.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.23 -48.5 15.61 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.327 2.018 . . . . 0.0 112.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p -135.8 -178.69 5.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.48 -168.32 33.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.651 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.76 142.86 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.733 ' N ' HD23 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -134.28 136.76 43.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.966 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -64.57 -179.73 0.32 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 29.6 Cg_exo -61.62 116.35 3.37 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.547 2.165 . . . . 0.0 112.377 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.44 29.75 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' B' ' 62' ' ' LEU . 0.5 OUTLIER -90.43 153.36 20.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.637 179.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -115.38 142.71 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.264 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.34 129.71 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.815 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.7 141.36 30.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.236 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.621 ' HE3' HD12 ' B' ' 31' ' ' ILE . 36.5 ttp -127.79 158.08 38.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.04 151.01 45.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.354 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.6 84.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.77 133.59 55.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.3 t -141.49 87.83 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.15 152.67 2.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' B' ' 24' ' ' ASP . 2.8 p -66.84 117.97 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -138.2 -164.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.57 139.14 43.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.69 18.64 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.508 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.83 -26.28 15.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 111.033 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -150.02 48.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.49 165.79 25.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.14 126.96 17.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 88.0 mt -151.47 84.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.44 25.11 7.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.216 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 73.49 93.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.894 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.42 147.63 49.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -142.39 137.3 30.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' B' ' 91' ' ' ILE . 77.9 mt -110.23 94.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.676 HG23 ' OD1' ' B' ' 119' ' ' ASN . 0.2 OUTLIER -78.19 140.22 38.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.484 HG23 HD13 ' B' ' 45' ' ' ILE . 3.9 mp -133.02 111.24 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.937 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.93 124.29 50.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.021 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 11.8 p90 -133.44 142.05 48.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.666 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.7 OUTLIER -141.26 145.07 35.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -60.74 131.35 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 3.9 p -73.6 142.36 80.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.05 162.49 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.512 2.141 . . . . 0.0 112.101 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.17 118.23 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.98 45.71 70.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.239 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.76 167.87 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 163.76 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.268 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 69.86 8.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.617 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.3 147.2 0.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.801 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.32 116.7 10.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.892 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.94 154.99 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -83.71 -26.43 29.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -22.68 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -59.45 -17.56 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.249 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.573 ' CZ ' HG22 ' B' ' 94' ' ' THR . 2.7 m-85 -124.88 38.55 4.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.891 0.377 . . . . 0.0 110.814 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -117.66 35.28 4.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.65 174.7 23.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.544 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.88 140.17 32.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 110.656 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.44 172.29 44.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.157 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.542 ' C ' HG23 ' B' ' 115' ' ' VAL . 0.0 OUTLIER 58.81 164.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.409 . . . . 0.0 110.897 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.666 HG13 ' HB ' ' B' ' 94' ' ' THR . 5.1 t 82.57 129.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.23 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.474 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 5.7 tpt180 -106.84 144.29 33.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.42 55.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.676 ' OD1' HG23 ' B' ' 90' ' ' THR . 1.5 m-80 -100.08 143.4 30.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.228 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.07 95.11 43.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.383 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 139.21 64.26 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.638 2.225 . . . . 0.0 112.548 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 7.6 mm -114.41 111.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.698 ' O ' HG13 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -112.6 128.05 56.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.098 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -89.63 107.4 19.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.2 76.86 9.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.832 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.1 177.15 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p 61.41 144.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.523 HG23 ' HD2' ' A' ' 5' ' ' PRO . 8.6 p -149.78 137.77 11.88 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.523 ' HD2' HG23 ' A' ' 4' ' ' VAL . 51.0 Cg_endo -68.82 142.02 50.98 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.522 2.148 . . . . 0.0 112.277 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.06 138.72 28.63 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.422 2.081 . . . . 0.0 112.342 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 111.84 2.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.541 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.837 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.3 p-10 -46.95 140.38 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.678 0.275 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 93' ' ' TRP . 1.3 pt -116.71 147.12 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.39 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.2 145.03 25.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.17 144.0 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.297 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -133.05 111.46 13.14 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.59 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 31' ' ' ILE . 32.0 Cg_endo -63.84 161.81 60.19 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.928 -1.28 . . . . 0.0 112.446 0.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -20.48 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.385 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.56 -49.35 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.901 0.381 . . . . 0.0 111.205 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 152.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.605 ' CG2' HD13 ' A' ' 122' ' ' ILE . 12.3 tt -105.95 153.21 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 123' ' ' GLU . 8.0 p -136.19 100.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.418 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.12 114.26 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.542 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.92 142.1 38.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.287 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -66.39 170.6 5.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.732 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 6.9 Cg_exo -73.96 167.04 80.69 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.514 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -110.99 32.84 4.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -117.41 7.22 12.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.25 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.76 149.82 48.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.926 0.393 . . . . 0.0 110.961 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -67.5 107.95 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -108.01 138.09 44.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.846 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.16 112.86 24.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.094 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -105.03 108.5 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -79.76 151.08 30.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.407 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.543 HD12 ' HD2' ' A' ' 13' ' ' PRO . 29.1 mm -126.06 150.06 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.713 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HB2' ' HG3' ' B' ' 22' ' ' PRO . 12.2 ttmm -104.85 120.57 41.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.93 0.395 . . . . 0.0 111.298 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.5 mt -121.9 130.06 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.717 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.5 m -139.76 155.02 47.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.148 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.46 114.24 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.763 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.837 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.35 18.53 7.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.387 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.09 -141.43 6.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.52 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.43 52.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -174.59 164.78 3.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.776 0.322 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.18 137.09 46.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.733 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.415 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 2.5 pt -139.11 114.86 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.33 122.67 9.78 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.919 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.83 ' CD1' HD23 ' A' ' 62' ' ' LEU . 29.4 p-90 -114.63 157.9 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 111.458 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.73 135.96 14.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.693 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.008 HG21 HG11 ' A' ' 55' ' ' VAL . 41.5 mm -93.06 141.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.472 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.26 133.03 15.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.58 160.37 32.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 111.139 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.73 -47.83 41.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -114.29 112.56 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 23.48 6.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.988 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -45.78 3.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -81.99 -50.82 8.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -76.21 154.08 35.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -143.84 110.9 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.774 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.008 HG11 HG21 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -100.04 146.71 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -164.26 123.75 1.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 135.42 38.59 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.774 -1.344 . . . . 0.0 112.08 0.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.48 -10.64 23.98 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 0.0 112.74 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 p -162.53 165.47 26.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.33 -154.78 25.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.542 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 t -135.02 149.26 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' CD1' ' A' ' 43' ' ' TRP . 0.9 OUTLIER -116.79 123.41 47.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -77.02 168.27 29.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.73 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 36.3 Cg_endo -65.25 116.46 3.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.573 2.182 . . . . 0.0 112.454 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt 62.09 28.61 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -101.34 150.06 23.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.127 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 30.0 mttt -111.19 154.84 23.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.614 HG11 HD21 ' A' ' 62' ' ' LEU . 8.9 p -149.94 142.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.003 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.67 136.06 36.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 159.09 25.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.69 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.78 124.75 34.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 55' ' ' VAL . 33.3 t -126.37 93.86 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.6 p -86.33 154.15 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.0 p -133.14 108.54 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.24 145.49 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 76' ' ' THR . 3.4 p -61.05 142.0 56.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.821 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.06 -169.92 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -116.44 111.77 20.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.41 20.37 11.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.35 -28.84 14.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.202 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.7 p -142.16 46.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -147.16 144.43 28.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.79 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.416 ' O ' HD23 ' A' ' 84' ' ' LEU . 17.4 m-20 -71.95 150.78 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 54.8 mt -132.95 66.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -157.48 31.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.025 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -132.72 6.35 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.649 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.91 117.19 33.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -149.02 134.19 18.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 122' ' ' ILE . 62.2 mt -86.96 161.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.543 ' N ' HG22 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -148.05 110.89 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.105 -179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 91' ' ' ILE . 3.6 mp -102.05 111.95 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' CG ' ' CB ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -113.72 131.61 56.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.969 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.498 ' CE2' HG12 ' A' ' 9' ' ' ILE . 17.8 p90 -141.67 150.48 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.67 ' HB ' HG13 ' A' ' 115' ' ' VAL . 11.6 t -154.34 154.61 33.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.49 153.51 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -101.41 133.06 21.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.786 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.03 158.2 11.91 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.461 2.108 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -52.73 124.21 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.85 32.19 70.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.386 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 101' ' ' ALA . . . -62.03 -18.28 60.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.581 0.229 . . . . 0.0 111.452 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 100' ' ' ALA . . . 73.01 166.06 0.3 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.359 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -87.22 71.29 10.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.22 129.42 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 77.5 t80 -56.94 150.32 16.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.4 155.24 45.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -93.05 22.33 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.35 -6.3 17.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.6 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.471 ' CH2' ' HA ' ' A' ' 104' ' ' PHE . 8.8 m0 -91.14 19.65 5.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.626 0.25 . . . . 0.0 111.057 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -144.64 21.27 1.66 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.758 0.313 . . . . 0.0 111.151 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -105.02 26.9 8.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.936 0.398 . . . . 0.0 110.586 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.63 67.95 1.07 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.346 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.98 118.61 28.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.752 0.311 . . . . 0.0 110.854 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 50.32 -98.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.407 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.9 ptp -168.2 110.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.73 0.3 . . . . 0.0 110.949 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.67 HG13 ' HB ' ' A' ' 94' ' ' THR . 19.6 t -82.64 143.14 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.36 125.36 50.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.438 ' CB ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -135.5 153.72 51.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.31 135.5 48.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.521 ' CG ' HG23 ' A' ' 90' ' ' THR . 5.6 m-80 -96.18 129.48 43.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.261 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.9 mt -111.43 98.7 41.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.652 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.92 150.14 10.22 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.66 2.24 . . . . 0.0 112.596 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 89' ' ' ILE . 37.5 mm -100.87 149.84 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.962 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.76 ' HB3' HG23 ' A' ' 18' ' ' VAL . 29.3 mt-10 -133.22 156.93 46.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.009 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 84' ' ' LEU . 54.6 m-85 -123.81 105.23 9.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.974 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.411 ' ND2' HG12 ' B' ' 18' ' ' VAL . 5.7 t30 -87.49 81.38 7.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.759 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.903 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.819 0.342 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.06 177.41 7.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p 61.15 144.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.534 HG23 ' HD2' ' B' ' 5' ' ' PRO . 8.6 p -149.77 137.71 11.83 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.135 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' B' ' 4' ' ' VAL . 51.6 Cg_endo -68.7 142.06 51.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.504 2.136 . . . . 0.0 112.214 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 138.94 29.14 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.5 2.133 . . . . 0.0 112.289 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.28 112.05 2.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.842 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 8.2 p-10 -47.0 140.34 4.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 111.089 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' B' ' 93' ' ' TRP . 1.3 pt -116.42 147.25 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.53 144.92 25.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.0 144.16 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.1 111.52 13.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' B' ' 31' ' ' ILE . 32.7 Cg_endo -63.86 162.01 59.65 Favored 'Cis proline' 0 C--N 1.351 0.669 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.42 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -20.38 11.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.57 -49.47 4.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.07 152.26 1.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.605 ' CG2' HD13 ' B' ' 122' ' ' ILE . 12.4 tt -105.88 153.19 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.752 HG23 ' HB3' ' B' ' 123' ' ' GLU . 7.9 p -136.23 100.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.99 114.21 3.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.75 142.37 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -66.53 170.34 5.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.663 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.876 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 6.7 Cg_exo -74.21 167.09 80.78 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.559 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -111.04 32.99 4.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -117.54 7.19 12.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.211 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.67 150.14 48.32 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -67.84 107.88 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.87 138.17 44.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 112.88 24.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.14 108.51 20.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -79.51 150.99 31.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.435 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.551 HD12 ' HD2' ' B' ' 13' ' ' PRO . 29.0 mm -126.1 150.15 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.689 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.455 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 12.0 ttmm -104.89 120.51 41.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.318 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -121.85 130.13 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.739 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -139.8 155.12 47.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 11.4 t-20 -92.53 114.32 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.692 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.41 18.71 6.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.356 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.18 -141.46 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.564 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.25 51.85 0.55 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -174.32 164.84 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.15 137.12 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.402 ' CD1' HG21 ' B' ' 9' ' ' ILE . 2.5 pt -139.05 115.14 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.317 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -71.58 122.56 9.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.922 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.848 ' CD1' HD23 ' B' ' 62' ' ' LEU . 29.5 p-90 -114.56 157.98 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.91 136.0 14.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.657 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.996 HG21 HG11 ' B' ' 55' ' ' VAL . 41.7 mm -93.13 141.92 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.5 133.1 15.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.754 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.73 160.45 32.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.06 0.457 . . . . 0.0 111.084 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -47.7 43.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -114.33 112.63 23.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 23.38 6.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -45.82 3.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.87 -50.97 8.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.13 154.26 35.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.143 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 9.7 m -144.03 110.81 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.996 HG11 HG21 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -100.07 146.53 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.213 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -164.19 123.74 1.31 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.26 135.33 38.02 Favored 'Cis proline' 0 C--N 1.352 0.748 0 C-N-CA 123.756 -1.352 . . . . 0.0 112.137 0.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.4 -10.45 23.96 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.507 2.138 . . . . 0.0 112.744 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 24.3 p -162.75 165.44 25.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.31 -154.93 26.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 t -134.88 149.28 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.789 0.328 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.848 HD23 ' CD1' ' B' ' 43' ' ' TRP . 0.9 OUTLIER -116.88 123.28 46.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.99 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 0.6 OUTLIER -76.84 168.26 29.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.703 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 36.5 Cg_endo -65.25 116.56 3.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.587 2.191 . . . . 0.0 112.381 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt 62.04 28.55 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' B' ' 67' ' ' LYS . 0.2 OUTLIER -101.24 150.3 23.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 67' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 66' ' ' GLU . 30.1 mttt -111.44 154.84 24.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.99 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.608 HG11 HD21 ' B' ' 62' ' ' LEU . 8.6 p -149.94 142.88 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.968 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.66 135.95 36.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.28 159.18 25.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.92 124.59 33.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.317 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.72 HG22 HG12 ' B' ' 55' ' ' VAL . 31.0 t -126.27 93.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -86.44 154.26 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 p -133.25 108.42 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -53.23 145.41 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.969 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.5 p -61.04 141.88 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.97 -169.8 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -116.54 111.55 20.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.29 20.54 11.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.41 -29.15 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 60.0 p -141.96 46.74 1.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -147.19 144.41 28.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.411 ' O ' HD23 ' B' ' 84' ' ' LEU . 16.8 m-20 -71.87 150.97 43.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.453 ' HB3' ' CE1' ' B' ' 124' ' ' TYR . 55.6 mt -133.16 67.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.784 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -157.51 32.08 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -132.8 6.31 3.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.615 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.81 117.27 33.96 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.878 0.37 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -149.11 134.08 18.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.635 HG13 HD11 ' B' ' 122' ' ' ILE . 61.9 mt -86.77 161.09 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.548 ' N ' HG22 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -147.99 111.01 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.593 HD12 ' N ' ' B' ' 91' ' ' ILE . 3.7 mp -102.12 111.92 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 0.4 OUTLIER -113.68 131.63 56.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.498 ' CE2' HG12 ' B' ' 9' ' ' ILE . 18.0 p90 -141.59 150.74 42.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.678 ' HB ' HG13 ' B' ' 115' ' ' VAL . 11.5 t -154.55 154.68 33.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.56 153.49 4.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.966 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.408 ' HB ' ' CB ' ' B' ' 100' ' ' ALA . 0.6 OUTLIER -101.37 132.99 21.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 96' ' ' THR . 53.1 Cg_exo -55.0 158.17 11.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.5 2.133 . . . . 0.0 112.316 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -52.67 124.29 13.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.57 32.41 71.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.427 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' B' ' 101' ' ' ALA . . . -62.06 -18.35 60.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.611 0.243 . . . . 0.0 111.511 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 100' ' ' ALA . . . 73.29 166.2 0.3 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.215 0.531 . . . . 0.0 111.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -87.49 71.45 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.78 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.35 129.36 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.472 ' HA ' ' CH2' ' B' ' 108' ' ' TRP . 77.3 t80 -56.83 150.29 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.45 155.13 45.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.973 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -92.93 22.32 5.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.159 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.33 -6.44 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.636 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.472 ' CH2' ' HA ' ' B' ' 104' ' ' PHE . 9.0 m0 -91.1 19.61 5.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.66 0.266 . . . . 0.0 111.069 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -144.58 21.1 1.67 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.746 0.307 . . . . 0.0 111.203 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -104.89 26.88 8.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.973 0.415 . . . . 0.0 110.551 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.58 68.15 1.08 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.257 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.09 118.7 28.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.743 0.306 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 50.03 -98.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.519 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 2.8 ptp -168.22 110.12 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.893 0.377 . . . . 0.0 110.937 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' B' ' 94' ' ' THR . 19.3 t -82.57 143.26 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.59 125.27 50.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.437 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -135.4 153.63 51.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.181 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.24 135.6 48.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.623 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.523 ' CG ' HG23 ' B' ' 90' ' ' THR . 5.7 m-80 -96.23 129.36 43.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.293 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 79.1 mt -111.3 98.75 41.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.681 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.94 150.17 10.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.638 2.225 . . . . 0.0 112.518 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.635 HD11 HG13 ' B' ' 89' ' ' ILE . 36.9 mm -100.92 149.9 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.006 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' B' ' 18' ' ' VAL . 30.4 mt-10 -133.23 156.87 46.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' B' ' 84' ' ' LEU . 55.5 m-85 -123.82 105.09 9.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.514 ' ND2' HG12 ' A' ' 18' ' ' VAL . 5.5 t30 -87.33 81.42 7.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.789 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.95 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.886 0.374 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 61.23 114.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -88.0 -179.63 6.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -81.25 141.88 50.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.71 168.03 25.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.569 2.18 . . . . 0.0 112.325 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HG2' ' HG3' ' A' ' 116' ' ' ARG . 60.6 Cg_endo -72.67 157.87 51.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.296 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 37' ' ' GLY . . . -82.09 129.6 9.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -50.77 129.99 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -99.16 120.22 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -81.8 142.52 32.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -136.95 155.72 49.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.45 106.58 4.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.02 154.47 48.54 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.508 0.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -50.36 11.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.199 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -159.49 41.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.117 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -153.53 92.9 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.33 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.722 ' CG2' HD13 ' A' ' 122' ' ' ILE . 10.4 tt -123.28 130.78 74.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.599 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.004 HG11 HG11 ' B' ' 18' ' ' VAL . 7.4 p -138.97 113.98 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.516 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -71.84 104.6 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.376 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 153.52 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.595 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.826 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -77.11 170.35 16.77 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.655 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.826 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 96.1 Cg_endo -79.07 166.77 78.23 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.786 0.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' CD2' ' A' ' 126' ' ' LEU . 22.3 m-85 -106.84 50.03 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.871 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.53 -3.33 10.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.309 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -137.5 150.31 47.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.844 0.354 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.82 110.72 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.25 83.49 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 114.94 10.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.81 132.92 42.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.15 138.89 38.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.96 145.18 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.442 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.86 138.85 39.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 34' ' ' THR . 47.0 mt -121.04 157.92 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.64 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 33' ' ' ILE . 88.8 m -162.12 148.53 13.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB3' HD11 ' A' ' 41' ' ' ILE . 23.8 p-10 -121.03 84.63 2.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 110.495 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.42 -27.32 0.68 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.56 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 7' ' ' GLY . . . -47.65 154.08 1.4 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.685 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.71 54.83 0.93 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.435 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 154.89 4.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -65.79 148.37 51.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 61' ' ' VAL . 26.5 pt -145.47 165.55 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -125.07 106.51 0.91 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 62.5 p-90 -104.29 157.58 17.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.227 0.537 . . . . 0.0 112.183 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 153.44 40.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.357 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.409 ' CD1' HG12 ' A' ' 91' ' ' ILE . 11.9 mm -119.92 145.36 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.979 0.419 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.69 134.83 20.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.683 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 89' ' ' ILE . 37.1 p -112.36 153.74 26.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -26.17 18.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.721 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.68 114.16 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.3 19.84 5.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.285 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -96.33 -44.27 7.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.87 -50.7 4.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.463 HD22 ' SG ' ' A' ' 74' ' ' CYS . 13.2 mt -78.96 153.76 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.27 151.25 28.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.017 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.8 150.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.786 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.15 115.71 0.62 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.51 139.56 61.34 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.219 -0.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 -32.94 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.655 2.237 . . . . 0.0 112.185 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 m -139.68 155.59 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 179.28 159.29 23.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.419 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 61' ' ' VAL . 10.6 p -96.1 114.6 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.217 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.91 166.07 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.428 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 3.9 m-20 -119.18 166.21 15.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.781 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.01 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.752 2.301 . . . . 0.0 112.518 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 70.18 38.92 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 34' ' ' THR . 0.1 OUTLIER -112.33 155.56 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.996 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.11 136.48 50.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.33 129.16 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 127.04 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.793 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.47 159.03 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.0 155.33 26.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.48 82.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.792 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -53.24 136.32 36.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.196 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.463 ' SG ' HD22 ' A' ' 53' ' ' LEU . 51.2 m -152.62 82.11 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.04 150.16 45.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.85 162.16 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -167.56 -169.51 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -102.33 114.53 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.98 22.19 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.407 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.84 -32.16 12.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.0 p -142.91 56.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.61 179.84 4.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.551 ' C ' HD23 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -100.68 82.42 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.002 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.75 HD13 ' CD2' ' A' ' 124' ' ' TYR . 8.3 mt -117.11 67.76 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.94 -27.97 24.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.54 -49.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.324 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.09 147.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -155.45 132.74 10.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.161 0.505 . . . . 0.0 111.938 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.446 HG12 HG22 ' A' ' 47' ' ' THR . 57.5 mt -101.15 102.18 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.71 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -83.75 138.12 33.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.091 0.472 . . . . 0.0 111.675 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 45' ' ' ILE . 12.9 mt -122.4 123.6 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 44.6 mt-10 -120.09 112.43 19.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 10.6 p90 -126.87 128.74 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.752 ' HB ' HG22 ' A' ' 115' ' ' VAL . 1.4 t -127.87 148.99 50.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.393 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -52.03 147.55 7.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.557 HG22 ' CH2' ' A' ' 108' ' ' TRP . 4.8 p -84.64 134.69 41.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.6 161.44 2.96 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.31 2.006 . . . . 0.0 111.94 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -50.81 125.39 13.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.76 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.21 48.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.241 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' THR . . . -66.62 143.32 57.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 111.241 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.14 164.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.267 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -88.4 69.82 9.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.61 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 179.16 137.69 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.802 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -54.97 145.75 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 5.2 mmt180 -131.74 150.71 52.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.09 -25.46 23.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.936 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.86 -14.97 59.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.502 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.557 ' CH2' HG22 ' A' ' 96' ' ' THR . 19.0 m0 -55.45 -20.43 12.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.281 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -95.41 38.87 1.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.739 0.304 . . . . 0.0 111.07 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -156.0 30.44 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.13 -154.52 7.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.554 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.35 155.48 25.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.35 -156.39 15.69 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.551 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.33 146.95 43.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 110.863 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.752 HG22 ' HB ' ' A' ' 94' ' ' THR . 25.5 t -122.6 130.22 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.504 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 10.5 mtt180 -103.09 137.38 41.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.17 102.42 6.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.22 170.84 8.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.583 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.8 122.86 13.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.98 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 106.26 38.33 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.663 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.2 138.63 82.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.514 2.143 . . . . 0.0 112.79 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 17' ' ' ILE . 5.0 mm -110.97 150.81 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.591 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 18' ' ' VAL . 67.6 mt-10 -141.53 140.87 33.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 0.0 111.423 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.75 ' CD2' HD13 ' A' ' 84' ' ' LEU . 38.4 m-85 -101.66 96.82 7.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.11 94.79 3.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.429 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 42.0 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.818 0.342 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 61.24 114.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 66.6 m -87.96 -179.65 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 m -81.17 141.9 50.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.203 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.8 168.02 25.68 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.637 2.224 . . . . 0.0 112.267 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.402 ' HG2' ' HG3' ' B' ' 116' ' ' ARG . 60.3 Cg_endo -72.68 157.88 51.5 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.596 2.197 . . . . 0.0 112.24 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.18 129.7 9.22 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -50.88 129.99 24.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' B' ' 35' ' ' ASN . 1.1 pt -99.11 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.007 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.406 ' ND2' ' HB ' ' B' ' 34' ' ' THR . 1.1 p30 -81.85 142.66 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.843 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 16.0 p -137.02 155.83 49.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.27 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.6 106.55 4.34 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.649 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.02 154.4 48.53 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.613 0.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -50.27 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.185 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -159.67 41.89 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -153.51 92.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.301 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.721 ' CG2' HD13 ' B' ' 122' ' ' ILE . 10.5 tt -123.19 130.89 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 1.004 HG11 HG11 ' A' ' 18' ' ' VAL . 7.6 p -138.97 113.84 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.568 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -71.76 104.69 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.3 153.32 42.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.439 . . . . 0.0 111.525 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.832 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -76.9 170.32 16.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.672 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.832 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 97.1 Cg_endo -78.97 166.97 77.93 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.027 -1.239 . . . . 0.0 112.759 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' B' ' 126' ' ' LEU . 22.2 m-85 -106.98 49.89 0.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.872 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.48 -3.16 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.304 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -137.57 150.36 47.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.82 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 110.75 3.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.19 83.84 1.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 85.6 m -72.27 114.77 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.62 133.0 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.29 138.93 38.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.92 145.31 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.07 138.5 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.941 0.4 . . . . 0.0 111.481 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.479 HG22 ' N ' ' B' ' 34' ' ' THR . 47.4 mt -120.79 157.67 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.659 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.479 ' N ' HG22 ' B' ' 33' ' ' ILE . 87.7 m -161.93 148.5 13.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' B' ' 41' ' ' ILE . 23.8 p-10 -120.95 84.6 2.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.513 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.47 -27.34 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.77 153.8 1.54 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.657 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.44 55.0 0.95 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 154.97 4.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.8 0.333 . . . . 0.0 110.827 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -65.9 148.23 52.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.737 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.595 ' O ' HG23 ' B' ' 61' ' ' VAL . 26.6 pt -145.16 165.57 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 111.586 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -125.15 106.21 0.89 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 62.7 p-90 -104.27 157.37 17.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.217 0.532 . . . . 0.0 112.207 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.88 153.38 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.422 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.414 ' CD1' HG12 ' B' ' 91' ' ' ILE . 12.3 mm -119.88 145.51 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.81 134.74 20.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.455 HG22 HG12 ' B' ' 89' ' ' ILE . 36.7 p -112.27 153.52 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.22 -26.21 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.739 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.65 114.15 7.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.23 19.85 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -96.32 -44.38 7.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.741 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.83 -50.79 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.466 HD22 ' SG ' ' B' ' 74' ' ' CYS . 13.3 mt -78.88 154.01 30.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.5 151.11 28.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.7 150.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.09 115.86 0.62 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.47 139.6 61.5 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.098 -0.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.41 -32.84 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.547 2.165 . . . . 0.0 112.102 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.64 155.58 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.479 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 179.4 159.5 23.55 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.411 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 41' ' ' ILE . 10.5 p -96.29 114.79 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.211 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.08 166.19 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.428 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 3.8 m-20 -119.29 166.2 15.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.685 2.257 . . . . 0.0 112.483 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? 69.81 39.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.434 ' O ' HG23 ' B' ' 34' ' ' THR . 0.1 OUTLIER -112.67 155.47 24.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.02 136.39 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.99 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -122.27 128.76 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.16 126.84 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.28 158.97 37.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.83 155.36 25.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.52 82.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.759 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 15.1 m -52.94 136.29 34.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.158 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.466 ' SG ' HD22 ' B' ' 53' ' ' LEU . 50.9 m -152.65 82.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.66 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.13 150.07 46.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.84 162.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -167.56 -169.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -102.46 114.63 28.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.1 22.22 5.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.344 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.03 -31.95 12.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.223 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.4 p -143.16 56.18 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -123.74 179.93 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.545 ' C ' HD23 ' B' ' 84' ' ' LEU . 1.0 OUTLIER -100.73 82.46 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.749 HD13 ' CD2' ' B' ' 124' ' ' TYR . 8.1 mt -117.08 67.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.73 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -28.05 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 178.61 -49.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.01 147.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 -155.5 132.67 10.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 111.869 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.455 HG12 HG22 ' B' ' 47' ' ' THR . 56.8 mt -101.11 102.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.744 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 20.3 m -83.73 137.89 33.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.187 0.518 . . . . 0.0 111.654 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' B' ' 45' ' ' ILE . 13.0 mt -122.32 123.47 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.269 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 44.4 mt-10 -119.99 112.48 19.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.499 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 10.5 p90 -126.84 128.79 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.573 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.751 ' HB ' HG22 ' B' ' 115' ' ' VAL . 1.4 t -128.02 148.91 50.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.391 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -51.91 147.73 6.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.569 HG22 ' CH2' ' B' ' 108' ' ' TRP . 4.6 p -84.75 134.71 41.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.63 161.57 2.91 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.384 2.056 . . . . 0.0 111.867 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -50.87 125.37 13.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.09 48.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.203 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' B' ' 96' ' ' THR . . . -66.51 143.11 57.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 0.0 111.34 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.65 164.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.288 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -88.61 69.82 8.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.53 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? 179.2 137.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.812 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -55.34 145.95 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.991 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.448 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 5.0 mmt180 -131.93 150.71 52.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.22 -25.25 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.007 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.93 -15.14 59.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.454 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.569 ' CH2' HG22 ' B' ' 96' ' ' THR . 19.0 m0 -55.27 -20.45 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.613 0.245 . . . . 0.0 111.25 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -95.55 39.13 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 111.104 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -156.19 30.44 0.34 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.23 -154.66 7.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.518 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.26 155.41 26.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.871 0.367 . . . . 0.0 110.953 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.35 -156.35 15.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.31 146.89 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.751 HG22 ' HB ' ' B' ' 94' ' ' THR . 25.5 t -122.5 130.45 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.499 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 10.5 mtt180 -103.18 137.51 41.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.734 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.31 102.3 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.411 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.11 170.91 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.578 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -142.78 123.02 13.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.53 106.2 38.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.677 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.14 138.81 83.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.62 2.213 . . . . 0.0 112.77 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.721 HD13 ' CG2' ' B' ' 17' ' ' ILE . 5.0 mm -111.21 150.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.513 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.574 ' O ' HG23 ' B' ' 18' ' ' VAL . 67.6 mt-10 -141.79 140.59 33.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 111.442 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.749 ' CD2' HD13 ' B' ' 84' ' ' LEU . 37.5 m-85 -101.44 96.68 7.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.94 94.88 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' B' ' 23' ' ' TYR . 41.3 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.822 0.344 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -34.44 78.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -147.7 -79.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.99 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 4' ' ' VAL . 16.4 m -154.08 108.27 2.46 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.118 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.03 171.38 11.36 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.498 2.132 . . . . 0.0 112.277 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.29 135.51 46.96 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.568 2.178 . . . . 0.0 112.173 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.3 122.91 16.17 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.273 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.7 108.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.36 145.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.317 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.5 146.7 23.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.576 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.07 155.9 49.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.24 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -153.96 106.23 2.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.645 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.73 161.97 45.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.474 0.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.3 -10.96 11.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.616 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.503 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -108.28 -56.35 2.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.879 0.371 . . . . 0.0 111.18 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.89 -175.43 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.492 ' CG2' HD13 ' A' ' 122' ' ' ILE . 9.5 tt -150.26 136.34 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 123' ' ' GLU . 7.3 p -126.19 107.94 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.711 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -65.13 119.99 11.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -84.37 134.95 34.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 111.654 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -51.74 170.5 0.21 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.683 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 89.1 Cg_endo -80.13 164.11 81.07 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 124.065 -1.223 . . . . 0.0 112.721 0.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.519 ' CE2' HD23 ' A' ' 126' ' ' LEU . 20.2 m-85 -109.62 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.81 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.22 5.65 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.155 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.67 129.09 25.93 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 0.0 110.773 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.79 106.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -105.61 150.3 25.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.44 97.97 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -87.23 125.52 34.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.4 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 71' ' ' ALA . 12.3 m80 -94.97 130.68 41.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' HE3' ' A' ' 70' ' ' MET . 28.6 mt -97.84 150.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -104.6 134.27 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.361 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 70' ' ' MET . 23.8 mt -136.87 154.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.1 m -153.83 158.35 40.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.061 0.458 . . . . 0.0 111.238 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 20.4 t-20 -107.85 114.04 27.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.544 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.02 19.91 6.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.424 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.3 -177.26 19.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.632 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.45 19.63 26.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.71 161.94 37.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -65.67 164.11 15.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 pt -149.19 142.0 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.403 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -102.42 100.98 2.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.731 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.406 ' CD1' HD12 ' A' ' 62' ' ' LEU . 63.0 p-90 -105.71 149.76 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.047 0.451 . . . . 0.0 111.528 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.57 132.23 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.597 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 9.2 mm -92.75 151.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.268 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -138.63 138.2 37.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -124.25 148.97 46.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -55.7 -40.08 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -127.52 118.17 23.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.73 16.72 7.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.408 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -110.88 -31.63 7.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -23.11 14.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 74' ' ' CYS . 34.9 mt -126.85 138.75 53.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 m -149.5 116.7 6.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 71' ' ' ALA . 2.7 t -94.43 153.48 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -145.65 123.3 6.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.0 144.93 77.32 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.498 0.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.21 -13.63 40.26 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.584 2.19 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.61 130.75 0.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 110.586 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.21 -178.82 25.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.668 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 61' ' ' VAL . 10.5 p -114.34 111.52 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.482 HD23 ' HG3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -80.56 145.48 31.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 2.8 m-20 -101.81 171.88 4.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' O ' ' CD ' ' A' ' 65' ' ' LYS . 42.3 Cg_exo -57.06 127.87 27.54 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.527 2.151 . . . . 0.0 112.505 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CD ' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 46.89 34.86 2.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.482 ' HG3' HD23 ' A' ' 62' ' ' LEU . 1.4 tp10 -101.4 136.64 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.67 113.82 27.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.057 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.87 155.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.87 119.3 26.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.662 ' HE3' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -112.83 164.66 13.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -118.46 155.46 30.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.5 t -129.68 104.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.798 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 125.69 32.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HA ' HD23 ' A' ' 53' ' ' LEU . 1.8 p -129.6 98.19 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.712 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.84 153.9 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 76' ' ' THR . 2.3 p -64.62 151.16 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.481 ' CZ ' ' CD2' ' A' ' 124' ' ' TYR . 3.5 p90 -148.58 -161.44 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.089 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.09 93.47 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -68.23 -19.02 64.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.58 -28.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.788 0.328 . . . . 0.0 111.462 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 71.7 p -143.56 59.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 81' ' ' THR . 47.1 mt-10 -159.24 160.31 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -82.76 153.16 25.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' A' ' 124' ' ' TYR . 12.5 mt -128.43 38.36 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.67 30.04 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.16 -45.37 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.39 138.47 54.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 132.3 3.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.82 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 78.4 mt -107.73 121.93 61.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 118' ' ' LYS . 4.0 m -103.79 138.76 39.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.0 mp -118.16 124.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 122.01 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.428 ' CZ2' ' HB2' ' A' ' 116' ' ' ARG . 6.2 p90 -130.94 143.66 50.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.724 ' CB ' HG22 ' A' ' 115' ' ' VAL . 1.3 t -145.18 120.57 10.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.22 142.83 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.595 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.534 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 6.9 p -82.01 146.06 54.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.953 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.69 165.92 14.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.547 2.164 . . . . 0.0 112.158 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -45.16 114.38 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.498 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.73 49.67 16.16 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.902 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -51.6 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 100' ' ' ALA . . . 172.68 163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.074 0.464 . . . . 0.0 111.243 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.49 69.51 9.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.518 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.21 128.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.735 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -48.97 131.28 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.994 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 108' ' ' TRP . 6.6 ttm180 -121.47 150.33 41.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 27.16 7.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.27 -1.09 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.787 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.534 ' CZ3' HG22 ' A' ' 96' ' ' THR . 7.2 m0 -92.47 19.87 6.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.588 0.232 . . . . 0.0 111.193 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -115.24 -23.39 8.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.28 . . . . 0.0 111.306 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -59.99 -32.28 70.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.092 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.4 146.35 40.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.566 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -91.96 150.29 21.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.777 0.323 . . . . 0.0 110.789 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.61 -77.5 1.91 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.264 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.608 ' C ' HG23 ' A' ' 115' ' ' VAL . 1.4 mpt? -47.58 169.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.976 0.417 . . . . 0.0 111.226 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.724 HG22 ' CB ' ' A' ' 94' ' ' THR . 4.5 t 87.07 106.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.39 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 93' ' ' TRP . 48.0 mtt-85 -98.87 146.14 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.67 156.78 17.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.385 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -145.18 161.74 38.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.524 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.93 148.97 34.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.33 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 15' ' ' GLN . 34.6 mt -151.17 86.36 4.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.569 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.1 158.77 3.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.697 2.265 . . . . 0.0 112.66 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.492 HD13 ' CG2' ' A' ' 17' ' ' ILE . 25.1 mm -114.53 145.72 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.048 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.739 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -139.06 165.12 27.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 111.037 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 90.1 m-85 -132.59 108.2 8.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.993 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -96.18 83.18 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 29.6 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.831 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.776 0.322 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -34.64 78.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -147.58 -79.38 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.527 ' O ' HG23 ' B' ' 4' ' ' VAL . 16.3 m -154.2 108.24 2.44 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.92 171.47 11.1 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.483 2.122 . . . . 0.0 112.308 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.27 135.47 46.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.206 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.35 122.98 16.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.306 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -50.67 108.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.25 145.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.67 146.64 24.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.559 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.88 156.09 48.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.232 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -154.18 106.32 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.661 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.76 162.06 45.87 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.872 -1.304 . . . . 0.0 112.381 0.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -11.02 11.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.502 ' O ' HD23 ' B' ' 120' ' ' LEU . 0.1 OUTLIER -108.23 -56.31 2.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 111.204 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -154.9 -175.3 5.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.491 ' CG2' HD13 ' B' ' 122' ' ' ILE . 9.5 tt -150.44 136.36 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.638 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' B' ' 123' ' ' GLU . 7.3 p -126.25 107.86 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.702 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -65.19 119.96 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.3 134.99 34.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.847 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -51.72 170.52 0.21 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.637 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.847 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -80.19 164.12 80.87 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.704 0.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.524 ' CE2' HD23 ' B' ' 126' ' ' LEU . 20.2 m-85 -109.58 47.42 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.29 5.62 5.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.66 128.97 25.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.768 0.318 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.7 106.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.65 150.33 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.676 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.49 97.87 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.091 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.04 125.52 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.546 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.425 ' NE2' ' HB2' ' B' ' 71' ' ' ALA . 12.8 m80 -94.95 130.64 41.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.657 HD12 ' HE3' ' B' ' 70' ' ' MET . 28.7 mt -97.89 150.54 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -104.6 134.48 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.461 HD11 ' SD ' ' B' ' 70' ' ' MET . 23.8 mt -137.01 154.92 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.818 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.442 ' N ' HG22 ' B' ' 33' ' ' ILE . 52.9 m -153.93 158.2 40.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.145 0.497 . . . . 0.0 111.251 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 20.4 t-20 -107.75 114.05 27.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.493 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.19 20.09 6.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.365 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.61 -177.58 18.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.32 19.92 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.613 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.89 162.07 37.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.734 0.302 . . . . 0.0 110.788 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -65.86 164.09 15.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.664 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 pt -149.18 141.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.429 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.26 101.12 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.696 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -105.85 149.71 26.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 111.516 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.46 132.38 19.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.673 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 9.1 mm -92.77 151.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.323 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -138.7 138.29 37.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 30.6 p -124.29 149.19 46.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.2 p -55.95 -40.14 72.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -127.4 117.97 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.853 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.51 16.62 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.383 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -110.77 -31.7 7.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -23.19 14.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' B' ' 74' ' ' CYS . 34.9 mt -126.75 138.75 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.963 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 36.7 m -149.39 116.73 6.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.496 HG13 ' O ' ' B' ' 71' ' ' ALA . 2.7 t -94.52 153.47 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -145.64 123.41 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.98 145.03 77.62 Favored 'Cis proline' 0 C--N 1.351 0.67 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.481 -0.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.2 -13.63 40.29 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.15 . . . . 0.0 112.524 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.6 130.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.613 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.12 -178.79 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.606 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.627 ' O ' HG13 ' B' ' 61' ' ' VAL . 10.3 p -114.41 111.37 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.465 HD23 ' HG3' ' B' ' 66' ' ' GLU . 0.2 OUTLIER -80.38 145.56 31.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.021 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' B' ' 35' ' ' ASN . 2.9 m-20 -101.8 171.79 5.01 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.417 ' O ' ' CD ' ' B' ' 65' ' ' LYS . 41.5 Cg_exo -56.91 127.94 27.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.546 2.164 . . . . 0.0 112.558 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.417 ' CD ' ' O ' ' B' ' 64' ' ' PRO . 0.0 OUTLIER 46.72 34.8 2.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.623 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.465 ' HG3' HD23 ' B' ' 62' ' ' LEU . 1.4 tp10 -101.32 136.77 40.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 113.9 27.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.014 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.92 155.22 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.96 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.95 119.21 26.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.022 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.657 ' HE3' HD12 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -112.75 164.7 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.722 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.496 ' O ' HG13 ' B' ' 55' ' ' VAL . . . -118.55 155.29 31.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.54 104.72 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.776 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.34 125.19 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.977 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' CYS . . . . . 0.477 ' HA ' HD23 ' B' ' 53' ' ' LEU . 1.7 p -129.11 98.1 4.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 153.89 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -64.73 151.11 45.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.76 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.483 ' CZ ' ' CD2' ' B' ' 124' ' ' TYR . 3.5 p90 -148.52 -161.55 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.999 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.05 93.41 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.458 ' HB3' HD21 ' B' ' 126' ' ' LEU . . . -68.08 -19.17 64.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.45 -29.23 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.751 0.31 . . . . 0.0 111.404 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -143.28 59.33 1.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -159.22 160.34 35.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -82.82 153.36 25.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' B' ' 124' ' ' TYR . 12.4 mt -128.53 38.24 4.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.52 30.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.41 -45.19 3.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.48 138.53 54.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 132.26 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 77.6 mt -107.73 121.81 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.619 HG23 ' O ' ' B' ' 118' ' ' LYS . 4.0 m -103.77 138.84 39.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.556 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.0 mp -118.26 124.33 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.31 121.95 37.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' B' ' 116' ' ' ARG . 6.2 p90 -130.91 143.7 50.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.091 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.72 ' CB ' HG22 ' B' ' 115' ' ' VAL . 1.3 t -145.18 120.5 10.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.24 142.87 0.94 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.513 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.519 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 6.9 p -81.99 146.03 54.59 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 165.76 15.12 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.597 2.198 . . . . 0.0 112.168 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -44.9 114.5 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.537 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.55 49.63 15.5 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.905 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' B' ' 101' ' ' ALA . . . -51.35 -76.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.035 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' B' ' 100' ' ' ALA . . . 172.38 163.57 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 111.161 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.55 69.41 9.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.4 128.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -48.98 131.24 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.065 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HB2' ' CZ2' ' B' ' 108' ' ' TRP . 6.6 ttm180 -121.41 150.28 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 26.93 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -113.08 -1.01 14.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.789 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.519 ' CZ3' HG22 ' B' ' 96' ' ' THR . 7.0 m0 -92.67 20.15 6.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.703 0.287 . . . . 0.0 111.185 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.48 -23.57 8.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.179 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -59.92 -32.08 70.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.105 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.68 146.38 41.64 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -92.04 150.32 21.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.815 0.341 . . . . 0.0 110.713 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.65 -77.46 1.91 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.37 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.595 ' C ' HG23 ' B' ' 115' ' ' VAL . 1.4 mpt? -47.65 169.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.041 0.448 . . . . 0.0 111.246 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.72 HG22 ' CB ' ' B' ' 94' ' ' THR . 4.5 t 87.06 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.318 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.427 ' HB2' ' CZ2' ' B' ' 93' ' ' TRP . 48.2 mtt-85 -99.05 146.23 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.78 156.73 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.619 ' O ' HG23 ' B' ' 90' ' ' THR . 0.0 OUTLIER -145.11 161.73 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.481 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -144.96 148.95 34.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.502 HD23 ' O ' ' B' ' 15' ' ' GLN . 35.1 mt -151.11 86.44 4.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.09 158.94 2.94 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.691 2.261 . . . . 0.0 112.683 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.491 HD13 ' CG2' ' B' ' 17' ' ' ILE . 25.3 mm -114.74 145.73 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.002 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.743 ' HB3' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -139.08 165.0 28.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.056 0.455 . . . . 0.0 111.093 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' B' ' 77' ' ' PHE . 90.0 m-85 -132.51 108.09 8.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.976 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.05 83.23 3.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.569 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 30.3 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.906 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 53.99 91.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.02 -176.26 3.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.002 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 m -54.78 156.92 5.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.85 171.48 15.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.58 2.187 . . . . 0.0 112.243 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.27 138.83 62.94 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.532 2.155 . . . . 0.0 112.303 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.15 -152.92 0.41 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.0 m-20 -112.06 151.84 28.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.765 0.316 . . . . 0.0 110.885 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.75 127.55 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.157 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.409 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -73.19 152.48 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.0 143.03 30.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.95 111.08 24.59 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.51 168.53 24.73 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.09 -1.213 . . . . 0.0 112.828 0.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -38.9 -48.76 1.61 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.99 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.6 ' CG ' HD22 ' A' ' 120' ' ' LEU . 1.1 tm0? 177.22 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.033 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.57 112.19 16.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.58 HD13 ' CE1' ' A' ' 19' ' ' PHE . 8.1 tt -113.22 130.06 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 38.8 t -105.37 87.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.879 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 17' ' ' ILE . 6.9 m-85 -51.81 101.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 21.8 m-80 -72.13 137.82 47.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.539 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.845 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -70.2 169.34 13.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.845 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 72.6 Cg_endo -76.11 166.23 83.41 Favored 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.641 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 17.2 m-85 -108.14 30.41 6.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.14 7.38 36.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.353 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -135.18 154.64 51.55 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.859 0.361 . . . . 0.0 111.101 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -71.34 131.98 44.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -140.24 93.15 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.78 111.4 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CD2' HD11 ' A' ' 17' ' ' ILE . 76.2 m-85 -98.09 106.42 18.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' B' ' 22' ' ' PRO . 7.7 m80 -79.37 121.29 24.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -109.81 125.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HG3' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -95.21 155.42 16.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 34' ' ' THR . 34.0 mt -133.89 154.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.9 m -144.84 151.69 39.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' HB2' HD22 ' A' ' 62' ' ' LEU . 14.0 t-20 -98.51 105.48 17.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.673 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -92.88 20.93 6.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.28 20.26 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.469 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.81 40.34 2.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 175.87 161.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 41' ' ' ILE . 13.5 ptp180 -55.15 169.85 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.706 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 40' ' ' ARG . 3.7 pt -158.92 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.82 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.16 107.08 2.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.444 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.543 ' CD1' HD12 ' A' ' 62' ' ' LEU . 51.3 p-90 -103.76 159.37 15.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 112.033 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -145.73 145.06 30.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.449 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 91' ' ' ILE . 13.1 mm -123.9 151.11 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.033 0.444 . . . . 0.0 111.553 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.38 163.41 39.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.504 HG22 HG12 ' A' ' 89' ' ' ILE . 24.1 p -139.37 149.82 44.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.984 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -50.42 -31.06 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.967 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -136.1 117.74 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.03 16.56 8.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.327 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -54.84 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.93 -40.14 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 122.4 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.638 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.12 107.84 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.207 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 72' ' ' VAL . 2.6 m -97.53 129.12 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.029 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -140.28 140.92 24.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.06 153.37 97.47 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.917 -1.285 . . . . 0.0 112.265 0.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.55 -11.68 26.45 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.589 2.193 . . . . 0.0 112.662 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.4 p -172.68 158.77 4.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.903 0.382 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 175.86 148.04 6.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.69 128.02 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.543 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -97.84 165.32 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -117.41 169.59 7.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.32 112.96 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.584 2.189 . . . . 0.0 112.515 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 62.56 34.86 14.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.282 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.512 ' O ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -102.19 154.61 18.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.43 160.28 16.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.436 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.01 151.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.698 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 ' HG3' ' A' ' 32' ' ' LYS . 12.4 tp -111.2 125.13 53.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 ttm -121.61 158.54 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.75 38.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.507 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 55' ' ' VAL . 54.6 t -114.05 91.73 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.749 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.38 129.41 39.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.247 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 10.7 t -130.56 140.16 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.1 151.97 26.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 p -55.6 111.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.918 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 23' ' ' TYR . 27.2 p90 -118.82 -172.43 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.98 126.93 52.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 84' ' ' LEU . . . -105.17 19.01 21.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.329 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.28 -25.19 21.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -135.64 29.23 3.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.53 129.2 20.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.69 146.94 29.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 79' ' ' ALA . 29.1 mt -117.31 41.44 2.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.35 25.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' HG21 ' A' ' 48' ' ' THR . 24.0 m120 -118.26 -15.1 9.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.468 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.98 114.52 13.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.841 0.353 . . . . 0.0 111.013 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.19 135.52 21.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.504 HG12 HG22 ' A' ' 47' ' ' THR . 15.6 mt -98.46 107.63 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -71.03 121.12 17.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.06 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 45' ' ' ILE . 14.2 mm -109.86 149.76 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.816 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -148.23 159.92 43.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.496 ' CZ2' ' HB3' ' A' ' 116' ' ' ARG . 10.0 p90 -177.91 123.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 134.75 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -56.34 112.78 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 p -58.72 148.22 68.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.942 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.22 164.68 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.628 2.219 . . . . 0.0 112.316 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.48 115.54 1.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.292 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.04 47.81 32.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.732 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.09 166.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 110.955 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.49 16.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.097 0.475 . . . . 0.0 111.404 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 70.96 8.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.643 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 132.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.838 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -53.25 152.45 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 13.3 mmm180 -136.91 145.25 44.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.35 -27.71 19.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.55 -18.76 65.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.407 ' CD2' ' HB2' ' A' ' 105' ' ' ARG . 26.5 m0 -56.58 -20.35 20.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.307 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -116.54 43.44 2.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 111.049 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -112.81 -30.59 7.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.809 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.83 145.7 15.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.533 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 155.71 27.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 0.0 110.891 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.08 -92.32 0.28 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.553 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -99.36 106.52 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.62 127.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.496 ' HB3' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -119.07 157.87 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.94 124.61 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.35 131.76 40.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.762 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.1 122.65 39.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.075 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.6 HD22 ' CG ' ' A' ' 15' ' ' GLN . 1.5 mt -81.72 133.42 52.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.547 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HD3' ' NE2' ' A' ' 15' ' ' GLN . 94.9 Cg_endo -79.35 134.94 11.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.611 2.207 . . . . 0.0 112.697 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 89' ' ' ILE . 7.5 mm -108.06 82.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.016 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 162.06 26.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' A' ' 122' ' ' ILE . 57.5 m-85 -131.08 100.75 5.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.901 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.446 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 28.6 t30 -80.07 81.5 6.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.919 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.837 0.351 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 53.97 91.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.96 -176.3 3.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 m -54.75 156.92 5.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.81 171.56 15.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.604 2.203 . . . . 0.0 112.277 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.33 139.07 63.75 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.317 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.41 -152.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.561 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.9 m-20 -112.21 151.76 29.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.831 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.62 127.28 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.413 ' HB2' ' HB ' ' B' ' 34' ' ' THR . 1.0 OUTLIER -73.0 152.5 41.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.09 142.95 30.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 0.0 111.488 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.89 111.0 24.77 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.38 168.48 24.26 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.9 0.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.7 t -38.85 -48.76 1.59 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.98 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.604 ' CG ' HD22 ' B' ' 120' ' ' LEU . 1.1 tm0? 177.21 -50.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 111.008 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -79.58 112.14 16.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.585 HD13 ' CE1' ' B' ' 19' ' ' PHE . 7.7 tt -113.33 130.18 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 39.2 t -105.3 87.31 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.934 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CE1' HD13 ' B' ' 17' ' ' ILE . 6.8 m-85 -51.37 100.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.423 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -71.97 137.73 47.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.48 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.844 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -70.15 169.27 13.93 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.697 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.844 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.1 Cg_endo -76.16 166.27 83.27 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.736 0.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.425 ' HB3' ' CE1' ' B' ' 77' ' ' PHE . 17.1 m-85 -108.22 30.38 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.09 7.46 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -135.27 154.63 51.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.341 . . . . 0.0 111.12 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -71.37 132.12 44.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -140.31 93.24 2.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.85 111.48 11.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.984 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD2' HD11 ' B' ' 17' ' ' ILE . 76.0 m-85 -98.06 106.5 18.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -79.45 121.51 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.12 125.32 67.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.513 ' HG3' HD12 ' B' ' 69' ' ' LEU . 0.1 OUTLIER -95.29 155.43 16.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.268 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.417 HG22 ' N ' ' B' ' 34' ' ' THR . 33.8 mt -133.99 153.83 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.1 m -144.75 151.74 39.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 111.474 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.551 ' HB2' HD22 ' B' ' 62' ' ' LEU . 14.2 t-20 -98.63 105.54 17.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.616 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -92.83 20.85 6.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.308 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.54 -161.12 20.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.89 40.28 2.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.531 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 175.89 161.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.541 ' O ' HG23 ' B' ' 41' ' ' ILE . 13.5 ptp180 -55.21 169.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.607 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.541 HG23 ' O ' ' B' ' 40' ' ' ARG . 3.7 pt -158.92 115.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 0.0 111.864 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.06 107.18 2.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.478 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.534 ' CD1' HD12 ' B' ' 62' ' ' LEU . 51.2 p-90 -103.87 159.22 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.723 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -145.51 145.11 30.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.353 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.769 HD12 HD12 ' B' ' 91' ' ' ILE . 13.0 mm -123.89 150.94 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 111.627 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.23 163.51 38.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.552 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.496 HG22 HG12 ' B' ' 89' ' ' ILE . 24.3 p -139.5 149.69 44.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.465 HG21 ' O ' ' B' ' 86' ' ' ASN . 0.7 OUTLIER -50.27 -31.24 13.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.008 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -135.89 117.74 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.0 16.48 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.78 -55.03 2.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 110.506 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.82 -40.3 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.88 122.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.711 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.06 108.2 13.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.433 HG12 HG22 ' B' ' 72' ' ' VAL . 2.6 m -97.83 129.09 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.027 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -140.21 140.92 24.68 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.0 153.46 97.64 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.199 0.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.72 -11.52 26.03 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.52 2.146 . . . . 0.0 112.582 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 20.1 p -172.74 158.67 4.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 175.98 147.99 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.51 128.1 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' B' ' 35' ' ' ASN . 0.1 OUTLIER -97.91 165.37 11.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.807 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.9 OUTLIER -117.54 169.63 7.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.451 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.43 112.66 1.19 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.645 2.23 . . . . 0.0 112.534 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp 62.8 34.99 14.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.197 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.512 ' O ' HD21 ' B' ' 62' ' ' LEU . 0.0 OUTLIER -102.19 154.64 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.51 160.38 16.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.344 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.15 151.88 15.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.629 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.513 HD12 ' HG3' ' B' ' 32' ' ' LYS . 12.4 tp -111.2 125.12 53.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.311 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 2.1 ttm -121.7 158.62 28.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.523 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.8 38.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.489 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.433 HG22 HG12 ' B' ' 55' ' ' VAL . 54.4 t -114.17 91.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.651 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.29 129.36 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 10.8 t -130.67 140.0 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -110.04 152.24 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.038 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.3 p -55.8 112.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' B' ' 23' ' ' TYR . 27.5 p90 -119.02 -172.39 2.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.005 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.0 127.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' B' ' 84' ' ' LEU . . . -105.05 18.71 21.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.13 -25.13 22.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 111.121 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.8 p -135.69 29.23 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.037 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.42 129.35 20.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.87 146.94 30.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' B' ' 79' ' ' ALA . 29.1 mt -117.32 41.57 2.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.42 24.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.465 ' O ' HG21 ' B' ' 48' ' ' THR . 23.9 m120 -118.0 -15.28 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.561 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.94 114.6 13.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.888 0.375 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.2 135.53 21.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.496 HG12 HG22 ' B' ' 47' ' ' THR . 15.7 mt -98.52 107.65 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -70.97 121.1 17.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.128 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.769 HD12 HD12 ' B' ' 45' ' ' ILE . 14.4 mm -109.89 149.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.907 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -148.12 159.98 43.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.016 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' B' ' 116' ' ' ARG . 10.1 p90 -177.94 123.57 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.908 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.79 134.66 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -56.56 112.57 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.0 p -58.4 147.94 66.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.01 164.68 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.602 2.201 . . . . 0.0 112.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.51 115.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.208 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.98 47.77 31.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.825 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 166.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.019 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.75 164.63 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.179 0.514 . . . . 0.0 111.342 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 71.03 7.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.608 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.91 132.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.07 152.27 4.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 13.3 mmm180 -136.77 145.28 44.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -27.89 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.49 -18.5 65.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.279 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.412 ' CD2' ' HB2' ' B' ' 105' ' ' ARG . 26.1 m0 -56.86 -20.22 21.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.73 43.76 2.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.981 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -113.01 -30.67 6.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.794 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.92 145.72 15.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.98 155.78 27.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.892 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.1 -92.39 0.28 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.536 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.7 mpt? -99.35 106.52 18.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.866 0.365 . . . . 0.0 110.983 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' B' ' 114' ' ' MET . 7.4 p 175.59 127.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.483 ' HB3' ' CZ2' ' B' ' 93' ' ' TRP . 0.1 OUTLIER -119.09 157.94 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.04 124.86 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.057 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.56 131.75 40.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.08 122.55 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.604 HD22 ' CG ' ' B' ' 15' ' ' GLN . 1.5 mt -81.66 133.31 52.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.665 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.416 ' HD3' ' NE2' ' B' ' 15' ' ' GLN . 91.6 Cg_endo -79.16 134.95 11.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.622 2.215 . . . . 0.0 112.661 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.492 HD11 HG13 ' B' ' 89' ' ' ILE . 7.6 mm -108.23 82.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.44 161.89 26.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.154 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' B' ' 122' ' ' ILE . 58.6 m-85 -130.89 101.0 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.455 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 28.9 t30 -80.58 81.55 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.908 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.805 0.336 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.03 137.16 32.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.024 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -125.87 132.67 52.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.74 141.35 37.8 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.193 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.71 159.79 51.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.496 2.13 . . . . 0.0 112.367 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.25 116.13 4.56 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.572 2.181 . . . . 0.0 112.266 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.38 114.07 3.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.546 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.75 146.33 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pt -110.8 146.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -96.01 141.18 29.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.47 145.36 50.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.157 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.4 118.13 12.59 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.33 157.27 72.63 Favored 'Cis proline' 0 C--N 1.352 0.74 0 C-N-CA 124.22 -1.158 . . . . 0.0 112.644 0.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.11 -33.11 75.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.411 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 2.8 tt0 -179.47 51.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.743 0.306 . . . . 0.0 111.32 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -174.21 108.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.313 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.9 tt -131.08 155.25 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 123' ' ' GLU . 73.8 t -135.5 96.14 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.678 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE2' ' CG2' ' A' ' 122' ' ' ILE . 18.8 m-85 -63.28 100.12 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -69.67 151.4 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.493 . . . . 0.0 111.89 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.802 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -48.64 170.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.802 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 80.1 Cg_endo -87.62 169.02 39.76 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.241 -1.149 . . . . 0.0 112.961 0.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' A' ' 125' ' ' ASN . 21.7 m-30 -110.42 18.97 19.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.185 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -104.1 3.21 32.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.983 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.64 -171.49 3.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.697 0.284 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -99.13 105.56 17.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.35 121.46 38.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -106.55 107.51 18.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.49 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -97.2 126.19 42.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.155 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -86.89 141.1 29.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.814 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 32' ' ' LYS . 17.1 mt -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.575 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 31' ' ' ILE . 8.4 mttm -102.89 119.38 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -117.34 145.85 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.2 m -147.61 158.42 44.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 111.323 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -111.26 113.56 26.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.457 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.32 23.18 6.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.72 -158.66 23.63 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.531 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.61 18.7 5.4 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.617 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.87 159.74 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.5 mpp_? -57.3 151.64 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.666 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt -150.36 121.34 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.861 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 168.5 54.31 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -166.03 155.21 11.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.523 0.662 . . . . 0.0 112.109 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.78 156.78 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.061 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.474 ' CG2' HG11 ' A' ' 55' ' ' VAL . 15.7 mm -121.51 136.19 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.948 0.404 . . . . 0.0 111.796 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 126.18 17.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.519 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.0 p -112.25 162.08 15.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.195 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.49 -28.2 1.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.282 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.42 120.5 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.7 11.34 27.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.486 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.62 -54.12 2.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 110.679 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.96 -28.19 60.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mt -115.22 122.08 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.46 157.84 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG11 ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -123.94 155.04 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.875 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 9.0 t70 -166.87 109.17 0.65 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 73.1 Cg_endo -76.1 140.79 67.96 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.83 -1.321 . . . . 0.0 112.32 0.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.41 -24.89 30.77 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.406 2.071 . . . . 0.0 112.209 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.9 p -151.91 172.85 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.78 -163.33 35.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.648 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 t -137.88 152.57 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 111.2 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.555 HD11 HG21 ' A' ' 68' ' ' VAL . 5.7 mp -124.52 161.45 26.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.6 p30 -115.03 170.53 5.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.744 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 49.4 Cg_exo -56.7 114.0 1.72 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.485 2.124 . . . . 0.0 112.562 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.02 39.24 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.546 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.35 139.31 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.52 112.3 21.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.555 HG21 HD11 ' A' ' 62' ' ' LEU . 27.3 m -101.75 149.12 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.29 127.18 43.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.765 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.448 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 54.0 ttp -113.7 161.38 17.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.082 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.448 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -129.48 141.4 51.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.094 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.07 101.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.8 145.98 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 142.63 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.691 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.9 143.07 26.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.005 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -57.07 161.47 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.145 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -172.27 -160.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -127.29 94.4 3.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.21 -22.18 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.33 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.78 -43.95 94.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -131.27 60.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -158.28 162.14 37.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -70.43 152.24 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.585 HD22 ' CB ' ' A' ' 124' ' ' TYR . 12.4 mt -138.26 23.26 2.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -145.54 27.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.971 0.415 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.38 -28.46 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.101 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.53 124.63 24.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.81 132.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.654 HG13 HD11 ' A' ' 122' ' ' ILE . 66.6 mt -94.47 127.88 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.8 m -112.58 104.58 12.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 91' ' ' ILE . 4.3 mp -87.43 148.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.404 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 4.9 mt-10 -144.77 154.27 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.294 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -162.42 149.46 13.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.621 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -148.0 141.84 25.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.779 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.02 139.5 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 p -92.6 146.65 32.73 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.2 163.4 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.518 2.145 . . . . 0.0 112.107 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.16 112.32 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.979 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.56 47.1 58.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.72 155.46 19.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 111.21 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.68 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.29 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -88.42 69.76 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.618 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -173.01 124.69 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -52.31 125.76 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.22 149.77 27.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -21.89 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 110' ' ' GLN . 24.3 pt-20 -73.77 -9.74 58.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.633 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -69.31 -29.59 67.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.621 ' CZ ' HG22 ' A' ' 94' ' ' THR . 15.0 m-85 -105.78 37.2 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 1.3 pp0? -120.46 25.64 9.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.922 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.28 150.41 20.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.583 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.47 156.8 25.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.93 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.74 -83.07 0.32 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.594 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 1.6 mpt? -114.34 104.34 11.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.926 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.4 p 175.36 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.664 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -107.26 155.84 19.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.991 0.424 . . . . 0.0 111.157 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.404 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -145.71 132.64 20.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.952 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 152.22 33.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 120' ' ' LEU . 16.8 m-20 -102.86 156.37 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.809 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 119' ' ' ASN . 5.0 mp -134.51 129.33 19.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.56 128.07 6.75 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.645 2.23 . . . . 0.0 112.2 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.654 HD11 HG13 ' A' ' 89' ' ' ILE . 11.6 mm -100.0 138.86 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.513 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.562 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -119.51 160.08 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.284 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CB ' HD22 ' A' ' 84' ' ' LEU . 38.7 m-85 -123.11 117.74 26.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 38.2 t30 -114.8 141.48 47.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.49 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 32.6 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.835 0.35 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.09 137.26 32.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 31.4 t -125.9 132.76 52.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.72 141.44 38.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.83 159.73 51.68 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.52 2.146 . . . . 0.0 112.27 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.26 116.0 4.51 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.519 2.146 . . . . 0.0 112.349 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.99 114.28 3.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.09 146.21 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 pt -110.57 146.11 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.21 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.87 141.16 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.664 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.46 145.5 50.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.41 ' HB3' ' CG ' ' A' ' 22' ' ' PRO . 32.8 mt-30 -135.62 117.97 12.31 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.534 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 157.18 72.3 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 124.217 -1.159 . . . . 0.0 112.729 0.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.01 -33.1 75.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.444 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 120' ' ' LEU . 2.7 tt0 -179.6 51.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' B' ' 121' ' ' PRO . 1.4 ptpt -174.54 108.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.388 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.429 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.9 tt -131.02 155.55 42.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' B' ' 123' ' ' GLU . 74.2 t -135.82 96.19 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.737 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' B' ' 122' ' ' ILE . 18.8 m-85 -63.36 100.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.086 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -69.64 151.21 46.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.151 0.501 . . . . 0.0 111.869 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.82 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -48.35 170.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.82 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 73.9 Cg_endo -87.73 168.76 39.75 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 124.312 -1.12 . . . . 0.0 112.94 0.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' B' ' 125' ' ' ASN . 21.9 m-30 -110.15 18.85 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -103.99 3.22 33.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.927 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.55 -171.38 3.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.771 0.32 . . . . 0.0 110.555 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -99.29 105.52 17.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.34 121.65 38.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.373 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.4 m -106.63 107.8 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.413 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.46 126.43 42.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.094 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -87.05 141.21 28.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.743 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.422 HG22 ' N ' ' B' ' 32' ' ' LYS . 18.0 mt -113.68 154.63 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.478 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.422 ' N ' HG22 ' B' ' 31' ' ' ILE . 8.4 mttm -102.81 119.58 39.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 111.479 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 75.2 mt -117.48 145.88 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.585 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.4 HG22 ' N ' ' B' ' 35' ' ' ASN . 53.5 m -147.69 158.41 44.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.365 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.4 ' N ' HG22 ' B' ' 34' ' ' THR . 7.0 t-20 -111.17 113.77 26.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 23.01 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.67 -158.36 23.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.577 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.57 18.38 5.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.658 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.65 159.84 42.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.779 0.323 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' B' ' 62' ' ' LEU . 3.5 mpp_? -57.29 151.87 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 pt -150.61 121.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.322 . . . . 0.0 111.804 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' B' ' 93' ' ' TRP . . . -74.25 168.66 54.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.451 -0.88 . . . . 0.0 110.906 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -166.05 155.31 11.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.536 0.668 . . . . 0.0 112.075 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.9 156.91 43.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.057 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.473 ' CG2' HG11 ' B' ' 55' ' ' VAL . 15.1 mm -121.63 136.22 59.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.905 0.383 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.33 126.09 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.505 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 34.8 p -112.23 162.25 15.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.249 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -28.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.41 120.55 23.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.73 11.46 26.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.467 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -54.23 2.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.355 . . . . 0.0 110.704 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -74.71 -28.32 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.804 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 mt -115.06 122.08 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.829 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.36 157.88 26.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.254 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.473 HG11 ' CG2' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -123.99 155.06 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' B' ' 57' ' ' PRO . 9.0 t70 -166.98 109.11 0.64 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' B' ' 56' ' ' ASP . 72.7 Cg_endo -76.02 140.73 67.73 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.404 0.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.35 -24.81 31.16 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.458 2.105 . . . . 0.0 112.242 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.0 p -152.01 172.74 15.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.647 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.03 -163.64 35.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.597 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.64 152.74 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 111.115 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.563 HD11 HG21 ' B' ' 68' ' ' VAL . 5.5 mp -124.82 161.43 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.6 p30 -114.98 170.55 5.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 51.7 Cg_exo -56.82 113.97 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.562 2.175 . . . . 0.0 112.568 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.1 39.25 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.486 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -111.42 139.33 46.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.262 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.63 112.22 20.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.786 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.563 HG21 HD11 ' B' ' 62' ' ' LEU . 27.4 m -101.77 149.3 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.359 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.37 127.24 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.443 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 53.8 ttp -113.63 161.35 17.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.443 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -129.46 141.54 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.25 101.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.9 145.99 32.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.06 142.68 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.669 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.94 143.11 26.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 4.2 p -57.08 161.71 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -172.33 -160.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.76 94.69 4.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.35 -22.47 66.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.99 93.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.301 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 80.6 p -131.26 60.37 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -158.5 161.96 37.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -70.25 151.88 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' B' ' 124' ' ' TYR . 12.2 mt -137.97 23.34 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.088 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -145.45 27.55 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.58 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.26 -28.48 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -70.44 124.48 24.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 132.67 21.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.061 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.661 HG13 HD11 ' B' ' 122' ' ' ILE . 66.6 mt -94.41 127.96 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 87.3 m -112.63 104.7 12.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.528 HD12 ' H ' ' B' ' 91' ' ' ILE . 4.3 mp -87.46 148.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.627 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.4 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 4.9 mt-10 -144.84 154.36 42.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.405 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 4.3 p90 -162.53 149.52 13.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.028 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.617 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 0.0 OUTLIER -148.05 141.83 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.08 139.38 28.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.7 p -92.53 146.61 32.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.27 163.03 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.607 2.205 . . . . 0.0 112.175 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.71 112.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.34 47.59 55.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 155.55 20.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.95 163.97 2.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.373 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -88.0 69.68 9.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.62 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -172.98 124.68 0.43 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -52.39 125.65 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 149.85 27.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -21.74 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' B' ' 110' ' ' GLN . 24.3 pt-20 -73.9 -9.62 58.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.69 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -69.34 -29.62 67.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.687 0.279 . . . . 0.0 111.021 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.617 ' CZ ' HG22 ' B' ' 94' ' ' THR . 15.0 m-85 -105.84 37.16 2.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.811 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' B' ' 107' ' ' GLU . 1.3 pp0? -120.44 25.58 9.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.23 150.76 20.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.603 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.72 156.82 24.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.68 -83.23 0.32 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.595 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -114.0 104.31 12.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 111.097 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.664 ' O ' HG13 ' B' ' 115' ' ' VAL . 7.4 p 175.41 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 32.4 mtt180 -107.12 155.79 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.168 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' ARG . . . . . 0.4 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -145.82 132.47 19.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.976 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 152.24 33.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.626 ' O ' HD12 ' B' ' 120' ' ' LEU . 17.1 m-20 -102.73 156.53 17.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.797 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 119' ' ' ASN . 5.0 mp -134.67 129.2 19.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.102 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' B' ' 16' ' ' LYS . 96.1 Cg_endo -80.37 128.09 6.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.458 2.105 . . . . 0.0 112.167 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.661 HD11 HG13 ' B' ' 89' ' ' ILE . 11.6 mm -99.94 138.73 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.564 ' HB3' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -119.38 160.14 22.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.584 ' CB ' HD22 ' B' ' 84' ' ' LEU . 38.5 m-85 -123.14 117.82 26.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 111.569 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.433 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 38.1 t30 -114.82 141.72 47.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.522 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 32.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.836 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.907 0.384 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -99.87 88.76 3.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.35 176.31 10.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.61 157.79 81.8 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.26 153.33 7.14 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.652 2.235 . . . . 0.0 112.451 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HG2' ' HG2' ' A' ' 116' ' ' ARG . 57.3 Cg_endo -71.07 159.85 51.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.648 2.232 . . . . 0.0 112.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.37 -146.56 5.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.604 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -125.3 137.72 54.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG23 ' NE1' ' A' ' 93' ' ' TRP . 1.1 pt -113.19 149.79 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.236 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 153.45 20.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.603 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -144.98 152.48 40.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.273 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -137.71 116.47 9.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.488 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.02 154.25 76.81 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.963 -1.265 . . . . 0.0 112.484 0.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.9 9.1 38.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.688 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.17 -59.57 1.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 121' ' ' PRO . 12.8 pttm -169.37 173.38 6.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -121.51 155.23 25.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.018 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 44.7 t -118.15 85.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.634 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 29' ' ' TYR . 5.2 m-30 -49.7 102.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -73.3 135.6 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.837 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -54.15 170.33 0.32 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.695 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.837 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 98.4 Cg_endo -78.6 168.47 75.08 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.837 0.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.2 m-85 -112.98 29.93 7.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.01 6.44 12.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.05 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -140.82 157.83 44.83 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.39 114.05 14.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -115.67 149.82 37.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.5 m -114.98 126.92 55.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.471 ' CZ ' ' CG ' ' A' ' 19' ' ' PHE . 42.9 m-85 -107.18 128.68 54.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.506 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -90.98 115.17 27.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.455 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.05 143.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.565 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.72 140.95 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 111.626 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.55 HD11 ' HE2' ' A' ' 70' ' ' MET . 61.5 mt -134.49 152.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.481 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 33' ' ' ILE . 49.5 m -152.59 158.78 42.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.24 0.543 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.768 ' HB2' HD23 ' A' ' 62' ' ' LEU . 52.4 t30 -112.76 107.37 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.29 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -78.97 -4.29 49.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.661 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 -173.15 49.54 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.34 22.46 10.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -145.16 -179.65 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.94 155.81 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.428 HD13 ' OD1' ' A' ' 35' ' ' ASN . 20.9 pt -148.86 170.88 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.985 0.422 . . . . 0.0 111.304 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.56 108.17 0.98 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.724 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 30.6 p-90 -104.8 157.83 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 112.023 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.33 157.65 41.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 55' ' ' VAL . 2.7 mp -121.86 142.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.908 0.385 . . . . 0.0 111.939 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.31 125.87 14.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.737 HG22 HG12 ' A' ' 89' ' ' ILE . 55.6 p -102.03 158.34 16.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.226 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -46.24 -33.83 3.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.051 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -137.86 123.87 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.36 8.3 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.474 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.65 -47.54 5.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.752 0.31 . . . . 0.0 110.864 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -82.14 -53.61 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.739 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.728 HD12 ' HB ' ' A' ' 47' ' ' THR . 14.8 mt -91.07 155.36 18.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.816 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.6 152.38 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -119.15 153.6 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -172.83 110.28 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.31 140.72 60.82 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.722 -1.366 . . . . 0.0 112.344 0.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.23 -6.11 16.9 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.556 2.171 . . . . 0.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 p -174.76 171.4 3.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.726 0.298 . . . . 0.0 110.683 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.03 171.75 38.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.634 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.09 120.51 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 0.0 111.116 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.768 HD23 ' HB2' ' A' ' 35' ' ' ASN . 5.5 tp -94.37 159.42 15.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.45 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -115.44 167.25 10.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 9.9 Cg_endo -53.28 109.47 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.68 2.253 . . . . 0.0 112.411 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? 62.47 46.85 5.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.42 153.74 25.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -121.12 142.6 49.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.403 HG13 HD11 ' A' ' 62' ' ' LEU . 35.4 m -143.45 149.67 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.009 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 69' ' ' LEU . 10.8 tp -96.67 153.51 17.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.988 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.55 ' HE2' HD11 ' A' ' 33' ' ' ILE . 3.8 ttm -134.16 148.28 50.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -111.0 129.8 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 97.78 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.68 125.42 29.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.73 147.8 31.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -101.1 142.17 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -55.74 148.91 15.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 79' ' ' ALA . 35.3 p90 -161.79 -164.67 1.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.421 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 3.6 m-80 -125.9 113.15 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . . . -97.38 21.5 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.278 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.01 -23.52 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.2 p -138.51 40.4 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -151.51 145.15 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -61.36 147.14 45.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.48 ' HB3' ' CD2' ' A' ' 124' ' ' TYR . 11.0 mt -130.51 63.85 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -160.06 27.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.526 ' O ' HG21 ' A' ' 48' ' ' THR . 24.2 m-80 -129.05 4.91 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.685 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.91 111.58 23.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -146.13 132.73 19.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.279 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.737 HG12 HG22 ' A' ' 47' ' ' THR . 63.0 mt -94.18 130.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 118' ' ' LYS . 99.5 m -106.3 126.19 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.0 mp -115.18 116.76 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.9 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' OE2' HG22 ' A' ' 90' ' ' THR . 0.1 OUTLIER -118.31 159.55 23.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.006 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.406 ' NE1' HG23 ' A' ' 9' ' ' ILE . 9.4 p90 -155.96 130.59 9.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.693 ' HB ' HG22 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -128.06 140.82 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -53.77 137.09 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.0 p -80.47 149.92 69.4 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.18 163.99 2.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 112.08 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -50.67 108.24 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.937 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.96 47.74 59.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.435 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.69 173.1 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.368 . . . . 0.0 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.5 164.66 26.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.1 70.08 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 178.8 136.81 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -53.97 149.09 9.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -138.73 148.16 43.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -18.95 62.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.34 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.13 -6.79 45.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.831 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 48.7 m0 -87.55 13.25 10.56 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.494 0.187 . . . . 0.0 111.448 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 115' ' ' VAL . 49.3 m-85 -154.19 30.9 0.44 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.872 0.367 . . . . 0.0 110.613 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -110.99 -26.47 9.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.071 -179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 110' ' ' GLN . . . -83.73 171.17 48.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -96.07 145.71 25.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.314 . . . . 0.0 110.486 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.98 176.4 48.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.191 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.6 ' C ' HG23 ' A' ' 115' ' ' VAL . 12.5 mmt 59.22 166.69 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.073 0.463 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 94' ' ' THR . 3.4 t 82.92 116.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.139 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HG2' ' HG2' ' A' ' 6' ' ' PRO . 27.0 mmt-85 -92.23 146.32 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.5 134.03 54.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -127.53 161.18 29.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.624 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -131.08 154.32 48.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 95.1 5.48 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.756 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 58.5 Cg_exo -52.13 150.99 17.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.692 2.262 . . . . 0.0 112.678 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.0 mm -108.63 149.51 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HB3' HG13 ' A' ' 18' ' ' VAL . 1.7 tt0 -131.45 164.43 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.43 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -130.28 114.35 15.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.242 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.457 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 4.8 t-20 -103.16 80.72 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 43.9 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.815 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.842 0.353 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -99.91 88.6 3.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.21 176.17 10.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.47 157.87 81.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.211 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.38 153.28 7.48 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.625 2.217 . . . . 0.0 112.408 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.01 159.54 52.13 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.11 -146.83 5.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.614 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.0 OUTLIER -125.1 137.56 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.826 0.346 . . . . 0.0 110.867 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.421 HG23 ' NE1' ' B' ' 93' ' ' TRP . 1.1 pt -113.18 149.73 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.22 153.34 20.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.712 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -144.82 152.32 40.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -137.51 116.43 10.04 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.467 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.05 154.22 76.95 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.016 -1.244 . . . . 0.0 112.58 0.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.89 9.15 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.737 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.401 ' O ' ' HD2' ' B' ' 121' ' ' PRO . 0.6 OUTLIER -127.36 -59.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.802 0.334 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 121' ' ' PRO . 12.7 pttm -169.55 173.4 6.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.011 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -121.66 155.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 45.1 t -118.23 84.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.476 ' CG ' ' CZ ' ' B' ' 29' ' ' TYR . 5.2 m-30 -49.51 102.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.602 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -73.37 135.5 44.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.446 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.856 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -53.91 170.44 0.3 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.787 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.856 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 97.0 Cg_endo -78.45 168.61 74.95 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.723 0.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.2 m-85 -113.11 29.85 7.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.956 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.91 6.72 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.132 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.09 157.82 44.77 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.25 114.02 14.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.092 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -115.86 149.63 38.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -114.87 126.76 55.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 111.246 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.476 ' CZ ' ' CG ' ' B' ' 19' ' ' PHE . 43.4 m-85 -106.92 128.68 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.476 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -91.07 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -103.84 142.91 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.545 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.58 140.91 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.551 HD11 ' HE2' ' B' ' 70' ' ' MET . 61.6 mt -134.5 152.96 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.408 ' N ' HG22 ' B' ' 33' ' ' ILE . 49.5 m -152.61 158.96 43.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.413 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.764 ' HB2' HD23 ' B' ' 62' ' ' LEU . 52.3 t30 -112.94 107.39 15.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.313 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -79.0 -4.1 48.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.82 -173.1 49.54 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.453 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.4 22.43 10.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -145.03 -179.53 6.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.366 . . . . 0.0 110.829 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.04 155.9 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.428 HD13 ' OD1' ' B' ' 35' ' ' ASN . 21.2 pt -148.88 170.82 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.41 107.88 0.96 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.727 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 30.8 p-90 -104.7 157.67 17.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 112.093 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.5 41.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.231 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.739 ' HB ' HG11 ' B' ' 55' ' ' VAL . 2.7 mp -121.67 142.81 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.012 0.434 . . . . 0.0 111.924 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.51 125.86 14.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.751 HG22 HG12 ' B' ' 89' ' ' ILE . 56.2 p -101.97 158.6 16.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.23 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.533 HG21 ' O ' ' B' ' 86' ' ' ASN . 0.1 OUTLIER -46.46 -33.79 4.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.067 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -137.81 123.78 20.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.24 8.33 16.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.487 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -47.39 5.07 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.752 0.311 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 mtt-85 -82.18 -53.69 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LEU . . . . . 0.719 HD12 ' HB ' ' B' ' 47' ' ' THR . 15.2 mt -91.05 155.59 18.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.778 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.7 152.26 29.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.027 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.739 HG11 ' HB ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -119.15 153.58 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.02 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 56' ' ' ASP . . . . . 0.666 ' O ' ' HB3' ' B' ' 71' ' ' ALA . 0.5 OUTLIER -172.75 110.35 0.35 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.38 140.69 60.86 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.29 0.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.18 -6.16 16.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.595 2.197 . . . . 0.0 112.846 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 3.8 p -174.75 171.42 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.716 0.293 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.01 171.83 38.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.556 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.18 120.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.764 HD23 ' HB2' ' B' ' 35' ' ' ASN . 5.5 tp -94.2 159.43 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.448 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -115.48 167.31 10.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 9.8 Cg_endo -53.36 109.46 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.643 2.228 . . . . 0.0 112.434 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? 62.62 46.74 5.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.35 153.62 25.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -121.01 142.47 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.42 149.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.65 153.41 17.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.551 ' HE2' HD11 ' B' ' 33' ' ' ILE . 3.8 ttm -134.03 148.38 51.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' B' ' 56' ' ' ASP . . . -111.08 129.8 55.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.038 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 97.94 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.2 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.35 29.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.826 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 38.6 t -108.56 147.66 31.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.977 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -101.09 142.23 32.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -55.85 148.75 16.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.039 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' B' ' 79' ' ' ALA . 35.2 p90 -161.53 -164.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ASN . . . . . 0.427 ' N ' ' CD2' ' B' ' 77' ' ' PHE . 3.6 m-80 -125.96 113.05 16.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' B' ' 77' ' ' PHE . . . -97.28 21.56 9.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.399 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.85 -23.57 12.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.29 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 58.3 p -138.58 40.54 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.311 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -151.74 145.13 24.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -61.35 147.28 45.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.477 ' HB3' ' CD2' ' B' ' 124' ' ' TYR . 11.4 mt -130.5 63.58 1.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -159.93 27.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.533 ' O ' HG21 ' B' ' 48' ' ' THR . 24.2 m-80 -129.33 4.92 5.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.765 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.93 111.57 23.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.645 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -146.04 132.73 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.27 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.751 HG12 HG22 ' B' ' 47' ' ' THR . 62.5 mt -94.23 130.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.633 HG23 ' O ' ' B' ' 118' ' ' LYS . 99.5 m -106.31 125.86 51.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.548 HD12 ' N ' ' B' ' 91' ' ' ILE . 4.0 mp -114.86 116.92 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.918 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.476 ' OE2' HG22 ' B' ' 90' ' ' THR . 0.1 OUTLIER -118.54 159.5 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.421 ' NE1' HG23 ' B' ' 9' ' ' ILE . 9.2 p90 -155.96 130.68 9.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.674 ' HB ' HG22 ' B' ' 115' ' ' VAL . 0.7 OUTLIER -128.15 140.85 51.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -53.83 137.37 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 59.1 p -80.69 149.92 68.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.14 164.24 1.87 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.539 2.159 . . . . 0.0 112.074 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.01 108.31 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.98 47.62 59.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.462 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.51 172.98 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.53 164.69 26.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.275 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.11 69.76 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.17 137.12 0.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.835 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -54.12 148.97 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -138.61 148.15 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.301 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.2 -6.54 43.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.798 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.473 ' O ' ' CD1' ' B' ' 109' ' ' PHE . 48.8 m0 -87.75 13.38 10.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.527 0.203 . . . . 0.0 111.467 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.585 ' CE2' HG11 ' B' ' 115' ' ' VAL . 49.3 m-85 -154.33 31.06 0.43 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.853 0.359 . . . . 0.0 110.589 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' B' ' 111' ' ' GLY . 0.0 OUTLIER -111.32 -26.23 9.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.055 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 111' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' B' ' 110' ' ' GLN . . . -83.95 171.15 48.43 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.591 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -96.01 145.61 25.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.583 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.93 176.52 48.3 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.149 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.592 ' C ' HG23 ' B' ' 115' ' ' VAL . 12.5 mmt 59.25 166.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' B' ' 94' ' ' THR . 3.4 t 83.06 116.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -91.94 146.26 23.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.764 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.57 134.13 54.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 118' ' ' LYS . . . . . 0.633 ' O ' HG23 ' B' ' 90' ' ' THR . 0.2 OUTLIER -127.56 161.01 29.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -130.84 154.32 48.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.48 95.11 5.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.72 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' B' ' 15' ' ' GLN . 59.1 Cg_exo -52.17 151.11 17.66 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.681 2.254 . . . . 0.0 112.639 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 19.9 mm -108.68 149.34 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.993 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.424 ' HB3' HG13 ' B' ' 18' ' ' VAL . 1.7 tt0 -131.31 164.41 25.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.022 0.439 . . . . 0.0 111.02 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' B' ' 84' ' ' LEU . 89.4 m-85 -130.23 114.28 15.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.249 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.445 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 4.8 t-20 -103.34 80.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 43.4 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -148.18 -60.17 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 1.6 m -162.98 -79.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 3' ' ' SER . 5.2 m 43.96 101.34 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.944 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.7 Cg_endo -73.59 128.32 12.54 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.567 2.178 . . . . 0.0 112.258 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 52.5 Cg_exo -55.05 140.6 80.2 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.367 2.045 . . . . 0.0 112.229 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.8 132.36 46.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.537 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 26.6 m-20 -51.22 128.76 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.454 HD12 HG23 ' A' ' 11' ' ' THR . 1.6 pp -102.35 142.84 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.22 150.02 35.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.454 HG23 HD12 ' A' ' 9' ' ' ILE . 1.7 p -142.2 150.05 40.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -146.13 104.51 4.12 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.758 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 31' ' ' ILE . 31.6 Cg_endo -63.7 159.94 64.69 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.465 0.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.37 -18.24 12.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.81 -46.78 4.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' PRO . 31.5 pttt -172.73 -179.13 2.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.2 tt -135.93 138.72 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.031 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.512 HG22 ' CB ' ' A' ' 123' ' ' GLU . 61.4 t -121.94 91.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -59.96 102.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.554 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.88 138.43 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.462 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -60.22 167.71 2.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.716 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 7.7 Cg_endo -88.05 164.8 43.31 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 124.415 -1.077 . . . . 0.0 112.484 0.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 38.6 m-85 -101.19 47.52 0.91 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.964 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.71 1.78 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.485 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' C ' HG22 ' A' ' 76' ' ' THR . 49.7 p-10 -139.35 152.09 46.88 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.839 0.352 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -63.01 121.19 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.781 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -112.86 99.98 8.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.067 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.4 m -99.76 109.59 22.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.448 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 60.4 m-85 -92.09 163.85 13.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.1 0.476 . . . . 0.0 111.222 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -118.09 109.19 16.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.738 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 ' HD2' ' A' ' 13' ' ' PRO . 8.9 mm -91.1 141.9 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.94 128.63 56.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 34' ' ' THR . 36.3 mt -128.9 153.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 33' ' ' ILE . 58.6 m -148.82 157.71 43.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 111.275 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.635 ' HB2' HD23 ' A' ' 62' ' ' LEU . 11.4 t-20 -104.4 73.84 1.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -57.71 -26.09 61.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.15 -62.49 5.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.57 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.5 21.67 4.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.682 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -149.7 159.3 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.44 149.03 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 pt -154.37 167.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.63 100.14 0.48 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.87 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -95.57 157.04 16.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . . . -153.11 128.94 10.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.01 142.67 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 111.469 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -145.23 132.84 20.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.572 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.71 155.14 29.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.042 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -65.45 -35.21 80.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.76 112.76 17.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.2 21.63 9.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -46.3 6.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -106.11 -33.07 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 mt -95.96 131.92 41.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.43 167.18 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.5 p -151.99 160.53 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.315 0.578 . . . . 0.0 111.004 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 55' ' ' VAL . 23.1 t70 -165.42 125.98 1.31 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.65 143.54 77.4 Favored 'Cis proline' 0 C--N 1.352 0.75 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.303 -0.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.03 4.89 6.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 113.035 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.7 p -179.71 158.28 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.09 164.7 30.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.627 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.08 117.51 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 111.127 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 35' ' ' ASN . 5.0 tp -90.49 160.8 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.452 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -109.99 178.62 0.97 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 22.5 Cg_exo -65.35 105.72 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.737 2.291 . . . . 0.0 112.649 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 72.08 22.65 3.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.256 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -87.2 150.08 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -116.63 132.29 56.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.82 143.46 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.905 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.1 126.04 54.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.428 ' HE2' HG21 ' A' ' 31' ' ' ILE . 25.9 ptt? -122.68 168.13 12.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.56 137.43 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.747 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.677 ' O ' HG13 ' A' ' 72' ' ' VAL . 8.8 p -115.41 96.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 144.19 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 t -138.76 81.93 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -51.88 153.48 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.446 HG22 ' C ' ' A' ' 25' ' ' ASP . 2.4 p -65.65 122.53 17.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 8.8 p90 -130.91 179.32 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.84 127.28 56.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.8 18.35 6.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.513 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.93 -29.36 13.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.9 p -136.15 42.72 2.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -143.16 133.37 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -52.55 134.24 35.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.488 HD22 ' CG ' ' A' ' 124' ' ' TYR . 16.8 mt -121.88 21.38 10.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -144.07 21.78 1.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -132.32 4.03 3.99 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.694 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -96.75 118.86 34.13 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 110.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.7 133.11 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 90' ' ' THR . 17.7 mt -85.3 164.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.507 ' N ' HG22 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -143.47 121.39 12.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 111.405 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.03 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.793 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -99.63 122.47 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 5.6 p90 -133.59 143.7 48.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.3 136.75 33.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -50.1 144.66 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.29 139.42 41.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.71 160.82 47.04 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -48.73 129.33 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.169 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.94 38.06 94.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.647 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 134.09 45.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.63 163.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.144 0.497 . . . . 0.0 111.289 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.29 6.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.54 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.01 145.55 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.812 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 44' ' ' ALA . 71.8 t80 -57.43 115.77 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 0.5 OUTLIER -106.06 153.75 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.827 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -87.19 -27.42 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.68 -33.2 72.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 54.0 m0 -53.54 -31.85 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -87.11 -33.17 19.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -103.0 37.23 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.943 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.8 -146.06 5.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.433 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -90.24 154.8 19.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.357 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.85 -174.24 16.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.455 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.19 132.66 56.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.74 125.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.25 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -97.05 108.05 20.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -103.26 115.89 31.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.03 157.69 16.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.433 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.31 126.01 17.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.394 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.6 114.46 47.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.15 145.56 79.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.495 HD13 ' CG2' ' A' ' 17' ' ' ILE . 40.1 mm -95.03 151.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.852 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.512 ' CB ' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -136.6 156.68 48.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.488 ' CG ' HD22 ' A' ' 84' ' ' LEU . 6.5 m-85 -127.69 104.93 8.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.98 78.46 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.664 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.922 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.824 0.345 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -148.01 -60.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.412 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 1.5 m -163.12 -79.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.836 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 3' ' ' SER . 5.2 m 43.85 101.42 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.873 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.6 128.26 12.47 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.571 2.181 . . . . 0.0 112.256 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.93 140.39 79.19 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.462 2.108 . . . . 0.0 112.272 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.75 132.36 46.76 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.414 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 27.5 m-20 -51.07 128.96 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.461 HD12 HG23 ' B' ' 11' ' ' THR . 1.6 pp -102.46 142.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.31 150.1 35.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' THR . . . . . 0.461 HG23 HD12 ' B' ' 9' ' ' ILE . 1.7 p -142.26 149.98 40.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -146.07 104.48 4.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' B' ' 31' ' ' ILE . 32.2 Cg_endo -63.66 160.24 63.66 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.399 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -18.45 12.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.69 -46.55 4.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.77 0.319 . . . . 0.0 111.274 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' B' ' 13' ' ' PRO . 31.3 pttt -172.87 -179.29 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.1 tt -135.72 138.82 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.059 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' B' ' 123' ' ' GLU . 62.5 t -122.09 91.47 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.23 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -59.91 102.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.562 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.85 138.58 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.468 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -60.4 167.73 2.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.717 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.752 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 7.8 Cg_endo -88.16 164.51 42.98 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.385 -1.09 . . . . 0.0 112.544 0.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' TYR . . . . . 0.403 ' CD1' ' CE1' ' B' ' 77' ' ' PHE . 39.4 m-85 -100.9 47.64 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.061 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.68 1.67 11.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.44 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ASP . . . . . 0.454 ' C ' HG22 ' B' ' 76' ' ' THR . 50.0 p-10 -139.21 152.11 47.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -63.01 121.16 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.724 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -112.86 100.16 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.996 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -99.9 109.85 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.627 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.447 ' HB2' ' CG1' ' B' ' 72' ' ' VAL . 59.9 m-85 -92.29 163.85 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 111.133 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -118.12 109.04 15.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.704 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.522 HD12 ' HD2' ' B' ' 13' ' ' PRO . 9.0 mm -91.05 141.95 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.02 128.53 56.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.414 HG22 ' N ' ' B' ' 34' ' ' THR . 36.0 mt -128.86 153.34 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' THR . . . . . 0.414 ' N ' HG22 ' B' ' 33' ' ' ILE . 59.5 m -148.77 157.53 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.642 ' HB2' HD23 ' B' ' 62' ' ' LEU . 11.3 t-20 -104.3 73.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.926 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -57.79 -25.93 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.4 -62.32 5.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.572 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.58 21.53 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.651 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 mtm-85 -149.63 159.32 44.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.4 148.87 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.725 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.22 167.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.992 0.425 . . . . 0.0 111.522 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.54 100.11 0.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.839 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -95.56 157.07 16.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 111.589 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' B' ' 104' ' ' PHE . . . -153.23 129.04 10.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.713 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 25.6 mm -93.05 142.6 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 111.472 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -145.23 132.77 20.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.651 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.58 155.18 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 3.0 p -65.5 -35.27 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.7 112.76 17.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.29 21.77 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.97 -46.29 6.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -106.17 -33.27 7.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -95.71 131.83 41.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.796 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.47 167.05 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.504 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.5 p -151.79 160.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' ASP . . . . . 0.504 ' N ' HG22 ' B' ' 55' ' ' VAL . 22.9 t70 -165.46 126.03 1.31 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.54 143.6 77.73 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.831 -1.32 . . . . 0.0 112.252 -0.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.88 4.72 6.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.618 2.212 . . . . 0.0 113.095 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 9.6 p -179.7 158.23 0.79 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.14 164.74 30.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.603 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.2 t -100.19 117.65 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 111.087 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' B' ' 35' ' ' ASN . 5.0 tp -90.53 160.97 15.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -110.14 178.39 1.02 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.804 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 22.3 Cg_exo -65.11 106.03 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 71.81 22.5 3.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.363 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -87.1 150.2 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -116.69 132.19 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.68 143.64 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.922 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.3 125.88 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.403 ' HE2' HG21 ' B' ' 31' ' ' ILE . 25.9 ptt? -122.45 168.32 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.77 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.65 137.48 53.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.721 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.672 ' O ' HG13 ' B' ' 72' ' ' VAL . 8.9 p -115.51 96.23 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.722 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 144.14 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 t -138.76 81.88 1.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.732 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.7 153.4 2.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.454 HG22 ' C ' ' B' ' 25' ' ' ASP . 2.4 p -65.7 122.62 17.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CE1' ' CD1' ' B' ' 23' ' ' TYR . 9.2 p90 -130.97 179.22 6.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.93 127.32 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.69 18.07 6.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.599 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.76 -29.3 13.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.6 p -136.14 42.67 2.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -143.14 133.41 24.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -52.6 134.32 35.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.007 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' B' ' 124' ' ' TYR . 16.9 mt -121.95 21.29 10.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -143.95 21.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.897 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -132.28 4.1 4.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.733 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.74 118.99 34.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.731 0.3 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.72 133.3 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.5 HG22 ' N ' ' B' ' 90' ' ' THR . 18.2 mt -85.43 164.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.524 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.5 ' N ' HG22 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -143.47 121.59 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.09 92.04 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.811 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -99.77 122.56 42.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.459 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 5.6 p90 -133.76 143.8 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.856 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 137.18 33.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.785 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -50.29 144.96 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.54 139.5 41.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.68 161.01 46.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.535 2.157 . . . . 0.0 112.32 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -48.9 129.27 17.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.89 38.16 94.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.65 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 134.16 45.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.09 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.57 163.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.127 0.489 . . . . 0.0 111.331 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.43 6.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.634 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.81 145.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' B' ' 44' ' ' ALA . 71.8 t80 -57.44 115.73 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 0.5 OUTLIER -105.95 153.56 21.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.04 -27.43 23.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.69 -33.07 72.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' B' ' 105' ' ' ARG . 54.0 m0 -53.69 -31.79 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.937 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -87.17 -33.29 19.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -102.75 37.08 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.75 -146.18 5.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.59 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -90.22 154.58 19.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.947 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.95 -174.39 16.92 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.97 132.74 56.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.836 0.35 . . . . 0.0 110.808 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.88 125.29 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.459 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -97.33 107.88 20.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -102.99 115.91 31.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.26 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 157.59 16.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.444 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -141.34 125.9 17.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.53 114.55 47.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.3 145.52 78.1 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.406 2.07 . . . . 0.0 112.645 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.495 HD13 ' CG2' ' B' ' 17' ' ' ILE . 40.7 mm -94.97 151.51 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.887 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.503 ' CB ' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -136.7 156.59 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' B' ' 84' ' ' LEU . 6.4 m-85 -127.47 105.05 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.038 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.2 78.57 9.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.834 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.14 156.15 42.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.2 t -87.65 168.78 12.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.59 157.68 39.58 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.057 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.9 146.84 97.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.527 2.151 . . . . 0.0 112.188 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.15 142.98 47.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.562 2.175 . . . . 0.0 112.295 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.13 126.13 13.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.444 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 16.8 m-20 -52.73 121.9 8.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.573 HG22 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -94.49 128.98 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.02 146.62 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.741 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.21 138.69 35.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.065 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -136.11 112.1 10.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.723 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.09 154.55 70.02 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.401 0.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.45 -38.94 88.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.116 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.04 49.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -169.16 118.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.26 147.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.704 HG11 HG11 ' B' ' 18' ' ' VAL . 7.4 p -139.43 99.72 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 111.603 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 19.2 m-30 -51.51 108.18 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.74 137.15 40.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -59.85 167.09 2.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.732 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 83.3 Cg_endo -86.68 161.61 52.65 Favored 'Cis proline' 0 C--N 1.348 0.548 0 C-N-CA 124.013 -1.244 . . . . 0.0 112.583 0.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.97 29.51 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -107.07 7.06 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.533 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -148.68 147.83 29.35 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -56.98 117.99 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 112.16 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.9 m -102.7 114.2 28.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.001 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.567 ' CE1' ' CD1' ' A' ' 19' ' ' PHE . 4.9 m-85 -96.01 122.08 38.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -81.1 132.51 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.65 152.49 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HB2' ' HG3' ' B' ' 22' ' ' PRO . 0.8 OUTLIER -113.27 127.73 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.238 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -131.54 130.3 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.79 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.9 m -142.15 156.61 45.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.215 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.573 ' HA ' HG22 ' A' ' 9' ' ' ILE . 25.9 t-20 -100.08 113.75 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -92.23 20.23 6.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.344 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.65 -140.39 9.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.583 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.31 29.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -155.89 148.39 23.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.574 ' HG2' HG12 ' A' ' 61' ' ' VAL . 5.7 ttp180 -54.67 159.24 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 61' ' ' VAL . 12.1 pt -154.2 166.45 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.041 0.448 . . . . 0.0 111.577 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.19 109.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.597 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -104.21 161.67 13.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.226 0.536 . . . . 0.0 111.79 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.36 151.29 26.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.28 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.723 HD12 HG13 ' A' ' 91' ' ' ILE . 20.0 mm -122.14 140.4 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.14 131.28 23.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.507 HG22 HG12 ' A' ' 89' ' ' ILE . 67.1 p -114.03 154.81 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.068 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.06 -37.09 73.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -124.89 112.16 16.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.2 -37.53 9.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.759 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -32.38 7.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.81 141.87 29.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.72 132.48 27.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -115.09 128.0 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -145.71 129.52 8.55 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 58.8 Cg_endo -71.52 133.35 28.03 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.153 -0.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 51.4 Cg_exo -55.33 -46.81 29.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.388 2.059 . . . . 0.0 112.232 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.83 150.3 36.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.728 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.74 -172.03 27.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.598 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.574 HG12 ' HG2' ' A' ' 40' ' ' ARG . 6.0 t -123.16 114.49 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.842 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.433 HD21 HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -87.86 161.44 17.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.028 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -121.23 178.39 1.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.675 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 33.5 Cg_exo -61.55 108.89 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.623 2.215 . . . . 0.0 112.323 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.72 34.45 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.06 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -95.74 151.23 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.798 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -106.44 156.81 18.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 HD21 ' A' ' 62' ' ' LEU . 59.4 t -148.74 147.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 69' ' ' LEU . 2.8 mt -112.55 135.63 53.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.686 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 157.74 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.3 123.03 26.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.97 85.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.192 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.73 131.62 49.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.939 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.5 t -123.53 87.59 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.91 149.42 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.001 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 76' ' ' THR . 2.9 p -63.93 135.88 56.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 83' ' ' ASP . 26.4 p90 -145.35 -164.5 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -127.15 131.48 50.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.61 19.97 13.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.376 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.68 -37.48 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.287 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 77.6 p -138.65 25.03 2.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 81' ' ' THR . 28.4 mt-10 -161.13 161.87 31.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER 59.63 166.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.957 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.64 HD23 ' CE1' ' A' ' 124' ' ' TYR . 6.2 mt 84.18 54.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ASN . 1.1 p30 -125.4 27.36 6.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.964 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 85' ' ' ASN . 10.7 m-20 82.37 97.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.753 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.7 139.2 53.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.92 132.89 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 122' ' ' ILE . 8.4 mt -83.67 166.03 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.744 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 89' ' ' ILE . 2.5 m -140.63 117.56 11.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 111.057 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.723 HG13 HD12 ' A' ' 45' ' ' ILE . 3.3 mp -108.34 103.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.79 140.45 48.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.49 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 9.4 p90 -149.94 141.47 23.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.009 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.552 HG21 ' O ' ' A' ' 108' ' ' TRP . 4.0 t -132.43 147.43 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.992 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -52.4 137.86 28.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.663 HG22 ' CH2' ' A' ' 108' ' ' TRP . 3.0 p -82.38 143.36 48.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 47.2 Cg_exo -55.87 160.73 9.42 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.495 2.13 . . . . 0.0 112.071 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.8 121.38 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.41 42.56 65.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.09 160.64 17.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.401 . . . . 0.0 111.149 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.85 164.37 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.218 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -88.12 70.17 9.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.583 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.23 134.98 0.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.829 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.12 145.04 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.488 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 3.0 mmt180 -124.8 152.31 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -80.7 -44.55 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.046 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.51 -14.07 62.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.526 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.663 ' CH2' HG22 ' A' ' 96' ' ' THR . 5.0 m0 -51.49 -24.57 5.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.333 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -99.2 -27.36 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.4 23.53 4.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.985 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.68 -70.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.221 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.54 112.88 7.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.951 0.405 . . . . 0.0 110.254 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.836 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -46.37 -73.61 0.29 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.994 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 8.1 mtt -43.89 109.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.377 . . . . 0.0 111.492 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 113' ' ' GLY . 58.5 t -139.06 124.31 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.49 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -87.65 141.25 28.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.168 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.41 129.2 39.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.766 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -126.22 162.83 24.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.596 ' O ' HD12 ' A' ' 120' ' ' LEU . 53.2 m-80 -143.7 142.82 31.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 119' ' ' ASN . 8.6 mp -128.56 95.75 31.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.67 135.61 70.47 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.516 HD11 HG13 ' A' ' 89' ' ' ILE . 17.4 mm -97.24 144.76 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 18' ' ' VAL . 8.9 mt-10 -132.39 163.67 28.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.685 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.64 ' CE1' HD23 ' A' ' 84' ' ' LEU . 1.8 m-85 -126.08 125.7 43.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.319 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -114.76 80.93 1.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.841 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.924 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.779 0.323 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.26 155.97 42.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -87.48 168.63 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.45 157.74 39.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.97 146.83 97.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.559 2.173 . . . . 0.0 112.261 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 142.87 47.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 112.35 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.99 125.86 12.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.524 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 16.5 m-20 -52.71 121.73 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.934 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' B' ' 35' ' ' ASN . 1.1 pt -94.28 129.13 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.2 146.84 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.684 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.4 138.91 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.038 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -136.22 112.13 10.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.08 154.59 69.98 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 123.99 -1.254 . . . . 0.0 112.43 0.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.29 -39.25 89.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.949 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.85 49.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -169.29 118.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.04 148.18 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.704 HG11 HG11 ' A' ' 18' ' ' VAL . 7.4 p -139.62 99.72 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 19.5 m-30 -51.6 108.1 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.465 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.83 137.16 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.367 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -59.69 167.08 2.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.859 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.727 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 81.9 Cg_endo -86.7 161.64 52.5 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.976 -1.26 . . . . 0.0 112.613 0.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.0 29.62 3.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -107.09 6.99 29.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.474 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -148.75 147.83 29.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.01 117.76 4.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.97 112.2 22.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -102.75 114.33 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' B' ' 19' ' ' PHE . 5.1 m-85 -96.1 121.9 38.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.814 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -80.95 132.44 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.061 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.6 152.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -113.34 127.87 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.62 130.37 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.794 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 51.1 m -142.13 156.69 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.19 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' B' ' 9' ' ' ILE . 26.1 t-20 -100.22 113.71 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.892 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -92.18 20.19 6.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.43 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.61 -140.33 9.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.535 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.27 29.45 0.97 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -155.91 148.31 23.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.768 0.318 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ARG . . . . . 0.572 ' HG2' HG12 ' B' ' 61' ' ' VAL . 5.6 ttp180 -54.52 159.12 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.431 ' O ' HG13 ' B' ' 61' ' ' VAL . 12.3 pt -154.19 166.4 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.592 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.14 109.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.566 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -104.26 161.66 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.299 0.571 . . . . 0.0 111.789 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.23 151.43 26.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.352 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.73 HD12 HG13 ' B' ' 91' ' ' ILE . 20.5 mm -122.32 140.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 0.0 111.637 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.23 131.07 22.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.641 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' THR . . . . . 0.527 HG22 HG12 ' B' ' 89' ' ' ILE . 67.8 p -113.92 154.84 26.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.144 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.05 -37.21 73.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -124.85 112.13 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.26 -37.15 9.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.767 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -32.22 7.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.9 141.58 29.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 132.46 27.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.022 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.48 HG11 HG21 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -115.08 127.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.047 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.47 129.54 8.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' B' ' 58' ' ' PRO . 58.7 Cg_endo -71.68 133.46 28.72 Favored 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.731 -1.362 . . . . 0.0 112.092 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 57' ' ' PRO . 50.7 Cg_exo -55.35 -46.78 29.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.355 2.037 . . . . 0.0 112.286 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.3 p -144.84 150.18 36.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.732 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.64 -172.1 27.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.586 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.572 HG12 ' HG2' ' B' ' 40' ' ' ARG . 5.9 t -123.02 114.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.436 HD21 HG23 ' B' ' 68' ' ' VAL . 0.4 OUTLIER -87.78 161.24 17.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.071 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.446 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -121.01 178.32 1.21 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.797 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 30.7 Cg_exo -61.5 108.98 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.653 2.235 . . . . 0.0 112.355 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.53 34.75 9.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -95.9 151.04 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -106.49 156.71 18.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.436 HG23 HD21 ' B' ' 62' ' ' LEU . 59.1 t -148.71 147.31 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.234 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' B' ' 69' ' ' LEU . 2.9 mt -112.43 135.69 52.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.63 157.73 34.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 111.126 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.25 123.08 26.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.01 85.49 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.261 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 131.83 50.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 t -123.75 87.58 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.89 149.54 2.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 p -63.93 135.99 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' PHE . . . . . 0.496 ' CD2' ' HB2' ' B' ' 83' ' ' ASP . 26.5 p90 -145.57 -164.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -127.11 131.31 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.95 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.384 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.63 -37.62 5.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 111.265 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 77.9 p -138.54 25.1 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' B' ' 81' ' ' THR . 28.5 mt-10 -161.03 161.83 31.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ASP . . . . . 0.496 ' HB2' ' CD2' ' B' ' 77' ' ' PHE . 0.6 OUTLIER 59.56 166.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 110.95 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.628 HD23 ' CE1' ' B' ' 124' ' ' TYR . 6.2 mt 84.3 54.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.492 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' B' ' 86' ' ' ASN . 1.2 p30 -125.65 27.48 6.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.946 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' B' ' 85' ' ' ASN . 10.9 m-20 82.31 97.15 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.76 139.29 53.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.88 132.93 4.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.527 HG12 HG22 ' B' ' 47' ' ' THR . 8.8 mt -83.73 166.23 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.473 ' H ' HG22 ' B' ' 89' ' ' ILE . 2.5 m -140.79 117.38 10.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.962 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ILE . . . . . 0.73 HG13 HD12 ' B' ' 45' ' ' ILE . 3.4 mp -108.22 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.73 140.56 48.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 9.5 p90 -149.91 141.6 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.558 HG21 ' O ' ' B' ' 108' ' ' TRP . 4.0 t -132.63 147.24 52.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ASN . . . . . 0.415 ' HA ' HG22 ' B' ' 41' ' ' ILE . 0.7 OUTLIER -52.32 138.03 27.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.67 HG22 ' CH2' ' B' ' 108' ' ' TRP . 3.1 p -82.5 143.37 47.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.8 160.72 9.28 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 121.48 5.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.21 42.67 63.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.46 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.12 160.55 18.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 111.134 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.79 164.22 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.27 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -87.94 70.15 9.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.634 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.27 134.91 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.836 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -58.89 144.96 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.499 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 3.0 mmt180 -124.81 152.15 44.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -80.57 -44.54 18.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.613 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.67 ' CH2' HG22 ' B' ' 96' ' ' THR . 4.9 m0 -51.63 -24.44 5.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.78 0.324 . . . . 0.0 110.96 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -99.29 -27.11 13.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -93.66 23.73 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.88 -70.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.245 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.48 112.88 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.843 0.354 . . . . 0.0 110.228 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' GLY . . . . . 0.84 ' O ' HG23 ' B' ' 115' ' ' VAL . . . -46.45 -73.47 0.3 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.962 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 8.4 mtt -44.14 109.81 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.93 0.395 . . . . 0.0 111.482 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 113' ' ' GLY . 57.6 t -139.1 124.34 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.854 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' ARG . . . . . 0.479 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -87.75 141.21 28.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.47 129.08 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -125.97 162.82 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.598 ' O ' HD12 ' B' ' 120' ' ' LEU . 54.0 m-80 -143.77 142.79 31.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.842 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.598 HD12 ' O ' ' B' ' 119' ' ' ASN . 8.7 mp -128.55 95.81 31.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.61 135.57 70.34 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.629 2.219 . . . . 0.0 112.146 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.516 HD11 HG13 ' B' ' 89' ' ' ILE . 17.5 mm -97.27 144.5 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.277 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' B' ' 18' ' ' VAL . 9.2 mt-10 -132.3 163.62 28.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' TYR . . . . . 0.628 ' CE1' HD23 ' B' ' 84' ' ' LEU . 1.8 m-85 -125.93 125.92 43.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.286 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -114.93 81.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.986 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.743 0.306 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -137.12 133.62 35.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.22 86.17 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.984 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.57 HG23 ' HD2' ' A' ' 5' ' ' PRO . 6.8 p -142.29 140.62 19.42 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.02 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD2' HG23 ' A' ' 4' ' ' VAL . 75.2 Cg_exo -49.6 142.15 24.9 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.461 2.107 . . . . 0.0 112.285 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 51.4 Cg_exo -52.83 156.41 9.34 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.489 2.126 . . . . 0.0 112.331 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.52 122.86 23.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.5 m-20 -52.43 115.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.38 138.09 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.85 146.43 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -135.65 149.67 49.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 111.153 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.561 ' O ' HG23 ' A' ' 31' ' ' ILE . 38.9 mt-30 -135.4 116.37 11.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.51 163.81 63.74 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.514 0.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 t -44.6 -62.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.383 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.41 ' HA ' HD22 ' A' ' 120' ' ' LEU . 2.2 tt0 -173.16 48.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 104.89 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 8.2 tt -131.93 145.31 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 123' ' ' GLU . 6.6 p -150.6 121.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -72.65 113.9 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -81.89 134.61 35.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -65.68 170.72 4.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.805 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.841 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 62.5 Cg_endo -73.19 164.99 85.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.766 -1.348 . . . . 0.0 112.675 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -107.27 46.65 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -115.11 -4.77 12.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.406 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -123.08 144.47 49.28 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.94 126.78 31.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.85 155.43 41.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.52 116.06 16.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -102.42 116.12 31.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -92.49 131.7 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 12' ' ' GLN . 5.3 mm -107.55 143.25 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.525 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -104.65 119.91 40.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.397 . . . . 0.0 111.242 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -112.88 153.79 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.748 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.69 155.86 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.143 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -102.48 109.9 21.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.582 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.15 19.19 6.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.63 -143.53 12.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.457 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.54 20.73 2.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 159.86 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' C ' ' HG1' ' A' ' 96' ' ' THR . 15.2 mtm180 -55.85 152.36 10.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.728 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.69 116.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.38 115.47 5.11 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.841 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.545 ' CD1' HD12 ' A' ' 62' ' ' LEU . 67.4 p-90 -118.06 158.86 24.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.122 0.487 . . . . 0.0 111.566 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.6 152.99 31.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.566 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.432 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 5.9 mm -104.02 154.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.424 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -155.65 132.64 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.678 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.27 160.16 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.161 0.505 . . . . 0.0 111.272 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.13 -55.16 36.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.44 113.16 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.59 22.05 5.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -113.23 -58.57 2.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.915 0.388 . . . . 0.0 110.788 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -33.2 63.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.779 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -98.02 145.88 26.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.689 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.92 147.11 36.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.03 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.3 p -139.98 160.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.26 0.552 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 55' ' ' VAL . 9.8 t70 -172.92 129.04 0.55 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.06 146.71 86.74 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.217 -0.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.95 -0.42 10.65 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.66 2.24 . . . . 0.0 113.151 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.55 177.1 0.36 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.822 0.344 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 154.71 167.37 16.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.64 128.93 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 111.115 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.545 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.86 123.06 46.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.72 171.54 12.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 114.54 2.31 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.618 2.212 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.49 28.49 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.293 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.75 148.27 23.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.768 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 128.38 52.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.117 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.38 138.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.033 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.58 123.54 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.448 ' CG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.24 163.06 17.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 154.58 51.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -134.37 89.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.702 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 p -74.0 139.44 44.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m -131.05 149.38 52.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.659 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.76 148.73 24.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 111.196 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -71.49 127.65 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.756 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.69 -173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.006 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -129.59 121.46 27.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.484 ' CB ' HD11 ' A' ' 126' ' ' LEU . . . -65.99 -21.01 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.39 65.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.38 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.9 p -141.15 67.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.304 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -150.19 171.92 16.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.65 136.53 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.0 mt -152.78 86.51 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.46 22.43 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.265 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.83 93.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.174 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.1 152.54 43.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.354 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.418 ' HA ' HG12 ' A' ' 122' ' ' ILE . 2.6 ptm180 -157.8 131.02 7.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.706 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 90' ' ' THR . 7.1 mm -85.1 163.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.317 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 89' ' ' ILE . 78.2 m -144.2 118.92 9.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.88 0.371 . . . . 0.0 111.493 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.13 97.16 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.76 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.38 133.95 48.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.101 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -138.66 154.89 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.682 ' HB ' HG13 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -147.31 151.41 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -55.71 150.88 11.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.521 HG22 ' CZ2' ' A' ' 108' ' ' TRP . 0.6 OUTLIER -96.07 142.17 24.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.0 156.59 61.73 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.609 2.206 . . . . 0.0 112.279 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -50.16 128.24 18.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.993 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.83 34.46 87.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.39 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.35 127.04 29.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.153 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.88 166.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.249 0.547 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -85.89 70.85 10.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.0 128.77 0.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -52.11 151.31 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.22 155.77 49.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.039 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.46 -34.44 16.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.99 -24.98 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.521 ' CZ2' HG22 ' A' ' 96' ' ' THR . 21.9 m0 -50.05 -34.7 22.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.985 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.667 ' CD2' HG11 ' A' ' 115' ' ' VAL . 4.9 m-85 -94.12 -32.93 13.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.999 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.5 49.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.93 -132.65 2.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.503 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.25 151.32 22.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.91 0.386 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.37 138.37 9.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.508 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt -72.29 130.38 40.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.682 HG13 ' HB ' ' A' ' 94' ' ' THR . 12.7 t -109.06 125.23 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.234 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.1 142.45 27.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.93 97.77 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.04 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -87.27 159.34 18.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.76 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.6 120.25 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.885 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 15' ' ' GLN . 4.7 mt -94.73 135.18 24.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.76 130.42 5.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.664 2.243 . . . . 0.0 112.627 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 3.4 mm -114.04 119.54 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 18' ' ' VAL . 45.7 mt-10 -117.82 157.53 26.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.533 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.37 109.06 18.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.959 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -83.13 81.56 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 79' ' ' ALA . 67.5 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.852 0.358 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -137.03 133.73 35.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.14 85.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.048 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.575 HG23 ' HD2' ' B' ' 5' ' ' PRO . 6.6 p -142.17 140.69 19.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' PRO . . . . . 0.575 ' HD2' HG23 ' B' ' 4' ' ' VAL . 73.4 Cg_exo -49.47 142.06 24.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.537 2.158 . . . . 0.0 112.257 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 5' ' ' PRO . 51.8 Cg_exo -52.83 156.51 9.19 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.532 2.155 . . . . 0.0 112.281 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.63 122.88 23.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.536 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 2.5 m-20 -52.44 115.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.84 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.32 137.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.78 146.47 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 149.55 49.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.572 ' O ' HG23 ' B' ' 31' ' ' ILE . 38.8 mt-30 -135.4 116.45 11.99 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 163.65 63.67 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.533 0.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.5 t -44.48 -62.42 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.462 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.41 ' HA ' HD22 ' B' ' 120' ' ' LEU . 2.2 tt0 -173.26 48.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.996 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.05 104.82 2.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.479 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 8.3 tt -131.96 145.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.762 HG23 ' O ' ' B' ' 123' ' ' GLU . 6.8 p -150.88 121.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -72.49 113.62 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.704 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -81.58 134.41 35.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.868 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -65.59 170.85 4.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PRO . . . . . 0.868 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 64.8 Cg_endo -73.12 164.92 85.66 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.866 -1.306 . . . . 0.0 112.723 0.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -107.24 46.67 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -115.15 -4.6 12.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.395 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.27 144.44 49.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.913 0.387 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.9 126.68 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.992 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.84 155.37 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.44 115.96 16.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -102.36 116.23 32.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.659 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -92.74 131.5 37.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.254 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.572 HG23 ' O ' ' B' ' 12' ' ' GLN . 5.2 mm -107.31 143.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.616 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -104.59 120.09 40.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.267 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 mt -113.09 153.73 14.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.78 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.72 155.98 34.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 111.17 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -102.64 109.89 21.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.24 19.37 5.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.48 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.74 -143.64 12.84 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.432 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.44 20.81 2.23 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.52 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.74 160.08 37.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.855 0.359 . . . . 0.0 110.808 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -56.04 152.65 10.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.61 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.93 116.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.445 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.67 115.5 5.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.878 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.552 ' CD1' HD12 ' B' ' 62' ' ' LEU . 67.5 p-90 -118.18 158.75 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.101 0.477 . . . . 0.0 111.495 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.43 153.2 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.527 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.436 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 5.9 mm -104.2 154.26 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.431 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -155.61 132.73 10.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.677 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.3 160.35 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.0 111.251 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.39 -54.88 40.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.7 113.23 26.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.771 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.56 21.97 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -113.2 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -33.16 63.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.16 145.74 26.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.77 146.96 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.479 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.3 p -139.74 160.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.295 0.569 . . . . 0.0 110.922 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' ASP . . . . . 0.479 ' N ' HG22 ' B' ' 55' ' ' VAL . 9.8 t70 -172.69 128.98 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.793 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.07 146.72 86.8 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.293 -0.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.03 -0.46 10.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.678 2.252 . . . . 0.0 113.084 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.64 177.07 0.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 154.8 167.21 16.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.65 129.02 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.552 HD12 ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -103.99 123.19 46.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.951 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.74 171.47 12.34 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.81 114.45 2.29 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.591 2.194 . . . . 0.0 112.346 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.61 28.31 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.228 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 148.37 22.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.766 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 128.45 52.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.08 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.48 138.49 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.51 123.51 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.01 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' MET . . . . . 0.449 ' CG ' ' HB ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -119.22 163.08 17.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.962 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.72 51.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.435 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -134.58 89.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.589 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 20.5 p -74.06 139.38 44.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.99 149.35 52.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.588 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.59 148.86 24.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.252 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -71.52 127.72 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.78 -173.85 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.957 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.52 121.54 27.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ALA . . . . . 0.48 ' CB ' HD11 ' B' ' 126' ' ' LEU . . . -66.21 -20.8 66.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.306 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.9 -43.45 66.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -140.97 67.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.274 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -150.28 171.82 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.059 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.56 136.35 45.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 55.7 mt -152.59 86.48 1.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.5 22.43 12.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.238 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 73.74 93.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.37 152.27 43.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.349 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.426 ' HA ' HG12 ' B' ' 122' ' ' ILE . 2.6 ptm180 -157.44 131.01 7.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.515 HG22 ' N ' ' B' ' 90' ' ' THR . 7.1 mm -85.1 163.36 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.515 ' N ' HG22 ' B' ' 89' ' ' ILE . 81.9 m -144.08 118.88 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.389 . . . . 0.0 111.492 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.06 97.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.718 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -104.5 133.91 48.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.02 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -138.68 154.91 48.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' THR . . . . . 0.673 ' HB ' HG13 ' B' ' 115' ' ' VAL . 1.0 OUTLIER -147.12 151.32 36.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -55.63 150.85 11.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.009 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.521 HG22 ' CZ2' ' B' ' 108' ' ' TRP . 0.6 OUTLIER -96.04 142.19 24.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 156.48 62.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.206 . . . . 0.0 112.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -50.09 128.25 18.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.74 34.54 87.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.371 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.42 126.99 29.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.66 166.72 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.381 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -86.0 70.88 10.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.02 128.81 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -52.11 151.25 3.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.15 155.7 49.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.39 -34.35 16.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.02 -25.04 68.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' TRP . . . . . 0.521 ' CZ2' HG22 ' B' ' 96' ' ' THR . 22.3 m0 -49.93 -34.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.043 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' B' ' 115' ' ' VAL . 4.7 m-85 -94.11 -33.09 13.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.985 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.41 49.25 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.88 -132.76 2.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.41 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -100.97 151.64 21.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.93 138.45 9.49 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.569 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt -72.49 130.3 40.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.673 HG13 ' HB ' ' B' ' 94' ' ' THR . 12.4 t -108.78 125.32 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.254 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.24 142.51 27.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.99 97.61 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.074 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -87.08 159.26 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.48 120.29 11.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' B' ' 15' ' ' GLN . 4.6 mt -94.77 135.21 23.99 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.81 130.45 5.04 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.665 2.243 . . . . 0.0 112.814 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 3.4 mm -114.08 119.39 61.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.623 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.762 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.1 mt-10 -117.72 157.49 26.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 111.48 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.36 109.13 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -83.28 81.62 8.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' B' ' 79' ' ' ALA . 67.9 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.527 0.167 0 CA-C-O 120.683 0.201 . . . . 0.0 112.28 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.13 97.02 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.621 2.214 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.56 131.46 26.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 9.0 m-20 -57.74 109.03 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.1 pt -68.72 123.37 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.74 145.37 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.51 136.24 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.241 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' B' ' 22' ' ' PRO . 14.7 mt-30 -140.85 105.57 6.28 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.66 161.48 40.68 Favored 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.506 0.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.3 t -92.36 -26.07 18.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.71 49.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.53 107.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 17' ' ' ILE . 12.9 tt -129.7 120.1 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 125' ' ' ASN . 46.0 t -109.27 92.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.564 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 20.9 m-85 -52.74 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -67.18 141.41 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.431 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.13 169.42 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.821 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.774 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 66.3 Cg_endo -91.1 166.97 28.8 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.371 -1.096 . . . . 0.0 112.974 0.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.431 ' O ' ' HB ' ' A' ' 76' ' ' THR . 22.3 m-85 -108.87 31.1 5.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.755 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.37 3.61 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.399 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.601 ' N ' HG22 ' A' ' 76' ' ' THR . 3.3 t70 -164.31 151.49 11.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.821 0.343 . . . . 0.0 110.78 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.65 109.11 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.49 110.46 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.669 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 83.0 m -93.43 110.85 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 19' ' ' PHE . 79.6 m-85 -89.02 121.8 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -77.9 131.43 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.435 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.675 HD12 ' HE3' ' A' ' 70' ' ' MET . 16.0 mt -113.89 151.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -112.93 121.76 45.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 111.482 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.602 HD11 ' CE ' ' A' ' 70' ' ' MET . 39.3 mt -125.45 150.19 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.505 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.81 145.37 27.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.42 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.13 106.69 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.279 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.51 20.68 5.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.422 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.12 -170.8 24.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.18 -28.72 8.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.74 178.3 5.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.446 ' HB2' HG12 ' A' ' 61' ' ' VAL . 4.0 ptp180 -64.81 170.64 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 12.2 pt -152.98 136.18 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.655 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.84 112.2 4.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.511 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.472 ' HE1' HD13 ' A' ' 62' ' ' LEU . 37.6 p-90 -117.17 156.98 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.221 0.534 . . . . 0.0 111.811 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.99 153.35 40.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.286 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 mm -115.46 151.27 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.578 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -147.5 130.51 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.531 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.527 HG22 HG23 ' A' ' 89' ' ' ILE . 36.3 p -120.41 154.7 34.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 p -52.0 -30.27 24.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -139.07 117.8 12.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.69 17.11 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -108.74 -49.58 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -76.3 -50.51 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.52 148.41 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -136.53 107.35 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.89 118.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -142.17 136.46 14.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.93 132.77 28.11 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.575 -1.427 . . . . 0.0 112.05 -0.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.4 -45.57 9.13 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.404 2.069 . . . . 0.0 112.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 p -133.36 148.75 51.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.82 175.29 46.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 40' ' ' ARG . 4.9 t -116.21 108.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.597 HD11 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -80.29 158.83 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.31 170.13 5.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.62 110.57 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.647 2.231 . . . . 0.0 112.259 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.66 37.0 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.29 142.28 31.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.219 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -102.57 143.16 32.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.597 HG11 HD11 ' A' ' 62' ' ' LEU . 8.9 p -141.78 148.5 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 31' ' ' ILE . 1.4 mm? -104.49 143.82 32.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.675 ' HE3' HD12 ' A' ' 31' ' ' ILE . 3.1 ttp -120.31 156.34 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.649 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.669 ' HB1' ' CG2' ' A' ' 28' ' ' THR . . . -130.79 113.95 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.294 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 72' ' ' VAL . 7.3 p -114.16 88.14 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.94 146.48 33.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.6 107.5 9.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.74 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 146.17 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.037 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 25' ' ' ASP . 5.3 p -56.75 164.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -178.65 -173.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -116.15 109.52 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.97 16.94 13.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.457 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.47 -24.94 29.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.9 p -147.01 44.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.35 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.73 134.71 55.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.626 HD13 ' HB2' ' A' ' 124' ' ' TYR . 91.4 mt -127.71 69.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -155.68 28.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -130.35 6.45 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.617 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.87 119.3 34.12 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.45 136.0 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.056 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.872 HG13 HD11 ' A' ' 122' ' ' ILE . 7.8 mt -98.69 165.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 89' ' ' ILE . 58.2 m -137.75 123.07 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.871 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 91' ' ' ILE . 3.3 mp -121.79 112.2 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.54 155.01 35.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.461 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 11.4 p90 -157.59 147.28 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.469 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -141.25 134.12 28.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HA ' HG22 ' A' ' 41' ' ' ILE . 13.2 p30 -52.52 125.2 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.404 ' OG1' ' HG3' ' A' ' 40' ' ' ARG . 43.7 p -66.6 151.63 96.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.7 165.05 28.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.536 2.158 . . . . 0.0 112.148 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.93 117.44 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.43 51.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.234 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.43 166.08 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 0.0 111.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.09 164.31 25.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.314 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.94 69.42 9.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.63 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.08 122.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.88 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.2 122.28 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -117.23 150.52 38.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.91 -19.02 45.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.41 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.83 -23.66 66.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 0.0 111.234 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.16 -13.95 43.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 C--N 1.333 -0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 111.191 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.823 0.344 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' A' ' 94' ' ' THR . 12.6 t -115.24 136.15 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.461 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 12.4 tpt180 -99.4 152.86 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.92 137.71 9.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.07 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -145.21 132.23 20.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -91.56 133.86 35.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.82 117.8 61.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.668 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.37 128.7 19.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.354 2.036 . . . . 0.0 112.359 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.872 HD11 HG13 ' A' ' 89' ' ' ILE . 32.5 mm -92.54 148.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.225 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.54 ' HB3' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.21 160.2 40.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.657 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.626 ' HB2' HD13 ' A' ' 84' ' ' LEU . 81.3 m-85 -132.15 110.74 10.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.207 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.671 ' HB2' HG12 ' A' ' 18' ' ' VAL . 2.8 t30 -99.29 132.24 44.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.633 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.941 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.718 0.216 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.13 97.18 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.54 2.16 . . . . 0.0 112.308 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 131.72 27.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 9.1 m-20 -57.91 108.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.889 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.1 pt -68.7 123.46 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 145.19 55.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.657 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.34 136.07 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.234 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -140.66 105.64 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.78 161.57 41.2 Favored 'Cis proline' 0 C--N 1.35 0.658 0 C-N-CA 123.854 -1.311 . . . . 0.0 112.461 0.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.8 t -92.37 -26.06 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.112 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.67 49.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.68 106.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.529 HG23 ' O ' ' B' ' 17' ' ' ILE . 13.0 tt -129.58 120.12 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' B' ' 125' ' ' ASN . 45.9 t -109.27 92.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.573 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.484 ' HA ' ' CE2' ' B' ' 29' ' ' TYR . 21.0 m-85 -52.91 96.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.495 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -67.17 141.35 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.441 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.14 169.47 0.16 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.805 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.782 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 64.6 Cg_endo -91.13 166.82 28.77 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.948 0.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.434 ' O ' ' HB ' ' B' ' 76' ' ' THR . 22.3 m-85 -108.83 31.23 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.719 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.55 3.71 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.429 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . 0.6 ' N ' HG22 ' B' ' 76' ' ' THR . 3.3 t70 -164.38 151.27 11.37 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.5 109.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.4 110.49 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.674 ' CG2' ' HB1' ' B' ' 71' ' ' ALA . 88.9 m -93.45 110.72 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.047 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.507 ' O ' HG12 ' B' ' 72' ' ' VAL . 79.6 m-85 -88.93 121.82 31.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' B' ' 70' ' ' MET . 37.9 m80 -77.87 131.36 37.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.659 HD12 ' HE3' ' B' ' 70' ' ' MET . 16.2 mt -113.77 152.03 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.486 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -113.08 121.53 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.524 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.601 HD11 ' CE ' ' B' ' 70' ' ' MET . 39.2 mt -125.3 150.24 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.567 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 53.6 m -148.9 145.11 27.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.423 . . . . 0.0 111.437 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -88.89 106.66 18.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.265 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.43 20.34 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.4 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.93 -170.87 24.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.554 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.12 -28.54 9.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.93 178.21 5.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.461 ' HB2' HG12 ' B' ' 61' ' ' VAL . 3.9 ptp180 -64.72 170.7 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.851 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.438 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 12.1 pt -152.95 136.09 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.623 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.66 112.17 4.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.471 ' HE1' HD13 ' B' ' 62' ' ' LEU . 38.1 p-90 -117.21 157.03 26.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.209 0.528 . . . . 0.0 111.861 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.05 153.48 40.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.257 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 mm -115.49 151.51 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -147.76 130.46 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.516 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.522 HG22 HG23 ' B' ' 89' ' ' ILE . 35.4 p -120.42 154.7 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.923 0.392 . . . . 0.0 111.12 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -52.07 -30.11 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -139.18 117.65 12.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.54 17.26 7.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.26 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -108.84 -49.63 3.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -76.25 -50.5 14.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.62 148.32 24.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.999 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -136.49 107.11 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.62 118.66 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.2 136.32 14.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.05 132.75 28.1 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.603 -1.416 . . . . 0.0 112.079 -0.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.54 -45.31 9.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.449 2.1 . . . . 0.0 112.191 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -133.48 148.56 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.766 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.64 175.23 46.33 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.526 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' B' ' 40' ' ' ARG . 5.0 t -116.17 108.35 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.597 HD11 HG11 ' B' ' 68' ' ' VAL . 1.1 mp -80.13 158.81 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.21 170.11 6.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.7 110.33 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.637 2.225 . . . . 0.0 112.3 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.89 36.97 9.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.402 ' HG2' ' HG ' ' B' ' 62' ' ' LEU . 0.4 OUTLIER -100.18 142.31 31.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.272 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -102.74 143.03 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.597 HG11 HD11 ' B' ' 62' ' ' LEU . 9.0 p -141.71 148.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.065 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.513 HD13 ' O ' ' B' ' 31' ' ' ILE . 1.4 mm? -104.32 143.9 32.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.659 ' HE3' HD12 ' B' ' 31' ' ' ILE . 3.1 ttp -120.29 156.41 31.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.701 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.674 ' HB1' ' CG2' ' B' ' 28' ' ' THR . . . -130.87 113.88 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.237 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.649 HG13 ' O ' ' B' ' 72' ' ' VAL . 7.2 p -114.1 87.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.968 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 28' ' ' THR . 0.2 OUTLIER -78.78 146.57 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.69 107.62 9.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.708 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.78 146.2 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.6 HG22 ' N ' ' B' ' 25' ' ' ASP . 5.4 p -56.75 164.32 1.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -178.61 -173.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -116.3 109.31 17.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.93 17.16 12.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.492 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.68 -24.92 28.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.056 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 59.7 p -146.94 44.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.58 22.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.841 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -64.12 134.7 55.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' B' ' 124' ' ' TYR . 90.9 mt -127.64 69.74 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -155.64 29.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -130.41 6.34 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.629 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.75 119.24 33.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.826 0.346 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.39 136.09 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.871 HG13 HD11 ' B' ' 122' ' ' ILE . 7.9 mt -98.82 165.53 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.47 ' H ' HG22 ' B' ' 89' ' ' ILE . 58.7 m -137.81 122.84 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.47 ' N ' HD12 ' B' ' 91' ' ' ILE . 3.3 mp -121.51 112.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.52 154.81 36.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.833 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.469 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 11.4 p90 -157.42 147.14 20.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.464 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -141.06 134.11 29.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.407 ' HA ' HG22 ' B' ' 41' ' ' ILE . 13.2 p30 -52.44 125.37 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.405 ' OG1' ' HG3' ' B' ' 40' ' ' ARG . 43.8 p -66.86 151.6 96.69 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.63 165.01 28.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.586 2.19 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.91 117.39 1.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.38 47.63 50.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.218 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.52 166.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 111.324 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.21 164.22 25.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.88 69.51 9.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.585 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.99 122.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.12 122.17 6.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -116.98 150.56 38.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -19.01 44.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.332 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.76 -23.73 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.773 0.321 . . . . 0.0 111.242 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.19 -13.85 42.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.772 0.32 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.464 HG13 ' HB ' ' B' ' 94' ' ' THR . 12.7 t -115.16 136.12 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.469 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 12.4 tpt180 -99.38 152.79 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.78 137.8 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.796 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -91.44 133.78 35.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.71 117.72 62.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.656 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.37 128.76 19.94 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.389 2.06 . . . . 0.0 112.294 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.871 HD11 HG13 ' B' ' 89' ' ' ILE . 31.9 mm -92.63 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.537 ' HB3' HG13 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -140.17 160.2 40.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.726 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.612 ' CB ' HD13 ' B' ' 84' ' ' LEU . 80.9 m-85 -132.1 110.78 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.231 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.671 ' HB2' HG12 ' B' ' 18' ' ' VAL . 2.9 t30 -99.46 132.19 44.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.623 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.955 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.659 0.191 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.07 124.0 10.91 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.481 2.121 . . . . 0.0 112.266 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 111.09 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -54.07 120.23 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.65 130.67 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.46 151.18 27.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.587 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.09 149.59 46.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 111.303 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 31' ' ' ILE . 5.4 mt-30 -141.28 108.89 6.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.454 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.6 159.72 51.33 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 124.038 -1.234 . . . . 0.0 112.501 0.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.15 -3.57 12.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -120.43 -48.48 2.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -170.38 141.24 1.96 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 tt -109.07 144.83 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.605 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.893 HG11 HG11 ' B' ' 18' ' ' VAL . 10.2 p -125.11 101.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.774 0.321 . . . . 0.0 111.653 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' CD1' ' A' ' 29' ' ' TYR . 30.8 m-85 -58.11 111.15 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.463 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -72.22 139.77 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.736 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -57.55 167.42 1.34 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.844 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.736 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -89.99 163.12 34.9 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.734 0.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -101.31 28.83 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.13 5.81 46.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.06 156.12 41.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.778 0.323 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -76.35 108.1 9.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.89 136.34 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.79 106.94 17.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 39.5 m-85 -91.94 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -79.96 154.05 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 12' ' ' GLN . 26.0 mt -130.32 147.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.793 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -100.98 126.98 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.185 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.7 HD11 ' CE ' ' A' ' 70' ' ' MET . 13.6 mt -124.16 159.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 33' ' ' ILE . 98.5 m -156.28 153.7 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' OD1' HD13 ' A' ' 41' ' ' ILE . 13.3 t30 -112.61 76.01 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.752 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.62 -30.98 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.954 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.07 174.43 3.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.354 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.01 35.14 4.84 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.553 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.22 171.54 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -74.61 152.35 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.449 HD13 ' OD1' ' A' ' 35' ' ' ASN . 8.7 pt -149.82 142.53 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 111.554 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -98.94 107.97 3.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.455 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CD1' HD12 ' A' ' 62' ' ' LEU . 37.5 p-90 -109.48 157.56 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.171 0.51 . . . . 0.0 111.756 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.592 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -148.13 155.56 41.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.485 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.671 HD12 HG13 ' A' ' 91' ' ' ILE . 6.2 mm -121.64 144.93 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.8 135.86 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.917 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.415 HG22 HG23 ' A' ' 89' ' ' ILE . 2.6 p -118.69 156.73 28.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.006 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.8 p -49.87 -64.27 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 114.17 25.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.99 22.5 5.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -42.89 5.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -95.14 -51.34 4.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.8 mt -76.13 140.18 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.9 125.02 28.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.38 140.72 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -168.02 127.06 1.01 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 11.9 Cg_exo -70.71 132.6 24.12 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 123.937 -1.276 . . . . 0.0 111.977 -0.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 52.3 Cg_exo -54.96 -44.15 52.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.46 2.106 . . . . 0.0 112.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 104' ' ' PHE . 3.5 m -139.38 141.4 37.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.711 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.38 155.84 26.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.548 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.78 115.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 0.0 111.019 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -87.42 156.41 19.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -110.97 178.53 0.97 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.805 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.1 Cg_exo -58.21 110.24 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.533 2.155 . . . . 0.0 112.282 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.68 40.65 29.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.67 155.64 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -114.23 143.98 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.874 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.456 HG23 ' HB ' ' A' ' 33' ' ' ILE . 8.1 m -133.61 151.55 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.73 141.47 30.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.092 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.7 ' CE ' HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -125.52 161.27 27.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.565 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.73 132.19 23.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.304 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.11 90.37 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.046 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 148.4 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.98 152.58 42.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -105.84 137.24 44.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.019 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 76' ' ' THR . 3.8 p -59.97 145.86 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -165.56 -166.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -114.6 118.52 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.46 19.22 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.07 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -142.66 46.5 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.008 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -143.03 147.74 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.57 150.81 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' A' ' 124' ' ' TYR . 49.6 mt -128.29 29.08 5.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.16 32.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.03 -19.09 12.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.389 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.57 117.79 23.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.2 137.77 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 90' ' ' THR . 6.3 mt -108.13 166.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.488 ' H ' HG22 ' A' ' 89' ' ' ILE . 8.4 m -153.1 123.6 7.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.809 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.671 HG13 HD12 ' A' ' 45' ' ' ILE . 3.6 mp -112.69 122.5 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 135.78 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.747 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 10.9 p90 -141.1 145.1 35.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 111.026 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.428 HG21 ' HA ' ' A' ' 109' ' ' PHE . 5.0 t -131.27 149.67 52.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -51.52 135.91 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.81 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 129.77 65.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.472 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 53.0 Cg_exo -55.03 159.9 8.88 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.411 2.074 . . . . 0.0 112.245 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -51.68 124.95 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.998 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.78 42.52 78.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HB1' ' CZ2' ' A' ' 108' ' ' TRP . . . -59.53 143.31 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.073 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.33 164.36 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 69.51 9.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.599 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.95 129.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.738 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE2' ' SG ' ' A' ' 59' ' ' CYS . 34.8 t80 -49.04 128.14 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -120.01 150.66 40.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -86.07 -36.6 19.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.74 -19.66 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.283 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.484 ' CZ2' ' HB1' ' A' ' 100' ' ' ALA . 18.2 m0 -53.58 -22.28 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.428 ' HA ' HG21 ' A' ' 94' ' ' THR . 57.1 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.983 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.855 0.359 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.65 150.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.53 139.89 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -128.44 146.53 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.46 159.61 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.734 ' O ' HD22 ' A' ' 120' ' ' LEU . 87.3 m-20 -129.06 147.81 50.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.477 . . . . 0.0 111.369 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 119' ' ' ASN . 1.9 mm? -138.34 86.73 16.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 147.64 92.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.654 2.236 . . . . 0.0 112.613 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.2 mm -100.67 152.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HB3' ' CB ' ' A' ' 18' ' ' VAL . 6.9 tp10 -141.45 154.54 45.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.979 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' A' ' 84' ' ' LEU . 2.3 m-85 -113.51 126.86 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.168 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HB2' HG22 ' A' ' 18' ' ' VAL . 10.0 t30 -109.55 82.05 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.772 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.981 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.707 0.211 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.09 123.85 10.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.514 2.143 . . . . 0.0 112.24 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.69 111.16 0.85 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.614 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -54.01 120.13 5.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.849 0.356 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.53 130.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.49 151.35 27.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.552 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.33 149.48 45.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 111.255 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.451 ' O ' HG23 ' B' ' 31' ' ' ILE . 5.4 mt-30 -141.05 108.94 6.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.576 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.59 159.83 50.96 Favored 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.902 -1.291 . . . . 0.0 112.504 0.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.18 -3.36 12.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.721 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -120.49 -48.66 2.28 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.823 0.345 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -170.3 141.46 2.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.355 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -109.43 144.8 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.568 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.893 HG11 HG11 ' A' ' 18' ' ' VAL . 10.4 p -125.09 101.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.857 0.361 . . . . 0.0 111.693 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.474 ' CD2' ' CD1' ' B' ' 29' ' ' TYR . 30.6 m-85 -58.21 111.02 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.405 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -72.08 139.69 48.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.269 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -57.4 167.52 1.25 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.868 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.715 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 69.7 Cg_endo -89.9 163.17 35.29 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.77 0.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -101.42 28.78 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.028 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.18 5.67 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.421 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.88 156.36 42.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.703 0.287 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -76.5 108.16 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.97 136.6 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.95 106.97 17.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.474 ' CD1' ' CD2' ' B' ' 19' ' ' PHE . 39.7 m-85 -91.97 113.45 25.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.65 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -79.73 154.07 28.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.382 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.451 HG23 ' O ' ' B' ' 12' ' ' GLN . 25.9 mt -130.4 147.03 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.783 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -100.83 126.94 47.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.226 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.712 HD11 ' CE ' ' B' ' 70' ' ' MET . 13.8 mt -124.02 159.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.487 ' N ' HG22 ' B' ' 33' ' ' ILE . 98.1 m -156.45 153.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.071 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.437 ' OD1' HD13 ' B' ' 41' ' ' ILE . 13.4 t30 -112.76 75.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.789 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.59 -30.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.998 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.3 174.61 3.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 35.36 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.33 171.72 18.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -74.77 152.45 39.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.437 HD13 ' OD1' ' B' ' 35' ' ' ASN . 8.5 pt -149.91 142.52 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.39 . . . . 0.0 111.582 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.92 107.96 3.51 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.408 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.464 ' CD1' HD12 ' B' ' 62' ' ' LEU . 37.6 p-90 -109.35 157.51 18.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.204 0.526 . . . . 0.0 111.729 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.58 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -148.1 155.46 41.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.401 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.68 HD12 HG13 ' B' ' 91' ' ' ILE . 6.2 mm -121.65 144.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 111.298 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.74 136.13 20.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.42 HG22 HG23 ' B' ' 89' ' ' ILE . 2.7 p -119.04 156.77 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 4.4 p -49.94 -64.12 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.2 114.19 25.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.94 22.6 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -42.93 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.768 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -95.15 -51.47 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.12 140.17 41.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.82 125.29 29.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.53 140.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.985 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -168.17 126.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.6 132.5 23.64 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.948 -0.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.87 -44.06 53.36 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.39 2.06 . . . . 0.0 112.233 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' B' ' 104' ' ' PHE . 3.5 m -139.59 141.22 37.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.27 155.81 26.37 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.626 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.74 115.53 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 111.088 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.464 HD12 ' CD1' ' B' ' 43' ' ' TRP . 0.4 OUTLIER -87.29 156.75 19.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.455 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.2 OUTLIER -111.29 178.61 0.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 32.2 Cg_exo -58.33 110.21 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 0.0 112.282 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.83 40.72 28.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 155.62 18.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.027 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -114.34 143.77 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' B' ' 33' ' ' ILE . 8.6 m -133.4 151.8 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.02 141.19 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.179 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.712 ' CE ' HD11 ' B' ' 33' ' ' ILE . 0.6 OUTLIER -125.19 161.27 27.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.704 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.77 132.25 23.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.283 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.15 90.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.13 148.44 48.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.94 152.55 42.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.823 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -105.82 137.32 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -60.02 145.97 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -165.68 -166.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -114.38 118.66 34.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.6 19.0 15.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 -28.29 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -142.46 46.37 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -142.77 147.93 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.64 151.04 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.482 HD22 ' CG ' ' B' ' 124' ' ' TYR . 49.0 mt -128.53 29.23 5.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.38 32.91 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.01 -18.98 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.66 117.59 23.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.02 137.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.482 HG22 ' H ' ' B' ' 90' ' ' THR . 6.2 mt -107.98 166.55 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.482 ' H ' HG22 ' B' ' 89' ' ' ILE . 8.3 m -153.14 123.45 7.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.68 HG13 HD12 ' B' ' 45' ' ' ILE . 3.6 mp -112.58 122.51 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.254 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.13 135.99 51.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.764 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' B' ' 43' ' ' TRP . 10.9 p90 -141.32 145.12 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.419 HG21 ' HA ' ' B' ' 109' ' ' PHE . 5.0 t -131.22 149.88 52.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -51.59 136.09 27.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.22 129.84 65.13 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . 0.47 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 53.0 Cg_exo -55.1 159.93 9.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.444 2.096 . . . . 0.0 112.235 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.84 124.94 13.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.01 42.34 80.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.54 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.48 ' HB1' ' CZ2' ' B' ' 108' ' ' TRP . . . -59.45 143.07 50.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.09 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.22 164.42 7.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.084 0.468 . . . . 0.0 111.266 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.84 69.28 9.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.575 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.7 129.41 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.825 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.428 ' CE2' ' SG ' ' B' ' 59' ' ' CYS . 34.9 t80 -49.02 128.09 15.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.012 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.07 150.52 40.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -85.9 -36.66 19.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.59 -19.68 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.306 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.48 ' CZ2' ' HB1' ' B' ' 100' ' ' ALA . 18.2 m0 -53.62 -22.4 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.104 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.419 ' HA ' HG21 ' B' ' 94' ' ' THR . 57.6 m-85 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.76 0.314 . . . . 0.0 110.948 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.897 0.38 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 43.6 t -91.68 150.01 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.64 139.72 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.766 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.22 146.54 50.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.41 159.44 43.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.732 ' O ' HD22 ' B' ' 120' ' ' LEU . 87.2 m-20 -128.9 147.83 50.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.381 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.732 HD22 ' O ' ' B' ' 119' ' ' ASN . 1.9 mm? -138.25 86.75 16.67 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.38 147.76 92.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.586 2.191 . . . . 0.0 112.576 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 28.8 mm -100.72 152.2 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.442 ' HB3' ' CB ' ' B' ' 18' ' ' VAL . 7.1 tp10 -141.63 154.52 45.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.896 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.482 ' CG ' HD22 ' B' ' 84' ' ' LEU . 2.4 m-85 -113.56 126.96 55.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.492 ' HB2' HG22 ' B' ' 18' ' ' VAL . 10.0 t30 -109.67 81.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.913 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo . . . . . 0 N--CA 1.465 -0.193 0 CA-C-O 120.722 0.218 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' CG ' ' HG3' ' A' ' 116' ' ' ARG . 65.4 Cg_endo -73.95 110.39 3.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.526 2.151 . . . . 0.0 112.261 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.94 132.81 28.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.957 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.2 m-20 -55.78 140.41 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.632 HG23 ' NE1' ' A' ' 93' ' ' TRP . 9.2 pt -102.78 146.34 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.2 142.85 27.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.91 151.54 51.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.024 0.44 . . . . 0.0 111.16 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -135.67 111.5 10.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.528 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.97 165.09 43.11 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.958 -1.268 . . . . 0.0 112.609 0.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.9 t -45.57 -70.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.431 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.797 ' HA ' HD22 ' A' ' 120' ' ' LEU . 4.4 mt-30 -154.76 39.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.007 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 137.9 4.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.242 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 12.3 tt -148.2 138.34 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.795 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 123' ' ' GLU . 48.2 t -119.11 116.23 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 111.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.38 95.9 2.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.349 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -70.55 135.8 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.594 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.867 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -74.8 172.6 8.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.381 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.867 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 92.3 Cg_endo -82.12 163.87 75.32 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 124.275 -1.135 . . . . 0.0 113.065 0.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.06 45.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 76' ' ' THR . 70.8 m-20 -124.97 8.11 8.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.64 8.38 3.07 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.454 ' HG3' ' CG2' ' A' ' 76' ' ' THR . 15.0 mttt 62.5 137.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -140.17 95.81 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.945 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -76.16 118.21 18.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.748 ' O ' HG12 ' A' ' 72' ' ' VAL . 95.7 m-85 -101.79 111.71 24.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -84.2 135.38 34.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.3 mt -112.92 138.0 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.686 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 125.66 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.655 HD11 ' CE ' ' A' ' 70' ' ' MET . 14.3 mt -120.63 155.0 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.426 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.2 m -150.64 158.32 44.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 111.221 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -96.29 108.95 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.738 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.957 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -95.37 22.42 6.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.094 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.57 -152.07 10.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.613 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.9 -19.43 4.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.696 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.04 152.73 39.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.318 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 168.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.752 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.744 HD12 ' CD1' ' A' ' 93' ' ' TRP . 25.1 pt -155.34 149.05 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.642 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.49 112.62 3.88 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.13 161.52 13.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 0.0 111.85 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 151.28 37.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.115 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.1 144.18 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 111.891 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.07 143.98 46.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 89' ' ' ILE . 76.9 p -138.68 150.63 46.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.069 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.0 78.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -137.51 114.49 10.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.7 mtp -90.46 10.57 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.567 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.12 -35.48 10.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.927 0.394 . . . . 0.0 110.626 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HD3' ' CG ' ' A' ' 77' ' ' PHE . 2.5 ttm180 -94.55 -25.5 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.779 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.17 141.1 50.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.8 p -133.8 110.98 10.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.42 121.79 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.027 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -142.2 131.02 11.97 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.948 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.8 140.81 67.66 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.658 -1.392 . . . . 0.0 112.154 -0.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.25 -39.65 12.7 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 21.9 m -138.19 167.12 22.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.26 -168.73 41.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.731 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 41' ' ' ILE . 11.7 p -150.6 138.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.64 0.257 . . . . 0.0 110.832 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 66' ' ' GLU . 1.1 pt? -134.19 151.35 51.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.403 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.444 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 1.1 m-20 -84.11 178.01 2.65 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 27.7 Cg_exo -62.45 127.48 21.0 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.736 2.291 . . . . 0.0 112.422 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER 81.61 -7.98 1.39 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.035 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.519 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -81.34 156.74 25.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.6 149.74 51.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.976 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.62 152.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 mt -104.85 138.49 41.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 33' ' ' ILE . 43.1 mtm -129.21 154.12 47.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.77 117.61 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.312 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 29' ' ' TYR . 7.5 p -106.31 86.84 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.9 131.29 42.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.63 97.55 5.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.732 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -51.94 148.92 5.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.17 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' A' ' 26' ' ' LYS . 3.2 p -64.23 138.37 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 21.7 p90 -154.21 -173.69 4.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -105.68 109.47 21.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.02 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -95.43 18.89 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.81 -24.15 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -139.17 52.13 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -141.6 176.16 9.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.63 112.24 25.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.538 HD13 ' CD2' ' A' ' 124' ' ' TYR . 22.9 mt -134.25 60.38 1.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -141.98 17.31 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.352 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.08 10.02 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.77 137.25 39.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HA ' HG12 ' A' ' 122' ' ' ILE . 13.6 ptt180 -163.4 133.86 4.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 47' ' ' THR . 56.7 mt -96.74 112.09 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 118' ' ' LYS . 87.6 m -93.98 122.49 36.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.4 mp -111.49 109.93 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.884 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.04 131.73 55.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.976 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.744 ' CD1' HD12 ' A' ' 41' ' ' ILE . 5.9 p90 -136.5 141.81 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 1.3 t -131.85 144.55 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.76 143.05 26.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 144.13 57.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 43.3 Cg_endo -67.7 159.17 53.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.562 2.175 . . . . 0.0 112.165 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -51.45 124.06 11.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.05 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.38 35.96 91.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.57 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -65.15 135.92 56.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.814 0.34 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.09 164.48 0.63 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.146 0.498 . . . . 0.0 111.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.39 70.2 7.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.567 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.38 139.04 0.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -50.49 139.25 16.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 1.2 mmp_? -129.97 148.57 51.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -32.62 39.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.6 -9.48 58.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.46 ' CG ' ' HB2' ' A' ' 105' ' ' ARG . 17.6 m0 -62.66 -18.49 62.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.57 0.224 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 94' ' ' THR . 10.6 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.745 0.307 . . . . 0.0 110.795 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 94' ' ' THR . 11.0 t -106.43 130.25 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.426 ' HD3' ' CZ2' ' A' ' 93' ' ' TRP . 13.6 mtt-85 -94.31 135.11 36.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -123.55 118.68 27.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -117.93 162.97 17.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.814 ' C ' HD23 ' A' ' 120' ' ' LEU . 3.0 p30 -140.87 143.22 34.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 119' ' ' ASN . 4.6 mt -124.6 104.65 30.8 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.678 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.93 138.7 87.17 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.489 2.126 . . . . 0.0 112.453 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 14.1 mm -113.93 104.91 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.958 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.739 ' O ' HG13 ' A' ' 18' ' ' VAL . 4.2 mt-10 -97.05 117.92 32.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 84' ' ' LEU . 11.6 m-85 -81.8 99.39 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.407 ' HB2' HG12 ' A' ' 18' ' ' VAL . 1.4 m-20 -73.8 83.65 1.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.007 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 79' ' ' ALA . 30.6 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.749 0.229 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.402 ' CG ' ' HG3' ' B' ' 116' ' ' ARG . 66.4 Cg_endo -73.96 110.35 3.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.536 2.157 . . . . 0.0 112.249 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.86 132.86 27.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.958 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 37.2 m-20 -55.77 140.43 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.625 HG23 ' NE1' ' B' ' 93' ' ' TRP . 9.4 pt -102.82 146.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.209 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.26 142.97 26.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.01 151.38 51.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -135.6 111.42 10.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.12 164.96 44.42 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.958 -1.267 . . . . 0.0 112.607 0.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.5 t -45.43 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.476 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.815 ' HA ' HD22 ' B' ' 120' ' ' LEU . 4.4 mt-30 -154.75 39.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.044 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.8 137.86 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.262 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 12.4 tt -148.24 138.25 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.725 HG13 ' O ' ' B' ' 123' ' ' GLU . 48.0 t -118.99 116.29 50.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.526 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.55 95.98 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -70.51 135.85 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.889 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -74.77 172.52 8.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.889 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -82.23 164.13 74.53 Favored 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.257 -1.143 . . . . 0.0 112.975 0.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.31 45.35 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 70.7 m-20 -124.95 7.93 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.36 8.29 3.13 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' B' ' 76' ' ' THR . 15.1 mttt 62.7 138.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.661 0.267 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -140.53 95.76 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -76.05 118.47 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.734 ' O ' HG12 ' B' ' 72' ' ' VAL . 95.9 m-85 -102.04 111.87 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -84.49 135.46 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.225 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 41.8 mt -112.92 138.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.715 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 125.59 54.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.961 0.41 . . . . 0.0 111.186 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.666 HD11 ' CE ' ' B' ' 70' ' ' MET . 14.1 mt -120.6 155.0 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.872 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 33' ' ' ILE . 52.4 m -150.65 158.42 44.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.057 0.456 . . . . 0.0 111.279 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -96.24 109.13 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.705 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.958 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -95.56 22.49 7.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.53 -151.99 9.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.93 -19.52 4.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.61 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.2 152.68 39.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.993 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 168.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.687 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.761 HD12 ' CD1' ' B' ' 93' ' ' TRP . 24.8 pt -155.29 149.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.622 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -106.65 112.86 3.92 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.31 161.52 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.279 0.561 . . . . 0.0 111.935 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.03 151.45 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.146 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.23 144.1 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 111.876 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.04 143.84 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.34 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.475 HG22 HG12 ' B' ' 89' ' ' ILE . 74.7 p -138.58 150.73 46.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.017 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -36.04 78.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -137.56 114.55 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 42.5 mtp -90.53 10.76 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.46 -35.09 10.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 0.0 110.604 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.411 ' HD3' ' CG ' ' B' ' 77' ' ' PHE . 2.5 ttm180 -94.87 -25.5 16.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.23 141.01 50.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 97.7 p -133.81 110.67 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.2 121.71 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -142.1 131.0 12.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.86 140.94 68.56 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.068 -0.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.46 -39.44 12.5 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.109 . . . . 0.0 112.247 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 22.5 m -138.36 167.11 22.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.28 -168.74 41.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.682 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.648 HG23 ' O ' ' B' ' 41' ' ' ILE . 11.8 p -150.7 138.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.674 0.274 . . . . 0.0 110.769 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.522 HD12 ' O ' ' B' ' 66' ' ' GLU . 1.1 pt? -134.34 151.48 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.211 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.442 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 1.1 m-20 -84.25 177.82 2.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 27.8 Cg_exo -62.26 127.18 20.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.787 2.325 . . . . 0.0 112.435 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER 81.95 -8.26 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.977 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.522 ' O ' HD12 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -81.16 156.84 25.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.55 149.85 51.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.81 152.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 12.6 mt -104.72 138.3 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.666 ' CE ' HD11 ' B' ' 33' ' ' ILE . 43.1 mtm -128.98 154.16 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.87 117.6 13.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.734 HG12 ' O ' ' B' ' 29' ' ' TYR . 7.3 p -106.46 86.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.98 131.2 41.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 p -123.39 97.59 5.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.702 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -52.17 148.92 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.058 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' B' ' 26' ' ' LYS . 3.2 p -64.3 138.31 58.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.411 ' CG ' ' HD3' ' B' ' 52' ' ' ARG . 21.3 p90 -154.12 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' B' ' 82' ' ' GLU . 42.3 m-80 -105.73 109.67 21.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.953 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.76 19.23 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.428 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.35 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.3 p -139.2 52.21 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' B' ' 78' ' ' ASN . 8.6 mm-40 -141.65 175.92 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.51 111.95 24.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' B' ' 124' ' ' TYR . 22.4 mt -134.04 60.54 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -142.03 17.27 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.1 10.09 2.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.89 137.27 39.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -163.45 133.88 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.475 HG12 HG22 ' B' ' 47' ' ' THR . 55.8 mt -96.78 112.03 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 118' ' ' LYS . 88.5 m -93.87 122.53 36.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.333 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.454 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.4 mp -111.62 109.83 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.877 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -111.92 131.8 55.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.761 ' CD1' HD12 ' B' ' 41' ' ' ILE . 5.8 p90 -136.62 141.84 43.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.023 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.549 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 1.3 t -131.86 144.5 50.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.66 142.96 26.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.12 144.34 58.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . 0.444 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 41.5 Cg_endo -67.93 159.2 53.98 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.658 2.239 . . . . 0.0 112.215 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -51.46 123.83 10.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.45 35.94 91.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -65.05 136.04 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.754 0.311 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.38 164.24 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.218 0.532 . . . . 0.0 111.277 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 70.27 7.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.653 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.33 138.95 0.09 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.39 138.91 16.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.466 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 1.2 mmp_? -129.69 148.48 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -32.51 40.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.73 -9.22 58.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.649 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.466 ' CG ' ' HB2' ' B' ' 105' ' ' ARG . 17.9 m0 -62.86 -18.63 63.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.658 0.266 . . . . 0.0 111.256 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' B' ' 94' ' ' THR . 10.6 m-85 . . . . . 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.36 . . . . 0.0 110.891 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' B' ' 94' ' ' THR . 11.1 t -106.41 130.36 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.425 ' HD3' ' CZ2' ' B' ' 93' ' ' TRP . 13.8 mtt-85 -94.46 134.86 36.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.076 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -123.43 118.59 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.548 ' O ' HG23 ' B' ' 90' ' ' THR . 0.0 OUTLIER -117.82 163.06 17.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.754 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.816 ' C ' HD23 ' B' ' 120' ' ' LEU . 3.1 p30 -141.08 143.23 34.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.142 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.816 HD23 ' C ' ' B' ' 119' ' ' ASN . 4.5 mt -124.51 104.49 31.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.82 138.76 86.98 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.503 2.135 . . . . 0.0 112.429 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 13.8 mm -113.95 104.8 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.946 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.725 ' O ' HG13 ' B' ' 18' ' ' VAL . 4.1 mt-10 -96.95 117.77 31.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.981 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.54 ' CD2' HD13 ' B' ' 84' ' ' LEU . 11.1 m-85 -81.76 99.2 8.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.41 ' HB2' HG12 ' B' ' 18' ' ' VAL . 1.4 m-20 -73.68 83.63 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.054 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.9 mt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.908 179.751 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.683 0.201 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.65 106.29 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.621 2.214 . . . . 0.0 112.24 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.65 129.91 49.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.2 m-20 -55.0 128.87 35.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.857 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.2 138.69 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.318 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 149.73 39.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.693 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.29 149.87 35.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.962 0.411 . . . . 0.0 111.094 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.9 mm-40 -144.86 107.17 4.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.662 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.87 154.64 61.49 Favored 'Cis proline' 0 C--N 1.352 0.717 0 C-N-CA 123.748 -1.355 . . . . 0.0 112.457 0.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.2 m -59.45 -53.11 61.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -160.05 39.89 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.47 111.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.085 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -129.9 134.01 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.941 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.721 HG23 ' HB3' ' A' ' 123' ' ' GLU . 6.1 p -130.69 110.63 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -57.34 154.37 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.968 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.14 120.13 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.372 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -50.33 169.01 0.21 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.848 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 61.4 Cg_endo -72.7 163.44 88.73 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.443 0.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 24.4 m-85 -111.63 34.92 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.017 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.76 4.5 25.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.72 131.63 20.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.826 0.346 . . . . 0.0 110.74 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -51.77 122.58 8.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -118.39 150.22 39.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.642 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.72 109.83 14.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.643 ' O ' HG12 ' A' ' 72' ' ' VAL . 14.6 m-85 -98.33 116.59 30.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.406 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -81.4 130.6 35.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.739 HD12 ' HE3' ' A' ' 70' ' ' MET . 12.2 mt -110.77 143.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.527 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 131.6 46.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 111.47 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.441 HD11 ' CE ' ' A' ' 70' ' ' MET . 64.2 mt -125.93 154.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.639 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.2 m -153.21 156.65 38.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 111.328 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -105.66 109.31 21.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -94.61 21.64 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.89 -145.47 13.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.545 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.79 -39.39 0.29 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -103.36 159.34 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -52.04 158.68 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.77 117.18 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 111.545 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.0 116.91 4.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.906 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.896 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 26.2 p-90 -113.78 154.9 26.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.597 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.61 156.33 45.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.896 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 2.3 mp -118.08 147.29 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.434 . . . . 0.0 111.742 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -145.27 131.26 19.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 p -113.19 150.09 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.567 HG23 ' HG3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -51.86 -36.2 47.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.07 115.81 11.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.8 mmm -93.31 21.86 5.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.411 ' NH1' ' HB2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -104.45 -37.22 7.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.869 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -101.99 -27.94 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.013 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.5 150.16 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.61 109.75 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.76 144.47 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -159.27 136.38 6.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.52 144.54 81.34 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.66 -1.392 . . . . 0.0 112.236 0.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 -4.85 15.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.589 2.192 . . . . 0.0 112.96 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -171.87 161.67 5.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 169.96 157.75 12.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.608 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 t -94.14 134.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 62' ' ' LEU . 5.5 tp -108.89 132.87 53.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.441 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -88.87 168.37 15.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 25.3 Cg_endo -62.12 113.59 1.95 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.538 2.158 . . . . 0.0 112.359 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.7 30.89 2.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.67 148.37 24.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.792 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' CG ' ' OG1' ' A' ' 34' ' ' THR . 42.0 mttt -115.64 121.87 43.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 14.0 p -112.4 146.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.73 147.12 23.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.253 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.739 ' HE3' HD12 ' A' ' 31' ' ' ILE . 13.4 ttp -129.47 156.93 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.494 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.42 122.38 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.591 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 29' ' ' TYR . 12.6 p -111.91 115.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.27 129.26 46.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.6 t -116.18 127.57 54.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.66 147.99 31.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.111 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 76' ' ' THR . 2.7 p -62.65 161.02 12.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -176.68 -175.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 111.02 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.43 108.65 20.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.28 18.7 6.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.453 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.48 -38.4 12.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.3 p -131.31 44.31 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.074 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -138.13 177.25 8.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.833 ' O ' HD23 ' A' ' 84' ' ' LEU . 96.9 m-20 -91.3 149.66 21.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.988 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 83' ' ' ASP . 47.5 mt -139.46 29.37 2.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.54 26.59 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.53 -12.51 9.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.53 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.77 120.33 24.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.567 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.8 OUTLIER -149.94 134.52 17.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.91 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.696 HG13 HD11 ' A' ' 122' ' ' ILE . 5.8 mt -98.12 165.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.575 HG21 ' HD2' ' A' ' 117' ' ' ARG . 92.4 m -136.73 118.77 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.951 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.8 mp -116.59 108.88 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.78 156.71 24.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -155.81 141.11 17.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.587 ' HB ' HG23 ' A' ' 115' ' ' VAL . 13.6 t -138.57 154.65 48.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -68.0 128.81 37.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.45 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 20.9 p -70.38 139.81 87.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.784 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 72.1 Cg_exo -48.25 164.22 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.417 2.078 . . . . 0.0 112.35 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.26 99.73 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.64 45.3 94.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.473 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.17 -85.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.744 0.307 . . . . 0.0 111.102 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.38 1.51 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.126 0.489 . . . . 0.0 111.277 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 70.45 10.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.67 124.26 0.05 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.463 ' HA ' ' CZ3' ' A' ' 108' ' ' TRP . 31.7 t80 -56.46 145.03 28.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -135.31 156.36 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.14 30.32 1.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -116.96 -34.14 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.958 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CD1' ' CD ' ' A' ' 97' ' ' PRO . 24.7 m0 -59.3 -29.71 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 115' ' ' VAL . 4.6 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 109' ' ' PHE . 7.4 p -111.54 130.74 64.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -104.04 154.5 19.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.824 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.575 ' HD2' HG21 ' A' ' 90' ' ' THR . 1.4 ttp85 -132.47 141.93 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -126.74 163.07 24.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.7 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -141.03 124.24 16.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.033 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.37 117.24 57.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.772 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.89 137.38 32.07 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.33 2.02 . . . . 0.0 112.236 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.696 HD11 HG13 ' A' ' 89' ' ' ILE . 8.7 mm -105.68 136.06 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.721 ' HB3' HG23 ' A' ' 18' ' ' VAL . 2.2 mt-10 -124.95 157.94 34.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 88.0 m-85 -120.62 96.68 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.241 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.447 ' ND2' HG12 ' B' ' 18' ' ' VAL . 66.4 t30 -79.2 81.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.894 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.898 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo . . . . . 0 CA--C 1.526 0.125 0 CA-C-O 120.748 0.228 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.81 106.4 1.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.541 2.161 . . . . 0.0 112.248 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.82 129.76 48.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.443 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.726 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 8.4 m-20 -54.78 128.63 33.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.84 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.12 138.89 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.88 149.81 39.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.38 149.92 35.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.532 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.8 mm-40 -144.88 107.34 4.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.648 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' LYS . 26.4 Cg_endo -61.72 154.72 60.44 Favored 'Cis proline' 0 C--N 1.351 0.668 0 C-N-CA 123.802 -1.333 . . . . 0.0 112.391 0.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.9 m -59.58 -53.13 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.9 39.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' B' ' 13' ' ' PRO . 0.3 OUTLIER -163.47 111.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.063 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.02 133.99 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.732 HG23 ' HB3' ' B' ' 123' ' ' GLU . 6.1 p -130.67 110.76 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.284 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 21.6 m-85 -57.37 154.39 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.92 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.36 119.95 37.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.827 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -50.13 169.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.928 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.827 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 60.5 Cg_endo -72.55 163.67 87.83 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.598 -1.417 . . . . 0.0 112.385 0.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 24.4 m-85 -111.76 34.7 4.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.6 4.61 26.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.312 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -144.74 131.55 20.16 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.831 0.348 . . . . 0.0 110.85 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -51.64 122.73 8.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.038 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -118.67 150.08 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.552 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.56 109.97 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 111.217 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 72' ' ' VAL . 15.0 m-85 -98.5 116.42 30.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -81.25 130.49 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.484 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.757 HD12 ' HE3' ' B' ' 70' ' ' MET . 12.1 mt -110.81 143.48 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 131.68 46.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 0.0 111.508 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.438 HD11 ' CE ' ' B' ' 70' ' ' MET . 64.4 mt -126.03 154.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.645 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' B' ' 33' ' ' ILE . 53.2 m -153.13 156.66 39.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 111.285 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -105.64 109.45 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.479 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -94.65 21.51 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.231 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.87 -145.5 13.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.67 -39.44 0.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.577 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -103.13 159.36 15.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -52.16 158.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.55 117.19 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.607 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.98 116.89 4.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.876 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.92 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 26.1 p-90 -113.74 154.89 26.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.648 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.58 156.4 45.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.419 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.92 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 2.3 mp -118.06 147.33 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.976 0.417 . . . . 0.0 111.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -145.39 131.14 19.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 68.8 p -113.15 150.14 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.069 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.581 HG23 ' HG3' ' B' ' 88' ' ' ARG . 0.8 OUTLIER -51.94 -36.09 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.809 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.18 115.77 11.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 79.2 mmm -93.33 22.09 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.942 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' B' ' 51' ' ' ARG . 0.1 OUTLIER -104.65 -37.33 7.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 ttp85 -101.9 -27.93 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.42 150.26 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.85 110.02 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.04 144.61 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.37 136.35 6.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.85 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 144.53 81.31 Favored 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.688 -1.38 . . . . 0.0 112.3 -0.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.0 -4.68 15.47 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.947 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -172.01 161.63 5.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 169.91 157.86 12.89 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.656 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.09 134.05 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.794 0.33 . . . . 0.0 110.998 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' ' 62' ' ' LEU . 5.6 tp -108.89 132.53 53.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -88.54 168.34 16.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 24.9 Cg_endo -62.05 113.45 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.509 2.139 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.94 30.6 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 148.37 24.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.416 ' CG ' ' OG1' ' B' ' 34' ' ' THR . 42.1 mttt -115.73 121.83 43.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 13.8 p -112.41 146.15 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.85 147.27 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.194 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.757 ' HE3' HD12 ' B' ' 31' ' ' ILE . 13.4 ttp -129.58 156.92 43.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.471 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.32 122.71 16.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.578 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 29' ' ' TYR . 12.6 p -112.3 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.658 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.62 129.1 46.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 111.297 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.01 127.7 55.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.751 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.81 148.05 31.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -62.84 160.97 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.763 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -176.53 -175.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.37 108.66 20.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.39 18.9 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.456 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.56 -38.54 12.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 111.086 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.0 p -131.2 44.31 2.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -138.06 177.32 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.827 ' O ' HD23 ' B' ' 84' ' ' LEU . 97.2 m-20 -91.35 149.62 21.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.827 HD23 ' O ' ' B' ' 83' ' ' ASP . 47.6 mt -139.5 29.41 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.37 26.31 1.98 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.972 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.18 -12.62 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.64 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.61 120.22 24.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.946 0.403 . . . . 0.0 111.104 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.581 ' HG3' HG23 ' B' ' 48' ' ' THR . 0.8 OUTLIER -149.78 134.6 17.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.911 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.706 HG13 HD11 ' B' ' 122' ' ' ILE . 5.8 mt -98.23 165.56 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.983 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.584 HG21 ' HD2' ' B' ' 117' ' ' ARG . 93.8 m -136.64 118.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.447 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.8 mp -116.58 108.9 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -114.78 156.56 24.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -155.62 141.05 17.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.578 ' HB ' HG23 ' B' ' 115' ' ' VAL . 13.7 t -138.55 154.61 48.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -67.97 128.91 38.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.458 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 21.2 p -70.45 139.8 86.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . 0.481 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 70.9 Cg_exo -48.2 164.08 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.541 2.161 . . . . 0.0 112.303 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.11 99.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.53 45.47 94.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.22 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 70.32 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.75 124.27 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.817 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.464 ' HA ' ' CZ3' ' B' ' 108' ' ' TRP . 30.5 t80 -56.49 145.07 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -135.43 156.38 49.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.19 30.48 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -116.99 -34.2 4.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CD1' ' CD ' ' B' ' 97' ' ' PRO . 25.0 m0 -59.23 -29.84 67.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.58 ' CD2' HG21 ' B' ' 115' ' ' VAL . 4.6 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.58 HG21 ' CD2' ' B' ' 109' ' ' PHE . 7.4 p -111.65 130.7 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -103.9 154.53 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.584 ' HD2' HG21 ' B' ' 90' ' ' THR . 1.4 ttp85 -132.56 142.05 48.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.91 162.93 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -140.94 124.36 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.36 117.45 57.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.734 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 137.39 31.76 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.365 2.044 . . . . 0.0 112.225 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.706 HD11 HG13 ' B' ' 89' ' ' ILE . 8.8 mm -105.66 136.13 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.732 ' HB3' HG23 ' B' ' 18' ' ' VAL . 2.2 mt-10 -124.96 158.08 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.443 ' HB3' ' CE2' ' B' ' 23' ' ' TYR . 87.8 m-85 -120.73 96.54 5.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.435 ' ND2' HG12 ' A' ' 18' ' ' VAL . 66.4 t30 -79.14 81.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 37.1 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.828 -179.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo . . . . . 0 N--CA 1.465 -0.148 0 CA-C-O 120.775 0.24 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.15 146.69 82.41 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.527 2.151 . . . . 0.0 112.223 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.28 113.01 3.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.528 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 14.7 m-20 -48.1 121.56 4.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 0.0 111.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.434 HG12 ' CE2' ' A' ' 93' ' ' TRP . 5.0 pt -93.21 147.02 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -92.67 145.34 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.57 154.15 51.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.136 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.629 ' O ' HG23 ' A' ' 31' ' ' ILE . 13.6 mm-40 -139.97 127.93 12.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.389 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.706 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 51.0 Cg_endo -68.78 163.97 77.55 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.697 0.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.4 -53.21 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.725 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HG3' ' HG ' ' A' ' 120' ' ' LEU . 2.2 tt0 -178.3 50.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.165 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -169.92 107.15 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.174 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -120.95 150.22 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 123' ' ' GLU . 42.4 t -132.99 95.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.0 111.641 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -54.8 97.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.265 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -59.09 151.39 22.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -64.2 169.69 4.42 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.656 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.754 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 66.8 Cg_endo -93.11 164.12 23.14 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.502 -1.041 . . . . 0.0 112.789 0.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.01 37.29 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.695 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.64 -5.87 13.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.59 -161.43 1.29 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.838 0.351 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.39 142.39 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -159.56 91.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.466 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.699 HG23 ' C ' ' A' ' 72' ' ' VAL . 31.5 m -83.3 143.83 30.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.511 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -121.48 130.3 53.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.176 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.35 133.89 42.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.04 0.448 . . . . 0.0 111.671 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 12' ' ' GLN . 9.4 mm -99.99 149.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.05 126.38 46.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.277 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 34' ' ' THR . 37.5 mt -125.09 153.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 33' ' ' ILE . 78.5 m -154.49 155.27 34.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.787 ' HB2' HD12 ' A' ' 62' ' ' LEU . 64.8 t30 -102.86 81.74 2.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -54.75 -23.4 17.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.96 -160.26 7.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.625 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.06 0.94 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.7 139.15 12.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.19 138.59 16.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 95' ' ' ASN . 1.2 pt -137.62 174.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -132.94 98.16 0.34 Allowed Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.684 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.982 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 30.1 p-90 -92.43 155.68 17.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.126 0.489 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.3 158.12 43.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.446 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.982 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -125.32 149.68 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.001 0.429 . . . . 0.0 111.723 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -159.66 131.31 6.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.484 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -109.79 158.39 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.307 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -29.89 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.45 117.8 23.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.18 18.19 7.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -109.4 -43.74 4.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.6 -58.97 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mt -83.9 140.79 31.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.09 107.46 5.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.011 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.812 HG11 ' CG2' ' A' ' 45' ' ' ILE . 3.2 m -74.42 152.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -168.52 113.27 0.56 Allowed Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.35 141.11 70.79 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.304 0.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HB3' HG23 ' A' ' 55' ' ' VAL . 73.6 Cg_endo -75.59 -3.87 14.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.544 2.162 . . . . 0.0 112.747 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.2 p -170.42 147.6 3.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.792 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.23 175.32 43.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 41' ' ' ILE . 6.4 t -106.2 122.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -94.16 125.27 38.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 4.7 m-20 -81.74 161.42 61.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.95 100.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.561 2.174 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt 69.47 45.21 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' HD11 ' A' ' 62' ' ' LEU . 3.4 tp10 -107.61 154.13 21.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -110.77 137.14 48.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.988 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.673 ' CG1' HD21 ' A' ' 62' ' ' LEU . 7.7 p -136.42 145.56 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.91 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.1 117.14 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.419 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 1.8 tmm? -101.66 147.93 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.419 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -113.92 140.91 47.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.439 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.699 ' C ' HG23 ' A' ' 28' ' ' THR . 44.0 t -124.95 84.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -57.23 129.42 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.05 122.07 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -92.31 138.76 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.844 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.38 162.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -169.21 -161.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.19 119.89 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.6 19.42 20.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.39 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.35 -31.01 12.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.3 p -136.87 44.77 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.07 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -144.31 139.81 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.509 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.2 m-20 -54.93 146.59 17.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 83' ' ' ASP . 16.2 mt -130.86 32.24 4.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.26 27.89 1.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -127.68 6.19 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.654 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.04 119.99 39.14 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 122' ' ' ILE . 0.8 OUTLIER -150.47 131.23 14.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.291 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.917 HG13 HD11 ' A' ' 122' ' ' ILE . 37.6 mt -84.67 162.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.51 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.559 HG23 ' ND2' ' A' ' 119' ' ' ASN . 78.2 m -138.66 137.36 36.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 0.0 111.375 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.6 mt -120.53 146.94 24.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.606 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 4.4 mt-10 -149.28 111.59 4.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.192 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.434 ' CE2' HG12 ' A' ' 9' ' ' ILE . 7.8 p90 -123.79 138.53 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.491 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -139.46 130.39 26.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 41' ' ' ILE . 21.1 p30 -54.03 125.03 17.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -67.05 144.68 98.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 163.05 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.433 2.089 . . . . 0.0 112.204 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.46 118.39 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.983 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.37 46.12 52.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.47 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.83 151.13 46.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.12 164.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.284 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 71.13 5.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.6 142.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.763 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.36 134.44 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 155.22 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.986 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -93.4 -6.74 46.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.653 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.81 -17.59 35.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.546 0.213 . . . . 0.0 111.464 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.36 -16.15 32.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.294 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 1.5 m-85 . . . . . 0 C--N 1.332 -0.166 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 t -122.28 117.1 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.34 147.24 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.415 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.457 ' HB3' ' CG ' ' A' ' 92' ' ' GLU . 12.8 ptp180 -143.93 153.84 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.045 0.45 . . . . 0.0 111.507 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -147.73 131.78 17.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.559 ' ND2' HG23 ' A' ' 90' ' ' THR . 1.5 m120 -104.29 134.13 48.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.132 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HG ' ' HG3' ' A' ' 15' ' ' GLN . 6.1 mp -107.79 137.7 19.83 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.5 138.73 17.66 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.542 2.161 . . . . 0.0 112.597 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.917 HD11 HG13 ' A' ' 89' ' ' ILE . 11.5 mm -101.52 146.56 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.029 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.813 ' HB2' HG22 ' A' ' 18' ' ' VAL . 2.7 mt-10 -132.67 163.72 28.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 71.5 m-85 -126.37 131.5 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.195 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.665 ' HB2' HG12 ' A' ' 18' ' ' VAL . 4.2 t30 -120.18 115.16 23.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 8.1 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo . . . . . 0 CA--C 1.528 0.184 0 CA-C-O 120.744 0.227 . . . . 0.0 112.22 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 146.76 82.39 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.554 2.169 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.23 113.21 3.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.451 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.557 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 15.3 m-20 -48.24 121.72 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' B' ' 93' ' ' TRP . 5.1 pt -93.34 146.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -92.83 145.45 24.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.768 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.62 154.24 51.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.098 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.63 ' O ' HG23 ' B' ' 31' ' ' ILE . 13.5 mm-40 -139.95 127.94 12.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 51.1 Cg_endo -68.9 163.77 78.48 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.047 -1.231 . . . . 0.0 112.695 0.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.23 -53.25 4.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.694 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.41 ' HG3' ' HG ' ' B' ' 120' ' ' LEU . 2.2 tt0 -178.32 50.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.141 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -170.04 106.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.7 150.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' B' ' 123' ' ' GLU . 42.2 t -133.07 95.35 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.705 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -54.89 96.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.309 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -59.01 151.21 22.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.761 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.767 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -63.97 169.72 4.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.602 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.767 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 65.5 Cg_endo -93.14 164.07 23.07 Favored 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.476 -1.052 . . . . 0.0 112.834 0.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -102.87 37.23 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.705 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 -5.87 14.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.231 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.58 -161.33 1.27 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.847 0.356 . . . . 0.0 110.957 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.54 142.27 27.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -159.28 91.07 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.42 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.699 HG23 ' C ' ' B' ' 72' ' ' VAL . 31.1 m -83.38 143.88 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.562 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -121.65 130.12 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.159 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.07 133.78 42.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.949 0.404 . . . . 0.0 111.688 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.63 HG23 ' O ' ' B' ' 12' ' ' GLN . 9.6 mm -99.9 149.65 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.89 126.52 46.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 34' ' ' THR . 37.8 mt -125.18 153.83 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.909 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' B' ' 33' ' ' ILE . 82.1 m -154.46 155.23 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.075 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.768 ' HB2' HD12 ' B' ' 62' ' ' LEU . 64.6 t30 -102.9 81.67 2.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -54.73 -23.26 16.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 -160.43 7.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.29 0.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.511 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.83 138.99 12.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.775 0.321 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.18 138.67 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' B' ' 95' ' ' ASN . 1.2 pt -137.76 174.1 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -132.95 98.35 0.34 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.643 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.964 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 29.9 p-90 -92.46 155.82 17.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 111.816 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.47 157.88 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.964 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -125.12 149.46 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.7 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -159.41 131.35 6.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 24.1 p -109.9 158.43 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.93 -29.93 22.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.57 117.91 23.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.27 18.25 7.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -109.3 -43.98 4.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.847 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.35 -59.1 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.68 140.7 31.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.22 107.37 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.821 HG11 ' CG2' ' B' ' 45' ' ' ILE . 3.2 m -74.26 152.16 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.133 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -168.41 113.16 0.57 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.738 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.28 141.09 70.71 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.791 -1.337 . . . . 0.0 112.417 0.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HB3' HG23 ' B' ' 55' ' ' VAL . 73.6 Cg_endo -75.52 -4.11 14.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.529 2.153 . . . . 0.0 112.723 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.3 p -170.25 147.44 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.04 175.38 43.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.479 HG13 ' O ' ' B' ' 41' ' ' ILE . 6.6 t -106.33 122.28 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.143 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.768 HD12 ' HB2' ' B' ' 35' ' ' ASN . 0.2 OUTLIER -93.72 125.34 38.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' B' ' 66' ' ' GLU . 4.7 m-20 -81.85 161.47 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.93 100.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.574 2.183 . . . . 0.0 112.382 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt 69.29 45.44 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.509 ' O ' HD11 ' B' ' 62' ' ' LEU . 3.4 tp10 -107.79 154.23 21.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -110.89 137.14 48.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.668 ' CG1' HD21 ' B' ' 62' ' ' LEU . 7.5 p -136.4 145.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.23 117.19 33.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.421 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 1.8 tmm? -101.68 147.81 26.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.431 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -113.83 140.98 47.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 111.443 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.699 ' C ' HG23 ' B' ' 28' ' ' THR . 43.6 t -124.98 84.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.84 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . 0.508 ' N ' HG23 ' B' ' 28' ' ' THR . 0.4 OUTLIER -57.15 129.48 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.21 121.86 36.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.01 138.76 31.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.44 162.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -169.18 -161.98 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.08 119.99 37.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.54 19.19 20.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.29 -31.09 12.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 73.6 p -136.8 44.8 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -144.49 139.8 28.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.513 ' O ' HD23 ' B' ' 84' ' ' LEU . 1.1 m-20 -54.86 146.68 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.513 HD23 ' O ' ' B' ' 83' ' ' ASP . 16.1 mt -130.91 32.23 4.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.27 28.27 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -127.95 6.17 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.19 120.36 39.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.748 0.309 . . . . 0.0 110.757 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.424 ' HA ' HG12 ' B' ' 122' ' ' ILE . 0.8 OUTLIER -150.79 131.0 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.255 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.931 HG13 HD11 ' B' ' 122' ' ' ILE . 37.2 mt -84.5 161.88 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.585 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.575 HG23 ' ND2' ' B' ' 119' ' ' ASN . 73.6 m -138.49 137.5 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -120.59 146.95 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.684 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 4.3 mt-10 -149.34 111.54 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.868 0.366 . . . . 0.0 111.135 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.429 ' CE2' HG12 ' B' ' 9' ' ' ILE . 7.9 p90 -123.74 138.59 54.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 0.7 OUTLIER -139.6 130.18 25.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.997 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.592 ' HA ' HG22 ' B' ' 41' ' ' ILE . 21.2 p30 -53.78 125.03 16.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.9 p -67.09 144.86 98.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.86 163.03 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.536 2.157 . . . . 0.0 112.162 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.49 118.63 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.031 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.1 46.1 50.98 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.442 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.9 151.26 46.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.17 164.32 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.314 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.54 71.27 5.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.35 142.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.09 134.34 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.14 155.36 31.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -93.51 -6.7 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.691 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.87 -17.49 35.44 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.602 0.239 . . . . 0.0 111.518 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.44 -16.07 32.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.323 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 1.5 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 110.972 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 t -122.59 117.13 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.36 147.22 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.511 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.447 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 12.7 ptp180 -143.87 153.86 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 111.469 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -147.72 131.79 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.575 ' ND2' HG23 ' B' ' 90' ' ' THR . 1.5 m120 -104.25 134.27 47.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.159 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.41 ' HG ' ' HG3' ' B' ' 15' ' ' GLN . 6.0 mp -107.92 137.57 19.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.36 138.42 17.66 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.589 2.193 . . . . 0.0 112.616 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.931 HD11 HG13 ' B' ' 89' ' ' ILE . 11.8 mm -101.19 146.82 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.819 ' HB2' HG22 ' B' ' 18' ' ' VAL . 2.7 mt-10 -132.93 163.8 28.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.478 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 70.1 m-85 -126.48 131.31 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.651 ' HB2' HG12 ' B' ' 18' ' ' VAL . 4.2 t30 -119.8 115.17 23.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 8.2 mt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.732 0.222 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.09 120.94 9.16 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.75 143.66 35.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.379 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.694 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 73.8 m-20 -61.84 114.06 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 3.0 pt -73.31 142.51 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.095 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.455 HD22 ' HB2' ' A' ' 36' ' ' ALA . 2.3 m-80 -86.77 139.09 31.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.76 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 149.49 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 83.4 mm-40 -142.66 105.41 5.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.755 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 155.14 54.13 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 123.844 -1.315 . . . . 0.0 112.348 0.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.9 -44.34 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.931 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.02 44.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.984 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.76 109.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.604 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.8 tt -130.76 142.82 42.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.722 HG11 HG11 ' B' ' 18' ' ' VAL . 7.3 p -139.77 99.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.513 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 19.8 m-85 -52.58 121.65 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.89 131.15 34.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -55.53 168.18 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.803 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 93.2 Cg_endo -83.67 163.89 68.86 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.674 0.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.1 25.46 10.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.847 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.32 7.96 45.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.483 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.478 ' N ' HG22 ' A' ' 76' ' ' THR . 14.2 p-10 -140.73 175.44 9.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -103.1 112.6 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.08 147.62 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 128.62 56.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 19' ' ' PHE . 65.6 m-85 -92.23 119.74 32.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.744 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -78.46 132.77 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.693 HD11 ' CG2' ' A' ' 72' ' ' VAL . 11.1 mt -120.84 148.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.519 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -112.45 125.52 54.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 111.355 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.506 HD11 ' CE ' ' A' ' 70' ' ' MET . 30.3 mt -122.93 151.42 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.508 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 10' ' ' ASN . 99.5 m -147.92 155.66 41.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -98.28 75.65 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -52.62 -26.27 13.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.105 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.49 -148.97 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.33 3.78 4.79 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.108 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -138.0 172.91 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.907 0.354 . . . . 0.0 110.831 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 86.9 mtm180 -70.22 155.45 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.673 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.614 HD12 ' CD1' ' A' ' 93' ' ' TRP . 20.8 pt -149.31 134.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 111.794 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.04 113.17 4.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.487 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.443 ' HE1' HD12 ' A' ' 62' ' ' LEU . 62.1 p-90 -108.58 160.36 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.309 0.576 . . . . 0.0 111.919 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.65 22.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.967 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.696 ' CD1' HG23 ' A' ' 91' ' ' ILE . 11.7 mm -115.49 139.07 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.724 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.85 129.6 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.673 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 89' ' ' ILE . 70.0 p -107.71 148.36 29.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -54.21 -27.71 36.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -125.61 104.37 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.51 24.94 6.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -106.57 -44.67 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.779 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.95 -40.0 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.81 150.23 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.16 177.04 11.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.97 154.44 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -161.85 128.67 2.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 11.3 Cg_exo -71.07 133.26 27.0 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 123.892 -1.295 . . . . 0.0 111.945 -0.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 53.2 Cg_exo -54.91 -47.7 25.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.381 2.054 . . . . 0.0 112.102 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.0 p -136.27 165.83 24.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.668 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.26 -167.77 37.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.566 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 61' ' ' VAL . 11.8 p -138.25 125.35 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.339 . . . . 0.0 111.118 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.951 HD11 ' CG1' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -103.21 160.25 14.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB3' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -110.55 172.32 3.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.435 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 36.6 Cg_exo -60.84 116.23 3.22 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.618 2.212 . . . . 0.0 112.354 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 69.94 27.57 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.231 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' O ' HD23 ' A' ' 62' ' ' LEU . 2.0 mt-10 -103.59 148.24 26.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.476 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.78 136.82 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.223 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.951 ' CG1' HD11 ' A' ' 62' ' ' LEU . 11.8 p -125.88 155.2 35.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.436 ' N ' HG22 ' A' ' 68' ' ' VAL . 83.4 mt -103.63 141.13 36.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.596 ' HE3' HD12 ' A' ' 31' ' ' ILE . 4.3 mtm -124.2 155.7 38.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.41 121.68 31.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.168 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.693 ' CG2' HD11 ' A' ' 31' ' ' ILE . 21.9 t -95.95 100.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -65.87 117.68 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.984 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.5 m -123.03 116.18 23.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.66 151.92 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 25' ' ' ASP . 7.1 p -53.94 167.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 79' ' ' ALA . 34.1 p90 -177.59 -164.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -130.88 98.14 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . . . -72.04 -22.47 61.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.41 -39.0 31.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.9 p -129.82 47.09 2.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -143.24 151.79 40.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.06 147.99 47.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 23.2 mt -125.95 24.09 7.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.27 28.53 1.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.771 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -124.94 7.4 8.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.46 123.88 48.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.23 148.15 35.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.651 HG13 HD11 ' A' ' 122' ' ' ILE . 67.9 mt -118.58 108.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 120.8 33.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.28 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.696 HG23 ' CD1' ' A' ' 45' ' ' ILE . 4.3 mp -111.38 100.21 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.911 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.408 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 11.5 mt-10 -97.66 157.8 15.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.614 ' CD1' HD12 ' A' ' 41' ' ' ILE . 10.2 p90 -163.64 142.36 7.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.039 0.447 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 115' ' ' VAL . 1.5 t -143.06 131.34 22.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -48.05 146.5 2.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.837 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 1.7 p -90.22 140.92 27.32 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.423 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 52.9 Cg_exo -52.18 160.72 3.04 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.496 2.13 . . . . 0.0 111.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.42 117.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.49 48.98 33.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.401 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.49 48.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 111.438 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.7 165.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.129 0.49 . . . . 0.0 111.554 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.12 73.81 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.45 152.35 3.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.881 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -64.25 153.09 39.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.835 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 2.4 mmt180 -142.88 150.25 39.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.032 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.443 ' HB3' ' NH1' ' A' ' 106' ' ' ARG . 8.0 ttp-105 -102.58 25.78 8.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.69 -29.68 7.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.837 ' CZ3' HG22 ' A' ' 96' ' ' THR . 23.2 m0 -62.56 -27.57 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.3 mtm . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.5 p 169.98 98.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.93 160.41 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.133 0.492 . . . . 0.0 111.597 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.408 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 4.8 ptp85 -141.41 104.54 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.751 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -92.17 166.45 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -128.55 152.23 48.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.939 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.99 93.13 17.64 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.04 133.1 53.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.622 2.215 . . . . 0.0 112.471 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.651 HD11 HG13 ' A' ' 89' ' ' ILE . 12.9 mm -99.08 146.05 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.494 ' C ' HG23 ' A' ' 18' ' ' VAL . 36.2 mt-10 -138.36 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.285 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 13.4 m-85 -119.26 137.51 53.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -121.36 78.93 1.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.983 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 CA--C 1.528 0.193 0 CA-C-O 120.75 0.229 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.04 121.03 9.31 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.498 2.132 . . . . 0.0 112.283 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.96 143.74 36.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.337 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 73.8 m-20 -61.94 114.03 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 3.0 pt -73.26 142.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.448 HD22 ' HB2' ' B' ' 36' ' ' ALA . 2.3 m-80 -86.62 139.1 31.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.92 149.57 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -142.84 105.44 5.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.627 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 154.85 54.33 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.894 -1.294 . . . . 0.0 112.317 0.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.41 -44.5 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.93 44.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.69 109.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.147 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.609 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.8 tt -130.57 142.84 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.722 HG11 HG11 ' A' ' 18' ' ' VAL . 7.3 p -139.81 99.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 111.503 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.452 ' HA ' ' CZ ' ' B' ' 29' ' ' TYR . 19.8 m-85 -52.54 121.59 7.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.442 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -86.7 131.02 34.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 111.325 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.792 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -55.33 168.25 0.6 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.792 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 94.8 Cg_endo -83.6 163.81 69.3 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.925 -1.281 . . . . 0.0 112.669 0.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.05 25.46 10.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.951 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.3 7.89 45.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.363 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . 0.483 ' N ' HG22 ' B' ' 76' ' ' THR . 14.4 p-10 -140.71 175.19 9.81 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -102.74 112.55 25.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.2 147.63 51.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 128.62 56.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.452 ' CZ ' ' HA ' ' B' ' 19' ' ' PHE . 66.9 m-85 -92.14 119.66 32.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.35 132.72 37.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.4 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.69 HD11 ' CG2' ' B' ' 72' ' ' VAL . 11.0 mt -120.78 148.53 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.55 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.39 125.47 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.506 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.503 HD11 ' CE ' ' B' ' 70' ' ' MET . 30.1 mt -122.87 151.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.564 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' B' ' 10' ' ' ASN . 99.3 m -147.88 155.49 41.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 0.0 111.553 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -98.2 75.83 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -52.86 -25.92 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.171 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.69 -149.05 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.444 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.26 3.68 4.81 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.93 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -137.9 172.77 12.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.94 0.37 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' B' ' 62' ' ' LEU . 87.0 mtm180 -69.97 155.48 40.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.599 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.631 HD12 ' CD1' ' B' ' 93' ' ' TRP . 20.5 pt -149.36 134.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 0.0 111.781 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.06 113.34 4.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.426 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.44 ' HE1' HD12 ' B' ' 62' ' ' LEU . 61.8 p-90 -108.72 160.24 16.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 0.0 111.866 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 144.9 22.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.033 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.707 ' CD1' HG23 ' B' ' 91' ' ' ILE . 11.9 mm -115.76 139.04 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 111.689 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.76 130.04 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.599 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.524 HG22 HG12 ' B' ' 89' ' ' ILE . 71.4 p -108.23 148.09 30.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.061 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -53.82 -27.98 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.963 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -125.37 104.73 8.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.89 25.07 6.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -106.54 -44.92 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.65 -39.97 6.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.88 150.25 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.18 177.05 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.89 154.68 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -162.16 128.64 2.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' B' ' 58' ' ' PRO . 11.4 Cg_exo -71.09 133.27 27.09 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.888 -1.297 . . . . 0.0 111.96 0.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' B' ' 57' ' ' PRO . 53.1 Cg_exo -55.0 -47.61 25.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.372 2.048 . . . . 0.0 112.123 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 11.7 p -136.33 165.6 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.05 -167.74 37.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.559 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.451 ' O ' HG13 ' B' ' 61' ' ' VAL . 11.9 p -138.28 125.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 111.046 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.944 HD11 ' CG1' ' B' ' 68' ' ' VAL . 0.2 OUTLIER -103.13 160.18 14.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.426 ' HB3' ' CD ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER -110.58 172.4 3.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.747 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.426 ' CD ' ' HB3' ' B' ' 63' ' ' ASP . 36.4 Cg_exo -60.88 116.35 3.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.622 2.215 . . . . 0.0 112.363 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.81 27.83 4.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.452 ' O ' HD23 ' B' ' 62' ' ' LEU . 2.0 mt-10 -103.86 148.23 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.45 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 136.91 55.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.944 ' CG1' HD11 ' B' ' 62' ' ' LEU . 12.0 p -125.98 155.29 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.035 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.447 ' N ' HG22 ' B' ' 68' ' ' VAL . 83.1 mt -103.77 141.28 36.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.597 ' HE3' HD12 ' B' ' 31' ' ' ILE . 4.2 mtm -124.36 155.64 38.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.47 121.77 31.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.201 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.69 ' CG2' HD11 ' B' ' 31' ' ' ILE . 21.9 t -96.02 100.25 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.015 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.5 m -66.03 117.54 8.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.84 116.13 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.73 151.77 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.483 HG22 ' N ' ' B' ' 25' ' ' ASP . 7.2 p -53.8 167.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' B' ' 79' ' ' ALA . 34.2 p90 -177.8 -164.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -130.61 98.29 4.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' B' ' 77' ' ' PHE . . . -72.22 -22.43 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.34 -39.13 30.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.5 p -129.65 47.02 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -143.17 151.81 41.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -71.02 148.38 47.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 23.4 mt -126.26 24.08 6.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.31 28.45 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.738 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -124.9 7.51 8.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.614 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.48 123.78 48.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.06 148.34 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.651 HG13 HD11 ' B' ' 122' ' ' ILE . 67.4 mt -118.67 108.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.48 120.67 33.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.707 HG23 ' CD1' ' B' ' 45' ' ' ILE . 4.3 mp -111.29 100.13 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.411 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 11.4 mt-10 -97.52 157.85 15.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.631 ' CD1' HD12 ' B' ' 41' ' ' ILE . 10.0 p90 -163.69 142.19 7.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 111.183 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 t -142.89 131.48 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.657 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -48.35 146.44 2.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.845 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 1.7 p -90.09 140.86 27.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.85 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . 0.421 ' HD2' ' NE1' ' B' ' 108' ' ' TRP . 53.4 Cg_exo -52.04 160.77 2.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.471 2.114 . . . . 0.0 112.025 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.62 117.61 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.6 48.85 34.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.375 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.36 48.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.83 165.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.176 0.512 . . . . 0.0 111.483 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.13 73.73 1.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.769 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.39 152.26 3.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.06 153.11 38.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 2.4 mmt180 -142.94 150.08 39.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.94 0.4 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.437 ' HB3' ' NH1' ' B' ' 106' ' ' ARG . 8.1 ttp-105 -102.43 25.66 8.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -29.56 7.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.845 ' CZ3' HG22 ' B' ' 96' ' ' THR . 23.4 m0 -62.78 -27.35 69.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 4.3 mtm . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.608 HG13 ' O ' ' B' ' 115' ' ' VAL . 7.4 p 169.88 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.081 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.84 160.55 14.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.158 0.504 . . . . 0.0 111.542 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.411 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 4.6 ptp85 -141.51 104.25 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -92.04 166.47 12.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 111.132 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -128.51 152.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.91 93.17 17.84 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.11 133.23 54.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.651 HD11 HG13 ' B' ' 89' ' ' ILE . 12.9 mm -99.19 146.16 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.504 ' C ' HG23 ' B' ' 18' ' ' VAL . 35.8 mt-10 -138.38 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 13.7 m-85 -119.35 137.12 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.996 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -121.09 79.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.463 -0.272 0 CA-C-O 120.658 0.191 . . . . 0.0 112.398 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.62 132.85 26.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.552 2.168 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.05 -142.78 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.565 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.904 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 5.4 t0 -130.8 136.97 49.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 93' ' ' TRP . 23.0 pt -93.93 153.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.42 133.05 49.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.658 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.7 p -126.42 155.16 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HD3' ' B' ' 22' ' ' PRO . 28.8 mm-40 -139.97 114.54 7.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.84 161.63 67.5 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.924 -1.282 . . . . 0.0 112.497 0.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -50.13 70.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.177 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -167.76 46.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.084 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -162.9 106.96 1.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.931 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 17' ' ' ILE . 11.1 tt -131.19 125.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.129 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.5 p -122.04 101.57 10.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.186 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 22.9 m-85 -47.32 162.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.567 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -122.85 119.4 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.969 0.414 . . . . 0.0 111.545 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.87 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.66 0.13 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.755 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.87 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 77.6 Cg_endo -76.84 164.27 87.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.764 0.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.82 40.92 2.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -108.14 6.8 27.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.4 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.49 -160.99 1.23 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.797 0.332 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.26 112.34 24.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -112.48 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.52 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 113.78 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.429 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 8.7 m-85 -105.51 112.64 25.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.259 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -84.13 145.09 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.638 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.425 HD12 ' CE ' ' A' ' 70' ' ' MET . 3.7 mt -116.12 145.43 21.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.383 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' CD ' ' HG3' ' B' ' 22' ' ' PRO . 6.9 tttt -94.32 129.67 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.962 0.411 . . . . 0.0 111.528 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.6 mt -128.55 151.76 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.705 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -152.33 155.83 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' OD1' HD11 ' A' ' 41' ' ' ILE . 1.3 m-20 -94.61 100.79 12.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -90.48 18.03 6.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.512 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.11 -149.83 19.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.07 -26.75 2.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -125.55 162.39 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.855 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -52.06 168.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.449 HD12 ' CD1' ' A' ' 93' ' ' TRP . 13.9 pt -154.22 129.97 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.635 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.03 106.43 2.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.517 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.18 156.52 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.158 0.504 . . . . 0.0 111.909 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.455 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -148.64 154.72 40.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.036 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG13 ' A' ' 91' ' ' ILE . 9.4 mm -127.73 137.96 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 111.72 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -142.36 129.55 20.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.643 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 HG12 ' A' ' 89' ' ' ILE . 43.9 p -104.25 157.26 17.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.111 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.27 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -143.0 118.33 10.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.17 17.81 6.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.272 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -110.05 -39.22 5.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.365 . . . . 0.0 110.952 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.42 -27.06 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.466 HD11 ' OD2' ' A' ' 87' ' ' ASP . 1.7 mt -116.62 149.72 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -138.83 144.16 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.25 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -133.02 120.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.731 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.18 136.49 24.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 132.49 27.26 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.632 -1.404 . . . . 0.0 112.0 0.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.39 -39.38 44.3 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.334 2.023 . . . . 0.0 112.112 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.24 163.58 35.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.87 154.68 10.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.82 122.34 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.757 0.313 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 68' ' ' VAL . 3.7 tp -98.42 149.27 22.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.46 167.99 12.89 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.76 121.44 9.17 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.632 2.222 . . . . 0.0 112.384 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.85 18.43 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 152.76 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -122.3 153.02 39.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' CG1' HD11 ' A' ' 62' ' ' LEU . 3.2 m -147.63 152.9 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.84 91.93 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.251 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.449 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 35.4 ttp -72.7 158.95 34.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.615 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -124.41 129.82 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.9 93.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.992 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.96 127.61 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.43 101.73 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.753 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.0 145.24 44.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.129 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.39 162.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CZ ' ' CE2' ' A' ' 124' ' ' TYR . 0.5 OUTLIER -168.55 -163.14 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.88 119.14 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.58 18.36 20.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.506 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.95 -23.07 15.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.19 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.9 p -141.44 49.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.1 147.77 21.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -60.61 139.04 57.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 75.2 mt -116.29 27.08 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -146.63 27.59 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.608 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.72 -29.33 9.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 53' ' ' LEU . 1.4 m-20 -62.78 132.93 53.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.903 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -148.5 145.61 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 47' ' ' THR . 71.5 mt -121.39 115.62 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.935 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 118' ' ' LYS . 81.1 m -96.4 124.42 40.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.604 HD13 HD13 ' A' ' 120' ' ' LEU . 4.6 mp -116.32 113.26 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -110.85 155.49 22.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CD1' HD12 ' A' ' 41' ' ' ILE . 6.6 p90 -154.81 129.16 9.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.782 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.72 ' CB ' HG22 ' A' ' 115' ' ' VAL . 4.4 t -130.37 135.08 47.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.4 138.64 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.0 p -76.92 138.79 65.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.36 165.3 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.478 2.119 . . . . 0.0 112.043 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -50.35 105.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.63 48.67 49.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.36 -79.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.404 ' CB ' ' NH1' ' A' ' 105' ' ' ARG . . . 179.5 164.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 111.298 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -92.43 70.29 5.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.22 142.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.761 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -51.69 138.08 23.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.2 149.7 48.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -99.57 25.21 7.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.413 ' HG2' ' HG2' ' A' ' 105' ' ' ARG . 6.8 pt-20 -116.94 -16.54 10.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.409 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -69.27 -19.23 63.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 111.344 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 3.2 m-85 . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.734 0.302 . . . . 0.0 111.261 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.567 ' C ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.992 0.425 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.72 HG22 ' CB ' ' A' ' 94' ' ' THR . 3.8 t 82.84 111.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.238 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.13 151.75 21.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.607 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.99 140.38 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 0.0 111.276 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 90' ' ' THR . 5.3 tttp -126.17 162.12 26.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.546 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -130.88 152.52 50.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.604 HD13 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -139.25 95.73 9.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.729 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 120' ' ' LEU . 26.5 Cg_endo -62.61 127.41 20.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.468 2.112 . . . . 0.0 112.213 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 mm -96.16 154.54 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 93.2 mt-10 -145.66 163.18 35.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.467 ' CE2' ' CZ ' ' A' ' 77' ' ' PHE . 33.7 m-85 -125.35 120.9 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.065 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -100.73 88.98 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.947 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.962 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.73 0.221 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.57 132.78 26.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.527 2.151 . . . . 0.0 112.302 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -142.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.879 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 5.5 t0 -130.69 137.16 49.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' B' ' 93' ' ' TRP . 22.9 pt -94.15 153.01 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.183 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.35 132.98 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -126.42 155.18 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.142 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -139.89 114.49 7.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.588 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.88 161.46 68.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.607 0.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -50.15 70.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -167.78 46.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -162.87 106.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.422 HG23 ' O ' ' B' ' 17' ' ' ILE . 10.9 tt -131.15 125.42 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.659 HG13 ' O ' ' B' ' 18' ' ' VAL . 7.6 p -122.1 101.64 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.494 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 22.9 m-85 -47.4 162.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.576 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -122.94 119.31 30.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.558 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.843 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.07 170.54 0.13 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.755 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.843 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.2 Cg_endo -76.78 164.34 87.63 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.749 0.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.89 40.95 2.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.789 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.34 7.16 27.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.479 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.74 -160.98 1.23 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.833 0.349 . . . . 0.0 110.779 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.4 112.65 25.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . 0.424 ' HB3' ' CZ ' ' B' ' 29' ' ' TYR . 0.3 OUTLIER -112.54 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 113.59 27.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.487 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 8.6 m-85 -105.3 112.65 25.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.259 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -84.08 144.96 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.691 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.429 HD12 ' CE ' ' B' ' 70' ' ' MET . 3.8 mt -116.09 145.36 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.408 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -94.28 129.63 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.977 0.418 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 58.5 mt -128.54 151.65 35.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -152.23 155.73 38.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 111.398 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.431 ' OD1' HD11 ' B' ' 41' ' ' ILE . 1.3 m-20 -94.64 100.76 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.59 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -90.36 18.01 6.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.04 -149.73 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.52 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.19 -26.79 2.85 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.49 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -125.63 162.3 25.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -51.85 168.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' B' ' 93' ' ' TRP . 14.0 pt -154.13 129.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 111.66 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.01 106.45 2.67 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.511 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.28 156.56 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.54 . . . . 0.0 111.85 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.464 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -148.57 155.04 40.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.963 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.599 HD12 HG13 ' B' ' 91' ' ' ILE . 9.3 mm -127.92 137.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -142.39 129.48 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.606 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.541 HG22 HG12 ' B' ' 89' ' ' ILE . 43.8 p -104.13 157.35 17.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.53 -27.6 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.98 118.18 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.713 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.1 17.8 6.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -110.18 -39.04 5.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.48 -27.11 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.454 HD11 ' OD2' ' B' ' 87' ' ' ASP . 1.7 mt -116.59 149.86 38.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -139.01 144.3 38.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.513 HG11 HG21 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -133.27 120.99 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -135.24 136.5 24.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.11 132.44 27.1 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.046 -0.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.37 -39.59 44.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.401 2.067 . . . . 0.0 112.088 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.1 p -146.06 163.51 35.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.344 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.94 154.56 10.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.835 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.65 122.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 111.001 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.514 HD11 ' CG1' ' B' ' 68' ' ' VAL . 3.7 tp -98.58 149.39 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.54 168.06 12.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.94 121.37 9.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 112.356 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.9 18.64 9.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.94 21.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.328 . . . . 0.0 110.767 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -122.43 152.99 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.514 ' CG1' HD11 ' B' ' 62' ' ' LEU . 3.1 m -147.58 152.92 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.016 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.81 92.02 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.232 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.444 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 35.7 ttp -72.78 158.99 34.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.444 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -124.6 129.68 51.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.72 93.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.91 127.49 32.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.28 101.94 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.24 145.11 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.11 162.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.456 ' CZ ' ' CE2' ' B' ' 124' ' ' TYR . 0.5 OUTLIER -168.57 -163.06 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.896 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.95 119.21 38.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.71 18.31 20.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.526 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.22 15.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.7 p -141.3 49.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.22 147.68 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -60.56 139.1 57.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 76.1 mt -116.38 27.23 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.109 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -146.66 27.38 1.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.7 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.63 -29.22 9.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . 0.454 ' OD2' HD11 ' B' ' 53' ' ' LEU . 1.4 m-20 -62.93 132.88 53.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -148.45 145.5 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.996 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.541 HG12 HG22 ' B' ' 47' ' ' THR . 71.5 mt -121.32 115.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.013 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.439 HG23 ' O ' ' B' ' 118' ' ' LYS . 81.7 m -96.23 124.45 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.599 HG13 HD12 ' B' ' 45' ' ' ILE . 4.6 mp -116.33 113.23 42.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.812 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -110.71 155.47 22.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.452 ' CD1' HD12 ' B' ' 41' ' ' ILE . 6.8 p90 -154.9 128.79 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.734 ' CB ' HG22 ' B' ' 115' ' ' VAL . 4.3 t -129.94 135.01 47.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.25 138.69 44.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 68.7 p -77.07 138.79 64.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 165.08 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.525 2.15 . . . . 0.0 112.057 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -50.21 105.41 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.56 48.85 48.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.395 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.65 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 0.0 111.24 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.409 ' CB ' ' NH1' ' B' ' 105' ' ' ARG . . . 179.53 164.76 1.04 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.168 0.509 . . . . 0.0 111.307 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -92.54 70.36 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.699 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.17 141.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.686 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -51.8 137.88 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HG2' ' HG2' ' B' ' 107' ' ' GLU . 0.0 OUTLIER -125.96 149.76 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -99.46 25.11 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.188 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . 0.412 ' HG2' ' HG2' ' B' ' 105' ' ' ARG . 6.7 pt-20 -116.9 -16.64 10.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.45 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -69.2 -19.27 63.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.605 0.24 . . . . 0.0 111.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.308 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . 0.581 ' C ' HG23 ' B' ' 115' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.941 0.4 . . . . 0.0 111.015 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.734 HG22 ' CB ' ' B' ' 94' ' ' THR . 3.9 t 82.82 112.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.248 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.23 151.75 21.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.93 140.13 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 111.315 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.439 ' O ' HG23 ' B' ' 90' ' ' THR . 5.2 tttp -126.1 162.17 25.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -131.0 152.63 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.095 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.596 HD13 HD13 ' B' ' 91' ' ' ILE . 0.3 OUTLIER -139.29 95.87 9.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.646 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.66 127.49 20.81 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.439 2.093 . . . . 0.0 112.132 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 13.1 mm -96.3 154.52 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.268 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -145.63 163.31 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.456 ' CE2' ' CZ ' ' B' ' 77' ' ' PHE . 33.8 m-85 -125.27 121.26 33.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -101.1 88.87 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.948 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.908 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.749 0.229 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ARG . 58.5 Cg_endo -71.63 149.51 55.28 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -165.51 1.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.67 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 1.4 m-20 -111.23 111.88 23.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.88 147.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.58 149.69 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.799 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.36 151.5 45.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.56 107.71 3.81 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.37 157.38 62.06 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.347 0.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.441 ' C ' HD21 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -112.05 -20.15 12.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.277 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.48 ' C ' HD23 ' A' ' 120' ' ' LEU . 37.9 mt-30 -94.71 -45.93 7.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 111.096 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.78 -176.66 0.24 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 122' ' ' ILE . 17.4 tt -144.33 156.28 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' A' ' 123' ' ' GLU . 3.6 p -133.09 92.43 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 19.2 m-30 -50.78 113.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.668 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -79.14 136.21 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.804 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -50.89 168.52 0.24 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.684 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.804 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 2.0 Cg_endo -82.58 163.76 73.94 Favored 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.255 -1.144 . . . . 0.0 112.364 0.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -106.33 26.61 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -110.68 7.1 22.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.106 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -141.46 134.14 28.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.788 0.328 . . . . 0.0 111.034 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -55.42 107.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -116.66 124.15 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.416 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -99.8 113.21 25.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.985 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 85.5 m-85 -89.73 99.33 12.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.489 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -66.68 153.32 43.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.577 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mt -139.27 148.73 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' CB ' ' HG3' ' B' ' 22' ' ' PRO . 25.3 ttmt -104.91 140.48 38.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.41 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 34' ' ' THR . 46.7 mt -131.54 154.03 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.779 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.435 ' N ' HG22 ' A' ' 33' ' ' ILE . 55.0 m -145.47 155.59 43.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.029 0.442 . . . . 0.0 111.189 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.865 ' HB2' HD23 ' A' ' 62' ' ' LEU . 36.0 t-20 -104.08 102.27 12.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -93.42 21.32 6.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.85 -122.86 4.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.542 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.36 -42.0 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.563 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -113.26 166.6 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.44 156.3 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.417 HG12 ' ND2' ' A' ' 35' ' ' ASN . 21.9 pt -143.82 174.01 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -130.33 100.03 0.46 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.918 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 -92.12 159.35 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 111.712 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.64 130.73 11.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.514 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.429 ' CG2' HG11 ' A' ' 55' ' ' VAL . 5.6 mm -100.31 141.09 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.732 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -142.0 131.99 24.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.575 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 55' ' ' VAL . 11.1 p -107.46 156.97 18.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.41 . . . . 0.0 111.399 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -48.32 -29.16 3.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.057 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.38 122.77 13.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.65 -8.62 59.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.417 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.17 -41.19 13.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 110.604 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -84.8 -59.28 2.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.65 134.12 37.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.706 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 m -127.49 109.13 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 47' ' ' THR . 16.0 m -68.29 156.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 32.5 t0 -170.09 113.85 0.48 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.3 149.58 92.19 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.112 -1.203 . . . . 0.0 112.278 0.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.88 -15.31 21.12 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 0.0 112.586 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -179.49 153.26 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.83 167.73 40.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.791 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 t -98.36 120.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.865 HD23 ' HB2' ' A' ' 35' ' ' ASN . 4.5 tp -96.98 162.93 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.418 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -115.17 170.97 4.92 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.19 111.13 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.576 2.184 . . . . 0.0 112.419 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.27 39.79 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -106.74 154.31 21.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.894 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.38 38.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 10.5 p -138.39 143.36 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.937 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.23 151.64 23.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.411 ' CE ' HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -133.47 161.56 34.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.764 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -146.98 118.24 7.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.268 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -107.82 86.51 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.992 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.16 145.57 53.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 43.2 t -136.19 102.96 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.18 150.16 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -67.4 112.46 4.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HE2' ' HB2' ' A' ' 79' ' ' ALA . 44.8 p90 -123.58 178.02 5.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.93 89.97 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . . . -55.18 -26.57 39.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.87 -49.12 59.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.7 p -125.61 50.63 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.068 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -136.28 162.34 33.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -80.12 130.2 35.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.501 HD22 ' CE2' ' A' ' 124' ' ' TYR . 12.2 mt -125.9 52.91 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -112.77 -23.66 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.495 ' HB3' HG21 ' A' ' 48' ' ' THR . 15.0 m120 -65.46 -91.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.842 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 122' ' ' ILE . 2.1 p-10 41.66 84.64 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.573 0.225 . . . . 0.0 111.513 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB2' HG23 ' A' ' 48' ' ' THR . 6.2 mtm-85 -167.4 135.17 2.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.607 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 122' ' ' ILE . 28.1 mt -119.81 163.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.874 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.53 ' N ' HG22 ' A' ' 89' ' ' ILE . 22.2 m -149.59 114.63 5.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.963 0.411 . . . . 0.0 111.363 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 120' ' ' LEU . 4.7 mp -110.37 98.7 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.955 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.89 137.9 40.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.0 p90 -139.08 150.3 45.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.242 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.598 ' HB ' HG13 ' A' ' 115' ' ' VAL . 4.4 t -147.6 132.24 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -53.33 147.79 9.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 p -98.2 142.87 25.27 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.751 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.13 160.62 3.07 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.377 2.051 . . . . 0.0 112.039 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -47.03 116.28 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.175 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.4 50.77 23.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.42 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 62.74 7.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.727 0.299 . . . . 0.0 111.549 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.42 164.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.612 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -104.55 73.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.57 147.83 0.18 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.71 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.41 150.39 48.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.48 146.85 38.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.14 -23.77 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.22 -22.26 64.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.162 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.83 -30.07 71.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' A' ' 115' ' ' VAL . 9.2 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.989 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.598 HG13 ' HB ' ' A' ' 94' ' ' THR . 14.1 t -128.44 128.3 68.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HB2' ' HG2' ' A' ' 6' ' ' PRO . 1.2 ttt180 -96.8 152.61 18.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.582 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.03 130.08 18.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.042 0.449 . . . . 0.0 111.585 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -115.74 162.74 16.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.033 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -131.95 149.34 52.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 0.0 111.48 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 91' ' ' ILE . 2.1 mt -143.26 98.47 5.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 37.2 Cg_exo -57.91 151.04 59.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.703 2.269 . . . . 0.0 112.795 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 89' ' ' ILE . 43.9 mm -101.46 158.26 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.018 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.67 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -140.08 153.66 46.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.902 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.501 ' CE2' HD22 ' A' ' 84' ' ' LEU . 31.7 m-85 -119.81 113.54 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -102.94 82.63 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.975 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 CA--C 1.528 0.191 0 CA-C-O 120.702 0.209 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.412 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 59.4 Cg_endo -71.73 149.54 54.75 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.576 2.184 . . . . 0.0 112.335 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.68 -165.53 1.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.5 m-20 -111.17 111.85 23.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.89 147.54 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.49 149.52 21.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.19 151.55 45.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.6 107.63 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 28.3 Cg_endo -62.33 157.6 61.28 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.824 -1.323 . . . . 0.0 112.377 0.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . 0.434 ' C ' HD21 ' B' ' 120' ' ' LEU . 0.0 OUTLIER -112.39 -20.24 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.231 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.485 ' C ' HD23 ' B' ' 120' ' ' LEU . 37.9 mt-30 -94.67 -46.09 7.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.891 0.376 . . . . 0.0 111.068 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.89 -176.46 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' B' ' 122' ' ' ILE . 17.5 tt -144.69 156.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.244 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.642 HG23 ' HB3' ' B' ' 123' ' ' GLU . 3.5 p -133.22 92.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.566 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 19.0 m-30 -50.87 112.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.74 136.22 37.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.303 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.771 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -50.88 168.62 0.24 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.795 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.771 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 1.9 Cg_endo -82.54 163.73 74.1 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 124.276 -1.135 . . . . 0.0 112.476 0.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.35 26.43 9.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -110.43 6.97 22.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.125 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -141.4 134.22 28.82 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 120.787 0.327 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -55.38 107.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -116.67 124.13 48.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.716 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.404 ' CG2' ' HB1' ' B' ' 71' ' ' ALA . 0.2 OUTLIER -99.75 113.23 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.566 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 85.8 m-85 -89.86 99.44 12.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.471 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -66.73 153.43 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.578 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mt -139.43 148.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 25.4 ttmt -105.03 140.54 38.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.443 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.436 HG22 ' N ' ' B' ' 34' ' ' THR . 46.1 mt -131.45 154.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.828 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.7 m -145.47 155.72 43.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.998 0.428 . . . . 0.0 111.208 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.897 ' HB2' HD23 ' B' ' 62' ' ' LEU . 36.1 t-20 -104.26 102.38 12.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.535 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -93.44 21.23 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.293 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.89 -122.78 4.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.444 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.33 -42.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -113.2 166.63 11.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.49 156.45 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.422 HG12 ' ND2' ' B' ' 35' ' ' ASN . 21.5 pt -143.92 174.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.35 100.0 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.883 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -92.01 159.4 15.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.234 0.54 . . . . 0.0 111.651 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.73 130.81 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.414 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.438 ' CG2' HG11 ' B' ' 55' ' ' VAL . 5.6 mm -100.34 141.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 111.717 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -142.08 131.94 24.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.513 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.445 HG23 HG13 ' B' ' 55' ' ' VAL . 11.4 p -107.52 156.88 18.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 111.316 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.541 HG23 ' HB2' ' B' ' 88' ' ' ARG . 0.0 OUTLIER -48.32 -29.02 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.57 122.82 12.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.77 -8.59 59.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.455 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.12 -41.23 13.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -84.66 -59.59 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.778 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -94.48 134.1 37.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.756 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -127.46 109.01 11.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.445 HG13 HG23 ' B' ' 47' ' ' THR . 16.1 m -68.07 156.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.071 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' B' ' 71' ' ' ALA . 32.9 t0 -169.96 113.87 0.48 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.32 149.81 92.62 Favored 'Cis proline' 0 C--N 1.351 0.667 0 C-N-CA 124.014 -1.244 . . . . 0.0 112.249 0.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.92 -15.45 20.95 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 112.546 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p -179.52 153.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.538 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.46 168.17 41.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.696 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 26.3 t -98.7 121.12 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.011 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.897 HD23 ' HB2' ' B' ' 35' ' ' ASN . 4.6 tp -96.98 163.13 13.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.4 OUTLIER -115.36 171.08 4.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.29 111.32 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.571 2.181 . . . . 0.0 112.349 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.04 39.87 9.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.42 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.6 OUTLIER -106.87 154.38 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.799 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.6 38.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 10.5 p -138.63 143.36 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.28 151.62 23.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.413 ' CE ' HD11 ' B' ' 33' ' ' ILE . 0.7 OUTLIER -133.39 161.6 34.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.728 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' B' ' 56' ' ' ASP . . . -146.96 118.29 7.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.309 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 t -108.03 86.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.35 145.44 53.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.033 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.7 t -136.07 103.19 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.26 150.32 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -67.64 112.47 4.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.472 ' HE2' ' HB2' ' B' ' 79' ' ' ALA . 44.7 p90 -123.47 178.17 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.97 89.91 3.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.472 ' HB2' ' HE2' ' B' ' 77' ' ' PHE . . . -55.1 -26.74 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.028 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.18 57.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 61.3 p -125.65 50.56 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.066 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.12 162.46 32.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -80.15 130.22 35.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.502 HD22 ' CE2' ' B' ' 124' ' ' TYR . 12.6 mt -125.82 52.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -112.51 -23.43 10.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.492 ' HB3' HG21 ' B' ' 48' ' ' THR . 14.9 m120 -65.64 -91.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.779 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . 0.446 ' CB ' ' HB ' ' B' ' 122' ' ' ILE . 2.1 p-10 41.51 84.59 0.02 OUTLIER 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.76 0.314 . . . . 0.0 111.564 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.541 ' HB2' HG23 ' B' ' 48' ' ' THR . 6.3 mtm-85 -167.25 135.17 2.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.643 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.805 HD11 HD11 ' B' ' 122' ' ' ILE . 29.0 mt -119.8 163.69 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.795 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.537 ' N ' HG22 ' B' ' 89' ' ' ILE . 21.8 m -149.5 114.79 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.939 0.4 . . . . 0.0 111.247 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.513 ' CD1' HD12 ' B' ' 120' ' ' LEU . 4.7 mp -110.47 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.861 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 137.79 40.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.832 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -138.97 150.29 45.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.597 ' HB ' HG13 ' B' ' 115' ' ' VAL . 4.6 t -147.7 132.07 17.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -53.19 147.62 9.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -98.08 142.83 25.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.18 160.62 3.14 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.428 2.085 . . . . 0.0 112.022 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -46.98 116.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.58 50.78 24.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.364 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.04 62.81 7.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.726 0.298 . . . . 0.0 111.562 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.36 164.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.24 0.543 . . . . 0.0 111.663 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -104.48 73.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.49 147.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.3 150.44 48.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 146.84 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.677 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.1 -23.68 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.162 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.33 -22.17 64.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.149 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -62.98 -30.08 71.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.062 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' B' ' 115' ' ' VAL . 9.2 m-85 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.983 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.597 HG13 ' HB ' ' B' ' 94' ' ' THR . 13.7 t -128.5 128.32 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.412 ' HB2' ' HG2' ' B' ' 6' ' ' PRO . 1.2 ttt180 -96.82 152.56 18.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.604 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.06 130.06 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.449 . . . . 0.0 111.546 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 90' ' ' THR . 0.0 OUTLIER -115.78 162.73 16.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.966 179.24 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -131.96 149.19 52.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 0.0 111.498 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.513 HD12 ' CD1' ' B' ' 91' ' ' ILE . 2.1 mt -143.25 98.46 5.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.665 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 88' ' ' ARG . 38.0 Cg_exo -57.77 151.03 58.68 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.789 2.326 . . . . 0.0 112.642 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.805 HD11 HD11 ' B' ' 89' ' ' ILE . 43.7 mm -101.47 158.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.968 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.642 ' HB3' HG23 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -140.0 153.67 46.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.891 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.502 ' CE2' HD22 ' B' ' 84' ' ' LEU . 32.1 m-85 -119.84 113.51 20.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -102.96 82.86 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.684 0.202 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.52 109.75 2.7 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.607 2.204 . . . . 0.0 112.226 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.45 135.75 47.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.505 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.2 m-20 -49.25 152.49 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 33' ' ' ILE . 11.3 pt -118.0 147.16 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.63 140.9 31.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.578 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.79 139.12 47.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.188 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -137.25 110.07 9.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 28.8 Cg_endo -62.54 167.52 32.84 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.672 0.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -43.08 -68.41 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.429 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.11 43.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.69 123.54 3.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.037 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.55 151.89 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.4 p -138.61 100.15 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.39 113.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -81.21 132.87 35.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.862 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.11 0.14 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.857 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.862 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 72.1 Cg_endo -76.72 167.74 79.16 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.733 0.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.4 m-85 -115.85 31.54 6.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.013 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.6 6.59 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.271 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.556 ' N ' HG22 ' A' ' 76' ' ' THR . 11.0 m-20 -149.76 -178.57 6.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.14 107.95 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -111.16 132.98 53.87 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.545 HG21 ' HB1' ' A' ' 71' ' ' ALA . 95.4 m -107.15 135.78 48.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.78 ' O ' HG12 ' A' ' 72' ' ' VAL . 6.3 m-85 -116.88 121.81 42.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.642 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.02 150.88 45.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.435 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -133.43 153.96 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.702 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.24 135.25 53.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.409 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 9' ' ' ILE . 69.4 mt -145.46 121.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -118.19 153.46 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 111.108 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.624 ' ND2' HD13 ' A' ' 41' ' ' ILE . 3.7 t-20 -94.54 81.68 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.95 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -63.8 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.43 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.92 -154.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.629 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.72 -19.33 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.743 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -132.61 167.16 20.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.009 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 41' ' ' ILE . 37.6 mtp180 -49.78 164.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.811 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.624 HD13 ' ND2' ' A' ' 35' ' ' ASN . 31.2 pt -156.74 132.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.798 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 60' ' ' GLY . . . -94.13 109.48 3.83 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -99.51 159.3 15.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.988 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.77 155.05 44.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.408 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.464 ' CG2' HG21 ' A' ' 55' ' ' VAL . 25.1 mm -117.24 132.37 67.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 111.586 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 150.8 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.737 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 p -143.27 153.71 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -41.97 95.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.62 114.87 15.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.68 20.6 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -97.14 -31.69 12.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -113.37 -19.25 11.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.3 mt -108.11 132.45 53.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.05 107.74 5.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -100.73 127.12 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.032 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.22 130.96 22.8 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.1 142.86 76.05 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.875 -1.302 . . . . 0.0 112.022 0.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.22 -31.7 43.93 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.434 2.089 . . . . 0.0 112.036 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -145.91 -177.93 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.495 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.404 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . 164.27 -171.0 39.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.596 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.31 129.47 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.604 HD13 HG23 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.4 153.55 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.141 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.2 p30 -90.05 168.1 15.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 32.3 Cg_exo -61.79 133.69 46.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.497 2.131 . . . . 0.0 112.231 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 tttm 77.7 12.07 1.99 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.841 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -108.51 142.98 38.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.187 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.27 161.21 13.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.193 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.604 HG23 HD13 ' A' ' 62' ' ' LEU . 41.8 t -135.62 141.93 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.03 118.95 33.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.946 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.533 ' SD ' HD12 ' A' ' 33' ' ' ILE . 9.8 mtm -112.46 158.21 20.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 28' ' ' THR . . . -126.71 102.23 6.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.22 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 29' ' ' TYR . 7.4 p -88.05 109.43 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.809 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.2 m -91.24 129.88 37.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.302 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 41.0 t -114.99 150.82 35.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.9 154.58 21.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.119 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 25' ' ' ASP . 3.9 p -58.59 161.03 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -173.53 -165.63 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.94 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 92.4 m-20 -121.92 82.86 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 77' ' ' PHE . . . -57.24 -22.11 38.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.216 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.296 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.4 p -141.56 43.13 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.168 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 19.6 mm-40 -122.52 6.5 9.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.26 140.01 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' A' ' 124' ' ' TYR . 2.2 mt -115.23 24.46 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -142.26 28.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.767 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.21 9.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.02 126.91 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.84 139.63 26.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.5 mt -107.35 122.36 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.615 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 118' ' ' LYS . 68.0 m -110.56 118.66 36.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.487 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.15 154.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -149.71 101.72 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.512 ' NE1' HG23 ' A' ' 9' ' ' ILE . 15.1 p90 -122.14 137.9 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.997 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.732 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -134.37 148.97 50.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.029 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -60.22 144.16 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -85.77 150.89 54.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 39.3 Cg_endo -67.04 163.63 33.22 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.5 2.133 . . . . 0.0 112.059 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -47.18 116.45 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.21 46.64 56.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.688 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.688 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -65.13 150.65 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.113 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.41 165.03 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.142 0.496 . . . . 0.0 111.282 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.9 71.33 7.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.621 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.02 140.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.05 120.21 9.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HG2' ' HG2' ' A' ' 107' ' ' GLU . 0.9 OUTLIER -101.16 156.16 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.024 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.77 -27.16 16.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.434 ' HG2' ' HG2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -65.16 -18.22 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.339 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.85 -16.25 57.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.428 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 2.5 m-85 . . . . . 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.596 ' C ' HG23 ' A' ' 115' ' ' VAL . 2.9 mtt . . . . . 0 CA--C 1.523 -0.09 0 CA-C-O 121.03 0.443 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.732 HG13 ' HB ' ' A' ' 94' ' ' THR . 3.3 t 81.76 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.118 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.28 26.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.773 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.76 139.39 46.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.004 0.43 . . . . 0.0 111.174 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 90' ' ' THR . 26.0 mtpp -125.37 166.77 15.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.489 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -121.69 152.05 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -141.31 88.56 9.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 141.8 47.29 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.566 2.177 . . . . 0.0 112.633 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.37 138.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.817 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.6 mm-40 -131.62 159.18 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.264 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.571 ' HB2' HD22 ' A' ' 84' ' ' LEU . 97.7 m-85 -122.8 113.07 18.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 60.4 t30 -95.15 90.57 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' A' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 N--CA 1.465 -0.15 0 CA-C-O 120.729 0.22 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.45 109.75 2.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.508 2.139 . . . . 0.0 112.33 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.38 135.8 47.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 2.1 m-20 -49.31 152.45 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 111.017 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.585 HD12 HG23 ' B' ' 33' ' ' ILE . 11.2 pt -117.99 147.2 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.66 140.82 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.63 139.53 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -137.62 109.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.561 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.564 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 28.7 Cg_endo -62.46 167.29 33.23 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.996 -1.252 . . . . 0.0 112.636 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.3 m -43.01 -68.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.469 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.24 43.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.63 123.19 3.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.19 151.68 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.61 HG13 ' O ' ' B' ' 18' ' ' VAL . 7.4 p -138.36 100.13 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.602 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.38 113.19 1.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . 0.401 HD21 HG13 ' A' ' 18' ' ' VAL . 6.6 m-80 -81.06 132.73 35.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.315 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.856 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.15 170.12 0.14 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.856 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.6 Cg_endo -76.71 167.84 78.86 Favored 'Cis proline' 0 C--N 1.35 0.628 0 C-N-CA 123.898 -1.293 . . . . 0.0 112.699 0.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.5 m-85 -115.87 31.49 6.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.031 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.63 6.65 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.3 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . 0.559 ' N ' HG22 ' B' ' 76' ' ' THR . 11.2 m-20 -149.78 -178.69 6.6 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.75 0.31 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.07 108.08 20.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.942 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -111.43 132.78 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . 0.54 HG21 ' HB1' ' B' ' 71' ' ' ALA . 94.9 m -106.89 135.96 47.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.785 ' O ' HG12 ' B' ' 72' ' ' VAL . 6.5 m-85 -116.91 122.09 43.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.29 150.85 44.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.443 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -133.48 153.8 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.662 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.09 135.32 53.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.439 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.585 HG23 HD12 ' B' ' 9' ' ' ILE . 68.5 mt -145.48 121.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.6 m -118.32 153.47 33.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.63 ' ND2' HD13 ' B' ' 41' ' ' ILE . 3.8 t-20 -94.52 81.63 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -63.74 -15.91 59.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.473 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.04 -154.19 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.84 -19.43 5.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.639 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mtp85 -132.72 167.29 20.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.402 ' O ' HG23 ' B' ' 41' ' ' ILE . 37.8 mtp180 -49.86 164.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.63 HD13 ' ND2' ' B' ' 35' ' ' ASN . 31.3 pt -156.6 132.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.746 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.01 109.22 3.78 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.475 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.46 159.22 15.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.241 0.543 . . . . 0.0 111.899 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.7 155.08 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' HG21 ' B' ' 55' ' ' VAL . 25.4 mm -117.24 132.4 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.928 0.394 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.07 150.65 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.809 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 31.5 p -143.16 153.75 43.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.008 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.6 -42.01 95.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.61 114.85 15.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.64 20.68 7.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . 0.401 ' HG3' ' HG2' ' B' ' 52' ' ' ARG . 3.4 ptp180 -97.21 -31.58 12.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.401 ' HG2' ' HG3' ' B' ' 51' ' ' ARG . 1.4 ptt180 -113.38 -19.34 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -108.06 132.51 53.48 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.09 107.57 5.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -100.56 127.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -131.32 130.96 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.16 142.76 75.74 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.001 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.11 -31.87 44.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.491 2.127 . . . . 0.0 111.97 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 p -145.75 -177.98 5.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.424 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.26 -170.89 39.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.37 129.47 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.589 HD13 HG23 ' B' ' 68' ' ' VAL . 1.0 OUTLIER -125.45 153.57 43.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.193 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.2 p30 -90.2 168.0 15.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.836 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 30.9 Cg_exo -61.71 133.71 46.66 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.455 2.103 . . . . 0.0 112.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.8 tttm 77.53 12.42 2.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.882 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 1.2 tp10 -108.73 142.96 38.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.12 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.19 161.24 13.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.183 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.589 HG23 HD13 ' B' ' 62' ' ' LEU . 41.5 t -135.61 141.65 41.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.097 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 mt -117.78 118.99 33.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.016 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.547 ' SD ' HD12 ' B' ' 33' ' ' ILE . 9.7 mtm -112.53 158.07 20.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' B' ' 28' ' ' THR . . . -126.63 102.12 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.284 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.785 HG12 ' O ' ' B' ' 29' ' ' TYR . 7.3 p -87.88 109.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 43.0 m -91.32 130.06 37.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.1 t -115.09 150.9 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.681 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.98 154.66 21.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.559 HG22 ' N ' ' B' ' 25' ' ' ASP . 3.7 p -58.67 160.87 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' B' ' 79' ' ' ALA . 0.7 OUTLIER -173.38 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 92.4 m-20 -121.91 82.77 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.509 ' HB2' ' CZ ' ' B' ' 77' ' ' PHE . . . -57.26 -22.12 39.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.232 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.335 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -141.72 43.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' B' ' 78' ' ' ASN . 19.8 mm-40 -122.58 6.29 9.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.627 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.41 140.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' B' ' 124' ' ' TYR . 2.2 mt -115.52 24.31 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -142.01 28.33 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.12 9.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.06 126.86 35.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.82 139.79 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 78.2 mt -107.65 122.16 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.631 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.489 HG23 ' O ' ' B' ' 118' ' ' LYS . 64.0 m -110.17 118.77 37.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.369 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.38 154.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.7 101.7 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.506 ' NE1' HG23 ' B' ' 9' ' ' ILE . 15.3 p90 -122.17 137.77 54.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.034 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.718 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.8 OUTLIER -134.26 149.2 50.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.004 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.46 143.99 52.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 70.7 p -85.59 150.89 54.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 39.8 Cg_endo -67.03 163.54 33.54 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.63 2.22 . . . . 0.0 111.996 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -47.1 116.53 1.4 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.12 46.56 56.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.78 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.681 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -65.01 150.69 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.48 164.96 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.462 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -89.78 71.24 7.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.99 140.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.84 120.22 9.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.419 ' HG2' ' HG2' ' B' ' 107' ' ' GLU . 0.9 OUTLIER -101.22 156.2 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.94 -26.86 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.996 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -65.3 -18.39 65.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.303 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.6 -16.39 56.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.405 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 2.4 m-85 . . . . . 0 C--N 1.332 -0.165 0 CA-C-O 120.673 0.273 . . . . 0.0 111.05 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . 0.597 ' C ' HG23 ' B' ' 115' ' ' VAL . 2.9 mtt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.718 HG13 ' HB ' ' B' ' 94' ' ' THR . 3.3 t 81.72 117.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.53 148.08 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.45 139.55 46.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.994 0.426 . . . . 0.0 111.199 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 90' ' ' THR . 25.9 mtpp -125.43 166.72 16.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.595 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -121.77 151.78 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.076 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -140.99 88.56 10.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.17 141.49 48.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.632 2.222 . . . . 0.0 112.607 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.09 138.36 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.597 ' C ' HG23 ' B' ' 18' ' ' VAL . 1.6 mm-40 -131.68 159.06 39.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 111.256 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.578 ' HB2' HD22 ' B' ' 84' ' ' LEU . 97.5 m-85 -122.78 113.04 18.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 60.4 t30 -95.03 90.58 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' B' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.674 0.197 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.9 123.18 8.74 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.557 2.171 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.69 138.32 46.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.3 m-20 -59.03 130.65 48.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.27 120.34 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.225 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 146.75 24.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.631 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.78 153.44 49.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.888 0.375 . . . . 0.0 111.218 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.1 mt-30 -144.85 108.94 4.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.0 165.18 37.32 Favored 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.842 -1.316 . . . . 0.0 112.664 0.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -45.13 -59.61 2.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.934 ' HA ' HD22 ' A' ' 120' ' ' LEU . 22.9 pt20 -170.9 45.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.15 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -178.52 132.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 29' ' ' TYR . 18.7 tt -132.28 153.85 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 125' ' ' ASN . 57.1 t -120.78 92.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.674 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.14 95.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.283 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.81 139.39 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.579 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.913 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -76.56 175.23 4.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.586 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.913 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 40.6 Cg_endo -66.7 165.58 64.44 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.683 0.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.63 43.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -123.06 7.21 9.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.323 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.17 142.14 48.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.3 115.63 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.05 103.3 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -84.76 102.47 13.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 17' ' ' ILE . 93.5 m-85 -89.48 117.91 28.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.39 135.43 33.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 12' ' ' GLN . 22.5 mt -119.98 133.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -97.93 139.18 34.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 111.342 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -133.02 146.22 32.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.652 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.4 m -150.09 156.53 41.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 0.0 111.212 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' HB2' HD23 ' A' ' 62' ' ' LEU . 18.4 t30 -97.89 111.07 23.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.727 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.51 19.45 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.21 -140.49 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.566 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.44 53.19 0.47 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -175.97 177.12 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.445 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 25.5 ttm-85 -77.61 151.15 34.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 62' ' ' LEU . 4.3 pt -146.58 167.47 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 111.38 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -132.64 106.14 0.63 Allowed Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.585 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -104.42 160.41 14.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.259 0.552 . . . . 0.0 111.75 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . . . -157.65 143.11 17.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.461 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.426 HD12 HG13 ' A' ' 91' ' ' ILE . 14.3 mm -99.4 154.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.008 0.432 . . . . 0.0 111.634 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.53 132.08 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.4 149.7 42.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.77 -32.14 69.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.96 109.21 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.732 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.69 24.88 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.013 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.54 -55.38 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.23 -28.23 27.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.46 156.69 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.982 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.44 141.33 28.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.2 p -139.21 161.07 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.966 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -176.49 131.06 0.37 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.813 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.17 148.71 92.58 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.186 0.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.6 -12.8 24.76 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.599 2.2 . . . . 0.0 112.847 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.54 172.75 0.72 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.45 174.48 38.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.449 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' HG2' ' A' ' 40' ' ' ARG . 21.7 t -107.12 114.42 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 35' ' ' ASN . 3.7 tp -87.53 169.54 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.072 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.412 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -129.89 176.3 2.94 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.792 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.6 Cg_exo -61.24 114.45 2.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.633 2.222 . . . . 0.0 112.291 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.69 32.28 13.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -97.9 148.0 23.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -113.53 156.2 24.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.84 144.76 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.04 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.51 137.07 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.0 158.76 34.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.03 35.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.187 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.03 91.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.895 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -82.77 151.67 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.48 116.61 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.11 142.78 58.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 p -56.55 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -133.43 -168.89 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -121.31 119.8 33.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 84' ' ' LEU . . . -98.46 18.92 15.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.47 -24.44 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.229 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.3 p -143.1 41.63 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.036 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -138.33 159.59 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.653 ' O ' HD23 ' A' ' 84' ' ' LEU . 22.6 t0 -89.2 134.19 34.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.9 mt -123.62 56.09 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.48 25.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -134.02 6.58 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.637 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.57 108.21 19.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.812 0.339 . . . . 0.0 110.824 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.08 136.1 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.101 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.805 HG13 HD11 ' A' ' 122' ' ' ILE . 12.8 mt -94.87 163.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.5 ' N ' HG22 ' A' ' 89' ' ' ILE . 10.0 m -144.87 123.96 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.128 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.1 mp -115.51 98.1 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.85 136.93 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.675 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' ' 116' ' ' ARG . 6.6 p90 -145.52 143.69 30.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.161 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -141.46 143.48 33.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.78 122.48 14.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.582 HG22 ' CH2' ' A' ' 108' ' ' TRP . 12.0 p -52.93 145.05 24.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 37.1 Cg_endo -65.79 160.53 43.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.534 2.156 . . . . 0.0 112.292 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.4 119.16 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.7 41.5 97.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.763 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.674 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -71.33 139.57 49.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.8 164.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 0.0 111.403 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 70.32 7.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.45 131.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 73.5 t80 -51.25 152.01 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.33 152.09 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -91.77 -23.71 19.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.069 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -18.91 65.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.39 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CH2' HG22 ' A' ' 96' ' ' THR . 34.6 m0 -60.18 -16.14 30.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.276 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.819 0.342 . . . . 0.0 110.89 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.2 mmt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.2 p 176.84 115.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.446 ' HB3' ' CZ3' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -102.23 154.14 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -139.73 96.82 3.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.029 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.34 162.42 18.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.648 ' C ' HD23 ' A' ' 120' ' ' LEU . 67.2 m-80 -140.56 126.52 19.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.934 HD22 ' HA ' ' A' ' 15' ' ' GLN . 1.4 mt -110.85 100.52 46.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.42 144.13 74.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.604 2.203 . . . . 0.0 112.529 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.805 HD11 HG13 ' A' ' 89' ' ' ILE . 8.2 mm -110.53 93.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.68 140.81 32.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD2' HD13 ' A' ' 84' ' ' LEU . 21.3 m-85 -103.7 104.43 14.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.046 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.524 ' HB2' HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -78.66 82.45 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo . . . . . 0 C--O 1.232 0.193 0 CA-C-O 120.711 0.213 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.02 123.27 8.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.186 . . . . 0.0 112.286 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.7 138.33 46.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.567 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 11.5 m-20 -58.95 130.75 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.37 120.51 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.85 146.89 24.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.537 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.93 153.3 49.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.204 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.612 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.2 mt-30 -144.72 108.99 4.77 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.07 165.17 37.76 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.611 0.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -45.02 -59.55 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.942 ' HA ' HD22 ' B' ' 120' ' ' LEU . 22.9 pt20 -170.95 44.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.148 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -178.49 132.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.41 . . . . 0.0 111.254 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' B' ' 29' ' ' TYR . 18.5 tt -132.25 154.0 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.721 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' B' ' 125' ' ' ASN . 57.5 t -120.98 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.812 0.339 . . . . 0.0 111.579 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -57.21 95.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.277 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.581 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.931 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -76.49 175.28 4.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.931 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 40.2 Cg_endo -66.51 165.73 62.55 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.951 -1.271 . . . . 0.0 112.786 -0.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 43.69 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.89 6.98 9.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.361 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.0 142.06 48.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.849 0.357 . . . . 0.0 110.972 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -65.16 115.44 5.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -115.91 103.16 10.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.749 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -84.53 102.37 12.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.083 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.439 ' CD1' HD11 ' B' ' 17' ' ' ILE . 93.8 m-85 -89.51 117.87 28.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.725 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.26 135.36 33.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.332 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.612 HG23 ' O ' ' B' ' 12' ' ' GLN . 22.6 mt -119.93 133.12 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.681 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -97.99 138.96 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.38 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -132.9 146.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 55.1 m -150.13 156.41 41.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.276 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.537 ' HB2' HD23 ' B' ' 62' ' ' LEU . 18.4 t30 -97.71 111.08 23.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.51 19.34 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.2 -140.26 9.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.6 53.16 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -175.92 177.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.448 ' HG2' ' CG1' ' B' ' 61' ' ' VAL . 25.9 ttm-85 -77.66 151.17 34.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.438 ' O ' HG13 ' B' ' 61' ' ' VAL . 4.3 pt -146.66 167.37 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 111.428 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -132.56 106.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.568 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 34.0 p-90 -104.53 160.57 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 111.703 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' B' ' 104' ' ' PHE . . . -157.87 142.92 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.461 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.423 HD12 HG13 ' B' ' 91' ' ' ILE . 14.2 mm -99.11 154.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.694 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.75 131.94 15.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.25 149.57 42.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.066 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.6 -32.33 68.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.75 109.18 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.66 24.71 5.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -55.3 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.36 -28.24 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.33 156.64 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.5 141.36 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.491 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.2 p -139.29 160.96 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.197 0.522 . . . . 0.0 111.004 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . 0.491 ' N ' HG22 ' B' ' 55' ' ' VAL . 0.5 OUTLIER -176.43 131.08 0.38 Allowed Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.826 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.17 148.6 92.31 Favored 'Cis proline' 0 C--N 1.352 0.731 0 C-N-CA 123.691 -1.379 . . . . 0.0 112.314 -0.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.49 -12.63 24.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.617 2.211 . . . . 0.0 112.916 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.37 172.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.33 174.4 38.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.556 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' B' ' 40' ' ' ARG . 21.7 t -106.99 114.64 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.066 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 35' ' ' ASN . 3.7 tp -87.78 169.35 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.408 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.3 OUTLIER -129.76 176.26 2.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 34.2 Cg_exo -61.17 114.4 2.18 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.665 2.244 . . . . 0.0 112.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.72 32.27 13.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -97.79 148.2 23.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -113.69 156.27 24.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.93 144.72 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.52 137.1 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.08 158.83 34.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.829 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.43 146.76 35.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.78 90.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -82.76 151.47 26.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.32 116.48 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.07 142.76 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -56.58 128.07 34.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.39 -168.8 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.02 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -121.45 119.71 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' B' ' 84' ' ' LEU . . . -98.35 18.93 15.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.38 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.53 -24.47 20.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.8 p -143.14 41.8 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -138.54 159.47 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.644 ' O ' HD23 ' B' ' 84' ' ' LEU . 22.6 t0 -89.1 134.06 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.644 HD23 ' O ' ' B' ' 83' ' ' ASP . 9.0 mt -123.45 55.98 1.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.44 25.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -133.76 6.33 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.687 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.54 108.05 19.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.797 0.332 . . . . 0.0 110.864 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.0 136.27 26.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.03 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.813 HG13 HD11 ' B' ' 122' ' ' ILE . 12.6 mt -94.93 163.92 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.494 ' N ' HG22 ' B' ' 89' ' ' ILE . 9.7 m -144.95 123.89 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.1 mp -115.51 98.05 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.007 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.77 136.94 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.451 ' CZ3' ' HB3' ' B' ' 116' ' ' ARG . 6.7 p90 -145.53 143.7 30.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 2.5 t -141.49 143.51 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.82 122.38 14.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.576 HG22 ' CH2' ' B' ' 108' ' ' TRP . 12.0 p -52.76 144.94 23.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 37.2 Cg_endo -65.81 160.67 42.72 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.617 2.211 . . . . 0.0 112.22 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.43 119.1 3.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.085 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.66 41.92 97.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.587 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.659 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -71.63 139.7 49.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 111.048 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.09 164.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.342 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 70.46 7.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.651 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.51 131.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' B' ' 44' ' ' ALA . 74.1 t80 -51.21 151.98 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.21 152.26 50.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -92.21 -23.49 19.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.056 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -19.0 65.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.348 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.576 ' CH2' HG22 ' B' ' 96' ' ' THR . 34.0 m0 -60.09 -16.36 31.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.213 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 5.1 mmt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.816 0.341 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.521 HG13 ' O ' ' B' ' 115' ' ' VAL . 7.2 p 176.72 115.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.451 ' HB3' ' CZ3' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -102.33 154.21 19.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -139.71 96.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.032 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 162.52 18.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.649 ' C ' HD23 ' B' ' 120' ' ' LEU . 67.2 m-80 -140.59 126.63 19.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.942 HD22 ' HA ' ' B' ' 15' ' ' GLN . 1.4 mt -110.98 100.53 46.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.4 144.15 73.94 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.425 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.813 HD11 HG13 ' B' ' 89' ' ' ILE . 8.3 mm -110.49 93.71 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.195 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.78 141.06 32.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.0 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.406 ' CD2' HD13 ' B' ' 84' ' ' LEU . 21.3 m-85 -103.9 104.43 14.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.516 ' HB2' HG12 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -78.8 82.38 5.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.896 -179.917 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.661 0.192 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.97 119.2 5.9 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.594 2.196 . . . . 0.0 112.284 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.64 131.6 40.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.757 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 5.8 m-20 -48.5 113.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.2 pt -85.12 124.64 40.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.072 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -67.7 138.09 56.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.831 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.52 153.37 51.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.48 102.49 4.66 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.853 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.44 ' HG3' ' HB ' ' A' ' 17' ' ' ILE . 20.2 Cg_endo -60.18 157.51 46.39 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.311 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.59 -10.82 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.763 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.05 -61.5 1.67 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.909 0.385 . . . . 0.0 111.069 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 13' ' ' PRO . 7.2 mttm -143.86 175.19 10.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.236 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' ILE . 19.5 tt -148.11 123.16 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.729 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 123' ' ' GLU . 44.8 t -113.41 118.01 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.457 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 29' ' ' TYR . 48.4 m-85 -77.12 96.03 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.48 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -70.36 131.95 44.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.535 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.745 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -58.39 169.19 1.04 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.736 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.745 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 67.8 Cg_endo -89.1 160.27 38.72 Favored 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.296 -1.127 . . . . 0.0 112.803 0.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.411 ' OH ' ' HB2' ' A' ' 19' ' ' PHE . 32.6 m-85 -97.88 46.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.924 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 76' ' ' THR . 11.1 t70 -132.7 9.0 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.43 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.34 -5.87 7.7 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.59 134.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -153.32 101.27 2.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.2 m -75.12 102.71 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 36.9 m-85 -74.09 116.06 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.21 121.09 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.614 HD12 ' HE3' ' A' ' 70' ' ' MET . 64.7 mt -104.47 126.79 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.38 124.69 36.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.499 HD11 ' CE ' ' A' ' 70' ' ' MET . 13.5 mt -119.29 158.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 33' ' ' ILE . 55.3 m -162.0 153.07 17.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -95.87 108.79 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.628 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -93.34 22.11 5.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.87 -147.29 20.54 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.569 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.71 -25.38 2.86 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.686 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -122.85 167.45 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 110.99 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.43 162.34 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.553 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 8.3 pt -150.24 137.86 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.828 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.47 111.21 4.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.599 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.439 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 27.5 p-90 -105.22 157.86 16.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.116 0.484 . . . . 0.0 111.772 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.65 148.89 33.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.47 HD13 HG23 ' A' ' 91' ' ' ILE . 15.5 mm -121.67 150.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -151.75 135.93 16.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.681 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.36 154.53 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -62.42 -32.67 73.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.014 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.15 108.23 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.962 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.09 25.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.765 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.07 -38.11 6.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.775 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.29 -32.01 7.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.82 118.33 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.673 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.6 m -122.15 106.8 11.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.91 154.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.21 129.88 0.55 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.171 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 10.3 Cg_exo -71.56 131.67 22.12 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.942 -1.274 . . . . 0.0 111.88 -0.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 32.0 Cg_exo -58.23 -48.43 15.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.407 2.071 . . . . 0.0 112.051 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.3 p -135.96 -178.84 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.53 -168.22 33.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.64 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -144.75 142.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -134.04 136.91 44.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.033 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -64.77 -179.66 0.32 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.968 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 29.6 Cg_exo -61.52 116.18 3.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.585 2.19 . . . . 0.0 112.435 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.52 29.8 2.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' CB ' ' HB2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -90.53 153.26 20.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.636 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -115.29 142.57 46.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.264 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.3 129.82 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.775 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.74 141.19 30.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.614 ' HE3' HD12 ' A' ' 31' ' ' ILE . 36.4 ttp -127.58 158.04 38.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.88 151.05 45.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.391 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.7 84.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.015 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.67 133.74 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 87.86 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.807 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.28 152.67 2.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 2.7 p -66.87 117.64 9.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -137.9 -163.99 1.54 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.62 139.04 43.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.712 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.56 18.64 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.509 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.33 15.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.02 47.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -138.29 165.82 25.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.15 127.0 18.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.5 84.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.997 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.53 25.16 7.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.178 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 73.27 93.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -70.37 147.61 49.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -142.35 137.37 30.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.418 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 78.8 mt -110.32 94.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.664 HG23 ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -78.2 140.24 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 45' ' ' ILE . 3.9 mp -132.96 111.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.006 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.91 124.43 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.027 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 11.7 p90 -133.5 142.08 48.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.678 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -141.3 144.99 34.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -60.74 131.36 50.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 p -73.61 142.45 80.8 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.01 162.74 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.475 2.116 . . . . 0.0 112.16 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.44 118.31 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.95 45.65 70.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.265 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.75 167.71 7.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.211 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.11 163.67 27.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.34 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.44 69.83 8.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.13 146.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -69.8 116.72 10.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.99 155.14 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -84.01 -26.04 29.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -22.66 66.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -59.35 -17.7 31.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 94' ' ' THR . 2.7 m-85 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 110.801 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.538 ' C ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 120.959 0.409 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 94' ' ' THR . 5.1 t 82.55 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.252 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.472 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 5.7 tpt180 -106.83 144.27 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -134.04 103.5 5.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 131.49 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.544 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.664 ' OD1' HG23 ' A' ' 90' ' ' THR . 1.5 m-80 -100.17 143.36 30.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.9 94.98 42.96 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.506 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.13 139.2 62.8 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.632 2.221 . . . . 0.0 112.58 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 7.6 mm -114.51 111.9 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.705 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -112.96 127.91 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -89.39 107.4 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.27 76.89 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.946 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo . . . . . 0 C--O 1.231 0.137 0 CA-C-O 120.731 0.221 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.1 119.33 6.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.566 2.177 . . . . 0.0 112.256 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.67 131.4 40.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.293 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.749 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 5.8 m-20 -48.13 113.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 111.019 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.469 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.2 pt -85.13 124.54 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -67.65 138.1 56.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.43 153.34 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.4 102.4 4.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.433 ' HG3' ' HB ' ' B' ' 17' ' ' ILE . 19.1 Cg_endo -60.12 157.71 45.69 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.777 -1.343 . . . . 0.0 112.222 0.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.73 -10.78 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.729 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.06 -61.58 1.66 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.886 0.374 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' B' ' 13' ' ' PRO . 7.5 mttm -143.8 174.96 10.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.232 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.454 HG23 ' O ' ' B' ' 17' ' ' ILE . 19.5 tt -147.94 123.23 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.698 HG13 ' O ' ' B' ' 123' ' ' GLU . 44.4 t -113.49 117.96 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.53 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.461 ' CE2' ' CD1' ' B' ' 29' ' ' TYR . 48.3 m-85 -77.08 95.98 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.531 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -70.28 131.84 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.629 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.766 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -58.39 169.24 1.03 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.68 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.766 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 67.7 Cg_endo -89.12 160.23 38.62 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.712 0.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' B' ' 19' ' ' PHE . 32.5 m-85 -97.92 46.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.882 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 11.1 t70 -132.87 8.98 4.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.345 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -5.97 7.74 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.68 134.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.768 0.318 . . . . 0.0 110.596 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.39 101.35 2.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -75.24 102.75 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CD1' ' CE2' ' B' ' 19' ' ' PHE . 36.9 m-85 -74.17 116.0 14.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' B' ' 70' ' ' MET . 12.2 m80 -94.18 121.02 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.621 HD12 ' HE3' ' B' ' 70' ' ' MET . 64.3 mt -104.37 126.85 59.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.45 124.8 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.508 HD11 ' CE ' ' B' ' 70' ' ' MET . 13.7 mt -119.35 158.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.953 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.435 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.9 m -162.0 153.17 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -95.99 108.91 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -93.44 22.03 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.147 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.78 -147.46 20.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.573 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.59 -25.36 2.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.685 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' B' ' 64' ' ' PRO . 0.0 OUTLIER -122.8 167.46 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.937 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.55 162.32 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.538 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 8.2 pt -150.22 137.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.401 . . . . 0.0 111.878 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -99.46 111.15 4.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.568 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.441 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 27.6 p-90 -105.09 157.85 16.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 111.763 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.68 148.97 33.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.484 HD13 HG23 ' B' ' 91' ' ' ILE . 15.6 mm -121.71 150.67 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 111.679 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -151.8 136.1 16.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.51 154.42 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.387 . . . . 0.0 111.15 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 68.6 p -62.35 -32.76 73.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.03 108.13 13.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.006 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 30.7 mmm -102.92 25.13 9.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.13 -38.17 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.773 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.23 -32.0 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.79 118.63 36.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.667 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m -122.4 106.71 11.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.192 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.85 154.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.27 129.87 0.54 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.61 131.66 22.15 Favored 'Cis proline' 0 C--N 1.35 0.636 0 C-N-CA 123.932 -1.278 . . . . 0.0 111.887 -0.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.23 -48.5 15.61 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.327 2.018 . . . . 0.0 112.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p -135.8 -178.69 5.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.48 -168.32 33.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.651 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.76 142.86 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.733 HD23 ' N ' ' B' ' 62' ' ' LEU . 0.4 OUTLIER -134.28 136.76 43.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.966 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -64.57 -179.73 0.32 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 29.6 Cg_exo -61.62 116.35 3.37 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.547 2.165 . . . . 0.0 112.377 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.44 29.75 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' B' ' 62' ' ' LEU . 0.5 OUTLIER -90.43 153.36 20.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.637 179.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -115.38 142.71 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.264 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.34 129.71 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.815 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.7 141.36 30.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.236 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.621 ' HE3' HD12 ' B' ' 31' ' ' ILE . 36.5 ttp -127.79 158.08 38.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.04 151.01 45.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.354 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.6 84.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.77 133.59 55.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.3 t -141.49 87.83 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.15 152.67 2.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' B' ' 24' ' ' ASP . 2.8 p -66.84 117.97 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -138.2 -164.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.57 139.14 43.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.69 18.64 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.508 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.83 -26.28 15.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 111.033 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -150.02 48.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.49 165.79 25.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.14 126.96 17.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 88.0 mt -151.47 84.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.44 25.11 7.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.216 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 73.49 93.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.894 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.42 147.63 49.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -142.39 137.3 30.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' B' ' 91' ' ' ILE . 77.9 mt -110.23 94.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.676 HG23 ' OD1' ' B' ' 119' ' ' ASN . 0.2 OUTLIER -78.19 140.22 38.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.484 HG23 HD13 ' B' ' 45' ' ' ILE . 3.9 mp -133.02 111.24 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.937 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.93 124.29 50.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.021 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 11.8 p90 -133.44 142.05 48.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.666 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.7 OUTLIER -141.26 145.07 35.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -60.74 131.35 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 3.9 p -73.6 142.36 80.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.05 162.49 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.512 2.141 . . . . 0.0 112.101 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.17 118.23 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.98 45.71 70.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.239 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.76 167.87 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 163.76 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.268 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 69.86 8.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.617 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.3 147.2 0.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.801 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.32 116.7 10.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.892 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.94 154.99 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -83.71 -26.43 29.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -22.68 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -59.45 -17.56 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.249 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.573 ' CZ ' HG22 ' B' ' 94' ' ' THR . 2.7 m-85 . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.891 0.377 . . . . 0.0 110.814 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . 0.542 ' C ' HG23 ' B' ' 115' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.96 0.409 . . . . 0.0 110.897 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.666 HG13 ' HB ' ' B' ' 94' ' ' THR . 5.1 t 82.57 129.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.23 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.474 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 5.7 tpt180 -106.84 144.29 33.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.42 55.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.676 ' OD1' HG23 ' B' ' 90' ' ' THR . 1.5 m-80 -100.08 143.4 30.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.228 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.07 95.11 43.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.383 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 139.21 64.26 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.638 2.225 . . . . 0.0 112.548 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 7.6 mm -114.41 111.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.698 ' O ' HG13 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -112.6 128.05 56.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.098 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -89.63 107.4 19.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.2 76.86 9.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.832 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 CA--C 1.528 0.204 0 CA-C-O 120.602 0.168 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.06 138.72 28.63 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.422 2.081 . . . . 0.0 112.342 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 111.84 2.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.541 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.837 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.3 p-10 -46.95 140.38 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.678 0.275 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 93' ' ' TRP . 1.3 pt -116.71 147.12 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.39 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.2 145.03 25.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.17 144.0 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.297 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -133.05 111.46 13.14 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.59 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 31' ' ' ILE . 32.0 Cg_endo -63.84 161.81 60.19 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.928 -1.28 . . . . 0.0 112.446 0.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -20.48 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.385 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.56 -49.35 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.901 0.381 . . . . 0.0 111.205 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 152.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.605 ' CG2' HD13 ' A' ' 122' ' ' ILE . 12.3 tt -105.95 153.21 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 123' ' ' GLU . 8.0 p -136.19 100.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.418 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.12 114.26 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.542 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.92 142.1 38.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.287 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -66.39 170.6 5.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.732 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 6.9 Cg_exo -73.96 167.04 80.69 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.514 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -110.99 32.84 4.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -117.41 7.22 12.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.25 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.76 149.82 48.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.926 0.393 . . . . 0.0 110.961 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -67.5 107.95 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -108.01 138.09 44.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.846 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.16 112.86 24.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.094 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -105.03 108.5 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -79.76 151.08 30.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.407 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.543 HD12 ' HD2' ' A' ' 13' ' ' PRO . 29.1 mm -126.06 150.06 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.713 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HB2' ' HG3' ' B' ' 22' ' ' PRO . 12.2 ttmm -104.85 120.57 41.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.93 0.395 . . . . 0.0 111.298 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.5 mt -121.9 130.06 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.717 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.5 m -139.76 155.02 47.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.148 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.46 114.24 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.763 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.837 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.35 18.53 7.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.387 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.09 -141.43 6.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.52 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.43 52.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -174.59 164.78 3.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.776 0.322 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.18 137.09 46.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.733 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.415 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 2.5 pt -139.11 114.86 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.33 122.67 9.78 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.919 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.83 ' CD1' HD23 ' A' ' 62' ' ' LEU . 29.4 p-90 -114.63 157.9 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 111.458 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.73 135.96 14.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.693 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.008 HG21 HG11 ' A' ' 55' ' ' VAL . 41.5 mm -93.06 141.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.472 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.26 133.03 15.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.58 160.37 32.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 111.139 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.73 -47.83 41.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -114.29 112.56 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 23.48 6.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.988 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -45.78 3.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -81.99 -50.82 8.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -76.21 154.08 35.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -143.84 110.9 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.774 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.008 HG11 HG21 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -100.04 146.71 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -164.26 123.75 1.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 135.42 38.59 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.774 -1.344 . . . . 0.0 112.08 0.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.48 -10.64 23.98 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 0.0 112.74 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 p -162.53 165.47 26.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.33 -154.78 25.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.542 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 t -135.02 149.26 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' CD1' ' A' ' 43' ' ' TRP . 0.9 OUTLIER -116.79 123.41 47.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -77.02 168.27 29.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.73 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 36.3 Cg_endo -65.25 116.46 3.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.573 2.182 . . . . 0.0 112.454 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt 62.09 28.61 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -101.34 150.06 23.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.127 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 30.0 mttt -111.19 154.84 23.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.614 HG11 HD21 ' A' ' 62' ' ' LEU . 8.9 p -149.94 142.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.003 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.67 136.06 36.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 159.09 25.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.69 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.78 124.75 34.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 55' ' ' VAL . 33.3 t -126.37 93.86 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.6 p -86.33 154.15 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.0 p -133.14 108.54 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.24 145.49 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 76' ' ' THR . 3.4 p -61.05 142.0 56.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.821 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.06 -169.92 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -116.44 111.77 20.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.41 20.37 11.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.35 -28.84 14.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.202 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.7 p -142.16 46.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -147.16 144.43 28.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.79 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.416 ' O ' HD23 ' A' ' 84' ' ' LEU . 17.4 m-20 -71.95 150.78 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 54.8 mt -132.95 66.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -157.48 31.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.025 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -132.72 6.35 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.649 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.91 117.19 33.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -149.02 134.19 18.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 122' ' ' ILE . 62.2 mt -86.96 161.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.543 ' N ' HG22 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -148.05 110.89 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.105 -179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 91' ' ' ILE . 3.6 mp -102.05 111.95 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.438 ' CG ' ' CB ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -113.72 131.61 56.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.969 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.498 ' CE2' HG12 ' A' ' 9' ' ' ILE . 17.8 p90 -141.67 150.48 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.67 ' HB ' HG13 ' A' ' 115' ' ' VAL . 11.6 t -154.34 154.61 33.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.49 153.51 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -101.41 133.06 21.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.786 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.03 158.2 11.91 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.461 2.108 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -52.73 124.21 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.85 32.19 70.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.386 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 101' ' ' ALA . . . -62.03 -18.28 60.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.581 0.229 . . . . 0.0 111.452 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 100' ' ' ALA . . . 73.01 166.06 0.3 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.359 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -87.22 71.29 10.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.22 129.42 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 77.5 t80 -56.94 150.32 16.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.4 155.24 45.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -93.05 22.33 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.35 -6.3 17.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.6 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.471 ' CH2' ' HA ' ' A' ' 104' ' ' PHE . 8.8 m0 -91.14 19.65 5.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.626 0.25 . . . . 0.0 111.057 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 C--N 1.333 -0.132 0 CA-C-O 120.758 0.313 . . . . 0.0 111.151 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.9 ptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.73 0.3 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.67 HG13 ' HB ' ' A' ' 94' ' ' THR . 19.6 t -82.64 143.14 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.36 125.36 50.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.438 ' CB ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -135.5 153.72 51.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.31 135.5 48.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.521 ' CG ' HG23 ' A' ' 90' ' ' THR . 5.6 m-80 -96.18 129.48 43.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.261 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.9 mt -111.43 98.7 41.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.652 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.92 150.14 10.22 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.66 2.24 . . . . 0.0 112.596 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 89' ' ' ILE . 37.5 mm -100.87 149.84 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.962 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.76 ' HB3' HG23 ' A' ' 18' ' ' VAL . 29.3 mt-10 -133.22 156.93 46.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.009 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 84' ' ' LEU . 54.6 m-85 -123.81 105.23 9.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.974 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.411 ' ND2' HG12 ' B' ' 18' ' ' VAL . 5.7 t30 -87.49 81.38 7.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.759 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.903 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 CA--C 1.527 0.128 0 CA-C-O 120.663 0.193 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 138.94 29.14 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.5 2.133 . . . . 0.0 112.289 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.28 112.05 2.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.842 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 8.2 p-10 -47.0 140.34 4.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 111.089 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' B' ' 93' ' ' TRP . 1.3 pt -116.42 147.25 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.53 144.92 25.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.0 144.16 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.1 111.52 13.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' B' ' 31' ' ' ILE . 32.7 Cg_endo -63.86 162.01 59.65 Favored 'Cis proline' 0 C--N 1.351 0.669 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.42 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -20.38 11.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.57 -49.47 4.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.07 152.26 1.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.605 ' CG2' HD13 ' B' ' 122' ' ' ILE . 12.4 tt -105.88 153.19 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.752 HG23 ' HB3' ' B' ' 123' ' ' GLU . 7.9 p -136.23 100.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.99 114.21 3.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.75 142.37 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -66.53 170.34 5.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.663 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.876 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 6.7 Cg_exo -74.21 167.09 80.78 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.559 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -111.04 32.99 4.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -117.54 7.19 12.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.211 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.67 150.14 48.32 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -67.84 107.88 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.87 138.17 44.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 112.88 24.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.14 108.51 20.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -79.51 150.99 31.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.435 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.551 HD12 ' HD2' ' B' ' 13' ' ' PRO . 29.0 mm -126.1 150.15 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.689 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.455 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 12.0 ttmm -104.89 120.51 41.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.318 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -121.85 130.13 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.739 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -139.8 155.12 47.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 11.4 t-20 -92.53 114.32 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.692 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.41 18.71 6.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.356 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.18 -141.46 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.564 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.25 51.85 0.55 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -174.32 164.84 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.15 137.12 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 2.5 pt -139.05 115.14 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.317 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -71.58 122.56 9.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.922 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.848 ' CD1' HD23 ' B' ' 62' ' ' LEU . 29.5 p-90 -114.56 157.98 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.91 136.0 14.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.657 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.996 HG21 HG11 ' B' ' 55' ' ' VAL . 41.7 mm -93.13 141.92 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.5 133.1 15.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.754 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.73 160.45 32.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.06 0.457 . . . . 0.0 111.084 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -47.7 43.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -114.33 112.63 23.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 23.38 6.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -45.82 3.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.87 -50.97 8.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.13 154.26 35.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.143 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 9.7 m -144.03 110.81 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.996 HG11 HG21 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -100.07 146.53 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.213 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -164.19 123.74 1.31 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.26 135.33 38.02 Favored 'Cis proline' 0 C--N 1.352 0.748 0 C-N-CA 123.756 -1.352 . . . . 0.0 112.137 0.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.4 -10.45 23.96 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.507 2.138 . . . . 0.0 112.744 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 24.3 p -162.75 165.44 25.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.31 -154.93 26.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 t -134.88 149.28 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.789 0.328 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.848 HD23 ' CD1' ' B' ' 43' ' ' TRP . 0.9 OUTLIER -116.88 123.28 46.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.99 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 0.6 OUTLIER -76.84 168.26 29.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.703 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 36.5 Cg_endo -65.25 116.56 3.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.587 2.191 . . . . 0.0 112.381 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt 62.04 28.55 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' B' ' 67' ' ' LYS . 0.2 OUTLIER -101.24 150.3 23.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 66' ' ' GLU . 30.1 mttt -111.44 154.84 24.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.99 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.608 HG11 HD21 ' B' ' 62' ' ' LEU . 8.6 p -149.94 142.88 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.968 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.66 135.95 36.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.28 159.18 25.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.92 124.59 33.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.317 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.72 HG22 HG12 ' B' ' 55' ' ' VAL . 31.0 t -126.27 93.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -86.44 154.26 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 p -133.25 108.42 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -53.23 145.41 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.969 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.5 p -61.04 141.88 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.97 -169.8 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -116.54 111.55 20.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.29 20.54 11.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.41 -29.15 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 60.0 p -141.96 46.74 1.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -147.19 144.41 28.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.411 ' O ' HD23 ' B' ' 84' ' ' LEU . 16.8 m-20 -71.87 150.97 43.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.453 ' HB3' ' CE1' ' B' ' 124' ' ' TYR . 55.6 mt -133.16 67.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.784 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -157.51 32.08 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -132.8 6.31 3.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.615 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.81 117.27 33.96 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.878 0.37 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -149.11 134.08 18.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.635 HG13 HD11 ' B' ' 122' ' ' ILE . 61.9 mt -86.77 161.09 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.548 ' N ' HG22 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -147.99 111.01 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.593 ' N ' HD12 ' B' ' 91' ' ' ILE . 3.7 mp -102.12 111.92 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 0.4 OUTLIER -113.68 131.63 56.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.498 ' CE2' HG12 ' B' ' 9' ' ' ILE . 18.0 p90 -141.59 150.74 42.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.678 ' HB ' HG13 ' B' ' 115' ' ' VAL . 11.5 t -154.55 154.68 33.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.56 153.49 4.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.966 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.408 ' HB ' ' CB ' ' B' ' 100' ' ' ALA . 0.6 OUTLIER -101.37 132.99 21.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 96' ' ' THR . 53.1 Cg_exo -55.0 158.17 11.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.5 2.133 . . . . 0.0 112.316 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -52.67 124.29 13.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.57 32.41 71.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.427 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' B' ' 101' ' ' ALA . . . -62.06 -18.35 60.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.611 0.243 . . . . 0.0 111.511 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 100' ' ' ALA . . . 73.29 166.2 0.3 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.215 0.531 . . . . 0.0 111.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -87.49 71.45 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.78 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.35 129.36 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.472 ' HA ' ' CH2' ' B' ' 108' ' ' TRP . 77.3 t80 -56.83 150.29 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.45 155.13 45.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.973 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -92.93 22.32 5.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.159 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.33 -6.44 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.636 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.472 ' CH2' ' HA ' ' B' ' 104' ' ' PHE . 9.0 m0 -91.1 19.61 5.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.66 0.266 . . . . 0.0 111.069 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.746 0.307 . . . . 0.0 111.203 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 2.8 ptp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.893 0.377 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' B' ' 94' ' ' THR . 19.3 t -82.57 143.26 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.59 125.27 50.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.437 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -135.4 153.63 51.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.181 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.24 135.6 48.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.623 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.523 ' CG ' HG23 ' B' ' 90' ' ' THR . 5.7 m-80 -96.23 129.36 43.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.293 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 79.1 mt -111.3 98.75 41.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.681 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.94 150.17 10.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.638 2.225 . . . . 0.0 112.518 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.635 HD11 HG13 ' B' ' 89' ' ' ILE . 36.9 mm -100.92 149.9 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.006 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' B' ' 18' ' ' VAL . 30.4 mt-10 -133.23 156.87 46.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' B' ' 84' ' ' LEU . 55.5 m-85 -123.82 105.09 9.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.514 ' ND2' HG12 ' A' ' 18' ' ' VAL . 5.5 t30 -87.33 81.42 7.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.789 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.95 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 N--CA 1.465 -0.166 0 CA-C-O 120.697 0.207 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HG2' ' HG3' ' A' ' 116' ' ' ARG . 60.6 Cg_endo -72.67 157.87 51.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.296 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 37' ' ' GLY . . . -82.09 129.6 9.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -50.77 129.99 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -99.16 120.22 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -81.8 142.52 32.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -136.95 155.72 49.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.45 106.58 4.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.02 154.47 48.54 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.508 0.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -50.36 11.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.199 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -159.49 41.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.117 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -153.53 92.9 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.33 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.722 ' CG2' HD13 ' A' ' 122' ' ' ILE . 10.4 tt -123.28 130.78 74.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.599 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.004 HG11 HG11 ' B' ' 18' ' ' VAL . 7.4 p -138.97 113.98 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.516 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -71.84 104.6 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.376 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 153.52 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.595 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.826 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -77.11 170.35 16.77 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.655 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.826 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 96.1 Cg_endo -79.07 166.77 78.23 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.786 0.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' CD2' ' A' ' 126' ' ' LEU . 22.3 m-85 -106.84 50.03 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.871 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.53 -3.33 10.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.309 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -137.5 150.31 47.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.844 0.354 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.82 110.72 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.25 83.49 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 114.94 10.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.81 132.92 42.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.15 138.89 38.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.96 145.18 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.442 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.86 138.85 39.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 34' ' ' THR . 47.0 mt -121.04 157.92 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.64 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 33' ' ' ILE . 88.8 m -162.12 148.53 13.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB3' HD11 ' A' ' 41' ' ' ILE . 23.8 p-10 -121.03 84.63 2.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 110.495 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.42 -27.32 0.68 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.56 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 7' ' ' GLY . . . -47.65 154.08 1.4 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.685 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.71 54.83 0.93 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.435 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 154.89 4.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -65.79 148.37 51.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 61' ' ' VAL . 26.5 pt -145.47 165.55 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -125.07 106.51 0.91 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 62.5 p-90 -104.29 157.58 17.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.227 0.537 . . . . 0.0 112.183 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 153.44 40.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.357 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.409 ' CD1' HG12 ' A' ' 91' ' ' ILE . 11.9 mm -119.92 145.36 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.979 0.419 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.69 134.83 20.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.683 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 89' ' ' ILE . 37.1 p -112.36 153.74 26.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -26.17 18.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.721 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.68 114.16 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.3 19.84 5.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.285 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -96.33 -44.27 7.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.87 -50.7 4.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.463 HD22 ' SG ' ' A' ' 74' ' ' CYS . 13.2 mt -78.96 153.76 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.27 151.25 28.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.017 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.8 150.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.786 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.15 115.71 0.62 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.51 139.56 61.34 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.219 -0.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 -32.94 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.655 2.237 . . . . 0.0 112.185 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 m -139.68 155.59 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 179.28 159.29 23.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.419 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 61' ' ' VAL . 10.6 p -96.1 114.6 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.217 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.91 166.07 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.428 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 3.9 m-20 -119.18 166.21 15.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.781 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.01 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.752 2.301 . . . . 0.0 112.518 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 70.18 38.92 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 34' ' ' THR . 0.1 OUTLIER -112.33 155.56 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.996 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.11 136.48 50.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.33 129.16 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 127.04 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.793 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.47 159.03 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.0 155.33 26.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.48 82.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.792 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -53.24 136.32 36.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.196 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.463 ' SG ' HD22 ' A' ' 53' ' ' LEU . 51.2 m -152.62 82.11 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.04 150.16 45.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.85 162.16 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -167.56 -169.51 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -102.33 114.53 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.98 22.19 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.407 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.84 -32.16 12.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.0 p -142.91 56.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.61 179.84 4.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.551 ' C ' HD23 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -100.68 82.42 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.002 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.75 HD13 ' CD2' ' A' ' 124' ' ' TYR . 8.3 mt -117.11 67.76 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.417 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -85.94 -27.97 24.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 85' ' ' ASN . 3.0 m-80 178.54 -49.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.324 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.09 147.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -155.45 132.74 10.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.161 0.505 . . . . 0.0 111.938 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.446 HG12 HG22 ' A' ' 47' ' ' THR . 57.5 mt -101.15 102.18 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.71 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -83.75 138.12 33.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.091 0.472 . . . . 0.0 111.675 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 45' ' ' ILE . 12.9 mt -122.4 123.6 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 44.6 mt-10 -120.09 112.43 19.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 10.6 p90 -126.87 128.74 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.752 ' HB ' HG22 ' A' ' 115' ' ' VAL . 1.4 t -127.87 148.99 50.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.393 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -52.03 147.55 7.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.557 HG22 ' CH2' ' A' ' 108' ' ' TRP . 4.8 p -84.64 134.69 41.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.6 161.44 2.96 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.31 2.006 . . . . 0.0 111.94 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -50.81 125.39 13.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.76 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.21 48.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.241 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' THR . . . -66.62 143.32 57.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 111.241 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.14 164.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.267 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -88.4 69.82 9.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.61 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 179.16 137.69 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.802 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -54.97 145.75 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 5.2 mmt180 -131.74 150.71 52.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.09 -25.46 23.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.936 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.86 -14.97 59.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.502 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.557 ' CH2' HG22 ' A' ' 96' ' ' THR . 19.0 m0 -55.45 -20.43 12.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.281 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.739 0.304 . . . . 0.0 111.07 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.86 0.362 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.752 HG22 ' HB ' ' A' ' 94' ' ' THR . 25.5 t -122.6 130.22 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.504 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 10.5 mtt180 -103.09 137.38 41.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.17 102.42 6.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.22 170.84 8.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.583 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.8 122.86 13.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.98 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 106.26 38.33 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.663 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.2 138.63 82.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.514 2.143 . . . . 0.0 112.79 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 17' ' ' ILE . 5.0 mm -110.97 150.81 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.591 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 18' ' ' VAL . 67.6 mt-10 -141.53 140.87 33.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 0.0 111.423 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.75 ' CD2' HD13 ' A' ' 84' ' ' LEU . 38.4 m-85 -101.66 96.82 7.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.11 94.79 3.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.429 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 42.0 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 CA--C 1.527 0.144 0 CA-C-O 120.74 0.225 . . . . 0.0 112.267 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.402 ' HG2' ' HG3' ' B' ' 116' ' ' ARG . 60.3 Cg_endo -72.68 157.88 51.5 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.596 2.197 . . . . 0.0 112.24 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.18 129.7 9.22 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -50.88 129.99 24.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' B' ' 35' ' ' ASN . 1.1 pt -99.11 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.007 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.406 ' ND2' ' HB ' ' B' ' 34' ' ' THR . 1.1 p30 -81.85 142.66 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.843 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 16.0 p -137.02 155.83 49.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.27 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.6 106.55 4.34 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.649 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.02 154.4 48.53 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.613 0.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -50.27 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.185 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -159.67 41.89 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -153.51 92.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.301 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.721 ' CG2' HD13 ' B' ' 122' ' ' ILE . 10.5 tt -123.19 130.89 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 1.004 HG11 HG11 ' A' ' 18' ' ' VAL . 7.6 p -138.97 113.84 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.568 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -71.76 104.69 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.3 153.32 42.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.439 . . . . 0.0 111.525 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.832 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -76.9 170.32 16.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.672 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.832 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 97.1 Cg_endo -78.97 166.97 77.93 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.027 -1.239 . . . . 0.0 112.759 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' B' ' 126' ' ' LEU . 22.2 m-85 -106.98 49.89 0.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.872 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.48 -3.16 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.304 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -137.57 150.36 47.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.82 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 110.75 3.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.19 83.84 1.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 85.6 m -72.27 114.77 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.62 133.0 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.29 138.93 38.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.92 145.31 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.07 138.5 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.941 0.4 . . . . 0.0 111.481 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.479 HG22 ' N ' ' B' ' 34' ' ' THR . 47.4 mt -120.79 157.67 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.659 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.479 ' N ' HG22 ' B' ' 33' ' ' ILE . 87.7 m -161.93 148.5 13.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' B' ' 41' ' ' ILE . 23.8 p-10 -120.95 84.6 2.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.513 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.47 -27.34 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.77 153.8 1.54 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.657 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.44 55.0 0.95 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 154.97 4.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.8 0.333 . . . . 0.0 110.827 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -65.9 148.23 52.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.737 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.595 ' O ' HG23 ' B' ' 61' ' ' VAL . 26.6 pt -145.16 165.57 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 111.586 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -125.15 106.21 0.89 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 62.7 p-90 -104.27 157.37 17.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.217 0.532 . . . . 0.0 112.207 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.88 153.38 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.422 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.414 ' CD1' HG12 ' B' ' 91' ' ' ILE . 12.3 mm -119.88 145.51 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.81 134.74 20.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.455 HG22 HG12 ' B' ' 89' ' ' ILE . 36.7 p -112.27 153.52 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.22 -26.21 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.739 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.65 114.15 7.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.23 19.85 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -96.32 -44.38 7.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.741 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.83 -50.79 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.466 HD22 ' SG ' ' B' ' 74' ' ' CYS . 13.3 mt -78.88 154.01 30.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.5 151.11 28.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.7 150.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.09 115.86 0.62 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.47 139.6 61.5 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.098 -0.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.41 -32.84 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.547 2.165 . . . . 0.0 112.102 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.64 155.58 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.479 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 179.4 159.5 23.55 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.411 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 41' ' ' ILE . 10.5 p -96.29 114.79 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.211 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.08 166.19 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.428 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 3.8 m-20 -119.29 166.2 15.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.685 2.257 . . . . 0.0 112.483 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? 69.81 39.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.434 ' O ' HG23 ' B' ' 34' ' ' THR . 0.1 OUTLIER -112.67 155.47 24.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.02 136.39 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.99 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -122.27 128.76 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.16 126.84 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.28 158.97 37.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.83 155.36 25.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.52 82.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.759 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 15.1 m -52.94 136.29 34.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.158 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.466 ' SG ' HD22 ' B' ' 53' ' ' LEU . 50.9 m -152.65 82.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.66 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.13 150.07 46.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.84 162.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -167.56 -169.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -102.46 114.63 28.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.1 22.22 5.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.344 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.03 -31.95 12.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.223 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.4 p -143.16 56.18 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -123.74 179.93 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.545 ' C ' HD23 ' B' ' 84' ' ' LEU . 1.0 OUTLIER -100.73 82.46 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.749 HD13 ' CD2' ' B' ' 124' ' ' TYR . 8.1 mt -117.08 67.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.73 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 0.7 OUTLIER -85.97 -28.05 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 85' ' ' ASN . 2.9 m-80 178.61 -49.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.01 147.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 -155.5 132.67 10.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 111.869 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.455 HG12 HG22 ' B' ' 47' ' ' THR . 56.8 mt -101.11 102.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.744 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 20.3 m -83.73 137.89 33.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.187 0.518 . . . . 0.0 111.654 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' B' ' 45' ' ' ILE . 13.0 mt -122.32 123.47 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.269 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 44.4 mt-10 -119.99 112.48 19.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.499 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 10.5 p90 -126.84 128.79 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.573 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.751 ' HB ' HG22 ' B' ' 115' ' ' VAL . 1.4 t -128.02 148.91 50.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.391 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -51.91 147.73 6.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.569 HG22 ' CH2' ' B' ' 108' ' ' TRP . 4.6 p -84.75 134.71 41.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.63 161.57 2.91 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.384 2.056 . . . . 0.0 111.867 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -50.87 125.37 13.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.09 48.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.203 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' B' ' 96' ' ' THR . . . -66.51 143.11 57.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 0.0 111.34 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.65 164.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.288 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -88.61 69.82 8.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.53 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? 179.2 137.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.812 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -55.34 145.95 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.991 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.448 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 5.0 mmt180 -131.93 150.71 52.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.22 -25.25 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.007 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.93 -15.14 59.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.454 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.569 ' CH2' HG22 ' B' ' 96' ' ' THR . 19.0 m0 -55.27 -20.45 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.613 0.245 . . . . 0.0 111.25 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 111.104 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.789 0.328 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.751 HG22 ' HB ' ' B' ' 94' ' ' THR . 25.5 t -122.5 130.45 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.499 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 10.5 mtt180 -103.18 137.51 41.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.734 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.31 102.3 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.411 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.11 170.91 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.578 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -142.78 123.02 13.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.53 106.2 38.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.677 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.14 138.81 83.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.62 2.213 . . . . 0.0 112.77 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.721 HD13 ' CG2' ' B' ' 17' ' ' ILE . 5.0 mm -111.21 150.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.513 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.574 ' O ' HG23 ' B' ' 18' ' ' VAL . 67.6 mt-10 -141.79 140.59 33.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 111.442 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.749 ' CD2' HD13 ' B' ' 84' ' ' LEU . 37.5 m-85 -101.44 96.68 7.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.449 ' ND2' HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -75.94 94.88 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' B' ' 23' ' ' TYR . 41.3 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 CA--C 1.527 0.147 0 CA-C-O 120.666 0.194 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.29 135.51 46.96 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.568 2.178 . . . . 0.0 112.173 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.3 122.91 16.17 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.273 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.7 108.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.36 145.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.317 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.5 146.7 23.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.576 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.07 155.9 49.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.24 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -153.96 106.23 2.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.645 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.73 161.97 45.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.474 0.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.3 -10.96 11.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.616 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.503 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -108.28 -56.35 2.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.879 0.371 . . . . 0.0 111.18 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.89 -175.43 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.492 ' CG2' HD13 ' A' ' 122' ' ' ILE . 9.5 tt -150.26 136.34 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 123' ' ' GLU . 7.3 p -126.19 107.94 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.711 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -65.13 119.99 11.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -84.37 134.95 34.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 111.654 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -51.74 170.5 0.21 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.683 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 89.1 Cg_endo -80.13 164.11 81.07 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 124.065 -1.223 . . . . 0.0 112.721 0.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.519 ' CE2' HD23 ' A' ' 126' ' ' LEU . 20.2 m-85 -109.62 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.81 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.22 5.65 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.155 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.67 129.09 25.93 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 0.0 110.773 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.79 106.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -105.61 150.3 25.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.44 97.97 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -87.23 125.52 34.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.4 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 71' ' ' ALA . 12.3 m80 -94.97 130.68 41.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' HE3' ' A' ' 70' ' ' MET . 28.6 mt -97.84 150.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -104.6 134.27 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.361 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 70' ' ' MET . 23.8 mt -136.87 154.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.1 m -153.83 158.35 40.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.061 0.458 . . . . 0.0 111.238 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 20.4 t-20 -107.85 114.04 27.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.544 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.02 19.91 6.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.424 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.3 -177.26 19.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.632 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.45 19.63 26.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.71 161.94 37.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -65.67 164.11 15.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 pt -149.19 142.0 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.403 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -102.42 100.98 2.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.731 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.406 ' CD1' HD12 ' A' ' 62' ' ' LEU . 63.0 p-90 -105.71 149.76 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.047 0.451 . . . . 0.0 111.528 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.57 132.23 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.597 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 9.2 mm -92.75 151.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.268 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -138.63 138.2 37.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -124.25 148.97 46.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -55.7 -40.08 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -127.52 118.17 23.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.73 16.72 7.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.408 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -110.88 -31.63 7.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -23.11 14.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 74' ' ' CYS . 34.9 mt -126.85 138.75 53.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 m -149.5 116.7 6.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 71' ' ' ALA . 2.7 t -94.43 153.48 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -145.65 123.3 6.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.0 144.93 77.32 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.498 0.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.21 -13.63 40.26 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.584 2.19 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.61 130.75 0.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 110.586 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.21 -178.82 25.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.668 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 61' ' ' VAL . 10.5 p -114.34 111.52 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.482 HD23 ' HG3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -80.56 145.48 31.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 2.8 m-20 -101.81 171.88 4.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' O ' ' CD ' ' A' ' 65' ' ' LYS . 42.3 Cg_exo -57.06 127.87 27.54 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.527 2.151 . . . . 0.0 112.505 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CD ' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 46.89 34.86 2.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.482 ' HG3' HD23 ' A' ' 62' ' ' LEU . 1.4 tp10 -101.4 136.64 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.67 113.82 27.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.057 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.87 155.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.87 119.3 26.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.662 ' HE3' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -112.83 164.66 13.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -118.46 155.46 30.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.5 t -129.68 104.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.798 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 125.69 32.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HA ' HD23 ' A' ' 53' ' ' LEU . 1.8 p -129.6 98.19 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.712 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.84 153.9 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 76' ' ' THR . 2.3 p -64.62 151.16 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.481 ' CZ ' ' CD2' ' A' ' 124' ' ' TYR . 3.5 p90 -148.58 -161.44 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.089 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.09 93.47 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -68.23 -19.02 64.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.58 -28.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.788 0.328 . . . . 0.0 111.462 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 71.7 p -143.56 59.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 81' ' ' THR . 47.1 mt-10 -159.24 160.31 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -82.76 153.16 25.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' A' ' 124' ' ' TYR . 12.5 mt -128.43 38.36 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.67 30.04 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.16 -45.37 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.39 138.47 54.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 132.3 3.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.82 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 78.4 mt -107.73 121.93 61.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 118' ' ' LYS . 4.0 m -103.79 138.76 39.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.0 mp -118.16 124.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 122.01 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.428 ' CZ2' ' HB2' ' A' ' 116' ' ' ARG . 6.2 p90 -130.94 143.66 50.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.724 ' CB ' HG22 ' A' ' 115' ' ' VAL . 1.3 t -145.18 120.57 10.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -43.22 142.83 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.595 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.534 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 6.9 p -82.01 146.06 54.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.953 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.69 165.92 14.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.547 2.164 . . . . 0.0 112.158 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -45.16 114.38 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.498 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.73 49.67 16.16 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.902 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -51.6 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 100' ' ' ALA . . . 172.68 163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.074 0.464 . . . . 0.0 111.243 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.49 69.51 9.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.518 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.21 128.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.735 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -48.97 131.28 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.994 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 108' ' ' TRP . 6.6 ttm180 -121.47 150.33 41.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 27.16 7.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.27 -1.09 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.787 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.534 ' CZ3' HG22 ' A' ' 96' ' ' THR . 7.2 m0 -92.47 19.87 6.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.588 0.232 . . . . 0.0 111.193 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.28 . . . . 0.0 111.306 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.608 ' C ' HG23 ' A' ' 115' ' ' VAL . 1.4 mpt? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.976 0.417 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.724 HG22 ' CB ' ' A' ' 94' ' ' THR . 4.5 t 87.07 106.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.39 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 93' ' ' TRP . 48.0 mtt-85 -98.87 146.14 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.67 156.78 17.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.385 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -145.18 161.74 38.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.524 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.93 148.97 34.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.33 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 15' ' ' GLN . 34.6 mt -151.17 86.36 4.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.569 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.1 158.77 3.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.697 2.265 . . . . 0.0 112.66 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.492 HD13 ' CG2' ' A' ' 17' ' ' ILE . 25.1 mm -114.53 145.72 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.048 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.739 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -139.06 165.12 27.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 111.037 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 90.1 m-85 -132.59 108.2 8.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.993 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.18 83.18 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 29.6 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.831 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.684 0.202 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.27 135.47 46.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.206 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.35 122.98 16.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.306 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -50.67 108.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.25 145.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.67 146.64 24.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.559 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.88 156.09 48.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.232 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -154.18 106.32 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.661 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.76 162.06 45.87 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.872 -1.304 . . . . 0.0 112.381 0.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -11.02 11.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.502 ' O ' HD23 ' B' ' 120' ' ' LEU . 0.1 OUTLIER -108.23 -56.31 2.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 111.204 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -154.9 -175.3 5.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.491 ' CG2' HD13 ' B' ' 122' ' ' ILE . 9.5 tt -150.44 136.36 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.638 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' B' ' 123' ' ' GLU . 7.3 p -126.25 107.86 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.702 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -65.19 119.96 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.3 134.99 34.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.847 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -51.72 170.52 0.21 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.637 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.847 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -80.19 164.12 80.87 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.704 0.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.524 ' CE2' HD23 ' B' ' 126' ' ' LEU . 20.2 m-85 -109.58 47.42 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.29 5.62 5.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.66 128.97 25.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.768 0.318 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.7 106.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.65 150.33 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.676 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.49 97.87 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.091 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.04 125.52 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.546 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.425 ' NE2' ' HB2' ' B' ' 71' ' ' ALA . 12.8 m80 -94.95 130.64 41.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.657 HD12 ' HE3' ' B' ' 70' ' ' MET . 28.7 mt -97.89 150.54 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -104.6 134.48 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.461 HD11 ' SD ' ' B' ' 70' ' ' MET . 23.8 mt -137.01 154.92 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.818 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.442 ' N ' HG22 ' B' ' 33' ' ' ILE . 52.9 m -153.93 158.2 40.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.145 0.497 . . . . 0.0 111.251 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 20.4 t-20 -107.75 114.05 27.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.493 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.19 20.09 6.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.365 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.61 -177.58 18.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.32 19.92 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.613 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.89 162.07 37.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.734 0.302 . . . . 0.0 110.788 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -65.86 164.09 15.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.664 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 pt -149.18 141.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.429 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.26 101.12 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.696 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -105.85 149.71 26.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 111.516 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.46 132.38 19.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.673 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 9.1 mm -92.77 151.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.323 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -138.7 138.29 37.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 30.6 p -124.29 149.19 46.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.2 p -55.95 -40.14 72.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -127.4 117.97 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.853 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.51 16.62 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.383 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -110.77 -31.7 7.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -23.19 14.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' B' ' 74' ' ' CYS . 34.9 mt -126.75 138.75 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.963 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 36.7 m -149.39 116.73 6.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.496 HG13 ' O ' ' B' ' 71' ' ' ALA . 2.7 t -94.52 153.47 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -145.64 123.41 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.98 145.03 77.62 Favored 'Cis proline' 0 C--N 1.351 0.67 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.481 -0.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.2 -13.63 40.29 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.15 . . . . 0.0 112.524 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.6 130.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.613 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.12 -178.79 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.606 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.627 ' O ' HG13 ' B' ' 61' ' ' VAL . 10.3 p -114.41 111.37 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.465 HD23 ' HG3' ' B' ' 66' ' ' GLU . 0.2 OUTLIER -80.38 145.56 31.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.021 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' B' ' 35' ' ' ASN . 2.9 m-20 -101.8 171.79 5.01 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.417 ' O ' ' CD ' ' B' ' 65' ' ' LYS . 41.5 Cg_exo -56.91 127.94 27.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.546 2.164 . . . . 0.0 112.558 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.417 ' CD ' ' O ' ' B' ' 64' ' ' PRO . 0.0 OUTLIER 46.72 34.8 2.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.623 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.465 ' HG3' HD23 ' B' ' 62' ' ' LEU . 1.4 tp10 -101.32 136.77 40.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 113.9 27.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.014 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.92 155.22 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.96 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.95 119.21 26.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.022 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.657 ' HE3' HD12 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -112.75 164.7 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.722 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.496 ' O ' HG13 ' B' ' 55' ' ' VAL . . . -118.55 155.29 31.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.54 104.72 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.776 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.34 125.19 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.977 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . 0.477 ' HA ' HD23 ' B' ' 53' ' ' LEU . 1.7 p -129.11 98.1 4.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 153.89 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -64.73 151.11 45.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.76 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.483 ' CZ ' ' CD2' ' B' ' 124' ' ' TYR . 3.5 p90 -148.52 -161.55 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.999 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.05 93.41 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.458 ' HB3' HD21 ' B' ' 126' ' ' LEU . . . -68.08 -19.17 64.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.45 -29.23 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.751 0.31 . . . . 0.0 111.404 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -143.28 59.33 1.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -159.22 160.34 35.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -82.82 153.36 25.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' B' ' 124' ' ' TYR . 12.4 mt -128.53 38.24 4.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.52 30.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.41 -45.19 3.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.48 138.53 54.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 132.26 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 77.6 mt -107.73 121.81 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.619 HG23 ' O ' ' B' ' 118' ' ' LYS . 4.0 m -103.77 138.84 39.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.556 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.0 mp -118.26 124.33 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.31 121.95 37.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' B' ' 116' ' ' ARG . 6.2 p90 -130.91 143.7 50.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.091 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.72 ' CB ' HG22 ' B' ' 115' ' ' VAL . 1.3 t -145.18 120.5 10.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -43.24 142.87 0.94 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.513 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.519 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 6.9 p -81.99 146.03 54.59 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 165.76 15.12 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.597 2.198 . . . . 0.0 112.168 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -44.9 114.5 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.537 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.55 49.63 15.5 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.905 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' B' ' 101' ' ' ALA . . . -51.35 -76.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.035 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' B' ' 100' ' ' ALA . . . 172.38 163.57 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 111.161 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.55 69.41 9.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.4 128.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -48.98 131.24 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.065 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HB2' ' CZ2' ' B' ' 108' ' ' TRP . 6.6 ttm180 -121.41 150.28 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 26.93 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -113.08 -1.01 14.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.789 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.519 ' CZ3' HG22 ' B' ' 96' ' ' THR . 7.0 m0 -92.67 20.15 6.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.703 0.287 . . . . 0.0 111.185 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.179 -179.811 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . 0.595 ' C ' HG23 ' B' ' 115' ' ' VAL . 1.4 mpt? . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 121.041 0.448 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.72 HG22 ' CB ' ' B' ' 94' ' ' THR . 4.5 t 87.06 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.318 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.427 ' HB2' ' CZ2' ' B' ' 93' ' ' TRP . 48.2 mtt-85 -99.05 146.23 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.78 156.73 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.619 ' O ' HG23 ' B' ' 90' ' ' THR . 0.0 OUTLIER -145.11 161.73 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.481 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -144.96 148.95 34.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.502 HD23 ' O ' ' B' ' 15' ' ' GLN . 35.1 mt -151.11 86.44 4.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.09 158.94 2.94 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.691 2.261 . . . . 0.0 112.683 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.491 HD13 ' CG2' ' B' ' 17' ' ' ILE . 25.3 mm -114.74 145.73 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.002 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.743 ' HB3' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -139.08 165.0 28.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.056 0.455 . . . . 0.0 111.093 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' B' ' 77' ' ' PHE . 90.0 m-85 -132.51 108.09 8.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.976 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.05 83.23 3.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.569 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 30.3 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.906 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 CA--C 1.527 0.14 0 CA-C-O 120.752 0.23 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.27 138.83 62.94 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.532 2.155 . . . . 0.0 112.303 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.15 -152.92 0.41 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.0 m-20 -112.06 151.84 28.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.765 0.316 . . . . 0.0 110.885 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.75 127.55 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.157 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.409 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -73.19 152.48 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.0 143.03 30.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.95 111.08 24.59 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.51 168.53 24.73 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.09 -1.213 . . . . 0.0 112.828 0.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -38.9 -48.76 1.61 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.99 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.6 ' CG ' HD22 ' A' ' 120' ' ' LEU . 1.1 tm0? 177.22 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.033 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.57 112.19 16.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.58 HD13 ' CE1' ' A' ' 19' ' ' PHE . 8.1 tt -113.22 130.06 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 38.8 t -105.37 87.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.879 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 17' ' ' ILE . 6.9 m-85 -51.81 101.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 21.8 m-80 -72.13 137.82 47.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.539 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.845 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -70.2 169.34 13.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.845 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 72.6 Cg_endo -76.11 166.23 83.41 Favored 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.641 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 17.2 m-85 -108.14 30.41 6.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.14 7.38 36.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.353 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -135.18 154.64 51.55 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.859 0.361 . . . . 0.0 111.101 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -71.34 131.98 44.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -140.24 93.15 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.78 111.4 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CD2' HD11 ' A' ' 17' ' ' ILE . 76.2 m-85 -98.09 106.42 18.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' B' ' 22' ' ' PRO . 7.7 m80 -79.37 121.29 24.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -109.81 125.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HG3' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -95.21 155.42 16.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 34' ' ' THR . 34.0 mt -133.89 154.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.9 m -144.84 151.69 39.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' HB2' HD22 ' A' ' 62' ' ' LEU . 14.0 t-20 -98.51 105.48 17.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.673 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -92.88 20.93 6.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.28 20.26 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.469 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.81 40.34 2.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 175.87 161.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 41' ' ' ILE . 13.5 ptp180 -55.15 169.85 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.706 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 40' ' ' ARG . 3.7 pt -158.92 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.82 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.16 107.08 2.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.444 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.543 ' CD1' HD12 ' A' ' 62' ' ' LEU . 51.3 p-90 -103.76 159.37 15.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 112.033 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -145.73 145.06 30.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.449 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 91' ' ' ILE . 13.1 mm -123.9 151.11 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.033 0.444 . . . . 0.0 111.553 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.38 163.41 39.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.504 HG22 HG12 ' A' ' 89' ' ' ILE . 24.1 p -139.37 149.82 44.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.984 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -50.42 -31.06 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.967 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -136.1 117.74 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.03 16.56 8.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.327 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -54.84 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.93 -40.14 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 122.4 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.638 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.12 107.84 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.207 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 72' ' ' VAL . 2.6 m -97.53 129.12 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.029 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -140.28 140.92 24.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.06 153.37 97.47 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.917 -1.285 . . . . 0.0 112.265 0.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.55 -11.68 26.45 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.589 2.193 . . . . 0.0 112.662 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.4 p -172.68 158.77 4.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.903 0.382 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 175.86 148.04 6.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.69 128.02 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.543 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -97.84 165.32 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -117.41 169.59 7.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.32 112.96 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.584 2.189 . . . . 0.0 112.515 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 62.56 34.86 14.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.282 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.512 ' O ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -102.19 154.61 18.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.43 160.28 16.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.436 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.01 151.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.698 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 ' HG3' ' A' ' 32' ' ' LYS . 12.4 tp -111.2 125.13 53.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 ttm -121.61 158.54 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.75 38.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.507 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 55' ' ' VAL . 54.6 t -114.05 91.73 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.749 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.38 129.41 39.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.247 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 10.7 t -130.56 140.16 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.1 151.97 26.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 p -55.6 111.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.918 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 23' ' ' TYR . 27.2 p90 -118.82 -172.43 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.98 126.93 52.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 84' ' ' LEU . . . -105.17 19.01 21.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.329 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.28 -25.19 21.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -135.64 29.23 3.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.53 129.2 20.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.69 146.94 29.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 79' ' ' ALA . 29.1 mt -117.31 41.44 2.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.35 25.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' HG21 ' A' ' 48' ' ' THR . 24.0 m120 -118.26 -15.1 9.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.468 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.98 114.52 13.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.841 0.353 . . . . 0.0 111.013 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.19 135.52 21.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.504 HG12 HG22 ' A' ' 47' ' ' THR . 15.6 mt -98.46 107.63 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -71.03 121.12 17.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.06 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 45' ' ' ILE . 14.2 mm -109.86 149.76 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.816 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -148.23 159.92 43.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.496 ' CZ2' ' HB3' ' A' ' 116' ' ' ARG . 10.0 p90 -177.91 123.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 134.75 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -56.34 112.78 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 p -58.72 148.22 68.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.942 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.22 164.68 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.628 2.219 . . . . 0.0 112.316 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.48 115.54 1.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.292 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.04 47.81 32.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.732 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.09 166.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 110.955 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.49 16.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.097 0.475 . . . . 0.0 111.404 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 70.96 8.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.643 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 132.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.838 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -53.25 152.45 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 13.3 mmm180 -136.91 145.25 44.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.35 -27.71 19.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.55 -18.76 65.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.407 ' CD2' ' HB2' ' A' ' 105' ' ' ARG . 26.5 m0 -56.58 -20.35 20.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.307 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 111.049 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.7 mpt? . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.62 127.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.496 ' HB3' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -119.07 157.87 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.94 124.61 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.35 131.76 40.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.762 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.1 122.65 39.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.075 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.6 HD22 ' CG ' ' A' ' 15' ' ' GLN . 1.5 mt -81.72 133.42 52.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.547 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HD3' ' NE2' ' A' ' 15' ' ' GLN . 94.9 Cg_endo -79.35 134.94 11.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.611 2.207 . . . . 0.0 112.697 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 89' ' ' ILE . 7.5 mm -108.06 82.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.016 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 162.06 26.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' A' ' 122' ' ' ILE . 57.5 m-85 -131.08 100.75 5.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.901 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.446 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 28.6 t30 -80.07 81.5 6.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.919 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 CA-C-O 120.731 0.221 . . . . 0.0 112.277 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.33 139.07 63.75 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.317 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.41 -152.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.561 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.9 m-20 -112.21 151.76 29.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.831 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.62 127.28 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . 0.413 ' HB2' ' HB ' ' B' ' 34' ' ' THR . 1.0 OUTLIER -73.0 152.5 41.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.09 142.95 30.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 0.0 111.488 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.89 111.0 24.77 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.38 168.48 24.26 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.9 0.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.7 t -38.85 -48.76 1.59 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.98 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.604 ' CG ' HD22 ' B' ' 120' ' ' LEU . 1.1 tm0? 177.21 -50.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 111.008 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -79.58 112.14 16.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.585 HD13 ' CE1' ' B' ' 19' ' ' PHE . 7.7 tt -113.33 130.18 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 39.2 t -105.3 87.31 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.934 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CE1' HD13 ' B' ' 17' ' ' ILE . 6.8 m-85 -51.37 100.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.423 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -71.97 137.73 47.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.48 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.844 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -70.15 169.27 13.93 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.697 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.844 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.1 Cg_endo -76.16 166.27 83.27 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.736 0.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.425 ' HB3' ' CE1' ' B' ' 77' ' ' PHE . 17.1 m-85 -108.22 30.38 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.09 7.46 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -135.27 154.63 51.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.341 . . . . 0.0 111.12 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -71.37 132.12 44.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -140.31 93.24 2.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.85 111.48 11.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.984 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD2' HD11 ' B' ' 17' ' ' ILE . 76.0 m-85 -98.06 106.5 18.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -79.45 121.51 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.12 125.32 67.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.513 ' HG3' HD12 ' B' ' 69' ' ' LEU . 0.1 OUTLIER -95.29 155.43 16.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.268 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.417 HG22 ' N ' ' B' ' 34' ' ' THR . 33.8 mt -133.99 153.83 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.1 m -144.75 151.74 39.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 111.474 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.551 ' HB2' HD22 ' B' ' 62' ' ' LEU . 14.2 t-20 -98.63 105.54 17.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.616 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -92.83 20.85 6.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.308 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.54 -161.12 20.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.89 40.28 2.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.531 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 175.89 161.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.541 ' O ' HG23 ' B' ' 41' ' ' ILE . 13.5 ptp180 -55.21 169.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.607 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.541 HG23 ' O ' ' B' ' 40' ' ' ARG . 3.7 pt -158.92 115.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 0.0 111.864 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.06 107.18 2.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.478 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.534 ' CD1' HD12 ' B' ' 62' ' ' LEU . 51.2 p-90 -103.87 159.22 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.723 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -145.51 145.11 30.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.353 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.769 HD12 HD12 ' B' ' 91' ' ' ILE . 13.0 mm -123.89 150.94 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 111.627 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.23 163.51 38.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.552 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.496 HG22 HG12 ' B' ' 89' ' ' ILE . 24.3 p -139.5 149.69 44.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.465 HG21 ' O ' ' B' ' 86' ' ' ASN . 0.7 OUTLIER -50.27 -31.24 13.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.008 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -135.89 117.74 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.0 16.48 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.78 -55.03 2.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 110.506 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.82 -40.3 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.88 122.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.711 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.06 108.2 13.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.433 HG12 HG22 ' B' ' 72' ' ' VAL . 2.6 m -97.83 129.09 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.027 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -140.21 140.92 24.68 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.0 153.46 97.64 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.199 0.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.72 -11.52 26.03 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.52 2.146 . . . . 0.0 112.582 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 20.1 p -172.74 158.67 4.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 175.98 147.99 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.51 128.1 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' B' ' 35' ' ' ASN . 0.1 OUTLIER -97.91 165.37 11.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.807 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.9 OUTLIER -117.54 169.63 7.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.451 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.43 112.66 1.19 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.645 2.23 . . . . 0.0 112.534 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp 62.8 34.99 14.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.197 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.512 ' O ' HD21 ' B' ' 62' ' ' LEU . 0.0 OUTLIER -102.19 154.64 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.51 160.38 16.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.344 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.15 151.88 15.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.629 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.513 HD12 ' HG3' ' B' ' 32' ' ' LYS . 12.4 tp -111.2 125.12 53.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.311 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 2.1 ttm -121.7 158.62 28.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.523 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.8 38.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.489 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.433 HG22 HG12 ' B' ' 55' ' ' VAL . 54.4 t -114.17 91.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.651 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.29 129.36 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 10.8 t -130.67 140.0 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -110.04 152.24 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.038 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.3 p -55.8 112.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' B' ' 23' ' ' TYR . 27.5 p90 -119.02 -172.39 2.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.005 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.0 127.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' B' ' 84' ' ' LEU . . . -105.05 18.71 21.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.13 -25.13 22.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 111.121 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.8 p -135.69 29.23 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.037 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.42 129.35 20.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.87 146.94 30.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' B' ' 79' ' ' ALA . 29.1 mt -117.32 41.57 2.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.42 24.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.465 ' O ' HG21 ' B' ' 48' ' ' THR . 23.9 m120 -118.0 -15.28 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.561 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.94 114.6 13.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.888 0.375 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.2 135.53 21.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.496 HG12 HG22 ' B' ' 47' ' ' THR . 15.7 mt -98.52 107.65 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -70.97 121.1 17.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.128 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.769 HD12 HD12 ' B' ' 45' ' ' ILE . 14.4 mm -109.89 149.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.907 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -148.12 159.98 43.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.016 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' B' ' 116' ' ' ARG . 10.1 p90 -177.94 123.57 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.908 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.79 134.66 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -56.56 112.57 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.0 p -58.4 147.94 66.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.01 164.68 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.602 2.201 . . . . 0.0 112.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.51 115.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.208 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.98 47.77 31.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.825 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 166.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.019 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.75 164.63 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.179 0.514 . . . . 0.0 111.342 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 71.03 7.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.608 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.91 132.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.07 152.27 4.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 13.3 mmm180 -136.77 145.28 44.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -27.89 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.49 -18.5 65.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.279 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.412 ' CD2' ' HB2' ' B' ' 105' ' ' ARG . 26.1 m0 -56.86 -20.22 21.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.981 -179.904 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.7 mpt? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.866 0.365 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' B' ' 114' ' ' MET . 7.4 p 175.59 127.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.483 ' HB3' ' CZ2' ' B' ' 93' ' ' TRP . 0.1 OUTLIER -119.09 157.94 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.04 124.86 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.057 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.56 131.75 40.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.401 ' N ' ' ND2' ' B' ' 119' ' ' ASN . 0.7 OUTLIER -96.08 122.55 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.604 HD22 ' CG ' ' B' ' 15' ' ' GLN . 1.5 mt -81.66 133.31 52.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.665 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.416 ' HD3' ' NE2' ' B' ' 15' ' ' GLN . 91.6 Cg_endo -79.16 134.95 11.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.622 2.215 . . . . 0.0 112.661 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.492 HD11 HG13 ' B' ' 89' ' ' ILE . 7.6 mm -108.23 82.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.44 161.89 26.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.154 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' B' ' 122' ' ' ILE . 58.6 m-85 -130.89 101.0 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.455 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 28.9 t30 -80.58 81.55 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.908 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 CA--C 1.527 0.166 0 CA-C-O 120.677 0.199 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.25 116.13 4.56 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.572 2.181 . . . . 0.0 112.266 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.38 114.07 3.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.546 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.75 146.33 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pt -110.8 146.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -96.01 141.18 29.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.47 145.36 50.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.157 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.4 118.13 12.59 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.33 157.27 72.63 Favored 'Cis proline' 0 C--N 1.352 0.74 0 C-N-CA 124.22 -1.158 . . . . 0.0 112.644 0.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.11 -33.11 75.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.411 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 2.8 tt0 -179.47 51.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.743 0.306 . . . . 0.0 111.32 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -174.21 108.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.313 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.9 tt -131.08 155.25 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 123' ' ' GLU . 73.8 t -135.5 96.14 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.678 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE2' ' CG2' ' A' ' 122' ' ' ILE . 18.8 m-85 -63.28 100.12 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -69.67 151.4 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.493 . . . . 0.0 111.89 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.802 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -48.64 170.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.802 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 80.1 Cg_endo -87.62 169.02 39.76 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.241 -1.149 . . . . 0.0 112.961 0.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' A' ' 125' ' ' ASN . 21.7 m-30 -110.42 18.97 19.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.185 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -104.1 3.21 32.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.983 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.64 -171.49 3.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.697 0.284 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -99.13 105.56 17.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.35 121.46 38.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -106.55 107.51 18.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.49 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -97.2 126.19 42.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.155 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -86.89 141.1 29.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.814 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 32' ' ' LYS . 17.1 mt -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.575 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 31' ' ' ILE . 8.4 mttm -102.89 119.38 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -117.34 145.85 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.2 m -147.61 158.42 44.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 111.323 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -111.26 113.56 26.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.457 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.32 23.18 6.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.72 -158.66 23.63 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.531 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.61 18.7 5.4 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.617 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.87 159.74 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.5 mpp_? -57.3 151.64 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.666 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt -150.36 121.34 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.861 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 168.5 54.31 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -166.03 155.21 11.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.523 0.662 . . . . 0.0 112.109 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.78 156.78 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.061 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.474 ' CG2' HG11 ' A' ' 55' ' ' VAL . 15.7 mm -121.51 136.19 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.948 0.404 . . . . 0.0 111.796 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 126.18 17.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.519 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.0 p -112.25 162.08 15.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.195 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.49 -28.2 1.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.282 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.42 120.5 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.7 11.34 27.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.486 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.62 -54.12 2.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 110.679 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.96 -28.19 60.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mt -115.22 122.08 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.46 157.84 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.474 HG11 ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -123.94 155.04 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.875 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 9.0 t70 -166.87 109.17 0.65 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 73.1 Cg_endo -76.1 140.79 67.96 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.83 -1.321 . . . . 0.0 112.32 0.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.41 -24.89 30.77 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.406 2.071 . . . . 0.0 112.209 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.9 p -151.91 172.85 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.78 -163.33 35.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.648 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 t -137.88 152.57 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 111.2 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.555 HD11 HG21 ' A' ' 68' ' ' VAL . 5.7 mp -124.52 161.45 26.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.6 p30 -115.03 170.53 5.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.744 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 49.4 Cg_exo -56.7 114.0 1.72 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.485 2.124 . . . . 0.0 112.562 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.02 39.24 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.546 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.35 139.31 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.52 112.3 21.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.555 HG21 HD11 ' A' ' 62' ' ' LEU . 27.3 m -101.75 149.12 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.29 127.18 43.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.765 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.448 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 54.0 ttp -113.7 161.38 17.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.082 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.448 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -129.48 141.4 51.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.094 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.07 101.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.8 145.98 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 142.63 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.691 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.9 143.07 26.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.005 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -57.07 161.47 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.145 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -172.27 -160.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -127.29 94.4 3.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.21 -22.18 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.33 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.78 -43.95 94.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -131.27 60.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -158.28 162.14 37.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -70.43 152.24 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.585 HD22 ' CB ' ' A' ' 124' ' ' TYR . 12.4 mt -138.26 23.26 2.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -145.54 27.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.971 0.415 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.38 -28.46 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.101 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.53 124.63 24.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.81 132.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.654 HG13 HD11 ' A' ' 122' ' ' ILE . 66.6 mt -94.47 127.88 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.8 m -112.58 104.58 12.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 91' ' ' ILE . 4.3 mp -87.43 148.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.404 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 4.9 mt-10 -144.77 154.27 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.294 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -162.42 149.46 13.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.621 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -148.0 141.84 25.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.779 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.02 139.5 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 p -92.6 146.65 32.73 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.2 163.4 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.518 2.145 . . . . 0.0 112.107 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.16 112.32 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.979 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.56 47.1 58.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.72 155.46 19.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 111.21 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.68 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.29 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -88.42 69.76 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.618 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -173.01 124.69 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -52.31 125.76 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.22 149.77 27.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -21.89 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -73.77 -9.74 58.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.633 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -69.31 -29.59 67.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.621 ' CZ ' HG22 ' A' ' 94' ' ' THR . 15.0 m-85 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 1.6 mpt? . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.926 0.393 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.4 p 175.36 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.664 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -107.26 155.84 19.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.991 0.424 . . . . 0.0 111.157 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.404 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -145.71 132.64 20.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.952 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 152.22 33.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 120' ' ' LEU . 5.1 m120 -102.86 156.37 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.809 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 119' ' ' ASN . 5.0 mp -134.51 129.33 19.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.56 128.07 6.75 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.645 2.23 . . . . 0.0 112.2 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.654 HD11 HG13 ' A' ' 89' ' ' ILE . 11.6 mm -100.0 138.86 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.513 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.562 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -119.51 160.08 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.284 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CB ' HD22 ' A' ' 84' ' ' LEU . 38.7 m-85 -123.11 117.74 26.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 38.2 t30 -114.8 141.48 47.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.49 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 32.6 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo . . . . . 0 CA--C 1.527 0.151 0 CA-C-O 120.699 0.208 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.26 116.0 4.51 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.519 2.146 . . . . 0.0 112.349 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.99 114.28 3.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.09 146.21 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 pt -110.57 146.11 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.21 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.87 141.16 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.664 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.46 145.5 50.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.41 ' HB3' ' CG ' ' A' ' 22' ' ' PRO . 32.8 mt-30 -135.62 117.97 12.31 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.534 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 157.18 72.3 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 124.217 -1.159 . . . . 0.0 112.729 0.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.01 -33.1 75.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.444 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 120' ' ' LEU . 2.7 tt0 -179.6 51.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' B' ' 121' ' ' PRO . 1.4 ptpt -174.54 108.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.388 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.429 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.9 tt -131.02 155.55 42.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' B' ' 123' ' ' GLU . 74.2 t -135.82 96.19 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.737 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' B' ' 122' ' ' ILE . 18.8 m-85 -63.36 100.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.086 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -69.64 151.21 46.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.151 0.501 . . . . 0.0 111.869 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.82 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -48.35 170.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.82 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 73.9 Cg_endo -87.73 168.76 39.75 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 124.312 -1.12 . . . . 0.0 112.94 0.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' B' ' 125' ' ' ASN . 21.9 m-30 -110.15 18.85 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -103.99 3.22 33.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.927 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.55 -171.38 3.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.771 0.32 . . . . 0.0 110.555 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -99.29 105.52 17.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.34 121.65 38.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.373 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.4 m -106.63 107.8 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.413 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.46 126.43 42.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.094 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -87.05 141.21 28.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.743 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.422 HG22 ' N ' ' B' ' 32' ' ' LYS . 18.0 mt -113.68 154.63 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.478 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.422 ' N ' HG22 ' B' ' 31' ' ' ILE . 8.4 mttm -102.81 119.58 39.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 111.479 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 75.2 mt -117.48 145.88 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.585 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.4 HG22 ' N ' ' B' ' 35' ' ' ASN . 53.5 m -147.69 158.41 44.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.365 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.4 ' N ' HG22 ' B' ' 34' ' ' THR . 7.0 t-20 -111.17 113.77 26.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 23.01 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.67 -158.36 23.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.577 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.57 18.38 5.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.658 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.65 159.84 42.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.779 0.323 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' B' ' 62' ' ' LEU . 3.5 mpp_? -57.29 151.87 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 pt -150.61 121.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.322 . . . . 0.0 111.804 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' B' ' 93' ' ' TRP . . . -74.25 168.66 54.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.451 -0.88 . . . . 0.0 110.906 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -166.05 155.31 11.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.536 0.668 . . . . 0.0 112.075 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.9 156.91 43.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.057 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.473 ' CG2' HG11 ' B' ' 55' ' ' VAL . 15.1 mm -121.63 136.22 59.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.905 0.383 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.33 126.09 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.505 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 34.8 p -112.23 162.25 15.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.249 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -28.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.41 120.55 23.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.73 11.46 26.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.467 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -54.23 2.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.355 . . . . 0.0 110.704 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -74.71 -28.32 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.804 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 mt -115.06 122.08 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.829 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.36 157.88 26.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.254 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.473 HG11 ' CG2' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -123.99 155.06 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' B' ' 57' ' ' PRO . 9.0 t70 -166.98 109.11 0.64 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' B' ' 56' ' ' ASP . 72.7 Cg_endo -76.02 140.73 67.73 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.404 0.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.35 -24.81 31.16 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.458 2.105 . . . . 0.0 112.242 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.0 p -152.01 172.74 15.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.647 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.03 -163.64 35.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.597 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.64 152.74 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 111.115 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.563 HD11 HG21 ' B' ' 68' ' ' VAL . 5.5 mp -124.82 161.43 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.6 p30 -114.98 170.55 5.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 51.7 Cg_exo -56.82 113.97 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.562 2.175 . . . . 0.0 112.568 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.1 39.25 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.486 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -111.42 139.33 46.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.262 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.63 112.22 20.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.786 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.563 HG21 HD11 ' B' ' 62' ' ' LEU . 27.4 m -101.77 149.3 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.359 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.37 127.24 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.443 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 53.8 ttp -113.63 161.35 17.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.443 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -129.46 141.54 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.25 101.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.9 145.99 32.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.06 142.68 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.669 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.94 143.11 26.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 4.2 p -57.08 161.71 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -172.33 -160.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.76 94.69 4.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.35 -22.47 66.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.99 93.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.301 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 80.6 p -131.26 60.37 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -158.5 161.96 37.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -70.25 151.88 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' B' ' 124' ' ' TYR . 12.2 mt -137.97 23.34 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.088 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -145.45 27.55 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.58 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.26 -28.48 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -70.44 124.48 24.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 132.67 21.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.061 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.661 HG13 HD11 ' B' ' 122' ' ' ILE . 66.6 mt -94.41 127.96 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 87.3 m -112.63 104.7 12.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.528 ' H ' HD12 ' B' ' 91' ' ' ILE . 4.3 mp -87.46 148.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.627 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.4 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 4.9 mt-10 -144.84 154.36 42.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.405 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 4.3 p90 -162.53 149.52 13.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.028 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.617 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 0.0 OUTLIER -148.05 141.83 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.08 139.38 28.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.7 p -92.53 146.61 32.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.27 163.03 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.607 2.205 . . . . 0.0 112.175 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.71 112.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.34 47.59 55.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 155.55 20.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.95 163.97 2.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.373 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -88.0 69.68 9.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.62 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -172.98 124.68 0.43 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -52.39 125.65 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 149.85 27.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -21.74 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -73.9 -9.62 58.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.69 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -69.34 -29.62 67.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.687 0.279 . . . . 0.0 111.021 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.617 ' CZ ' HG22 ' B' ' 94' ' ' THR . 15.0 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.811 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.229 0.019 0 CA-C-O 120.883 0.373 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.664 HG13 ' O ' ' B' ' 115' ' ' VAL . 7.4 p 175.41 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 32.4 mtt180 -107.12 155.79 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.168 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . 0.4 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -145.82 132.47 19.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.976 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 152.24 33.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.626 ' O ' HD12 ' B' ' 120' ' ' LEU . 5.2 m120 -102.73 156.53 17.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.797 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 119' ' ' ASN . 5.0 mp -134.67 129.2 19.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.102 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' B' ' 16' ' ' LYS . 96.1 Cg_endo -80.37 128.09 6.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.458 2.105 . . . . 0.0 112.167 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.661 HD11 HG13 ' B' ' 89' ' ' ILE . 11.6 mm -99.94 138.73 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.564 ' HB3' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -119.38 160.14 22.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.584 ' CB ' HD22 ' B' ' 84' ' ' LEU . 38.5 m-85 -123.14 117.82 26.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 111.569 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.433 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 38.1 t30 -114.82 141.72 47.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.522 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 32.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.836 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo . . . . . 0 C--O 1.232 0.204 0 CA-C-O 120.707 0.211 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HG2' ' HG2' ' A' ' 116' ' ' ARG . 57.3 Cg_endo -71.07 159.85 51.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.648 2.232 . . . . 0.0 112.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.37 -146.56 5.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.604 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -125.3 137.72 54.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG23 ' NE1' ' A' ' 93' ' ' TRP . 1.1 pt -113.19 149.79 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.236 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 153.45 20.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.603 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -144.98 152.48 40.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.273 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -137.71 116.47 9.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.488 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.02 154.25 76.81 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.963 -1.265 . . . . 0.0 112.484 0.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.9 9.1 38.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.688 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.17 -59.57 1.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 121' ' ' PRO . 12.8 pttm -169.37 173.38 6.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -121.51 155.23 25.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.018 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 44.7 t -118.15 85.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.634 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 29' ' ' TYR . 5.2 m-30 -49.7 102.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -73.3 135.6 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.837 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -54.15 170.33 0.32 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.695 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.837 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 98.4 Cg_endo -78.6 168.47 75.08 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.837 0.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.2 m-85 -112.98 29.93 7.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.01 6.44 12.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.05 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -140.82 157.83 44.83 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.39 114.05 14.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -115.67 149.82 37.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.5 m -114.98 126.92 55.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.471 ' CZ ' ' CG ' ' A' ' 19' ' ' PHE . 42.9 m-85 -107.18 128.68 54.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.506 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -90.98 115.17 27.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.455 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.05 143.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.565 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.72 140.95 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 111.626 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.55 HD11 ' HE2' ' A' ' 70' ' ' MET . 61.5 mt -134.49 152.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.481 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 33' ' ' ILE . 49.5 m -152.59 158.78 42.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.24 0.543 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.768 ' HB2' HD23 ' A' ' 62' ' ' LEU . 52.4 t30 -112.76 107.37 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.29 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -78.97 -4.29 49.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.661 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 -173.15 49.54 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.34 22.46 10.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -145.16 -179.65 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.94 155.81 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.428 HD13 ' OD1' ' A' ' 35' ' ' ASN . 20.9 pt -148.86 170.88 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.985 0.422 . . . . 0.0 111.304 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.56 108.17 0.98 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.724 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 30.6 p-90 -104.8 157.83 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 112.023 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.33 157.65 41.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 55' ' ' VAL . 2.7 mp -121.86 142.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.908 0.385 . . . . 0.0 111.939 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.31 125.87 14.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.737 HG22 HG12 ' A' ' 89' ' ' ILE . 55.6 p -102.03 158.34 16.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.226 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -46.24 -33.83 3.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.051 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -137.86 123.87 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.36 8.3 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.474 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.65 -47.54 5.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.752 0.31 . . . . 0.0 110.864 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -82.14 -53.61 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.739 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.728 HD12 ' HB ' ' A' ' 47' ' ' THR . 14.8 mt -91.07 155.36 18.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.816 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.6 152.38 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -119.15 153.6 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -172.83 110.28 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.31 140.72 60.82 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.722 -1.366 . . . . 0.0 112.344 0.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.23 -6.11 16.9 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.556 2.171 . . . . 0.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 p -174.76 171.4 3.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.726 0.298 . . . . 0.0 110.683 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.03 171.75 38.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.634 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.09 120.51 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 0.0 111.116 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.768 HD23 ' HB2' ' A' ' 35' ' ' ASN . 5.5 tp -94.37 159.42 15.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.45 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -115.44 167.25 10.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 9.9 Cg_endo -53.28 109.47 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.68 2.253 . . . . 0.0 112.411 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? 62.47 46.85 5.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.42 153.74 25.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -121.12 142.6 49.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.403 HG13 HD11 ' A' ' 62' ' ' LEU . 35.4 m -143.45 149.67 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.009 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 69' ' ' LEU . 10.8 tp -96.67 153.51 17.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.988 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.55 ' HE2' HD11 ' A' ' 33' ' ' ILE . 3.8 ttm -134.16 148.28 50.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -111.0 129.8 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 97.78 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.68 125.42 29.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.73 147.8 31.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -101.1 142.17 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -55.74 148.91 15.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 79' ' ' ALA . 35.3 p90 -161.79 -164.67 1.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.421 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 3.6 m-80 -125.9 113.15 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . . . -97.38 21.5 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.278 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.01 -23.52 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.2 p -138.51 40.4 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -151.51 145.15 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -61.36 147.14 45.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.48 ' HB3' ' CD2' ' A' ' 124' ' ' TYR . 11.0 mt -130.51 63.85 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -160.06 27.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.526 ' O ' HG21 ' A' ' 48' ' ' THR . 24.2 m-80 -129.05 4.91 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.685 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.91 111.58 23.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -146.13 132.73 19.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.279 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.737 HG12 HG22 ' A' ' 47' ' ' THR . 63.0 mt -94.18 130.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 118' ' ' LYS . 99.5 m -106.3 126.19 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.0 mp -115.18 116.76 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.9 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' OE2' HG22 ' A' ' 90' ' ' THR . 0.1 OUTLIER -118.31 159.55 23.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.006 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.406 ' NE1' HG23 ' A' ' 9' ' ' ILE . 9.4 p90 -155.96 130.59 9.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.693 ' HB ' HG22 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -128.06 140.82 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -53.77 137.09 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.0 p -80.47 149.92 69.4 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.18 163.99 2.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 112.08 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -50.67 108.24 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.937 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.96 47.74 59.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.435 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.69 173.1 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.368 . . . . 0.0 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.5 164.66 26.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.1 70.08 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 178.8 136.81 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -53.97 149.09 9.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -138.73 148.16 43.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -18.95 62.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.34 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.13 -6.79 45.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.831 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 48.7 m0 -87.55 13.25 10.56 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.494 0.187 . . . . 0.0 111.448 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 115' ' ' VAL . 49.3 m-85 . . . . . 0 C--N 1.333 -0.131 0 CA-C-O 120.872 0.367 . . . . 0.0 110.613 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.6 ' C ' HG23 ' A' ' 115' ' ' VAL . 12.5 mmt . . . . . 0 CA--C 1.521 -0.169 0 CA-C-O 121.073 0.463 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 94' ' ' THR . 3.4 t 82.92 116.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.139 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HG2' ' HG2' ' A' ' 6' ' ' PRO . 27.0 mmt-85 -92.23 146.32 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.5 134.03 54.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -127.53 161.18 29.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.624 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -131.08 154.32 48.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 95.1 5.48 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.756 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 58.5 Cg_exo -52.13 150.99 17.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.692 2.262 . . . . 0.0 112.678 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.0 mm -108.63 149.51 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HB3' HG13 ' A' ' 18' ' ' VAL . 1.7 tt0 -131.45 164.43 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.43 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -130.28 114.35 15.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.242 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.457 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 25.4 t30 -103.16 80.72 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 43.9 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.815 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo . . . . . 0 CA--C 1.528 0.197 0 CA-C-O 120.698 0.208 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.01 159.54 52.13 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.11 -146.83 5.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.614 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.0 OUTLIER -125.1 137.56 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.826 0.346 . . . . 0.0 110.867 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.421 HG23 ' NE1' ' B' ' 93' ' ' TRP . 1.1 pt -113.18 149.73 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.22 153.34 20.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.712 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -144.82 152.32 40.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -137.51 116.43 10.04 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.467 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.05 154.22 76.95 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.016 -1.244 . . . . 0.0 112.58 0.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.89 9.15 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.737 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.401 ' O ' ' HD2' ' B' ' 121' ' ' PRO . 0.6 OUTLIER -127.36 -59.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.802 0.334 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 121' ' ' PRO . 12.7 pttm -169.55 173.4 6.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.011 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -121.66 155.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 45.1 t -118.23 84.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.476 ' CG ' ' CZ ' ' B' ' 29' ' ' TYR . 5.2 m-30 -49.51 102.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.602 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -73.37 135.5 44.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.446 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.856 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -53.91 170.44 0.3 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.787 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.856 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 97.0 Cg_endo -78.45 168.61 74.95 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.723 0.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.2 m-85 -113.11 29.85 7.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.956 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.91 6.72 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.132 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.09 157.82 44.77 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.25 114.02 14.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.092 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -115.86 149.63 38.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -114.87 126.76 55.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 111.246 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.476 ' CZ ' ' CG ' ' B' ' 19' ' ' PHE . 43.4 m-85 -106.92 128.68 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.476 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -91.07 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -103.84 142.91 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.545 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.58 140.91 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.551 HD11 ' HE2' ' B' ' 70' ' ' MET . 61.6 mt -134.5 152.96 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.408 ' N ' HG22 ' B' ' 33' ' ' ILE . 49.5 m -152.61 158.96 43.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.413 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.764 ' HB2' HD23 ' B' ' 62' ' ' LEU . 52.3 t30 -112.94 107.39 15.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.313 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -79.0 -4.1 48.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.82 -173.1 49.54 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.453 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.4 22.43 10.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -145.03 -179.53 6.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.366 . . . . 0.0 110.829 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.04 155.9 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.428 HD13 ' OD1' ' B' ' 35' ' ' ASN . 21.2 pt -148.88 170.82 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.41 107.88 0.96 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.727 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 30.8 p-90 -104.7 157.67 17.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 112.093 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.5 41.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.231 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.739 ' HB ' HG11 ' B' ' 55' ' ' VAL . 2.7 mp -121.67 142.81 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.012 0.434 . . . . 0.0 111.924 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.51 125.86 14.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.751 HG22 HG12 ' B' ' 89' ' ' ILE . 56.2 p -101.97 158.6 16.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.23 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.533 HG21 ' O ' ' B' ' 86' ' ' ASN . 0.1 OUTLIER -46.46 -33.79 4.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.067 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -137.81 123.78 20.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.24 8.33 16.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.487 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -47.39 5.07 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.752 0.311 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 mtt-85 -82.18 -53.69 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . 0.719 HD12 ' HB ' ' B' ' 47' ' ' THR . 15.2 mt -91.05 155.59 18.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.778 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.7 152.26 29.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.027 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.739 HG11 ' HB ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -119.15 153.58 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.02 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . 0.666 ' O ' ' HB3' ' B' ' 71' ' ' ALA . 0.5 OUTLIER -172.75 110.35 0.35 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.38 140.69 60.86 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.29 0.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.18 -6.16 16.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.595 2.197 . . . . 0.0 112.846 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 3.8 p -174.75 171.42 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.716 0.293 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.01 171.83 38.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.556 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.18 120.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.764 HD23 ' HB2' ' B' ' 35' ' ' ASN . 5.5 tp -94.2 159.43 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.448 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -115.48 167.31 10.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 9.8 Cg_endo -53.36 109.46 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.643 2.228 . . . . 0.0 112.434 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? 62.62 46.74 5.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.35 153.62 25.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -121.01 142.47 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.42 149.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.65 153.41 17.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.551 ' HE2' HD11 ' B' ' 33' ' ' ILE . 3.8 ttm -134.03 148.38 51.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' B' ' 56' ' ' ASP . . . -111.08 129.8 55.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.038 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 97.94 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.2 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.35 29.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.826 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 38.6 t -108.56 147.66 31.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.977 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -101.09 142.23 32.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -55.85 148.75 16.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.039 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' B' ' 79' ' ' ALA . 35.2 p90 -161.53 -164.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . 0.427 ' N ' ' CD2' ' B' ' 77' ' ' PHE . 3.6 m-80 -125.96 113.05 16.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' B' ' 77' ' ' PHE . . . -97.28 21.56 9.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.399 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.85 -23.57 12.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.29 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 58.3 p -138.58 40.54 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.311 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -151.74 145.13 24.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -61.35 147.28 45.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.477 ' HB3' ' CD2' ' B' ' 124' ' ' TYR . 11.4 mt -130.5 63.58 1.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -159.93 27.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.533 ' O ' HG21 ' B' ' 48' ' ' THR . 24.2 m-80 -129.33 4.92 5.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.765 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.93 111.57 23.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.645 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -146.04 132.73 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.27 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.751 HG12 HG22 ' B' ' 47' ' ' THR . 62.5 mt -94.23 130.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.633 HG23 ' O ' ' B' ' 118' ' ' LYS . 99.5 m -106.31 125.86 51.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.548 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.0 mp -114.86 116.92 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.918 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.476 ' OE2' HG22 ' B' ' 90' ' ' THR . 0.1 OUTLIER -118.54 159.5 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.421 ' NE1' HG23 ' B' ' 9' ' ' ILE . 9.2 p90 -155.96 130.68 9.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.674 ' HB ' HG22 ' B' ' 115' ' ' VAL . 0.7 OUTLIER -128.15 140.85 51.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -53.83 137.37 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 59.1 p -80.69 149.92 68.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.14 164.24 1.87 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.539 2.159 . . . . 0.0 112.074 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.01 108.31 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.98 47.62 59.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.462 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.51 172.98 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.53 164.69 26.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.275 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.11 69.76 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.17 137.12 0.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.835 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -54.12 148.97 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -138.61 148.15 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.301 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.2 -6.54 43.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.798 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.473 ' O ' ' CD1' ' B' ' 109' ' ' PHE . 48.8 m0 -87.75 13.38 10.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.527 0.203 . . . . 0.0 111.467 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.585 ' CE2' HG11 ' B' ' 115' ' ' VAL . 49.3 m-85 . . . . . 0 C--N 1.333 -0.139 0 CA-C-O 120.853 0.359 . . . . 0.0 110.589 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . 0.592 ' C ' HG23 ' B' ' 115' ' ' VAL . 12.5 mmt . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' B' ' 94' ' ' THR . 3.4 t 83.06 116.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -91.94 146.26 23.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.764 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.57 134.13 54.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . 0.633 ' O ' HG23 ' B' ' 90' ' ' THR . 0.2 OUTLIER -127.56 161.01 29.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -130.84 154.32 48.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.48 95.11 5.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.72 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' B' ' 15' ' ' GLN . 59.1 Cg_exo -52.17 151.11 17.66 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.681 2.254 . . . . 0.0 112.639 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 19.9 mm -108.68 149.34 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.993 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.424 ' HB3' HG13 ' B' ' 18' ' ' VAL . 1.7 tt0 -131.31 164.41 25.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.022 0.439 . . . . 0.0 111.02 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' B' ' 84' ' ' LEU . 89.4 m-85 -130.23 114.28 15.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.249 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.445 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 24.6 t30 -103.34 80.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 43.4 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.7 Cg_endo . . . . . 0 CA--C 1.529 0.27 0 CA-C-O 120.56 0.15 . . . . 0.0 112.258 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 52.5 Cg_exo -55.05 140.6 80.2 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.367 2.045 . . . . 0.0 112.229 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.8 132.36 46.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.537 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 26.6 m-20 -51.22 128.76 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.454 HD12 HG23 ' A' ' 11' ' ' THR . 1.6 pp -102.35 142.84 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.22 150.02 35.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.454 HG23 HD12 ' A' ' 9' ' ' ILE . 1.7 p -142.2 150.05 40.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -146.13 104.51 4.12 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.758 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 31' ' ' ILE . 31.6 Cg_endo -63.7 159.94 64.69 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.465 0.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.37 -18.24 12.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.81 -46.78 4.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' PRO . 31.5 pttt -172.73 -179.13 2.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.2 tt -135.93 138.72 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.031 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.512 HG22 ' CB ' ' A' ' 123' ' ' GLU . 61.4 t -121.94 91.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -59.96 102.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.554 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.88 138.43 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.462 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -60.22 167.71 2.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.716 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 7.7 Cg_endo -88.05 164.8 43.31 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 124.415 -1.077 . . . . 0.0 112.484 0.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 38.6 m-85 -101.19 47.52 0.91 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.964 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.71 1.78 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.485 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.446 ' C ' HG22 ' A' ' 76' ' ' THR . 49.7 p-10 -139.35 152.09 46.88 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.839 0.352 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -63.01 121.19 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.781 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -112.86 99.98 8.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.067 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.4 m -99.76 109.59 22.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.448 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 60.4 m-85 -92.09 163.85 13.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.1 0.476 . . . . 0.0 111.222 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -118.09 109.19 16.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.738 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 ' HD2' ' A' ' 13' ' ' PRO . 8.9 mm -91.1 141.9 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.94 128.63 56.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 34' ' ' THR . 36.3 mt -128.9 153.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 33' ' ' ILE . 58.6 m -148.82 157.71 43.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 111.275 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.635 ' HB2' HD23 ' A' ' 62' ' ' LEU . 11.4 t-20 -104.4 73.84 1.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -57.71 -26.09 61.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.15 -62.49 5.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.57 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.5 21.67 4.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.682 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -149.7 159.3 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.44 149.03 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 pt -154.37 167.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.63 100.14 0.48 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.87 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -95.57 157.04 16.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . . . -153.11 128.94 10.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.01 142.67 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 111.469 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -145.23 132.84 20.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.572 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.71 155.14 29.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.042 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -65.45 -35.21 80.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.76 112.76 17.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.2 21.63 9.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -46.3 6.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -106.11 -33.07 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 mt -95.96 131.92 41.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.43 167.18 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.5 p -151.99 160.53 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.315 0.578 . . . . 0.0 111.004 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 55' ' ' VAL . 23.1 t70 -165.42 125.98 1.31 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.65 143.54 77.4 Favored 'Cis proline' 0 C--N 1.352 0.75 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.303 -0.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.03 4.89 6.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 113.035 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.7 p -179.71 158.28 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.09 164.7 30.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.627 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.08 117.51 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 111.127 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 35' ' ' ASN . 5.0 tp -90.49 160.8 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.452 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -109.99 178.62 0.97 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 22.5 Cg_exo -65.35 105.72 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.737 2.291 . . . . 0.0 112.649 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 72.08 22.65 3.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.256 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -87.2 150.08 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -116.63 132.29 56.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.82 143.46 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.905 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.1 126.04 54.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.428 ' HE2' HG21 ' A' ' 31' ' ' ILE . 25.9 ptt? -122.68 168.13 12.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.56 137.43 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.747 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.677 ' O ' HG13 ' A' ' 72' ' ' VAL . 8.8 p -115.41 96.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 144.19 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 t -138.76 81.93 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -51.88 153.48 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.446 HG22 ' C ' ' A' ' 25' ' ' ASP . 2.4 p -65.65 122.53 17.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 8.8 p90 -130.91 179.32 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.84 127.28 56.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.8 18.35 6.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.513 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.93 -29.36 13.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.9 p -136.15 42.72 2.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -143.16 133.37 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -52.55 134.24 35.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.488 HD22 ' CG ' ' A' ' 124' ' ' TYR . 16.8 mt -121.88 21.38 10.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -144.07 21.78 1.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -132.32 4.03 3.99 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.694 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -96.75 118.86 34.13 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 110.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.7 133.11 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 90' ' ' THR . 17.7 mt -85.3 164.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.507 ' N ' HG22 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -143.47 121.39 12.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 111.405 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.03 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.793 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -99.63 122.47 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 5.6 p90 -133.59 143.7 48.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.3 136.75 33.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -50.1 144.66 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.29 139.42 41.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.71 160.82 47.04 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -48.73 129.33 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.169 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.94 38.06 94.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.647 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 134.09 45.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.63 163.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.144 0.497 . . . . 0.0 111.289 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.29 6.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.54 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.01 145.55 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.812 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 44' ' ' ALA . 71.8 t80 -57.43 115.77 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 0.5 OUTLIER -106.06 153.75 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.827 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -87.19 -27.42 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.68 -33.2 72.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 54.0 m0 -53.54 -31.85 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.948 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.74 125.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.25 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -97.05 108.05 20.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -103.26 115.89 31.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.03 157.69 16.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.433 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.31 126.01 17.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.394 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.6 114.46 47.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.15 145.56 79.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.495 HD13 ' CG2' ' A' ' 17' ' ' ILE . 40.1 mm -95.03 151.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.852 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.512 ' CB ' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -136.6 156.68 48.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.488 ' CG ' HD22 ' A' ' 84' ' ' LEU . 6.5 m-85 -127.69 104.93 8.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.98 78.46 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.664 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.922 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 CA--C 1.529 0.236 0 CA-C-O 120.513 0.131 . . . . 0.0 112.256 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.93 140.39 79.19 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.462 2.108 . . . . 0.0 112.272 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.75 132.36 46.76 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.414 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 27.5 m-20 -51.07 128.96 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.461 HD12 HG23 ' B' ' 11' ' ' THR . 1.6 pp -102.46 142.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.31 150.1 35.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . 0.461 HG23 HD12 ' B' ' 9' ' ' ILE . 1.7 p -142.26 149.98 40.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -146.07 104.48 4.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' B' ' 31' ' ' ILE . 32.2 Cg_endo -63.66 160.24 63.66 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.399 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -18.45 12.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.69 -46.55 4.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.77 0.319 . . . . 0.0 111.274 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' B' ' 13' ' ' PRO . 31.3 pttt -172.87 -179.29 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.1 tt -135.72 138.82 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.059 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' B' ' 123' ' ' GLU . 62.5 t -122.09 91.47 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.23 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -59.91 102.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.562 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.85 138.58 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.468 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -60.4 167.73 2.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.717 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.752 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 7.8 Cg_endo -88.16 164.51 42.98 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.385 -1.09 . . . . 0.0 112.544 0.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . 0.403 ' CD1' ' CE1' ' B' ' 77' ' ' PHE . 39.4 m-85 -100.9 47.64 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.061 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.68 1.67 11.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.44 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . 0.454 ' C ' HG22 ' B' ' 76' ' ' THR . 50.0 p-10 -139.21 152.11 47.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -63.01 121.16 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.724 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -112.86 100.16 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.996 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -99.9 109.85 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.627 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.447 ' HB2' ' CG1' ' B' ' 72' ' ' VAL . 59.9 m-85 -92.29 163.85 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 111.133 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -118.12 109.04 15.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.704 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.522 HD12 ' HD2' ' B' ' 13' ' ' PRO . 9.0 mm -91.05 141.95 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.02 128.53 56.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.414 HG22 ' N ' ' B' ' 34' ' ' THR . 36.0 mt -128.86 153.34 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . 0.414 ' N ' HG22 ' B' ' 33' ' ' ILE . 59.5 m -148.77 157.53 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.642 ' HB2' HD23 ' B' ' 62' ' ' LEU . 11.3 t-20 -104.3 73.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.926 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -57.79 -25.93 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.4 -62.32 5.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.572 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.58 21.53 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.651 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 mtm-85 -149.63 159.32 44.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.4 148.87 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.725 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.22 167.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.992 0.425 . . . . 0.0 111.522 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.54 100.11 0.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.839 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -95.56 157.07 16.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 111.589 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' B' ' 104' ' ' PHE . . . -153.23 129.04 10.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.713 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 25.6 mm -93.05 142.6 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 111.472 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -145.23 132.77 20.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.651 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.58 155.18 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 3.0 p -65.5 -35.27 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.7 112.76 17.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.29 21.77 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.97 -46.29 6.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -106.17 -33.27 7.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -95.71 131.83 41.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.796 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.47 167.05 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.504 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.5 p -151.79 160.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . 0.504 ' N ' HG22 ' B' ' 55' ' ' VAL . 22.9 t70 -165.46 126.03 1.31 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.54 143.6 77.73 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.831 -1.32 . . . . 0.0 112.252 -0.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.88 4.72 6.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.618 2.212 . . . . 0.0 113.095 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 9.6 p -179.7 158.23 0.79 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.14 164.74 30.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.603 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.2 t -100.19 117.65 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 111.087 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' B' ' 35' ' ' ASN . 5.0 tp -90.53 160.97 15.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -110.14 178.39 1.02 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.804 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 22.3 Cg_exo -65.11 106.03 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 71.81 22.5 3.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.363 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -87.1 150.2 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -116.69 132.19 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.68 143.64 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.922 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.3 125.88 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.403 ' HE2' HG21 ' B' ' 31' ' ' ILE . 25.9 ptt? -122.45 168.32 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.77 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.65 137.48 53.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.721 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.672 HG13 ' O ' ' B' ' 72' ' ' VAL . 8.9 p -115.51 96.23 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.722 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 144.14 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 t -138.76 81.88 1.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.732 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.7 153.4 2.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.454 HG22 ' C ' ' B' ' 25' ' ' ASP . 2.4 p -65.7 122.62 17.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CE1' ' CD1' ' B' ' 23' ' ' TYR . 9.2 p90 -130.97 179.22 6.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.93 127.32 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.69 18.07 6.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.599 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.76 -29.3 13.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.6 p -136.14 42.67 2.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -143.14 133.41 24.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -52.6 134.32 35.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.007 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' B' ' 124' ' ' TYR . 16.9 mt -121.95 21.29 10.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -143.95 21.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.897 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -132.28 4.1 4.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.733 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.74 118.99 34.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.731 0.3 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.72 133.3 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.5 HG22 ' N ' ' B' ' 90' ' ' THR . 18.2 mt -85.43 164.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.524 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.5 ' N ' HG22 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -143.47 121.59 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.09 92.04 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.811 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -99.77 122.56 42.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.459 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 5.6 p90 -133.76 143.8 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.856 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 137.18 33.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.785 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -50.29 144.96 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.54 139.5 41.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.68 161.01 46.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.535 2.157 . . . . 0.0 112.32 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -48.9 129.27 17.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.89 38.16 94.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.65 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 134.16 45.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.09 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.57 163.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.127 0.489 . . . . 0.0 111.331 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.43 6.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.634 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.81 145.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' B' ' 44' ' ' ALA . 71.8 t80 -57.44 115.73 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 0.5 OUTLIER -105.95 153.56 21.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.04 -27.43 23.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.69 -33.07 72.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' B' ' 105' ' ' ARG . 54.0 m0 -53.69 -31.79 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.937 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.836 0.35 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.88 125.29 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.459 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -97.33 107.88 20.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -102.99 115.91 31.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.26 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 157.59 16.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.444 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -141.34 125.9 17.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.53 114.55 47.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.3 145.52 78.1 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.406 2.07 . . . . 0.0 112.645 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.495 HD13 ' CG2' ' B' ' 17' ' ' ILE . 40.7 mm -94.97 151.51 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.887 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.503 ' CB ' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -136.7 156.59 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' B' ' 84' ' ' LEU . 6.4 m-85 -127.47 105.05 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.038 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.2 78.57 9.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.834 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo . . . . . 0 CA--C 1.527 0.156 0 CA-C-O 120.776 0.24 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.15 142.98 47.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.562 2.175 . . . . 0.0 112.295 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.13 126.13 13.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.444 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 16.8 m-20 -52.73 121.9 8.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.573 HG22 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -94.49 128.98 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.02 146.62 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.741 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.21 138.69 35.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.065 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -136.11 112.1 10.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.723 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.09 154.55 70.02 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.401 0.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.45 -38.94 88.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.116 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.04 49.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -169.16 118.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.26 147.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.704 HG11 HG11 ' B' ' 18' ' ' VAL . 7.4 p -139.43 99.72 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 111.603 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 19.2 m-30 -51.51 108.18 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.74 137.15 40.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -59.85 167.09 2.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.732 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 83.3 Cg_endo -86.68 161.61 52.65 Favored 'Cis proline' 0 C--N 1.348 0.548 0 C-N-CA 124.013 -1.244 . . . . 0.0 112.583 0.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.97 29.51 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -107.07 7.06 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.533 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -148.68 147.83 29.35 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -56.98 117.99 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 112.16 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.9 m -102.7 114.2 28.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.001 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.567 ' CE1' ' CD1' ' A' ' 19' ' ' PHE . 4.9 m-85 -96.01 122.08 38.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -81.1 132.51 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.65 152.49 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HB2' ' HG3' ' B' ' 22' ' ' PRO . 0.8 OUTLIER -113.27 127.73 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.238 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -131.54 130.3 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.79 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.9 m -142.15 156.61 45.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.215 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.573 ' HA ' HG22 ' A' ' 9' ' ' ILE . 25.9 t-20 -100.08 113.75 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -92.23 20.23 6.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.344 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.65 -140.39 9.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.583 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.31 29.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -155.89 148.39 23.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.574 ' HG2' HG12 ' A' ' 61' ' ' VAL . 5.7 ttp180 -54.67 159.24 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 61' ' ' VAL . 12.1 pt -154.2 166.45 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.041 0.448 . . . . 0.0 111.577 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.19 109.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.597 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -104.21 161.67 13.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.226 0.536 . . . . 0.0 111.79 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.36 151.29 26.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.28 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.723 HD12 HG13 ' A' ' 91' ' ' ILE . 20.0 mm -122.14 140.4 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.14 131.28 23.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.507 HG22 HG12 ' A' ' 89' ' ' ILE . 67.1 p -114.03 154.81 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.068 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.06 -37.09 73.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -124.89 112.16 16.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.2 -37.53 9.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.759 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -32.38 7.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.81 141.87 29.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.72 132.48 27.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -115.09 128.0 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -145.71 129.52 8.55 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 58.8 Cg_endo -71.52 133.35 28.03 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.153 -0.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 51.4 Cg_exo -55.33 -46.81 29.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.388 2.059 . . . . 0.0 112.232 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.83 150.3 36.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.728 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.74 -172.03 27.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.598 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.574 HG12 ' HG2' ' A' ' 40' ' ' ARG . 6.0 t -123.16 114.49 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.842 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.433 HD21 HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -87.86 161.44 17.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.028 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -121.23 178.39 1.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.675 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 33.5 Cg_exo -61.55 108.89 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.623 2.215 . . . . 0.0 112.323 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.72 34.45 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.06 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -95.74 151.23 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.798 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -106.44 156.81 18.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 HD21 ' A' ' 62' ' ' LEU . 59.4 t -148.74 147.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 69' ' ' LEU . 2.8 mt -112.55 135.63 53.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.686 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 157.74 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.3 123.03 26.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.97 85.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.192 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.73 131.62 49.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.939 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.5 t -123.53 87.59 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.91 149.42 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.001 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 76' ' ' THR . 2.9 p -63.93 135.88 56.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 83' ' ' ASP . 26.4 p90 -145.35 -164.5 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -127.15 131.48 50.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.61 19.97 13.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.376 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.68 -37.48 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.287 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 77.6 p -138.65 25.03 2.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 81' ' ' THR . 28.4 mt-10 -161.13 161.87 31.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER 59.63 166.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.957 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.64 HD23 ' CE1' ' A' ' 124' ' ' TYR . 6.2 mt 84.18 54.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ASN . 1.1 p30 -125.4 27.36 6.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.964 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 85' ' ' ASN . 10.7 m-20 82.37 97.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.753 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.7 139.2 53.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.92 132.89 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 122' ' ' ILE . 8.4 mt -83.67 166.03 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.744 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 89' ' ' ILE . 2.5 m -140.63 117.56 11.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 111.057 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.723 HG13 HD12 ' A' ' 45' ' ' ILE . 3.3 mp -108.34 103.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.79 140.45 48.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.49 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 9.4 p90 -149.94 141.47 23.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.009 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.552 HG21 ' O ' ' A' ' 108' ' ' TRP . 4.0 t -132.43 147.43 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.992 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -52.4 137.86 28.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.663 HG22 ' CH2' ' A' ' 108' ' ' TRP . 3.0 p -82.38 143.36 48.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 47.2 Cg_exo -55.87 160.73 9.42 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.495 2.13 . . . . 0.0 112.071 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.8 121.38 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.41 42.56 65.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.09 160.64 17.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.401 . . . . 0.0 111.149 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.85 164.37 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.218 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -88.12 70.17 9.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.583 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.23 134.98 0.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.829 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.12 145.04 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.488 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 3.0 mmt180 -124.8 152.31 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -80.7 -44.55 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.046 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.51 -14.07 62.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.526 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.663 ' CH2' HG22 ' A' ' 96' ' ' THR . 5.0 m0 -51.49 -24.57 5.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.333 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 8.1 mtt . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.891 0.377 . . . . 0.0 111.492 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.06 124.31 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.49 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -87.65 141.25 28.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.168 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.41 129.2 39.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.766 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -126.22 162.83 24.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.596 ' O ' HD12 ' A' ' 120' ' ' LEU . 53.2 m-80 -143.7 142.82 31.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 119' ' ' ASN . 8.6 mp -128.56 95.75 31.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.67 135.61 70.47 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.516 HD11 HG13 ' A' ' 89' ' ' ILE . 17.4 mm -97.24 144.76 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 18' ' ' VAL . 8.9 mt-10 -132.39 163.67 28.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.685 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.64 ' CE1' HD23 ' A' ' 84' ' ' LEU . 1.8 m-85 -126.08 125.7 43.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.319 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -114.76 80.93 1.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.841 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.924 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo . . . . . 0 C--O 1.231 0.149 0 CA-C-O 120.752 0.23 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 142.87 47.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 112.35 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.99 125.86 12.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.524 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 16.5 m-20 -52.71 121.73 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.934 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' B' ' 35' ' ' ASN . 1.1 pt -94.28 129.13 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.2 146.84 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.684 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.4 138.91 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.038 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -136.22 112.13 10.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.08 154.59 69.98 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 123.99 -1.254 . . . . 0.0 112.43 0.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.29 -39.25 89.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.949 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.85 49.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -169.29 118.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.04 148.18 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.704 HG11 HG11 ' A' ' 18' ' ' VAL . 7.4 p -139.62 99.72 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 19.5 m-30 -51.6 108.1 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.465 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.83 137.16 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.367 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -59.69 167.08 2.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.859 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.727 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 81.9 Cg_endo -86.7 161.64 52.5 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.976 -1.26 . . . . 0.0 112.613 0.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.0 29.62 3.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -107.09 6.99 29.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.474 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -148.75 147.83 29.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.01 117.76 4.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.97 112.2 22.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -102.75 114.33 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' B' ' 19' ' ' PHE . 5.1 m-85 -96.1 121.9 38.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.814 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -80.95 132.44 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.061 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.6 152.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -113.34 127.87 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.62 130.37 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.794 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 51.1 m -142.13 156.69 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.19 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' B' ' 9' ' ' ILE . 26.1 t-20 -100.22 113.71 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.892 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -92.18 20.19 6.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.43 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.61 -140.33 9.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.535 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.27 29.45 0.97 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -155.91 148.31 23.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.768 0.318 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . 0.572 ' HG2' HG12 ' B' ' 61' ' ' VAL . 5.6 ttp180 -54.52 159.12 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.431 ' O ' HG13 ' B' ' 61' ' ' VAL . 12.3 pt -154.19 166.4 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.592 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.14 109.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.566 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -104.26 161.66 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.299 0.571 . . . . 0.0 111.789 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.23 151.43 26.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.352 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.73 HD12 HG13 ' B' ' 91' ' ' ILE . 20.5 mm -122.32 140.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 0.0 111.637 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.23 131.07 22.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.641 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . 0.527 HG22 HG12 ' B' ' 89' ' ' ILE . 67.8 p -113.92 154.84 26.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.144 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.05 -37.21 73.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -124.85 112.13 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.26 -37.15 9.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.767 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -32.22 7.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.9 141.58 29.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 132.46 27.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.022 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.48 HG11 HG21 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -115.08 127.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.047 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.47 129.54 8.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' B' ' 58' ' ' PRO . 58.7 Cg_endo -71.68 133.46 28.72 Favored 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.731 -1.362 . . . . 0.0 112.092 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 57' ' ' PRO . 50.7 Cg_exo -55.35 -46.78 29.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.355 2.037 . . . . 0.0 112.286 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.3 p -144.84 150.18 36.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.732 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.64 -172.1 27.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.586 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.572 HG12 ' HG2' ' B' ' 40' ' ' ARG . 5.9 t -123.02 114.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.436 HD21 HG23 ' B' ' 68' ' ' VAL . 0.4 OUTLIER -87.78 161.24 17.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.071 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.446 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -121.01 178.32 1.21 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.797 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 30.7 Cg_exo -61.5 108.98 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.653 2.235 . . . . 0.0 112.355 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.53 34.75 9.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -95.9 151.04 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -106.49 156.71 18.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . 0.436 HG23 HD21 ' B' ' 62' ' ' LEU . 59.1 t -148.71 147.31 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.234 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' B' ' 69' ' ' LEU . 2.9 mt -112.43 135.69 52.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.63 157.73 34.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 111.126 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.25 123.08 26.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.01 85.49 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.261 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 131.83 50.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 t -123.75 87.58 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.89 149.54 2.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 p -63.93 135.99 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . 0.496 ' CD2' ' HB2' ' B' ' 83' ' ' ASP . 26.5 p90 -145.57 -164.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -127.11 131.31 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.95 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.384 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.63 -37.62 5.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 111.265 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 77.9 p -138.54 25.1 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' B' ' 81' ' ' THR . 28.5 mt-10 -161.03 161.83 31.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . 0.496 ' HB2' ' CD2' ' B' ' 77' ' ' PHE . 0.6 OUTLIER 59.56 166.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 110.95 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.628 HD23 ' CE1' ' B' ' 124' ' ' TYR . 6.2 mt 84.3 54.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.492 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' B' ' 86' ' ' ASN . 1.2 p30 -125.65 27.48 6.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.946 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' B' ' 85' ' ' ASN . 10.9 m-20 82.31 97.15 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.76 139.29 53.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.88 132.93 4.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.527 HG12 HG22 ' B' ' 47' ' ' THR . 8.8 mt -83.73 166.23 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.473 ' H ' HG22 ' B' ' 89' ' ' ILE . 2.5 m -140.79 117.38 10.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.962 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . 0.73 HG13 HD12 ' B' ' 45' ' ' ILE . 3.4 mp -108.22 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.73 140.56 48.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 9.5 p90 -149.91 141.6 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.558 HG21 ' O ' ' B' ' 108' ' ' TRP . 4.0 t -132.63 147.24 52.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . 0.415 ' HA ' HG22 ' B' ' 41' ' ' ILE . 0.7 OUTLIER -52.32 138.03 27.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.67 HG22 ' CH2' ' B' ' 108' ' ' TRP . 3.1 p -82.5 143.37 47.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.8 160.72 9.28 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 121.48 5.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.21 42.67 63.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.46 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.12 160.55 18.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 111.134 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.79 164.22 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.27 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -87.94 70.15 9.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.634 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.27 134.91 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.836 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -58.89 144.96 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . 0.499 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 3.0 mmt180 -124.81 152.15 44.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -80.57 -44.54 18.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.613 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.67 ' CH2' HG22 ' B' ' 96' ' ' THR . 4.9 m0 -51.63 -24.44 5.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.78 0.324 . . . . 0.0 110.96 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 8.4 mtt . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.93 0.395 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.1 124.34 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.854 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . 0.479 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -87.75 141.21 28.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.47 129.08 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -125.97 162.82 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.598 ' O ' HD12 ' B' ' 120' ' ' LEU . 54.0 m-80 -143.77 142.79 31.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.842 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.598 HD12 ' O ' ' B' ' 119' ' ' ASN . 8.7 mp -128.55 95.81 31.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.61 135.57 70.34 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.629 2.219 . . . . 0.0 112.146 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.516 HD11 HG13 ' B' ' 89' ' ' ILE . 17.5 mm -97.27 144.5 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.277 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' B' ' 18' ' ' VAL . 9.2 mt-10 -132.3 163.62 28.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . 0.628 ' CE1' HD23 ' B' ' 84' ' ' LEU . 1.8 m-85 -125.93 125.92 43.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.286 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -114.93 81.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.986 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 75.2 Cg_exo . . . . . 0 CA--C 1.528 0.19 0 CA-C-O 120.623 0.176 . . . . 0.0 112.285 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 51.4 Cg_exo -52.83 156.41 9.34 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.489 2.126 . . . . 0.0 112.331 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.52 122.86 23.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.5 m-20 -52.43 115.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.38 138.09 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.85 146.43 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -135.65 149.67 49.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 111.153 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.561 ' O ' HG23 ' A' ' 31' ' ' ILE . 38.9 mt-30 -135.4 116.37 11.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.51 163.81 63.74 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.514 0.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 t -44.6 -62.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.383 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.41 ' HA ' HD22 ' A' ' 120' ' ' LEU . 2.2 tt0 -173.16 48.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 104.89 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 8.2 tt -131.93 145.31 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 123' ' ' GLU . 6.6 p -150.6 121.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -72.65 113.9 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -81.89 134.61 35.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -65.68 170.72 4.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.805 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.841 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 62.5 Cg_endo -73.19 164.99 85.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.766 -1.348 . . . . 0.0 112.675 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -107.27 46.65 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -115.11 -4.77 12.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.406 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -123.08 144.47 49.28 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.94 126.78 31.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.85 155.43 41.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.52 116.06 16.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -102.42 116.12 31.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -92.49 131.7 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 12' ' ' GLN . 5.3 mm -107.55 143.25 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.525 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -104.65 119.91 40.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.397 . . . . 0.0 111.242 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -112.88 153.79 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.748 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.69 155.86 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.143 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -102.48 109.9 21.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.582 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.15 19.19 6.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.63 -143.53 12.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.457 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.54 20.73 2.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 159.86 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' C ' ' HG1' ' A' ' 96' ' ' THR . 15.2 mtm180 -55.85 152.36 10.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.728 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.69 116.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.38 115.47 5.11 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.841 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.545 ' CD1' HD12 ' A' ' 62' ' ' LEU . 67.4 p-90 -118.06 158.86 24.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.122 0.487 . . . . 0.0 111.566 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.6 152.99 31.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.566 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.432 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 5.9 mm -104.02 154.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.424 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -155.65 132.64 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.678 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.27 160.16 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.161 0.505 . . . . 0.0 111.272 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.13 -55.16 36.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.44 113.16 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.59 22.05 5.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -113.23 -58.57 2.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.915 0.388 . . . . 0.0 110.788 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -33.2 63.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.779 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -98.02 145.88 26.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.689 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.92 147.11 36.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.03 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.3 p -139.98 160.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.26 0.552 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 55' ' ' VAL . 9.8 t70 -172.92 129.04 0.55 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.06 146.71 86.74 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.217 -0.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.95 -0.42 10.65 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.66 2.24 . . . . 0.0 113.151 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.55 177.1 0.36 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.822 0.344 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 154.71 167.37 16.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.64 128.93 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 111.115 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.545 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.86 123.06 46.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.72 171.54 12.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 114.54 2.31 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.618 2.212 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.49 28.49 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.293 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.75 148.27 23.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.768 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 128.38 52.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.117 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.38 138.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.033 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.58 123.54 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.448 ' CG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.24 163.06 17.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 154.58 51.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -134.37 89.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.702 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 p -74.0 139.44 44.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m -131.05 149.38 52.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.659 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.76 148.73 24.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 111.196 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -71.49 127.65 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.756 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.69 -173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.006 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -129.59 121.46 27.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.484 ' CB ' HD11 ' A' ' 126' ' ' LEU . . . -65.99 -21.01 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.39 65.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.38 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.9 p -141.15 67.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.304 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -150.19 171.92 16.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.65 136.53 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.0 mt -152.78 86.51 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.46 22.43 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.265 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER 73.83 93.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.174 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.1 152.54 43.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.354 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.418 ' HA ' HG12 ' A' ' 122' ' ' ILE . 2.6 ptm180 -157.8 131.02 7.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.706 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 90' ' ' THR . 7.1 mm -85.1 163.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.317 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 89' ' ' ILE . 78.2 m -144.2 118.92 9.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.88 0.371 . . . . 0.0 111.493 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.13 97.16 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.76 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.38 133.95 48.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.101 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -138.66 154.89 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.682 ' HB ' HG13 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -147.31 151.41 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -55.71 150.88 11.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.521 HG22 ' CZ2' ' A' ' 108' ' ' TRP . 0.6 OUTLIER -96.07 142.17 24.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.0 156.59 61.73 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.609 2.206 . . . . 0.0 112.279 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -50.16 128.24 18.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.993 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.83 34.46 87.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.39 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.35 127.04 29.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.153 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.88 166.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.249 0.547 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -85.89 70.85 10.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.0 128.77 0.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -52.11 151.31 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.22 155.77 49.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.039 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.46 -34.44 16.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.99 -24.98 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.521 ' CZ2' HG22 ' A' ' 96' ' ' THR . 21.9 m0 -50.05 -34.7 22.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.985 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.667 ' CD2' HG11 ' A' ' 115' ' ' VAL . 4.9 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.999 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.758 0.313 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.682 HG13 ' HB ' ' A' ' 94' ' ' THR . 12.7 t -109.06 125.23 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.234 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.1 142.45 27.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.93 97.77 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.04 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -87.27 159.34 18.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.76 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.6 120.25 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.885 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 15' ' ' GLN . 4.7 mt -94.73 135.18 24.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.76 130.42 5.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.664 2.243 . . . . 0.0 112.627 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 3.4 mm -114.04 119.54 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 18' ' ' VAL . 45.7 mt-10 -117.82 157.53 26.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.533 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.37 109.06 18.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.959 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -83.13 81.56 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 79' ' ' ALA . 67.5 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' B' ' 6' ' ' PRO . 73.4 Cg_exo . . . . . 0 C--O 1.232 0.206 0 CA-C-O 120.602 0.168 . . . . 0.0 112.257 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 5' ' ' PRO . 51.8 Cg_exo -52.83 156.51 9.19 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.532 2.155 . . . . 0.0 112.281 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.63 122.88 23.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.536 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 2.5 m-20 -52.44 115.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.84 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.32 137.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.78 146.47 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 149.55 49.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.572 ' O ' HG23 ' B' ' 31' ' ' ILE . 38.8 mt-30 -135.4 116.45 11.99 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 163.65 63.67 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.533 0.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.5 t -44.48 -62.42 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.462 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.41 ' HA ' HD22 ' B' ' 120' ' ' LEU . 2.2 tt0 -173.26 48.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.996 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.05 104.82 2.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.479 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 8.3 tt -131.96 145.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.762 HG23 ' O ' ' B' ' 123' ' ' GLU . 6.8 p -150.88 121.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -72.49 113.62 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.704 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -81.58 134.41 35.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.868 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -65.59 170.85 4.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' PRO . . . . . 0.868 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 64.8 Cg_endo -73.12 164.92 85.66 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.866 -1.306 . . . . 0.0 112.723 0.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -107.24 46.67 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -115.15 -4.6 12.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.395 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.27 144.44 49.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.913 0.387 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.9 126.68 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.992 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.84 155.37 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.44 115.96 16.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -102.36 116.23 32.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.659 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -92.74 131.5 37.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.254 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.572 HG23 ' O ' ' B' ' 12' ' ' GLN . 5.2 mm -107.31 143.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.616 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -104.59 120.09 40.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.267 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 mt -113.09 153.73 14.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.78 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.72 155.98 34.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 111.17 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -102.64 109.89 21.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.24 19.37 5.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.48 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.74 -143.64 12.84 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.432 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.44 20.81 2.23 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.52 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.74 160.08 37.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.855 0.359 . . . . 0.0 110.808 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -56.04 152.65 10.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.61 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.93 116.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.445 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.67 115.5 5.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.878 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.552 ' CD1' HD12 ' B' ' 62' ' ' LEU . 67.5 p-90 -118.18 158.75 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.101 0.477 . . . . 0.0 111.495 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.43 153.2 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.527 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.436 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 5.9 mm -104.2 154.26 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.431 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -155.61 132.73 10.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.677 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.3 160.35 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.0 111.251 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.39 -54.88 40.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.7 113.23 26.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.771 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.56 21.97 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -113.2 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -33.16 63.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.16 145.74 26.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.77 146.96 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.479 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.3 p -139.74 160.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.295 0.569 . . . . 0.0 110.922 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . 0.479 ' N ' HG22 ' B' ' 55' ' ' VAL . 9.8 t70 -172.69 128.98 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.793 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.07 146.72 86.8 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.293 -0.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.03 -0.46 10.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.678 2.252 . . . . 0.0 113.084 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.64 177.07 0.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 154.8 167.21 16.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.65 129.02 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.552 HD12 ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -103.99 123.19 46.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.951 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.74 171.47 12.34 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.81 114.45 2.29 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.591 2.194 . . . . 0.0 112.346 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.61 28.31 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.228 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 148.37 22.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.766 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 128.45 52.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.08 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.48 138.49 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.51 123.51 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.01 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' MET . . . . . 0.449 ' CG ' ' HB ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -119.22 163.08 17.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.962 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.72 51.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.435 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -134.58 89.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.589 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 20.5 p -74.06 139.38 44.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.99 149.35 52.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.588 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.59 148.86 24.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.252 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -71.52 127.72 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.78 -173.85 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.957 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.52 121.54 27.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ALA . . . . . 0.48 ' CB ' HD11 ' B' ' 126' ' ' LEU . . . -66.21 -20.8 66.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.306 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.9 -43.45 66.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -140.97 67.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.274 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -150.28 171.82 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.059 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.56 136.35 45.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 55.7 mt -152.59 86.48 1.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.5 22.43 12.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.238 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' B' ' 86' ' ' ASN . 0.3 OUTLIER 73.74 93.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.16 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.37 152.27 43.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.349 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.426 ' HA ' HG12 ' B' ' 122' ' ' ILE . 2.6 ptm180 -157.44 131.01 7.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.515 HG22 ' N ' ' B' ' 90' ' ' THR . 7.1 mm -85.1 163.36 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.515 ' N ' HG22 ' B' ' 89' ' ' ILE . 81.9 m -144.08 118.88 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.389 . . . . 0.0 111.492 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.06 97.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.718 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -104.5 133.91 48.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.02 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -138.68 154.91 48.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' THR . . . . . 0.673 ' HB ' HG13 ' B' ' 115' ' ' VAL . 1.0 OUTLIER -147.12 151.32 36.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -55.63 150.85 11.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.009 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' THR . . . . . 0.521 HG22 ' CZ2' ' B' ' 108' ' ' TRP . 0.6 OUTLIER -96.04 142.19 24.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 156.48 62.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.206 . . . . 0.0 112.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -50.09 128.25 18.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.74 34.54 87.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.371 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.42 126.99 29.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.66 166.72 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.381 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -86.0 70.88 10.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.02 128.81 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -52.11 151.25 3.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.15 155.7 49.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.39 -34.35 16.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.02 -25.04 68.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' TRP . . . . . 0.521 ' CZ2' HG22 ' B' ' 96' ' ' THR . 22.3 m0 -49.93 -34.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.043 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' B' ' 115' ' ' VAL . 4.7 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.985 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.673 HG13 ' HB ' ' B' ' 94' ' ' THR . 12.4 t -108.78 125.32 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.254 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.24 142.51 27.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.99 97.61 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.074 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -87.08 159.26 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.48 120.29 11.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' B' ' 15' ' ' GLN . 4.6 mt -94.77 135.21 23.99 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.81 130.45 5.04 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.665 2.243 . . . . 0.0 112.814 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 3.4 mm -114.08 119.39 61.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.623 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.762 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.1 mt-10 -117.72 157.49 26.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 111.48 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.36 109.13 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -83.28 81.62 8.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' B' ' 79' ' ' ALA . 67.9 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.796 0.332 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -108.09 -179.14 3.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.3 p -53.2 151.04 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.63 107.58 5.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.137 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.98 166.21 21.39 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.387 2.058 . . . . 0.0 112.28 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.13 97.02 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.621 2.214 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.56 131.46 26.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.534 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 9.0 m-20 -57.74 109.03 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.1 pt -68.72 123.37 22.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.117 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.74 145.37 54.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.51 136.24 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.241 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' B' ' 22' ' ' PRO . 14.7 mt-30 -140.85 105.57 6.28 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.557 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.66 161.48 40.68 Favored 'Cis proline' 0 C--N 1.35 0.651 0 C-N-CA 123.865 -1.306 . . . . 0.0 112.506 0.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.3 t -92.36 -26.07 18.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.71 49.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.075 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.53 107.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.974 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 17' ' ' ILE . 12.9 tt -129.7 120.1 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 125' ' ' ASN . 46.0 t -109.27 92.51 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.564 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 20.9 m-85 -52.74 96.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.56 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -67.18 141.41 57.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.431 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.774 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.13 169.42 0.16 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.821 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.774 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 66.3 Cg_endo -91.1 166.97 28.8 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.371 -1.096 . . . . 0.0 112.974 0.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.431 ' O ' ' HB ' ' A' ' 76' ' ' THR . 22.3 m-85 -108.87 31.1 5.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.755 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.37 3.61 50.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.399 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.601 ' N ' HG22 ' A' ' 76' ' ' THR . 3.3 t70 -164.31 151.49 11.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 120.821 0.343 . . . . 0.0 110.78 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.65 109.11 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.49 110.46 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.669 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 83.0 m -93.43 110.85 22.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 19' ' ' PHE . 79.6 m-85 -89.02 121.8 31.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.774 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -77.9 131.43 37.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.435 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.675 HD12 ' HE3' ' A' ' 70' ' ' MET . 16.0 mt -113.89 151.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.524 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -112.93 121.76 45.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.951 0.405 . . . . 0.0 111.482 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.602 HD11 ' CE ' ' A' ' 70' ' ' MET . 39.3 mt -125.45 150.19 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.505 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.3 m -148.81 145.37 27.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.42 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.13 106.69 18.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.279 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.51 20.68 5.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.422 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.12 -170.8 24.11 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.458 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.18 -28.72 8.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.74 178.3 5.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 0.0 110.925 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.446 ' HB2' HG12 ' A' ' 61' ' ' VAL . 4.0 ptp180 -64.81 170.64 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 12.2 pt -152.98 136.18 7.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.655 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.84 112.2 4.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.511 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.472 ' HE1' HD13 ' A' ' 62' ' ' LEU . 37.6 p-90 -117.17 156.98 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.221 0.534 . . . . 0.0 111.811 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.99 153.35 40.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.286 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.4 mm -115.46 151.27 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.578 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -147.5 130.51 16.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.531 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.527 HG22 HG23 ' A' ' 89' ' ' ILE . 36.3 p -120.41 154.7 34.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.135 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 p -52.0 -30.27 24.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -139.07 117.8 12.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.69 17.11 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.262 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -108.74 -49.58 3.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.847 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -76.3 -50.51 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.52 148.41 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.039 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -136.53 107.35 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -105.89 118.56 53.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.098 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -142.17 136.46 14.96 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.845 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.93 132.77 28.11 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.575 -1.427 . . . . 0.0 112.05 -0.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.4 -45.57 9.13 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.404 2.069 . . . . 0.0 112.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 27.1 p -133.36 148.75 51.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.748 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.82 175.29 46.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 40' ' ' ARG . 4.9 t -116.21 108.57 25.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.122 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.597 HD11 HG11 ' A' ' 68' ' ' VAL . 1.1 mp -80.29 158.83 26.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.782 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.31 170.13 5.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.817 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.62 110.57 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.647 2.231 . . . . 0.0 112.259 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.66 37.0 10.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.29 142.28 31.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.219 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -102.57 143.16 32.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.597 HG11 HD11 ' A' ' 62' ' ' LEU . 8.9 p -141.78 148.5 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.039 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 31' ' ' ILE . 1.4 mm? -104.49 143.82 32.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.675 ' HE3' HD12 ' A' ' 31' ' ' ILE . 3.1 ttp -120.31 156.34 31.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.649 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.669 ' HB1' ' CG2' ' A' ' 28' ' ' THR . . . -130.79 113.95 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.294 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 72' ' ' VAL . 7.3 p -114.16 88.14 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.94 146.48 33.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.272 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.6 107.5 9.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.74 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.58 146.17 7.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.037 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 25' ' ' ASP . 5.3 p -56.75 164.22 1.59 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -178.65 -173.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.846 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -116.15 109.52 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.97 16.94 13.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.457 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.47 -24.94 29.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.795 0.331 . . . . 0.0 111.107 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.9 p -147.01 44.67 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.35 21.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -63.73 134.71 55.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.626 HD13 ' HB2' ' A' ' 124' ' ' TYR . 91.4 mt -127.71 69.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -155.68 28.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.978 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -130.35 6.45 4.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.617 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.87 119.3 34.12 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.45 136.0 25.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.056 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.872 HG13 HD11 ' A' ' 122' ' ' ILE . 7.8 mt -98.69 165.55 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 89' ' ' ILE . 58.2 m -137.75 123.07 19.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.871 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 91' ' ' ILE . 3.3 mp -121.79 112.2 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.54 155.01 35.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.829 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.461 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 11.4 p90 -157.59 147.28 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.469 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -141.25 134.12 28.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HA ' HG22 ' A' ' 41' ' ' ILE . 13.2 p30 -52.52 125.2 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.404 ' OG1' ' HG3' ' A' ' 40' ' ' ARG . 43.7 p -66.6 151.63 96.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.7 165.05 28.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.536 2.158 . . . . 0.0 112.148 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.93 117.44 1.68 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.5 47.43 51.47 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.234 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.43 166.08 0.47 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.878 0.371 . . . . 0.0 111.327 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.09 164.31 25.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.314 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.94 69.42 9.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.63 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.08 122.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.88 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.2 122.28 6.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -117.23 150.52 38.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.91 -19.02 45.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.41 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.83 -23.66 66.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 0.0 111.234 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.16 -13.95 43.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.457 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -102.53 -22.71 13.98 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.725 0.298 . . . . 0.0 111.191 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -107.9 33.67 3.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.906 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.52 -140.4 6.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.473 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.89 149.42 21.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.835 0.35 . . . . 0.0 110.91 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.61 -166.0 16.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.469 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.27 152.47 48.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.469 HG13 ' HB ' ' A' ' 94' ' ' THR . 12.6 t -115.24 136.15 52.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.189 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.461 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 12.4 tpt180 -99.4 152.86 19.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.831 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.92 137.71 9.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.07 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -145.21 132.23 20.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -91.56 133.86 35.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.82 117.8 61.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.668 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.37 128.7 19.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.354 2.036 . . . . 0.0 112.359 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.872 HD11 HG13 ' A' ' 89' ' ' ILE . 32.5 mm -92.54 148.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.225 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.54 ' HB3' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -140.21 160.2 40.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.657 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.626 ' HB2' HD13 ' A' ' 84' ' ' LEU . 81.3 m-85 -132.15 110.74 10.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.207 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.671 ' HB2' HG12 ' A' ' 18' ' ' VAL . 2.8 t30 -99.29 132.24 44.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.633 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.941 -179.944 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.788 0.327 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -108.03 -179.15 3.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.832 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 24.2 p -53.16 151.18 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.874 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 m -142.82 107.56 5.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.02 166.16 21.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.391 2.06 . . . . 0.0 112.263 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.13 97.18 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.54 2.16 . . . . 0.0 112.308 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 131.72 27.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.591 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 9.1 m-20 -57.91 108.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.813 0.34 . . . . 0.0 110.889 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.438 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.1 pt -68.7 123.46 22.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.86 145.19 55.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.657 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.34 136.07 32.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.234 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -140.66 105.64 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.543 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.78 161.57 41.2 Favored 'Cis proline' 0 C--N 1.35 0.658 0 C-N-CA 123.854 -1.311 . . . . 0.0 112.461 0.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.8 t -92.37 -26.06 18.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.112 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -175.67 49.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.016 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 mttm 179.68 106.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.05 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.529 HG23 ' O ' ' B' ' 17' ' ' ILE . 13.0 tt -129.58 120.12 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' B' ' 125' ' ' ASN . 45.9 t -109.27 92.68 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.573 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.484 ' HA ' ' CE2' ' B' ' 29' ' ' TYR . 21.0 m-85 -52.91 96.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.495 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -67.17 141.35 57.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.441 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.14 169.47 0.16 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.805 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.782 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 64.6 Cg_endo -91.13 166.82 28.77 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 124.414 -1.077 . . . . 0.0 112.948 0.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.434 ' O ' ' HB ' ' B' ' 76' ' ' THR . 22.3 m-85 -108.83 31.23 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.719 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -97.55 3.71 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.429 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . 0.6 ' N ' HG22 ' B' ' 76' ' ' THR . 3.3 t70 -164.38 151.27 11.37 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.789 0.328 . . . . 0.0 110.773 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -52.5 109.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.973 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -103.4 110.49 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.821 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.674 ' CG2' ' HB1' ' B' ' 71' ' ' ALA . 88.9 m -93.45 110.72 22.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.047 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.507 ' O ' HG12 ' B' ' 72' ' ' VAL . 79.6 m-85 -88.93 121.82 31.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.709 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' B' ' 70' ' ' MET . 37.9 m80 -77.87 131.36 37.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.438 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.659 HD12 ' HE3' ' B' ' 70' ' ' MET . 16.2 mt -113.77 152.03 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.486 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 4.2 mptt -113.08 121.53 44.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.524 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.601 HD11 ' CE ' ' B' ' 70' ' ' MET . 39.2 mt -125.3 150.24 30.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.567 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 53.6 m -148.9 145.11 27.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.987 0.423 . . . . 0.0 111.437 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -88.89 106.66 18.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.265 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.43 20.34 5.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.4 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.93 -170.87 24.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.554 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.12 -28.54 9.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.525 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.93 178.21 5.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.461 ' HB2' HG12 ' B' ' 61' ' ' VAL . 3.9 ptp180 -64.72 170.7 3.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.851 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.438 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 12.1 pt -152.95 136.09 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.623 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.66 112.17 4.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.52 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.471 ' HE1' HD13 ' B' ' 62' ' ' LEU . 38.1 p-90 -117.21 157.03 26.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.209 0.528 . . . . 0.0 111.861 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.05 153.48 40.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.257 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 15.3 mm -115.49 151.51 17.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.969 0.414 . . . . 0.0 111.58 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -147.76 130.46 16.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.516 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.522 HG22 HG23 ' B' ' 89' ' ' ILE . 35.4 p -120.42 154.7 34.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.923 0.392 . . . . 0.0 111.12 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 p -52.07 -30.11 24.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.964 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -139.18 117.65 12.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.2 mmt -90.54 17.26 7.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.26 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -108.84 -49.63 3.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.871 0.367 . . . . 0.0 110.898 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -76.25 -50.5 14.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 mt -88.62 148.32 24.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.999 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -136.49 107.11 6.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.62 118.66 53.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.117 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -142.2 136.32 14.83 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.89 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.05 132.75 28.1 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.603 -1.416 . . . . 0.0 112.079 -0.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.54 -45.31 9.28 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.449 2.1 . . . . 0.0 112.191 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -133.48 148.56 51.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.766 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.64 175.23 46.33 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.526 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' B' ' 40' ' ' ARG . 5.0 t -116.17 108.35 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 111.09 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.597 HD11 HG11 ' B' ' 68' ' ' VAL . 1.1 mp -80.13 158.81 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.814 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.21 170.11 6.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.7 110.33 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.637 2.225 . . . . 0.0 112.3 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 tttt 63.89 36.97 9.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.871 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.402 ' HG2' ' HG ' ' B' ' 62' ' ' LEU . 0.4 OUTLIER -100.18 142.31 31.84 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.272 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -102.74 143.03 32.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.597 HG11 HD11 ' B' ' 62' ' ' LEU . 9.0 p -141.71 148.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.065 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.513 HD13 ' O ' ' B' ' 31' ' ' ILE . 1.4 mm? -104.32 143.9 32.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.993 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.659 ' HE3' HD12 ' B' ' 31' ' ' ILE . 3.1 ttp -120.29 156.41 31.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.701 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.674 ' HB1' ' CG2' ' B' ' 28' ' ' THR . . . -130.87 113.88 14.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.237 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.649 HG13 ' O ' ' B' ' 72' ' ' VAL . 7.2 p -114.1 87.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.968 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' B' ' 28' ' ' THR . 0.2 OUTLIER -78.78 146.57 33.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.201 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 27.1 p -129.69 107.62 9.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.708 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.78 146.2 8.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.992 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.6 HG22 ' N ' ' B' ' 25' ' ' ASP . 5.4 p -56.75 164.32 1.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -178.61 -173.36 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -116.3 109.31 17.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.93 17.16 12.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.492 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.68 -24.92 28.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.855 0.36 . . . . 0.0 111.056 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 59.7 p -146.94 44.68 1.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -141.42 129.58 22.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.841 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 -64.12 134.7 55.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' B' ' 124' ' ' TYR . 90.9 mt -127.64 69.74 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -155.64 29.03 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -130.41 6.34 4.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.629 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -95.75 119.24 33.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.826 0.346 . . . . 0.0 110.963 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -144.39 136.09 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.871 HG13 HD11 ' B' ' 122' ' ' ILE . 7.9 mt -98.82 165.53 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.47 ' H ' HG22 ' B' ' 89' ' ' ILE . 58.7 m -137.81 122.84 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.47 ' N ' HD12 ' B' ' 91' ' ' ILE . 3.3 mp -121.51 112.19 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -121.52 154.81 36.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.833 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.469 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 11.4 p90 -157.42 147.14 20.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.464 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.6 OUTLIER -141.06 134.11 29.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.407 ' HA ' HG22 ' B' ' 41' ' ' ILE . 13.2 p30 -52.44 125.37 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.405 ' OG1' ' HG3' ' B' ' 40' ' ' ARG . 43.8 p -66.86 151.6 96.69 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.954 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.63 165.01 28.91 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.586 2.19 . . . . 0.0 112.205 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.91 117.39 1.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.38 47.63 50.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.218 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.52 166.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 111.324 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.21 164.22 25.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.28 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.88 69.51 9.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.585 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.99 122.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.87 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -50.12 122.17 6.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 9.3 ttt85 -116.98 150.56 38.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.98 -19.01 44.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.332 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.76 -23.73 66.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.773 0.321 . . . . 0.0 111.242 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 53.9 m0 -63.19 -13.85 42.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -102.55 -22.75 13.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.734 0.302 . . . . 0.0 111.141 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -107.82 33.58 4.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.966 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.33 -140.35 6.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.492 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.83 149.36 21.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.889 0.376 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 102.39 -165.95 17.1 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.555 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.3 152.35 48.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.772 0.32 . . . . 0.0 110.954 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.464 HG13 ' HB ' ' B' ' 94' ' ' THR . 12.7 t -115.16 136.12 52.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.469 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 12.4 tpt180 -99.38 152.79 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -159.78 137.8 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -145.35 132.17 20.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.796 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -91.44 133.78 35.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.033 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.71 117.72 62.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.656 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.37 128.76 19.94 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.389 2.06 . . . . 0.0 112.294 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.871 HD11 HG13 ' B' ' 89' ' ' ILE . 31.9 mm -92.63 148.51 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.257 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.537 ' HB3' HG13 ' B' ' 18' ' ' VAL . 0.0 OUTLIER -140.17 160.2 40.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.726 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.612 ' CB ' HD13 ' B' ' 84' ' ' LEU . 80.9 m-85 -132.1 110.78 10.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.231 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.671 ' HB2' HG12 ' B' ' 18' ' ' VAL . 2.9 t30 -99.46 132.19 44.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.623 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.955 -179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.771 0.32 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -94.95 82.33 3.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.046 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.2 m -82.9 172.37 12.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.8 m -140.64 136.16 16.27 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.03 168.3 25.13 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.556 2.17 . . . . 0.0 112.247 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.07 124.0 10.91 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.481 2.121 . . . . 0.0 112.266 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.77 111.09 0.84 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.624 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -54.07 120.23 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 0.0 110.981 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.65 130.67 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.46 151.18 27.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.587 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.09 149.59 46.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.906 0.384 . . . . 0.0 111.303 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.452 ' O ' HG23 ' A' ' 31' ' ' ILE . 5.4 mt-30 -141.28 108.89 6.25 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.454 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.6 159.72 51.33 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 124.038 -1.234 . . . . 0.0 112.501 0.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.15 -3.57 12.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.753 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -120.43 -48.48 2.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -170.38 141.24 1.96 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 tt -109.07 144.83 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.605 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.893 HG11 HG11 ' B' ' 18' ' ' VAL . 10.2 p -125.11 101.44 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.774 0.321 . . . . 0.0 111.653 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CD2' ' CD1' ' A' ' 29' ' ' TYR . 30.8 m-85 -58.11 111.15 1.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.463 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -72.22 139.77 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.411 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.736 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -57.55 167.42 1.34 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.844 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.736 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -89.99 163.12 34.9 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 124.115 -1.202 . . . . 0.0 112.734 0.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -101.31 28.83 5.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.009 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.13 5.81 46.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.469 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.06 156.12 41.76 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.778 0.323 . . . . 0.0 110.786 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -76.35 108.1 9.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.89 136.34 50.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.79 106.94 17.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.469 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 39.5 m-85 -91.94 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.577 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -79.96 154.05 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.409 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 12' ' ' GLN . 26.0 mt -130.32 147.2 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.793 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -100.98 126.98 47.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.185 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.7 HD11 ' CE ' ' A' ' 70' ' ' MET . 13.6 mt -124.16 159.74 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.055 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 33' ' ' ILE . 98.5 m -156.28 153.7 29.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' OD1' HD13 ' A' ' 41' ' ' ILE . 13.3 t30 -112.61 76.01 0.95 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.752 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.62 -30.98 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.954 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.07 174.43 3.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.354 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.01 35.14 4.84 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.553 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.22 171.54 19.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.952 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.7 mtm180 -74.61 152.35 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.449 HD13 ' OD1' ' A' ' 35' ' ' ASN . 8.7 pt -149.82 142.53 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.944 0.402 . . . . 0.0 111.554 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -98.94 107.97 3.51 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.455 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.472 ' CD1' HD12 ' A' ' 62' ' ' LEU . 37.5 p-90 -109.48 157.56 18.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.171 0.51 . . . . 0.0 111.756 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.592 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -148.13 155.56 41.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.485 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.671 HD12 HG13 ' A' ' 91' ' ' ILE . 6.2 mm -121.64 144.93 29.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.8 135.86 20.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.917 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.415 HG22 HG23 ' A' ' 89' ' ' ILE . 2.6 p -118.69 156.73 28.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.006 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.8 p -49.87 -64.27 0.86 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.055 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.03 114.17 25.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.012 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.99 22.5 5.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -42.89 5.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.801 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 77.7 mtm180 -95.14 -51.34 4.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.92 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.8 mt -76.13 140.18 41.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.9 125.02 28.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.38 140.72 20.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -168.02 127.06 1.01 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 11.9 Cg_exo -70.71 132.6 24.12 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 123.937 -1.276 . . . . 0.0 111.977 -0.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 52.3 Cg_exo -54.96 -44.15 52.53 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.46 2.106 . . . . 0.0 112.24 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' CE2' ' A' ' 104' ' ' PHE . 3.5 m -139.38 141.4 37.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.711 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.38 155.84 26.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.548 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.78 115.59 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.752 0.31 . . . . 0.0 111.019 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -87.42 156.41 19.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -110.97 178.53 0.97 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.805 179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.1 Cg_exo -58.21 110.24 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.533 2.155 . . . . 0.0 112.282 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.68 40.65 29.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.902 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.67 155.64 18.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.045 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -114.23 143.98 43.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.874 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.456 HG23 ' HB ' ' A' ' 33' ' ' ILE . 8.1 m -133.61 151.55 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.898 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.73 141.47 30.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.092 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.7 ' CE ' HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -125.52 161.27 27.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.565 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.73 132.19 23.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.304 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.11 90.37 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.046 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.99 148.4 48.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.98 152.58 42.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.803 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -105.84 137.24 44.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.019 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 76' ' ' THR . 3.8 p -59.97 145.86 44.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -165.56 -166.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.96 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.0 m-20 -114.6 118.52 33.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.46 19.22 14.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.495 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.22 -28.07 15.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.137 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 64.2 p -142.66 46.5 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.008 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -143.03 147.74 35.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.57 150.81 22.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.889 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' A' ' 124' ' ' TYR . 49.6 mt -128.29 29.08 5.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.16 32.9 1.22 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.629 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.03 -19.09 12.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.389 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -84.57 117.79 23.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.812 0.339 . . . . 0.0 110.912 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.2 137.77 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 90' ' ' THR . 6.3 mt -108.13 166.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.488 ' H ' HG22 ' A' ' 89' ' ' ILE . 8.4 m -153.1 123.6 7.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.809 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.671 HG13 HD12 ' A' ' 45' ' ' ILE . 3.6 mp -112.69 122.5 66.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.3 135.78 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.747 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 43' ' ' TRP . 10.9 p90 -141.1 145.1 35.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 0.0 111.026 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.428 HG21 ' HA ' ' A' ' 109' ' ' PHE . 5.0 t -131.27 149.67 52.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.036 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -51.52 135.91 27.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.81 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 129.77 65.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.472 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 53.0 Cg_exo -55.03 159.9 8.88 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.411 2.074 . . . . 0.0 112.245 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -51.68 124.95 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.998 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 54.78 42.52 78.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HB1' ' CZ2' ' A' ' 108' ' ' TRP . . . -59.53 143.31 50.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.884 0.373 . . . . 0.0 111.073 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.33 164.36 7.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.248 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 69.51 9.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.599 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.95 129.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.738 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE2' ' SG ' ' A' ' 59' ' ' CYS . 34.8 t80 -49.04 128.14 15.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -120.01 150.66 40.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.963 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttt85 -86.07 -36.6 19.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.921 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.74 -19.66 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.283 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.484 ' CZ2' ' HB1' ' A' ' 100' ' ' ALA . 18.2 m0 -53.58 -22.28 8.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.203 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.428 ' HA ' HG21 ' A' ' 94' ' ' THR . 57.1 m-85 -88.81 -33.81 17.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.983 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -99.41 51.73 0.94 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.954 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -133.27 -120.1 2.08 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.565 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -109.27 143.41 38.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.41 -171.3 19.31 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.579 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.84 145.51 43.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.65 150.03 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.53 139.89 52.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -128.44 146.53 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.46 159.61 42.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.734 ' O ' HD22 ' A' ' 120' ' ' LEU . 87.3 m-20 -129.06 147.81 50.95 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.101 0.477 . . . . 0.0 111.369 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.734 HD22 ' O ' ' A' ' 119' ' ' ASN . 1.9 mm? -138.34 86.73 16.46 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.188 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.29 147.64 92.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.654 2.236 . . . . 0.0 112.613 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.2 mm -100.67 152.12 5.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HB3' ' CB ' ' A' ' 18' ' ' VAL . 6.9 tp10 -141.45 154.54 45.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.979 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' A' ' 84' ' ' LEU . 2.3 m-85 -113.51 126.86 55.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.168 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.484 ' HB2' HG22 ' A' ' 18' ' ' VAL . 10.0 t30 -109.55 82.05 1.53 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.772 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.981 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.85 0.357 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -95.17 82.45 3.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 68.8 m -82.97 172.6 12.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.803 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 m -140.85 136.0 15.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.09 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -73.92 168.22 25.31 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.496 2.131 . . . . 0.0 112.27 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.09 123.85 10.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.514 2.143 . . . . 0.0 112.24 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -48.69 111.16 0.85 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.614 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -54.01 120.13 5.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.849 0.356 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.53 130.83 36.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.49 151.35 27.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.552 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.33 149.48 45.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.916 0.388 . . . . 0.0 111.255 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.451 ' O ' HG23 ' B' ' 31' ' ' ILE . 5.4 mt-30 -141.05 108.94 6.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.576 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.59 159.83 50.96 Favored 'Cis proline' 0 C--N 1.351 0.678 0 C-N-CA 123.902 -1.291 . . . . 0.0 112.504 0.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.18 -3.36 12.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.721 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -120.49 -48.66 2.28 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.823 0.345 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -170.3 141.46 2.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.355 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 tt -109.43 144.8 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.568 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.893 HG11 HG11 ' A' ' 18' ' ' VAL . 10.4 p -125.09 101.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.857 0.361 . . . . 0.0 111.693 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.474 ' CD2' ' CD1' ' B' ' 29' ' ' TYR . 30.6 m-85 -58.21 111.02 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.405 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -72.08 139.69 48.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.269 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -57.4 167.52 1.25 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.868 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.715 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 69.7 Cg_endo -89.9 163.17 35.29 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 124.204 -1.165 . . . . 0.0 112.77 0.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -101.42 28.78 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.028 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -99.18 5.67 46.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.421 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.88 156.36 42.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.703 0.287 . . . . 0.0 110.837 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -76.5 108.16 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.002 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -110.97 136.6 49.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.829 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -108.95 106.97 17.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.474 ' CD1' ' CD2' ' B' ' 19' ' ' PHE . 39.7 m-85 -91.97 113.45 25.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.65 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -79.73 154.07 28.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.382 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.451 HG23 ' O ' ' B' ' 12' ' ' GLN . 25.9 mt -130.4 147.03 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.783 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -100.83 126.94 47.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.226 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.712 HD11 ' CE ' ' B' ' 70' ' ' MET . 13.8 mt -124.02 159.93 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.046 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.487 ' N ' HG22 ' B' ' 33' ' ' ILE . 98.1 m -156.45 153.87 29.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.071 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.437 ' OD1' HD13 ' B' ' 41' ' ' ILE . 13.4 t30 -112.76 75.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.789 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -39.59 -30.75 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.998 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.3 174.61 3.58 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.31 35.36 4.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.33 171.72 18.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.76 0.314 . . . . 0.0 110.936 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -74.77 152.45 39.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.804 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.437 HD13 ' OD1' ' B' ' 35' ' ' ASN . 8.5 pt -149.91 142.52 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.918 0.39 . . . . 0.0 111.582 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.92 107.96 3.51 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.408 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.464 ' CD1' HD12 ' B' ' 62' ' ' LEU . 37.6 p-90 -109.35 157.51 18.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.204 0.526 . . . . 0.0 111.729 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.58 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -148.1 155.46 41.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.401 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.68 HD12 HG13 ' B' ' 91' ' ' ILE . 6.2 mm -121.65 144.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.363 . . . . 0.0 111.298 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.74 136.13 20.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.42 HG22 HG23 ' B' ' 89' ' ' ILE . 2.7 p -119.04 156.77 29.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 4.4 p -49.94 -64.12 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.152 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.2 114.19 25.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.94 22.6 5.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.92 -42.93 5.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.768 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -95.15 -51.47 4.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 19.5 mt -76.12 140.17 41.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.883 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -132.82 125.29 29.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.966 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.53 140.82 20.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.985 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -168.17 126.95 0.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.6 132.5 23.64 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.948 -0.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.87 -44.06 53.36 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.39 2.06 . . . . 0.0 112.233 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . 0.428 ' SG ' ' CE2' ' B' ' 104' ' ' PHE . 3.5 m -139.59 141.22 37.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.722 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -153.27 155.81 26.37 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.626 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.74 115.53 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.791 0.329 . . . . 0.0 111.088 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.464 HD12 ' CD1' ' B' ' 43' ' ' TRP . 0.4 OUTLIER -87.29 156.75 19.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.455 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.2 OUTLIER -111.29 178.61 0.95 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.804 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 32.2 Cg_exo -58.33 110.21 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.524 2.149 . . . . 0.0 112.282 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 56.83 40.72 28.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.91 155.62 18.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.027 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -114.34 143.77 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' B' ' 33' ' ' ILE . 8.6 m -133.4 151.8 34.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.02 141.19 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.179 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.712 ' CE ' HD11 ' B' ' 33' ' ' ILE . 0.6 OUTLIER -125.19 161.27 27.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.704 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.77 132.25 23.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.283 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.9 t -128.15 90.45 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.959 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.13 148.44 48.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -123.94 152.55 42.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.823 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -105.82 137.32 43.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -60.02 145.97 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -165.68 -166.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -114.38 118.66 34.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.6 19.0 15.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 -28.29 15.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 111.137 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.5 p -142.46 46.37 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -142.77 147.93 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.64 151.04 21.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.825 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.482 HD22 ' CG ' ' B' ' 124' ' ' TYR . 49.0 mt -128.53 29.23 5.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -144.38 32.91 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.745 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.01 -18.98 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -84.66 117.59 23.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.837 0.351 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -147.02 137.68 23.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.482 HG22 ' H ' ' B' ' 90' ' ' THR . 6.2 mt -107.98 166.55 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.482 ' H ' HG22 ' B' ' 89' ' ' ILE . 8.3 m -153.14 123.45 7.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.68 HG13 HD12 ' B' ' 45' ' ' ILE . 3.6 mp -112.58 122.51 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.254 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.13 135.99 51.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.764 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' B' ' 43' ' ' TRP . 10.9 p90 -141.32 145.12 35.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.989 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.419 HG21 ' HA ' ' B' ' 109' ' ' PHE . 5.0 t -131.22 149.88 52.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -51.59 136.09 27.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.22 129.84 65.13 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.863 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . 0.47 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 53.0 Cg_exo -55.1 159.93 9.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.444 2.096 . . . . 0.0 112.235 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.84 124.94 13.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 55.01 42.34 80.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.54 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.48 ' HB1' ' CZ2' ' B' ' 108' ' ' TRP . . . -59.45 143.07 50.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.853 0.359 . . . . 0.0 111.09 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.22 164.42 7.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.084 0.468 . . . . 0.0 111.266 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.84 69.28 9.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.575 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -177.7 129.41 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.825 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.428 ' CE2' ' SG ' ' B' ' 59' ' ' CYS . 34.9 t80 -49.02 128.09 15.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.012 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -120.07 150.52 40.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.992 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -85.9 -36.66 19.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.59 -19.68 63.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.306 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.48 ' CZ2' ' HB1' ' B' ' 100' ' ' ALA . 18.2 m0 -53.62 -22.4 8.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.104 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.419 ' HA ' HG21 ' B' ' 94' ' ' THR . 57.6 m-85 -88.68 -33.78 17.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.76 0.314 . . . . 0.0 110.948 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -99.57 51.72 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -133.22 -120.39 2.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.424 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -109.12 143.49 38.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.856 0.36 . . . . 0.0 110.87 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.51 -171.29 19.22 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.528 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.85 145.49 43.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 110.928 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 43.6 t -91.68 150.01 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.171 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.64 139.72 52.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.766 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -128.22 146.54 50.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.41 159.44 43.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.55 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.732 ' O ' HD22 ' B' ' 120' ' ' LEU . 87.2 m-20 -128.9 147.83 50.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.381 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.732 HD22 ' O ' ' B' ' 119' ' ' ASN . 1.9 mm? -138.25 86.75 16.67 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.38 147.76 92.85 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.586 2.191 . . . . 0.0 112.576 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 28.8 mm -100.72 152.2 5.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.038 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.442 ' HB3' ' CB ' ' B' ' 18' ' ' VAL . 7.1 tp10 -141.63 154.52 45.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.896 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.482 ' CG ' HD22 ' B' ' 84' ' ' LEU . 2.4 m-85 -113.56 126.96 55.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.104 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.492 ' HB2' HG22 ' B' ' 18' ' ' VAL . 10.0 t30 -109.67 81.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.266 -0.874 . . . . 0.0 110.913 -179.86 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.846 0.355 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.52 139.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.69 168.89 18.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 4' ' ' VAL . 26.9 m -146.2 103.12 4.08 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.039 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.41 160.24 32.3 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.544 2.163 . . . . 0.0 112.382 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' CG ' ' HG3' ' A' ' 116' ' ' ARG . 65.4 Cg_endo -73.95 110.39 3.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.526 2.151 . . . . 0.0 112.261 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.94 132.81 28.09 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.521 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.957 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 36.2 m-20 -55.78 140.41 42.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.735 0.302 . . . . 0.0 110.941 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.632 HG23 ' NE1' ' A' ' 93' ' ' TRP . 9.2 pt -102.78 146.34 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.207 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.2 142.85 27.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.67 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.91 151.54 51.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.024 0.44 . . . . 0.0 111.16 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -135.67 111.5 10.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.528 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.97 165.09 43.11 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.958 -1.268 . . . . 0.0 112.609 0.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.9 t -45.57 -70.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.431 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.797 ' HA ' HD22 ' A' ' 120' ' ' LEU . 4.4 mt-30 -154.76 39.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.007 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.71 137.9 4.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.242 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 12.3 tt -148.2 138.34 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.795 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.739 HG13 ' O ' ' A' ' 123' ' ' GLU . 48.2 t -119.11 116.23 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.919 0.39 . . . . 0.0 111.471 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.38 95.9 2.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.349 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -70.55 135.8 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.594 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.867 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -74.8 172.6 8.54 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.381 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.867 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 92.3 Cg_endo -82.12 163.87 75.32 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 124.275 -1.135 . . . . 0.0 113.065 0.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.06 45.42 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.862 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HA ' ' HB ' ' A' ' 76' ' ' THR . 70.8 m-20 -124.97 8.11 8.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.64 8.38 3.07 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.454 ' HG3' ' CG2' ' A' ' 76' ' ' THR . 15.0 mttt 62.5 137.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 110.823 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -140.17 95.81 2.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.945 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.6 m -76.16 118.21 18.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.748 ' O ' HG12 ' A' ' 72' ' ' VAL . 95.7 m-85 -101.79 111.71 24.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.737 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -84.2 135.38 34.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.254 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.3 mt -112.92 138.0 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.686 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 125.66 54.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.288 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.655 HD11 ' CE ' ' A' ' 70' ' ' MET . 14.3 mt -120.63 155.0 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.875 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.426 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.2 m -150.64 158.32 44.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.079 0.466 . . . . 0.0 111.221 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -96.29 108.95 21.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.738 179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.957 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -95.37 22.42 6.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.094 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.57 -152.07 10.0 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.613 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.9 -19.43 4.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.696 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -122.04 152.73 39.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.769 0.318 . . . . 0.0 111.016 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.17 168.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.752 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.744 HD12 ' CD1' ' A' ' 93' ' ' TRP . 25.1 pt -155.34 149.05 12.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.642 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.49 112.62 3.88 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.13 161.52 13.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 0.0 111.85 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 151.28 37.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.115 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.1 144.18 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.993 0.425 . . . . 0.0 111.891 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.07 143.98 46.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.321 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 89' ' ' ILE . 76.9 p -138.68 150.63 46.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.918 0.39 . . . . 0.0 111.069 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.03 -36.0 78.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -137.51 114.49 10.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.859 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.7 mtp -90.46 10.57 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.567 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.12 -35.48 10.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.927 0.394 . . . . 0.0 110.626 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HD3' ' CG ' ' A' ' 77' ' ' PHE . 2.5 ttm180 -94.55 -25.5 16.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.779 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.17 141.1 50.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.8 p -133.8 110.98 10.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.935 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.42 121.79 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.027 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -142.2 131.02 11.97 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.948 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.8 140.81 67.66 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.658 -1.392 . . . . 0.0 112.154 -0.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.25 -39.65 12.7 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.491 2.127 . . . . 0.0 112.215 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 21.9 m -138.19 167.12 22.49 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.61 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.26 -168.73 41.59 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.731 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 41' ' ' ILE . 11.7 p -150.6 138.72 14.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.64 0.257 . . . . 0.0 110.832 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 66' ' ' GLU . 1.1 pt? -134.19 151.35 51.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.945 0.403 . . . . 0.0 111.146 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.444 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 1.1 m-20 -84.11 178.01 2.65 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.444 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 27.7 Cg_exo -62.45 127.48 21.0 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.736 2.291 . . . . 0.0 112.422 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER 81.61 -7.98 1.39 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.035 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.519 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -81.34 156.74 25.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.901 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.6 149.74 51.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.976 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.62 152.4 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 mt -104.85 138.49 41.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.655 ' CE ' HD11 ' A' ' 33' ' ' ILE . 43.1 mtm -129.21 154.12 47.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.77 117.61 13.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.312 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 29' ' ' TYR . 7.5 p -106.31 86.84 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.9 131.29 42.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -123.63 97.55 5.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.732 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -51.94 148.92 5.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.17 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.454 ' CG2' ' HG3' ' A' ' 26' ' ' LYS . 3.2 p -64.23 138.37 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.417 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 21.7 p90 -154.21 -173.69 4.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -105.68 109.47 21.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.02 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -95.43 18.89 11.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.399 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.81 -24.15 22.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -139.17 52.13 1.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.174 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -141.6 176.16 9.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.63 112.24 25.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.538 HD13 ' CD2' ' A' ' 124' ' ' TYR . 22.9 mt -134.25 60.38 1.7 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -141.98 17.31 2.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.352 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.08 10.02 2.35 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.77 137.25 39.17 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.991 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HA ' HG12 ' A' ' 122' ' ' ILE . 13.6 ptt180 -163.4 133.86 4.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.037 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.465 HG12 HG22 ' A' ' 47' ' ' THR . 56.7 mt -96.74 112.09 28.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 118' ' ' LYS . 87.6 m -93.98 122.49 36.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.355 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.4 mp -111.49 109.93 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.884 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -112.04 131.73 55.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.976 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.744 ' CD1' HD12 ' A' ' 41' ' ' ILE . 5.9 p90 -136.5 141.81 43.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.008 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 1.3 t -131.85 144.55 50.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.76 143.05 26.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.19 144.13 57.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 43.3 Cg_endo -67.7 159.17 53.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.562 2.175 . . . . 0.0 112.165 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -51.45 124.06 11.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.05 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.38 35.96 91.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.57 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -65.15 135.92 56.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.814 0.34 . . . . 0.0 111.096 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.09 164.48 0.63 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.146 0.498 . . . . 0.0 111.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.39 70.2 7.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.567 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.38 139.04 0.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -50.49 139.25 16.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.899 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.46 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 1.2 mmp_? -129.97 148.57 51.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.917 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -32.62 39.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.6 -9.48 58.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.54 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.46 ' CG ' ' HB2' ' A' ' 105' ' ' ARG . 17.6 m0 -62.66 -18.49 62.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.57 0.224 . . . . 0.0 111.248 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 94' ' ' THR . 10.6 m-85 -104.9 28.59 7.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.745 0.307 . . . . 0.0 110.795 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -150.38 32.9 0.64 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -121.21 -142.5 6.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.431 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.7 141.27 29.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.856 0.36 . . . . 0.0 110.748 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.34 -179.9 20.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.66 149.2 33.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.761 0.315 . . . . 0.0 110.955 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.482 HG13 ' HB ' ' A' ' 94' ' ' THR . 11.0 t -106.43 130.25 58.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.991 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.426 ' HD3' ' CZ2' ' A' ' 93' ' ' TRP . 13.6 mtt-85 -94.31 135.11 36.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.0 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -123.55 118.68 27.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -117.93 162.97 17.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.814 ' C ' HD23 ' A' ' 120' ' ' LEU . 3.0 p30 -140.87 143.22 34.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.084 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 119' ' ' ASN . 4.6 mt -124.6 104.65 30.8 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.678 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.93 138.7 87.17 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.489 2.126 . . . . 0.0 112.453 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.473 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 14.1 mm -113.93 104.91 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.958 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.739 ' O ' HG13 ' A' ' 18' ' ' VAL . 4.2 mt-10 -97.05 117.92 32.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.538 ' CD2' HD13 ' A' ' 84' ' ' LEU . 11.6 m-85 -81.8 99.39 8.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.774 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' HB2' HG12 ' A' ' 18' ' ' VAL . 1.4 m-20 -73.8 83.65 1.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.007 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 79' ' ' ALA . 30.6 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.878 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.816 0.341 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 62.44 139.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.55 168.78 18.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.946 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.639 HG23 ' O ' ' B' ' 4' ' ' VAL . 26.8 m -146.2 103.01 4.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.25 160.32 32.79 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.547 2.165 . . . . 0.0 112.382 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.402 ' CG ' ' HG3' ' B' ' 116' ' ' ARG . 66.4 Cg_endo -73.96 110.35 3.06 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.536 2.157 . . . . 0.0 112.249 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.86 132.86 27.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.575 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.958 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 37.2 m-20 -55.77 140.43 42.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.789 0.328 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.625 HG23 ' NE1' ' B' ' 93' ' ' TRP . 9.4 pt -102.82 146.39 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.209 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -92.26 142.97 26.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.576 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.01 151.38 51.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.93 0.395 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -135.6 111.42 10.57 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.12 164.96 44.42 Favored 'Cis proline' 0 C--N 1.35 0.629 0 C-N-CA 123.958 -1.267 . . . . 0.0 112.607 0.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.5 t -45.43 -70.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.476 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.815 ' HA ' HD22 ' B' ' 120' ' ' LEU . 4.4 mt-30 -154.75 39.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.044 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.8 137.86 4.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 0.0 111.262 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 12.4 tt -148.24 138.25 16.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.725 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.725 HG13 ' O ' ' B' ' 123' ' ' GLU . 48.0 t -118.99 116.29 50.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.526 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.55 95.98 2.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.309 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -70.51 135.85 48.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.528 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.889 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -74.77 172.52 8.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.384 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.889 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -82.23 164.13 74.53 Favored 'Cis proline' 0 C--N 1.351 0.665 0 C-N-CA 124.257 -1.143 . . . . 0.0 112.975 0.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -102.31 45.35 0.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.8 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.405 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 70.7 m-20 -124.95 7.93 8.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.444 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -136.36 8.29 3.13 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.462 ' HG3' ' CG2' ' B' ' 76' ' ' THR . 15.1 mttt 62.7 138.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.661 0.267 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -140.53 95.76 2.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.97 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 9.4 m -76.05 118.47 18.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.734 ' O ' HG12 ' B' ' 72' ' ' VAL . 95.9 m-85 -102.04 111.87 24.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -84.49 135.46 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.225 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 41.8 mt -112.92 138.21 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.715 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.84 125.59 54.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.961 0.41 . . . . 0.0 111.186 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.666 HD11 ' CE ' ' B' ' 70' ' ' MET . 14.1 mt -120.6 155.0 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.872 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 33' ' ' ILE . 52.4 m -150.65 158.42 44.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.057 0.456 . . . . 0.0 111.279 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -96.24 109.13 21.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.705 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.958 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -95.56 22.49 7.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.53 -151.99 9.99 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.657 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.93 -19.52 4.79 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.61 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.2 152.68 39.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.993 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.97 168.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.687 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.761 HD12 ' CD1' ' B' ' 93' ' ' TRP . 24.8 pt -155.29 149.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.622 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -106.65 112.86 3.92 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -102.31 161.52 13.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.279 0.561 . . . . 0.0 111.935 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.03 151.45 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.146 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.23 144.1 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.079 0.466 . . . . 0.0 111.876 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -135.04 143.84 46.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.34 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.475 HG22 HG12 ' B' ' 89' ' ' ILE . 74.7 p -138.58 150.73 46.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.017 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -36.04 78.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -137.56 114.55 10.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 42.5 mtp -90.53 10.76 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.522 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.46 -35.09 10.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.925 0.393 . . . . 0.0 110.604 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.411 ' HD3' ' CG ' ' B' ' 77' ' ' PHE . 2.5 ttm180 -94.87 -25.5 16.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.23 141.01 50.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 97.7 p -133.81 110.67 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.2 121.71 52.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.055 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -142.1 131.0 12.06 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.86 140.94 68.56 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.69 -1.379 . . . . 0.0 112.068 -0.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.46 -39.44 12.5 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.109 . . . . 0.0 112.247 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 22.5 m -138.36 167.11 22.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.595 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.28 -168.74 41.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.682 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.648 HG23 ' O ' ' B' ' 41' ' ' ILE . 11.8 p -150.7 138.83 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.674 0.274 . . . . 0.0 110.769 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.522 HD12 ' O ' ' B' ' 66' ' ' GLU . 1.1 pt? -134.34 151.48 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.887 0.375 . . . . 0.0 111.211 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.442 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 1.1 m-20 -84.25 177.82 2.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 27.8 Cg_exo -62.26 127.18 20.34 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.787 2.325 . . . . 0.0 112.435 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.412 ' CB ' ' O ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER 81.95 -8.26 1.31 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.977 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.522 ' O ' HD12 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -81.16 156.84 25.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.55 149.85 51.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.81 152.14 25.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 12.6 mt -104.72 138.3 41.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.917 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.666 ' CE ' HD11 ' B' ' 33' ' ' ILE . 43.1 mtm -128.98 154.16 46.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -137.87 117.6 13.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.341 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.734 HG12 ' O ' ' B' ' 29' ' ' TYR . 7.3 p -106.46 86.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.71 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 8.5 m -72.98 131.2 41.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 p -123.39 97.59 5.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.702 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 p30 -52.17 148.92 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.058 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.462 ' CG2' ' HG3' ' B' ' 26' ' ' LYS . 3.2 p -64.3 138.31 58.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.88 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.411 ' CG ' ' HD3' ' B' ' 52' ' ' ARG . 21.3 p90 -154.12 -173.56 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' B' ' 82' ' ' GLU . 42.3 m-80 -105.73 109.67 21.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.953 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.76 19.23 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.428 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.87 -24.35 22.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.359 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.3 p -139.2 52.21 1.76 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.103 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' B' ' 78' ' ' ASN . 8.6 mm-40 -141.65 175.92 9.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.51 111.95 24.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' B' ' 124' ' ' TYR . 22.4 mt -134.04 60.54 1.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.931 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -142.03 17.27 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.1 10.09 2.35 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -76.89 137.27 39.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.937 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -163.45 133.88 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.475 HG12 HG22 ' B' ' 47' ' ' THR . 55.8 mt -96.78 112.03 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 118' ' ' LYS . 88.5 m -93.87 122.53 36.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.333 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.454 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.4 mp -111.62 109.83 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.877 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -111.92 131.8 55.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.761 ' CD1' HD12 ' B' ' 41' ' ' ILE . 5.8 p90 -136.62 141.84 43.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.023 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.549 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 1.3 t -131.86 144.5 50.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -54.66 142.96 26.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.2 p -80.12 144.34 58.52 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . 0.444 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 41.5 Cg_endo -67.93 159.2 53.98 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.658 2.239 . . . . 0.0 112.215 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -51.46 123.83 10.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.45 35.94 91.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.55 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -65.05 136.04 56.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.754 0.311 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.38 164.24 0.73 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.218 0.532 . . . . 0.0 111.277 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.03 70.27 7.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.653 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.33 138.95 0.09 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.894 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -50.39 138.91 16.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.466 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 1.2 mmp_? -129.69 148.48 51.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -32.51 40.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.954 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.73 -9.22 58.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.649 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.466 ' CG ' ' HB2' ' B' ' 105' ' ' ARG . 17.9 m0 -62.86 -18.63 63.18 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.658 0.266 . . . . 0.0 111.256 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' B' ' 94' ' ' THR . 10.6 m-85 -104.69 28.46 7.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.855 0.36 . . . . 0.0 110.891 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -150.28 32.75 0.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.97 -142.62 6.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.485 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.65 141.22 29.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.31 -179.69 20.44 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.81 149.24 33.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.766 0.317 . . . . 0.0 110.946 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' B' ' 94' ' ' THR . 11.1 t -106.41 130.36 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.425 ' HD3' ' CZ2' ' B' ' 93' ' ' TRP . 13.8 mtt-85 -94.46 134.86 36.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.076 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -123.43 118.59 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.007 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.548 ' O ' HG23 ' B' ' 90' ' ' THR . 0.0 OUTLIER -117.82 163.06 17.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.754 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.816 ' C ' HD23 ' B' ' 120' ' ' LEU . 3.1 p30 -141.08 143.23 34.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.142 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.816 HD23 ' C ' ' B' ' 119' ' ' ASN . 4.5 mt -124.51 104.49 31.17 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.82 138.76 86.98 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.503 2.135 . . . . 0.0 112.429 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 13.8 mm -113.95 104.8 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.946 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.725 ' O ' HG13 ' B' ' 18' ' ' VAL . 4.1 mt-10 -96.95 117.77 31.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.981 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.54 ' CD2' HD13 ' B' ' 84' ' ' LEU . 11.1 m-85 -81.76 99.2 8.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.41 ' HB2' HG12 ' B' ' 18' ' ' VAL . 1.4 m-20 -73.68 83.63 1.59 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.054 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.9 mt . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.908 179.751 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.74 155.18 27.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.941 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.3 t -102.09 -56.48 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.809 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.532 HG23 ' HD2' ' A' ' 5' ' ' PRO . 6.6 p -177.7 141.11 0.44 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.948 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 4' ' ' VAL . 50.0 Cg_exo -53.17 147.58 34.53 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.603 2.202 . . . . 0.0 112.323 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.65 106.29 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.621 2.214 . . . . 0.0 112.24 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.65 129.91 49.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.44 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.2 m-20 -55.0 128.87 35.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.857 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.2 138.69 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.318 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.65 149.73 39.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.693 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.29 149.87 35.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.962 0.411 . . . . 0.0 111.094 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.9 mm-40 -144.86 107.17 4.6 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.662 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.87 154.64 61.49 Favored 'Cis proline' 0 C--N 1.352 0.717 0 C-N-CA 123.748 -1.355 . . . . 0.0 112.457 0.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.2 m -59.45 -53.11 61.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.936 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -160.05 39.89 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.052 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.47 111.39 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.085 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -129.9 134.01 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.941 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.721 HG23 ' HB3' ' A' ' 123' ' ' GLU . 6.1 p -130.69 110.63 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -57.34 154.37 10.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.354 -0.385 . . . . 0.0 109.968 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.14 120.13 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.965 0.412 . . . . 0.0 111.372 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.848 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -50.33 169.01 0.21 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.834 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.848 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 61.4 Cg_endo -72.7 163.44 88.73 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.666 -1.389 . . . . 0.0 112.443 0.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 24.4 m-85 -111.63 34.92 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.017 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.76 4.5 25.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.373 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -144.72 131.63 20.26 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 120.826 0.346 . . . . 0.0 110.74 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -51.77 122.58 8.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -118.39 150.22 39.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.642 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.72 109.83 14.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.643 ' O ' HG12 ' A' ' 72' ' ' VAL . 14.6 m-85 -98.33 116.59 30.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.406 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -81.4 130.6 35.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.547 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.739 HD12 ' HE3' ' A' ' 70' ' ' MET . 12.2 mt -110.77 143.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.527 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 131.6 46.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 111.47 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.441 HD11 ' CE ' ' A' ' 70' ' ' MET . 64.2 mt -125.93 154.21 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.639 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.433 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.2 m -153.21 156.65 38.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.0 111.328 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -105.66 109.31 21.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -94.61 21.64 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.89 -145.47 13.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.545 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.79 -39.39 0.29 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -103.36 159.34 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.9 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 mtm-85 -52.04 158.68 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.804 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.77 117.18 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.351 . . . . 0.0 111.545 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.0 116.91 4.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.906 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.896 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 26.2 p-90 -113.78 154.9 26.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.165 0.507 . . . . 0.0 111.597 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.61 156.33 45.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.896 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 2.3 mp -118.08 147.29 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.01 0.434 . . . . 0.0 111.742 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -145.27 131.26 19.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.549 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 p -113.19 150.09 32.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.104 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.567 HG23 ' HG3' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -51.86 -36.2 47.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.07 115.81 11.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.948 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 78.8 mmm -93.31 21.86 5.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.411 ' NH1' ' HB2' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -104.45 -37.22 7.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.869 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.5 ttp85 -101.99 -27.94 12.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.013 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.5 150.16 28.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.61 109.75 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.76 144.47 11.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -159.27 136.38 6.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.52 144.54 81.34 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.66 -1.392 . . . . 0.0 112.236 0.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.92 -4.85 15.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.589 2.192 . . . . 0.0 112.96 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -171.87 161.67 5.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.777 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.466 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 169.96 157.75 12.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.608 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 t -94.14 134.21 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.785 0.326 . . . . 0.0 110.917 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 62' ' ' LEU . 5.5 tp -108.89 132.87 53.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.983 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.441 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -88.87 168.37 15.86 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 25.3 Cg_endo -62.12 113.59 1.95 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.538 2.158 . . . . 0.0 112.359 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.7 30.89 2.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.67 148.37 24.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.792 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' CG ' ' OG1' ' A' ' 34' ' ' THR . 42.0 mttt -115.64 121.87 43.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 14.0 p -112.4 146.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.73 147.12 23.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.253 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.739 ' HE3' HD12 ' A' ' 31' ' ' ILE . 13.4 ttp -129.47 156.93 43.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.494 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.42 122.38 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.591 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 29' ' ' TYR . 12.6 p -111.91 115.47 49.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.27 129.26 46.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.862 0.363 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.6 t -116.18 127.57 54.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.694 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -79.66 147.99 31.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.111 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 76' ' ' THR . 2.7 p -62.65 161.02 12.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -176.68 -175.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.898 0.38 . . . . 0.0 111.02 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.43 108.65 20.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.901 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.28 18.7 6.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.453 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.48 -38.4 12.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.355 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.3 p -131.31 44.31 2.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.074 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -138.13 177.25 8.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.833 ' O ' HD23 ' A' ' 84' ' ' LEU . 96.9 m-20 -91.3 149.66 21.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.988 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 83' ' ' ASP . 47.5 mt -139.46 29.37 2.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.957 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.54 26.59 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.928 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.53 -12.51 9.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.53 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.77 120.33 24.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.567 ' HG3' HG23 ' A' ' 48' ' ' THR . 0.8 OUTLIER -149.94 134.52 17.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.91 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.696 HG13 HD11 ' A' ' 122' ' ' ILE . 5.8 mt -98.12 165.61 2.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.575 HG21 ' HD2' ' A' ' 117' ' ' ARG . 92.4 m -136.73 118.77 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.951 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.8 mp -116.59 108.88 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.01 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.78 156.71 24.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -155.81 141.11 17.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.587 ' HB ' HG23 ' A' ' 115' ' ' VAL . 13.6 t -138.57 154.65 48.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.992 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -68.0 128.81 37.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.45 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 20.9 p -70.38 139.81 87.17 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.784 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.466 ' CD ' ' CD1' ' A' ' 108' ' ' TRP . 72.1 Cg_exo -48.25 164.22 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.417 2.078 . . . . 0.0 112.35 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.26 99.73 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.64 45.3 94.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.473 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.17 -85.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.744 0.307 . . . . 0.0 111.102 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.38 1.51 Allowed 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.126 0.489 . . . . 0.0 111.277 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.3 70.45 10.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.576 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.67 124.26 0.05 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.463 ' HA ' ' CZ3' ' A' ' 108' ' ' TRP . 31.7 t80 -56.46 145.03 28.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -135.31 156.36 49.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.14 30.32 1.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -116.96 -34.14 4.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.958 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.466 ' CD1' ' CD ' ' A' ' 97' ' ' PRO . 24.7 m0 -59.3 -29.71 67.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.593 ' CD2' HG21 ' A' ' 115' ' ' VAL . 4.6 m-85 -85.45 -44.24 12.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -93.51 53.74 1.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.899 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.29 -157.3 9.71 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.535 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.13 154.63 41.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.823 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.08 -162.45 13.14 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.649 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.96 111.25 9.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.759 0.314 . . . . 0.0 110.85 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.593 HG21 ' CD2' ' A' ' 109' ' ' PHE . 7.4 p -111.54 130.74 64.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -104.04 154.5 19.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.824 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.575 ' HD2' HG21 ' A' ' 90' ' ' THR . 1.4 ttp85 -132.47 141.93 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -126.74 163.07 24.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.7 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -141.03 124.24 16.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.033 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.37 117.24 57.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.772 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.89 137.38 32.07 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.33 2.02 . . . . 0.0 112.236 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.696 HD11 HG13 ' A' ' 89' ' ' ILE . 8.7 mm -105.68 136.06 41.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.38 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.721 ' HB3' HG23 ' A' ' 18' ' ' VAL . 2.2 mt-10 -124.95 157.94 34.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.717 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 88.0 m-85 -120.62 96.68 5.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.241 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.447 ' ND2' HG12 ' B' ' 18' ' ' VAL . 66.4 t30 -79.2 81.96 5.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.894 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.898 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.897 0.379 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.67 155.14 27.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 21.2 t -101.92 -56.61 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.556 HG23 ' HD2' ' B' ' 5' ' ' PRO . 6.6 p -177.77 141.13 0.44 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.944 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.556 ' HD2' HG23 ' B' ' 4' ' ' VAL . 51.2 Cg_exo -53.2 147.59 34.81 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.601 2.201 . . . . 0.0 112.249 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.81 106.4 1.99 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.541 2.161 . . . . 0.0 112.248 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.82 129.76 48.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.443 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.726 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 8.4 m-20 -54.78 128.63 33.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.84 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 pt -90.12 138.89 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.263 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.88 149.81 39.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.38 149.92 35.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.172 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.532 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.8 mm-40 -144.88 107.34 4.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.648 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' LYS . 26.4 Cg_endo -61.72 154.72 60.44 Favored 'Cis proline' 0 C--N 1.351 0.668 0 C-N-CA 123.802 -1.333 . . . . 0.0 112.391 0.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 45.9 m -59.58 -53.13 61.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.9 39.84 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' B' ' 13' ' ' PRO . 0.3 OUTLIER -163.47 111.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.063 179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.9 tt -130.02 133.99 63.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.732 HG23 ' HB3' ' B' ' 123' ' ' GLU . 6.1 p -130.67 110.76 19.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.284 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.408 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 21.6 m-85 -57.37 154.39 10.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.92 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -116.36 119.95 37.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.868 0.366 . . . . 0.0 111.343 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.827 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -50.13 169.08 0.2 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.928 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.827 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 60.5 Cg_endo -72.55 163.67 87.83 Favored 'Cis proline' 0 C--N 1.348 0.549 0 C-N-CA 123.598 -1.417 . . . . 0.0 112.385 0.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 24.4 m-85 -111.76 34.7 4.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.6 4.61 26.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.312 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -144.74 131.55 20.16 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.831 0.348 . . . . 0.0 110.85 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -51.64 122.73 8.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.038 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -118.67 150.08 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.552 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 5.8 m -123.56 109.97 14.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.938 0.399 . . . . 0.0 111.217 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.651 ' O ' HG12 ' B' ' 72' ' ' VAL . 15.0 m-85 -98.5 116.42 30.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.463 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -81.25 130.49 35.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.484 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.757 HD12 ' HE3' ' B' ' 70' ' ' MET . 12.1 mt -110.81 143.48 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.62 131.68 46.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.031 0.443 . . . . 0.0 111.508 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.438 HD11 ' CE ' ' B' ' 70' ' ' MET . 64.4 mt -126.03 154.11 34.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.645 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' B' ' 33' ' ' ILE . 53.2 m -153.13 156.66 39.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 111.285 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -105.64 109.45 21.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.479 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -94.65 21.51 7.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.231 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.87 -145.5 13.94 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.67 -39.44 0.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.577 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -103.13 159.36 15.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.84 0.352 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 6.9 mtm-85 -52.16 158.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.76 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 4.1 pt -149.55 117.19 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.879 0.371 . . . . 0.0 111.607 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.98 116.89 4.3 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.876 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.92 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 26.1 p-90 -113.74 154.89 26.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.092 0.473 . . . . 0.0 111.648 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.58 156.4 45.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.419 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.92 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 2.3 mp -118.06 147.33 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.976 0.417 . . . . 0.0 111.749 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -145.39 131.14 19.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.578 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 68.8 p -113.15 150.14 32.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.069 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.581 HG23 ' HG3' ' B' ' 88' ' ' ARG . 0.8 OUTLIER -51.94 -36.09 48.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.809 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -138.18 115.77 11.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 79.2 mmm -93.33 22.09 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.942 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . 0.403 ' HB2' ' NH1' ' B' ' 51' ' ' ARG . 0.1 OUTLIER -104.65 -37.33 7.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.826 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 ttp85 -101.9 -27.93 12.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.044 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.42 150.26 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.85 110.02 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.977 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 m -99.04 144.61 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.035 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.37 136.35 6.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.85 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.48 144.53 81.31 Favored 'Cis proline' 0 C--N 1.352 0.735 0 C-N-CA 123.688 -1.38 . . . . 0.0 112.3 -0.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.0 -4.68 15.47 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.635 2.223 . . . . 0.0 112.947 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 28.2 p -172.01 161.63 5.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.761 0.315 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 169.91 157.86 12.89 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.656 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.09 134.05 33.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.794 0.33 . . . . 0.0 110.998 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' B' ' 62' ' ' LEU . 5.6 tp -108.89 132.53 53.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.019 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.445 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -88.54 168.34 16.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 24.9 Cg_endo -62.05 113.45 1.88 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.509 2.139 . . . . 0.0 112.365 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.94 30.6 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 148.37 24.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.918 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.416 ' CG ' ' OG1' ' B' ' 34' ' ' THR . 42.1 mttt -115.73 121.83 43.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.026 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 13.8 p -112.41 146.15 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.85 147.27 23.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.194 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.757 ' HE3' HD12 ' B' ' 31' ' ' ILE . 13.4 ttp -129.58 156.92 43.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.471 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.32 122.71 16.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.578 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.651 HG12 ' O ' ' B' ' 29' ' ' TYR . 12.6 p -112.3 115.77 50.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.658 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.62 129.1 46.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.941 0.4 . . . . 0.0 111.297 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -116.01 127.7 55.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.751 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -79.81 148.05 31.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.7 p -62.84 160.97 13.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.763 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -176.53 -175.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -104.37 108.66 20.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.39 18.9 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.456 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.56 -38.54 12.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.38 . . . . 0.0 111.086 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.0 p -131.2 44.31 2.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.081 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -138.06 177.32 7.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.827 ' O ' HD23 ' B' ' 84' ' ' LEU . 97.2 m-20 -91.35 149.62 21.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.854 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.827 HD23 ' O ' ' B' ' 83' ' ' ASP . 47.6 mt -139.5 29.41 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -141.37 26.31 1.98 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.972 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -119.18 -12.62 9.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.64 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.61 120.22 24.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.946 0.403 . . . . 0.0 111.104 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.581 ' HG3' HG23 ' B' ' 48' ' ' THR . 0.8 OUTLIER -149.78 134.6 17.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.911 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.706 HG13 HD11 ' B' ' 122' ' ' ILE . 5.8 mt -98.23 165.56 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.983 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.584 HG21 ' HD2' ' B' ' 117' ' ' ARG . 93.8 m -136.64 118.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.447 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.8 mp -116.58 108.9 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -114.78 156.56 24.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.99 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -155.62 141.05 17.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.973 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.578 ' HB ' HG23 ' B' ' 115' ' ' VAL . 13.7 t -138.55 154.61 48.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -67.97 128.91 38.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.859 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.458 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 21.2 p -70.45 139.8 86.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . 0.481 ' CD ' ' CD1' ' B' ' 108' ' ' TRP . 70.9 Cg_exo -48.2 164.08 0.21 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.541 2.161 . . . . 0.0 112.303 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.11 99.56 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.928 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 58.53 45.47 94.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.521 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.22 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.05 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.06 165.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.095 0.474 . . . . 0.0 111.278 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.25 70.32 10.53 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.544 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 178.75 124.27 0.05 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.817 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.464 ' HA ' ' CZ3' ' B' ' 108' ' ' TRP . 30.5 t80 -56.49 145.07 28.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -135.43 156.38 49.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 -94.19 30.48 1.91 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -116.99 -34.2 4.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.481 ' CD1' ' CD ' ' B' ' 97' ' ' PRO . 25.0 m0 -59.23 -29.84 67.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.58 ' CD2' HG21 ' B' ' 115' ' ' VAL . 4.6 m-85 -85.48 -43.91 13.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -93.79 53.84 1.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -165.45 -157.12 9.63 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.566 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -70.3 154.71 41.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.08 -162.52 13.12 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.664 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.95 111.41 9.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.58 HG21 ' CD2' ' B' ' 109' ' ' PHE . 7.4 p -111.65 130.7 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.194 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 -103.9 154.53 19.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.584 ' HD2' HG21 ' B' ' 90' ' ' THR . 1.4 ttp85 -132.56 142.05 48.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.91 162.93 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.759 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -140.94 124.36 16.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.36 117.45 57.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.734 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.99 137.39 31.76 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.365 2.044 . . . . 0.0 112.225 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.706 HD11 HG13 ' B' ' 89' ' ' ILE . 8.8 mm -105.66 136.13 41.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.359 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.732 ' HB3' HG23 ' B' ' 18' ' ' VAL . 2.2 mt-10 -124.96 158.08 34.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.772 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.443 ' HB3' ' CE2' ' B' ' 23' ' ' TYR . 87.8 m-85 -120.73 96.54 5.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.435 ' ND2' HG12 ' A' ' 18' ' ' VAL . 66.4 t30 -79.14 81.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.864 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 37.1 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.828 -179.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.878 0.37 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.38 86.91 1.92 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -171.25 44.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.9 m -52.0 144.71 19.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.222 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.43 167.36 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.537 2.158 . . . . 0.0 112.327 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.15 146.69 82.41 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.527 2.151 . . . . 0.0 112.223 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.28 113.01 3.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.528 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 14.7 m-20 -48.1 121.56 4.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 0.0 111.067 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.434 HG12 ' CE2' ' A' ' 93' ' ' TRP . 5.0 pt -93.21 147.02 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 -92.67 145.34 24.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.809 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.57 154.15 51.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.136 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.629 ' O ' HG23 ' A' ' 31' ' ' ILE . 13.6 mm-40 -139.97 127.93 12.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.389 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.706 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 51.0 Cg_endo -68.78 163.97 77.55 Favored 'Cis proline' 0 C--N 1.351 0.697 0 C-N-CA 123.995 -1.252 . . . . 0.0 112.697 0.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.4 -53.21 4.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.725 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HG3' ' HG ' ' A' ' 120' ' ' LEU . 2.2 tt0 -178.3 50.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.165 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -169.92 107.15 0.36 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.174 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -120.95 150.22 23.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.689 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.813 HG22 ' HB2' ' A' ' 123' ' ' GLU . 42.4 t -132.99 95.2 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.776 0.322 . . . . 0.0 111.641 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -54.8 97.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.265 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -59.09 151.39 22.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.754 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -64.2 169.69 4.42 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.656 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.754 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 66.8 Cg_endo -93.11 164.12 23.14 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 124.502 -1.041 . . . . 0.0 112.789 0.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -103.01 37.29 2.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.695 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.64 -5.87 13.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.344 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.59 -161.43 1.29 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.838 0.351 . . . . 0.0 110.941 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.39 142.39 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.452 ' CD2' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -159.56 91.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.466 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.699 HG23 ' C ' ' A' ' 72' ' ' VAL . 31.5 m -83.3 143.83 30.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.511 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -121.48 130.3 53.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.176 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.35 133.89 42.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.04 0.448 . . . . 0.0 111.671 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 12' ' ' GLN . 9.4 mm -99.99 149.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.05 126.38 46.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.277 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 34' ' ' THR . 37.5 mt -125.09 153.88 32.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.419 ' N ' HG22 ' A' ' 33' ' ' ILE . 78.5 m -154.49 155.27 34.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.0 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.787 ' HB2' HD12 ' A' ' 62' ' ' LEU . 64.8 t30 -102.86 81.74 2.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.091 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -54.75 -23.4 17.69 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.96 -160.26 7.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.625 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.06 0.94 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.591 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.7 139.15 12.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.798 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.19 138.59 16.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 95' ' ' ASN . 1.2 pt -137.62 174.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.461 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -132.94 98.16 0.34 Allowed Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.684 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.982 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 30.1 p-90 -92.43 155.68 17.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.126 0.489 . . . . 0.0 111.763 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.3 158.12 43.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.446 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.982 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 1.0 OUTLIER -125.32 149.68 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.001 0.429 . . . . 0.0 111.723 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -159.66 131.31 6.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.484 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.5 p -109.79 158.39 18.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.307 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -29.89 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.965 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.45 117.8 23.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.18 18.19 7.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.197 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -109.4 -43.74 4.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 110.818 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.6 -58.97 2.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.9 mt -83.9 140.79 31.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.09 107.46 5.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.011 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.812 HG11 ' CG2' ' A' ' 45' ' ' ILE . 3.2 m -74.42 152.28 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -168.52 113.27 0.56 Allowed Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.35 141.11 70.79 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.304 0.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HB3' HG23 ' A' ' 55' ' ' VAL . 73.6 Cg_endo -75.59 -3.87 14.48 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.544 2.162 . . . . 0.0 112.747 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.2 p -170.42 147.6 3.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.785 0.326 . . . . 0.0 110.792 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.23 175.32 43.6 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.477 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 41' ' ' ILE . 6.4 t -106.2 122.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.175 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.787 HD12 ' HB2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -94.16 125.27 38.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 4.7 m-20 -81.74 161.42 61.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -51.95 100.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.561 2.174 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt 69.47 45.21 0.84 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' O ' HD11 ' A' ' 62' ' ' LEU . 3.4 tp10 -107.61 154.13 21.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.957 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -110.77 137.14 48.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.988 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.673 ' CG1' HD21 ' A' ' 62' ' ' LEU . 7.7 p -136.42 145.56 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.91 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.1 117.14 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.419 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 1.8 tmm? -101.66 147.93 25.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.37 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.419 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -113.92 140.91 47.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 0.0 111.439 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.699 ' C ' HG23 ' A' ' 28' ' ' THR . 44.0 t -124.95 84.79 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.741 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 28' ' ' THR . 0.4 OUTLIER -57.23 129.42 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.128 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.05 122.07 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -92.31 138.76 31.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.844 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.38 162.99 0.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.937 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -169.21 -161.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.19 119.89 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.6 19.42 20.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.39 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.35 -31.01 12.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.3 p -136.87 44.77 2.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.07 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -144.31 139.81 28.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.509 ' O ' HD23 ' A' ' 84' ' ' LEU . 1.2 m-20 -54.93 146.59 17.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.975 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 83' ' ' ASP . 16.2 mt -130.86 32.24 4.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.909 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.26 27.89 1.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -127.68 6.19 6.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.654 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.04 119.99 39.14 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.773 0.32 . . . . 0.0 110.799 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.414 ' HA ' HG12 ' A' ' 122' ' ' ILE . 0.8 OUTLIER -150.47 131.23 14.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.291 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.917 HG13 HD11 ' A' ' 122' ' ' ILE . 37.6 mt -84.67 162.02 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.51 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.559 HG23 ' ND2' ' A' ' 119' ' ' ASN . 78.2 m -138.66 137.36 36.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.014 0.435 . . . . 0.0 111.375 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 38.6 mt -120.53 146.94 24.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.606 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.457 ' CG ' ' HB3' ' A' ' 117' ' ' ARG . 4.4 mt-10 -149.28 111.59 4.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.192 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.434 ' CE2' HG12 ' A' ' 9' ' ' ILE . 7.8 p90 -123.79 138.53 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.491 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 0.7 OUTLIER -139.46 130.39 26.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.976 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 41' ' ' ILE . 21.1 p30 -54.03 125.03 17.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 p -67.05 144.68 98.58 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.78 163.05 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.433 2.089 . . . . 0.0 112.204 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.46 118.39 2.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.983 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.37 46.12 52.47 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.47 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.83 151.13 46.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.845 0.355 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.12 164.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.284 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 71.13 5.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.609 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.6 142.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.763 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -61.36 134.44 56.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.789 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.33 155.22 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.986 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -93.4 -6.74 46.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.653 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.81 -17.59 35.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.546 0.213 . . . . 0.0 111.464 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.36 -16.15 32.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.294 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 1.5 m-85 -126.89 37.55 4.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.825 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -151.46 43.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.49 -117.96 0.61 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.617 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -97.97 156.18 16.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.989 0.423 . . . . 0.0 110.989 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.11 135.75 5.37 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.579 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -77.25 130.89 37.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.1 t -122.28 117.1 51.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.34 147.24 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.415 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.457 ' HB3' ' CG ' ' A' ' 92' ' ' GLU . 12.8 ptp180 -143.93 153.84 42.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.045 0.45 . . . . 0.0 111.507 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -147.73 131.78 17.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.338 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.559 ' ND2' HG23 ' A' ' 90' ' ' THR . 1.5 m120 -104.29 134.13 48.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.132 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.402 ' HG ' ' HG3' ' A' ' 15' ' ' GLN . 6.1 mp -107.79 137.7 19.83 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.808 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.5 138.73 17.66 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.542 2.161 . . . . 0.0 112.597 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.917 HD11 HG13 ' A' ' 89' ' ' ILE . 11.5 mm -101.52 146.56 9.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.029 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.813 ' HB2' HG22 ' A' ' 18' ' ' VAL . 2.7 mt-10 -132.67 163.72 28.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.89 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 71.5 m-85 -126.37 131.5 51.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.195 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.665 ' HB2' HG12 ' A' ' 18' ' ' VAL . 4.2 t30 -120.18 115.16 23.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.792 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 8.1 mt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.359 -0.829 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.793 0.33 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.35 86.88 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -171.25 44.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.6 m -51.99 144.85 19.24 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.174 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -49.52 167.43 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.566 2.177 . . . . 0.0 112.22 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.2 146.76 82.39 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.554 2.169 . . . . 0.0 112.3 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.23 113.21 3.85 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.451 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.557 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 15.3 m-20 -48.24 121.72 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 110.988 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.429 HG12 ' CE2' ' B' ' 93' ' ' TRP . 5.1 pt -93.34 146.99 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.243 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -92.83 145.45 24.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.768 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 2.2 p -135.62 154.24 51.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.098 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.63 ' O ' HG23 ' B' ' 31' ' ' ILE . 13.5 mm-40 -139.95 127.94 12.98 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.29 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.748 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 51.1 Cg_endo -68.9 163.77 78.48 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 124.047 -1.231 . . . . 0.0 112.695 0.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.1 m -42.23 -53.25 4.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.694 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.41 ' HG3' ' HG ' ' B' ' 120' ' ' LEU . 2.2 tt0 -178.32 50.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.141 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -170.04 106.95 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.1 tt -120.7 150.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.729 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' B' ' 123' ' ' GLU . 42.2 t -133.07 95.35 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.79 0.328 . . . . 0.0 111.705 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -54.89 96.88 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.309 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -59.01 151.21 22.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.761 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.767 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -63.97 169.72 4.17 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.602 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.767 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 65.5 Cg_endo -93.14 164.07 23.07 Favored 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 124.476 -1.052 . . . . 0.0 112.834 0.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -102.87 37.23 1.99 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.705 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.51 -5.87 14.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.231 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.58 -161.33 1.27 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 120.847 0.356 . . . . 0.0 110.957 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 11.4 mtmm -94.54 142.27 27.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.198 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . 0.442 ' CD2' ' O ' ' B' ' 22' ' ' PRO . 0.0 OUTLIER -159.28 91.07 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.42 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.699 HG23 ' C ' ' B' ' 72' ' ' VAL . 31.1 m -83.38 143.88 30.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.562 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -121.65 130.12 53.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.159 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.07 133.78 42.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.949 0.404 . . . . 0.0 111.688 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.63 HG23 ' O ' ' B' ' 12' ' ' GLN . 9.6 mm -99.9 149.65 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.524 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.89 126.52 46.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 34' ' ' THR . 37.8 mt -125.18 153.83 32.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.909 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' B' ' 33' ' ' ILE . 82.1 m -154.46 155.23 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.075 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.768 ' HB2' HD12 ' B' ' 62' ' ' LEU . 64.6 t30 -102.9 81.67 2.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -54.73 -23.26 16.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 -160.43 7.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.57 46.29 0.93 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.511 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.83 138.99 12.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.775 0.321 . . . . 0.0 110.832 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -50.18 138.67 15.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.828 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.592 HG22 ' HA ' ' B' ' 95' ' ' ASN . 1.2 pt -137.76 174.1 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.994 0.426 . . . . 0.0 111.418 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -132.95 98.35 0.34 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.643 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.964 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 29.9 p-90 -92.46 155.82 17.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.174 0.511 . . . . 0.0 111.816 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.47 157.88 43.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.451 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.964 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 1.0 OUTLIER -125.12 149.46 29.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.7 -179.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -159.41 131.35 6.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.494 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 24.1 p -109.9 158.43 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.93 -29.93 22.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.964 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -126.57 117.91 23.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.27 18.25 7.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.209 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -109.3 -43.98 4.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.847 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.35 -59.1 2.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.016 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.68 140.7 31.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.22 107.37 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.821 HG11 ' CG2' ' B' ' 45' ' ' ILE . 3.2 m -74.26 152.16 7.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.133 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -168.41 113.16 0.57 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.738 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.28 141.09 70.71 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.791 -1.337 . . . . 0.0 112.417 0.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HB3' HG23 ' B' ' 55' ' ' VAL . 73.6 Cg_endo -75.52 -4.11 14.81 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.529 2.153 . . . . 0.0 112.723 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.3 p -170.25 147.44 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.758 0.313 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.04 175.38 43.46 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.479 HG13 ' O ' ' B' ' 41' ' ' ILE . 6.6 t -106.33 122.28 59.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 111.143 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.768 HD12 ' HB2' ' B' ' 35' ' ' ASN . 0.2 OUTLIER -93.72 125.34 38.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.921 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.4 ' HB2' ' CB ' ' B' ' 66' ' ' GLU . 4.7 m-20 -81.85 161.47 60.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.93 100.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.574 2.183 . . . . 0.0 112.382 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt 69.29 45.44 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.509 ' O ' HD11 ' B' ' 62' ' ' LEU . 3.4 tp10 -107.79 154.23 21.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.886 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -110.89 137.14 48.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.668 ' CG1' HD21 ' B' ' 62' ' ' LEU . 7.5 p -136.4 145.64 30.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.861 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 9.0 tp -108.23 117.19 33.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.421 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 1.8 tmm? -101.68 147.81 26.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.431 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -113.83 140.98 47.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 111.443 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.699 ' C ' HG23 ' B' ' 28' ' ' THR . 43.6 t -124.98 84.74 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.84 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . 0.508 ' N ' HG23 ' B' ' 28' ' ' THR . 0.4 OUTLIER -57.15 129.48 41.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.069 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.21 121.86 36.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.789 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -92.01 138.76 31.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.44 162.98 0.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -169.18 -161.98 0.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.88 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -116.08 119.99 37.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.54 19.19 20.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.401 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.29 -31.09 12.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.865 0.364 . . . . 0.0 111.083 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 73.6 p -136.8 44.8 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -144.49 139.8 28.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.513 ' O ' HD23 ' B' ' 84' ' ' LEU . 1.1 m-20 -54.86 146.68 16.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.935 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.513 HD23 ' O ' ' B' ' 83' ' ' ASP . 16.1 mt -130.91 32.23 4.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -143.27 28.27 1.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -127.95 6.17 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.629 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.19 120.36 39.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.748 0.309 . . . . 0.0 110.757 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.424 ' HA ' HG12 ' B' ' 122' ' ' ILE . 0.8 OUTLIER -150.79 131.0 13.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.255 -179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.931 HG13 HD11 ' B' ' 122' ' ' ILE . 37.2 mt -84.5 161.88 3.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.585 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.575 HG23 ' ND2' ' B' ' 119' ' ' ASN . 73.6 m -138.49 137.5 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 111.301 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 38.8 mt -120.59 146.95 24.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.684 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.447 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 4.3 mt-10 -149.34 111.54 4.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.868 0.366 . . . . 0.0 111.135 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.429 ' CE2' HG12 ' B' ' 9' ' ' ILE . 7.9 p90 -123.74 138.59 54.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.488 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 0.7 OUTLIER -139.6 130.18 25.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.997 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.592 ' HA ' HG22 ' B' ' 41' ' ' ILE . 21.2 p30 -53.78 125.03 16.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.9 p -67.09 144.86 98.63 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.805 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.86 163.03 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.536 2.157 . . . . 0.0 112.162 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.49 118.63 2.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.031 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.1 46.1 50.98 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.442 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.9 151.26 46.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.861 0.362 . . . . 0.0 111.08 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.17 164.32 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 111.314 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.54 71.27 5.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.517 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 178.35 142.24 0.1 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.831 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -61.09 134.34 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.14 155.36 31.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.007 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -93.51 -6.7 46.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.691 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -85.87 -17.49 35.44 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.602 0.239 . . . . 0.0 111.518 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -60.44 -16.07 32.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.323 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 1.5 m-85 -126.88 37.37 4.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.813 0.34 . . . . 0.0 110.972 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -151.42 43.13 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 177.57 -117.96 0.61 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.579 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -98.05 156.25 16.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.984 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.18 135.6 5.32 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.538 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -77.09 131.17 38.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 t -122.59 117.13 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -100.36 147.22 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.511 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.447 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 12.7 ptp180 -143.87 153.86 42.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 111.469 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -147.72 131.79 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.314 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.575 ' ND2' HG23 ' B' ' 90' ' ' THR . 1.5 m120 -104.25 134.27 47.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.159 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.41 ' HG ' ' HG3' ' B' ' 15' ' ' GLN . 6.0 mp -107.92 137.57 19.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.36 138.42 17.66 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.589 2.193 . . . . 0.0 112.616 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.931 HD11 HG13 ' B' ' 89' ' ' ILE . 11.8 mm -101.19 146.82 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.096 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.819 ' HB2' HG22 ' B' ' 18' ' ' VAL . 2.7 mt-10 -132.93 163.8 28.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.478 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 70.1 m-85 -126.48 131.31 51.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.651 ' HB2' HG12 ' B' ' 18' ' ' VAL . 4.2 t30 -119.8 115.17 23.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 8.2 mt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.851 0.358 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -138.44 126.97 23.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.12 -178.42 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.968 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.66 153.11 42.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.14 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.63 158.75 54.93 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.531 2.154 . . . . 0.0 112.308 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.09 120.94 9.16 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.597 2.198 . . . . 0.0 112.206 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.75 143.66 35.7 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.379 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.694 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 73.8 m-20 -61.84 114.06 3.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.725 0.298 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.423 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 3.0 pt -73.31 142.51 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.095 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.455 HD22 ' HB2' ' A' ' 36' ' ' ALA . 2.3 m-80 -86.77 139.09 31.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.76 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.91 149.49 52.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 83.4 mm-40 -142.66 105.41 5.39 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.755 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 155.14 54.13 Favored 'Cis proline' 0 C--N 1.35 0.647 0 C-N-CA 123.844 -1.315 . . . . 0.0 112.348 0.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.9 -44.34 66.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.931 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.02 44.51 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.984 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.76 109.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.221 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.604 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.8 tt -130.76 142.82 42.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.736 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.722 HG11 HG11 ' B' ' 18' ' ' VAL . 7.3 p -139.77 99.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.513 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 19.8 m-85 -52.58 121.65 7.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.491 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -86.89 131.15 34.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.354 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -55.53 168.18 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.803 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 93.2 Cg_endo -83.67 163.89 68.86 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.94 -1.275 . . . . 0.0 112.674 0.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.1 25.46 10.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.847 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.32 7.96 45.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.483 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.478 ' N ' HG22 ' A' ' 76' ' ' THR . 14.2 p-10 -140.73 175.44 9.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -103.1 112.6 25.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.08 147.62 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 128.62 56.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.952 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 19' ' ' PHE . 65.6 m-85 -92.23 119.74 32.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.744 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -78.46 132.77 37.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.396 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.693 HD11 ' CG2' ' A' ' 72' ' ' VAL . 11.1 mt -120.84 148.56 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.519 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -112.45 125.52 54.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.921 0.391 . . . . 0.0 111.355 -179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.506 HD11 ' CE ' ' A' ' 70' ' ' MET . 30.3 mt -122.93 151.42 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.508 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 10' ' ' ASN . 99.5 m -147.92 155.66 41.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -98.28 75.65 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.808 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -52.62 -26.27 13.08 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.105 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.49 -148.97 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.548 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.33 3.78 4.79 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.108 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -138.0 172.91 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.907 0.354 . . . . 0.0 110.831 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 86.9 mtm180 -70.22 155.45 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.673 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.614 HD12 ' CD1' ' A' ' 93' ' ' TRP . 20.8 pt -149.31 134.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 111.794 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.04 113.17 4.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.487 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.443 ' HE1' HD12 ' A' ' 62' ' ' LEU . 62.1 p-90 -108.58 160.36 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.309 0.576 . . . . 0.0 111.919 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.65 22.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.967 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.696 ' CD1' HG23 ' A' ' 91' ' ' ILE . 11.7 mm -115.49 139.07 43.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 0.0 111.724 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.85 129.6 22.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.673 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 89' ' ' ILE . 70.0 p -107.71 148.36 29.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -54.21 -27.71 36.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -125.61 104.37 8.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.966 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.51 24.94 6.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -106.57 -44.67 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.779 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.95 -40.0 6.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.764 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.81 150.23 21.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.16 177.04 11.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.97 154.44 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -161.85 128.67 2.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 11.3 Cg_exo -71.07 133.26 27.0 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 123.892 -1.295 . . . . 0.0 111.945 -0.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 53.2 Cg_exo -54.91 -47.7 25.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.381 2.054 . . . . 0.0 112.102 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 11.0 p -136.27 165.83 24.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.668 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.26 -167.77 37.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.566 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 61' ' ' VAL . 11.8 p -138.25 125.35 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.339 . . . . 0.0 111.118 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.951 HD11 ' CG1' ' A' ' 68' ' ' VAL . 0.2 OUTLIER -103.21 160.25 14.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB3' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -110.55 172.32 3.66 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.655 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 36.6 Cg_exo -60.84 116.23 3.22 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.618 2.212 . . . . 0.0 112.354 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 69.94 27.57 4.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.231 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' O ' HD23 ' A' ' 62' ' ' LEU . 2.0 mt-10 -103.59 148.24 26.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.476 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.78 136.82 54.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.874 0.369 . . . . 0.0 111.223 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.951 ' CG1' HD11 ' A' ' 62' ' ' LEU . 11.8 p -125.88 155.2 35.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.436 ' N ' HG22 ' A' ' 68' ' ' VAL . 83.4 mt -103.63 141.13 36.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.596 ' HE3' HD12 ' A' ' 31' ' ' ILE . 4.3 mtm -124.2 155.7 38.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.41 121.68 31.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.168 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.693 ' CG2' HD11 ' A' ' 31' ' ' ILE . 21.9 t -95.95 100.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.077 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -65.87 117.68 8.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.984 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.5 m -123.03 116.18 23.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.756 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -96.66 151.92 19.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 25' ' ' ASP . 7.1 p -53.94 167.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 79' ' ' ALA . 34.1 p90 -177.59 -164.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -130.88 98.14 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.423 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . . . -72.04 -22.47 61.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.41 -39.0 31.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.9 p -129.82 47.09 2.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.188 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -143.24 151.79 40.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -71.06 147.99 47.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 124' ' ' TYR . 23.2 mt -125.95 24.09 7.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.994 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.27 28.53 1.67 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.771 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -124.94 7.4 8.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.619 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.46 123.88 48.76 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.947 0.403 . . . . 0.0 111.047 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.23 148.15 35.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.651 HG13 HD11 ' A' ' 122' ' ' ILE . 67.9 mt -118.58 108.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.865 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.77 120.8 33.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.28 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.696 HG23 ' CD1' ' A' ' 45' ' ' ILE . 4.3 mp -111.38 100.21 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.911 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.408 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 11.5 mt-10 -97.66 157.8 15.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.934 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.614 ' CD1' HD12 ' A' ' 41' ' ' ILE . 10.2 p90 -163.64 142.36 7.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.039 0.447 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 115' ' ' VAL . 1.5 t -143.06 131.34 22.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -48.05 146.5 2.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.837 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 1.7 p -90.22 140.92 27.32 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.423 ' HD2' ' NE1' ' A' ' 108' ' ' TRP . 52.9 Cg_exo -52.18 160.72 3.04 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.496 2.13 . . . . 0.0 111.91 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.42 117.68 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.49 48.98 33.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.401 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.49 48.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.715 0.293 . . . . 0.0 111.438 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.7 165.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.129 0.49 . . . . 0.0 111.554 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.12 73.81 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.7 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.45 152.35 3.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.881 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -64.25 153.09 39.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.835 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.48 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 2.4 mmt180 -142.88 150.25 39.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.032 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.443 ' HB3' ' NH1' ' A' ' 106' ' ' ARG . 8.0 ttp-105 -102.58 25.78 8.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.69 -29.68 7.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.837 ' CZ3' HG22 ' A' ' 96' ' ' THR . 23.2 m0 -62.56 -27.57 69.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -82.85 -40.79 19.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -61.31 -29.11 69.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.807 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.31 146.8 44.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.464 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -84.72 114.47 22.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.883 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.13 135.11 4.9 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.619 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.3 mtm 54.99 102.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.359 . . . . 0.0 111.247 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.5 p 169.98 98.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.178 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.93 160.41 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.133 0.492 . . . . 0.0 111.597 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 4.8 ptp85 -141.41 104.54 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.751 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -92.17 166.45 12.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -128.55 152.23 48.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.939 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.99 93.13 17.64 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.04 133.1 53.52 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.622 2.215 . . . . 0.0 112.471 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.651 HD11 HG13 ' A' ' 89' ' ' ILE . 12.9 mm -99.08 146.05 9.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.026 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.494 ' C ' HG23 ' A' ' 18' ' ' VAL . 36.2 mt-10 -138.36 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 111.285 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 13.4 m-85 -119.26 137.51 53.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.942 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -121.36 78.93 1.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.895 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.983 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.834 0.349 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -138.42 126.96 23.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.807 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.13 -178.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 6.9 m -108.7 153.03 42.5 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.53 158.77 54.96 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.567 2.178 . . . . 0.0 112.245 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.04 121.03 9.31 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.498 2.132 . . . . 0.0 112.283 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.96 143.74 36.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.337 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 73.8 m-20 -61.94 114.03 3.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.856 0.36 . . . . 0.0 110.976 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 3.0 pt -73.26 142.38 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.173 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.448 HD22 ' HB2' ' B' ' 36' ' ' ALA . 2.3 m-80 -86.62 139.1 31.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.764 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.92 149.57 52.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.973 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -142.84 105.44 5.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.627 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.88 154.85 54.33 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 123.894 -1.294 . . . . 0.0 112.317 0.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 1.8 p -70.41 -44.5 67.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -164.93 44.4 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.049 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.69 109.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.147 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.609 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.8 tt -130.57 142.84 42.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.722 HG11 HG11 ' A' ' 18' ' ' VAL . 7.3 p -139.81 99.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 111.503 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.452 ' HA ' ' CZ ' ' B' ' 29' ' ' TYR . 19.8 m-85 -52.54 121.59 7.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.442 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -86.7 131.02 34.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.89 0.376 . . . . 0.0 111.325 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.792 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -55.33 168.25 0.6 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.734 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.792 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 94.8 Cg_endo -83.6 163.81 69.3 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.925 -1.281 . . . . 0.0 112.669 0.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.05 25.46 10.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.951 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.3 7.89 45.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.363 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . 0.483 ' N ' HG22 ' B' ' 76' ' ' THR . 14.4 p-10 -140.71 175.19 9.81 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -102.74 112.55 25.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -129.2 147.63 51.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.806 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.21 128.62 56.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.992 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.452 ' CZ ' ' HA ' ' B' ' 19' ' ' PHE . 66.9 m-85 -92.14 119.66 32.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.759 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -78.35 132.72 37.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.4 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.69 HD11 ' CG2' ' B' ' 72' ' ' VAL . 11.0 mt -120.78 148.53 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.55 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.39 125.47 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 111.506 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.503 HD11 ' CE ' ' B' ' 70' ' ' MET . 30.1 mt -122.87 151.27 26.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.564 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' B' ' 10' ' ' ASN . 99.3 m -147.88 155.49 41.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 0.0 111.553 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -98.2 75.83 2.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.833 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -52.86 -25.92 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.171 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.69 -149.05 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.444 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.26 3.68 4.81 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.93 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -137.9 172.77 12.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.94 0.37 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' B' ' 62' ' ' LEU . 87.0 mtm180 -69.97 155.48 40.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.599 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.631 HD12 ' CD1' ' B' ' 93' ' ' TRP . 20.5 pt -149.36 134.35 10.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.868 0.366 . . . . 0.0 111.781 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.06 113.34 4.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.426 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.44 ' HE1' HD12 ' B' ' 62' ' ' LEU . 61.8 p-90 -108.72 160.24 16.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.32 0.581 . . . . 0.0 111.866 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 144.9 22.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.033 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.707 ' CD1' HG23 ' B' ' 91' ' ' ILE . 11.9 mm -115.76 139.04 44.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.931 0.396 . . . . 0.0 111.689 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -140.76 130.04 23.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.599 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.524 HG22 HG12 ' B' ' 89' ' ' ILE . 71.4 p -108.23 148.09 30.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.061 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 66.7 p -53.82 -27.98 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.963 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -125.37 104.73 8.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.89 25.07 6.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -106.54 -44.92 4.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -102.65 -39.97 6.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 8.8 mt -97.88 150.25 21.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.7 m -154.18 177.05 11.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.913 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t -146.89 154.68 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -162.16 128.64 2.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' B' ' 58' ' ' PRO . 11.4 Cg_exo -71.09 133.27 27.09 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.888 -1.297 . . . . 0.0 111.96 0.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' B' ' 57' ' ' PRO . 53.1 Cg_exo -55.0 -47.61 25.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.372 2.048 . . . . 0.0 112.123 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 11.7 p -136.33 165.6 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.05 -167.74 37.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.559 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.451 ' O ' HG13 ' B' ' 61' ' ' VAL . 11.9 p -138.28 125.37 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.347 . . . . 0.0 111.046 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.944 HD11 ' CG1' ' B' ' 68' ' ' VAL . 0.2 OUTLIER -103.13 160.18 14.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.935 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.426 ' HB3' ' CD ' ' B' ' 64' ' ' PRO . 0.4 OUTLIER -110.58 172.4 3.6 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.747 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.426 ' CD ' ' HB3' ' B' ' 63' ' ' ASP . 36.4 Cg_exo -60.88 116.35 3.3 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.622 2.215 . . . . 0.0 112.363 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.81 27.83 4.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.167 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.452 ' O ' HD23 ' B' ' 62' ' ' LEU . 2.0 mt-10 -103.86 148.23 26.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.45 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.69 136.91 55.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.904 0.383 . . . . 0.0 111.132 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.944 ' CG1' HD11 ' B' ' 62' ' ' LEU . 12.0 p -125.98 155.29 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.035 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.447 ' N ' HG22 ' B' ' 68' ' ' VAL . 83.1 mt -103.77 141.28 36.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.027 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.597 ' HE3' HD12 ' B' ' 31' ' ' ILE . 4.2 mtm -124.36 155.64 38.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.47 121.77 31.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.201 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.69 ' CG2' HD11 ' B' ' 31' ' ' ILE . 21.9 t -96.02 100.25 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.015 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 5.5 m -66.03 117.54 8.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.027 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -122.84 116.13 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.73 151.77 19.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.483 HG22 ' N ' ' B' ' 25' ' ' ASP . 7.2 p -53.8 167.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' B' ' 79' ' ' ALA . 34.2 p90 -177.8 -164.88 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -130.61 98.29 4.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.025 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' CE2' ' B' ' 77' ' ' PHE . . . -72.22 -22.43 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.34 -39.13 30.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.5 p -129.65 47.02 2.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.253 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -143.17 151.81 41.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -71.02 148.38 47.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.973 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.448 ' HB3' ' CD1' ' B' ' 124' ' ' TYR . 23.4 mt -126.26 24.08 6.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -142.31 28.45 1.67 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.738 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -124.9 7.51 8.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.614 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.48 123.78 48.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.92 0.39 . . . . 0.0 111.008 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -143.06 148.34 36.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.953 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.651 HG13 HD11 ' B' ' 122' ' ' ILE . 67.4 mt -118.67 108.31 23.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.48 120.67 33.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.707 HG23 ' CD1' ' B' ' 45' ' ' ILE . 4.3 mp -111.29 100.13 10.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.411 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 11.4 mt-10 -97.52 157.85 15.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.631 ' CD1' HD12 ' B' ' 41' ' ' ILE . 10.0 p90 -163.69 142.19 7.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.993 0.425 . . . . 0.0 111.183 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' B' ' 115' ' ' VAL . 1.6 t -142.89 131.48 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.657 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -48.35 146.44 2.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.845 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 1.7 p -90.09 140.86 27.5 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.85 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . 0.421 ' HD2' ' NE1' ' B' ' 108' ' ' TRP . 53.4 Cg_exo -52.04 160.77 2.85 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.471 2.114 . . . . 0.0 112.025 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.62 117.61 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.06 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.6 48.85 34.88 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.375 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.36 48.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 111.483 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.83 165.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.176 0.512 . . . . 0.0 111.483 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.13 73.73 1.73 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.769 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.39 152.26 3.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.967 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -64.06 153.11 38.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 2.4 mmt180 -142.94 150.08 39.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.94 0.4 . . . . 0.0 111.04 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.437 ' HB3' ' NH1' ' B' ' 106' ' ' ARG . 8.1 ttp-105 -102.43 25.66 8.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.61 -29.56 7.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.845 ' CZ3' HG22 ' B' ' 96' ' ' THR . 23.4 m0 -62.78 -27.35 69.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -82.99 -40.64 19.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.83 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -61.46 -29.11 69.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.824 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -69.27 146.87 44.95 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.443 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -84.83 114.45 22.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.863 0.363 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 120.07 135.12 4.91 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.77 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.431 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 4.3 mtm 54.93 102.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.385 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.608 HG13 ' O ' ' B' ' 115' ' ' VAL . 7.4 p 169.88 98.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.081 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.84 160.55 14.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.158 0.504 . . . . 0.0 111.542 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.411 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 4.6 ptp85 -141.51 104.25 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -92.04 166.47 12.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.116 0.484 . . . . 0.0 111.132 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -128.51 152.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.91 93.17 17.84 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.11 133.23 54.38 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.446 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.651 HD11 HG13 ' B' ' 89' ' ' ILE . 12.9 mm -99.19 146.16 9.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.044 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.504 ' C ' HG23 ' B' ' 18' ' ' VAL . 35.8 mt-10 -138.38 158.64 43.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' B' ' 84' ' ' LEU . 13.7 m-85 -119.35 137.12 53.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.996 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -121.09 79.1 1.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.816 0.341 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -119.33 130.11 55.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.954 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.4 t -163.48 -77.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.75 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.558 HG23 ' HD2' ' A' ' 5' ' ' PRO . 7.3 p -178.85 138.11 0.34 Allowed Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.133 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.558 ' HD2' HG23 ' A' ' 4' ' ' VAL . 73.1 Cg_endo -76.04 160.83 36.39 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.582 2.188 . . . . 0.0 112.398 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.62 132.85 26.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.552 2.168 . . . . 0.0 112.315 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.05 -142.78 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.565 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.904 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 5.4 t0 -130.8 136.97 49.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 93' ' ' TRP . 23.0 pt -93.93 153.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.168 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.42 133.05 49.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.658 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.7 p -126.42 155.16 42.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.103 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HD3' ' B' ' 22' ' ' PRO . 28.8 mm-40 -139.97 114.54 7.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.545 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.84 161.63 67.5 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 123.924 -1.282 . . . . 0.0 112.497 0.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.35 -50.13 70.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.177 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -167.76 46.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.084 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -162.9 106.96 1.08 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.931 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 17' ' ' ILE . 11.1 tt -131.19 125.3 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.129 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.5 p -122.04 101.57 10.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.186 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 22.9 m-85 -47.32 162.76 0.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.567 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -122.85 119.4 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.969 0.414 . . . . 0.0 111.545 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.87 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.66 0.13 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.755 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.87 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 77.6 Cg_endo -76.84 164.27 87.76 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.764 0.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.82 40.92 2.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.808 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -108.14 6.8 27.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.4 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.49 -160.99 1.23 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.797 0.332 . . . . 0.0 110.872 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.26 112.34 24.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -112.48 119.44 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.52 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.1 113.78 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.429 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.483 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 8.7 m-85 -105.51 112.64 25.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.259 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.8 m170 -84.13 145.09 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.026 0.441 . . . . 0.0 111.638 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.425 HD12 ' CE ' ' A' ' 70' ' ' MET . 3.7 mt -116.12 145.43 21.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.383 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' CD ' ' HG3' ' B' ' 22' ' ' PRO . 6.9 tttt -94.32 129.67 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.962 0.411 . . . . 0.0 111.528 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 58.6 mt -128.55 151.76 35.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.705 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 m -152.33 155.83 38.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.982 0.42 . . . . 0.0 111.372 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' OD1' HD11 ' A' ' 41' ' ' ILE . 1.3 m-20 -94.61 100.79 12.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.626 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -90.48 18.03 6.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.512 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.11 -149.83 19.31 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.07 -26.75 2.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -125.55 162.39 25.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.855 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -52.06 168.27 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.511 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.449 HD12 ' CD1' ' A' ' 93' ' ' TRP . 13.9 pt -154.22 129.97 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.904 0.383 . . . . 0.0 111.635 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.03 106.43 2.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.517 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.18 156.52 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.158 0.504 . . . . 0.0 111.909 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.455 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -148.64 154.72 40.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.036 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG13 ' A' ' 91' ' ' ILE . 9.4 mm -127.73 137.96 56.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 111.72 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -142.36 129.55 20.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.643 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 HG12 ' A' ' 89' ' ' ILE . 43.9 p -104.25 157.26 17.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.959 0.409 . . . . 0.0 111.111 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.27 -27.65 2.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.894 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -143.0 118.33 10.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.704 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.17 17.81 6.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.272 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -110.05 -39.22 5.1 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.865 0.365 . . . . 0.0 110.952 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.42 -27.06 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.831 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.466 HD11 ' OD2' ' A' ' 87' ' ' ASP . 1.7 mt -116.62 149.72 39.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -138.83 144.16 39.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.25 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -133.02 120.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.731 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.18 136.49 24.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -74.12 132.49 27.26 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.632 -1.404 . . . . 0.0 112.0 0.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.39 -39.38 44.3 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.334 2.023 . . . . 0.0 112.112 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.24 163.58 35.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.401 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.87 154.68 10.58 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.757 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.4 t -95.82 122.34 47.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.757 0.313 . . . . 0.0 110.931 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 68' ' ' VAL . 3.7 tp -98.42 149.27 22.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.966 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.46 167.99 12.89 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.76 121.44 9.17 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.632 2.222 . . . . 0.0 112.384 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.85 18.43 9.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.421 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.09 152.76 21.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.841 0.353 . . . . 0.0 110.738 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -122.3 153.02 39.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' CG1' HD11 ' A' ' 62' ' ' LEU . 3.2 m -147.63 152.9 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.84 91.93 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.251 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.449 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 35.4 ttp -72.7 158.95 34.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.615 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -124.41 129.82 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.9 93.15 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.992 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.96 127.61 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.036 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.43 101.73 5.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.753 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.0 145.24 44.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.129 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.39 162.24 0.15 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CZ ' ' CE2' ' A' ' 124' ' ' TYR . 0.5 OUTLIER -168.55 -163.14 0.43 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.863 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.88 119.14 38.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.58 18.36 20.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.506 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.95 -23.07 15.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.19 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.9 p -141.44 49.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.075 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.1 147.77 21.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -60.61 139.04 57.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 75.2 mt -116.29 27.08 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.077 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -146.63 27.59 1.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.608 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.72 -29.33 9.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.071 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.466 ' OD2' HD11 ' A' ' 53' ' ' LEU . 1.4 m-20 -62.78 132.93 53.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.903 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -148.5 145.61 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.902 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 HG22 ' A' ' 47' ' ' THR . 71.5 mt -121.39 115.62 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.935 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 118' ' ' LYS . 81.1 m -96.4 124.42 40.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.009 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.604 HD13 HD13 ' A' ' 120' ' ' LEU . 4.6 mp -116.32 113.26 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -110.85 155.49 22.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CD1' HD12 ' A' ' 41' ' ' ILE . 6.6 p90 -154.81 129.16 9.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.782 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.72 ' CB ' HG22 ' A' ' 115' ' ' VAL . 4.4 t -130.37 135.08 47.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.4 138.64 45.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.876 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.0 p -76.92 138.79 65.58 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.36 165.3 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.478 2.119 . . . . 0.0 112.043 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -50.35 105.31 0.09 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.861 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.63 48.67 49.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.378 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.36 -79.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.849 0.357 . . . . 0.0 111.137 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.404 ' CB ' ' NH1' ' A' ' 105' ' ' ARG . . . 179.5 164.66 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.167 0.508 . . . . 0.0 111.298 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -92.43 70.29 5.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.802 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.22 142.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.761 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -51.69 138.08 23.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.413 ' HG2' ' HG2' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -126.2 149.7 48.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.644 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -99.57 25.21 7.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 110' ' ' GLN . 6.8 pt-20 -116.94 -16.54 10.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.409 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -69.27 -19.23 63.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.614 0.245 . . . . 0.0 111.344 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 3.2 m-85 -110.32 31.49 5.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.734 0.302 . . . . 0.0 111.261 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -115.55 -21.92 9.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.393 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.51 -179.64 41.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.683 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -97.85 126.43 43.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.776 0.322 . . . . 0.0 110.753 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.57 -171.18 45.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.265 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.567 ' C ' HG23 ' A' ' 115' ' ' VAL . 0.3 OUTLIER 58.5 163.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.955 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.72 HG22 ' CB ' ' A' ' 94' ' ' THR . 3.8 t 82.84 111.92 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.238 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.13 151.75 21.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.607 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.99 140.38 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.958 0.409 . . . . 0.0 111.276 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 90' ' ' THR . 5.3 tttp -126.17 162.12 26.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.546 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -130.88 152.52 50.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.604 HD13 HD13 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -139.25 95.73 9.17 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.729 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 120' ' ' LEU . 26.5 Cg_endo -62.61 127.41 20.65 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.468 2.112 . . . . 0.0 112.213 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.0 mm -96.16 154.54 3.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.337 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 93.2 mt-10 -145.66 163.18 35.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.91 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.467 ' CE2' ' CZ ' ' A' ' 77' ' ' PHE . 33.7 m-85 -125.35 120.9 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.065 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -100.73 88.98 3.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.947 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.962 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.775 0.321 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.46 130.09 55.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 13.3 t -163.59 -77.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.735 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.559 HG23 ' HD2' ' B' ' 5' ' ' PRO . 7.3 p -178.84 138.11 0.34 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.149 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' B' ' 4' ' ' VAL . 73.1 Cg_endo -75.96 160.73 36.73 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.639 2.226 . . . . 0.0 112.388 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.57 132.78 26.12 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.527 2.151 . . . . 0.0 112.302 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.96 -142.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.879 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 5.5 t0 -130.69 137.16 49.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.837 0.351 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' B' ' 93' ' ' TRP . 22.9 pt -94.15 153.01 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.183 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -104.35 132.98 50.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 38.0 p -126.42 155.18 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.142 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -139.89 114.49 7.83 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.588 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.88 161.46 68.28 Favored 'Cis proline' 0 C--N 1.352 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.607 0.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.19 -50.15 70.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -167.78 46.19 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -162.87 106.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.422 HG23 ' O ' ' B' ' 17' ' ' ILE . 10.9 tt -131.15 125.42 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.659 HG13 ' O ' ' B' ' 18' ' ' VAL . 7.6 p -122.1 101.64 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.494 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 22.9 m-85 -47.4 162.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.576 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -122.94 119.31 30.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.943 0.401 . . . . 0.0 111.558 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.843 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.07 170.54 0.13 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.755 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.843 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.2 Cg_endo -76.78 164.34 87.63 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 123.979 -1.259 . . . . 0.0 112.749 0.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -112.89 40.95 2.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.789 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -108.34 7.16 27.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.479 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.74 -160.98 1.23 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.833 0.349 . . . . 0.0 110.779 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.4 112.65 25.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.044 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . 0.424 ' HB3' ' CZ ' ' B' ' 29' ' ' TYR . 0.3 OUTLIER -112.54 119.64 38.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.496 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 113.59 27.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.487 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 8.6 m-85 -105.3 112.65 25.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.259 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -84.08 144.96 28.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.973 0.416 . . . . 0.0 111.691 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.429 HD12 ' CE ' ' B' ' 70' ' ' MET . 3.8 mt -116.09 145.36 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.408 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -94.28 129.63 40.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.977 0.418 . . . . 0.0 111.492 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 58.5 mt -128.54 151.65 35.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.725 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -152.23 155.73 38.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.019 0.438 . . . . 0.0 111.398 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.431 ' OD1' HD11 ' B' ' 41' ' ' ILE . 1.3 m-20 -94.64 100.76 12.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.59 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.879 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -90.36 18.01 6.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.59 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -105.04 -149.73 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.52 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.19 -26.79 2.85 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.49 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -125.63 162.3 25.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -51.85 168.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.541 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' B' ' 93' ' ' TRP . 14.0 pt -154.13 129.88 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.879 0.371 . . . . 0.0 111.66 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.01 106.45 2.67 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.511 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -104.28 156.56 17.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.235 0.54 . . . . 0.0 111.85 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.464 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -148.57 155.04 40.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.963 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.599 HD12 HG13 ' B' ' 91' ' ' ILE . 9.3 mm -127.92 137.94 56.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.974 0.416 . . . . 0.0 111.728 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -142.39 129.48 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.606 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.541 HG22 HG12 ' B' ' 89' ' ' ILE . 43.8 p -104.13 157.35 17.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -48.53 -27.6 2.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -142.98 118.18 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.713 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 1.1 mtp -90.1 17.8 6.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.253 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -110.18 -39.04 5.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.771 0.319 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -95.48 -27.11 15.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.454 HD11 ' OD2' ' B' ' 87' ' ' ASP . 1.7 mt -116.59 149.86 38.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.797 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.6 t -139.01 144.3 38.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.184 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.513 HG11 HG21 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -133.27 120.99 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.662 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -135.24 136.5 24.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.11 132.44 27.1 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.599 -1.417 . . . . 0.0 112.046 -0.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.37 -39.59 44.11 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.401 2.067 . . . . 0.0 112.088 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.1 p -146.06 163.51 35.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.344 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.94 154.56 10.5 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.835 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 44.6 t -95.65 122.54 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.317 . . . . 0.0 111.001 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.514 HD11 ' CG1' ' B' ' 68' ' ' VAL . 3.7 tp -98.58 149.39 22.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.54 168.06 12.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.94 121.37 9.04 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.591 2.194 . . . . 0.0 112.356 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.9 18.64 9.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.504 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.22 152.94 21.31 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.79 0.328 . . . . 0.0 110.767 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -122.43 152.99 39.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.072 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.514 ' CG1' HD11 ' B' ' 62' ' ' LEU . 3.1 m -147.58 152.92 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.016 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -111.81 92.02 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.232 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.444 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 35.7 ttp -72.78 158.99 34.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.553 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.444 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -124.6 129.68 51.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.242 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.72 93.06 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.093 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.91 127.49 32.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.022 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.28 101.94 5.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -74.24 145.11 44.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.2 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.11 162.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.126 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.456 ' CZ ' ' CE2' ' B' ' 124' ' ' TYR . 0.5 OUTLIER -168.57 -163.06 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.896 179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -110.95 119.21 38.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.71 18.31 20.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.526 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.88 -23.22 15.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 63.7 p -141.3 49.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -157.22 147.68 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -60.56 139.1 57.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 76.1 mt -116.38 27.23 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.109 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -146.66 27.38 1.1 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.7 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.63 -29.22 9.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.062 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . 0.454 ' OD2' HD11 ' B' ' 53' ' ' LEU . 1.4 m-20 -62.93 132.88 53.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.945 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 -148.45 145.5 28.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.996 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.541 HG12 HG22 ' B' ' 47' ' ' THR . 71.5 mt -121.32 115.54 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.013 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.439 HG23 ' O ' ' B' ' 118' ' ' LYS . 81.7 m -96.23 124.45 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.599 HG13 HD12 ' B' ' 45' ' ' ILE . 4.6 mp -116.33 113.23 42.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.812 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -110.71 155.47 22.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.067 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.452 ' CD1' HD12 ' B' ' 41' ' ' ILE . 6.8 p90 -154.9 128.79 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.77 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.734 ' CB ' HG22 ' B' ' 115' ' ' VAL . 4.3 t -129.94 135.01 47.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.015 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -55.25 138.69 44.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.822 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 68.7 p -77.07 138.79 64.99 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.896 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.25 165.08 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.525 2.15 . . . . 0.0 112.057 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -50.21 105.41 0.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.56 48.85 48.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.395 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -56.65 -79.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.775 0.321 . . . . 0.0 111.24 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.409 ' CB ' ' NH1' ' B' ' 105' ' ' ARG . . . 179.53 164.76 1.04 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.168 0.509 . . . . 0.0 111.307 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -92.54 70.36 4.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.699 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 171.17 141.99 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.686 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -51.8 137.88 25.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HG2' ' HG2' ' B' ' 107' ' ' GLU . 0.0 OUTLIER -125.96 149.76 48.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.717 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -99.46 25.11 7.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.188 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' B' ' 110' ' ' GLN . 6.7 pt-20 -116.9 -16.64 10.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.45 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -69.2 -19.27 63.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.605 0.24 . . . . 0.0 111.39 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 3.1 m-85 -110.26 31.56 5.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.69 0.281 . . . . 0.0 111.308 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' B' ' 107' ' ' GLU . 0.0 OUTLIER -115.67 -22.0 9.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.356 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -74.51 -179.74 42.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.641 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -97.67 126.44 43.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.765 0.317 . . . . 0.0 110.746 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.6 -171.32 45.26 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.292 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.581 ' C ' HG23 ' B' ' 115' ' ' VAL . 0.3 OUTLIER 58.63 163.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.941 0.4 . . . . 0.0 111.015 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.734 HG22 ' CB ' ' B' ' 94' ' ' THR . 3.9 t 82.82 112.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.248 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -100.23 151.75 21.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.565 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -118.93 140.13 50.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.997 0.427 . . . . 0.0 111.315 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.439 ' O ' HG23 ' B' ' 90' ' ' THR . 5.2 tttp -126.1 162.17 25.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -131.0 152.63 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.095 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.596 HD13 HD13 ' B' ' 91' ' ' ILE . 0.3 OUTLIER -139.29 95.87 9.08 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.646 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.66 127.49 20.81 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.439 2.093 . . . . 0.0 112.132 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 13.1 mm -96.3 154.52 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.268 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -145.63 163.31 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.456 ' CE2' ' CZ ' ' B' ' 77' ' ' PHE . 33.8 m-85 -125.27 121.26 33.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.058 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -101.1 88.87 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.948 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.908 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.819 0.342 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.19 169.46 10.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.59 147.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.35 148.85 59.43 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.87 146.1 82.16 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.596 2.197 . . . . 0.0 112.275 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ARG . 58.5 Cg_endo -71.63 149.51 55.28 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.557 2.171 . . . . 0.0 112.401 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -165.51 1.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.497 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.67 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 1.4 m-20 -111.23 111.88 23.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.894 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.88 147.59 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.58 149.69 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.799 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.36 151.5 45.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.56 107.71 3.81 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.37 157.38 62.06 Favored 'Cis proline' 0 C--N 1.351 0.688 0 C-N-CA 123.741 -1.358 . . . . 0.0 112.347 0.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.441 ' C ' HD21 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -112.05 -20.15 12.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.277 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.48 ' C ' HD23 ' A' ' 120' ' ' LEU . 37.9 mt-30 -94.71 -45.93 7.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 111.096 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.78 -176.66 0.24 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.022 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 122' ' ' ILE . 17.4 tt -144.33 156.28 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.279 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' A' ' 123' ' ' GLU . 3.6 p -133.09 92.43 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.052 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' CD1' ' CD1' ' A' ' 29' ' ' TYR . 19.2 m-30 -50.78 113.03 0.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.668 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -79.14 136.21 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.37 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.804 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -50.89 168.52 0.24 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.684 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.804 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 2.0 Cg_endo -82.58 163.76 73.94 Favored 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.255 -1.144 . . . . 0.0 112.364 0.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -106.33 26.61 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.818 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -110.68 7.1 22.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.106 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -141.46 134.14 28.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.788 0.328 . . . . 0.0 111.034 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -55.42 107.03 0.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -116.66 124.15 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.416 ' CG2' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -99.8 113.21 25.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.985 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CD1' ' CD1' ' A' ' 19' ' ' PHE . 85.5 m-85 -89.73 99.33 12.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.489 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -66.68 153.32 43.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.577 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.0 mt -139.27 148.73 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' CB ' ' HG3' ' B' ' 22' ' ' PRO . 25.3 ttmt -104.91 140.48 38.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 0.0 111.41 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 34' ' ' THR . 46.7 mt -131.54 154.03 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.779 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.435 ' N ' HG22 ' A' ' 33' ' ' ILE . 55.0 m -145.47 155.59 43.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.029 0.442 . . . . 0.0 111.189 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.865 ' HB2' HD23 ' A' ' 62' ' ' LEU . 36.0 t-20 -104.08 102.27 12.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.546 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -93.42 21.32 6.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.85 -122.86 4.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.542 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.36 -42.0 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.563 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -113.26 166.6 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.802 0.334 . . . . 0.0 110.932 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.44 156.3 1.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.041 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.417 HG12 ' ND2' ' A' ' 35' ' ' ASN . 21.9 pt -143.82 174.01 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.247 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -130.33 100.03 0.46 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.918 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 -92.12 159.35 15.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.143 0.497 . . . . 0.0 111.712 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.64 130.73 11.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.514 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.429 ' CG2' HG11 ' A' ' 55' ' ' VAL . 5.6 mm -100.31 141.09 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.914 0.388 . . . . 0.0 111.732 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -142.0 131.99 24.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.575 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.44 HG23 HG13 ' A' ' 55' ' ' VAL . 11.1 p -107.46 156.97 18.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.96 0.41 . . . . 0.0 111.399 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.525 HG23 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -48.32 -29.16 3.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.057 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -143.38 122.77 13.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.65 -8.62 59.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.417 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.17 -41.19 13.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.861 0.363 . . . . 0.0 110.604 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -84.8 -59.28 2.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.829 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.65 134.12 37.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.706 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 m -127.49 109.13 11.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.163 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 47' ' ' THR . 16.0 m -68.29 156.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 32.5 t0 -170.09 113.85 0.48 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.3 149.58 92.19 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.112 -1.203 . . . . 0.0 112.278 0.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.88 -15.31 21.12 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.571 2.181 . . . . 0.0 112.586 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -179.49 153.26 0.56 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.83 167.73 40.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.791 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.1 t -98.36 120.97 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.865 HD23 ' HB2' ' A' ' 35' ' ' ASN . 4.5 tp -96.98 162.93 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.4 OUTLIER -115.17 170.97 4.92 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.19 111.13 0.72 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.576 2.184 . . . . 0.0 112.419 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.27 39.79 9.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.974 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -106.74 154.31 21.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.894 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.38 38.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.042 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 33' ' ' ILE . 10.5 p -138.39 143.36 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.937 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.23 151.64 23.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.411 ' CE ' HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -133.47 161.56 34.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.764 179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -146.98 118.24 7.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.268 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 t -107.82 86.51 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.992 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.16 145.57 53.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 43.2 t -136.19 102.96 5.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.18 150.16 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.962 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -67.4 112.46 4.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' HE2' ' HB2' ' A' ' 79' ' ' ALA . 44.8 p90 -123.58 178.02 5.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -119.93 89.97 3.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . . . -55.18 -26.57 39.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.063 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.87 -49.12 59.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.7 p -125.61 50.63 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.068 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -136.28 162.34 33.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.996 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -80.12 130.2 35.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.954 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.501 HD22 ' CE2' ' A' ' 124' ' ' TYR . 12.2 mt -125.9 52.91 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -112.77 -23.66 10.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' HB3' HG21 ' A' ' 48' ' ' THR . 15.0 m120 -65.46 -91.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.842 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 122' ' ' ILE . 2.1 p-10 41.66 84.64 0.02 OUTLIER 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.573 0.225 . . . . 0.0 111.513 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HB2' HG23 ' A' ' 48' ' ' THR . 6.2 mtm-85 -167.4 135.17 2.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.607 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 122' ' ' ILE . 28.1 mt -119.81 163.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.874 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.53 ' N ' HG22 ' A' ' 89' ' ' ILE . 22.2 m -149.59 114.63 5.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.963 0.411 . . . . 0.0 111.363 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' CD1' HD12 ' A' ' 120' ' ' LEU . 4.7 mp -110.37 98.7 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.955 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.89 137.9 40.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.0 p90 -139.08 150.3 45.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.242 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.598 ' HB ' HG13 ' A' ' 115' ' ' VAL . 4.4 t -147.6 132.24 17.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.739 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -53.33 147.79 9.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.959 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.7 p -98.2 142.87 25.27 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.751 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.13 160.62 3.07 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.377 2.051 . . . . 0.0 112.039 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -47.03 116.28 1.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.175 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.4 50.77 23.09 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.42 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.87 62.74 7.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.727 0.299 . . . . 0.0 111.549 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.42 164.64 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.211 0.529 . . . . 0.0 111.612 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -104.55 73.72 1.11 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.613 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.57 147.83 0.18 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.71 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -65.41 150.39 48.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.056 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.48 146.85 38.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.689 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.14 -23.77 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.178 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.22 -22.26 64.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.162 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -62.83 -30.07 71.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' A' ' 115' ' ' VAL . 9.2 m-85 -85.5 -26.35 26.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.989 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -110.02 58.24 0.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.27 -138.2 2.36 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.72 146.26 23.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.822 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.3 130.9 6.69 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.397 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt -67.57 152.25 45.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.598 HG13 ' HB ' ' A' ' 94' ' ' THR . 14.1 t -128.44 128.3 68.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.136 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.403 ' HB2' ' HG2' ' A' ' 6' ' ' PRO . 1.2 ttt180 -96.8 152.61 18.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.582 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.03 130.08 18.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.042 0.449 . . . . 0.0 111.585 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -115.74 162.74 16.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.033 179.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -131.95 149.34 52.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 0.0 111.48 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' A' ' 91' ' ' ILE . 2.1 mt -143.26 98.47 5.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.656 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 88' ' ' ARG . 37.2 Cg_exo -57.91 151.04 59.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.703 2.269 . . . . 0.0 112.795 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.819 HD11 HD11 ' A' ' 89' ' ' ILE . 43.9 mm -101.46 158.26 4.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.018 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.67 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -140.08 153.66 46.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.902 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.501 ' CE2' HD22 ' A' ' 84' ' ' LEU . 31.7 m-85 -119.81 113.54 20.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.074 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -102.94 82.63 2.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.5 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.975 -179.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.844 0.354 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.11 169.66 10.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.38 147.36 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.943 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.62 148.96 60.61 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.07 146.22 81.47 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.531 2.154 . . . . 0.0 112.215 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.412 ' HG2' ' HB2' ' B' ' 116' ' ' ARG . 59.4 Cg_endo -71.73 149.54 54.75 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.576 2.184 . . . . 0.0 112.335 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.68 -165.53 1.55 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.663 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.5 m-20 -111.17 111.85 23.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.814 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.4 pt -78.89 147.54 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.116 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.49 149.52 21.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.876 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.19 151.55 45.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.019 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -147.6 107.63 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.672 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 28.3 Cg_endo -62.33 157.6 61.28 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.824 -1.323 . . . . 0.0 112.377 0.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . 0.434 ' C ' HD21 ' B' ' 120' ' ' LEU . 0.0 OUTLIER -112.39 -20.24 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.231 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.485 ' C ' HD23 ' B' ' 120' ' ' LEU . 37.9 mt-30 -94.67 -46.09 7.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.891 0.376 . . . . 0.0 111.068 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.89 -176.46 0.24 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.091 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' B' ' 122' ' ' ILE . 17.5 tt -144.69 156.34 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.244 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.642 HG23 ' HB3' ' B' ' 123' ' ' GLU . 3.5 p -133.22 92.57 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.97 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.566 ' CD1' ' CD1' ' B' ' 29' ' ' TYR . 19.0 m-30 -50.87 112.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.739 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -78.74 136.22 37.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.303 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.771 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -50.88 168.62 0.24 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.795 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.771 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 1.9 Cg_endo -82.54 163.73 74.1 Favored 'Cis proline' 0 C--N 1.349 0.58 0 C-N-CA 124.276 -1.135 . . . . 0.0 112.476 0.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -106.35 26.43 9.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.799 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -110.43 6.97 22.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.125 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -141.4 134.22 28.82 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-O 120.787 0.327 . . . . 0.0 110.973 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 pttt -55.38 107.03 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -116.67 124.13 48.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.716 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.404 ' CG2' ' HB1' ' B' ' 71' ' ' ALA . 0.2 OUTLIER -99.75 113.23 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.566 ' CD1' ' CD1' ' B' ' 19' ' ' PHE . 85.8 m-85 -89.86 99.44 12.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.471 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -66.73 153.43 43.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.578 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 48.1 mt -139.43 148.73 23.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.523 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.431 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 25.4 ttmt -105.03 140.54 38.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.443 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.436 HG22 ' N ' ' B' ' 34' ' ' THR . 46.1 mt -131.45 154.05 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.828 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.7 m -145.47 155.72 43.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.998 0.428 . . . . 0.0 111.208 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.897 ' HB2' HD23 ' B' ' 62' ' ' LEU . 36.1 t-20 -104.26 102.38 12.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.535 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -93.44 21.23 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.293 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.89 -122.78 4.09 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.444 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.33 -42.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.52 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -113.2 166.63 11.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -51.49 156.45 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.102 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.422 HG12 ' ND2' ' B' ' 35' ' ' ASN . 21.5 pt -143.92 174.03 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.263 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.35 100.0 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.883 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -92.01 159.4 15.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.234 0.54 . . . . 0.0 111.651 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.73 130.81 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.414 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.438 ' CG2' HG11 ' B' ' 55' ' ' VAL . 5.6 mm -100.34 141.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.912 0.387 . . . . 0.0 111.717 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -142.08 131.94 24.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.513 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.445 HG23 HG13 ' B' ' 55' ' ' VAL . 11.4 p -107.52 156.88 18.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.039 0.447 . . . . 0.0 111.316 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.541 HG23 ' HB2' ' B' ' 88' ' ' ARG . 0.0 OUTLIER -48.32 -29.02 3.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.014 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -143.57 122.82 12.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 4.9 mmt -81.77 -8.59 59.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.455 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -88.12 -41.23 13.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.889 0.376 . . . . 0.0 110.671 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -84.66 -59.59 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.778 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 5.9 mt -94.48 134.1 37.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.756 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -127.46 109.01 11.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.15 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.445 HG13 HG23 ' B' ' 47' ' ' THR . 16.1 m -68.07 156.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.071 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' B' ' 71' ' ' ALA . 32.9 t0 -169.96 113.87 0.48 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.32 149.81 92.62 Favored 'Cis proline' 0 C--N 1.351 0.667 0 C-N-CA 124.014 -1.244 . . . . 0.0 112.249 0.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.92 -15.45 20.95 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.556 2.171 . . . . 0.0 112.546 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p -179.52 153.13 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.538 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -170.46 168.17 41.24 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.696 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 26.3 t -98.7 121.12 48.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 111.011 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.897 HD23 ' HB2' ' B' ' 35' ' ' ASN . 4.6 tp -96.98 163.13 13.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.4 OUTLIER -115.36 171.08 4.85 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.29 111.32 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.571 2.181 . . . . 0.0 112.349 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp 63.04 39.87 9.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.42 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.6 OUTLIER -106.87 154.38 21.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.799 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 146.6 38.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.077 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' B' ' 33' ' ' ILE . 10.5 p -138.63 143.36 32.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.902 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 mt -86.28 151.62 23.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.413 ' CE ' HD11 ' B' ' 33' ' ' ILE . 0.7 OUTLIER -133.39 161.6 34.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.728 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' B' ' 56' ' ' ASP . . . -146.96 118.29 7.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.309 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 14.7 t -108.03 86.61 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 2.5 m -62.35 145.44 53.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.033 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.7 t -136.07 103.19 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.82 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -56.26 150.32 14.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.969 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -67.64 112.47 4.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.472 ' HE2' ' HB2' ' B' ' 79' ' ' ALA . 44.7 p90 -123.47 178.17 5.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -119.97 89.91 3.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.472 ' HB2' ' HE2' ' B' ' 77' ' ' PHE . . . -55.1 -26.74 40.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.028 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -50.61 -49.18 57.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.118 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 61.3 p -125.65 50.56 1.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.066 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.12 162.46 32.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -80.15 130.22 35.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.843 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.502 HD22 ' CE2' ' B' ' 124' ' ' TYR . 12.6 mt -125.82 52.53 1.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -112.51 -23.43 10.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.492 ' HB3' HG21 ' B' ' 48' ' ' THR . 14.9 m120 -65.64 -91.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.779 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . 0.446 ' CB ' ' HB ' ' B' ' 122' ' ' ILE . 2.1 p-10 41.51 84.59 0.02 OUTLIER 'General case' 0 C--O 1.23 0.074 0 CA-C-O 120.76 0.314 . . . . 0.0 111.564 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.541 ' HB2' HG23 ' B' ' 48' ' ' THR . 6.3 mtm-85 -167.25 135.17 2.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.643 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.805 HD11 HD11 ' B' ' 122' ' ' ILE . 29.0 mt -119.8 163.69 16.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.795 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.537 ' N ' HG22 ' B' ' 89' ' ' ILE . 21.8 m -149.5 114.79 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.939 0.4 . . . . 0.0 111.247 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.513 ' CD1' HD12 ' B' ' 120' ' ' LEU . 4.7 mp -110.47 98.88 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.861 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -103.11 137.79 40.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.832 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.1 p90 -138.97 150.29 45.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.597 ' HB ' HG13 ' B' ' 115' ' ' VAL . 4.6 t -147.7 132.07 17.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -53.19 147.62 9.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 2.8 p -98.08 142.83 25.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.18 160.62 3.14 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.428 2.085 . . . . 0.0 112.022 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -46.98 116.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.58 50.78 24.17 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.364 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.04 62.81 7.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.726 0.298 . . . . 0.0 111.562 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . 55.36 164.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.24 0.543 . . . . 0.0 111.663 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -104.48 73.7 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.644 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 178.49 147.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.887 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -65.3 150.44 48.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.59 146.84 38.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.677 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -82.1 -23.68 35.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.162 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.33 -22.17 64.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.149 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -62.98 -30.08 71.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.062 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.505 ' CE2' HG11 ' B' ' 115' ' ' VAL . 9.2 m-85 -85.31 -26.48 26.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.983 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -109.96 58.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.952 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -162.41 -138.16 2.35 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.453 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.64 146.42 23.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.819 0.342 . . . . 0.0 110.863 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.15 130.56 6.63 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.597 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 9.2 mtt -67.13 152.23 46.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.866 0.365 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.597 HG13 ' HB ' ' B' ' 94' ' ' THR . 13.7 t -128.5 128.32 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.084 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.412 ' HB2' ' HG2' ' B' ' 6' ' ' PRO . 1.2 ttt180 -96.82 152.56 18.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.604 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -145.06 130.06 18.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.042 0.449 . . . . 0.0 111.546 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 90' ' ' THR . 0.0 OUTLIER -115.78 162.73 16.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.966 179.24 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -131.96 149.19 52.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.999 0.428 . . . . 0.0 111.498 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.513 HD12 ' CD1' ' B' ' 91' ' ' ILE . 2.1 mt -143.25 98.46 5.51 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.665 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' B' ' 88' ' ' ARG . 38.0 Cg_exo -57.77 151.03 58.68 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.789 2.326 . . . . 0.0 112.642 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.805 HD11 HD11 ' B' ' 89' ' ' ILE . 43.7 mm -101.47 158.2 4.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.968 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.642 ' HB3' HG23 ' B' ' 18' ' ' VAL . 0.8 OUTLIER -140.0 153.67 46.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.891 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.502 ' CE2' HD22 ' B' ' 84' ' ' LEU . 32.1 m-85 -119.84 113.51 20.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -102.96 82.86 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 21.1 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.819 0.343 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 68.39 123.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -69.52 -55.71 9.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.718 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.548 HG23 ' HD2' ' A' ' 5' ' ' PRO . 7.4 p 179.42 138.26 0.28 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 4' ' ' VAL . 72.8 Cg_endo -77.27 166.78 25.76 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.664 2.243 . . . . 0.0 112.416 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.52 109.75 2.7 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.607 2.204 . . . . 0.0 112.226 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.45 135.75 47.63 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.505 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.2 m-20 -49.25 152.49 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.071 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 33' ' ' ILE . 11.3 pt -118.0 147.16 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.63 140.9 31.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.578 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.79 139.12 47.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.188 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -137.25 110.07 9.0 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.667 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.641 ' HB3' ' HB3' ' B' ' 21' ' ' ALA . 28.8 Cg_endo -62.54 167.52 32.84 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.672 0.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.4 m -43.08 -68.41 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.429 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.11 43.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.085 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.69 123.54 3.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.037 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.55 151.89 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.802 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 18' ' ' VAL . 7.4 p -138.61 100.15 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.39 113.2 1.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.58 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -81.21 132.87 35.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.307 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.862 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -49.08 170.11 0.14 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.857 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.862 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 72.1 Cg_endo -76.72 167.74 79.16 Favored 'Cis proline' 0 C--N 1.35 0.614 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.733 0.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.4 m-85 -115.85 31.54 6.65 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.013 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.6 6.59 37.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.271 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.556 ' N ' HG22 ' A' ' 76' ' ' THR . 11.0 m-20 -149.76 -178.57 6.53 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.795 0.331 . . . . 0.0 110.967 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.14 107.95 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.98 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -111.16 132.98 53.87 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.861 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.545 HG21 ' HB1' ' A' ' 71' ' ' ALA . 95.4 m -107.15 135.78 48.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.126 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.78 ' O ' HG12 ' A' ' 72' ' ' VAL . 6.3 m-85 -116.88 121.81 42.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.642 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.02 150.88 45.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.435 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -133.43 153.96 38.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.702 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.24 135.25 53.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.982 0.42 . . . . 0.0 111.409 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 9' ' ' ILE . 69.4 mt -145.46 121.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.669 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.3 m -118.19 153.46 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.936 0.398 . . . . 0.0 111.108 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.624 ' ND2' HD13 ' A' ' 41' ' ' ILE . 3.7 t-20 -94.54 81.68 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.95 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -63.8 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.43 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.92 -154.3 0.01 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.629 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.72 -19.33 5.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.743 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.7 mtp85 -132.61 167.16 20.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 0.0 111.009 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' HG23 ' A' ' 41' ' ' ILE . 37.6 mtp180 -49.78 164.34 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.811 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.624 HD13 ' ND2' ' A' ' 35' ' ' ASN . 31.2 pt -156.74 132.32 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.798 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 60' ' ' GLY . . . -94.13 109.48 3.83 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -99.51 159.3 15.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.127 0.489 . . . . 0.0 111.988 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.77 155.05 44.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.408 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.464 ' CG2' HG21 ' A' ' 55' ' ' VAL . 25.1 mm -117.24 132.37 67.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.895 0.379 . . . . 0.0 111.586 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 150.8 41.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.737 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 p -143.27 153.71 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -41.97 95.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.971 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.62 114.87 15.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.68 20.6 7.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -97.14 -31.69 12.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.36 . . . . 0.0 110.816 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -113.37 -19.25 11.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.3 mt -108.11 132.45 53.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.93 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.05 107.74 5.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.63 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -100.73 127.12 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.032 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.22 130.96 22.8 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.1 142.86 76.05 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.875 -1.302 . . . . 0.0 112.022 0.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.22 -31.7 43.93 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.434 2.089 . . . . 0.0 112.036 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.7 p -145.91 -177.93 5.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.495 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' O ' ' HA2' ' A' ' 42' ' ' GLY . . . 164.27 -171.0 39.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.596 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -149.31 129.47 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 110.753 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.604 HD13 HG23 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.4 153.55 43.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.141 -179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.2 p30 -90.05 168.1 15.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.934 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 32.3 Cg_exo -61.79 133.69 46.33 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.497 2.131 . . . . 0.0 112.231 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.7 tttm 77.7 12.07 1.99 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.841 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -108.51 142.98 38.11 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.187 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.27 161.21 13.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.193 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG23 HD13 ' A' ' 62' ' ' LEU . 41.8 t -135.62 141.93 40.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 mt -118.03 118.95 33.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.946 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.533 ' SD ' HD12 ' A' ' 33' ' ' ILE . 9.8 mtm -112.46 158.21 20.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.886 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' HB1' HG21 ' A' ' 28' ' ' THR . . . -126.71 102.23 6.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.22 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 29' ' ' TYR . 7.4 p -88.05 109.43 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.809 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.2 m -91.24 129.88 37.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.302 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 41.0 t -114.99 150.82 35.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.672 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.9 154.58 21.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.119 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 25' ' ' ASP . 3.9 p -58.59 161.03 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.758 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -173.53 -165.63 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.94 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 92.4 m-20 -121.92 82.86 2.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 77' ' ' PHE . . . -57.24 -22.11 38.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.216 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.49 -43.08 45.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.296 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 78.4 p -141.56 43.13 1.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.168 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 78' ' ' ASN . 19.6 mm-40 -122.52 6.5 9.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.664 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.26 140.01 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.571 HD22 ' HB2' ' A' ' 124' ' ' TYR . 2.2 mt -115.23 24.46 11.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.972 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -142.26 28.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.767 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.21 9.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.02 126.91 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.84 139.63 26.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.975 0.417 . . . . 0.0 111.196 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.5 mt -107.35 122.36 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.615 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 118' ' ' LYS . 68.0 m -110.56 118.66 36.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.487 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.15 154.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.791 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -149.71 101.72 3.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.512 ' NE1' HG23 ' A' ' 9' ' ' ILE . 15.1 p90 -122.14 137.9 54.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.997 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.732 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.8 OUTLIER -134.37 148.97 50.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.029 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -60.22 144.16 50.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.968 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -85.77 150.89 54.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.028 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 39.3 Cg_endo -67.04 163.63 33.22 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.5 2.133 . . . . 0.0 112.059 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -47.18 116.45 1.39 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.355 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.21 46.64 56.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.688 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.688 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -65.13 150.65 47.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.773 0.321 . . . . 0.0 111.113 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.41 165.03 1.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.142 0.496 . . . . 0.0 111.282 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -89.9 71.33 7.56 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.621 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.02 140.78 0.24 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.913 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -60.05 120.21 9.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HG2' ' HG2' ' A' ' 107' ' ' GLU . 0.9 OUTLIER -101.16 156.16 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.024 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.77 -27.16 16.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.434 ' HG2' ' HG2' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -65.16 -18.22 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.339 -179.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.85 -16.25 57.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.428 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.46 ' N ' ' CD1' ' A' ' 109' ' ' PHE . 2.5 m-85 -125.67 50.71 1.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.826 0.346 . . . . 0.0 111.082 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 0.0 OUTLIER -133.04 24.65 4.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.97 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.26 -171.29 12.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.1 146.27 29.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.764 0.316 . . . . 0.0 110.631 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.14 179.17 25.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.273 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.596 ' C ' HG23 ' A' ' 115' ' ' VAL . 2.9 mtt 59.3 162.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.03 0.443 . . . . 0.0 110.883 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.732 HG13 ' HB ' ' A' ' 94' ' ' THR . 3.3 t 81.76 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.118 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.28 26.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.773 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.76 139.39 46.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.004 0.43 . . . . 0.0 111.174 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 90' ' ' THR . 26.0 mtpp -125.37 166.77 15.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.489 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -121.69 152.05 39.8 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -141.31 88.56 9.93 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.669 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.15 141.8 47.29 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.566 2.177 . . . . 0.0 112.633 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.37 138.42 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.817 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 18' ' ' VAL . 1.6 mm-40 -131.62 159.18 39.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.027 0.441 . . . . 0.0 111.264 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.571 ' HB2' HD22 ' A' ' 84' ' ' LEU . 97.7 m-85 -122.8 113.07 18.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.082 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' A' ' 23' ' ' TYR . 60.4 t30 -95.15 90.57 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' A' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.846 0.355 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 68.51 123.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -69.58 -55.66 9.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.722 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.561 HG23 ' HD2' ' B' ' 5' ' ' PRO . 7.4 p 179.33 138.24 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.079 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.561 ' HD2' HG23 ' B' ' 4' ' ' VAL . 71.7 Cg_endo -77.25 166.78 25.78 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.613 2.209 . . . . 0.0 112.37 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.45 109.75 2.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.508 2.139 . . . . 0.0 112.33 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.38 135.8 47.8 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.554 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 2.1 m-20 -49.31 152.45 1.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.351 . . . . 0.0 111.017 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.585 HD12 HG23 ' B' ' 33' ' ' ILE . 11.2 pt -117.99 147.2 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.228 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -83.66 140.82 31.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.555 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.63 139.53 47.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.035 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -137.62 109.99 8.73 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.561 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.564 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 28.7 Cg_endo -62.46 167.29 33.23 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.996 -1.252 . . . . 0.0 112.636 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 6.3 m -43.01 -68.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.469 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.24 43.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.08 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -159.63 123.19 3.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.081 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.19 151.68 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.61 HG13 ' O ' ' B' ' 18' ' ' VAL . 7.4 p -138.36 100.13 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.602 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -53.38 113.19 1.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.592 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . 0.401 HD21 HG13 ' A' ' 18' ' ' VAL . 6.6 m-80 -81.06 132.73 35.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.315 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.856 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -49.15 170.12 0.14 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.856 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.6 Cg_endo -76.71 167.84 78.86 Favored 'Cis proline' 0 C--N 1.35 0.628 0 C-N-CA 123.898 -1.293 . . . . 0.0 112.699 0.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.5 m-85 -115.87 31.49 6.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.031 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.63 6.65 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.3 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . 0.559 ' N ' HG22 ' B' ' 76' ' ' THR . 11.2 m-20 -149.78 -178.69 6.6 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.75 0.31 . . . . 0.0 110.929 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? -96.07 108.08 20.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.942 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -111.43 132.78 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.766 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . 0.54 HG21 ' HB1' ' B' ' 71' ' ' ALA . 94.9 m -106.89 135.96 47.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.785 ' O ' HG12 ' B' ' 72' ' ' VAL . 6.5 m-85 -116.91 122.09 43.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -71.29 150.85 44.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.443 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 15.0 mt -133.48 153.8 37.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.662 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.09 135.32 53.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.439 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.585 HG23 HD12 ' B' ' 9' ' ' ILE . 68.5 mt -145.48 121.28 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.73 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.6 m -118.32 153.47 33.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.922 0.391 . . . . 0.0 111.084 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.63 ' ND2' HD13 ' B' ' 41' ' ' ILE . 3.8 t-20 -94.52 81.63 3.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.944 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -63.74 -15.91 59.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.473 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.04 -154.19 0.01 OUTLIER Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.574 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.84 -19.43 5.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.639 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 29.8 mtp85 -132.72 167.29 20.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.909 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.402 ' O ' HG23 ' B' ' 41' ' ' ILE . 37.8 mtp180 -49.86 164.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.63 HD13 ' ND2' ' B' ' 35' ' ' ASN . 31.3 pt -156.6 132.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.899 0.38 . . . . 0.0 111.746 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.01 109.22 3.78 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.475 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -99.46 159.22 15.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.241 0.543 . . . . 0.0 111.899 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.7 155.08 44.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.431 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' HG21 ' B' ' 55' ' ' VAL . 25.4 mm -117.24 132.4 67.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.928 0.394 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.07 150.65 41.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.809 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 31.5 p -143.16 153.75 43.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.008 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -60.6 -42.01 95.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -131.61 114.85 15.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.64 20.68 7.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.139 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . 0.401 ' HG3' ' HG2' ' B' ' 52' ' ' ARG . 3.4 ptp180 -97.21 -31.58 12.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.401 ' HG2' ' HG3' ' B' ' 51' ' ' ARG . 1.4 ptt180 -113.38 -19.34 11.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -108.06 132.51 53.48 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 110.934 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.09 107.57 5.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.049 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -100.56 127.14 53.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.951 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -131.32 130.96 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.16 142.76 75.74 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.001 0.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.11 -31.87 44.53 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.491 2.127 . . . . 0.0 111.97 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.6 p -145.75 -177.98 5.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.424 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 164.26 -170.89 39.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.601 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.37 129.47 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.589 HD13 HG23 ' B' ' 68' ' ' VAL . 1.0 OUTLIER -125.45 153.57 43.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 111.193 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.2 p30 -90.2 168.0 15.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.836 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 30.9 Cg_exo -61.71 133.71 46.66 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.455 2.103 . . . . 0.0 112.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 31.8 tttm 77.53 12.42 2.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.882 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 1.2 tp10 -108.73 142.96 38.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.848 0.356 . . . . 0.0 110.12 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -98.19 161.24 13.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.183 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.589 HG23 HD13 ' B' ' 62' ' ' LEU . 41.5 t -135.61 141.65 41.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.097 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 mt -117.78 118.99 33.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.016 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.547 ' SD ' HD12 ' B' ' 33' ' ' ILE . 9.7 mtm -112.53 158.07 20.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.54 ' HB1' HG21 ' B' ' 28' ' ' THR . . . -126.63 102.12 6.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.284 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.785 HG12 ' O ' ' B' ' 29' ' ' TYR . 7.3 p -87.88 109.56 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.926 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 43.0 m -91.32 130.06 37.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.22 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 41.1 t -115.09 150.9 35.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.681 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.98 154.66 21.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.059 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.559 HG22 ' N ' ' B' ' 25' ' ' ASP . 3.7 p -58.67 160.87 5.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' B' ' 79' ' ' ALA . 0.7 OUTLIER -173.38 -165.59 0.28 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 92.4 m-20 -121.91 82.77 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.509 ' HB2' ' CZ ' ' B' ' 77' ' ' PHE . . . -57.26 -22.12 39.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.232 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.56 -42.84 45.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.335 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.1 p -141.72 43.16 1.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' B' ' 78' ' ' ASN . 19.8 mm-40 -122.58 6.29 9.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.627 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 2.5 t0 64.41 140.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' B' ' 124' ' ' TYR . 2.2 mt -115.52 24.31 11.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -142.01 28.33 1.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.73 -29.12 9.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -87.06 126.86 35.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.82 139.79 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.143 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 78.2 mt -107.65 122.16 61.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.631 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.489 HG23 ' O ' ' B' ' 118' ' ' LYS . 64.0 m -110.17 118.77 37.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.369 . . . . 0.0 111.512 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 5.7 mm -82.38 154.19 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -149.7 101.7 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.039 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.506 ' NE1' HG23 ' B' ' 9' ' ' ILE . 15.3 p90 -122.17 137.77 54.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.034 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.718 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.8 OUTLIER -134.26 149.2 50.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.004 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.46 143.99 52.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 70.7 p -85.59 150.89 54.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . 0.681 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 39.8 Cg_endo -67.03 163.54 33.54 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.63 2.22 . . . . 0.0 111.996 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -47.1 116.53 1.4 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.23 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.12 46.56 56.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.78 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.681 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -65.01 150.69 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.795 0.331 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.48 164.96 1.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.069 0.462 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 mttp -89.78 71.24 7.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.649 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.99 140.73 0.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.827 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -59.84 120.22 9.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.419 ' HG2' ' HG2' ' B' ' 107' ' ' GLU . 0.9 OUTLIER -101.22 156.2 17.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.053 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 ttt85 -93.94 -26.86 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.996 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' B' ' 105' ' ' ARG . 0.0 OUTLIER -65.3 -18.39 65.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.303 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -62.6 -16.39 56.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.405 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' B' ' 109' ' ' PHE . 2.4 m-85 -125.67 50.73 1.8 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.673 0.273 . . . . 0.0 111.05 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' B' ' 107' ' ' GLU . 0.0 OUTLIER -133.03 24.52 4.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.988 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -132.21 -171.31 12.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.481 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.93 146.26 29.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.81 0.338 . . . . 0.0 110.673 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.09 179.27 25.32 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.348 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.597 ' C ' HG23 ' B' ' 115' ' ' VAL . 2.9 mtt 59.23 162.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.961 0.41 . . . . 0.0 110.958 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.718 HG13 ' HB ' ' B' ' 94' ' ' THR . 3.3 t 81.72 117.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.53 148.08 26.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.851 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -133.45 139.55 46.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.994 0.426 . . . . 0.0 111.199 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.489 ' O ' HG23 ' B' ' 90' ' ' THR . 25.9 mtpp -125.43 166.72 16.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.595 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -121.77 151.78 40.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.076 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mp -140.99 88.56 10.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.17 141.49 48.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.632 2.222 . . . . 0.0 112.607 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 mm -107.09 138.36 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.752 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.597 ' C ' HG23 ' B' ' 18' ' ' VAL . 1.6 mm-40 -131.68 159.06 39.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 111.256 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.578 ' HB2' HD22 ' B' ' 84' ' ' LEU . 97.5 m-85 -122.78 113.04 18.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.095 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.407 ' N ' ' OH ' ' B' ' 23' ' ' TYR . 60.4 t30 -95.03 90.58 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 ' CE2' ' B' ' 23' ' ' TYR . 10.9 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.017 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.13 84.5 0.15 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.997 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -152.81 140.4 19.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.851 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 4' ' ' VAL . 31.1 m -135.44 115.19 11.58 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.095 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.29 160.33 3.5 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.369 2.046 . . . . 0.0 112.35 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.9 123.18 8.74 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.557 2.171 . . . . 0.0 112.301 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.69 138.32 46.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.509 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 11.3 m-20 -59.03 130.65 48.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.855 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.27 120.34 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.225 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.69 146.75 24.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.631 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.78 153.44 49.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.888 0.375 . . . . 0.0 111.218 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 31' ' ' ILE . 7.1 mt-30 -144.85 108.94 4.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.0 165.18 37.32 Favored 'Cis proline' 0 C--N 1.351 0.704 0 C-N-CA 123.842 -1.316 . . . . 0.0 112.664 0.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -45.13 -59.61 2.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.934 ' HA ' HD22 ' A' ' 120' ' ' LEU . 22.9 pt20 -170.9 45.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.15 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -178.52 132.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 111.172 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.449 HD11 ' CD1' ' A' ' 29' ' ' TYR . 18.7 tt -132.28 153.85 39.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 125' ' ' ASN . 57.1 t -120.78 92.2 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.732 0.301 . . . . 0.0 111.674 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.14 95.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.283 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.81 139.39 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.579 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.913 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -76.56 175.23 4.58 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.586 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.913 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 40.6 Cg_endo -66.7 165.58 64.44 Favored 'Cis proline' 0 C--N 1.351 0.675 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.683 0.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.63 43.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.937 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -123.06 7.21 9.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.323 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.17 142.14 48.48 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 110.946 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -65.3 115.63 5.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.05 103.3 10.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.797 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -84.76 102.47 13.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.449 ' CD1' HD11 ' A' ' 17' ' ' ILE . 93.5 m-85 -89.48 117.91 28.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.659 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -89.39 135.43 33.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 12' ' ' GLN . 22.5 mt -119.98 133.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.698 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -97.93 139.18 34.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.913 0.387 . . . . 0.0 111.342 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -133.02 146.22 32.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.652 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 55.4 m -150.09 156.53 41.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 0.0 111.212 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' HB2' HD23 ' A' ' 62' ' ' LEU . 18.4 t30 -97.89 111.07 23.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.727 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.51 19.45 6.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.396 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.21 -140.49 9.3 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.566 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.44 53.19 0.47 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.538 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.4 mtp180 -175.97 177.12 1.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.93 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.445 ' HG2' ' CG1' ' A' ' 61' ' ' VAL . 25.5 ttm-85 -77.61 151.15 34.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.948 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 62' ' ' LEU . 4.3 pt -146.58 167.47 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.046 0.45 . . . . 0.0 111.38 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -132.64 106.14 0.63 Allowed Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.585 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 34.5 p-90 -104.42 160.41 14.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.259 0.552 . . . . 0.0 111.75 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 104' ' ' PHE . . . -157.65 143.11 17.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.461 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.426 HD12 HG13 ' A' ' 91' ' ' ILE . 14.3 mm -99.4 154.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.008 0.432 . . . . 0.0 111.634 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.53 132.08 15.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.4 149.7 42.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.0 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.77 -32.14 69.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.758 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.96 109.21 11.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.732 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.69 24.88 5.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.013 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.54 -55.38 2.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.23 -28.23 27.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.6 mt -94.46 156.69 16.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.982 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.44 141.33 28.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.935 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.2 p -139.21 161.07 28.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.232 0.539 . . . . 0.0 110.966 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -176.49 131.06 0.37 Allowed Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.813 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.17 148.71 92.58 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.793 -1.336 . . . . 0.0 112.186 0.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.6 -12.8 24.76 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.599 2.2 . . . . 0.0 112.847 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.54 172.75 0.72 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.45 174.48 38.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.449 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG1' ' HG2' ' A' ' 40' ' ' ARG . 21.7 t -107.12 114.42 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.0 111.102 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 35' ' ' ASN . 3.7 tp -87.53 169.54 12.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.072 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.412 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -129.89 176.3 2.94 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.792 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 32.6 Cg_exo -61.24 114.45 2.21 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.633 2.222 . . . . 0.0 112.291 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.69 32.28 13.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.098 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.403 ' HG3' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -97.9 148.0 23.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -113.53 156.2 24.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.108 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.84 144.76 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.04 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.51 137.07 35.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.035 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.0 158.76 34.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.33 147.03 35.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.187 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -142.03 91.0 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.895 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -82.77 151.67 26.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.48 116.61 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.11 142.78 58.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 p -56.55 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -133.43 -168.89 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -121.31 119.8 33.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.915 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.547 ' HB1' HD11 ' A' ' 84' ' ' LEU . . . -98.46 18.92 15.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.47 -24.44 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.229 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.3 p -143.1 41.63 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.036 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -138.33 159.59 41.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.653 ' O ' HD23 ' A' ' 84' ' ' LEU . 22.6 t0 -89.2 134.19 34.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 83' ' ' ASP . 8.9 mt -123.62 56.09 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.48 25.22 0.78 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -134.02 6.58 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.637 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -93.57 108.21 19.95 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.812 0.339 . . . . 0.0 110.824 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.08 136.1 26.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.101 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.805 HG13 HD11 ' A' ' 122' ' ' ILE . 12.8 mt -94.87 163.83 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.5 ' N ' HG22 ' A' ' 89' ' ' ILE . 10.0 m -144.87 123.96 12.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 111.128 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.551 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.1 mp -115.51 98.1 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.047 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -101.85 136.93 40.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.675 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' ' 116' ' ' ARG . 6.6 p90 -145.52 143.69 30.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.882 0.372 . . . . 0.0 111.161 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.4 t -141.46 143.48 33.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.78 122.48 14.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.797 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.582 HG22 ' CH2' ' A' ' 108' ' ' TRP . 12.0 p -52.93 145.05 24.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.674 ' HG2' ' HB2' ' A' ' 100' ' ' ALA . 37.1 Cg_endo -65.79 160.53 43.31 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.534 2.156 . . . . 0.0 112.292 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.4 119.16 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.7 41.5 97.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.763 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.674 ' HB2' ' HG2' ' A' ' 97' ' ' PRO . . . -71.33 139.57 49.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 111.073 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.8 164.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 0.0 111.403 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.7 70.32 7.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.45 131.55 0.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.73 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 44' ' ' ALA . 73.5 t80 -51.25 152.01 2.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.005 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.33 152.09 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -91.77 -23.71 19.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.069 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -18.91 65.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.39 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CH2' HG22 ' A' ' 96' ' ' THR . 34.6 m0 -60.18 -16.14 30.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.276 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -126.34 40.22 3.77 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.819 0.342 . . . . 0.0 110.89 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.71 28.51 8.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.07 -179.16 40.37 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.04 156.28 27.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.952 0.406 . . . . 0.0 110.918 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.65 81.01 0.32 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.622 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.2 mmt 55.05 106.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.774 0.321 . . . . 0.0 111.074 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.2 p 176.84 115.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.446 ' HB3' ' CZ3' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -102.23 154.14 19.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -139.73 96.82 3.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.029 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.34 162.42 18.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.648 ' C ' HD23 ' A' ' 120' ' ' LEU . 67.2 m-80 -140.56 126.52 19.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.934 HD22 ' HA ' ' A' ' 15' ' ' GLN . 1.4 mt -110.85 100.52 46.53 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.42 144.13 74.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.604 2.203 . . . . 0.0 112.529 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.805 HD11 HG13 ' A' ' 89' ' ' ILE . 8.2 mm -110.53 93.64 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.194 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.68 140.81 32.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.059 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD2' HD13 ' A' ' 84' ' ' LEU . 21.3 m-85 -103.7 104.43 14.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.046 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.524 ' HB2' HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -78.66 82.45 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.845 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.892 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.812 0.339 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.11 84.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -152.81 140.44 19.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.768 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.532 HG23 ' O ' ' B' ' 4' ' ' VAL . 31.3 m -135.6 114.99 11.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.053 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -52.17 160.36 3.35 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.397 2.065 . . . . 0.0 112.303 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.02 123.27 8.76 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.58 2.186 . . . . 0.0 112.286 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.7 138.33 46.66 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.567 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.512 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 11.5 m-20 -58.95 130.75 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.798 0.332 . . . . 0.0 110.839 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pt -93.37 120.51 42.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.85 146.89 24.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.537 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.93 153.3 49.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.204 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.612 ' O ' HG23 ' B' ' 31' ' ' ILE . 7.2 mt-30 -144.72 108.99 4.77 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.636 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.07 165.17 37.76 Favored 'Cis proline' 0 C--N 1.351 0.69 0 C-N-CA 123.964 -1.265 . . . . 0.0 112.611 0.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -45.02 -59.55 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.435 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.942 ' HA ' HD22 ' B' ' 120' ' ' LEU . 22.9 pt20 -170.95 44.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.148 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -178.49 132.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.962 0.41 . . . . 0.0 111.254 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.439 HD11 ' CD1' ' B' ' 29' ' ' TYR . 18.5 tt -132.25 154.0 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.721 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' B' ' 125' ' ' ASN . 57.5 t -120.98 92.38 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.812 0.339 . . . . 0.0 111.579 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -57.21 95.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.277 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.581 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.931 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -76.49 175.28 4.51 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.615 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.931 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 40.2 Cg_endo -66.51 165.73 62.55 Favored 'Cis proline' 0 C--N 1.349 0.585 0 C-N-CA 123.951 -1.271 . . . . 0.0 112.786 -0.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -108.9 43.69 1.23 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.959 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -122.89 6.98 9.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.361 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -133.0 142.06 48.63 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.849 0.357 . . . . 0.0 110.972 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -65.16 115.44 5.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -115.91 103.16 10.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.749 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 28.3 m -84.53 102.37 12.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.083 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.439 ' CD1' HD11 ' B' ' 17' ' ' ILE . 93.8 m-85 -89.51 117.87 28.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.725 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -89.26 135.36 33.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.332 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.612 HG23 ' O ' ' B' ' 12' ' ' GLN . 22.6 mt -119.93 133.12 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.681 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -97.99 138.96 34.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.38 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 16.0 mt -132.9 146.31 32.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 55.1 m -150.13 156.41 41.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.995 0.426 . . . . 0.0 111.276 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.537 ' HB2' HD23 ' B' ' 62' ' ' LEU . 18.4 t30 -97.71 111.08 23.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.74 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.51 19.34 6.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.421 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.2 -140.26 9.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.492 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.6 53.16 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.464 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -175.92 177.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.84 0.352 . . . . 0.0 110.944 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.448 ' HG2' ' CG1' ' B' ' 61' ' ' VAL . 25.9 ttm-85 -77.66 151.17 34.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.438 ' O ' HG13 ' B' ' 61' ' ' VAL . 4.3 pt -146.66 167.37 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.418 . . . . 0.0 111.428 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -132.56 106.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.568 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 34.0 p-90 -104.53 160.57 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 111.703 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' B' ' 104' ' ' PHE . . . -157.87 142.92 16.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.461 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.423 HD12 HG13 ' B' ' 91' ' ' ILE . 14.2 mm -99.11 154.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.953 0.406 . . . . 0.0 111.694 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.75 131.94 15.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.586 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 8.9 p -121.25 149.57 42.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.066 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -58.6 -32.33 68.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.723 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -128.75 109.18 11.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.66 24.71 5.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.39 -55.3 2.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -84.36 -28.24 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 93.8 mt -94.33 156.64 16.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.005 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.5 141.36 28.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.491 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.2 p -139.29 160.96 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.197 0.522 . . . . 0.0 111.004 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . 0.491 ' N ' HG22 ' B' ' 55' ' ' VAL . 0.5 OUTLIER -176.43 131.08 0.38 Allowed Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.826 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.17 148.6 92.31 Favored 'Cis proline' 0 C--N 1.352 0.731 0 C-N-CA 123.691 -1.379 . . . . 0.0 112.314 -0.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.49 -12.63 24.94 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.617 2.211 . . . . 0.0 112.916 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.5 p 178.37 172.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.844 0.354 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 170.33 174.4 38.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.556 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.448 ' CG1' ' HG2' ' B' ' 40' ' ' ARG . 21.7 t -106.99 114.64 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.066 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' B' ' 35' ' ' ASN . 3.7 tp -87.78 169.35 12.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.408 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.3 OUTLIER -129.76 176.26 2.97 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.866 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 34.2 Cg_exo -61.17 114.4 2.18 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.665 2.244 . . . . 0.0 112.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt 63.72 32.27 13.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -97.79 148.2 23.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.932 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -113.69 156.27 24.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.998 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.93 144.72 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.106 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -95.52 137.1 35.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.08 158.83 34.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.829 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.43 146.76 35.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 47.8 t -141.78 90.92 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 30.2 t -82.76 151.47 26.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 p -135.32 116.48 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.86 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -64.07 142.76 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -56.58 128.07 34.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.914 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.39 -168.8 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.02 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -121.45 119.71 32.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' B' ' 84' ' ' LEU . . . -98.35 18.93 15.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.38 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.53 -24.47 20.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.849 0.357 . . . . 0.0 111.151 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.8 p -143.14 41.8 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.145 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -138.54 159.47 42.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.644 ' O ' HD23 ' B' ' 84' ' ' LEU . 22.6 t0 -89.1 134.06 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.644 HD23 ' O ' ' B' ' 83' ' ' ASP . 9.0 mt -123.45 55.98 1.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -150.44 25.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -133.76 6.33 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.687 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.54 108.05 19.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.797 0.332 . . . . 0.0 110.864 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -144.0 136.27 26.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.03 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.813 HG13 HD11 ' B' ' 122' ' ' ILE . 12.6 mt -94.93 163.92 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.494 ' N ' HG22 ' B' ' 89' ' ' ILE . 9.7 m -144.95 123.89 12.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.109 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.1 mp -115.51 98.05 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.007 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.77 136.94 40.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.7 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.451 ' CZ3' ' HB3' ' B' ' 116' ' ' ARG . 6.7 p90 -145.53 143.7 30.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.144 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 2.5 t -141.49 143.51 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -60.82 122.38 14.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.576 HG22 ' CH2' ' B' ' 108' ' ' TRP . 12.0 p -52.76 144.94 23.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . 0.659 ' HG2' ' HB2' ' B' ' 100' ' ' ALA . 37.2 Cg_endo -65.81 160.67 42.72 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.617 2.211 . . . . 0.0 112.22 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -49.43 119.1 3.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.085 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 59.66 41.92 97.63 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.587 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.659 ' HB2' ' HG2' ' B' ' 97' ' ' PRO . . . -71.63 139.7 49.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.746 0.308 . . . . 0.0 111.048 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.09 164.21 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.113 0.482 . . . . 0.0 111.342 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.55 70.46 7.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.651 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.51 131.5 0.16 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.787 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' B' ' 44' ' ' ALA . 74.1 t80 -51.21 151.98 2.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -136.21 152.26 50.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -92.21 -23.49 19.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.056 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -19.0 65.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.348 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.576 ' CH2' HG22 ' B' ' 96' ' ' THR . 34.0 m0 -60.09 -16.36 31.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.213 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -126.25 40.55 3.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.884 0.374 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 28.43 8.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.761 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.08 -179.09 40.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.596 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.07 156.16 27.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.912 0.387 . . . . 0.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.66 81.04 0.32 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.585 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 5.1 mmt 55.16 106.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.816 0.341 . . . . 0.0 110.978 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.521 HG13 ' O ' ' B' ' 115' ' ' VAL . 7.2 p 176.72 115.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.451 ' HB3' ' CZ3' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -102.33 154.21 19.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.816 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -139.71 96.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.032 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 162.52 18.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.895 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.649 ' C ' HD23 ' B' ' 120' ' ' LEU . 67.2 m-80 -140.59 126.63 19.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.031 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.942 HD22 ' HA ' ' B' ' 15' ' ' GLN . 1.4 mt -110.98 100.53 46.98 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.4 144.15 73.94 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.565 2.177 . . . . 0.0 112.425 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.813 HD11 HG13 ' B' ' 89' ' ' ILE . 8.3 mm -110.49 93.71 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.195 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.78 141.06 32.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.0 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.406 ' CD2' HD13 ' B' ' 84' ' ' LEU . 21.3 m-85 -103.9 104.43 14.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.137 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.516 ' HB2' HG12 ' B' ' 18' ' ' VAL . 1.0 OUTLIER -78.8 82.38 5.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.889 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.896 -179.917 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.796 0.332 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -118.89 79.46 1.4 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.31 173.07 6.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.831 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 2.2 m -137.97 129.31 15.93 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.173 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 4' ' ' VAL . 44.3 Cg_exo -56.62 172.11 0.8 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.519 2.146 . . . . 0.0 112.215 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.97 119.2 5.9 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.594 2.196 . . . . 0.0 112.284 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.64 131.6 40.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.757 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 5.8 m-20 -48.5 113.28 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 1.2 pt -85.12 124.64 40.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.072 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -67.7 138.09 56.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.831 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.52 153.37 51.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.48 102.49 4.66 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.853 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.44 ' HG3' ' HB ' ' A' ' 17' ' ' ILE . 20.2 Cg_endo -60.18 157.51 46.39 Favored 'Cis proline' 0 C--N 1.35 0.632 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.311 -0.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.59 -10.82 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.763 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.05 -61.5 1.67 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.909 0.385 . . . . 0.0 111.069 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 13' ' ' PRO . 7.2 mttm -143.86 175.19 10.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.236 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' ILE . 19.5 tt -148.11 123.16 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.729 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 123' ' ' GLU . 44.8 t -113.41 118.01 56.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.457 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 29' ' ' TYR . 48.4 m-85 -77.12 96.03 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.48 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -70.36 131.95 44.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.535 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.745 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -58.39 169.19 1.04 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.736 179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.745 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 67.8 Cg_endo -89.1 160.27 38.72 Favored 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.296 -1.127 . . . . 0.0 112.803 0.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.411 ' OH ' ' HB2' ' A' ' 19' ' ' PHE . 32.6 m-85 -97.88 46.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.924 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' HB ' ' A' ' 76' ' ' THR . 11.1 t70 -132.7 9.0 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.43 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.34 -5.87 7.7 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.59 134.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.798 0.332 . . . . 0.0 110.585 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.417 ' CD2' ' N ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -153.32 101.27 2.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.141 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.2 m -75.12 102.71 5.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.641 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 36.9 m-85 -74.09 116.06 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.21 121.09 35.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.957 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.614 HD12 ' HE3' ' A' ' 70' ' ' MET . 64.7 mt -104.47 126.79 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.006 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.38 124.69 36.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.499 HD11 ' CE ' ' A' ' 70' ' ' MET . 13.5 mt -119.29 158.12 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.019 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 33' ' ' ILE . 55.3 m -162.0 153.07 17.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.119 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -95.87 108.79 21.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.628 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -93.34 22.11 5.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.87 -147.29 20.54 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.569 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.71 -25.38 2.86 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.686 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -122.85 167.45 13.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 110.99 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.43 162.34 3.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.553 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.47 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 8.3 pt -150.24 137.86 13.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.894 0.378 . . . . 0.0 111.828 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.47 111.21 4.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.599 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.439 ' CD1' ' CD2' ' A' ' 62' ' ' LEU . 27.5 p-90 -105.22 157.86 16.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.116 0.484 . . . . 0.0 111.772 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.65 148.89 33.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.547 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.47 HD13 HG23 ' A' ' 91' ' ' ILE . 15.5 mm -121.67 150.58 24.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.982 0.42 . . . . 0.0 111.717 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -151.75 135.93 16.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.681 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.36 154.53 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.2 p -62.42 -32.67 73.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.014 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.15 108.23 13.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.962 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.09 25.12 9.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.765 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.07 -38.11 6.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.775 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.29 -32.01 7.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.755 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.82 118.33 36.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.673 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.6 m -122.15 106.8 11.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.91 154.15 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.21 129.88 0.55 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.171 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 10.3 Cg_exo -71.56 131.67 22.12 Favored 'Cis proline' 0 C--N 1.351 0.66 0 C-N-CA 123.942 -1.274 . . . . 0.0 111.88 -0.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 32.0 Cg_exo -58.23 -48.43 15.9 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.407 2.071 . . . . 0.0 112.051 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.3 p -135.96 -178.84 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.53 -168.22 33.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.64 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.9 t -144.75 142.8 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.7 0.286 . . . . 0.0 110.97 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -134.04 136.91 44.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.033 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -64.77 -179.66 0.32 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.968 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 29.6 Cg_exo -61.52 116.18 3.25 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.585 2.19 . . . . 0.0 112.435 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.52 29.8 2.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.435 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' CB ' ' HB2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -90.53 153.26 20.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.763 0.316 . . . . 0.0 110.636 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -115.29 142.57 46.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.264 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.3 129.82 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.775 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -84.74 141.19 30.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.614 ' HE3' HD12 ' A' ' 31' ' ' ILE . 36.4 ttp -127.58 158.04 38.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.601 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -139.88 151.05 45.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.391 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.7 84.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.015 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.67 133.74 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 87.86 2.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.807 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.28 152.67 2.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 2.7 p -66.87 117.64 9.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.004 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -137.9 -163.99 1.54 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.62 139.04 43.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.712 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.56 18.64 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.509 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.65 -26.33 15.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.1 p -150.02 47.86 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -138.29 165.82 25.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.15 127.0 18.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.5 84.43 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.997 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.53 25.16 7.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.178 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 73.27 93.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.8 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -70.37 147.61 49.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.78 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -142.35 137.37 30.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.418 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 78.8 mt -110.32 94.6 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.988 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.664 HG23 ' OD1' ' A' ' 119' ' ' ASN . 0.2 OUTLIER -78.2 140.24 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 45' ' ' ILE . 3.9 mp -132.96 111.16 16.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.006 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.91 124.43 50.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.027 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 11.7 p90 -133.5 142.08 48.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.923 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.678 ' HB ' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -141.3 144.99 34.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.053 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -60.74 131.36 50.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.843 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 p -73.61 142.45 80.8 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -51.01 162.74 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.475 2.116 . . . . 0.0 112.16 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -48.44 118.31 2.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.95 45.65 70.72 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.265 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.75 167.71 7.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.799 0.333 . . . . 0.0 111.211 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.11 163.67 27.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.34 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.44 69.83 8.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.13 146.79 0.18 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.967 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -69.8 116.72 10.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.99 155.14 18.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.995 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -84.01 -26.04 29.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -22.66 66.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -59.35 -17.7 31.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.581 ' CZ ' HG22 ' A' ' 94' ' ' THR . 2.7 m-85 -124.85 38.63 4.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.874 0.369 . . . . 0.0 110.801 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -117.71 35.25 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.921 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.7 174.63 24.06 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.638 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.8 140.2 32.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.341 . . . . 0.0 110.589 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.41 172.28 44.77 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.25 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.538 ' C ' HG23 ' A' ' 115' ' ' VAL . 0.0 OUTLIER 58.82 164.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 110.904 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 94' ' ' THR . 5.1 t 82.55 129.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.252 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.472 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 5.7 tpt180 -106.83 144.27 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.675 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -134.04 103.5 5.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.92 131.49 55.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.544 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.664 ' OD1' HG23 ' A' ' 90' ' ' THR . 1.5 m-80 -100.17 143.36 30.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.253 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.9 94.98 42.96 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.506 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.13 139.2 62.8 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.632 2.221 . . . . 0.0 112.58 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 7.6 mm -114.51 111.9 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.767 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.705 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -112.96 127.91 56.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -89.39 107.4 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.829 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.27 76.89 9.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 57.4 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.946 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.745 0.307 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -118.81 79.38 1.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.27 173.14 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.803 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -137.96 129.4 15.98 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.73 172.23 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.469 2.113 . . . . 0.0 112.149 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.1 119.33 6.13 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.566 2.177 . . . . 0.0 112.256 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.67 131.4 40.59 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.293 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.749 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 5.8 m-20 -48.13 113.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.838 0.352 . . . . 0.0 111.019 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.469 ' CG2' ' CD1' ' B' ' 41' ' ' ILE . 1.2 pt -85.13 124.54 40.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -67.65 138.1 56.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.782 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.43 153.34 51.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.4 102.4 4.7 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.433 ' HG3' ' HB ' ' B' ' 17' ' ' ILE . 19.1 Cg_endo -60.12 157.71 45.69 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.777 -1.343 . . . . 0.0 112.222 0.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.73 -10.78 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.729 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -118.06 -61.58 1.66 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.886 0.374 . . . . 0.0 111.125 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' B' ' 13' ' ' PRO . 7.5 mttm -143.8 174.96 10.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.232 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.454 HG23 ' O ' ' B' ' 17' ' ' ILE . 19.5 tt -147.94 123.23 2.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.698 HG13 ' O ' ' B' ' 123' ' ' GLU . 44.4 t -113.49 117.96 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.53 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.461 ' CE2' ' CD1' ' B' ' 29' ' ' TYR . 48.3 m-85 -77.08 95.98 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.531 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -70.28 131.84 44.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.629 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.766 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -58.39 169.24 1.03 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.68 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.766 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 67.7 Cg_endo -89.12 160.23 38.62 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 124.307 -1.122 . . . . 0.0 112.712 0.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' B' ' 19' ' ' PHE . 32.5 m-85 -97.92 46.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.882 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' HB ' ' B' ' 76' ' ' THR . 11.1 t70 -132.87 8.98 4.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.345 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.26 -5.97 7.74 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.68 134.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.768 0.318 . . . . 0.0 110.596 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.39 101.35 2.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.069 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 13.5 m -75.24 102.75 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.555 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.461 ' CD1' ' CE2' ' B' ' 19' ' ' PHE . 36.9 m-85 -74.17 116.0 14.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' B' ' 70' ' ' MET . 12.2 m80 -94.18 121.02 35.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.621 HD12 ' HE3' ' B' ' 70' ' ' MET . 64.3 mt -104.37 126.85 59.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.059 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -92.45 124.8 36.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.005 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.508 HD11 ' CE ' ' B' ' 70' ' ' MET . 13.7 mt -119.35 158.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.953 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.435 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.9 m -162.0 153.17 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.091 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -95.99 108.91 21.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.531 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -93.44 22.03 5.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.147 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.78 -147.46 20.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.573 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.59 -25.36 2.89 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.685 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.407 ' HA ' ' HG3' ' B' ' 64' ' ' PRO . 0.0 OUTLIER -122.8 167.46 13.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 0.0 110.937 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -58.55 162.32 3.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.538 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.469 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 8.2 pt -150.22 137.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.943 0.401 . . . . 0.0 111.878 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -99.46 111.15 4.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.568 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.441 ' CD1' ' CD2' ' B' ' 62' ' ' LEU . 27.6 p-90 -105.09 157.85 16.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.059 0.456 . . . . 0.0 111.763 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.68 148.97 33.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.474 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.484 HD13 HG23 ' B' ' 91' ' ' ILE . 15.6 mm -121.71 150.67 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.959 0.409 . . . . 0.0 111.679 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -151.8 136.1 16.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.675 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 10.9 p -122.51 154.42 37.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.914 0.387 . . . . 0.0 111.15 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 68.6 p -62.35 -32.76 73.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.048 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -122.03 108.13 13.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.006 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 30.7 mmm -102.92 25.13 9.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -105.13 -38.17 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.773 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -107.23 -32.0 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.738 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 1.6 mt -99.79 118.63 36.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.667 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m -122.4 106.71 11.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.192 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t -84.85 154.25 3.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.27 129.87 0.54 Allowed Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.06 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.61 131.66 22.15 Favored 'Cis proline' 0 C--N 1.35 0.636 0 C-N-CA 123.932 -1.278 . . . . 0.0 111.887 -0.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.23 -48.5 15.61 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.327 2.018 . . . . 0.0 112.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p -135.8 -178.69 5.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.48 -168.32 33.69 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.651 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 24.5 t -144.76 142.86 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.733 HD23 ' N ' ' B' ' 62' ' ' LEU . 0.4 OUTLIER -134.28 136.76 43.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.966 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -64.57 -179.73 0.32 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.932 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 29.6 Cg_exo -61.62 116.35 3.37 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.547 2.165 . . . . 0.0 112.377 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 72.44 29.75 2.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' B' ' 62' ' ' LEU . 0.5 OUTLIER -90.43 153.36 20.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.33 . . . . 0.0 110.637 179.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -115.38 142.71 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.264 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.34 129.71 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.815 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 tp -84.7 141.36 30.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.236 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.621 ' HE3' HD12 ' B' ' 31' ' ' ILE . 36.5 ttp -127.79 158.08 38.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.526 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.04 151.01 45.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.354 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -130.6 84.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.985 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.77 133.59 55.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.071 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.3 t -141.49 87.83 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.15 152.67 2.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.024 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' B' ' 24' ' ' ASP . 2.8 p -66.84 117.97 9.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.963 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -138.2 -164.05 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -135.57 139.14 43.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.749 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.69 18.64 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.508 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.83 -26.28 15.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.83 0.348 . . . . 0.0 111.033 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -150.02 48.15 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.49 165.79 25.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -51.14 126.96 17.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 88.0 mt -151.47 84.42 1.31 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.944 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -124.44 25.11 7.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.216 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 73.49 93.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.894 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.42 147.63 49.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.81 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -142.39 137.3 30.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' B' ' 91' ' ' ILE . 77.9 mt -110.23 94.52 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.05 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.676 HG23 ' OD1' ' B' ' 119' ' ' ASN . 0.2 OUTLIER -78.19 140.22 38.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.876 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.484 HG23 HD13 ' B' ' 45' ' ' ILE . 3.9 mp -133.02 111.24 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.937 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -115.93 124.29 50.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.021 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 11.8 p90 -133.44 142.05 48.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.666 ' HB ' HG13 ' B' ' 115' ' ' VAL . 0.7 OUTLIER -141.26 145.07 35.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.115 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 -60.74 131.35 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.838 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 3.9 p -73.6 142.36 80.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -51.05 162.49 1.12 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.512 2.141 . . . . 0.0 112.101 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.17 118.23 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.98 45.71 70.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.239 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.76 167.87 6.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 111.128 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.28 163.76 27.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.268 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.6 69.86 8.85 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.617 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 179.3 147.2 0.2 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.801 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -70.32 116.7 10.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.892 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.94 154.99 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.989 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -83.71 -26.43 29.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.944 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -22.68 66.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.145 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -59.45 -17.56 32.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.249 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.573 ' CZ ' HG22 ' B' ' 94' ' ' THR . 2.7 m-85 -124.88 38.55 4.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.891 0.377 . . . . 0.0 110.814 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -117.66 35.28 4.76 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.998 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -143.65 174.7 23.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.544 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.88 140.17 32.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 110.656 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.44 172.29 44.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.157 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.542 ' C ' HG23 ' B' ' 115' ' ' VAL . 0.0 OUTLIER 58.81 164.22 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.96 0.409 . . . . 0.0 110.897 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.666 HG13 ' HB ' ' B' ' 94' ' ' THR . 5.1 t 82.57 129.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.23 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.474 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 5.7 tpt180 -106.84 144.29 33.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -134.05 103.77 5.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.108 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.26 131.42 55.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.552 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.676 ' OD1' HG23 ' B' ' 90' ' ' THR . 1.5 m-80 -100.08 143.4 30.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.228 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 65.7 mt -116.07 95.11 43.78 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.383 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.29 139.21 64.26 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.638 2.225 . . . . 0.0 112.548 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 7.6 mm -114.41 111.56 36.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.779 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.698 ' O ' HG13 ' B' ' 18' ' ' VAL . 0.5 OUTLIER -112.6 128.05 56.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.098 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -89.63 107.4 19.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.2 76.86 9.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.994 0.426 . . . . 0.0 110.923 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.832 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.848 0.356 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.1 177.15 7.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.0 p 61.41 144.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.523 HG23 ' HD2' ' A' ' 5' ' ' PRO . 8.6 p -149.78 137.77 11.88 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.523 ' HD2' HG23 ' A' ' 4' ' ' VAL . 51.0 Cg_endo -68.82 142.02 50.98 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.522 2.148 . . . . 0.0 112.277 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.06 138.72 28.63 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.422 2.081 . . . . 0.0 112.342 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.79 111.84 2.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.541 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.837 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 8.3 p-10 -46.95 140.38 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.678 0.275 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 93' ' ' TRP . 1.3 pt -116.71 147.12 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.39 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.2 145.03 25.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.17 144.0 42.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.953 0.406 . . . . 0.0 111.297 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -133.05 111.46 13.14 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.59 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 31' ' ' ILE . 32.0 Cg_endo -63.84 161.81 60.19 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.928 -1.28 . . . . 0.0 112.446 0.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.7 -20.48 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.385 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.56 -49.35 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.901 0.381 . . . . 0.0 111.205 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.04 152.33 1.17 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.605 ' CG2' HD13 ' A' ' 122' ' ' ILE . 12.3 tt -105.95 153.21 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.988 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 123' ' ' GLU . 8.0 p -136.19 100.37 2.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.418 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -63.12 114.26 3.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.542 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -77.92 142.1 38.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.287 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -66.39 170.6 5.32 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.732 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 6.9 Cg_exo -73.96 167.04 80.69 Favored 'Cis proline' 0 C--N 1.348 0.521 0 C-N-CA 124.175 -1.177 . . . . 0.0 112.514 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -110.99 32.84 4.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -117.41 7.22 12.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.25 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.76 149.82 48.04 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-O 120.926 0.393 . . . . 0.0 110.961 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -67.5 107.95 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -108.01 138.09 44.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.846 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.16 112.86 24.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.094 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -105.03 108.5 20.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.646 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -79.76 151.08 30.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.407 -179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.543 HD12 ' HD2' ' A' ' 13' ' ' PRO . 29.1 mm -126.06 150.06 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.713 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.442 ' HB2' ' HG3' ' B' ' 22' ' ' PRO . 12.2 ttmm -104.85 120.57 41.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.93 0.395 . . . . 0.0 111.298 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.5 mt -121.9 130.06 74.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.717 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.5 m -139.76 155.02 47.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.003 0.43 . . . . 0.0 111.148 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -92.46 114.24 26.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.763 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.837 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.35 18.53 7.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.387 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.09 -141.43 6.52 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.52 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.43 52.13 0.54 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -174.59 164.78 3.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.776 0.322 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.18 137.09 46.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.733 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.415 ' CD1' ' CG2' ' A' ' 9' ' ' ILE . 2.5 pt -139.11 114.86 9.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.344 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.33 122.67 9.78 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.919 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.83 ' CD1' HD23 ' A' ' 62' ' ' LEU . 29.4 p-90 -114.63 157.9 22.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.022 0.439 . . . . 0.0 111.458 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.73 135.96 14.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.693 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.008 HG21 HG11 ' A' ' 55' ' ' VAL . 41.5 mm -93.06 141.71 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.472 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.26 133.03 15.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.58 160.37 32.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.025 0.44 . . . . 0.0 111.139 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.73 -47.83 41.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -114.29 112.56 23.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.941 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.42 23.48 6.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.988 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -45.78 3.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.001 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -81.99 -50.82 8.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.0 mt -76.21 154.08 35.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.0 m -143.84 110.9 5.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.774 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.008 HG11 HG21 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -100.04 146.71 8.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.246 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -164.26 123.75 1.3 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.781 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.33 135.42 38.59 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 123.774 -1.344 . . . . 0.0 112.08 0.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.48 -10.64 23.98 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.465 2.11 . . . . 0.0 112.74 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.5 p -162.53 165.47 26.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.847 0.356 . . . . 0.0 110.839 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.33 -154.78 25.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.542 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 t -135.02 149.26 29.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.321 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.83 HD23 ' CD1' ' A' ' 43' ' ' TRP . 0.9 OUTLIER -116.79 123.41 47.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -77.02 168.27 29.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.73 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 36.3 Cg_endo -65.25 116.46 3.89 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.573 2.182 . . . . 0.0 112.454 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt 62.09 28.61 17.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.013 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -101.34 150.06 23.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.127 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 66' ' ' GLU . 30.0 mttt -111.19 154.84 23.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.614 HG11 HD21 ' A' ' 62' ' ' LEU . 8.9 p -149.94 142.91 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.003 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.67 136.06 36.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.094 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 159.09 25.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.69 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.78 124.75 34.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 55' ' ' VAL . 33.3 t -126.37 93.86 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.907 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.6 p -86.33 154.15 21.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.0 p -133.14 108.54 8.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.764 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -53.24 145.49 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.979 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.401 ' H ' HG23 ' A' ' 76' ' ' THR . 3.4 p -61.05 142.0 56.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.821 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.06 -169.92 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.876 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -116.44 111.77 20.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.847 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.41 20.37 11.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.378 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.35 -28.84 14.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.202 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.7 p -142.16 46.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -147.16 144.43 28.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.79 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.416 ' O ' HD23 ' A' ' 84' ' ' LEU . 17.4 m-20 -71.95 150.78 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 54.8 mt -132.95 66.97 1.55 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.96 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -157.48 31.96 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.025 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -132.72 6.35 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.649 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.91 117.19 33.74 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.829 0.347 . . . . 0.0 110.865 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.0 ptt180 -149.02 134.19 18.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.057 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 122' ' ' ILE . 62.2 mt -86.96 161.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.754 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.543 ' N ' HG22 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -148.05 110.89 4.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.892 0.377 . . . . 0.0 111.105 -179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 91' ' ' ILE . 3.6 mp -102.05 111.95 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.438 ' CG ' ' CB ' ' A' ' 117' ' ' ARG . 0.4 OUTLIER -113.72 131.61 56.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.969 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.498 ' CE2' HG12 ' A' ' 9' ' ' ILE . 17.8 p90 -141.67 150.48 41.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.67 ' HB ' HG13 ' A' ' 115' ' ' VAL . 11.6 t -154.34 154.61 33.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.49 153.51 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.861 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -101.41 133.06 21.11 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.786 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.03 158.2 11.91 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.461 2.108 . . . . 0.0 112.322 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -52.73 124.21 13.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.85 32.19 70.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.386 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 101' ' ' ALA . . . -62.03 -18.28 60.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.581 0.229 . . . . 0.0 111.452 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 100' ' ' ALA . . . 73.01 166.06 0.3 Allowed 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.359 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -87.22 71.29 10.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.731 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.22 129.42 0.46 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.925 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 77.5 t80 -56.94 150.32 16.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.4 155.24 45.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -93.05 22.33 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.35 -6.3 17.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.6 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.471 ' CH2' ' HA ' ' A' ' 104' ' ' PHE . 8.8 m0 -91.14 19.65 5.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.626 0.25 . . . . 0.0 111.057 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -144.64 21.27 1.66 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.758 0.313 . . . . 0.0 111.151 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -105.02 26.9 8.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.936 0.398 . . . . 0.0 110.586 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.63 67.95 1.07 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.346 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.98 118.61 28.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.752 0.311 . . . . 0.0 110.854 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 50.32 -98.93 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.407 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.9 ptp -168.2 110.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.73 0.3 . . . . 0.0 110.949 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.67 HG13 ' HB ' ' A' ' 94' ' ' THR . 19.6 t -82.64 143.14 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.36 125.36 50.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.438 ' CB ' ' CG ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -135.5 153.72 51.64 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.31 135.5 48.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.627 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.521 ' CG ' HG23 ' A' ' 90' ' ' THR . 5.6 m-80 -96.18 129.48 43.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.261 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.9 mt -111.43 98.7 41.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.652 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -49.92 150.14 10.22 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.66 2.24 . . . . 0.0 112.596 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 89' ' ' ILE . 37.5 mm -100.87 149.84 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.962 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.76 ' HB3' HG23 ' A' ' 18' ' ' VAL . 29.3 mt-10 -133.22 156.93 46.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.009 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 84' ' ' LEU . 54.6 m-85 -123.81 105.23 9.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.974 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.411 ' ND2' HG12 ' B' ' 18' ' ' VAL . 5.7 t30 -87.49 81.38 7.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.759 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.903 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.819 0.342 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.06 177.41 7.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p 61.15 144.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.534 HG23 ' HD2' ' B' ' 5' ' ' PRO . 8.6 p -149.77 137.71 11.83 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.135 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' B' ' 4' ' ' VAL . 51.6 Cg_endo -68.7 142.06 51.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.504 2.136 . . . . 0.0 112.214 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 138.94 29.14 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.5 2.133 . . . . 0.0 112.289 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.28 112.05 2.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.533 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.842 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 8.2 p-10 -47.0 140.34 4.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 111.089 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' B' ' 93' ' ' TRP . 1.3 pt -116.42 147.25 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.247 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -94.53 144.92 25.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.468 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.0 144.16 43.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.399 . . . . 0.0 111.259 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -133.1 111.52 13.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' B' ' 31' ' ' ILE . 32.7 Cg_endo -63.86 162.01 59.65 Favored 'Cis proline' 0 C--N 1.351 0.669 0 C-N-CA 123.829 -1.321 . . . . 0.0 112.42 0.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.95 -20.38 11.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.246 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -97.57 -49.47 4.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 111.198 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.07 152.26 1.16 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.605 ' CG2' HD13 ' B' ' 122' ' ' ILE . 12.4 tt -105.88 153.19 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.079 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.752 HG23 ' HB3' ' B' ' 123' ' ' GLU . 7.9 p -136.23 100.3 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -62.99 114.21 3.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.539 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.75 142.37 38.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.328 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.876 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -66.53 170.34 5.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.663 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.876 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 6.7 Cg_exo -74.21 167.09 80.78 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 124.131 -1.195 . . . . 0.0 112.559 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -111.04 32.99 4.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.905 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -117.54 7.19 12.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.211 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.67 150.14 48.32 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.835 0.35 . . . . 0.0 110.925 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -67.84 107.88 2.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.87 138.17 44.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 112.88 24.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.044 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.14 108.51 20.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.58 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -79.51 150.99 31.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.435 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.551 HD12 ' HD2' ' B' ' 13' ' ' PRO . 29.0 mm -126.1 150.15 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.689 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.455 ' HB2' ' CG ' ' A' ' 22' ' ' PRO . 12.0 ttmm -104.89 120.51 41.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.91 0.386 . . . . 0.0 111.318 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -121.85 130.13 74.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.739 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 52.9 m -139.8 155.12 47.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.976 0.417 . . . . 0.0 111.208 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 11.4 t-20 -92.53 114.32 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.692 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.842 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.41 18.71 6.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.356 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -119.18 -141.46 6.52 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.564 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.25 51.85 0.55 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.455 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -174.32 164.84 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.855 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 7.7 mtm-85 -72.15 137.12 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.761 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' B' ' 9' ' ' ILE . 2.5 pt -139.05 115.14 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.317 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -71.58 122.56 9.47 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.922 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.848 ' CD1' HD23 ' B' ' 62' ' ' LEU . 29.5 p-90 -114.56 157.98 22.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.113 0.482 . . . . 0.0 111.454 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.91 136.0 14.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.657 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.996 HG21 HG11 ' B' ' 55' ' ' VAL . 41.7 mm -93.13 141.92 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.942 0.401 . . . . 0.0 111.377 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -150.5 133.1 15.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.754 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.73 160.45 32.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.06 0.457 . . . . 0.0 111.084 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.9 -47.7 43.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -114.33 112.63 23.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.38 23.38 6.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -45.82 3.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -81.87 -50.97 8.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 10.2 mt -76.13 154.26 35.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.143 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 9.7 m -144.03 110.81 5.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.757 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.996 HG11 HG21 ' B' ' 45' ' ' ILE . 0.9 OUTLIER -100.07 146.53 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.213 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -164.19 123.74 1.31 Allowed Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.777 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.26 135.33 38.02 Favored 'Cis proline' 0 C--N 1.352 0.748 0 C-N-CA 123.756 -1.352 . . . . 0.0 112.137 0.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -73.4 -10.45 23.96 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.507 2.138 . . . . 0.0 112.744 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 24.3 p -162.75 165.44 25.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.832 0.349 . . . . 0.0 110.816 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 161.31 -154.93 26.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 t -134.88 149.28 29.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.789 0.328 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.848 HD23 ' CD1' ' B' ' 43' ' ' TRP . 0.9 OUTLIER -116.88 123.28 46.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.99 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.438 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 0.6 OUTLIER -76.84 168.26 29.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.703 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 36.5 Cg_endo -65.25 116.56 3.94 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.587 2.191 . . . . 0.0 112.381 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt 62.04 28.55 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.039 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' B' ' 67' ' ' LYS . 0.2 OUTLIER -101.24 150.3 23.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 66' ' ' GLU . 30.1 mttt -111.44 154.84 24.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.99 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.608 HG11 HD21 ' B' ' 62' ' ' LEU . 8.6 p -149.94 142.88 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.968 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 13.1 mt -95.66 135.95 36.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.28 159.18 25.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -129.92 124.59 33.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.317 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.72 HG22 HG12 ' B' ' 55' ' ' VAL . 31.0 t -126.27 93.92 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -86.44 154.26 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.2 p -133.25 108.42 8.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -53.23 145.41 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.969 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 3.5 p -61.04 141.88 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -144.97 -169.8 3.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.985 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -116.54 111.55 20.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.29 20.54 11.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.366 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.41 -29.15 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 60.0 p -141.96 46.74 1.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -147.19 144.41 28.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.411 ' O ' HD23 ' B' ' 84' ' ' LEU . 16.8 m-20 -71.87 150.97 43.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.453 ' HB3' ' CE1' ' B' ' 124' ' ' TYR . 55.6 mt -133.16 67.09 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.784 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -157.51 32.08 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.942 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -132.8 6.31 3.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.615 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.81 117.27 33.96 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.878 0.37 . . . . 0.0 110.82 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 24.1 ptt180 -149.11 134.08 18.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.08 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.635 HG13 HD11 ' B' ' 122' ' ' ILE . 61.9 mt -86.77 161.09 2.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.885 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.548 ' N ' HG22 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -147.99 111.01 4.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 111.11 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.593 ' N ' HD12 ' B' ' 91' ' ' ILE . 3.7 mp -102.12 111.92 33.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.437 ' CG ' ' HB3' ' B' ' 117' ' ' ARG . 0.4 OUTLIER -113.68 131.63 56.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.08 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.498 ' CE2' HG12 ' B' ' 9' ' ' ILE . 18.0 p90 -141.59 150.74 42.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.678 ' HB ' HG13 ' B' ' 115' ' ' VAL . 11.5 t -154.55 154.68 33.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -53.56 153.49 4.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.966 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.408 ' HB ' ' CB ' ' B' ' 100' ' ' ALA . 0.6 OUTLIER -101.37 132.99 21.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 96' ' ' THR . 53.1 Cg_exo -55.0 158.17 11.88 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.5 2.133 . . . . 0.0 112.316 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -52.67 124.29 13.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.89 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 69.57 32.41 71.17 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.427 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' B' ' 101' ' ' ALA . . . -62.06 -18.35 60.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.611 0.243 . . . . 0.0 111.511 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 100' ' ' ALA . . . 73.29 166.2 0.3 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.215 0.531 . . . . 0.0 111.231 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -87.49 71.45 9.82 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.78 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.35 129.36 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.472 ' HA ' ' CH2' ' B' ' 108' ' ' TRP . 77.3 t80 -56.83 150.29 16.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.94 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -141.45 155.13 45.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.973 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -92.93 22.32 5.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.159 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.33 -6.44 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.636 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.472 ' CH2' ' HA ' ' B' ' 104' ' ' PHE . 9.0 m0 -91.1 19.61 5.64 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.66 0.266 . . . . 0.0 111.069 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -144.58 21.1 1.67 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.746 0.307 . . . . 0.0 111.203 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -104.89 26.88 8.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.973 0.415 . . . . 0.0 110.551 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.58 68.15 1.08 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.257 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -123.09 118.7 28.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.743 0.306 . . . . 0.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 50.03 -98.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.519 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 2.8 ptp -168.22 110.12 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.893 0.377 . . . . 0.0 110.937 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' B' ' 94' ' ' THR . 19.3 t -82.57 143.26 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.128 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.59 125.27 50.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.872 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.437 ' HB3' ' CG ' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -135.4 153.63 51.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.181 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -130.24 135.6 48.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.623 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.523 ' CG ' HG23 ' B' ' 90' ' ' THR . 5.7 m-80 -96.23 129.36 43.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.293 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 79.1 mt -111.3 98.75 41.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.681 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -49.94 150.17 10.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.638 2.225 . . . . 0.0 112.518 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.635 HD11 HG13 ' B' ' 89' ' ' ILE . 36.9 mm -100.92 149.9 6.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.006 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.752 ' HB3' HG23 ' B' ' 18' ' ' VAL . 30.4 mt-10 -133.23 156.87 46.74 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' B' ' 84' ' ' LEU . 55.5 m-85 -123.82 105.09 9.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.042 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.514 ' ND2' HG12 ' A' ' 18' ' ' VAL . 5.5 t30 -87.33 81.42 7.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.789 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.95 179.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.886 0.374 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 61.23 114.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -88.0 -179.63 6.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.968 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.9 m -81.25 141.88 50.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.096 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.71 168.03 25.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.569 2.18 . . . . 0.0 112.325 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.406 ' HG2' ' HG3' ' A' ' 116' ' ' ARG . 60.6 Cg_endo -72.67 157.87 51.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.296 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 37' ' ' GLY . . . -82.09 129.6 9.16 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -50.77 129.99 24.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.772 0.32 . . . . 0.0 111.009 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -99.16 120.22 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.958 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -81.8 142.52 32.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 p -136.95 155.72 49.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.45 106.58 4.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.02 154.47 48.54 Favored 'Cis proline' 0 C--N 1.351 0.71 0 C-N-CA 123.947 -1.272 . . . . 0.0 112.508 0.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.31 -50.36 11.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.199 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -159.49 41.83 0.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.117 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -153.53 92.9 1.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.33 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.722 ' CG2' HD13 ' A' ' 122' ' ' ILE . 10.4 tt -123.28 130.78 74.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.599 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.004 HG11 HG11 ' B' ' 18' ' ' VAL . 7.4 p -138.97 113.98 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 0.0 111.516 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -71.84 104.6 3.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.376 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.28 153.52 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.595 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.826 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -77.11 170.35 16.77 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.655 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.826 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 96.1 Cg_endo -79.07 166.77 78.23 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.004 -1.248 . . . . 0.0 112.786 0.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' CD2' ' A' ' 126' ' ' LEU . 22.3 m-85 -106.84 50.03 0.78 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.871 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.53 -3.33 10.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.309 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -137.5 150.31 47.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.844 0.354 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.82 110.72 3.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.25 83.49 1.77 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 114.94 10.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.81 132.92 42.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.15 138.89 38.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.96 145.18 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.442 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.86 138.85 39.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 34' ' ' THR . 47.0 mt -121.04 157.92 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.64 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.484 ' N ' HG22 ' A' ' 33' ' ' ILE . 88.8 m -162.12 148.53 13.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.188 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB3' HD11 ' A' ' 41' ' ' ILE . 23.8 p-10 -121.03 84.63 2.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 110.495 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.42 -27.32 0.68 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.56 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 7' ' ' GLY . . . -47.65 154.08 1.4 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.685 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.71 54.83 0.93 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.435 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.59 154.89 4.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.791 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -65.79 148.37 51.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.692 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 61' ' ' VAL . 26.5 pt -145.47 165.55 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.089 0.471 . . . . 0.0 111.521 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -125.07 106.51 0.91 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.462 ' CD1' ' O ' ' A' ' 60' ' ' GLY . 62.5 p-90 -104.29 157.58 17.04 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.227 0.537 . . . . 0.0 112.183 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.04 153.44 40.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.357 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.409 ' CD1' HG12 ' A' ' 91' ' ' ILE . 11.9 mm -119.92 145.36 26.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.979 0.419 . . . . 0.0 111.599 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.69 134.83 20.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.683 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.446 HG22 HG12 ' A' ' 89' ' ' ILE . 37.1 p -112.36 153.74 26.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.071 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.43 -26.17 18.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.721 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.68 114.16 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.764 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.3 19.84 5.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.285 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -96.33 -44.27 7.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.807 0.337 . . . . 0.0 110.696 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.87 -50.7 4.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.463 HD22 ' SG ' ' A' ' 74' ' ' CYS . 13.2 mt -78.96 153.76 30.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.27 151.25 28.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.017 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.8 150.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.786 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.15 115.71 0.62 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.51 139.56 61.34 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.053 -1.228 . . . . 0.0 112.219 -0.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.17 -32.94 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.655 2.237 . . . . 0.0 112.185 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 18.9 m -139.68 155.59 47.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.534 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.462 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 179.28 159.29 23.12 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.419 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 61' ' ' VAL . 10.6 p -96.1 114.6 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 111.217 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.91 166.07 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.428 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 3.9 m-20 -119.18 166.21 15.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.781 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.01 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.752 2.301 . . . . 0.0 112.518 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 tppt? 70.18 38.92 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.117 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 34' ' ' THR . 0.1 OUTLIER -112.33 155.56 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.996 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.11 136.48 50.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.994 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.33 129.16 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.039 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 127.04 35.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.793 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.47 159.03 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -114.0 155.33 26.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.45 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.48 82.8 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.792 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 m -53.24 136.32 36.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.196 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.463 ' SG ' HD22 ' A' ' 53' ' ' LEU . 51.2 m -152.62 82.11 1.23 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.715 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -64.04 150.16 45.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.85 162.16 1.34 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.902 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -167.56 -169.51 1.22 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -102.33 114.53 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.98 22.19 5.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.407 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.84 -32.16 12.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.332 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.0 p -142.91 56.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.24 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -123.61 179.84 4.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.551 ' C ' HD23 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -100.68 82.42 2.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.002 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.75 HD13 ' CD2' ' A' ' 124' ' ' TYR . 8.3 mt -117.11 67.76 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.417 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -85.94 -27.97 24.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 85' ' ' ASN . 3.0 m-80 178.54 -49.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.324 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.09 147.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -155.45 132.74 10.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.161 0.505 . . . . 0.0 111.938 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.446 HG12 HG22 ' A' ' 47' ' ' THR . 57.5 mt -101.15 102.18 13.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.71 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.5 m -83.75 138.12 33.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.091 0.472 . . . . 0.0 111.675 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.409 HG12 ' CD1' ' A' ' 45' ' ' ILE . 12.9 mt -122.4 123.6 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.311 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' TRP . 44.6 mt-10 -120.09 112.43 19.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 10.6 p90 -126.87 128.74 46.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.603 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.752 ' HB ' HG22 ' A' ' 115' ' ' VAL . 1.4 t -127.87 148.99 50.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.393 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -52.03 147.55 7.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.557 HG22 ' CH2' ' A' ' 108' ' ' TRP . 4.8 p -84.64 134.69 41.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.6 161.44 2.96 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.31 2.006 . . . . 0.0 111.94 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 p-10 -50.81 125.39 13.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.76 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.21 48.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.241 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' THR . . . -66.62 143.32 57.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 111.241 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.14 164.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.267 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -88.4 69.82 9.02 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.61 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 179.16 137.69 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.802 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -54.97 145.75 19.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.969 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.441 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 5.2 mmt180 -131.74 150.71 52.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.873 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.09 -25.46 23.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.936 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.86 -14.97 59.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.502 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.557 ' CH2' HG22 ' A' ' 96' ' ' THR . 19.0 m0 -55.45 -20.43 12.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.652 0.263 . . . . 0.0 111.281 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -95.41 38.87 1.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.739 0.304 . . . . 0.0 111.07 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -156.0 30.44 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.938 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.13 -154.52 7.29 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.554 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.35 155.48 25.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.832 0.349 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.35 -156.39 15.69 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.551 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.33 146.95 43.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.86 0.362 . . . . 0.0 110.863 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.752 HG22 ' HB ' ' A' ' 94' ' ' THR . 25.5 t -122.6 130.22 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.504 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 10.5 mtt180 -103.09 137.38 41.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.748 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.17 102.42 6.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.22 170.84 8.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.583 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -142.8 122.86 13.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.98 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.43 106.26 38.33 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.663 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.2 138.63 82.61 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.514 2.143 . . . . 0.0 112.79 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 17' ' ' ILE . 5.0 mm -110.97 150.81 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.591 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 18' ' ' VAL . 67.6 mt-10 -141.53 140.87 33.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.854 0.359 . . . . 0.0 111.423 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.75 ' CD2' HD13 ' A' ' 84' ' ' LEU . 38.4 m-85 -101.66 96.82 7.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.767 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.11 94.79 3.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.429 ' CD2' ' CE2' ' A' ' 23' ' ' TYR . 42.0 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.818 0.342 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 61.24 114.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 66.6 m -87.96 -179.65 6.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 m -81.17 141.9 50.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.203 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.8 168.02 25.68 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.637 2.224 . . . . 0.0 112.267 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.402 ' HG2' ' HG3' ' B' ' 116' ' ' ARG . 60.3 Cg_endo -72.68 157.88 51.5 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.596 2.197 . . . . 0.0 112.24 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.18 129.7 9.22 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.49 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -50.88 129.99 24.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.353 . . . . 0.0 111.001 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.449 HG22 ' HA ' ' B' ' 35' ' ' ASN . 1.1 pt -99.11 120.22 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.007 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.406 ' ND2' ' HB ' ' B' ' 34' ' ' THR . 1.1 p30 -81.85 142.66 32.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.843 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 16.0 p -137.02 155.83 49.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.27 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -145.6 106.55 4.34 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.649 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.02 154.4 48.53 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.896 -1.293 . . . . 0.0 112.613 0.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.22 -50.27 12.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.185 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -159.67 41.89 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.051 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -153.51 92.68 1.61 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.301 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.721 ' CG2' HD13 ' B' ' 122' ' ' ILE . 10.5 tt -123.19 130.89 74.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.635 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 1.004 HG11 HG11 ' A' ' 18' ' ' VAL . 7.6 p -138.97 113.84 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.568 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -71.76 104.69 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.366 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.3 153.32 42.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.439 . . . . 0.0 111.525 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.832 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -76.9 170.32 16.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.672 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.832 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 97.1 Cg_endo -78.97 166.97 77.93 Favored 'Cis proline' 0 C--N 1.35 0.627 0 C-N-CA 124.027 -1.239 . . . . 0.0 112.759 0.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' B' ' 126' ' ' LEU . 22.2 m-85 -106.98 49.89 0.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.872 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.48 -3.16 10.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.304 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -137.57 150.36 47.41 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.82 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.93 110.75 3.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -110.19 83.84 1.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.909 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 85.6 m -72.27 114.77 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -96.62 133.0 41.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -102.29 138.93 38.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.92 145.31 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.549 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.07 138.5 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.941 0.4 . . . . 0.0 111.481 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.479 HG22 ' N ' ' B' ' 34' ' ' THR . 47.4 mt -120.79 157.67 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.659 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.479 ' N ' HG22 ' B' ' 33' ' ' ILE . 87.7 m -161.93 148.5 13.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.547 ' HB3' HD11 ' B' ' 41' ' ' ILE . 23.8 p-10 -120.95 84.6 2.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.513 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.47 -27.34 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.502 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.77 153.8 1.54 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.657 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.44 55.0 0.95 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.63 154.97 4.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.8 0.333 . . . . 0.0 110.827 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -65.9 148.23 52.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.737 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.595 ' O ' HG23 ' B' ' 61' ' ' VAL . 26.6 pt -145.16 165.57 11.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.051 0.453 . . . . 0.0 111.586 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' B' ' 93' ' ' TRP . . . -125.15 106.21 0.89 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.449 ' CD1' ' O ' ' B' ' 60' ' ' GLY . 62.7 p-90 -104.27 157.37 17.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.217 0.532 . . . . 0.0 112.207 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.88 153.38 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.422 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.414 ' CD1' HG12 ' B' ' 91' ' ' ILE . 12.3 mm -119.88 145.51 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.953 0.406 . . . . 0.0 111.594 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.81 134.74 20.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.67 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.455 HG22 HG12 ' B' ' 89' ' ' ILE . 36.7 p -112.27 153.52 27.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -53.22 -26.21 16.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.739 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -144.65 114.15 7.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.23 19.85 5.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.348 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 mmt180 -96.32 -44.38 7.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.912 0.387 . . . . 0.0 110.741 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.83 -50.79 4.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.863 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.466 HD22 ' SG ' ' B' ' 74' ' ' CYS . 13.3 mt -78.88 154.01 30.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.5 151.11 28.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.7 150.79 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -168.09 115.86 0.62 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.47 139.6 61.5 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.098 -0.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.41 -32.84 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.547 2.165 . . . . 0.0 112.102 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 19.1 m -139.64 155.58 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.479 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.449 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 179.4 159.5 23.55 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.411 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 41' ' ' ILE . 10.5 p -96.29 114.79 33.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 111.211 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 mt -84.08 166.19 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.984 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.428 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 3.8 m-20 -119.29 166.2 15.13 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 11.2 Cg_endo -54.82 108.29 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.685 2.257 . . . . 0.0 112.483 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? 69.81 39.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.434 ' O ' HG23 ' B' ' 34' ' ' THR . 0.1 OUTLIER -112.67 155.47 24.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.925 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 2.5 pttt -129.02 136.39 50.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.99 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.0 m -122.27 128.76 75.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.097 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.16 126.84 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.28 158.97 37.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.83 155.36 25.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.513 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.52 82.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.759 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 15.1 m -52.94 136.29 34.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.158 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.466 ' SG ' HD22 ' B' ' 53' ' ' LEU . 50.9 m -152.65 82.1 1.23 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.66 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -64.13 150.07 46.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -54.84 162.16 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -167.56 -169.48 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.916 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -102.46 114.63 28.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.1 22.22 5.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.344 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.03 -31.95 12.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.223 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 62.4 p -143.16 56.18 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.163 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -123.74 179.93 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.545 ' C ' HD23 ' B' ' 84' ' ' LEU . 1.0 OUTLIER -100.73 82.46 2.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.749 HD13 ' CD2' ' B' ' 124' ' ' TYR . 8.1 mt -117.08 67.79 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.73 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' ND2' ' B' ' 86' ' ' ASN . 0.7 OUTLIER -85.97 -28.05 24.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.935 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' B' ' 85' ' ' ASN . 2.9 m-80 178.61 -49.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.227 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.01 147.48 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 77.4 mtm-85 -155.5 132.67 10.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 111.869 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.455 HG12 HG22 ' B' ' 47' ' ' THR . 56.8 mt -101.11 102.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.744 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 20.3 m -83.73 137.89 33.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.187 0.518 . . . . 0.0 111.654 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' B' ' 45' ' ' ILE . 13.0 mt -122.32 123.47 68.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.269 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 44.4 mt-10 -119.99 112.48 19.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.162 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.499 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 10.5 p90 -126.84 128.79 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.573 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.751 ' HB ' HG22 ' B' ' 115' ' ' VAL . 1.4 t -128.02 148.91 50.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.391 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -51.91 147.73 6.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.569 HG22 ' CH2' ' B' ' 108' ' ' TRP . 4.6 p -84.75 134.71 41.39 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.782 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.63 161.57 2.91 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.384 2.056 . . . . 0.0 111.867 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.6 p-10 -50.87 125.37 13.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 51.49 41.09 48.24 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.203 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' B' ' 96' ' ' THR . . . -66.51 143.11 57.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.911 0.386 . . . . 0.0 111.34 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.65 164.55 0.52 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.288 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 3.3 pttt -88.61 69.82 8.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.53 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? 179.2 137.94 0.1 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.812 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -55.34 145.95 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.991 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.448 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 5.0 mmt180 -131.93 150.71 52.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -88.22 -25.25 22.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.007 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.93 -15.14 59.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.454 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.569 ' CH2' HG22 ' B' ' 96' ' ' THR . 19.0 m0 -55.27 -20.45 11.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.613 0.245 . . . . 0.0 111.25 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -95.55 39.13 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.749 0.309 . . . . 0.0 111.104 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -156.19 30.44 0.34 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.23 -154.66 7.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.518 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.26 155.41 26.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.871 0.367 . . . . 0.0 110.953 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.35 -156.35 15.71 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.31 146.89 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.751 HG22 ' HB ' ' B' ' 94' ' ' THR . 25.5 t -122.5 130.45 74.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.499 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 10.5 mtt180 -103.18 137.51 41.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.734 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -131.31 102.3 5.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.411 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.11 170.91 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.578 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -142.78 123.02 13.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.998 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.53 106.2 38.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.677 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -60.14 138.81 83.97 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.62 2.213 . . . . 0.0 112.77 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.721 HD13 ' CG2' ' B' ' 17' ' ' ILE . 5.0 mm -111.21 150.98 13.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.513 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.574 ' O ' HG23 ' B' ' 18' ' ' VAL . 67.6 mt-10 -141.79 140.59 33.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.862 0.363 . . . . 0.0 111.442 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.749 ' CD2' HD13 ' B' ' 84' ' ' LEU . 37.5 m-85 -101.44 96.68 7.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.449 ' ND2' HG12 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -75.94 94.88 3.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' B' ' 23' ' ' TYR . 41.3 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.822 0.344 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -34.44 78.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -147.7 -79.42 0.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.99 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.4 m -154.08 108.27 2.46 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.118 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.03 171.38 11.36 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.498 2.132 . . . . 0.0 112.277 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.29 135.51 46.96 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.568 2.178 . . . . 0.0 112.173 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.3 122.91 16.17 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.273 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -50.7 108.44 0.23 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.787 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.36 145.62 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.317 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.5 146.7 23.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.576 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.07 155.9 49.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.24 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -153.96 106.23 2.47 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.645 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -61.73 161.97 45.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 123.891 -1.295 . . . . 0.0 112.474 0.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.3 -10.96 11.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.616 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.503 ' O ' HD23 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -108.28 -56.35 2.26 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.879 0.371 . . . . 0.0 111.18 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -154.89 -175.43 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.287 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.492 ' CG2' HD13 ' A' ' 122' ' ' ILE . 9.5 tt -150.26 136.34 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.611 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.739 HG23 ' HB3' ' A' ' 123' ' ' GLU . 7.3 p -126.19 107.94 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.711 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -65.13 119.99 11.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.298 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -84.37 134.95 34.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 111.654 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -51.74 170.5 0.21 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.683 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 89.1 Cg_endo -80.13 164.11 81.07 Favored 'Cis proline' 0 C--N 1.35 0.608 0 C-N-CA 124.065 -1.223 . . . . 0.0 112.721 0.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.519 ' CE2' HD23 ' A' ' 126' ' ' LEU . 20.2 m-85 -109.62 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.81 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.22 5.65 5.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.155 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.67 129.09 25.93 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 0.0 110.773 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.79 106.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -105.61 150.3 25.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.709 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.44 97.97 3.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.094 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -87.23 125.52 34.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.4 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.431 ' NE2' ' HB2' ' A' ' 71' ' ' ALA . 12.3 m80 -94.97 130.68 41.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.497 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.662 HD12 ' HE3' ' A' ' 70' ' ' MET . 28.6 mt -97.84 150.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -104.6 134.27 48.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.361 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.464 HD11 ' SD ' ' A' ' 70' ' ' MET . 23.8 mt -136.87 154.87 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.872 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.436 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.1 m -153.83 158.35 40.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.061 0.458 . . . . 0.0 111.238 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 20.4 t-20 -107.85 114.04 27.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.544 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.02 19.91 6.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.424 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.3 -177.26 19.09 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.632 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.45 19.63 26.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.527 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.71 161.94 37.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.807 0.337 . . . . 0.0 110.831 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -65.67 164.11 15.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.695 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.1 pt -149.19 142.0 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.403 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TRP . . . -102.42 100.98 2.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.731 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.406 ' CD1' HD12 ' A' ' 62' ' ' LEU . 63.0 p-90 -105.71 149.76 26.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.047 0.451 . . . . 0.0 111.528 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.57 132.23 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.597 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 89' ' ' ILE . 9.2 mm -92.75 151.27 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.268 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -138.63 138.2 37.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.4 p -124.25 148.97 46.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -55.7 -40.08 71.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -127.52 118.17 23.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.78 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.73 16.72 7.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.408 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -110.88 -31.63 7.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.954 0.407 . . . . 0.0 110.787 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.62 -23.11 14.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.964 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 74' ' ' CYS . 34.9 mt -126.85 138.75 53.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.988 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.1 m -149.5 116.7 6.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 71' ' ' ALA . 2.7 t -94.43 153.48 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.049 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -145.65 123.3 6.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.906 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.0 144.93 77.32 Favored 'Cis proline' 0 C--N 1.351 0.666 0 C-N-CA 123.851 -1.312 . . . . 0.0 112.498 0.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.21 -13.63 40.26 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.584 2.19 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.61 130.75 0.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.749 0.309 . . . . 0.0 110.586 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.21 -178.82 25.47 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.668 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.609 HG13 ' O ' ' A' ' 61' ' ' VAL . 10.5 p -114.34 111.52 36.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.482 HD23 ' HG3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -80.56 145.48 31.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.002 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 2.8 m-20 -101.81 171.88 4.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.708 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' O ' ' CD ' ' A' ' 65' ' ' LYS . 42.3 Cg_exo -57.06 127.87 27.54 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.527 2.151 . . . . 0.0 112.505 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' CD ' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER 46.89 34.86 2.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.586 179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.482 ' HG3' HD23 ' A' ' 62' ' ' LEU . 1.4 tp10 -101.4 136.64 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.67 113.82 27.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.057 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.1 m -102.87 155.17 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.87 119.3 26.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.662 ' HE3' HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -112.83 164.66 13.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.493 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -118.46 155.46 30.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.399 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 37.5 t -129.68 104.62 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.798 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.21 125.69 32.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HA ' HD23 ' A' ' 53' ' ' LEU . 1.8 p -129.6 98.19 4.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.712 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.84 153.9 1.61 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 76' ' ' THR . 2.3 p -64.62 151.16 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.717 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.481 ' CZ ' ' CD2' ' A' ' 124' ' ' TYR . 3.5 p90 -148.58 -161.44 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.089 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.09 93.47 2.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HB3' HD21 ' A' ' 126' ' ' LEU . . . -68.23 -19.02 64.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.482 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.58 -28.95 1.59 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.788 0.328 . . . . 0.0 111.462 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.406 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 71.7 p -143.56 59.18 1.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.071 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 81' ' ' THR . 47.1 mt-10 -159.24 160.31 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -82.76 153.16 25.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.874 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.404 HD22 ' HB2' ' A' ' 124' ' ' TYR . 12.5 mt -128.43 38.36 3.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.67 30.04 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.16 -45.37 3.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -57.39 138.47 54.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.39 132.3 3.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.82 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' A' ' 45' ' ' ILE . 78.4 mt -107.73 121.93 61.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 118' ' ' LYS . 4.0 m -103.79 138.76 39.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.0 mp -118.16 124.36 72.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.164 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 122.01 37.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.428 ' CZ2' ' HB2' ' A' ' 116' ' ' ARG . 6.2 p90 -130.94 143.66 50.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.787 0.327 . . . . 0.0 111.21 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.724 ' CB ' HG22 ' A' ' 115' ' ' VAL . 1.3 t -145.18 120.57 10.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -43.22 142.83 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.595 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.534 HG22 ' CZ3' ' A' ' 108' ' ' TRP . 6.9 p -82.01 146.06 54.6 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.953 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.69 165.92 14.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.547 2.164 . . . . 0.0 112.158 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -45.16 114.38 0.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.498 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.73 49.67 16.16 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.902 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -51.6 -76.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.762 0.315 . . . . 0.0 111.043 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 100' ' ' ALA . . . 172.68 163.65 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.074 0.464 . . . . 0.0 111.243 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.49 69.51 9.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.518 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.21 128.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.735 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -48.97 131.28 18.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.994 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.408 ' HB2' ' CZ2' ' A' ' 108' ' ' TRP . 6.6 ttm180 -121.47 150.33 41.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.87 27.16 7.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.809 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.27 -1.09 14.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.787 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.534 ' CZ3' HG22 ' A' ' 96' ' ' THR . 7.2 m0 -92.47 19.87 6.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.588 0.232 . . . . 0.0 111.193 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -115.24 -23.39 8.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.687 0.28 . . . . 0.0 111.306 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -59.99 -32.28 70.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.092 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.4 146.35 40.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.566 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -91.96 150.29 21.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.777 0.323 . . . . 0.0 110.789 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.61 -77.5 1.91 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.264 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.608 ' C ' HG23 ' A' ' 115' ' ' VAL . 1.4 mpt? -47.58 169.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.976 0.417 . . . . 0.0 111.226 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.724 HG22 ' CB ' ' A' ' 94' ' ' THR . 4.5 t 87.07 106.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.39 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.428 ' HB2' ' CZ2' ' A' ' 93' ' ' TRP . 48.0 mtt-85 -98.87 146.14 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.67 156.78 17.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.385 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -145.18 161.74 38.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.524 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -144.93 148.97 34.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.33 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 15' ' ' GLN . 34.6 mt -151.17 86.36 4.83 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.569 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -51.1 158.77 3.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.697 2.265 . . . . 0.0 112.66 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.492 HD13 ' CG2' ' A' ' 17' ' ' ILE . 25.1 mm -114.53 145.72 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.048 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.739 ' HB3' HG23 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -139.06 165.12 27.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 111.037 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 90.1 m-85 -132.59 108.2 8.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.993 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.18 83.18 3.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 29.6 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.831 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.776 0.322 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -34.64 78.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 2.4 t -147.58 -79.38 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.527 HG23 ' O ' ' B' ' 4' ' ' VAL . 16.3 m -154.2 108.24 2.44 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.92 171.47 11.1 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.483 2.122 . . . . 0.0 112.308 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.27 135.47 46.83 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.659 2.239 . . . . 0.0 112.206 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.35 122.98 16.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.306 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -50.67 108.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.746 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 pt -78.25 145.64 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.67 146.64 24.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.559 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.88 156.09 48.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.232 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -154.18 106.32 2.43 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.661 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.76 162.06 45.87 Favored 'Cis proline' 0 C--N 1.351 0.692 0 C-N-CA 123.872 -1.304 . . . . 0.0 112.381 0.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.4 -11.02 11.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.632 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.502 ' O ' HD23 ' B' ' 120' ' ' LEU . 0.1 OUTLIER -108.23 -56.31 2.26 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.824 0.345 . . . . 0.0 111.204 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -154.9 -175.3 5.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.241 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.491 ' CG2' HD13 ' B' ' 122' ' ' ILE . 9.5 tt -150.44 136.36 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.638 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.743 HG23 ' HB3' ' B' ' 123' ' ' GLU . 7.3 p -126.25 107.86 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.702 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -65.19 119.96 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.287 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -84.3 134.99 34.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.032 0.444 . . . . 0.0 111.667 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.847 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -51.72 170.52 0.21 Allowed Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.637 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.847 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 89.9 Cg_endo -80.19 164.12 80.87 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.974 -1.261 . . . . 0.0 112.704 0.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.524 ' CE2' HD23 ' B' ' 126' ' ' LEU . 20.2 m-85 -109.58 47.42 0.94 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.851 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.29 5.62 5.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.164 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.66 128.97 25.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.768 0.318 . . . . 0.0 110.782 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.7 106.76 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -105.65 150.33 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.676 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.49 97.87 3.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.091 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -87.04 125.52 34.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.546 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.425 ' NE2' ' HB2' ' B' ' 71' ' ' ALA . 12.8 m80 -94.95 130.64 41.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.504 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.657 HD12 ' HE3' ' B' ' 70' ' ' MET . 28.7 mt -97.89 150.54 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -104.6 134.48 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.461 HD11 ' SD ' ' B' ' 70' ' ' MET . 23.8 mt -137.01 154.92 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.818 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.442 ' N ' HG22 ' B' ' 33' ' ' ILE . 52.9 m -153.93 158.2 40.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.145 0.497 . . . . 0.0 111.251 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 20.4 t-20 -107.75 114.05 27.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.493 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.19 20.09 6.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.365 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -114.61 -177.58 18.96 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.486 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -110.32 19.92 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.613 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.89 162.07 37.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.734 0.302 . . . . 0.0 110.788 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 14.0 mtm180 -65.86 164.09 15.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.664 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 5.2 pt -149.18 141.83 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.429 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.26 101.12 2.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.696 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -105.85 149.71 26.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 111.516 -179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.46 132.38 19.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.673 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 89' ' ' ILE . 9.1 mm -92.77 151.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.323 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt -138.7 138.29 37.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.813 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 30.6 p -124.29 149.19 46.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.2 p -55.95 -40.14 72.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -127.4 117.97 23.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.853 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.51 16.62 7.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.383 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -110.77 -31.7 7.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.53 -23.19 14.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.97 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' B' ' 74' ' ' CYS . 34.9 mt -126.75 138.75 53.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.963 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 36.7 m -149.39 116.73 6.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.496 HG13 ' O ' ' B' ' 71' ' ' ALA . 2.7 t -94.52 153.47 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -145.64 123.41 6.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.852 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -77.98 145.03 77.62 Favored 'Cis proline' 0 C--N 1.351 0.67 0 C-N-CA 123.818 -1.326 . . . . 0.0 112.481 -0.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.2 -13.63 40.29 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.15 . . . . 0.0 112.524 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -175.6 130.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.613 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.12 -178.79 25.36 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.606 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.627 ' O ' HG13 ' B' ' 61' ' ' VAL . 10.3 p -114.41 111.37 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.969 0.414 . . . . 0.0 111.198 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.465 HD23 ' HG3' ' B' ' 66' ' ' GLU . 0.2 OUTLIER -80.38 145.56 31.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.021 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' B' ' 35' ' ' ASN . 2.9 m-20 -101.8 171.79 5.01 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.668 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.417 ' O ' ' CD ' ' B' ' 65' ' ' LYS . 41.5 Cg_exo -56.91 127.94 27.89 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.546 2.164 . . . . 0.0 112.558 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.417 ' CD ' ' O ' ' B' ' 64' ' ' PRO . 0.0 OUTLIER 46.72 34.8 2.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.623 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.465 ' HG3' HD23 ' B' ' 62' ' ' LEU . 1.4 tp10 -101.32 136.77 40.62 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 113.9 27.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.014 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.92 155.22 5.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.96 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.8 tp -126.95 119.21 26.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.022 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.657 ' HE3' HD12 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -112.75 164.7 13.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.722 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.496 ' O ' HG13 ' B' ' 55' ' ' VAL . . . -118.55 155.29 31.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.398 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.54 104.72 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.776 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.34 125.19 32.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.977 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . 0.477 ' HA ' HD23 ' B' ' 53' ' ' LEU . 1.7 p -129.11 98.1 4.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.5 153.89 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.3 p -64.73 151.11 45.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.76 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.483 ' CZ ' ' CD2' ' B' ' 124' ' ' TYR . 3.5 p90 -148.52 -161.55 1.37 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.999 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.05 93.41 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.458 ' HB3' HD21 ' B' ' 126' ' ' LEU . . . -68.08 -19.17 64.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.461 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -46.45 -29.23 1.64 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.751 0.31 . . . . 0.0 111.404 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.7 p -143.28 59.33 1.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -159.22 160.34 35.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -82.82 153.36 25.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' B' ' 124' ' ' TYR . 12.4 mt -128.53 38.24 4.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -146.52 30.18 1.01 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.41 -45.19 3.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -57.48 138.53 54.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.021 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 132.26 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.471 ' CG2' ' CG2' ' B' ' 45' ' ' ILE . 77.6 mt -107.73 121.81 61.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.105 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.619 HG23 ' O ' ' B' ' 118' ' ' LYS . 4.0 m -103.77 138.84 39.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.556 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.0 mp -118.26 124.33 72.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.31 121.95 37.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.427 ' CZ2' ' HB2' ' B' ' 116' ' ' ARG . 6.2 p90 -130.91 143.7 50.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.091 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.72 ' CB ' HG22 ' B' ' 115' ' ' VAL . 1.3 t -145.18 120.5 10.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -43.24 142.87 0.94 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.513 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.519 HG22 ' CZ3' ' B' ' 108' ' ' TRP . 6.9 p -81.99 146.03 54.59 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 165.76 15.12 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.597 2.198 . . . . 0.0 112.168 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -44.9 114.5 0.72 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.537 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 46.55 49.63 15.5 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.905 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' B' ' 101' ' ' ALA . . . -51.35 -76.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.835 0.35 . . . . 0.0 111.035 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' B' ' 100' ' ' ALA . . . 172.38 163.57 0.11 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.105 0.479 . . . . 0.0 111.161 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -87.55 69.41 9.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.488 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.4 128.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -48.98 131.24 18.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.065 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HB2' ' CZ2' ' B' ' 108' ' ' TRP . 6.6 ttm180 -121.41 150.28 41.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.971 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.88 26.93 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -113.08 -1.01 14.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.789 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.519 ' CZ3' HG22 ' B' ' 96' ' ' THR . 7.0 m0 -92.67 20.15 6.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.703 0.287 . . . . 0.0 111.185 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -115.48 -23.57 8.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.179 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -59.92 -32.08 70.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.105 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -58.68 146.38 41.64 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -92.04 150.32 21.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.815 0.341 . . . . 0.0 110.713 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.65 -77.46 1.91 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.37 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.595 ' C ' HG23 ' B' ' 115' ' ' VAL . 1.4 mpt? -47.65 169.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.041 0.448 . . . . 0.0 111.246 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.72 HG22 ' CB ' ' B' ' 94' ' ' THR . 4.5 t 87.06 106.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.318 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.427 ' HB2' ' CZ2' ' B' ' 93' ' ' TRP . 48.2 mtt-85 -99.05 146.23 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.78 156.73 17.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.113 0.483 . . . . 0.0 111.315 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.619 ' O ' HG23 ' B' ' 90' ' ' THR . 0.0 OUTLIER -145.11 161.73 38.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.481 179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -144.96 148.95 34.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.404 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.502 HD23 ' O ' ' B' ' 15' ' ' GLN . 35.1 mt -151.11 86.44 4.84 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.582 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.09 158.94 2.94 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.691 2.261 . . . . 0.0 112.683 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.491 HD13 ' CG2' ' B' ' 17' ' ' ILE . 25.3 mm -114.74 145.73 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.002 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.743 ' HB3' HG23 ' B' ' 18' ' ' VAL . 0.3 OUTLIER -139.08 165.0 28.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.056 0.455 . . . . 0.0 111.093 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.483 ' CD2' ' CZ ' ' B' ' 77' ' ' PHE . 90.0 m-85 -132.51 108.09 8.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.976 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -96.05 83.23 3.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.569 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 30.3 mt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.906 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.828 0.347 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 53.99 91.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.96 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.02 -176.26 3.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.002 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.2 m -54.78 156.92 5.99 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.85 171.48 15.58 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.58 2.187 . . . . 0.0 112.243 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.27 138.83 62.94 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.532 2.155 . . . . 0.0 112.303 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.15 -152.92 0.41 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.56 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.0 m-20 -112.06 151.84 28.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.765 0.316 . . . . 0.0 110.885 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.75 127.55 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.157 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.409 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 1.0 OUTLIER -73.19 152.48 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.501 179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.0 143.03 30.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.981 0.42 . . . . 0.0 111.52 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.95 111.08 24.59 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.332 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.51 168.53 24.73 Favored 'Cis proline' 0 C--N 1.351 0.679 0 C-N-CA 124.09 -1.213 . . . . 0.0 112.828 0.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.4 t -38.9 -48.76 1.61 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.99 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.6 ' CG ' HD22 ' A' ' 120' ' ' LEU . 1.1 tm0? 177.22 -50.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 111.033 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -79.57 112.19 16.59 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.58 HD13 ' CE1' ' A' ' 19' ' ' PHE . 8.1 tt -113.22 130.06 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.719 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 38.8 t -105.37 87.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.879 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.58 ' CE1' HD13 ' A' ' 17' ' ' ILE . 6.9 m-85 -51.81 101.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 21.8 m-80 -72.13 137.82 47.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.539 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.845 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -70.2 169.34 13.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.709 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.845 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 72.6 Cg_endo -76.11 166.23 83.41 Favored 'Cis proline' 0 C--N 1.349 0.586 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.641 0.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 17.2 m-85 -108.14 30.41 6.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.005 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.14 7.38 36.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.353 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -135.18 154.64 51.55 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.859 0.361 . . . . 0.0 111.101 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -71.34 131.98 44.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -140.24 93.15 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.78 111.4 11.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CD2' HD11 ' A' ' 17' ' ' ILE . 76.2 m-85 -98.09 106.42 18.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' B' ' 22' ' ' PRO . 7.7 m80 -79.37 121.29 24.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.7 mt -109.81 125.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.877 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HG3' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -95.21 155.42 16.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 34' ' ' THR . 34.0 mt -133.89 154.06 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.667 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 33' ' ' ILE . 53.9 m -144.84 151.69 39.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 111.521 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' HB2' HD22 ' A' ' 62' ' ' LEU . 14.0 t-20 -98.51 105.48 17.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.673 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -92.88 20.93 6.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.57 -161.28 20.26 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.469 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.81 40.34 2.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.534 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 175.87 161.91 0.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.673 0.273 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 41' ' ' ILE . 13.5 ptp180 -55.15 169.85 0.23 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.706 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 40' ' ' ARG . 3.7 pt -158.92 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.331 . . . . 0.0 111.82 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.16 107.08 2.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.444 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.543 ' CD1' HD12 ' A' ' 62' ' ' LEU . 51.3 p-90 -103.76 159.37 15.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.224 0.535 . . . . 0.0 112.033 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -145.73 145.06 30.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.449 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 91' ' ' ILE . 13.1 mm -123.9 151.11 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.033 0.444 . . . . 0.0 111.553 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.38 163.41 39.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.534 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.504 HG22 HG12 ' A' ' 89' ' ' ILE . 24.1 p -139.37 149.82 44.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.984 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -50.42 -31.06 13.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.967 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -136.1 117.74 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.03 16.56 8.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.327 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -54.84 2.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.847 0.356 . . . . 0.0 110.513 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.93 -40.14 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.756 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.1 122.4 46.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.638 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.12 107.84 13.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.207 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 HG22 ' A' ' 72' ' ' VAL . 2.6 m -97.53 129.12 48.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.029 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -140.28 140.92 24.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.951 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.06 153.37 97.47 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 123.917 -1.285 . . . . 0.0 112.265 0.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.55 -11.68 26.45 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.589 2.193 . . . . 0.0 112.662 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 20.4 p -172.68 158.77 4.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.903 0.382 . . . . 0.0 110.814 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.448 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 175.86 148.04 6.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.578 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 t -89.69 128.02 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.543 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -97.84 165.32 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 66' ' ' GLU . 0.9 OUTLIER -117.41 169.59 7.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.553 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.32 112.96 1.28 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.584 2.189 . . . . 0.0 112.515 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp 62.56 34.86 14.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.282 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.512 ' O ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -102.19 154.61 18.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.43 160.28 16.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.436 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.01 151.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.698 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 ' HG3' ' A' ' 32' ' ' LYS . 12.4 tp -111.2 125.13 53.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.926 0.393 . . . . 0.0 111.319 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 2.2 ttm -121.61 158.54 28.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.509 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.75 38.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.507 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 55' ' ' VAL . 54.6 t -114.05 91.73 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.749 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.38 129.41 39.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.247 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 10.7 t -130.56 140.16 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.658 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.1 151.97 26.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.922 0.391 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.5 p -55.6 111.94 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.918 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' CE1' ' HB3' ' A' ' 23' ' ' TYR . 27.2 p90 -118.82 -172.43 2.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -119.98 126.93 52.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 84' ' ' LEU . . . -105.17 19.01 21.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.329 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.28 -25.19 21.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.812 0.339 . . . . 0.0 111.023 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.7 p -135.64 29.23 3.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.53 129.2 20.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.69 146.94 29.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 79' ' ' ALA . 29.1 mt -117.31 41.44 2.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.847 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.35 25.11 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.453 ' O ' HG21 ' A' ' 48' ' ' THR . 24.0 m120 -118.26 -15.1 9.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.468 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.98 114.52 13.55 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.841 0.353 . . . . 0.0 111.013 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.19 135.52 21.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.504 HG12 HG22 ' A' ' 47' ' ' THR . 15.6 mt -98.46 107.63 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -71.03 121.12 17.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.06 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 45' ' ' ILE . 14.2 mm -109.86 149.76 12.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.816 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -148.23 159.92 43.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.039 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.496 ' CZ2' ' HB3' ' A' ' 116' ' ' ARG . 10.0 p90 -177.91 123.3 0.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.922 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.53 134.75 39.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -56.34 112.78 1.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 p -58.72 148.22 68.45 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.942 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -51.22 164.68 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.628 2.219 . . . . 0.0 112.316 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.48 115.54 1.16 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.292 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 49.04 47.81 32.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.732 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -58.09 166.16 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.342 . . . . 0.0 110.955 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.54 164.49 16.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.097 0.475 . . . . 0.0 111.404 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 70.96 8.04 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.643 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.83 132.68 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.838 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -53.25 152.45 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.407 ' HB2' ' CD2' ' A' ' 108' ' ' TRP . 13.3 mmm180 -136.91 145.25 44.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.35 -27.71 19.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.55 -18.76 65.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.32 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.407 ' CD2' ' HB2' ' A' ' 105' ' ' ARG . 26.5 m0 -56.58 -20.35 20.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.307 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -116.54 43.44 2.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.795 0.331 . . . . 0.0 111.049 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -112.81 -30.59 7.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.809 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.83 145.7 15.97 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.533 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.97 155.71 27.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 0.0 110.891 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.08 -92.32 0.28 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.553 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -99.36 106.52 18.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.016 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p 175.62 127.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.496 ' HB3' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -119.07 157.87 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.4 . . . . 0.0 111.128 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -162.94 124.61 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.097 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.35 131.76 40.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.762 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.1 122.65 39.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.075 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.6 HD22 ' CG ' ' A' ' 15' ' ' GLN . 1.5 mt -81.72 133.42 52.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.547 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HD3' ' NE2' ' A' ' 15' ' ' GLN . 94.9 Cg_endo -79.35 134.94 11.64 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.611 2.207 . . . . 0.0 112.697 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.48 HD11 HG13 ' A' ' 89' ' ' ILE . 7.5 mm -108.06 82.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.016 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.62 162.06 26.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.076 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.426 ' CE1' ' O ' ' A' ' 122' ' ' ILE . 57.5 m-85 -131.08 100.75 5.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.901 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.446 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 28.6 t30 -80.07 81.5 6.31 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.828 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.919 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.837 0.351 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 53.97 91.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.96 -176.3 3.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 9.5 m -54.75 156.92 5.93 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.81 171.56 15.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.604 2.203 . . . . 0.0 112.277 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.33 139.07 63.75 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.492 2.128 . . . . 0.0 112.317 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.41 -152.85 0.45 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.505 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.561 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.9 m-20 -112.21 151.76 29.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.761 0.315 . . . . 0.0 110.831 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.62 127.28 67.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.163 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.413 ' HB2' ' HB ' ' B' ' 34' ' ' THR . 1.0 OUTLIER -73.0 152.5 41.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.434 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.09 142.95 30.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.072 0.463 . . . . 0.0 111.488 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -125.89 111.0 24.77 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.435 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -61.38 168.48 24.26 Favored 'Cis proline' 0 C--N 1.35 0.62 0 C-N-CA 124.125 -1.198 . . . . 0.0 112.9 0.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 35.7 t -38.85 -48.76 1.59 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.98 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.604 ' CG ' HD22 ' B' ' 120' ' ' LEU . 1.1 tm0? 177.21 -50.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.408 . . . . 0.0 111.008 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -79.58 112.14 16.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.036 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.585 HD13 ' CE1' ' B' ' 19' ' ' PHE . 7.7 tt -113.33 130.18 67.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.683 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 39.2 t -105.3 87.31 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.934 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CE1' HD13 ' B' ' 17' ' ' ILE . 6.8 m-85 -51.37 100.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.423 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -71.97 137.73 47.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.48 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.844 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -70.15 169.27 13.93 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.697 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.844 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 72.1 Cg_endo -76.16 166.27 83.27 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.736 0.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.425 ' HB3' ' CE1' ' B' ' 77' ' ' PHE . 17.1 m-85 -108.22 30.38 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.959 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -104.09 7.46 36.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.37 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -135.27 154.63 51.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.815 0.341 . . . . 0.0 111.12 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -71.37 132.12 44.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -140.31 93.24 2.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.863 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 2.9 m -75.85 111.48 11.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.984 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.494 ' CD2' HD11 ' B' ' 17' ' ' ILE . 76.0 m-85 -98.06 106.5 18.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.786 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -79.45 121.51 25.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 31.8 mt -110.12 125.32 67.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.513 ' HG3' HD12 ' B' ' 69' ' ' LEU . 0.1 OUTLIER -95.29 155.43 16.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.268 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.417 HG22 ' N ' ' B' ' 34' ' ' THR . 33.8 mt -133.99 153.83 36.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.617 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.417 ' N ' HG22 ' B' ' 33' ' ' ILE . 54.1 m -144.75 151.74 39.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.068 0.461 . . . . 0.0 111.474 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.551 ' HB2' HD22 ' B' ' 62' ' ' LEU . 14.2 t-20 -98.63 105.54 17.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.616 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -92.83 20.85 6.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.308 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -108.54 -161.12 20.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.89 40.28 2.31 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.531 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 175.89 161.96 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.716 0.293 . . . . 0.0 110.838 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.541 ' O ' HG23 ' B' ' 41' ' ' ILE . 13.5 ptp180 -55.21 169.84 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.607 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.541 HG23 ' O ' ' B' ' 40' ' ' ARG . 3.7 pt -158.92 115.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 0.0 111.864 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.06 107.18 2.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.478 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.534 ' CD1' HD12 ' B' ' 62' ' ' LEU . 51.2 p-90 -103.87 159.22 15.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.723 ' O ' HD13 ' B' ' 45' ' ' ILE . . . -145.51 145.11 30.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.353 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.769 HD12 HD12 ' B' ' 91' ' ' ILE . 13.0 mm -123.89 150.94 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.948 0.404 . . . . 0.0 111.627 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -151.23 163.51 38.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.552 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.496 HG22 HG12 ' B' ' 89' ' ' ILE . 24.3 p -139.5 149.69 44.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.465 HG21 ' O ' ' B' ' 86' ' ' ASN . 0.7 OUTLIER -50.27 -31.24 13.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.008 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -135.89 117.74 15.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -90.0 16.48 8.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.318 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.78 -55.03 2.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 110.506 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -80.82 -40.3 25.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.724 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.88 122.37 45.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.711 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m -121.06 108.2 13.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.041 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.433 HG12 HG22 ' B' ' 72' ' ' VAL . 2.6 m -97.83 129.09 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.027 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -140.21 140.92 24.68 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.959 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.0 153.46 97.64 Favored 'Cis proline' 0 C--N 1.35 0.621 0 C-N-CA 123.945 -1.273 . . . . 0.0 112.199 0.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.72 -11.52 26.03 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.52 2.146 . . . . 0.0 112.582 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 20.1 p -172.74 158.67 4.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.845 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 175.98 147.99 6.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.601 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.51 128.1 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.976 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' B' ' 35' ' ' ASN . 0.1 OUTLIER -97.91 165.37 11.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.807 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.433 ' CB ' ' HG3' ' B' ' 66' ' ' GLU . 0.9 OUTLIER -117.54 169.63 7.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.451 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -57.43 112.66 1.19 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.645 2.23 . . . . 0.0 112.534 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp 62.8 34.99 14.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.197 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.512 ' O ' HD21 ' B' ' 62' ' ' LEU . 0.0 OUTLIER -102.19 154.64 18.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -109.51 160.38 16.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.344 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 t -144.15 151.88 15.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.629 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.513 HD12 ' HG3' ' B' ' 32' ' ' LYS . 12.4 tp -111.2 125.12 53.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.311 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 2.1 ttm -121.7 158.62 28.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.523 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.77 135.8 38.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.489 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.433 HG22 HG12 ' B' ' 55' ' ' VAL . 54.4 t -114.17 91.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.651 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.29 129.36 39.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.201 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 10.8 t -130.67 140.0 50.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.647 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -110.04 152.24 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.038 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.3 p -55.8 112.22 1.11 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' B' ' 23' ' ' TYR . 27.5 p90 -119.02 -172.39 2.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.005 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -120.0 127.06 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.882 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' B' ' 84' ' ' LEU . . . -105.05 18.71 21.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.13 -25.13 22.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.859 0.361 . . . . 0.0 111.121 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 66.8 p -135.69 29.23 3.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.037 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -142.42 129.35 20.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.894 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.87 146.94 30.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' B' ' 79' ' ' ALA . 29.1 mt -117.32 41.57 2.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -147.42 24.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.465 ' O ' HG21 ' B' ' 48' ' ' THR . 23.9 m120 -118.0 -15.28 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.561 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.94 114.6 13.59 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.888 0.375 . . . . 0.0 111.041 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -147.2 135.53 21.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.496 HG12 HG22 ' B' ' 47' ' ' THR . 15.7 mt -98.52 107.65 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 97.3 m -70.97 121.1 17.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.128 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.769 HD12 HD12 ' B' ' 45' ' ' ILE . 14.4 mm -109.89 149.69 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.907 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -148.12 159.98 43.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.016 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' B' ' 116' ' ' ARG . 10.1 p90 -177.94 123.57 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.908 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -135.79 134.66 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -56.56 112.57 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.0 p -58.4 147.94 66.34 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -51.01 164.68 0.58 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.602 2.201 . . . . 0.0 112.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -47.51 115.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.208 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 48.98 47.77 31.72 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.825 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -57.93 166.25 1.55 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 111.019 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.75 164.63 16.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.179 0.514 . . . . 0.0 111.342 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 71.03 7.96 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.608 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.91 132.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -53.07 152.27 4.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.412 ' HB2' ' CD2' ' B' ' 108' ' ' TRP . 13.3 mmm180 -136.77 145.28 44.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.31 -27.89 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.49 -18.5 65.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.279 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.412 ' CD2' ' HB2' ' B' ' 105' ' ' ARG . 26.1 m0 -56.86 -20.22 21.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.27 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -116.73 43.76 2.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.816 0.341 . . . . 0.0 110.981 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -113.01 -30.67 6.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.794 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -105.92 145.72 15.97 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.98 155.78 27.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.892 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 132.1 -92.39 0.28 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.536 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' B' ' 115' ' ' VAL . 2.7 mpt? -99.35 106.52 18.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.866 0.365 . . . . 0.0 110.983 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' B' ' 114' ' ' MET . 7.4 p 175.59 127.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.808 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.483 ' HB3' ' CZ2' ' B' ' 93' ' ' TRP . 0.1 OUTLIER -119.09 157.94 26.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.927 0.394 . . . . 0.0 111.101 -179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -163.04 124.86 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.057 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -133.56 131.75 40.09 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.401 ' N ' ' ND2' ' B' ' 119' ' ' ASN . 0.7 OUTLIER -96.08 122.55 39.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.604 HD22 ' CG ' ' B' ' 15' ' ' GLN . 1.5 mt -81.66 133.31 52.72 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.665 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.416 ' HD3' ' NE2' ' B' ' 15' ' ' GLN . 91.6 Cg_endo -79.16 134.95 11.87 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.622 2.215 . . . . 0.0 112.661 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.492 HD11 HG13 ' B' ' 89' ' ' ILE . 7.6 mm -108.23 82.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -68.44 161.89 26.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.154 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' B' ' 122' ' ' ILE . 58.6 m-85 -130.89 101.0 5.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.455 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 28.9 t30 -80.58 81.55 6.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.831 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.908 -179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.805 0.336 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.03 137.16 32.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.024 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -125.87 132.67 52.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.797 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.74 141.35 37.8 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.193 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.71 159.79 51.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.496 2.13 . . . . 0.0 112.367 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.25 116.13 4.56 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.572 2.181 . . . . 0.0 112.266 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -54.38 114.07 3.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.546 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -51.75 146.33 8.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 0.0 110.867 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 pt -110.8 146.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.255 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -96.01 141.18 29.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.47 145.36 50.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.157 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -135.4 118.13 12.59 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.404 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.33 157.27 72.63 Favored 'Cis proline' 0 C--N 1.352 0.74 0 C-N-CA 124.22 -1.158 . . . . 0.0 112.644 0.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.11 -33.11 75.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.392 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.411 ' HA ' ' HG ' ' A' ' 120' ' ' LEU . 2.8 tt0 -179.47 51.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.743 0.306 . . . . 0.0 111.32 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -174.21 108.41 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.313 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.9 tt -131.08 155.25 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 123' ' ' GLU . 73.8 t -135.5 96.14 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.678 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' CE2' ' CG2' ' A' ' 122' ' ' ILE . 18.8 m-85 -63.28 100.12 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.858 0.361 . . . . 0.0 110.071 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -69.67 151.4 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.493 . . . . 0.0 111.89 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.802 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -48.64 170.41 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.806 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.802 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 80.1 Cg_endo -87.62 169.02 39.76 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.241 -1.149 . . . . 0.0 112.961 0.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' A' ' 125' ' ' ASN . 21.7 m-30 -110.42 18.97 19.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.185 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -104.1 3.21 32.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.983 179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.64 -171.49 3.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 120.697 0.284 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -99.13 105.56 17.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.929 0.395 . . . . 0.0 111.017 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.35 121.46 38.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.499 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -106.55 107.51 18.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.49 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -97.2 126.19 42.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.155 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -86.89 141.1 29.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.045 0.45 . . . . 0.0 111.814 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 32' ' ' LYS . 17.1 mt -113.49 154.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.575 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' N ' HG22 ' A' ' 31' ' ' ILE . 8.4 mttm -102.89 119.38 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 -179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 74.9 mt -117.34 145.85 22.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.62 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.2 m -147.61 158.42 44.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.148 0.499 . . . . 0.0 111.323 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -111.26 113.56 26.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.457 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.32 23.18 6.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.72 -158.66 23.63 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.531 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.61 18.7 5.4 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.617 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.87 159.74 41.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.822 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.5 mpp_? -57.3 151.64 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.666 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt -150.36 121.34 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.774 0.321 . . . . 0.0 111.861 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.19 168.5 54.31 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -166.03 155.21 11.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.523 0.662 . . . . 0.0 112.109 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.78 156.78 43.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.061 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.474 ' CG2' HG11 ' A' ' 55' ' ' VAL . 15.7 mm -121.51 136.19 59.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.948 0.404 . . . . 0.0 111.796 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 126.18 17.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.519 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 35.0 p -112.25 162.08 15.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.195 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.49 -28.2 1.33 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.282 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.42 120.5 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.7 11.34 27.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.486 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.62 -54.12 2.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.962 0.41 . . . . 0.0 110.679 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -74.96 -28.19 60.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.788 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.7 mt -115.22 122.08 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.69 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.46 157.84 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.221 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.474 HG11 ' CG2' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -123.94 155.04 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.875 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 9.0 t70 -166.87 109.17 0.65 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.817 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 56' ' ' ASP . 73.1 Cg_endo -76.1 140.79 67.96 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.83 -1.321 . . . . 0.0 112.32 0.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.41 -24.89 30.77 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.406 2.071 . . . . 0.0 112.209 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 25.9 p -151.91 172.85 15.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.651 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.78 -163.33 35.2 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.648 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.9 t -137.88 152.57 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.804 0.335 . . . . 0.0 111.2 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.555 HD11 HG21 ' A' ' 68' ' ' VAL . 5.7 mp -124.52 161.45 26.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.684 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB2' ' HD2' ' A' ' 64' ' ' PRO . 1.6 p30 -115.03 170.53 5.4 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.744 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 63' ' ' ASP . 49.4 Cg_exo -56.7 114.0 1.72 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.485 2.124 . . . . 0.0 112.562 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.02 39.24 2.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.546 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.35 139.31 46.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.895 0.379 . . . . 0.0 110.261 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.52 112.3 21.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.781 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.555 HG21 HD11 ' A' ' 62' ' ' LEU . 27.3 m -101.75 149.12 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.21 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.29 127.18 43.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.765 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.448 ' HG2' ' N ' ' A' ' 71' ' ' ALA . 54.0 ttp -113.7 161.38 17.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.082 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.448 ' N ' ' HG2' ' A' ' 70' ' ' MET . . . -129.48 141.4 51.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.094 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.07 101.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.8 145.98 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.062 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.14 142.63 50.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.691 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.9 143.07 26.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.005 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.1 p -57.07 161.47 3.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.145 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -172.27 -160.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -127.29 94.4 3.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.093 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.21 -22.18 66.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.33 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.78 -43.95 94.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 74.6 p -131.27 60.27 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.304 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -158.28 162.14 37.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 p30 -70.43 152.24 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.585 HD22 ' CB ' ' A' ' 124' ' ' TYR . 12.4 mt -138.26 23.26 2.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -145.54 27.71 1.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.971 0.415 . . . . 0.0 110.634 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.38 -28.46 8.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.101 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.53 124.63 24.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.81 132.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.654 HG13 HD11 ' A' ' 122' ' ' ILE . 66.6 mt -94.47 127.88 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 86.8 m -112.58 104.58 12.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.34 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.516 ' H ' HD12 ' A' ' 91' ' ' ILE . 4.3 mp -87.43 148.45 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.578 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.404 ' HG2' ' CB ' ' A' ' 117' ' ' ARG . 4.9 mt-10 -144.77 154.27 42.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.936 0.398 . . . . 0.0 111.294 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 4.3 p90 -162.42 149.46 13.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.024 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.621 HG22 ' CZ ' ' A' ' 109' ' ' PHE . 0.0 OUTLIER -148.0 141.84 25.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.779 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.02 139.5 27.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.025 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.4 p -92.6 146.65 32.73 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.2 163.4 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.518 2.145 . . . . 0.0 112.107 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -50.16 112.32 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.979 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.56 47.1 58.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.72 155.46 19.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.857 0.361 . . . . 0.0 111.21 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.68 164.24 2.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.29 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -88.42 69.76 9.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.618 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -173.01 124.69 0.43 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -52.31 125.76 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.22 149.77 27.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.977 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.78 -21.89 29.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 110' ' ' GLN . 24.3 pt-20 -73.77 -9.74 58.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.633 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -69.31 -29.59 67.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.727 0.298 . . . . 0.0 111.115 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.621 ' CZ ' HG22 ' A' ' 94' ' ' THR . 15.0 m-85 -105.78 37.2 2.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.943 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 1.3 pp0? -120.46 25.64 9.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.922 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.28 150.41 20.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.583 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.47 156.8 25.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.867 0.365 . . . . 0.0 110.93 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.74 -83.07 0.32 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.594 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.402 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 1.6 mpt? -114.34 104.34 11.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.926 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.671 ' O ' HG13 ' A' ' 115' ' ' VAL . 7.4 p 175.36 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.664 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -107.26 155.84 19.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.991 0.424 . . . . 0.0 111.157 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.404 ' CB ' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -145.71 132.64 20.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.952 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 152.22 33.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.81 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 120' ' ' LEU . 5.1 m120 -102.86 156.37 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.809 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 119' ' ' ASN . 5.0 mp -134.51 129.33 19.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.56 128.07 6.75 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.645 2.23 . . . . 0.0 112.2 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.654 HD11 HG13 ' A' ' 89' ' ' ILE . 11.6 mm -100.0 138.86 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.513 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.562 ' HB3' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -119.51 160.08 23.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.284 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CB ' HD22 ' A' ' 84' ' ' LEU . 38.7 m-85 -123.11 117.74 26.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.536 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.445 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 38.2 t30 -114.8 141.48 47.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.49 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.511 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 32.6 mt . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.835 0.35 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -90.09 137.26 32.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 31.4 t -125.9 132.76 52.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.72 141.44 38.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.83 159.73 51.68 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.52 2.146 . . . . 0.0 112.27 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.26 116.0 4.51 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.519 2.146 . . . . 0.0 112.349 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -53.99 114.28 3.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.09 146.21 9.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.796 0.331 . . . . 0.0 110.916 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 pt -110.57 146.11 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.21 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -95.87 141.16 29.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.664 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.46 145.5 50.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.951 0.405 . . . . 0.0 111.193 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.41 ' HB3' ' CG ' ' A' ' 22' ' ' PRO . 32.8 mt-30 -135.62 117.97 12.31 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.534 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.22 157.18 72.3 Favored 'Cis proline' 0 C--N 1.352 0.72 0 C-N-CA 124.217 -1.159 . . . . 0.0 112.729 0.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -66.01 -33.1 75.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.444 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.408 ' HA ' ' HG ' ' B' ' 120' ' ' LEU . 2.7 tt0 -179.6 51.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.732 0.301 . . . . 0.0 111.301 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.407 ' HA ' ' HG2' ' B' ' 121' ' ' PRO . 1.4 ptpt -174.54 108.34 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.388 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.429 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.9 tt -131.02 155.55 42.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.748 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' B' ' 123' ' ' GLU . 74.2 t -135.82 96.19 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.737 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.412 ' CE2' ' CG2' ' B' ' 122' ' ' ILE . 18.8 m-85 -63.36 100.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.086 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -69.64 151.21 46.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.151 0.501 . . . . 0.0 111.869 -179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.82 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -48.35 170.48 0.11 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.773 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.82 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 73.9 Cg_endo -87.73 168.76 39.75 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 124.312 -1.12 . . . . 0.0 112.94 0.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.418 ' OH ' ' N ' ' B' ' 125' ' ' ASN . 21.9 m-30 -110.15 18.85 19.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.224 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -103.99 3.22 33.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.927 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.55 -171.38 3.67 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-O 120.771 0.32 . . . . 0.0 110.555 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -99.29 105.52 17.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.018 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -96.34 121.65 38.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.373 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 10.4 m -106.63 107.8 18.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.413 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -97.46 126.43 42.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.094 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -87.05 141.21 28.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.743 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.422 HG22 ' N ' ' B' ' 32' ' ' LYS . 18.0 mt -113.68 154.63 15.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.478 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.422 ' N ' HG22 ' B' ' 31' ' ' ILE . 8.4 mttm -102.81 119.58 39.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.919 0.39 . . . . 0.0 111.479 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 75.2 mt -117.48 145.88 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.585 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.4 HG22 ' N ' ' B' ' 35' ' ' ASN . 53.5 m -147.69 158.41 44.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 111.365 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.4 ' N ' HG22 ' B' ' 34' ' ' THR . 7.0 t-20 -111.17 113.77 26.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.427 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 23.01 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.08 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.67 -158.36 23.64 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.577 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.57 18.38 5.44 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.658 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -153.65 159.84 42.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.779 0.323 . . . . 0.0 110.844 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' B' ' 62' ' ' LEU . 3.5 mpp_? -57.29 151.87 15.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 pt -150.61 121.36 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.322 . . . . 0.0 111.804 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' B' ' 93' ' ' TRP . . . -74.25 168.66 54.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.451 -0.88 . . . . 0.0 110.906 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -166.05 155.31 11.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.536 0.668 . . . . 0.0 112.075 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -145.9 156.91 43.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.057 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.473 ' CG2' HG11 ' B' ' 55' ' ' VAL . 15.1 mm -121.63 136.22 59.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.905 0.383 . . . . 0.0 111.848 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.33 126.09 17.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.505 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 34.8 p -112.23 162.25 15.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.249 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -46.57 -28.2 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -131.41 120.55 23.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 5.4 mmt -92.73 11.46 26.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.467 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -115.76 -54.23 2.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.844 0.355 . . . . 0.0 110.704 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -74.71 -28.32 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.804 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 4.4 mt -115.06 122.08 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.829 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.36 157.88 26.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.254 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.473 HG11 ' CG2' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -123.99 155.06 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' B' ' 57' ' ' PRO . 9.0 t70 -166.98 109.11 0.64 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.973 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' B' ' 56' ' ' ASP . 72.7 Cg_endo -76.02 140.73 67.73 Favored 'Cis proline' 0 C--N 1.351 0.708 0 C-N-CA 123.825 -1.323 . . . . 0.0 112.404 0.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.35 -24.81 31.16 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.458 2.105 . . . . 0.0 112.242 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 26.0 p -152.01 172.74 15.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.647 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.03 -163.64 35.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.597 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 5.0 t -137.64 152.74 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 111.115 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.563 HD11 HG21 ' B' ' 68' ' ' VAL . 5.5 mp -124.82 161.43 26.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' B' ' 64' ' ' PRO . 1.6 p30 -114.98 170.55 5.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' B' ' 63' ' ' ASP . 51.7 Cg_exo -56.82 113.97 1.71 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.562 2.175 . . . . 0.0 112.568 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 68.1 39.25 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.486 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' B' ' 63' ' ' ASP . 0.3 OUTLIER -111.42 139.33 46.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 110.262 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.63 112.22 20.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.786 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.563 HG21 HD11 ' B' ' 62' ' ' LEU . 27.4 m -101.77 149.3 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.359 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.37 127.24 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.712 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.443 ' HG2' ' N ' ' B' ' 71' ' ' ALA . 53.8 ttp -113.63 161.35 17.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.443 ' N ' ' HG2' ' B' ' 70' ' ' MET . . . -129.46 141.54 50.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.001 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -132.25 101.79 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.9 145.99 32.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.06 142.68 50.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.669 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.94 143.11 26.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 4.2 p -57.08 161.71 2.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -172.33 -160.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.76 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.76 94.69 4.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.968 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.35 -22.47 66.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.227 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -43.99 93.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.301 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 80.6 p -131.26 60.37 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.277 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -158.5 161.96 37.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.934 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -70.25 151.88 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.584 HD22 ' CB ' ' B' ' 124' ' ' TYR . 12.2 mt -137.97 23.34 2.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.088 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -145.45 27.55 1.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.58 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.26 -28.48 8.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.154 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -70.44 124.48 24.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.918 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.61 132.67 21.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.061 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.661 HG13 HD11 ' B' ' 122' ' ' ILE . 66.6 mt -94.41 127.96 46.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 87.3 m -112.63 104.7 12.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.528 ' H ' HD12 ' B' ' 91' ' ' ILE . 4.3 mp -87.46 148.42 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.627 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.4 ' HG2' ' CB ' ' B' ' 117' ' ' ARG . 4.9 mt-10 -144.84 154.36 42.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.279 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.405 ' HB2' ' O ' ' B' ' 42' ' ' GLY . 4.3 p90 -162.53 149.52 13.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.028 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.617 HG22 ' CZ ' ' B' ' 109' ' ' PHE . 0.0 OUTLIER -148.05 141.83 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -53.08 139.38 28.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 8.7 p -92.53 146.61 32.71 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.27 163.03 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.607 2.205 . . . . 0.0 112.175 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -49.71 112.33 0.64 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.34 47.59 55.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.2 155.55 20.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.95 163.97 2.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.373 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -88.0 69.68 9.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.62 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -172.98 124.68 0.43 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -52.39 125.65 16.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 149.85 27.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.93 -21.74 29.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.112 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' B' ' 110' ' ' GLN . 24.3 pt-20 -73.9 -9.62 58.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.69 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -69.34 -29.62 67.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.687 0.279 . . . . 0.0 111.021 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.617 ' CZ ' HG22 ' B' ' 94' ' ' THR . 15.0 m-85 -105.84 37.16 2.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.811 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' B' ' 107' ' ' GLU . 1.3 pp0? -120.44 25.58 9.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -161.23 150.76 20.77 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.603 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.72 156.82 24.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.68 -83.23 0.32 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.595 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -114.0 104.31 12.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 111.097 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.664 HG13 ' O ' ' B' ' 115' ' ' VAL . 7.4 p 175.41 94.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.596 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 32.4 mtt180 -107.12 155.79 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.168 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . 0.4 ' CB ' ' HG2' ' B' ' 92' ' ' GLU . 0.0 OUTLIER -145.82 132.47 19.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.976 -179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.55 152.24 33.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.761 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.626 ' O ' HD12 ' B' ' 120' ' ' LEU . 5.2 m120 -102.73 156.53 17.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.797 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.626 HD12 ' O ' ' B' ' 119' ' ' ASN . 5.0 mp -134.67 129.2 19.29 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.102 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.407 ' HG2' ' HA ' ' B' ' 16' ' ' LYS . 96.1 Cg_endo -80.37 128.09 6.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.458 2.105 . . . . 0.0 112.167 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.661 HD11 HG13 ' B' ' 89' ' ' ILE . 11.6 mm -99.94 138.73 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.564 ' HB3' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -119.38 160.14 22.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.308 179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.584 ' CB ' HD22 ' B' ' 84' ' ' LEU . 38.5 m-85 -123.14 117.82 26.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.927 0.394 . . . . 0.0 111.569 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.433 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 38.1 t30 -114.82 141.72 47.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.522 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.525 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 32.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.836 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.907 0.384 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -99.87 88.76 3.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.35 176.31 10.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 m -76.61 157.79 81.8 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.139 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.26 153.33 7.14 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.652 2.235 . . . . 0.0 112.451 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HG2' ' HG2' ' A' ' 116' ' ' ARG . 57.3 Cg_endo -71.07 159.85 51.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.648 2.232 . . . . 0.0 112.262 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.37 -146.56 5.26 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.604 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 1.0 OUTLIER -125.3 137.72 54.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG23 ' NE1' ' A' ' 93' ' ' TRP . 1.1 pt -113.19 149.79 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.236 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.39 153.45 20.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.603 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -144.98 152.48 40.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.273 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -137.71 116.47 9.9 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.488 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.02 154.25 76.81 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 123.963 -1.265 . . . . 0.0 112.484 0.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.9 9.1 38.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.688 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -127.17 -59.57 1.24 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.782 0.325 . . . . 0.0 111.118 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 121' ' ' PRO . 12.8 pttm -169.37 173.38 6.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.9 tt -121.51 155.23 25.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.018 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 125' ' ' ASN . 44.7 t -118.15 85.06 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.634 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 29' ' ' TYR . 5.2 m-30 -49.7 102.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.581 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 55.2 m-80 -73.3 135.6 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.837 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -54.15 170.33 0.32 Allowed Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.695 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.837 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 98.4 Cg_endo -78.6 168.47 75.08 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.837 0.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 124' ' ' TYR . 18.2 m-85 -112.98 29.93 7.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.01 6.44 12.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.05 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -140.82 157.83 44.83 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.39 114.05 14.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -115.67 149.82 37.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.689 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.5 m -114.98 126.92 55.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.253 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.471 ' CZ ' ' CG ' ' A' ' 19' ' ' PHE . 42.9 m-85 -107.18 128.68 54.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.506 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -90.98 115.17 27.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.455 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.2 mm -104.05 143.03 16.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.565 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.72 140.95 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.034 0.445 . . . . 0.0 111.626 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.55 HD11 ' HE2' ' A' ' 70' ' ' MET . 61.5 mt -134.49 152.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.481 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 33' ' ' ILE . 49.5 m -152.59 158.78 42.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.24 0.543 . . . . 0.0 111.371 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.768 ' HB2' HD23 ' A' ' 62' ' ' LEU . 52.4 t30 -112.76 107.37 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.29 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -78.97 -4.29 49.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.661 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 -173.15 49.54 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.34 22.46 10.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.453 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -145.16 -179.65 6.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.94 155.81 25.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.428 HD13 ' OD1' ' A' ' 35' ' ' ASN . 20.9 pt -148.86 170.88 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.985 0.422 . . . . 0.0 111.304 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.56 108.17 0.98 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.556 -0.617 . . . . 0.0 111.556 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.724 ' CZ3' HD11 ' A' ' 45' ' ' ILE . 30.6 p-90 -104.8 157.83 16.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.288 0.566 . . . . 0.0 112.023 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.33 157.65 41.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.245 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.744 ' HB ' HG11 ' A' ' 55' ' ' VAL . 2.7 mp -121.86 142.64 37.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.908 0.385 . . . . 0.0 111.939 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.31 125.87 14.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.603 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.737 HG22 HG12 ' A' ' 89' ' ' ILE . 55.6 p -102.03 158.34 16.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.226 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -46.24 -33.83 3.97 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.051 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -137.86 123.87 20.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.817 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.36 8.3 16.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.474 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.65 -47.54 5.05 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.752 0.31 . . . . 0.0 110.864 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -82.14 -53.61 5.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.739 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.728 HD12 ' HB ' ' A' ' 47' ' ' THR . 14.8 mt -91.07 155.36 18.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.816 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.6 152.38 29.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.744 HG11 ' HB ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -119.15 153.6 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.962 -179.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -172.83 110.28 0.35 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.31 140.72 60.82 Favored 'Cis proline' 0 C--N 1.352 0.743 0 C-N-CA 123.722 -1.366 . . . . 0.0 112.344 0.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.23 -6.11 16.9 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.556 2.171 . . . . 0.0 112.813 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.7 p -174.76 171.4 3.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.726 0.298 . . . . 0.0 110.683 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.03 171.75 38.69 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.634 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.09 120.51 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.832 0.349 . . . . 0.0 111.116 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.768 HD23 ' HB2' ' A' ' 35' ' ' ASN . 5.5 tp -94.37 159.42 15.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.45 ' CB ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -115.44 167.25 10.33 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' A' ' 63' ' ' ASP . 9.9 Cg_endo -53.28 109.47 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.68 2.253 . . . . 0.0 112.411 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? 62.47 46.85 5.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.181 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.42 153.74 25.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.696 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 17.6 mtpt -121.12 142.6 49.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.403 HG13 HD11 ' A' ' 62' ' ' LEU . 35.4 m -143.45 149.67 18.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.009 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 69' ' ' LEU . 10.8 tp -96.67 153.51 17.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.988 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.55 ' HE2' HD11 ' A' ' 33' ' ' ILE . 3.8 ttm -134.16 148.28 50.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 56' ' ' ASP . . . -111.0 129.8 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.8 97.78 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.155 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.68 125.42 29.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.0 t -108.73 147.8 31.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -101.1 142.17 32.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.837 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.4 p -55.74 148.91 15.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.004 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 79' ' ' ALA . 35.3 p90 -161.79 -164.67 1.13 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.838 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.421 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 3.6 m-80 -125.9 113.15 16.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . . . -97.38 21.5 10.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.278 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -108.01 -23.52 11.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.2 p -138.51 40.4 2.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.377 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -151.51 145.15 24.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -61.36 147.14 45.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.48 ' HB3' ' CD2' ' A' ' 124' ' ' TYR . 11.0 mt -130.51 63.85 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -160.06 27.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.526 ' O ' HG21 ' A' ' 48' ' ' THR . 24.2 m-80 -129.05 4.91 5.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.685 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.91 111.58 23.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.767 0.318 . . . . 0.0 110.733 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 14.4 ptt-85 -146.13 132.73 19.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.279 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.737 HG12 HG22 ' A' ' 47' ' ' THR . 63.0 mt -94.18 130.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 118' ' ' LYS . 99.5 m -106.3 126.19 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' ILE . 4.0 mp -115.18 116.76 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.9 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' OE2' HG22 ' A' ' 90' ' ' THR . 0.1 OUTLIER -118.31 159.55 23.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.006 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.406 ' NE1' HG23 ' A' ' 9' ' ' ILE . 9.4 p90 -155.96 130.59 9.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.693 ' HB ' HG22 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -128.06 140.82 51.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.096 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -53.77 137.09 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.995 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 60.0 p -80.47 149.92 69.4 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.973 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.18 163.99 2.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.553 2.169 . . . . 0.0 112.08 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -50.67 108.24 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.937 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.96 47.74 59.17 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.435 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.69 173.1 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.368 . . . . 0.0 111.16 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.5 164.66 26.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.1 70.08 8.39 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.604 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 178.8 136.81 0.09 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -53.97 149.09 9.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -138.73 148.16 43.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -18.95 62.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.34 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.13 -6.79 45.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.831 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.477 ' O ' ' CD1' ' A' ' 109' ' ' PHE . 48.7 m0 -87.55 13.25 10.56 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.494 0.187 . . . . 0.0 111.448 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 115' ' ' VAL . 49.3 m-85 -154.19 30.9 0.44 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.872 0.367 . . . . 0.0 110.613 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -110.99 -26.47 9.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.071 -179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 110' ' ' GLN . . . -83.73 171.17 48.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.624 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -96.07 145.71 25.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.758 0.314 . . . . 0.0 110.486 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.98 176.4 48.23 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.191 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.6 ' C ' HG23 ' A' ' 115' ' ' VAL . 12.5 mmt 59.22 166.69 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.073 0.463 . . . . 0.0 110.861 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 94' ' ' THR . 3.4 t 82.92 116.45 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.139 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.401 ' HG2' ' HG2' ' A' ' 6' ' ' PRO . 27.0 mmt-85 -92.23 146.32 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.5 134.03 54.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.133 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.629 ' O ' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -127.53 161.18 29.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.624 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -131.08 154.32 48.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.49 95.1 5.48 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.756 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 58.5 Cg_exo -52.13 150.99 17.74 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.692 2.262 . . . . 0.0 112.678 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.0 mm -108.63 149.51 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HB3' HG13 ' A' ' 18' ' ' VAL . 1.7 tt0 -131.45 164.43 25.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.002 0.43 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -130.28 114.35 15.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.242 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.457 ' HB2' ' CG1' ' A' ' 18' ' ' VAL . 25.4 t30 -103.16 80.72 1.87 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.718 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.412 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . 43.9 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.815 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.842 0.353 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -99.91 88.6 3.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.21 176.17 10.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.47 157.87 81.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.211 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.38 153.28 7.48 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.625 2.217 . . . . 0.0 112.408 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.01 159.54 52.13 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.654 2.236 . . . . 0.0 112.321 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.11 -146.83 5.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.614 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.605 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 1.0 OUTLIER -125.1 137.56 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.826 0.346 . . . . 0.0 110.867 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.421 HG23 ' NE1' ' B' ' 93' ' ' TRP . 1.1 pt -113.18 149.73 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.216 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.22 153.34 20.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.712 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -144.82 152.32 40.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.031 0.443 . . . . 0.0 111.345 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -137.51 116.43 10.04 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.467 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.05 154.22 76.95 Favored 'Cis proline' 0 C--N 1.352 0.713 0 C-N-CA 124.016 -1.244 . . . . 0.0 112.58 0.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 2.9 t -93.89 9.15 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.737 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.401 ' O ' ' HD2' ' B' ' 121' ' ' PRO . 0.6 OUTLIER -127.36 -59.46 1.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.802 0.334 . . . . 0.0 111.168 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' B' ' 121' ' ' PRO . 12.7 pttm -169.55 173.4 6.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.011 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.8 tt -121.66 155.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' B' ' 125' ' ' ASN . 45.1 t -118.23 84.84 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.707 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.476 ' CG ' ' CZ ' ' B' ' 29' ' ' TYR . 5.2 m-30 -49.51 102.83 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.602 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -73.37 135.5 44.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.446 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.856 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -53.91 170.44 0.3 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.787 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.856 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 97.0 Cg_endo -78.45 168.61 74.95 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.723 0.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' B' ' 124' ' ' TYR . 18.2 m-85 -113.11 29.85 7.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.956 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.91 6.72 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.132 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -141.09 157.82 44.77 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.829 0.347 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -76.25 114.02 14.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.092 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -115.86 149.63 38.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -114.87 126.76 55.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 111.246 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.476 ' CZ ' ' CG ' ' B' ' 19' ' ' PHE . 43.4 m-85 -106.92 128.68 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.476 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -91.07 114.96 27.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.481 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 39.1 mm -103.84 142.91 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.545 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -100.58 140.91 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.616 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.551 HD11 ' HE2' ' B' ' 70' ' ' MET . 61.6 mt -134.5 152.96 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.52 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.408 ' N ' HG22 ' B' ' 33' ' ' ILE . 49.5 m -152.61 158.96 43.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 111.413 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.764 ' HB2' HD23 ' B' ' 62' ' ' LEU . 52.3 t30 -112.94 107.39 15.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.313 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -79.0 -4.1 48.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.676 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.82 -173.1 49.54 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.453 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.4 22.43 10.23 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.436 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -145.03 -179.53 6.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.87 0.366 . . . . 0.0 110.829 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.04 155.9 24.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.428 HD13 ' OD1' ' B' ' 35' ' ' ASN . 21.2 pt -148.88 170.82 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -126.41 107.88 0.96 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.727 ' CZ3' HD11 ' B' ' 45' ' ' ILE . 30.8 p-90 -104.7 157.67 17.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.274 0.559 . . . . 0.0 112.093 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.16 157.5 41.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.231 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.739 ' HB ' HG11 ' B' ' 55' ' ' VAL . 2.7 mp -121.67 142.81 36.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.012 0.434 . . . . 0.0 111.924 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -144.51 125.86 14.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.582 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.751 HG22 HG12 ' B' ' 89' ' ' ILE . 56.2 p -101.97 158.6 16.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.23 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.533 HG21 ' O ' ' B' ' 86' ' ' ASN . 0.1 OUTLIER -46.46 -33.79 4.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.067 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -137.81 123.78 20.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.824 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.24 8.33 16.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.487 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.82 -47.39 5.07 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.752 0.311 . . . . 0.0 110.867 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 mtt-85 -82.18 -53.69 5.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . 0.719 HD12 ' HB ' ' B' ' 47' ' ' THR . 15.2 mt -91.05 155.59 18.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.778 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.7 152.26 29.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.027 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.739 HG11 ' HB ' ' B' ' 45' ' ' ILE . 0.0 OUTLIER -119.15 153.58 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.02 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . 0.666 ' O ' ' HB3' ' B' ' 71' ' ' ALA . 0.5 OUTLIER -172.75 110.35 0.35 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.38 140.69 60.86 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 123.711 -1.37 . . . . 0.0 112.29 0.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.18 -6.16 16.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.595 2.197 . . . . 0.0 112.846 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 3.8 p -174.75 171.42 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.716 0.293 . . . . 0.0 110.66 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.01 171.83 38.75 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.556 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.18 120.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.764 HD23 ' HB2' ' B' ' 35' ' ' ASN . 5.5 tp -94.2 159.43 15.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.448 ' CB ' ' HD2' ' B' ' 64' ' ' PRO . 1.2 m-20 -115.48 167.31 10.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' B' ' 63' ' ' ASP . 9.8 Cg_endo -53.36 109.46 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.643 2.228 . . . . 0.0 112.434 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? 62.62 46.74 5.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.088 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.35 153.62 25.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -121.01 142.47 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.42 149.61 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.04 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 10.9 tp -96.65 153.41 17.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.551 ' HE2' HD11 ' B' ' 33' ' ' ILE . 3.8 ttm -134.03 148.38 51.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.938 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' B' ' 56' ' ' ASP . . . -111.08 129.8 55.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.038 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 39.3 t -116.83 97.94 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.2 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 125.35 29.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.826 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 38.6 t -108.56 147.66 31.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.977 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -101.09 142.23 32.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 5.6 p -55.85 148.75 16.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.039 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' B' ' 79' ' ' ALA . 35.2 p90 -161.53 -164.64 1.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.827 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . 0.427 ' N ' ' CD2' ' B' ' 77' ' ' PHE . 3.6 m-80 -125.96 113.05 16.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' B' ' 77' ' ' PHE . . . -97.28 21.56 9.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.399 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.85 -23.57 12.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.29 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 58.3 p -138.58 40.54 2.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.311 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -151.74 145.13 24.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.858 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -61.35 147.28 45.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.477 ' HB3' ' CD2' ' B' ' 124' ' ' TYR . 11.4 mt -130.5 63.58 1.57 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -159.93 27.47 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.002 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.533 ' O ' HG21 ' B' ' 48' ' ' THR . 24.2 m-80 -129.33 4.92 5.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.765 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.93 111.57 23.93 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.781 0.324 . . . . 0.0 110.645 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -146.04 132.73 19.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.27 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.751 HG12 HG22 ' B' ' 47' ' ' THR . 62.5 mt -94.23 130.56 42.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.633 HG23 ' O ' ' B' ' 118' ' ' LYS . 99.5 m -106.31 125.86 51.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.548 ' N ' HD12 ' B' ' 91' ' ' ILE . 4.0 mp -114.86 116.92 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.918 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.476 ' OE2' HG22 ' B' ' 90' ' ' THR . 0.1 OUTLIER -118.54 159.5 23.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.421 ' NE1' HG23 ' B' ' 9' ' ' ILE . 9.2 p90 -155.96 130.68 9.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.92 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.674 ' HB ' HG22 ' B' ' 115' ' ' VAL . 0.7 OUTLIER -128.15 140.85 51.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.031 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -53.83 137.37 38.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 59.1 p -80.69 149.92 68.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.14 164.24 1.87 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.539 2.159 . . . . 0.0 112.074 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -51.01 108.31 0.23 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 52.98 47.62 59.49 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.462 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.51 172.98 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.927 0.394 . . . . 0.0 111.192 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.53 164.69 26.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.275 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -89.11 69.76 8.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.683 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.17 137.12 0.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.835 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -54.12 148.97 10.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -138.61 148.15 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.301 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -72.2 -6.54 43.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.798 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.473 ' O ' ' CD1' ' B' ' 109' ' ' PHE . 48.8 m0 -87.75 13.38 10.7 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.527 0.203 . . . . 0.0 111.467 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.585 ' CE2' HG11 ' B' ' 115' ' ' VAL . 49.3 m-85 -154.33 31.06 0.43 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.853 0.359 . . . . 0.0 110.589 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . 0.415 ' HG3' ' N ' ' B' ' 111' ' ' GLY . 0.0 OUTLIER -111.32 -26.23 9.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.055 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . 0.415 ' N ' ' HG3' ' B' ' 110' ' ' GLN . . . -83.95 171.15 48.43 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.591 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -96.01 145.61 25.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.583 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.93 176.52 48.3 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.149 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.592 ' C ' HG23 ' B' ' 115' ' ' VAL . 12.5 mmt 59.25 166.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.038 0.447 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.674 HG22 ' HB ' ' B' ' 94' ' ' THR . 3.4 t 83.06 116.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.164 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 27.0 mmt-85 -91.94 146.26 23.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.764 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -122.57 134.13 54.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.037 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . 0.633 ' O ' HG23 ' B' ' 90' ' ' THR . 0.2 OUTLIER -127.56 161.01 29.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.671 179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -130.84 154.32 48.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.107 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.48 95.11 5.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.72 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' B' ' 15' ' ' GLN . 59.1 Cg_exo -52.17 151.11 17.66 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.681 2.254 . . . . 0.0 112.639 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 19.9 mm -108.68 149.34 11.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.993 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.424 ' HB3' HG13 ' B' ' 18' ' ' VAL . 1.7 tt0 -131.31 164.41 25.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.022 0.439 . . . . 0.0 111.02 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' B' ' 84' ' ' LEU . 89.4 m-85 -130.23 114.28 15.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.249 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.445 ' HB2' ' CG1' ' B' ' 18' ' ' VAL . 24.6 t30 -103.34 80.91 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.651 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' B' ' 21' ' ' ALA . 43.4 mt . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.856 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -148.18 -60.17 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 1.6 m -162.98 -79.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 3' ' ' SER . 5.2 m 43.96 101.34 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.944 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 64.7 Cg_endo -73.59 128.32 12.54 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.567 2.178 . . . . 0.0 112.258 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 52.5 Cg_exo -55.05 140.6 80.2 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.367 2.045 . . . . 0.0 112.229 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.8 132.36 46.63 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.537 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 26.6 m-20 -51.22 128.76 22.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.454 HD12 HG23 ' A' ' 11' ' ' THR . 1.6 pp -102.35 142.84 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.22 150.02 35.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.823 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.454 HG23 HD12 ' A' ' 9' ' ' ILE . 1.7 p -142.2 150.05 40.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.994 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -146.13 104.51 4.12 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.758 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.534 ' HD2' HD12 ' A' ' 31' ' ' ILE . 31.6 Cg_endo -63.7 159.94 64.69 Favored 'Cis proline' 0 C--N 1.351 0.706 0 C-N-CA 123.798 -1.334 . . . . 0.0 112.465 0.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.37 -18.24 12.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.366 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.81 -46.78 4.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.275 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 13' ' ' PRO . 31.5 pttt -172.73 -179.13 2.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.273 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' A' ' 122' ' ' ILE . 14.2 tt -135.93 138.72 47.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.031 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.512 HG22 ' CB ' ' A' ' 123' ' ' GLU . 61.4 t -121.94 91.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.292 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -59.96 102.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.554 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.88 138.43 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.462 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -60.22 167.71 2.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.716 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.743 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 7.7 Cg_endo -88.05 164.8 43.31 Favored 'Cis proline' 0 C--N 1.35 0.638 0 C-N-CA 124.415 -1.077 . . . . 0.0 112.484 0.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 38.6 m-85 -101.19 47.52 0.91 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.964 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.71 1.78 11.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.485 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.446 ' C ' HG22 ' A' ' 76' ' ' THR . 49.7 p-10 -139.35 152.09 46.88 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.839 0.352 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -63.01 121.19 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.781 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -112.86 99.98 8.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.067 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.4 m -99.76 109.59 22.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.639 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.448 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . 60.4 m-85 -92.09 163.85 13.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.1 0.476 . . . . 0.0 111.222 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -118.09 109.19 16.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.738 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.534 HD12 ' HD2' ' A' ' 13' ' ' PRO . 8.9 mm -91.1 141.9 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.085 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.94 128.63 56.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 34' ' ' THR . 36.3 mt -128.9 153.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.414 ' N ' HG22 ' A' ' 33' ' ' ILE . 58.6 m -148.82 157.71 43.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.985 0.421 . . . . 0.0 111.275 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.635 ' HB2' HD23 ' A' ' 62' ' ' LEU . 11.4 t-20 -104.4 73.84 1.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -57.71 -26.09 61.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.09 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.15 -62.49 5.64 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.57 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.5 21.67 4.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.682 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -149.7 159.3 44.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 110.838 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.44 149.03 17.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.742 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 pt -154.37 167.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.939 0.399 . . . . 0.0 111.426 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.63 100.14 0.48 Allowed Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.87 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 48.8 p-90 -95.57 157.04 16.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 0.0 111.566 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.563 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . . . -153.11 128.94 10.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.8 mm -93.01 142.67 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.009 0.433 . . . . 0.0 111.469 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -145.23 132.84 20.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.572 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.71 155.14 29.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.042 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -65.45 -35.21 80.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.76 112.76 17.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.2 21.63 9.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.136 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.82 -46.3 6.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.918 0.389 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -106.11 -33.07 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 mt -95.96 131.92 41.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.43 167.18 24.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.5 p -151.99 160.53 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.315 0.578 . . . . 0.0 111.004 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 55' ' ' VAL . 23.1 t70 -165.42 125.98 1.31 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.832 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.65 143.54 77.4 Favored 'Cis proline' 0 C--N 1.352 0.75 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.303 -0.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.03 4.89 6.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.591 2.194 . . . . 0.0 113.035 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.7 p -179.71 158.28 0.79 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.09 164.7 30.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.627 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 t -100.08 117.51 45.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.0 111.127 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 35' ' ' ASN . 5.0 tp -90.49 160.8 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.966 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.452 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -109.99 178.62 0.97 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 22.5 Cg_exo -65.35 105.72 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.737 2.291 . . . . 0.0 112.649 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 72.08 22.65 3.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.256 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HG3' ' HB2' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -87.2 150.08 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.807 0.337 . . . . 0.0 110.812 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -116.63 132.29 56.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.14 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.82 143.46 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.905 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.6 tp -112.1 126.04 54.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.428 ' HE2' HG21 ' A' ' 31' ' ' ILE . 25.9 ptt? -122.68 168.13 12.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.56 137.43 53.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.747 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.677 ' O ' HG13 ' A' ' 72' ' ' VAL . 8.8 p -115.41 96.16 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.718 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.08 144.19 57.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 t -138.76 81.93 1.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -51.88 153.48 2.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.07 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.446 HG22 ' C ' ' A' ' 25' ' ' ASP . 2.4 p -65.65 122.53 17.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.41 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 8.8 p90 -130.91 179.32 6.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.84 127.28 56.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.8 18.35 6.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.513 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.93 -29.36 13.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.9 p -136.15 42.72 2.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -143.16 133.37 24.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -52.55 134.24 35.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.981 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.488 HD22 ' CG ' ' A' ' 124' ' ' TYR . 16.8 mt -121.88 21.38 10.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.067 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -144.07 21.78 1.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.891 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -132.32 4.03 3.99 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.694 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -96.75 118.86 34.13 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 110.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.7 133.11 12.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.27 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 90' ' ' THR . 17.7 mt -85.3 164.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.593 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.507 ' N ' HG22 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -143.47 121.39 12.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.89 0.376 . . . . 0.0 111.405 -179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.03 91.87 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.793 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -99.63 122.47 42.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.449 ' CH2' ' HG2' ' A' ' 116' ' ' ARG . 5.6 p90 -133.59 143.7 48.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.3 136.75 33.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -50.1 144.66 6.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.013 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.29 139.42 41.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.71 160.82 47.04 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.491 2.127 . . . . 0.0 112.368 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -48.73 129.33 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.169 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.94 38.06 94.82 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.647 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.99 134.09 45.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.039 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.63 163.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.144 0.497 . . . . 0.0 111.289 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.29 6.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.54 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.01 145.55 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.812 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 44' ' ' ALA . 71.8 t80 -57.43 115.77 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' A' ' 108' ' ' TRP . 0.5 OUTLIER -106.06 153.75 21.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.827 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -87.19 -27.42 23.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.98 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.68 -33.2 72.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.949 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' A' ' 105' ' ' ARG . 54.0 m0 -53.54 -31.85 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.945 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -87.11 -33.17 19.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -103.0 37.23 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.943 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.8 -146.06 5.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.433 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -90.24 154.8 19.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.851 0.357 . . . . 0.0 110.932 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.85 -174.24 16.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.455 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.19 132.66 56.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.891 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.1 t -105.74 125.05 61.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.25 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.449 ' HG2' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -97.05 108.05 20.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.702 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -103.26 115.89 31.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.133 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.03 157.69 16.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.433 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -141.31 126.01 17.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.394 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.6 114.46 47.33 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.15 145.56 79.1 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.45 2.1 . . . . 0.0 112.637 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.495 HD13 ' CG2' ' A' ' 17' ' ' ILE . 40.1 mm -95.03 151.44 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.852 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.512 ' CB ' HG22 ' A' ' 18' ' ' VAL . 0.2 OUTLIER -136.6 156.68 48.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.961 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.488 ' CG ' HD22 ' A' ' 84' ' ' LEU . 6.5 m-85 -127.69 104.93 8.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.019 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.98 78.46 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.664 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.922 -179.956 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.824 0.345 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -148.01 -60.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.412 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 1.5 m -163.12 -79.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.836 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 3' ' ' SER . 5.2 m 43.85 101.42 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.873 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.6 128.26 12.47 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.571 2.181 . . . . 0.0 112.256 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.93 140.39 79.19 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.462 2.108 . . . . 0.0 112.272 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.75 132.36 46.76 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.414 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 27.5 m-20 -51.07 128.96 23.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 0.0 110.842 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.461 HD12 HG23 ' B' ' 11' ' ' THR . 1.6 pp -102.46 142.92 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.199 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.31 150.1 35.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . 0.461 HG23 HD12 ' B' ' 9' ' ' ILE . 1.7 p -142.26 149.98 40.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.027 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -146.07 104.48 4.13 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' B' ' 31' ' ' ILE . 32.2 Cg_endo -63.66 160.24 63.66 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 123.768 -1.347 . . . . 0.0 112.399 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -18.45 12.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.342 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -105.69 -46.55 4.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.77 0.319 . . . . 0.0 111.274 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' B' ' 13' ' ' PRO . 31.3 pttt -172.87 -179.29 2.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.247 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.495 ' CG2' HD13 ' B' ' 122' ' ' ILE . 14.1 tt -135.72 138.82 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.059 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' B' ' 123' ' ' GLU . 62.5 t -122.09 91.47 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.23 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -59.91 102.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.562 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -70.85 138.58 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.468 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -60.4 167.73 2.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.717 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.752 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 7.8 Cg_endo -88.16 164.51 42.98 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.385 -1.09 . . . . 0.0 112.544 0.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . 0.403 ' CD1' ' CE1' ' B' ' 77' ' ' PHE . 39.4 m-85 -100.9 47.64 0.91 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.061 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -119.68 1.67 11.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.44 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . 0.454 ' C ' HG22 ' B' ' 76' ' ' THR . 50.0 p-10 -139.21 152.11 47.09 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.838 0.351 . . . . 0.0 110.97 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -63.01 121.16 12.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.724 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -112.86 100.16 8.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.996 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 91.8 m -99.9 109.85 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.627 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.447 ' HB2' ' CG1' ' B' ' 72' ' ' VAL . 59.9 m-85 -92.29 163.85 13.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.14 0.495 . . . . 0.0 111.133 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -118.12 109.04 15.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.704 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.522 HD12 ' HD2' ' B' ' 13' ' ' PRO . 9.0 mm -91.05 141.95 13.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.111 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.02 128.53 56.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.414 HG22 ' N ' ' B' ' 34' ' ' THR . 36.0 mt -128.86 153.34 38.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.818 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . 0.414 ' N ' HG22 ' B' ' 33' ' ' ILE . 59.5 m -148.77 157.53 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.942 0.401 . . . . 0.0 111.236 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.642 ' HB2' HD23 ' B' ' 62' ' ' LEU . 11.3 t-20 -104.3 73.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.926 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -57.79 -25.93 61.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.4 -62.32 5.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.572 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.58 21.53 4.3 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.651 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 17.7 mtm-85 -149.63 159.32 44.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.799 0.333 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -56.4 148.87 17.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.725 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt -154.22 167.71 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.992 0.425 . . . . 0.0 111.522 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.54 100.11 0.48 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.839 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -95.56 157.07 16.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.014 0.435 . . . . 0.0 111.589 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.566 ' HB2' ' CE1' ' B' ' 104' ' ' PHE . . . -153.23 129.04 10.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.713 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 25.6 mm -93.05 142.6 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.995 0.426 . . . . 0.0 111.472 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -145.23 132.77 20.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.651 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 18.3 p -116.58 155.18 29.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 3.0 p -65.5 -35.27 80.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.916 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.7 112.76 17.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.29 21.77 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.97 -46.29 6.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -106.17 -33.27 7.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -95.71 131.83 41.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.796 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.47 167.05 24.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.504 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.5 p -151.79 160.65 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 111.111 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . 0.504 ' N ' HG22 ' B' ' 55' ' ' VAL . 22.9 t70 -165.46 126.03 1.31 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.895 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.54 143.6 77.73 Favored 'Cis proline' 0 C--N 1.351 0.694 0 C-N-CA 123.831 -1.32 . . . . 0.0 112.252 -0.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.88 4.72 6.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.618 2.212 . . . . 0.0 113.095 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 9.6 p -179.7 158.23 0.79 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.833 0.349 . . . . 0.0 110.967 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 176.14 164.74 30.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.603 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 14.2 t -100.19 117.65 45.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.829 0.347 . . . . 0.0 111.087 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' B' ' 35' ' ' ASN . 5.0 tp -90.53 160.97 15.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -110.14 178.39 1.02 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.804 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 22.3 Cg_exo -65.11 106.03 0.76 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.64 2.227 . . . . 0.0 112.631 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 11.0 tttt 71.81 22.5 3.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.363 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -87.1 150.2 24.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -116.69 132.19 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.68 143.64 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.922 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.3 125.88 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.011 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.403 ' HE2' HG21 ' B' ' 31' ' ' ILE . 25.9 ptt? -122.45 168.32 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.77 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.65 137.48 53.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.721 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.672 HG13 ' O ' ' B' ' 72' ' ' VAL . 8.9 p -115.51 96.23 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.722 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 144.14 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.262 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.9 t -138.76 81.88 1.87 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.732 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.7 153.4 2.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.118 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.454 HG22 ' C ' ' B' ' 25' ' ' ASP . 2.4 p -65.7 122.62 17.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.403 ' CE1' ' CD1' ' B' ' 23' ' ' TYR . 9.2 p90 -130.97 179.22 6.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -112.93 127.32 56.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.827 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.69 18.07 6.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.599 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.76 -29.3 13.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 69.6 p -136.14 42.67 2.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.141 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -143.14 133.41 24.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.797 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -52.6 134.32 35.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.007 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.495 HD22 ' CG ' ' B' ' 124' ' ' TYR . 16.9 mt -121.95 21.29 10.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -143.95 21.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.897 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -132.28 4.1 4.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.733 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.74 118.99 34.39 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.731 0.3 . . . . 0.0 110.618 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -153.72 133.3 12.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.246 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.5 HG22 ' N ' ' B' ' 90' ' ' THR . 18.2 mt -85.43 164.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.524 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.5 ' N ' HG22 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -143.47 121.59 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.09 92.04 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.811 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -99.77 122.56 42.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.049 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.459 ' CH2' ' HG2' ' B' ' 116' ' ' ARG . 5.6 p90 -133.76 143.8 48.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.856 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . . . . . . . . . 6.7 t -140.38 137.18 33.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.785 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -50.29 144.96 6.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.895 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.1 p -83.54 139.5 41.19 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.68 161.01 46.56 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.535 2.157 . . . . 0.0 112.32 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -48.9 129.27 17.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.89 38.16 94.92 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.65 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.09 134.16 45.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.845 0.355 . . . . 0.0 111.09 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.57 163.76 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.127 0.489 . . . . 0.0 111.331 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -90.43 70.43 6.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.634 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.81 145.5 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.813 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' B' ' 44' ' ' ALA . 71.8 t80 -57.44 115.73 2.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.1 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' B' ' 108' ' ' TRP . 0.5 OUTLIER -105.95 153.56 21.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.918 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -87.04 -27.43 23.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -60.69 -33.07 72.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.497 ' CE2' ' HB2' ' B' ' 105' ' ' ARG . 54.0 m0 -53.69 -31.79 49.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.937 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -87.17 -33.29 19.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -102.75 37.08 2.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.918 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.75 -146.18 5.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.59 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -90.22 154.58 19.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.947 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.95 -174.39 16.92 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.97 132.74 56.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.836 0.35 . . . . 0.0 110.808 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.88 125.29 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.167 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.459 ' HG2' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -97.33 107.88 20.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -102.99 115.91 31.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.26 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 157.59 16.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.444 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -141.34 125.9 17.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.955 0.407 . . . . 0.0 111.409 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.53 114.55 47.48 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.4 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.3 145.52 78.1 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.406 2.07 . . . . 0.0 112.645 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.495 HD13 ' CG2' ' B' ' 17' ' ' ILE . 40.7 mm -94.97 151.51 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.887 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.503 ' CB ' HG22 ' B' ' 18' ' ' VAL . 0.2 OUTLIER -136.7 156.59 48.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.023 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' B' ' 84' ' ' LEU . 6.4 m-85 -127.47 105.05 8.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.038 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -86.2 78.57 9.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.64 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.834 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.793 0.33 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.14 156.15 42.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.2 t -87.65 168.78 12.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.59 157.68 39.58 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.057 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.9 146.84 97.01 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.527 2.151 . . . . 0.0 112.188 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.15 142.98 47.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.562 2.175 . . . . 0.0 112.295 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.13 126.13 13.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.444 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.563 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 16.8 m-20 -52.73 121.9 8.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.679 0.276 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.573 HG22 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -94.49 128.98 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.177 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.02 146.62 53.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.741 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.21 138.69 35.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.065 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -136.11 112.1 10.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.723 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.09 154.55 70.02 Favored 'Cis proline' 0 C--N 1.35 0.64 0 C-N-CA 123.992 -1.253 . . . . 0.0 112.401 0.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.45 -38.94 88.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.116 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.04 49.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.087 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -169.16 118.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.26 147.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.584 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.704 HG11 HG11 ' B' ' 18' ' ' VAL . 7.4 p -139.43 99.72 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.813 0.339 . . . . 0.0 111.603 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 19.2 m-30 -51.51 108.18 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.483 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.74 137.15 40.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.412 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.732 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -59.85 167.09 2.9 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.732 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 83.3 Cg_endo -86.68 161.61 52.65 Favored 'Cis proline' 0 C--N 1.348 0.548 0 C-N-CA 124.013 -1.244 . . . . 0.0 112.583 0.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -97.97 29.51 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -107.07 7.06 29.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.533 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -148.68 147.83 29.35 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -56.98 117.99 4.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -114.21 112.16 22.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.9 m -102.7 114.2 28.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.001 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.567 ' CE1' ' CD1' ' A' ' 19' ' ' PHE . 4.9 m-85 -96.01 122.08 38.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.766 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -81.1 132.51 35.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.078 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.65 152.49 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' HB2' ' HG3' ' B' ' 22' ' ' PRO . 0.8 OUTLIER -113.27 127.73 56.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.238 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -131.54 130.3 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.79 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 50.9 m -142.15 156.61 45.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.042 0.449 . . . . 0.0 111.215 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.573 ' HA ' HG22 ' A' ' 9' ' ' ILE . 25.9 t-20 -100.08 113.75 26.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.838 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -92.23 20.23 6.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.344 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.65 -140.39 9.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.583 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.31 29.63 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -155.89 148.39 23.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.574 ' HG2' HG12 ' A' ' 61' ' ' VAL . 5.7 ttp180 -54.67 159.24 2.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 61' ' ' VAL . 12.1 pt -154.2 166.45 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.041 0.448 . . . . 0.0 111.577 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.19 109.21 1.24 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.597 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -104.21 161.67 13.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.226 0.536 . . . . 0.0 111.79 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.36 151.29 26.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.28 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.723 HD12 HG13 ' A' ' 91' ' ' ILE . 20.0 mm -122.14 140.4 46.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 111.739 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.14 131.28 23.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.571 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.507 HG22 HG12 ' A' ' 89' ' ' ILE . 67.1 p -114.03 154.81 27.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.068 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.06 -37.09 73.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -124.89 112.16 16.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.2 -37.53 9.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.759 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.04 -32.38 7.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.027 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.81 141.87 29.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.72 132.48 27.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.027 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -115.09 128.0 72.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -145.71 129.52 8.55 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 58.8 Cg_endo -71.52 133.35 28.03 Favored 'Cis proline' 0 C--N 1.35 0.631 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.153 -0.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 57' ' ' PRO . 51.4 Cg_exo -55.33 -46.81 29.75 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.388 2.059 . . . . 0.0 112.232 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.83 150.3 36.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.728 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.74 -172.03 27.48 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.598 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.574 HG12 ' HG2' ' A' ' 40' ' ' ARG . 6.0 t -123.16 114.49 42.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.842 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.433 HD21 HG23 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -87.86 161.44 17.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.028 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.456 ' CB ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -121.23 178.39 1.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.675 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 63' ' ' ASP . 33.5 Cg_exo -61.55 108.89 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.623 2.215 . . . . 0.0 112.323 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.72 34.45 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.06 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -95.74 151.23 19.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.798 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -106.44 156.81 18.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.908 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 HD21 ' A' ' 62' ' ' LEU . 59.4 t -148.74 147.33 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.202 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 69' ' ' LEU . 2.8 mt -112.55 135.63 53.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.686 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.56 157.74 34.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.974 0.416 . . . . 0.0 111.204 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.3 123.03 26.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.97 85.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.192 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.73 131.62 49.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.939 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.5 t -123.53 87.59 2.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.91 149.42 2.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.001 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 76' ' ' THR . 2.9 p -63.93 135.88 56.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 83' ' ' ASP . 26.4 p90 -145.35 -164.5 1.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -127.15 131.48 50.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.61 19.97 13.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.376 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.68 -37.48 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.287 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 77.6 p -138.65 25.03 2.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.072 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 81' ' ' THR . 28.4 mt-10 -161.13 161.87 31.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 0.6 OUTLIER 59.63 166.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.996 0.427 . . . . 0.0 110.957 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.64 HD23 ' CE1' ' A' ' 124' ' ' TYR . 6.2 mt 84.18 54.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.548 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 86' ' ' ASN . 1.1 p30 -125.4 27.36 6.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.964 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 85' ' ' ASN . 10.7 m-20 82.37 97.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.753 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.7 139.2 53.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.775 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.92 132.89 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.516 HG13 HD11 ' A' ' 122' ' ' ILE . 8.4 mt -83.67 166.03 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.744 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.486 ' N ' HG22 ' A' ' 89' ' ' ILE . 2.5 m -140.63 117.56 11.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 111.057 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.723 HG13 HD12 ' A' ' 45' ' ' ILE . 3.3 mp -108.34 103.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.79 140.45 48.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.789 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.49 ' CH2' ' HB3' ' A' ' 116' ' ' ARG . 9.4 p90 -149.94 141.47 23.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.938 0.399 . . . . 0.0 111.009 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.552 HG21 ' O ' ' A' ' 108' ' ' TRP . 4.0 t -132.43 147.43 52.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.992 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -52.4 137.86 28.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.663 HG22 ' CH2' ' A' ' 108' ' ' TRP . 3.0 p -82.38 143.36 48.02 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 96' ' ' THR . 47.2 Cg_exo -55.87 160.73 9.42 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.495 2.13 . . . . 0.0 112.071 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.8 121.38 5.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.848 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.41 42.56 65.1 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.465 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.09 160.64 17.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.401 . . . . 0.0 111.149 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.85 164.37 26.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.218 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -88.12 70.17 9.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.583 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.23 134.98 0.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.829 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.12 145.04 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.488 ' HB2' ' CG ' ' A' ' 108' ' ' TRP . 3.0 mmt180 -124.8 152.31 44.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -80.7 -44.55 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.046 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.51 -14.07 62.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.526 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.663 ' CH2' HG22 ' A' ' 96' ' ' THR . 5.0 m0 -51.49 -24.57 5.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.798 0.333 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -99.2 -27.36 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.4 23.53 4.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.985 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.68 -70.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.221 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.54 112.88 7.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.951 0.405 . . . . 0.0 110.254 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.836 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -46.37 -73.61 0.29 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.994 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 8.1 mtt -43.89 109.75 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.891 0.377 . . . . 0.0 111.492 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.836 HG23 ' O ' ' A' ' 113' ' ' GLY . 58.5 t -139.06 124.31 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.49 ' HB3' ' CH2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -87.65 141.25 28.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.168 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.41 129.2 39.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.766 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.1 mtpp -126.22 162.83 24.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.963 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.596 ' O ' HD12 ' A' ' 120' ' ' LEU . 53.2 m-80 -143.7 142.82 31.14 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 119' ' ' ASN . 8.6 mp -128.56 95.75 31.9 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.817 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -57.67 135.61 70.47 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.165 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.516 HD11 HG13 ' A' ' 89' ' ' ILE . 17.4 mm -97.24 144.76 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 18' ' ' VAL . 8.9 mt-10 -132.39 163.67 28.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.685 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.64 ' CE1' HD23 ' A' ' 84' ' ' LEU . 1.8 m-85 -126.08 125.7 43.0 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.319 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -114.76 80.93 1.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.841 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.924 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.779 0.323 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.26 155.97 42.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.963 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -87.48 168.63 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 m -92.45 157.74 39.77 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.12 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.97 146.83 97.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.559 2.173 . . . . 0.0 112.261 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.08 142.87 47.63 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.64 2.227 . . . . 0.0 112.35 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.99 125.86 12.94 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.524 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 16.5 m-20 -52.71 121.73 7.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.0 110.934 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.566 HG22 ' HA ' ' B' ' 35' ' ' ASN . 1.1 pt -94.28 129.13 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.248 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -68.2 146.84 53.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.684 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.4 138.91 35.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.038 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -136.22 112.13 10.18 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.699 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.08 154.59 69.98 Favored 'Cis proline' 0 C--N 1.352 0.719 0 C-N-CA 123.99 -1.254 . . . . 0.0 112.43 0.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 4.5 m -66.29 -39.25 89.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.949 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -175.85 49.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.114 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 4.0 tttp -169.29 118.55 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 111.206 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.04 148.18 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.704 HG11 HG11 ' A' ' 18' ' ' VAL . 7.4 p -139.62 99.72 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.831 0.348 . . . . 0.0 111.637 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CD1' ' CE1' ' B' ' 29' ' ' TYR . 19.5 m-30 -51.6 108.1 0.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.465 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.83 137.16 40.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.367 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.727 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -59.69 167.08 2.77 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.859 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.727 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 81.9 Cg_endo -86.7 161.64 52.5 Favored 'Cis proline' 0 C--N 1.349 0.581 0 C-N-CA 123.976 -1.26 . . . . 0.0 112.613 0.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -98.0 29.62 3.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -107.09 6.99 29.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.474 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -148.75 147.83 29.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -57.01 117.76 4.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.97 112.2 22.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -102.75 114.33 28.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' B' ' 19' ' ' PHE . 5.1 m-85 -96.1 121.9 38.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.814 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -80.95 132.44 35.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.061 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 32.2 mm -114.6 152.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.824 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -113.34 127.87 56.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.963 0.411 . . . . 0.0 111.152 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.62 130.37 62.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.794 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 51.1 m -142.13 156.69 45.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.994 0.426 . . . . 0.0 111.19 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . 0.566 ' HA ' HG22 ' B' ' 9' ' ' ILE . 26.1 t-20 -100.22 113.71 26.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.892 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -92.18 20.19 6.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.43 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.61 -140.33 9.44 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.535 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.27 29.45 0.97 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -155.91 148.31 23.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.768 0.318 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . 0.572 ' HG2' HG12 ' B' ' 61' ' ' VAL . 5.6 ttp180 -54.52 159.12 2.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.431 ' O ' HG13 ' B' ' 61' ' ' VAL . 12.3 pt -154.19 166.4 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.079 0.466 . . . . 0.0 111.592 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.14 109.27 1.25 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.566 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -104.26 161.66 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.299 0.571 . . . . 0.0 111.789 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.23 151.43 26.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.352 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.73 HD12 HG13 ' B' ' 91' ' ' ILE . 20.5 mm -122.32 140.53 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 0.0 111.637 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -142.23 131.07 22.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.641 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . 0.527 HG22 HG12 ' B' ' 89' ' ' ILE . 67.8 p -113.92 154.84 26.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.144 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.05 -37.21 73.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -124.85 112.13 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.921 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.58 23.42 10.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.083 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.26 -37.15 9.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.767 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -32.22 7.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mt -96.9 141.58 29.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.49 132.46 27.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.022 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.48 HG11 HG21 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -115.08 127.77 72.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.047 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -145.47 129.54 8.71 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.942 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' B' ' 58' ' ' PRO . 58.7 Cg_endo -71.68 133.46 28.72 Favored 'Cis proline' 0 C--N 1.351 0.676 0 C-N-CA 123.731 -1.362 . . . . 0.0 112.092 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 57' ' ' PRO . 50.7 Cg_exo -55.35 -46.78 29.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.355 2.037 . . . . 0.0 112.286 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 31.3 p -144.84 150.18 36.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.732 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.64 -172.1 27.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.586 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.572 HG12 ' HG2' ' B' ' 40' ' ' ARG . 5.9 t -123.02 114.24 41.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.747 0.308 . . . . 0.0 110.998 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.436 HD21 HG23 ' B' ' 68' ' ' VAL . 0.4 OUTLIER -87.78 161.24 17.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.071 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.446 ' CB ' ' CD ' ' B' ' 64' ' ' PRO . 0.1 OUTLIER -121.01 178.32 1.21 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.797 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' B' ' 63' ' ' ASP . 30.7 Cg_exo -61.5 108.98 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.653 2.235 . . . . 0.0 112.355 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tttt 64.53 34.75 9.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.408 ' HG3' ' HB3' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -95.9 151.04 19.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.831 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 10.9 mttm -106.49 156.71 18.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.436 HG23 HD21 ' B' ' 62' ' ' LEU . 59.1 t -148.71 147.31 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.234 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' B' ' 69' ' ' LEU . 2.9 mt -112.43 135.69 52.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.63 157.73 34.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.039 0.447 . . . . 0.0 111.126 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -132.25 123.08 26.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.893 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.01 85.49 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.261 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.81 131.83 50.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 t -123.75 87.58 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.83 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.89 149.54 2.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 2.9 p -63.93 135.99 56.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . 0.496 ' CD2' ' HB2' ' B' ' 83' ' ' ASP . 26.5 p90 -145.57 -164.58 1.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -127.11 131.31 50.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.95 13.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.384 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -111.63 -37.62 5.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 111.265 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.415 ' O ' ' CG ' ' B' ' 82' ' ' GLU . 77.9 p -138.54 25.1 2.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' B' ' 81' ' ' THR . 28.5 mt-10 -161.03 161.83 31.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . 0.496 ' HB2' ' CD2' ' B' ' 77' ' ' PHE . 0.6 OUTLIER 59.56 166.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.024 0.44 . . . . 0.0 110.95 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.628 HD23 ' CE1' ' B' ' 124' ' ' TYR . 6.2 mt 84.3 54.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.492 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' B' ' 86' ' ' ASN . 1.2 p30 -125.65 27.48 6.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.946 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' B' ' 85' ' ' ASN . 10.9 m-20 82.31 97.15 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -121.76 139.29 53.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -162.88 132.93 4.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.075 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.527 HG12 HG22 ' B' ' 47' ' ' THR . 8.8 mt -83.73 166.23 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.473 ' H ' HG22 ' B' ' 89' ' ' ILE . 2.5 m -140.79 117.38 10.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.962 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . 0.73 HG13 HD12 ' B' ' 45' ' ' ILE . 3.4 mp -108.22 103.67 15.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.038 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.73 140.56 48.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' B' ' 116' ' ' ARG . 9.5 p90 -149.91 141.6 23.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.558 HG21 ' O ' ' B' ' 108' ' ' TRP . 4.0 t -132.63 147.24 52.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . 0.415 ' HA ' HG22 ' B' ' 41' ' ' ILE . 0.7 OUTLIER -52.32 138.03 27.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.67 HG22 ' CH2' ' B' ' 108' ' ' TRP . 3.1 p -82.5 143.37 47.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -55.8 160.72 9.28 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.596 2.197 . . . . 0.0 112.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 121.48 5.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 53.21 42.67 63.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.46 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.12 160.55 18.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.906 0.384 . . . . 0.0 111.134 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.79 164.22 26.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.27 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -87.94 70.15 9.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.634 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.27 134.91 0.43 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.836 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -58.89 144.96 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.499 ' HB2' ' CG ' ' B' ' 108' ' ' TRP . 3.0 mmt180 -124.81 152.15 44.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.796 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -80.57 -44.54 18.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -68.52 -13.96 62.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.613 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.67 ' CH2' HG22 ' B' ' 96' ' ' THR . 4.9 m0 -51.63 -24.44 5.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.78 0.324 . . . . 0.0 110.96 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -99.29 -27.11 13.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -93.66 23.73 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.88 -70.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.245 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.48 112.88 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.843 0.354 . . . . 0.0 110.228 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . 0.84 ' O ' HG23 ' B' ' 115' ' ' VAL . . . -46.45 -73.47 0.3 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.962 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 8.4 mtt -44.14 109.81 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.93 0.395 . . . . 0.0 111.482 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.84 HG23 ' O ' ' B' ' 113' ' ' GLY . 57.6 t -139.1 124.34 21.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.854 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . 0.479 ' HB3' ' CH2' ' B' ' 93' ' ' TRP . 0.0 OUTLIER -87.75 141.21 28.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.107 -179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -132.47 129.08 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.8 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -125.97 162.82 24.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.598 ' O ' HD12 ' B' ' 120' ' ' LEU . 54.0 m-80 -143.77 142.79 31.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.842 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.598 HD12 ' O ' ' B' ' 119' ' ' ASN . 8.7 mp -128.55 95.81 31.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -57.61 135.57 70.34 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.629 2.219 . . . . 0.0 112.146 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.516 HD11 HG13 ' B' ' 89' ' ' ILE . 17.5 mm -97.27 144.5 10.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.277 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.513 ' HB3' HG23 ' B' ' 18' ' ' VAL . 9.2 mt-10 -132.3 163.62 28.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.683 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . 0.628 ' CE1' HD23 ' B' ' 84' ' ' LEU . 1.8 m-85 -125.93 125.92 43.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.286 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -114.93 81.0 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.986 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.743 0.306 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -137.12 133.62 35.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.22 86.17 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.984 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.57 HG23 ' HD2' ' A' ' 5' ' ' PRO . 6.8 p -142.29 140.62 19.42 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.02 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD2' HG23 ' A' ' 4' ' ' VAL . 75.2 Cg_exo -49.6 142.15 24.9 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.461 2.107 . . . . 0.0 112.285 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 51.4 Cg_exo -52.83 156.41 9.34 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.489 2.126 . . . . 0.0 112.331 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.52 122.86 23.86 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.628 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 2.5 m-20 -52.43 115.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.38 138.09 20.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.178 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.85 146.43 26.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.741 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 p -135.65 149.67 49.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.954 0.407 . . . . 0.0 111.153 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.561 ' O ' HG23 ' A' ' 31' ' ' ILE . 38.9 mt-30 -135.4 116.37 11.96 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.51 163.81 63.74 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 123.985 -1.256 . . . . 0.0 112.514 0.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.0 t -44.6 -62.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.383 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.41 ' HA ' HD22 ' A' ' 120' ' ' LEU . 2.2 tt0 -173.16 48.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.949 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 104.89 2.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.052 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' CG2' ' CD1' ' A' ' 122' ' ' ILE . 8.2 tt -131.93 145.31 35.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.987 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 123' ' ' GLU . 6.6 p -150.6 121.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.056 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -72.65 113.9 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.655 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -81.89 134.61 35.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB1' ' HA ' ' A' ' 22' ' ' PRO . . . -65.68 170.72 4.43 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.805 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.841 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . 62.5 Cg_endo -73.19 164.99 85.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 123.766 -1.348 . . . . 0.0 112.675 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -107.27 46.65 0.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.83 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -115.11 -4.77 12.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.406 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -123.08 144.47 49.28 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.877 0.37 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.94 126.78 31.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.85 155.43 41.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.52 116.06 16.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -102.42 116.12 31.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.638 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -92.49 131.7 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.184 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 12' ' ' GLN . 5.3 mm -107.55 143.25 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.525 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 16.3 tttm -104.65 119.91 40.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.933 0.397 . . . . 0.0 111.242 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.4 mt -112.88 153.79 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.748 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.69 155.86 33.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.978 0.418 . . . . 0.0 111.143 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -102.48 109.9 21.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.582 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 8' ' ' ASP . . . -91.15 19.19 6.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.493 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.63 -143.53 12.79 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.457 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.54 20.73 2.22 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.579 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 159.86 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.9 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' C ' ' HG1' ' A' ' 96' ' ' THR . 15.2 mtm180 -55.85 152.36 10.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.728 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.69 116.62 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.38 115.47 5.11 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.841 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.545 ' CD1' HD12 ' A' ' 62' ' ' LEU . 67.4 p-90 -118.06 158.86 24.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.122 0.487 . . . . 0.0 111.566 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.6 152.99 31.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.566 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.432 HD11 ' CZ3' ' A' ' 43' ' ' TRP . 5.9 mm -104.02 154.28 5.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.424 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -155.65 132.64 10.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.678 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.27 160.16 34.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.161 0.505 . . . . 0.0 111.272 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.13 -55.16 36.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.889 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.44 113.16 25.99 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.842 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.59 22.05 5.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -113.23 -58.57 2.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.915 0.388 . . . . 0.0 110.788 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -33.2 63.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.779 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -98.02 145.88 26.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.689 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.92 147.11 36.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.03 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 56' ' ' ASP . 2.3 p -139.98 160.74 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.26 0.552 . . . . 0.0 110.871 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.482 ' N ' HG22 ' A' ' 55' ' ' VAL . 9.8 t70 -172.92 129.04 0.55 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.886 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.06 146.71 86.74 Favored 'Cis proline' 0 C--N 1.351 0.702 0 C-N-CA 123.784 -1.34 . . . . 0.0 112.217 -0.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.95 -0.42 10.65 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.66 2.24 . . . . 0.0 113.151 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.55 177.1 0.36 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.822 0.344 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.468 ' O ' ' CD1' ' A' ' 43' ' ' TRP . . . 154.71 167.37 16.43 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.518 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.64 128.93 48.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 0.0 111.115 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.545 HD12 ' CD1' ' A' ' 43' ' ' TRP . 0.2 OUTLIER -103.86 123.06 46.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.72 171.54 12.17 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -61.74 114.54 2.31 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.618 2.212 . . . . 0.0 112.327 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.49 28.49 3.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.293 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.75 148.27 23.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.768 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 128.38 52.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.117 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.38 138.49 48.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.033 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.58 123.54 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.448 ' CG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -119.24 163.06 17.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.95 154.58 51.06 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.561 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.4 t -134.37 89.92 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.702 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.1 p -74.0 139.44 44.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 4.0 m -131.05 149.38 52.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.659 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.76 148.73 24.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 111.196 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 p -71.49 127.65 33.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.756 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.69 -173.85 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.006 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -129.59 121.46 27.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.484 ' CB ' HD11 ' A' ' 126' ' ' LEU . . . -65.99 -21.01 66.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.35 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.75 -43.39 65.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.38 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.9 p -141.15 67.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.304 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -150.19 171.92 16.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.0 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.65 136.53 45.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 56.0 mt -152.78 86.51 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.46 22.43 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.265 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 0.3 OUTLIER 73.83 93.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.174 179.904 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -71.1 152.54 43.37 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.354 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.418 ' HA ' HG12 ' A' ' 122' ' ' ILE . 2.6 ptm180 -157.8 131.02 7.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.993 0.425 . . . . 0.0 111.706 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 90' ' ' THR . 7.1 mm -85.1 163.47 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.317 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 89' ' ' ILE . 78.2 m -144.2 118.92 9.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.88 0.371 . . . . 0.0 111.493 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.13 97.16 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.76 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -104.38 133.95 48.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.101 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -138.66 154.89 48.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.682 ' HB ' HG13 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -147.31 151.41 36.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.954 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -55.71 150.88 11.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.521 HG22 ' CZ2' ' A' ' 108' ' ' TRP . 0.6 OUTLIER -96.07 142.17 24.19 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.0 156.59 61.73 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.609 2.206 . . . . 0.0 112.279 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -50.16 128.24 18.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.993 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.83 34.46 87.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.39 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.35 127.04 29.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.153 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.88 166.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.249 0.547 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -85.89 70.85 10.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.0 128.77 0.23 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.916 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -52.11 151.31 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.22 155.77 49.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.039 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.46 -34.44 16.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.948 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.99 -24.98 68.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.521 ' CZ2' HG22 ' A' ' 96' ' ' THR . 21.9 m0 -50.05 -34.7 22.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.985 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.667 ' CD2' HG11 ' A' ' 115' ' ' VAL . 4.9 m-85 -94.12 -32.93 13.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.999 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.5 49.25 1.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.93 -132.65 2.05 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.503 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -101.25 151.32 22.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.91 0.386 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.37 138.37 9.34 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.508 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt -72.29 130.38 40.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.682 HG13 ' HB ' ' A' ' 94' ' ' THR . 12.7 t -109.06 125.23 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.234 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.1 142.45 27.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.744 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.93 97.77 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.04 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -87.27 159.34 18.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.76 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.6 120.25 11.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.885 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 15' ' ' GLN . 4.7 mt -94.73 135.18 24.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.76 130.42 5.07 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.664 2.243 . . . . 0.0 112.627 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.474 ' CD1' ' CG2' ' A' ' 17' ' ' ILE . 3.4 mm -114.04 119.54 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 18' ' ' VAL . 45.7 mt-10 -117.82 157.53 26.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.533 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.37 109.06 18.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.959 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -83.13 81.56 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.484 HD11 ' CB ' ' A' ' 79' ' ' ALA . 67.5 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.852 0.358 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -137.03 133.73 35.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.14 85.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.048 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.575 HG23 ' HD2' ' B' ' 5' ' ' PRO . 6.6 p -142.17 140.69 19.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' PRO . . . . . 0.575 ' HD2' HG23 ' B' ' 4' ' ' VAL . 73.4 Cg_exo -49.47 142.06 24.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.537 2.158 . . . . 0.0 112.257 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 5' ' ' PRO . 51.8 Cg_exo -52.83 156.51 9.19 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.532 2.155 . . . . 0.0 112.281 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.63 122.88 23.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.536 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . 0.621 ' O ' ' HB3' ' B' ' 36' ' ' ALA . 2.5 m-20 -52.44 115.08 1.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.84 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.32 137.99 21.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.182 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.78 146.47 26.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.753 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 149.55 49.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.994 0.426 . . . . 0.0 111.173 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.572 ' O ' HG23 ' B' ' 31' ' ' ILE . 38.8 mt-30 -135.4 116.45 11.99 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.549 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.38 163.65 63.67 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.967 -1.264 . . . . 0.0 112.533 0.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' SER . . . . . . . . . . . . . 30.5 t -44.48 -62.42 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.462 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.41 ' HA ' HD22 ' B' ' 120' ' ' LEU . 2.2 tt0 -173.26 48.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.996 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.05 104.82 2.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.479 ' CG2' ' CD1' ' B' ' 122' ' ' ILE . 8.3 tt -131.96 145.51 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.762 HG23 ' O ' ' B' ' 123' ' ' GLU . 6.8 p -150.88 121.03 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -72.49 113.62 9.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.704 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -81.58 134.41 35.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.186 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.868 ' HB1' ' HA ' ' B' ' 22' ' ' PRO . . . -65.59 170.85 4.14 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PRO . . . . . 0.868 ' HA ' ' HB1' ' B' ' 21' ' ' ALA . 64.8 Cg_endo -73.12 164.92 85.66 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 123.866 -1.306 . . . . 0.0 112.723 0.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -107.24 46.67 0.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.889 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -115.15 -4.6 12.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.395 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -123.27 144.44 49.41 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.913 0.387 . . . . 0.0 110.888 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.9 126.68 31.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.992 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.84 155.37 41.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.44 115.96 16.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.039 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -102.36 116.23 32.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.659 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -92.74 131.5 37.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.254 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.572 HG23 ' O ' ' B' ' 12' ' ' GLN . 5.2 mm -107.31 143.22 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.616 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -104.59 120.09 40.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.967 0.413 . . . . 0.0 111.267 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 mt -113.09 153.73 14.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.78 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 54.0 m -155.72 155.98 34.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.988 0.423 . . . . 0.0 111.17 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -102.64 109.89 21.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.558 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' B' ' 8' ' ' ASP . . . -91.24 19.37 5.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.48 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.74 -143.64 12.84 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.432 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.44 20.81 2.23 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.52 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.74 160.08 37.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.855 0.359 . . . . 0.0 110.808 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -56.04 152.65 10.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.61 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 pt -148.93 116.88 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.445 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.67 115.5 5.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.878 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.552 ' CD1' HD12 ' B' ' 62' ' ' LEU . 67.5 p-90 -118.18 158.75 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.101 0.477 . . . . 0.0 111.495 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -153.43 153.2 32.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.527 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.436 HD11 ' CZ3' ' B' ' 43' ' ' TRP . 5.9 mm -104.2 154.26 6.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.431 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -155.61 132.73 10.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.677 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.3 160.35 34.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.139 0.495 . . . . 0.0 111.251 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 2.9 p -56.39 -54.88 40.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.933 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -108.7 113.23 26.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.771 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.56 21.97 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -113.2 -58.73 2.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.702 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.93 -33.16 63.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -98.16 145.74 26.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.719 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.77 146.96 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.083 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.479 HG22 ' N ' ' B' ' 56' ' ' ASP . 2.3 p -139.74 160.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.295 0.569 . . . . 0.0 110.922 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . 0.479 ' N ' HG22 ' B' ' 55' ' ' VAL . 9.8 t70 -172.69 128.98 0.57 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.793 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.07 146.72 86.8 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 123.795 -1.335 . . . . 0.0 112.293 -0.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.03 -0.46 10.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.678 2.252 . . . . 0.0 113.084 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' CYS . . . . . . . . . . . . . 4.2 p 177.64 177.07 0.37 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.782 0.325 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' B' ' 43' ' ' TRP . . . 154.8 167.21 16.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.65 129.02 48.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.803 0.335 . . . . 0.0 111.086 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.552 HD12 ' CD1' ' B' ' 43' ' ' TRP . 0.2 OUTLIER -103.99 123.19 46.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.951 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.74 171.47 12.34 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.81 114.45 2.29 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.591 2.194 . . . . 0.0 112.346 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 70.61 28.31 3.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.228 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 148.37 22.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.766 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.05 128.45 52.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.08 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 m -118.48 138.49 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -95.51 123.51 39.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.01 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' MET . . . . . 0.449 ' CG ' ' HB ' ' B' ' 31' ' ' ILE . 0.0 OUTLIER -119.22 163.08 17.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.962 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.92 154.72 51.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.435 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 74.9 t -134.58 89.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.589 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . . . . . . . . . 20.5 p -74.06 139.38 44.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.343 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 m -130.99 149.35 52.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.588 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.59 148.86 24.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.895 0.378 . . . . 0.0 111.252 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 1.5 p -71.52 127.72 33.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -143.78 -173.85 4.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.957 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -129.52 121.54 27.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ALA . . . . . 0.48 ' CB ' HD11 ' B' ' 126' ' ' LEU . . . -66.21 -20.8 66.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.306 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.9 -43.45 66.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.358 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . . . . . . . . . 72.6 p -140.97 67.57 1.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.274 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -150.28 171.82 16.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.059 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.56 136.35 45.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.953 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 55.7 mt -152.59 86.48 1.27 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.5 22.43 12.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.238 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' B' ' 86' ' ' ASN . 0.3 OUTLIER 73.74 93.17 0.08 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.16 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -71.37 152.27 43.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.349 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.426 ' HA ' HG12 ' B' ' 122' ' ' ILE . 2.6 ptm180 -157.44 131.01 7.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.007 0.432 . . . . 0.0 111.703 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.515 HG22 ' N ' ' B' ' 90' ' ' THR . 7.1 mm -85.1 163.36 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.24 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.515 ' N ' HG22 ' B' ' 89' ' ' ILE . 81.9 m -144.08 118.88 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.918 0.389 . . . . 0.0 111.492 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.06 97.36 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.718 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -104.5 133.91 48.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.02 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -138.68 154.91 48.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' THR . . . . . 0.673 ' HB ' HG13 ' B' ' 115' ' ' VAL . 1.0 OUTLIER -147.12 151.32 36.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -55.63 150.85 11.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.009 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.521 HG22 ' CZ2' ' B' ' 108' ' ' TRP . 0.6 OUTLIER -96.04 142.19 24.22 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.808 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 156.48 62.35 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.206 . . . . 0.0 112.311 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -50.09 128.25 18.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.74 34.54 87.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.371 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.42 126.99 29.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.818 0.342 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.66 166.72 1.74 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.381 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -86.0 70.88 10.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.649 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -176.02 128.81 0.23 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -52.11 151.25 3.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.15 155.7 49.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.056 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 -89.39 -34.35 16.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.03 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -63.02 -25.04 68.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.97 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' TRP . . . . . 0.521 ' CZ2' HG22 ' B' ' 96' ' ' THR . 22.3 m0 -49.93 -34.65 21.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.043 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' B' ' 115' ' ' VAL . 4.7 m-85 -94.11 -33.09 13.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.985 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.41 49.25 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -149.88 -132.76 2.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.41 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -100.97 151.64 21.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.93 138.45 9.49 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.569 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 26.7 mtt -72.49 130.3 40.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.673 HG13 ' HB ' ' B' ' 94' ' ' THR . 12.4 t -108.78 125.32 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.254 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -89.24 142.51 27.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 ptp85 -136.99 97.61 3.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.074 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' LYS . . . . . . . . . . . . . 12.5 mtmt -87.08 159.26 18.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.837 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.48 120.29 11.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' B' ' 15' ' ' GLN . 4.6 mt -94.77 135.21 23.99 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.772 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -83.81 130.45 5.04 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.665 2.243 . . . . 0.0 112.814 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' B' ' 17' ' ' ILE . 3.4 mm -114.08 119.39 61.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.623 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.762 ' O ' HG23 ' B' ' 18' ' ' VAL . 45.1 mt-10 -117.72 157.49 26.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 111.48 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -112.36 109.13 18.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.983 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -83.28 81.62 8.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.48 HD11 ' CB ' ' B' ' 79' ' ' ALA . 67.9 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.301 -0.857 . . . . 0.0 110.847 179.998 . . . . . . . . 1 1 . 1 stop_ save_